PT J
AU Awuah, WA
   Tan, JK
   Shkodina, AD
   Ferreira, T
   Adebusoye, FT
   Mazzoleni, A
   Wellington, J
   David, L
   Chilcott, E
   Huang, HL
   Abdul-Rahman, T
   Shet, V
   Atallah, O
   Kalmanovich, J
   Jiffry, R
   Madhu, DE
   Sikora, K
   Kmyta, O
   Delva, MY
AF Awuah, Wireko Andrew
   Tan, Joecelyn Kirani
   Shkodina, Anastasiia D.
   Ferreira, Tomas
   Adebusoye, Favour Tope
   Mazzoleni, Adele
   Wellington, Jack
   David, Lian
   Chilcott, Ellie
   Huang, Helen
   Abdul-Rahman, Toufik
   Shet, Vallabh
   Atallah, Oday
   Kalmanovich, Jacob
   Jiffry, Riaz
   Madhu, Divine Elizabeth
   Sikora, Kateryna
   Kmyta, Oleksii
   Delva, Mykhailo Yu
TI Hereditary spastic paraplegia: Novel insights into the pathogenesis and management
SO SAGE OPEN MEDICINE
LA English
DT Review
DE Hereditary spastic hyperplasia; genetics; neurodegeneration; metabolism
ID m-aaa protease; axonal-transport; mutations; autophagy; reveals; complex; gene; er; spatacsin; lysosome
AB Hereditary spastic paraplegia is a genetically heterogeneous neurodegenerative disorder characterised primarily by muscle stiffness in the lower limbs. Neurodegenerative disorders are conditions that result from cellular and metabolic abnormalities, many of which have strong genetic ties. While ageing is a known contributor to these changes, certain neurodegenerative disorders can manifest early in life, progressively affecting a person's quality of life. Hereditary spastic paraplegia is one such condition that can appear in individuals of any age. In hereditary spastic paraplegia, a distinctive feature is the degeneration of long nerve fibres in the corticospinal tract of the lower limbs. This degeneration is linked to various cellular and metabolic processes, including mitochondrial dysfunction, remodelling of the endoplasmic reticulum membrane, autophagy, abnormal myelination processes and alterations in lipid metabolism. Additionally, hereditary spastic paraplegia affects processes like endosome membrane trafficking, oxidative stress and mitochondrial DNA polymorphisms. Disease-causing genetic loci and associated genes influence the progression and severity of hereditary spastic paraplegia, potentially affecting various cellular and metabolic functions. Although hereditary spastic paraplegia does not reduce a person's lifespan, it significantly impairs their quality of life as they age, particularly with more severe symptoms. Regrettably, there are currently no treatments available to halt or reverse the pathological progression of hereditary spastic paraplegia. This review aims to explore the metabolic mechanisms underlying the pathophysiology of hereditary spastic paraplegia, emphasising the interactions of various genes identified in recent network studies. By comprehending these associations, targeted molecular therapies that address these biochemical processes can be developed to enhance treatment strategies for hereditary spastic paraplegia and guide clinical practice effectively.
C1 [Awuah, Wireko Andrew; Adebusoye, Favour Tope; Abdul-Rahman, Toufik; Sikora, Kateryna; Kmyta, Oleksii] Sumy State Univ, Sumy, Ukraine.
   [Tan, Joecelyn Kirani] Univ St Andrews, Fac Med, St Andrews, Scotland.
   [Shkodina, Anastasiia D.; Delva, Mykhailo Yu] Poltava State Med Univ, Dept Neurol Dis, Poltava, Ukraine.
   [Ferreira, Tomas] Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge, England.
   [Mazzoleni, Adele] Barts & London Queen Marys Sch Med & Dent, London, England.
   [Wellington, Jack; Chilcott, Ellie; Madhu, Divine Elizabeth] Cardiff Univ, Sch Med, Cardiff, Wales.
   [David, Lian] Univ East Anglia, Norwich Med Sch, Norwich, England.
   [Huang, Helen; Jiffry, Riaz] Univ Med & Hlth Sci, Royal Coll Surg Ireland, Dublin, Ireland.
   [Shet, Vallabh] Bangalore Med Coll & Res Inst, Fac Med, Bengaluru, Karnataka, India.
   [Atallah, Oday] Hannover Med Sch, Dept Neurosurg, Hannover, Germany.
   [Kalmanovich, Jacob] Drexel Univ, Coll Med, Philadelphia, PA USA.
   [Awuah, Wireko Andrew] Sumy State Univ, 2,Rymskogo Korsakova St, UA-40007 Sumy, Ukraine.
C3 Ministry of Education & Science of Ukraine; Sumy State University; University of St Andrews; Poltava State Medical University; University of Cambridge; University of London; Queen Mary University London; Cardiff University; University of East Anglia; Royal College of Surgeons - Ireland; Bangalore Medical College & Research Institute (BMCRI); Hannover Medical School; Drexel University; Ministry of Education & Science of Ukraine; Sumy State University
RP Awuah, WA (corresponding author), Sumy State Univ, 2,Rymskogo Korsakova St, UA-40007 Sumy, Ukraine.
EM andyvans36@yahoo.com
CR Agarwal AK, 2004, TRENDS MOL MED, V10, P440, DOI 10.1016/j.molmed.2004.07.009
   Aly KA, 2022, CURR OPIN CHEM BIOL, V71, P0, DOI 10.1016/j.cbpa.2022.102211
   [Anonymous], 2023, KIF1A GENE-GENECARDS | KIF1A PROTEIN | KIF1A ANTIBODY, V0, P0
   [Anonymous], 2023, SACS GENE-GENECARDS | SACS PROTEIN | SACS ANTIBODY, V0, P0
   Antczak J, 2019, NEURAL PLAST, V2019, P0, DOI 10.1155/2019/7638675
   Ardolino G, 2021, J SPINAL CORD MED, V44, P46, DOI 10.1080/10790268.2018.1543926
   Arribat Y, 2020, PLOS GENET, V16, P0, DOI 10.1371/journal.pgen.1008665
   Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81
   Atorino L, 2003, J CELL BIOL, V163, P777, DOI 10.1083/jcb.200304112
   Bagshaw RD, 2005, MOL CELL PROTEOMICS, V4, P133, DOI 10.1074/mcp.M400128-MCP200
   Bastani PB, 2023, J CLIN NEUROPHYSIOL, V40, P173, DOI 10.1097/WNP.0000000000000874
   Bellofatto M, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00003
   Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400
   Chang J, 2014, J CLIN INVEST, V124, P5249, DOI 10.1172/JCI77598
   Chapel A, 2013, MOL CELL PROTEOMICS, V12, P1572, DOI 10.1074/mcp.M112.021980
   Chen DD, 2010, SCIENCE, V327, P1261, DOI 10.1126/science.1184840
   Costamagna D, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11213351
   Coutelier M, 2015, BRAIN, V138, P2191, DOI 10.1093/brain/awv143
   De la Casa-Fages B, 2019, MOVEMENT DISORD, V34, P1547, DOI 10.1002/mds.27812
   de Lima FD, 2021, MOVEMENT DISORD, V36, P1654, DOI 10.1002/mds.28523
   Denton Kyle R, 2016, FRONT BIOL (BEIJING), V11, P339
   Dor T, 2014, J MED GENET, V51, P137, DOI 10.1136/jmedgenet-2013-102012
   Durand CM, 2022, BMC NEUROL, V22, P0, DOI 10.1186/s12883-022-02553-0
   Ebrahimi-Fakhari D, 2018, GENEREVIEWS, V0, P0
   Edwards TL, 2009, BIOCHEM J, V423, P31, DOI 10.1042/BJ20082398
   Estrada-Cuzcano A, 2017, BRAIN, V140, P287, DOI 10.1093/brain/aww307
   Faber I, 2018, MOVEMENT DISORD, V33, P1650, DOI 10.1002/mds.27491
   Faber I, 2018, NEUROIMAGE-CLIN, V19, P848, DOI 10.1016/j.nicl.2018.05.031
   Fichman Y, 2015, BIOL REV, V90, P1065, DOI 10.1111/brv.12146
   Fowler Philippa C, 2016, J RARE DIS RES TREAT, V1, P17
   Frasquet M, 2021, EUR J NEUROL, V28, P1334, DOI 10.1111/ene.14700
   Freeman C, 2013, BBA-MOL BASIS DIS, V1832, P160, DOI 10.1016/j.bbadis.2012.10.011
   FÃ¼ger P, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1003066
   Genecards, 2023, MARS1 GENE-GENECARDS | SYMC PROTEIN | SYMC ANTIBODY, V0, P0
   Gonzalez M, 2013, J NEUROL NEUROSUR PS, V84, P1247, DOI 10.1136/jnnp-2013-305049
   Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935
   Hashimoto Y, 2014, J BIOL CHEM, V289, P12946, DOI 10.1074/jbc.M113.528687
   Hauser S, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.544043
   Hauser S, 2019, MOL THER-METH CLIN D, V15, P359, DOI 10.1016/j.omtm.2019.10.011
   Hedera P, 2021, HEREDITARY SPASTIC P, V0, P0
   Hirst J, 2016, NEUROL-GENET, V2, P0, DOI 10.1212/NXG.0000000000000098
   Hsiao CT, 2016, PLOS ONE, V11, P0
   Ishihara S, 2020, J PERIPHER NERV SYST, V25, P125, DOI 10.1111/jns.12369
   Ito D, 2007, ANN NEUROL, V61, P237, DOI 10.1002/ana.21070
   Kara E, 2016, BRAIN, V139, P1904, DOI 10.1093/brain/aww111
   Klebe S, 2012, EUR J HUM GENET, V20, P645, DOI 10.1038/ejhg.2011.261
   Koh K, 2020, MOL GENET GENOM MED, V8, P0, DOI 10.1002/mgg3.1108
   Lai LL, 2020, ANN CLIN TRANSL NEUR, V7, P1862, DOI 10.1002/acn3.51169
   LaPointe NE, 2013, NEUROTOXICOLOGY, V37, P231, DOI 10.1016/j.neuro.2013.05.008
   Lavie J, 2017, HUM MOL GENET, V26, P674, DOI 10.1093/hmg/ddw425
   Lee YK, 2016, BMB REP, V49, P424, DOI 10.5483/BMBRep.2016.49.8.081
   Leo L, 2017, HUM MOL GENET, V26, P2321, DOI 10.1093/hmg/ddx125
   Lim YS, 2015, ANN NEUROL, V78, P679, DOI 10.1002/ana.24488
   Lo Giudice T, 2014, EXP NEUROL, V261, P518, DOI 10.1016/j.expneurol.2014.06.011
   Ma XR, 2020, FRONT NEUROL, V11, P0, DOI 10.3389/fneur.2020.00499
   Mackay-Sim A, 2021, BRAIN SCI, V11, P0, DOI 10.3390/brainsci11030403
   Maejima I, 2013, EMBO J, V32, P2336, DOI 10.1038/emboj.2013.171
   Manganelli V, 2021, AUTOPHAGY, V17, P2528, DOI 10.1080/15548627.2020.1834207
   Marelli C, 2018, BRAIN, V141, P72, DOI 10.1093/brain/awx297
   Martinelli P, 2009, HUM MOL GENET, V18, P2001, DOI 10.1093/hmg/ddp124
   Matsuzaki F, 2011, MOL BIOL CELL, V22, P4602, DOI 10.1091/mbc.E11-01-0068
   Mattera R, 2017, PROC NAT ACAD SCI U S A, V114, P0
   Mehta PR, 2019, J NEUROL NEUROSUR PS, V90, P268, DOI 10.1136/jnnp-2018-319089
   Merkwirth C, 2008, CELL, V135, P1165, DOI 10.1016/j.cell.2008.12.005
   Miyake Y, 2012, BMC NEUROL, V12, P0, DOI 10.1186/1471-2377-12-62
   Montecchiani C, 2016, BRAIN, V139, P73, DOI 10.1093/brain/awv320
   Montenegro G, 2012, J CLIN INVEST, V122, P538, DOI 10.1172/JCI60560
   Mou YC, 2019, NEURAL REGEN RES, V14, P574, DOI 10.4103/1673-5374.248108
   Murala S, 2021, NEUROL SCI, V42, P883, DOI 10.1007/s10072-020-04981-7
   Musacchio T, 2017, J NEUROL, V264, P11, DOI 10.1007/s00415-016-8301-2
   Musumeci O, 2011, NEUROL SCI, V32, P665, DOI 10.1007/s10072-010-0445-8
   Nam D, 2022, J PERIPHER NERV SYST, V27, P38, DOI 10.1111/jns.12476
   Nicita F, 2021, J MED GENET, V58, P475, DOI 10.1136/jmedgenet-2020-107007
   Nicolas A, 2018, NEURON, V97, P1268, DOI 10.1016/j.neuron.2018.02.027
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Noetzli L, 2014, GENE, V533, P447, DOI 10.1016/j.gene.2013.09.076
   Orlacchio A, 2010, BRAIN, V133, P591, DOI 10.1093/brain/awp325
   Oz-Levi D, 2012, AM J HUM GENET, V91, P1065, DOI 10.1016/j.ajhg.2012.09.015
   ÃztÃ¼rk Z, 2020, FRONT NEUROSCI-SWITZ, V14, P0, DOI 10.3389/fnins.2020.00048
   Panza E, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00131
   Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979
   Park TS, 2021, CUREUS, V13, P0
   Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371
   Patel H, 2002, NAT GENET, V31, P347, DOI 10.1038/ng937
   Peotter JL, 2022, P NATL ACAD SCI USA, V119, P0, DOI 10.1073/pnas.2210649119
   Piccinelli SC, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00580
   Pucks-Faes E, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00901
   Ramani PK, 2023, STATPEARLS. (TREASURE ISL. (FL)), V0, P0
   Rattay TW, 2019, BRAIN, V142, P1561, DOI 10.1093/brain/awz102
   Rebelo AP, 2023, BRAIN, V146, P4191, DOI 10.1093/brain/awad158
   Reinicke AT, 2019, J IMMUNOL, V203, P1730, DOI 10.4049/jimmunol.1801133
   Reversade B, 2009, NAT GENET, V41, P1016, DOI 10.1038/ng.413
   Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046
   RiviÃ¨re JB, 2011, AM J HUM GENET, V89, P219, DOI 10.1016/j.ajhg.2011.06.013
   Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667
   Rossi S, 2022, NEUROL-GENET, V8, P0, DOI 10.1212/NXG.0000000000000664
   Ruano L, 2014, NEUROEPIDEMIOLOGY, V42, P174, DOI 10.1159/000358801
   Sadr Z, 2023, NEUROMUSCULAR DISORD, V33, P295, DOI 10.1016/j.nmd.2023.02.001
   Sanderson CM, 2006, HUM MOL GENET, V15, P307, DOI 10.1093/hmg/ddi447
   Sardina F, 2020, LIFE SCI ALLIANCE, V3, P0, DOI 10.26508/lsa.202000799
   Schlipf NA, 2014, MOL GENET GENOM MED, V2, P379, DOI 10.1002/mgg3.87
   SchÃ¶ls L, 2017, BRAIN, V140, P3112, DOI 10.1093/brain/awx273
   SchÃ¼le R, 2016, ANN NEUROL, V79, P646, DOI 10.1002/ana.24611
   Seong E, 2018, ANN NEUROL, V83, P1075, DOI 10.1002/ana.25220
   Shen JL, 2021, CURR BIOL, V31, P0
   Shkodina AD, 2022, AGEING RES REV, V74, P0, DOI 10.1016/j.arr.2021.101554
   Slabicki M, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000408
   Slosarek EL, 2018, CELL REP, V24, P2248, DOI 10.1016/j.celrep.2018.07.081
   Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245
   Sperfeld AD, 2005, EUR NEUROL, V54, P181, DOI 10.1159/000090294
   Stevanin G, 2007, NAT GENET, V39, P366, DOI 10.1038/ng1980
   Tesson C, 2015, HUM GENET, V134, P511, DOI 10.1007/s00439-015-1536-7
   Marchesi LT, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10071678
   Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058
   Trummer B, 2018, FRONT NEUROL, V9, P0, DOI 10.3389/fneur.2018.01017
   van de Venis L, 2023, NEUROREHAB NEURAL RE, V37, P27, DOI 10.1177/15459683221147839
   Vander Stichele G, 2022, BMC NEUROL, V22, P0, DOI 10.1186/s12883-022-02595-4
   Varghaei P, 2022, PARKINSONISM RELAT D, V98, P62, DOI 10.1016/j.parkreldis.2022.03.019
   Vavouraki N, 2021, ISCIENCE, V24, P0, DOI 10.1016/j.isci.2021.102484
   VelÃ¡zquez AR, 2016, J CELL BIOL, V212, P621, DOI 10.1083/jcb.201508102
   Wali G, 2018, BRAIN SCI, V8, P0, DOI 10.3390/brainsci8080142
   Wang AN, 2023, J HEADACHE PAIN, V24, P0, DOI 10.1186/s10194-022-01537-2
   Wang Y, 2009, BBA-MOL CELL RES, V1793, P1710, DOI 10.1016/j.bbamcr.2009.09.004
   Wartosch L, 2015, TRAFFIC, V16, P727, DOI 10.1111/tra.12283
   Williams ET, 2017, J PARKINSON DIS, V7, P219, DOI 10.3233/JPD-161020
   Xu Y, 2019, CELL, V178, P552, DOI 10.1016/j.cell.2019.06.007
   Yahia A, 2023, EUR J HUM GENET, V0, P0, DOI DOI 10.1038/s41431-023-01344-6
   Yao L, 2023, ANN CLIN TRANSL NEUR, V10, P328, DOI 10.1002/acn3.51722
   Zhang LS, 2009, ACTA BIOCH BIOPH SIN, V41, P437, DOI 10.1093/abbs/gmp031
   Zhou X, 2023, ANN CLIN TRANSL NEUR, V10, P1590, DOI 10.1002/acn3.51848
   Zhu PP, 2022, HUM MOL GENET, V31, P2779, DOI 10.1093/hmg/ddac072
   Zhu ZY, 2022, EUR J MED GENET, V65, P0, DOI 10.1016/j.ejmg.2022.104608
   Zhu ZY, 2019, PARKINSONISM RELAT D, V69, P125, DOI 10.1016/j.parkreldis.2019.11.007
   Zuchner S, 2006, AM J HUM GENET, V79, P365, DOI 10.1086/505361
NR 134
TC 2
Z9 2
U1 1
U2 5
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 2050-3121
EI 
J9 SAGE OPEN MED
JI SAGE Open Med.
PD JUN 15
PY 2024
VL 12
IS 
BP 
EP 
DI 10.1177/20503121231221941
PG 20
WC Medicine, General & Internal
SC General & Internal Medicine
GA DR1U2
UT WOS:001133709600001
PM 38162912
DA 2024-11-01
ER

PT J
AU Filograna, R
   Gerlach, J
   Choi, HN
   Rigoni, G
   Barbaro, M
   Oscarson, M
   Lee, SM
   Tiklova, K
   RingnÃ©r, M
   Koolmeister, C
   Wibom, R
   Riggare, S
   Nennesmo, I
   Perlmann, T
   Wredenberg, A
   Wedell, A
   Motori, E
   Svenningsson, P
   Larsson, NG
AF Filograna, Roberta
   Gerlach, Jule
   Choi, Hae-Na
   Rigoni, Giovanni
   Barbaro, Michela
   Oscarson, Mikael
   Lee, Seungmin
   Tiklova, Katarina
   Ringner, Markus
   Koolmeister, Camilla
   Wibom, Rolf
   Riggare, Sara
   Nennesmo, Inger
   Perlmann, Thomas
   Wredenberg, Anna
   Wedell, Anna
   Motori, Elisa
   Svenningsson, Per
   Larsson, Nils-Goran
TI PARKIN is not required to sustain OXPHOS function in adult mammalian tissues
SO NPJ PARKINSONS DISEASE
LA English
DT Article
ID mitochondrial-dna mutations; deficient mice; mitophagy; protein; pink1; neurons; fbxl4; gene; neurodegeneration; degeneration
AB Loss-of-function variants in the PRKN gene encoding the ubiquitin E3 ligase PARKIN cause autosomal recessive early-onset Parkinson's disease (PD). Extensive in vitro and in vivo studies have reported that PARKIN is involved in multiple pathways of mitochondrial quality control, including mitochondrial degradation and biogenesis. However, these findings are surrounded by substantial controversy due to conflicting experimental data. In addition, the existing PARKIN-deficient mouse models have failed to faithfully recapitulate PD phenotypes. Therefore, we have investigated the mitochondrial role of PARKIN during ageing and in response to stress by employing a series of conditional Parkin knockout mice. We report that PARKIN loss does not affect oxidative phosphorylation (OXPHOS) capacity and mitochondrial DNA (mtDNA) levels in the brain, heart, and skeletal muscle of aged mice. We also demonstrate that PARKIN deficiency does not exacerbate the brain defects and the pro-inflammatory phenotype observed in mice carrying high levels of mtDNA mutations. To rule out compensatory mechanisms activated during embryonic development of Parkin-deficient mice, we generated a mouse model where loss of PARKIN was induced in adult dopaminergic (DA) neurons. Surprisingly, also these mice did not show motor impairment or neurodegeneration, and no major transcriptional changes were found in isolated midbrain DA neurons. Finally, we report a patient with compound heterozygous PRKN pathogenic variants that lacks PARKIN and has developed PD. The PARKIN deficiency did not impair OXPHOS activities or induce mitochondrial pathology in skeletal muscle from the patient. Altogether, our results argue that PARKIN is dispensable for OXPHOS function in adult mammalian tissues.
C1 [Filograna, Roberta; Gerlach, Jule; Rigoni, Giovanni; Lee, Seungmin; Koolmeister, Camilla; Wredenberg, Anna; Larsson, Nils-Goran] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.
   [Choi, Hae-Na; Motori, Elisa] Univ Cologne, Inst Biochem, Cologne, Germany.
   [Choi, Hae-Na; Motori, Elisa] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respons, Cologne, Germany.
   [Barbaro, Michela; Oscarson, Mikael; Wibom, Rolf; Wredenberg, Anna; Wedell, Anna] Karolinska Univ Hosp, Ctr Inherited Metab Dis, Stockholm, Sweden.
   [Tiklova, Katarina; Perlmann, Thomas] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.
   [Ringner, Markus] Lund Univ, Dept Biol, Sci Life Lab, Natl Bioinformat Infrastructure Sweden, Lund, Sweden.
   [Riggare, Sara] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.
   [Nennesmo, Inger] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.
   [Wedell, Anna] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.
   [Svenningsson, Per] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.
   [Svenningsson, Per] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden.
C3 Karolinska Institutet; University of Cologne; University of Cologne; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Lund University; Uppsala University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital
RP Filograna, R; Larsson, NG (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.
EM roberta.filograna@ki.se; nils-goran.larsson@ki.se
FU Vetenskapsradet [2022-01477]; Knut och Alice Wallenbergs Stiftelse; Hjaernfonden [FO2018-0151]; Parkinsonfonden; Loo och Hans Ostermans stiftelse, ahlen-stiftelsen; KI Research Foundation Grants; StratNeuro; Hedlunds stiftelse; Knut och Alice Wallenbergs Stiftelse, National Bioinformatics Infrastructure Sweden at SciLifeLab; Stockholm City Council;  [VR 2020-00884];  [2015-00418]; Vinnova [2022-01477] Funding Source: Vinnova; Swedish Research Council [2022-01477] Funding Source: Swedish Research Council
CR Alsina D, 2020, EMBO MOL MED, V12, P0, DOI 10.15252/emmm.201911659
   [Anonymous], 2021, MUSCLE BIOPSY, V0, P0
   Asakawa S, 2009, BIOCHEM BIOPH RES CO, V389, P181, DOI 10.1016/j.bbrc.2009.08.115
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Bravo P, 2018, MOL GENET GENOM MED, V6, P1243, DOI 10.1002/mgg3.482
   Cao Y, 2023, EMBO J, V42, P0, DOI 10.15252/embj.2022113033
   Cornelissen T, 2018, ELIFE, V7, P0, DOI 10.7554/eLife.35878
   Elcocks H, 2023, EMBO J, V42, P0, DOI 10.15252/embj.2022112799
   Filograna R, 2019, SCI ADV, V5, P0, DOI 10.1126/sciadv.aav9824
   Filograna R, 2021, PLOS GENET, V17, P0, DOI 10.1371/journal.pgen.1009822
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Ge P, 2020, MOL NEURODEGENER, V15, P0, DOI 10.1186/s13024-020-00367-7
   Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419
   Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Horowitz JM, 2001, J CHEM NEUROANAT, V21, P75, DOI 10.1016/S0891-0618(00)00111-3
   Huemer M, 2015, J INHERIT METAB DIS, V38, P905, DOI 10.1007/s10545-015-9836-6
   Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849
   Joch M, 2007, MOL BIOL CELL, V18, P3105, DOI 10.1091/mbc.E05-11-1027
   Kasten M, 2018, MOVEMENT DISORD, V33, P730, DOI 10.1002/mds.27352
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kilarski LL, 2012, MOVEMENT DISORD, V27, P1522, DOI 10.1002/mds.25132
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kumar A, 2015, EMBO J, V34, P2506, DOI 10.15252/embj.201592337
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lee JJ, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-59647-3
   Lee JJ, 2018, J CELL BIOL, V217, P1613, DOI 10.1083/jcb.201801044
   Love MI, 2014, GENOME BIOL, V15, P0, DOI 10.1186/s13059-014-0550-8
   Lubbe SJ, 2021, HUM MOL GENET, V30, P78, DOI 10.1093/hmg/ddaa273
   LÃ¼cking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   Matsumine H, 1997, AM J HUM GENET, V60, P588
   McWilliams TG, 2018, CELL METAB, V27, P439, DOI 10.1016/j.cmet.2017.12.008
   Moehlman AT, 2023, PLOS GENET, V19, P0, DOI 10.1371/journal.pgen.1010828
   Morbelli S, 2020, EUR J NUCL MED MOL I, V47, P1885, DOI 10.1007/s00259-020-04817-8
   Mourier A, 2014, CELL METAB, V20, P1069, DOI 10.1016/j.cmet.2014.11.005
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Nguyen-Dien GT, 2023, EMBO J, V42, P0, DOI 10.15252/embj.2022112767
   Noda S, 2020, NEUROBIOL DIS, V136, P0, DOI 10.1016/j.nbd.2019.104717
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Peker N, 2018, AM J PHYSIOL-CELL PH, V315, PC164, DOI 10.1152/ajpcell.00064.2017
   Peng W, 2023, SCI ADV, V9, P0, DOI 10.1126/sciadv.adh3347
   Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102
   Picelli S, 2013, NAT METHODS, V10, P1096, DOI 10.1038/NMETH.2639
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   Pinto M, 2018, J NEUROSCI, V38, P1042, DOI 10.1523/JNEUROSCI.1384-17.2017
   Riley BE, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms2982
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Ross JM, 2011, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/3266
   Ross JM, 2010, P NATL ACAD SCI USA, V107, P20087, DOI 10.1073/pnas.1008189107
   Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043
   Sato S, 2006, J NEUROSCI RES, V84, P1350, DOI 10.1002/jnr.21032
   Scott L, 2022, J NEUROSCI, V42, P9263, DOI 10.1523/JNEUROSCI.0545-22.2022
   Seirafi M, 2015, FEBS J, V282, P2076, DOI 10.1111/febs.13249
   Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060
   Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010
   Simard ML, 2018, J PATHOL, V245, P311, DOI 10.1002/path.5084
   Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9
   SÃ¶rensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108
   Stevens DA, 2015, P NATL ACAD SCI USA, V112, P11696, DOI 10.1073/pnas.1500624112
   Stranneheim H, 2021, GENOME MED, V13, P0, DOI 10.1186/s13073-021-00855-5
   Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013
   Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101
   Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125
   West AB, 2004, HUM GENET, V114, P327, DOI 10.1007/s00439-003-1074-6
   Whitworth AJ, 2017, CURR OPIN GENET DEV, V44, P47, DOI 10.1016/j.gde.2017.01.016
   Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4
   Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934
   Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107
NR 74
TC 2
Z9 2
U1 1
U2 1
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 
EI 2373-8057
J9 NPJ PARKINSONS DIS
JI npj Parkinsons Dis.
PD APR 29
PY 2024
VL 10
IS 1
BP 
EP 
DI 10.1038/s41531-024-00707-0
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA SG7J5
UT WOS:001233366000001
PM 38684669
DA 2024-11-01
ER

PT J
AU Liang, KX
AF Liang, Kristina Xiao
TI Interplay of mitochondria and diabetes: Unveiling novel therapeutic strategies
SO MITOCHONDRION
LA English
DT Review
DE Mitochondrial dysfunction; Insulin resistance; Beta -cell failure; Mitochondria-targeted therapeutics; Reactive oxygen species (ROS)
ID improves insulin sensitivity; chronic oxidative stress; pancreatic beta-cells; molecular-mechanisms; skeletal-muscle; targeted antioxidants; hepatic steatosis; glucose toxicity; receptor gene; dysfunction
AB The interplay between mitochondrial function and diabetes has gained significant attention due to its crucial role in the pathogenesis and progression of the disease. Mitochondria, known as the cellular powerhouses, are essential for glucose metabolism. Dysfunction of these organelles has been implicated in the development of insulin resistance and beta-cell failure, both prominent features of diabetes. This comprehensive review explores the intricate mechanisms involved, including the generation of reactive oxygen species and the impact of mitochondrial DNA (mtDNA) mutations. Moreover, the review delves into emerging therapeutic strategies that specifically target mitochondria, such as mitochondria-targeted antioxidants, agents promoting mitochondrial biogenesis, and compounds modulating mitochondrial dynamics. The potential of these novel approaches is critically evaluated, taking into account their benefits and limitations, to provide a well-rounded perspective. Ultimately, this review emphasizes the importance of advancing our understanding of mitochondrial biology to revolutionize the treatment of diabetes.
C1 [Liang, Kristina Xiao] Univ Bergen, Dept Clin Med K1, Bergen, Norway.
C3 University of Bergen
RP Liang, KX (corresponding author), Univ Bergen, Dept Clin Med K1, Bergen, Norway.
EM xiao.liang@uib.no
FU Meltzers Hoyskolefonds [103517133]; Gerda Meyer Nyquist Guldbrandson og Gerdt Meyer Nyquists legat [103816102]
CR ACCILI D, 1989, EMBO J, V8, P2509, DOI 10.1002/j.1460-2075.1989.tb08388.x
   Al-Ghamdi BA, 2022, SAUDI J BIOL SCI, V29, P0, DOI 10.1016/j.sjbs.2022.103434
   Alberts B, 2007, MOL BIOL CELL, V0, P0, DOI DOI 10.1201/9780203833445
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9
   [Anonymous], 2016, DIABETES CARE, V39, PS1, DOI 10.2337/dc16-S001, 10.2337/dc19-SINT01, 10.2337/dc20-SINT, 10.2337/dc19-Sint01, 10.2337/dc20-Sint
   Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7
   Banday Mujeeb Z, 2020, AVICENNA J MED, V10, P174, DOI 10.4103/ajm.ajm_53_20
   Barres R, 2011, AM J CLIN NUTR, V93, P897S, DOI 10.3945/ajcn.110.001933
   Berg JM, 2015, BIOCHEMISTRY, V0, P0
   Bhatti JS, 2022, FREE RADICAL BIO MED, V184, P114, DOI 10.1016/j.freeradbiomed.2022.03.019
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Birk AV, 2013, J AM SOC NEPHROL, V24, P1250, DOI 10.1681/ASN.2012121216
   Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615
   Buhl ES, 2002, DIABETES, V51, P2199, DOI 10.2337/diabetes.51.7.2199
   Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638
   Chen W, 2023, SIGNAL TRANSDUCT TAR, V8, P0, DOI 10.1038/s41392-023-01547-9
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Choi RH, 2019, BIOCHEM BIOPH RES CO, V519, P633, DOI 10.1016/j.bbrc.2019.09.049
   Conte M, 2021, GEROSCIENCE, V43, P985, DOI 10.1007/s11357-020-00287-w
   Dadwal A, 2018, ARTIF CELL NANOMED B, V46, P295, DOI 10.1080/21691401.2018.1457039
   DeFronzo RA, 2015, NAT REV DIS PRIMERS, V1, P0, DOI 10.1038/nrdp.2015.19
   Ding Y, 2022, DIABET METAB SYND OB, V15, P1687, DOI 10.2147/DMSO.S363978
   Dvoretskaya Y, 2021, ANTIOXIDANTS-BASEL, V10, P0, DOI 10.3390/antiox10111749
   Escribano-LÃ³pez I, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8091322
   Escribano-Lopez I, 2016, REDOX BIOL, V10, P200, DOI 10.1016/j.redox.2016.10.017
   Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011
   Freyssenet D, 1996, ARCH PHYSIOL BIOCHEM, V104, P129, DOI 10.1076/apab.104.2.129.12878
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Galicia-Garcia U, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21176275
   Galloway CA, 2013, ANTIOXID REDOX SIGN, V19, P415, DOI 10.1089/ars.2012.4779
   Genders AJ, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21186948
   Gilbert M, 2021, J DIABETES INVEST, V12, P1934, DOI 10.1111/jdi.13614
   Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940
   Groten CJ, 2022, COMMUN BIOL, V5, P0, DOI 10.1038/s42003-022-03848-1
   Gruber J, 2013, BIOTECHNOL ADV, V31, P563, DOI 10.1016/j.biotechadv.2012.09.005
   Hacihamdioglu B, 2021, J CLIN RES PEDIATR E, V13, P100, DOI 10.4274/jcrpe.galenos.2020.2019.0213
   Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634
   Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2
   Hu L, 2019, THERANOSTICS, V9, P3687, DOI 10.7150/thno.33684
   Huynh TV, 2023, CELLS-BASEL, V12, P0, DOI 10.3390/cells12091223
   Iglesias MA, 2002, DIABETES, V51, P2886, DOI 10.2337/diabetes.51.10.2886
   Karolina DS, 2012, J CLIN ENDOCR METAB, V97, PE2271, DOI 10.1210/jc.2012-1996
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Li ME, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-11265-y
   Ling C, 2019, CELL METAB, V29, P1028, DOI 10.1016/j.cmet.2019.03.009
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   Maassen JA, 2004, DIABETES, V53, PS103, DOI 10.2337/diabetes.53.2007.S103
   Maechler P, 2013, MOL CELL ENDOCRINOL, V379, P12, DOI 10.1016/j.mce.2013.06.019
   Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943
   Mihaylov SR, 2023, NAT COMMUN, V14, P0, DOI 10.1038/s41467-023-41304-8
   Mitchell P, 2011, BBA-BIOENERGETICS, V1807, P1507, DOI 10.1016/j.bbabio.2011.09.018
   Mulder H, 2009, MOL CELL ENDOCRINOL, V297, P34, DOI 10.1016/j.mce.2008.05.015
   Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Patel KK, 2021, DIABETES OBES METAB, V23, P39, DOI 10.1111/dom.14180
   Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314
   Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603
   Picard M, 2015, P NATL ACAD SCI USA, V112, PE6614, DOI 10.1073/pnas.1515733112
   Pickles S, 2018, CURR BIOL, V28, PR170, DOI 10.1016/j.cub.2018.01.004
   Pold R, 2005, DIABETES, V54, P928, DOI 10.2337/diabetes.54.4.928
   Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581
   Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018
   Raffaello A, 2016, TRENDS BIOCHEM SCI, V41, P1035, DOI 10.1016/j.tibs.2016.09.001
   Rey F, 2022, NEURAL REGEN RES, V17, P754, DOI 10.4103/1673-5374.322430
   Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8
   Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412
   Robertson RP, 2007, CELL BIOCHEM BIOPHYS, V48, P139, DOI 10.1007/s12013-007-0026-5
   Robertson RP, 2004, DIABETES, V53, PS119, DOI 10.2337/diabetes.53.2007.S119
   Rocha M, 2020, TRENDS ENDOCRIN MET, V31, P725, DOI 10.1016/j.tem.2020.03.004
   Roger AJ, 2017, CURR BIOL, V27, PR1177, DOI 10.1016/j.cub.2017.09.015
   RÃ¶nn T, 2023, NAT COMMUN, V14, P0, DOI 10.1038/s41467-023-43719-9
   Sacks B, 2021, BMC PHARMACOL TOXICO, V22, P0, DOI 10.1186/s40360-021-00518-6
   Scalise M, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9092028
   Sergi D, 2019, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.00532
   Shan Z, 2022, AGING-US, V14, P2902, DOI 10.18632/aging.203969
   Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531
   Smith RAJ, 2011, DISCOV MED, V11, P106
   Song YM, 2015, AUTOPHAGY, V11, P46, DOI 10.4161/15548627.2014.984271
   Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1
   Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014
   Szeto HH, 2008, ANTIOXID REDOX SIGN, V10, P601, DOI 10.1089/ars.2007.1892
   Sztretye M, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/3849692
   Tanwar J, 2021, MITOCHONDRION, V57, P9, DOI 10.1016/j.mito.2020.12.001
   TAYLOR SI, 1990, DIABETES CARE, V13, P257, DOI 10.2337/diacare.13.3.257
   Teodoro JS, 2019, FRONT PHYSIOL, V9, P0, DOI 10.3389/fphys.2018.01857
   Teresak P, 2022, AUTOPHAGY, V18, P24, DOI 10.1080/15548627.2021.1888244
   Tian CW, 2022, FRONT CELL DEV BIOL, V10, P0, DOI 10.3389/fcell.2022.832356
   Toney AM, 2019, OBESITY, V27, P612, DOI 10.1002/oby.22404
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Ãnal F, 2014, TURK J GASTROENTEROL, V25, P147, DOI 10.5152/tjg.2014.3419
   Vezza T, 2022, WORLD J MENS HEALTH, V40, P399, DOI 10.5534/wjmh.210146
   Walker BR, 2022, BIOMOLECULES, V12, P0, DOI 10.3390/biom12030427
   Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Wang CH, 2017, J BIOMED SCI, V24, P0, DOI 10.1186/s12929-017-0375-3
   Wang L, 2022, FRONT MOL NEUROSCI, V15, P0, DOI 10.3389/fnmol.2022.974480
   Wang QL, 2017, DIABETES, V66, P193, DOI 10.2337/db16-0915
   Wang SW, 2020, NUTR DIABETES, V10, P0, DOI 10.1038/s41387-020-00130-3
   Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033
   Wu PS, 2023, MOLECULES, V28, P0, DOI 10.3390/molecules28145525
   WÃ¼rtz P, 2012, DIABETES, V61, P1372, DOI 10.2337/db11-1355
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Yu SB, 2018, J MOL BIOL, V430, P3922, DOI 10.1016/j.jmb.2018.07.027
   Zeviani M, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11040637
   Zoico E, 2019, FRONT ENDOCRINOL, V10, P0, DOI 10.3389/fendo.2019.00368
NR 108
TC 0
Z9 0
U1 6
U2 7
PU ELSEVIER SCI LTD
PI London
PA 125 London Wall, London, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAR 15
PY 2024
VL 75
IS 
BP 
EP 
DI 10.1016/j.mito.2024.101850
EA FEB 2024
PG 12
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA QC1D8
UT WOS:001218580600001
PM 38331015
DA 2024-11-01
ER

PT J
AU Dhawan, S
   Musa, AH
   Mantripragada, K
AF Dhawan, Saurav
   Musa, Abdel H.
   Mantripragada, Khyathi
TI Novel Mitochondrial Cytopathy Causing Mitochondrial Encephalomyopathy With Lactic Acidosis and Stroke-Like Episodes Syndrome and Tubulointerstitial Nephropathy
SO CUREUS JOURNAL OF MEDICAL SCIENCE
LA English
DT Article
DE novel mutation; mitochondrial disorder; stroke; kidney transplant; melas
ID renal manifestations; disease; adults; melas
AB Mitochondrial cytopathies, predominantly MT-TL1 mutations and, to a lesser extent, MT-ND5, have been associated with mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS), manifesting as multi-organ dysfunction. This is just the second instance of MELAS secondary to the pathogenic novel m.13091T>C variant of MT-ND5. Moreover, nephropathy associated with MT-ND5 mutation has only been reported in nine cases so far. A middle-aged man presented in a state of acute confusion with speech difficulty with both receptive and expressive aphasia. He had a background of refractory seizures, chronic atypical migraine, childhood-onset optic neuropathy, and end-stage renal disease requiring renal transplant. During admission, he had episodes of aggression and paranoid beliefs. Magnetic resonance (MR) imaging of the head showed multiple areas of cortical abnormality, unusual for age, including a large frontal infarct crossing arterial boundaries. Cerebrospinal fluid (CSF) protein and lactate were high, whereas, the electroencephalography (EEG) result was normal. Muscle biopsy mitochondrial DNA gene sequencing derived novel MT-ND5 gene variant m.13091T>C p.(Met252Thr). Kidney biopsy previously had shown interstitial fibrosis and tubular atrophy. He was managed as acute ischaemic stroke along with a combination of clobazam, levetiracetam, and eslicarbazepine for seizures. MELAS typically presents with seizures, stroke-like episodes, cortical visual loss, and recurrent migraine headaches. The previous reported case of m.13091T>C mutation followed a similar progression, however, there was no associated nephropathy and normal visual acuity. Kidney transplants in affected patients of MELAS have been associated with a high survival rate. MT-ND5 mutation-associated nephropathy has shown a variable manifestation, either as focal segmental glomerular sclerosis (FSGS) or tubulo-interstitial disease.
C1 [Dhawan, Saurav; Musa, Abdel H.] Manchester Univ Natl Hlth Serv NHS Fdn Trust, Internal Med, Manchester, Lancs, England.
   [Mantripragada, Khyathi] Stockport Natl Hlth Serv NHS Trust, Internal Med, Stockport, England.
RP Dhawan, S (corresponding author), Manchester Univ Natl Hlth Serv NHS Fdn Trust, Internal Med, Manchester, Lancs, England.
EM saurav322dhawan@gmail.com
CR Alcubilla-Prats P, 2017, MED CLIN-BARCELONA, V148, P357, DOI 10.1016/j.medcle.2017.04.002
   Bakis H, 2020, CLIN GENET, V97, P628, DOI 10.1111/cge.13670
   Barone V, 2022, FRONT GENET, V13, P0, DOI 10.3389/fgene.2022.887696
   Chinnery PF, 2020, PRIMARY MITOCHONDRIAL DISORDERS OVERVIEW, V0, P0
   Danhelovska T, 2020, BMC PEDIATR, V20, P0, DOI 10.1186/s12887-020-1912-x
   El-Hattab AW, 2001, MELAS. GENEREVIEWS, V0, P0
   Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214
   Ferreira F, 2023, NEFROLOGIA, V43, P1, DOI 10.1016/j.nefro.2023.03.004
   Finsterer J, 2017, BIOMED REP, V6, P487, DOI 10.3892/br.2017.892
   Hall AM, 2015, KIDNEY INT, V87, P610, DOI 10.1038/ki.2014.297
   Motoda Atsuko, 2013, RINSHO SHINKEIGAKU, V53, P446
   Naganuma T, 2023, MOL GENET METAB REP, V35, P0, DOI 10.1016/j.ymgmr.2023.100963
   Parikh S, 2016, MOL GENET METAB, V118, P178, DOI 10.1016/j.ymgme.2016.04.009
   Swart Grace, 2024, J NEUROOPHTHALMOL, V44, P190, DOI 10.1097/WNO.0000000000001946
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 15
TC 0
Z9 0
U1 0
U2 0
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 
EI 2168-8184
J9 CUREUS J MED SCIENCE
JI Cureus J Med Sci
PD AUG 12
PY 2024
VL 16
IS 8
BP 
EP 
DI 10.7759/cureus.66722
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA D3S2O
UT WOS:001295410900001
PM 39262552
DA 2024-11-01
ER

PT J
AU Guglielmi, V
   Cheli, M
   Tonin, P
   Vattemi, G
AF Guglielmi, Valeria
   Cheli, Marta
   Tonin, Paola
   Vattemi, Gaetano
TI Sporadic Inclusion Body Myositis at the Crossroads between Muscle Degeneration, Inflammation, and Aging
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE sporadic inclusion body myositis (sIBM); muscle fiber degeneration; protein aggregation; inflammation; aging; inflammaging
ID cultured human muscle; endoplasmic-reticulum stress; cytosolic 5'-nucleotidase 1a; mitochondrial-dna deletions; unfolded protein response; paired-helical filaments; infiltrating t-cells; alpha-b-crystallin; mhc class-i; nf-kappa-b
AB Sporadic inclusion body myositis (sIBM) is the most common muscle disease of older people and is clinically characterized by slowly progressive asymmetrical muscle weakness, predominantly affecting the quadriceps, deep finger flexors, and foot extensors. At present, there are no enduring treatments for this relentless disease that eventually leads to severe disability and wheelchair dependency. Although sIBM is considered a rare muscle disorder, its prevalence is certainly higher as the disease is often undiagnosed or misdiagnosed. The histopathological phenotype of sIBM muscle biopsy includes muscle fiber degeneration and endomysial lymphocytic infiltrates that mainly consist of cytotoxic CD8+ T cells surrounding nonnecrotic muscle fibers expressing MHCI. Muscle fiber degeneration is characterized by vacuolization and the accumulation of congophilic misfolded multi-protein aggregates, mainly in their non-vacuolated cytoplasm. Many players have been identified in sIBM pathogenesis, including environmental factors, autoimmunity, abnormalities of protein transcription and processing, the accumulation of several toxic proteins, the impairment of autophagy and the ubiquitin-proteasome system, oxidative and nitrative stress, endoplasmic reticulum stress, myonuclear degeneration, and mitochondrial dysfunction. Aging has also been proposed as a contributor to the disease. However, the interplay between these processes and the primary event that leads to the coexistence of autoimmune and degenerative changes is still under debate. Here, we outline our current understanding of disease pathogenesis, focusing on degenerative mechanisms, and discuss the possible involvement of aging.
C1 [Guglielmi, Valeria] Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, Cellular & Mol Biol Canc Program, La Jolla, CA 92037 USA.
   [Guglielmi, Valeria] Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, Immun & Pathogenesis Program, La Jolla, CA 92037 USA.
   [Cheli, Marta; Tonin, Paola; Vattemi, Gaetano] Univ Verona, Dept Neurosci Biomed & Movement Sci, I-37134 Verona, Italy.
C3 Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; University of Verona
RP Vattemi, G (corresponding author), Univ Verona, Dept Neurosci Biomed & Movement Sci, I-37134 Verona, Italy.
EM vguglielmi@sbpdiscovery.org; marta.cheli@univr.it; paola.tonin@univr.it; gaetano.vattemi@univr.it
FU NEXTGENERATIONEU (NGEU); Ministry of University and Research (MUR); National Recovery and Resilience Plan (NRRP); Project MNESYS - A Multiscale integrated approach to the study of the nervous system in health and disease [DN.1553 11.10.2022, PE0000006]
CR Abdo WF, 2009, ACTA NEUROPATHOL, V118, P429, DOI 10.1007/s00401-009-0554-8
   Adams V, 2002, CARDIOVASC RES, V54, P95, DOI 10.1016/S0008-6363(02)00228-6
   Afzali AM, 2017, AUTOIMMUN REV, V16, P478, DOI 10.1016/j.autrev.2017.03.001
   Ahmed M, 2016, SCI TRANSL MED, V8, P0, DOI 10.1126/scitranslmed.aad4583
   Allenbach Y, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0088788
   Amato AA, 2021, NEUROLOGY, V96, PE1595, DOI 10.1212/WNL.0000000000011626
   Amemiya K, 2000, BRAIN, V123, P2030, DOI 10.1093/brain/123.10.2030
   Amthor H, 2004, DEV BIOL, V270, P19, DOI 10.1016/j.ydbio.2004.01.046
   Ansari B, 2020, MUSCLE NERVE, V61, P496, DOI 10.1002/mus.26813
   Argyriou A, 2023, EMBO MOL MED, V15, P0, DOI 10.15252/emmm.202217240
   Askanas V, 1996, NEUROLOGY, V46, P0
   ASKANAS V, 1991, NEUROSCI LETT, V130, P73, DOI 10.1016/0304-3940(91)90230-Q
   Askanas V, 2005, MICROSC RES TECHNIQ, V67, P114, DOI 10.1002/jemt.20186
   ASKANAS V, 1993, NEUROREPORT, V5, P25, DOI 10.1097/00001756-199310000-00006
   ASKANAS V, 1992, AM J PATHOL, V141, P31
   ASKANAS V, 1993, ANN NEUROL, V34, P551, DOI 10.1002/ana.410340408
   ASKANAS V, 1994, AM J PATHOL, V144, P177
   Askanas V, 1998, INCLUSION-BODY MYOSITIS AND MYOPATHIES, VVolume 378, P0
   Askanas V, 2015, BBA-MOL BASIS DIS, V1852, P633, DOI 10.1016/j.bbadis.201409.005
   Askanas V, 2012, J NEUROPATH EXP NEUR, V71, P680, DOI 10.1097/NEN.0b013e31826183c8
   Askanas V, 2009, BRAIN PATHOL, V19, P493, DOI 10.1111/j.1750-3639.2009.00290.x
   Badrising UA, 2002, ANN NEUROL, V51, P369, DOI 10.1002/ana.10121
   Banwell BL, 2000, NEUROLOGY, V54, P1033, DOI 10.1212/WNL.54.5.1033
   Barohn RJ, 2006, NEUROLOGY, V66, PS123, DOI 10.1212/01.wnl.0000192258.32408.54
   BARTOCCIONI E, 1994, CLIN EXP IMMUNOL, V95, P166
   Behrens L, 1998, J IMMUNOL, V161, P5943
   Bender A, 1998, J NEUROIMMUNOL, V84, P86, DOI 10.1016/S0165-5728(97)00246-4
   Benveniste O, 2021, LANCET RHEUMATOL, V3, PE40, DOI 10.1016/S2665-9913(20)30280-0
   Benveniste O, 2015, ACTA NEUROPATHOL, V129, P611, DOI 10.1007/s00401-015-1384-5
   Benveniste O, 2011, BRAIN, V134, P3176, DOI 10.1093/brain/awr213
   BEYENBURG S, 1993, CLIN INVESTIGATOR, V71, P351
   Bhatt PS, 2019, NEUROMUSCULAR DISORD, V29, P242, DOI 10.1016/j.nmd.2019.02.001
   Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090
   Bradshaw EM, 2007, J IMMUNOL, V178, P547, DOI 10.4049/jimmunol.178.1.547
   BriceÃ±o O, 2016, AGING CELL, V15, P14, DOI 10.1111/acel.12384
   Britson KA, 2022, SCI TRANSL MED, V14, P0, DOI 10.1126/scitranslmed.abi9196
   Broccolini A, 2000, NEUROSCI LETT, V287, P1, DOI 10.1016/S0304-3940(00)01156-3
   Broccolini A, 2004, J NEUROPATH EXP NEUR, V63, P650, DOI 10.1093/jnen/63.6.650
   Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054
   Buzkova J, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201809091
   Cacciottolo M, 2013, NEUROPATH APPL NEURO, V39, P750, DOI 10.1111/nan.12038
   Callan Aoife, 2017, J NEUROMUSCUL DIS, V4, P127, DOI 10.3233/JND-160198
   CantÃ³-Santos J, 2023, ANTIOXIDANTS-BASEL, V12, P0, DOI 10.3390/antiox12081639
   CantÃ³-Santos J, 2023, J CACHEXIA SARCOPENI, V14, P964, DOI 10.1002/jcsm.13178
   CARPENTER S, 1978, NEUROLOGY, V28, P8, DOI 10.1212/WNL.28.1.8
   Carter HN, 2018, J PHYSIOL-LONDON, V596, P3567, DOI 10.1113/JP275998
   CatalÃ¡n-GarcÃ­a M, 2016, CLIN SCI, V130, P1741, DOI 10.1042/CS20160080
   Chen B, 2011, CSH PERSPECT BIOL, V3, P0, DOI 10.1101/cshperspect.a004374
   Cherin P, 2002, NEUROLOGY, V58, P326, DOI 10.1212/WNL.58.2.326
   Ching JK, 2013, HUM MOL GENET, V22, P1167, DOI 10.1093/hmg/dds524
   Chow VW, 2010, NEUROMOL MED, V12, P1, DOI 10.1007/s12017-009-8104-z
   CHUNG SS, 1994, AGING-CLIN EXP RES, V6, P193, DOI 10.1007/BF03324239
   Conboy IM, 2005, CELL CYCLE, V4, P407, DOI 10.4161/cc.4.3.1518
   Connor SG, 2023, PLOS ONE, V18, P0, DOI 10.1371/journal.pone.0283394
   Cortese A, 2014, NEUROBIOL AGING, V35, P1491, DOI 10.1016/j.neurobiolaging.2013.12.029
   Coudert JD, 2022, CLIN TRANSL IMMUNOL, V11, P0, DOI 10.1002/cti2.1416
   Cox FM, 2011, RHEUMATOLOGY, V50, P1153, DOI 10.1093/rheumatology/ker001
   Cui CY, 2019, AGING CELL, V18, P0, DOI 10.1111/acel.13032
   DAgostino C, 2011, ACTA NEUROPATHOL, V122, P627, DOI 10.1007/s00401-011-0874-3
   Dalakas MC, 2009, BRAIN, V132, P1536, DOI 10.1093/brain/awp104
   Dalakas MC, 2001, NEUROLOGY, V56, P323, DOI 10.1212/WNL.56.3.323
   Dalakas MC, 1997, NEUROLOGY, V48, P712, DOI 10.1212/WNL.48.3.712
   DANON MJ, 1982, ARCH NEUROL-CHICAGO, V39, P760, DOI 10.1001/archneur.1982.00510240022006
   Das L, 2013, APPL IMMUNOHISTO M M, V21, P539, DOI 10.1097/PAI.0b013e31827d7f16
   Dastmalchi M, 2008, ANN RHEUM DIS, V67, P1670, DOI 10.1136/ard.2007.077974
   Day K, 2010, DEV BIOL, V340, P330, DOI 10.1016/j.ydbio.2010.01.006
   De Paepe B, 2019, BIOMOLECULES, V9, P0, DOI 10.3390/biom9010015
   Decman V, 2010, J IMMUNOL, V184, P5151, DOI 10.4049/jimmunol.0902063
   Diederichsen LP, 2023, MUSCLE NERVE, V68, P73, DOI 10.1002/mus.27841
   Dimachkie MM, 2011, J NEUROIMMUNOL, V231, P32, DOI 10.1016/j.jneuroim.2010.10.013
   Dion E, 2002, J RHEUMATOL, V29, P1897
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   DzanguÃ©-Tchoupou G, 2019, AUTOIMMUN REV, V18, P325, DOI 10.1016/j.autrev.2019.02.003
   Eggenhuizen PJ, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21197015
   Engel AG, 2004, MYOLOGY, V3rd ed., P1367
   ENGEL AG, 1984, ANN NEUROL, V16, P209, DOI 10.1002/ana.410160207
   Engel WK, 2006, NEUROLOGY, V66, PS20, DOI 10.1212/01.wnl.0000192260.33106.bb
   Englund P, 2001, AM J PATHOL, V159, P1263, DOI 10.1016/S0002-9440(10)62513-8
   Fagnoni FF, 2000, BLOOD, V95, P2860, DOI 10.1182/blood.V95.9.2860.009k35_2860_2868
   Felice KJ, 2018, NEUROMUSCULAR DISORD, V28, P660, DOI 10.1016/j.nmd.2018.06.005
   Fernando R, 2019, FREE RADICAL BIO MED, V132, P58, DOI 10.1016/j.freeradbiomed.2018.08.037
   Ferrer I, 2004, J NEUROPATH EXP NEUR, V63, P484, DOI 10.1093/jnen/63.5.484
   Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2
   Fraser JK, 2014, ADV WOUND CARE, V3, P38, DOI 10.1089/wound.2012.0408
   Fratta P, 2005, AM J PATHOL, V167, P517, DOI 10.1016/S0002-9440(10)62994-X
   Fyhr IM, 1997, J NEUROIMMUNOL, V79, P185, DOI 10.1016/S0165-5728(97)00122-7
   Fyhr IM, 1996, SCAND J IMMUNOL, V43, P109, DOI 10.1046/j.1365-3083.1996.d01-10.x
   Fyhr IM, 1998, J NEUROIMMUNOL, V91, P129, DOI 10.1016/S0165-5728(98)00163-5
   Gao ZY, 2022, FRONT IMMUNOL, V13, P0, DOI 10.3389/fimmu.2022.977394
   Georgantas RW, 2014, ARTHRITIS RHEUMATOL, V66, P1022, DOI 10.1002/art.38292
   Girolamo F, 2013, NEUROPATH APPL NEURO, V39, P736, DOI 10.1111/nan.12040
   Goebels N, 1996, J CLIN INVEST, V97, P2905, DOI 10.1172/JCI118749
   Gonzalez Chapa Jorge Armando, 2024, CLIN EXP RHEUMATOL, V42, P394, DOI 10.55563/clinexprheumatol/5lfq5x
   Gonzalez-Chapa JA, 2023, RAMBAM MAIMONIDES ME, V14, P0, DOI 10.5041/RMMJ.10493
   Goodman Brent P, 2012, J CLIN NEUROMUSCUL DIS, V14, P78, DOI 10.1097/CND.0b013e3182650718
   Goronzy JJ, 2007, EXP GERONTOL, V42, P400, DOI 10.1016/j.exger.2006.11.016
   Goronzy JJ, 2019, NAT REV IMMUNOL, V19, P573, DOI 10.1038/s41577-019-0180-1
   Goyal NA, 2016, J NEUROL NEUROSUR PS, V87, P373, DOI 10.1136/jnnp-2014-310008
   Greenberg SA, 2005, NEUROLOGY, V65, P1782, DOI 10.1212/01.wnl.0000187124.92826.20
   Greenberg SA, 2007, MUSCLE NERVE, V35, P17, DOI 10.1002/mus.20649
   Greenberg SA, 2006, MUSCLE NERVE, V34, P406, DOI 10.1002/mus.20584
   Greenberg SA, 2019, BRAIN, V142, P2590, DOI 10.1093/brain/awz207
   Greenberg SA, 2019, NAT REV RHEUMATOL, V15, P257, DOI 10.1038/s41584-019-0186-x
   Greenberg SA, 2014, MUSCLE NERVE, V50, P488, DOI 10.1002/mus.24199
   Greenberg SA, 2009, CURR OPIN NEUROL, V22, P516, DOI 10.1097/WCO.0b013e3283311ddf
   GÃ¼ttsches AK, 2017, ANN NEUROL, V81, P227, DOI 10.1002/ana.24847
   Guimaraes JB, 2017, AM J ROENTGENOL, V209, P1340, DOI 10.2214/AJR.17.17849
   Hanna MG, 2019, LANCET NEUROL, V18, P834, DOI 10.1016/S1474-4422(19)30200-5
   Hedberg-Oldfors C, 2021, BRAIN PATHOL, V31, P0, DOI 10.1111/bpa.12931
   Herbert MK, 2016, ANN RHEUM DIS, V75, P696, DOI 10.1136/annrheumdis-2014-206691
   Lain AH, 2011, J NEUROL NEUROSUR PS, V82, P1414, DOI 10.1136/jnnp.2010.208868
   Hiniker A, 2013, ACTA NEUROPATHOL COM, V1, P0, DOI 10.1186/2051-5960-1-29
   Hofbauer M, 2003, P NATL ACAD SCI USA, V100, P4090, DOI 10.1073/pnas.0236183100
   Hollemann D, 2008, J NEUROPATH EXP NEUR, V67, P711, DOI 10.1097/NEN.0b013e31817d8064
   Huang MX, 2021, PROG NEUROBIOL, V204, P0, DOI 10.1016/j.pneurobio.2021.102114
   Ikenaga C, 2021, ANN CLIN TRANSL NEUR, V8, P571, DOI 10.1002/acn3.51294
   Ikezoe K, 2006, J NEUROL NEUROSUR PS, V77, P1187, DOI 10.1136/jnnp.2005.081810
   Iyer SR, 2021, EXP GERONTOL, V150, P0, DOI 10.1016/j.exger.2021.111338
   Jackson MJ, 2011, J PHYSIOL-LONDON, V589, P2139, DOI 10.1113/jphysiol.2011.206623
   Jiang Roy, 2023, IMMUNOHORIZONS, V7, P310, DOI 10.4049/immunohorizons.2200078
   JOFFE MM, 1993, AM J MED, V94, P379, DOI 10.1016/0002-9343(93)90148-I
   Johnson Liam G, 2009, J CLIN NEUROMUSCUL DIS, V10, P178, DOI 10.1097/CND.0b013e3181a23c86
   KADENBACH B, 1995, MUTAT RES-DNAGING G, V338, P161, DOI 10.1016/0921-8734(95)00021-W
   Kannanayakal TJ, 2008, NEUROSCI LETT, V431, P141, DOI 10.1016/j.neulet.2007.11.066
   KATAYAMA M, 1991, BIOCHEM INT, V25, P47
   Kitajima Y, 2020, J PHYSIOL SCI, V70, P0, DOI 10.1186/s12576-020-00768-9
   Kitazawa M, 2008, ANN NEUROL, V64, P15, DOI 10.1002/ana.21325
   Knauss S, 2019, NEUROL-NEUROIMMUNOL, V6, P0, DOI 10.1212/NXI.0000000000000558
   Kosmidis ML, 2019, NEUROL-NEUROIMMUNOL, V6, P0, DOI 10.1212/NXI.0000000000000581
   Kosmidis ML, 2013, J NEUROL SCI, V334, P123, DOI 10.1016/j.jns.2013.08.007
   KrystufkovÃ¡ O, 2009, ANN RHEUM DIS, V68, P836, DOI 10.1136/ard.2008.091405
   Kumamoto T, 2004, ACTA NEUROPATHOL, V107, P59, DOI 10.1007/s00401-003-0774-2
   Kummer K, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms241310675
   Kuswanto W, 2016, IMMUNITY, V44, P355, DOI 10.1016/j.immuni.2016.01.009
   Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955
   Larman HB, 2013, ANN NEUROL, V73, P408, DOI 10.1002/ana.23840
   Lax NZ, 2011, NEUROSCIENTIST, V17, P645, DOI 10.1177/1073858411385469
   Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098
   LEFF RL, 1993, MEDICINE, V72, P225, DOI 10.1097/00005792-199307000-00002
   Li K, 2014, PROTEOME SCI, V12, P0, DOI 10.1186/s12953-014-0045-2
   Li XH, 2020, MOL CANCER, V19, P0, DOI 10.1186/s12943-020-1138-4
   Lilleker JB, 2017, ANN RHEUM DIS, V76, P0, DOI 10.1136/annrheumdis-2016-210282
   Lindberg C, 2003, NEUROLOGY, V61, P260, DOI 10.1212/01.WNL.0000071852.27182.C7
   LINDBERG C, 1995, SCAND J IMMUNOL, V41, P421, DOI 10.1111/j.1365-3083.1995.tb03587.x
   LINDBERG C, 1994, EUR J IMMUNOL, V24, P2659, DOI 10.1002/eji.1830241114
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Liu WJ, 2016, CELL MOL BIOL LETT, V21, P0, DOI 10.1186/s11658-016-0031-z
   Liu ZH, 2022, CELL BIOSCI, V12, P0, DOI 10.1186/s13578-022-00805-7
   Lloyd TE, 2016, ARTHRIT CARE RES, V68, P66, DOI 10.1002/acr.22600
   de Padilla CML, 2008, CURR OPIN RHEUMATOL, V20, P669, DOI 10.1097/BOR.0b013e3283157538
   LÃ³pez-OtÃ­n C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lucchini M, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms241311139
   Lucchini M, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10051146
   LÃ¼nemann JD, 2007, ANN NEUROL, V61, P476, DOI 10.1002/ana.21115
   Masters SL, 2011, TRENDS MOL MED, V17, P276, DOI 10.1016/j.molmed.2011.01.005
   Matsubara S, 2022, J NEUROPATH EXP NEUR, V81, P825, DOI 10.1093/jnen/nlac067
   Maurage CA, 2004, NEUROPATH APPL NEURO, V30, P624, DOI 10.1111/j.1365-2990.2004.00577.x
   McConkey DJ, 2012, ADV CANCER RES, V116, P131, DOI 10.1016/B978-0-12-394387-3.00004-5
   McCord B, 2023, SCI REP-UK, V13, P0, DOI 10.1038/s41598-023-42824-5
   Mcleish E, 2024, BRIEF BIOINFORM, V25, P0, DOI 10.1093/bib/bbad514
   Mendell JR, 2017, MOL THER, V25, P870, DOI 10.1016/j.ymthe.2017.02.015
   MENDELL JR, 1991, ARCH NEUROL-CHICAGO, V48, P1229, DOI 10.1001/archneur.1991.00530240033013
   Muller S, 2009, EUR J HISTOCHEM, V53, Pe12, DOI 10.4081/EJH.2009.E12
   MuÃ±oz-Braceras S, 2023, CELLS-BASEL, V12, P0, DOI 10.3390/cells12172198
   MÃ¼ntzing K, 2003, SCAND J IMMUNOL, V58, P195, DOI 10.1046/j.1365-3083.2003.01251.x
   Murakami A, 2022, ANN CLIN TRANSL NEUR, V9, P1602, DOI 10.1002/acn3.51657
   Murata K, 1999, AM J PATHOL, V155, P453, DOI 10.1016/S0002-9440(10)65141-3
   Jorgensen AN, 2022, SCAND J MED SCI SPOR, V32, P359, DOI 10.1111/sms.14079
   Naddaf E, 2022, FRONT NEUROL, V13, P0, DOI 10.3389/fneur.2022.1020113
   Nagy S, 2023, J NEUROL, V270, P1787, DOI 10.1007/s00415-022-11459-3
   Nakano S, 2001, NEUROLOGY, V56, P87, DOI 10.1212/WNL.56.1.87
   Nakano S, 2008, NEUROMUSCULAR DISORD, V18, P27, DOI 10.1016/j.nmd.2007.08.005
   Nalbandian A, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0122888
   NALBANTOGLU J, 1994, AM J PATHOL, V144, P874
   Needham M, 2008, J CLIN NEUROSCI, V15, P1350, DOI 10.1016/j.jocn.2008.01.011
   Nelke C, 2023, ACTA NEUROPATHOL, V146, P725, DOI 10.1007/s00401-023-02637-2
   Nogalska A, 2006, J NEUROCHEM, V96, P1491, DOI 10.1111/j.1471-4159.2006.03668.x
   Nogalska A, 2007, EXP NEUROL, V204, P610, DOI 10.1016/j.expneurol.2006.12.014
   Nogalska A, 2015, J NEUROPATH EXP NEUR, V74, P538, DOI 10.1097/NEN.0000000000000196
   Nogalska A, 2010, ACTA NEUROPATHOL, V120, P661, DOI 10.1007/s00401-010-0737-3
   Nogalska A, 2010, AM J PATHOL, V177, P1377, DOI 10.2353/ajpath.2010.100050
   Nogalska A, 2009, ACTA NEUROPATHOL, V118, P407, DOI 10.1007/s00401-009-0564-6
   Oh TH, 2008, AM J PHYS MED REHAB, V87, P883, DOI 10.1097/PHM.0b013e31818a50e2
   OHANLON TP, 1994, J AUTOIMMUN, V7, P321, DOI 10.1006/jaut.1994.1023
   Oikawa Y, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0231064
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   Olzmann JA, 2008, CURR MED CHEM, V15, P47
   ORIMO S, 1994, NEUROMUSCULAR DISORD, V4, P219, DOI 10.1016/0960-8966(94)90022-1
   Oyama M, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0237890
   Pandya JM, 2010, ARTHRITIS RHEUM-US, V62, P3457, DOI 10.1002/art.27665
   Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015
   Pars K, 2013, MUSCLE NERVE, V48, P838, DOI 10.1002/mus.23895
   Pathak RU, 2021, AGEING RES REV, V67, P0, DOI 10.1016/j.arr.2021.101264
   Paul P, 2021, MUSCLE NERVE, V63, P490, DOI 10.1002/mus.27157
   Peng TI, 2006, BBA-MOL BASIS DIS, V1762, P241, DOI 10.1016/j.bbadis.2005.10.008
   Perandini LA, 2018, FEBS J, V285, P1973, DOI 10.1111/febs.14417
   Peterson Courtney M, 2012, J AGING RES, V2012, P194821, DOI 10.1155/2012/194821
   Phillips BA, 2001, MUSCLE NERVE, V24, P1526, DOI 10.1002/mus.1178
   Pinal-Fernandez I, 2020, ANN RHEUM DIS, V79, P1234, DOI 10.1136/annrheumdis-2019-216599
   Pinal-Fernandez I, 2019, NEUROLOGY, V93, PE1193, DOI 10.1212/WNL.0000000000008128
   Pinkus JL, 2014, NEUROMUSCULAR DISORD, V24, P611, DOI 10.1016/j.nmd.2014.04.012
   Pinto MV, 2022, RHEUMATOLOGY, V61, P2504, DOI 10.1093/rheumatology/keab754
   Pluk H, 2013, ANN NEUROL, V73, P397, DOI 10.1002/ana.23822
   Price Mark A, 2016, J NEUROMUSCUL DIS, V3, P67
   Read A, 2021, BIOLOGY-BASEL, V10, P0, DOI 10.3390/biology10050384
   Rietveld A, 2018, FRONT IMMUNOL, V9, P0, DOI 10.3389/fimmu.2018.01200
   Roos A, 2019, FRONT IMMUNOL, V10, P0, DOI 10.3389/fimmu.2019.01040
   Rutkove SB, 2002, NEUROLOGY, V58, P1081, DOI 10.1212/WNL.58.7.1081
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Sabadashka M, 2021, CELL BIOL INT, V45, P481, DOI 10.1002/cbin.11301
   Sachdev R, 2018, MOL NEUROBIOL, V55, P8355, DOI 10.1007/s12035-018-0997-9
   Salajegheh M, 2007, NEUROLOGY, V69, P1672, DOI 10.1212/01.wnl.0000265398.77681.09
   Salajegheh M, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0020266
   Salajegheh M, 2010, MUSCLE NERVE, V42, P576, DOI 10.1002/mus.21739
   Salam N, 2013, INDIAN J MED RES, V138, P595
   Salam S, 2023, CLIN EXP RHEUMATOL, V41, P340, DOI 10.55563/clinexprheumatol/jq7zxd
   Saperstein D, 2016, NEUROLOGY, V86, P0
   SARKOZI E, 1993, NEUROREPORT, V4, P815, DOI 10.1097/00001756-199306000-00055
   Satoh M, 2017, CLIN REV ALLERG IMMU, V52, P1, DOI 10.1007/s12016-015-8510-y
   Saule P, 2006, MECH AGEING DEV, V127, P274, DOI 10.1016/j.mad.2005.11.001
   Schiaffino S, 2017, FEBS J, V284, P517, DOI 10.1111/febs.13827
   Schmidt J, 2004, BRAIN, V127, P1182, DOI 10.1093/brain/awh148
   Schmidt J, 2008, BRAIN, V131, P1228, DOI 10.1093/brain/awn053
   Schmidt K, 2016, BMC NEUROL, V16, P0, DOI 10.1186/s12883-016-0568-5
   Shi FS, 2015, LIFE SCI, V135, P9, DOI 10.1016/j.lfs.2015.05.011
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Skolka MP, 2023, CURR OPIN RHEUMATOL, V35, P404, DOI 10.1097/BOR.0000000000000958
   Sontag EM, 2017, ANNU REV BIOCHEM, V86, P97, DOI 10.1146/annurev-biochem-060815-014616
   Soto-Heredero G, 2023, ANNU REV IMMUNOL, V41, P181, DOI 10.1146/annurev-immunol-101721-064501
   Spector SA, 1997, MUSCLE NERVE, V20, P1242, DOI 10.1002/(SICI)1097-4598(199710)20:10<1242::AID-MUS6>3.3.CO;2-X
   Spits H, 2002, NAT REV IMMUNOL, V2, P760, DOI 10.1038/nri913
   Strioga M, 2011, IMMUNOLOGY, V134, P17, DOI 10.1111/j.1365-2567.2011.03470.x
   Sultan SM, 2008, CLIN EXP RHEUMATOL, V26, P887
   Szczesny B, 2010, MECH AGEING DEV, V131, P330, DOI 10.1016/j.mad.2010.03.009
   Tanida Isei, 2008, V445, V0, PP77, DOI 10.1007/978-1-59745-157-4_4
   Tasca G, 2015, MUSCLE NERVE, V52, P956, DOI 10.1002/mus.24661
   Tawara N, 2017, ANN NEUROL, V81, P512, DOI 10.1002/ana.24919
   Tawil R, 2004, NEUROLOGY, V63, P718
   Terracciano C, 2008, FREE RADICAL BIO MED, V45, P773, DOI 10.1016/j.freeradbiomed.2008.05.030
   Terracciano C, 2010, J NEUROCHEM, V112, P389, DOI 10.1111/j.1471-4159.2009.06461.x
   Thomas AC, 2014, FRONT IMMUNOL, V5, P0, DOI 10.3389/fimmu.2014.00478
   Toth MJ, 2005, AM J PHYSIOL-ENDOC M, V288, PE883, DOI 10.1152/ajpendo.00353.2004
   Tsuruta Y, 2002, ACTA NEUROPATHOL, V103, P59, DOI 10.1007/s004010100428
   Valentini N, 2023, CLIN EXP IMMUNOL, V213, P40, DOI 10.1093/cei/uxad051
   Vattemi G, 2004, AM J PATHOL, V164, P1, DOI 10.1016/S0002-9440(10)63089-1
   Vattemi G, 2003, EXP NEUROL, V179, P150, DOI 10.1016/S0014-4886(02)00025-0
   Vattemi G, 2001, LANCET, V358, P1962, DOI 10.1016/S0140-6736(01)06969-0
   Vattemi G, 2014, AUTOIMMUN HIGHLIGHTS, V5, P77, DOI 10.1007/s13317-014-0062-2
   Vattemi G, 2009, ACTA NEUROPATHOL, V117, P569, DOI 10.1007/s00401-009-0511-6
   Wallace A, 2019, NEUROLOGY, V92, PE1773, DOI 10.1212/WNL.0000000000007265
   Walston JD, 2012, CURR OPIN RHEUMATOL, V24, P623, DOI 10.1097/BOR.0b013e328358d59b
   Walter MC, 2000, J NEUROL, V247, P22, DOI 10.1007/s004150050005
   Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038
   Wanschitz JV, 2013, NEUROMUSCULAR DISORD, V23, P75, DOI 10.1016/j.nmd.2012.09.003
   Waschbisch A, 2008, ARTHRITIS RHEUM, V58, P3600, DOI 10.1002/art.23997
   Wei YH, 1998, ANN NY ACAD SCI, V854, P155, DOI 10.1111/j.1749-6632.1998.tb09899.x
   Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401
   Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862
   Wilczynski GM, 2000, AM J PATHOL, V156, P1835, DOI 10.1016/S0002-9440(10)65056-0
   Wilczynski GM, 2000, NEUROSCI LETT, V293, P33, DOI 10.1016/S0304-3940(00)01485-3
   Williams Gary, 1994, AMERICAN JOURNAL OF PHYSIOLOGY, V267, P0
   WÃ³jcik S, 2005, ACTA NEUROPATHOL, V110, P173, DOI 10.1007/s00401-005-1035-3
   Wojcik S, 2006, NEUROMUSCULAR DISORD, V16, P839, DOI 10.1016/j.nmd.2006.08.009
   Wu JH, 2022, CELL DEATH DIS, V13, P0, DOI 10.1038/s41419-022-05142-8
   Yamashita S, 2023, J NEUROL NEUROSUR PS, V94, P1018, DOI 10.1136/jnnp-2023-331474
   Yang CC, 1996, NEUROREPORT, V8, P153, DOI 10.1097/00001756-199612200-00031
   Yao J, 2024, SIGNAL TRANSDUCT TAR, V9, P0, DOI 10.1038/s41392-023-01687-y
   Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X
   Zhen C, 2022, FRONT IMMUNOL, V13, P0, DOI 10.3389/fimmu.2022.1051609
   Zubair AS, 2023, FRONT NEUROL, V14, P0, DOI 10.3389/fneur.2023.1146015
NR 272
TC 2
Z9 2
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAR 15
PY 2024
VL 25
IS 5
BP 
EP 
DI 10.3390/ijms25052742
PG 32
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA KV3V9
UT WOS:001182708700001
PM 38473988
DA 2024-11-01
ER

PT J
AU Chin, HL
   San Lai, P
   Tay, SKH
AF Chin, Hui -Lin
   San Lai, Poh
   Tay, Stacey Kiat Hong
TI A clinical approach to diagnosis and management of mitochondrial myopathies
SO NEUROTHERAPEUTICS
LA English
DT Review
DE Mitochondrial myopathy; Mitochondrial disease; Genetic sequencing; Diagnostic approach; Mitochondrial disease treatment
ID replacement therapy; lactic-acidosis; mouse model; mutation; diseases; gene; deficiency; exercise; metabolism; disorders
AB This paper provides an overview of the different types of mitochondrial myopathies (MM), associated phenotypes, genotypes as well as a practical clinical approach towards disease diagnosis, surveillance, and management. nDNA-related MM are more common in pediatric-onset disease whilst mtDNA-related MMs are more frequent in adults. Genotype-phenotype correlation in MM is challenging due to clinical and genetic heterogeneity. The multisystemic nature of many MMs adds to the diagnostic challenge. Diagnostic approaches utilizing genetic sequencing with next generation sequencing approaches such as gene panel, exome and genome sequencing are available. This aids molecular diagnosis, heteroplasmy detection in MM patients and furthers knowledge of known mitochondrial genes. Precise disease diagnosis can end the diagnostic odyssey for patients, avoid unnecessary testing, provide prognosis, facilitate anticipatory management, and enable access to available therapies or clinical trials. Adjunctive tests such as functional and exercise testing could aid surveillance of MM patients. Management requires a multi-disciplinary approach, systemic screening for comorbidities, cofactor supplementation, avoidance of substances that inhibit the respiratory chain and exercise training. This update of the current understanding on MMs provides practical perspectives on current diagnostic and management approaches for this complex group of disorders.
C1 [Chin, Hui -Lin; Tay, Stacey Kiat Hong] Khoo Teck Puat Natl Univ, Childrens Med Inst, Natl Univ Hosp, Dept Paediat,Div Genet & Metab, Singapore, Singapore.
   [Chin, Hui -Lin; San Lai, Poh; Tay, Stacey Kiat Hong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore, Singapore.
   [Tay, Stacey Kiat Hong] Khoo Teck Puat Natl Univ, Natl Univ Hosp, Dept Paediat, Div Neurol,Childrens Med Inst, Singapore, Singapore.
C3 National University of Singapore; National University of Singapore; National University of Singapore
RP Tay, SKH (corresponding author), Khoo Teck Puat Natl Univ, Childrens Med Inst, Natl Univ Hosp, Dept Paediat,Div Genet & Metab, Singapore, Singapore.; Tay, SKH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore, Singapore.; Tay, SKH (corresponding author), Khoo Teck Puat Natl Univ, Natl Univ Hosp, Dept Paediat, Div Neurol,Childrens Med Inst, Singapore, Singapore.
EM paetaykh@nus.edu.sg
CR Abouhajar A, 2022, TRIALS, V23, P0, DOI 10.1186/s13063-022-06544-x
   Arena IG, 2022, J CLIN MED, V11, P0, DOI 10.3390/jcm11030632
   Ashworth BE, 2016, BMC NEUROSCI, V17, P0, DOI 10.1186/s12868-016-0259-6
   Barcelos I, 2020, CURR OPIN PEDIATR, V32, P707, DOI 10.1097/MOP.0000000000000954
   Bartsakoulia M, 2018, HUM MOL GENET, V27, P1186, DOI 10.1093/hmg/ddy033
   Basu S, 2020, PLOS GENET, V16, P0, DOI 10.1371/journal.pgen.1009242
   Bax BE, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8081096
   Bi R, 2022, INNOVATION-AMSTERDAM, V3, P0, DOI 10.1016/j.xinn.2022.100329
   Bian WP, 2019, ACS SYNTH BIOL, V8, P621, DOI 10.1021/acssynbio.8b00411
   Bottoni P, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms24010124
   Chini EN, 2020, CELL METAB, V31, P1041, DOI 10.1016/j.cmet.2020.05.013
   Cicero AFG, 2020, J CLIN LIPIDOL, V14, P646, DOI 10.1016/j.jacl.2020.07.007
   Comte C, 2013, NUCLEIC ACIDS RES, V41, P418, DOI 10.1093/nar/gks965
   DAnnibale OM, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11172635
   de Barcelos IP, 2019, CURR OPIN NEUROL, V32, P715, DOI 10.1097/WCO.0000000000000743
   de la Barca JMC, 2016, BRAIN, V139, P2864, DOI 10.1093/brain/aww222
   de Laat P, 2021, J MED GENET, V58, P48, DOI 10.1136/jmedgenet-2019-106800
   De Vries MC, 2020, J INHERIT METAB DIS, V43, P800, DOI 10.1002/jimd.12196
   Desbats MA, 2015, J INHERIT METAB DIS, V38, P145, DOI 10.1007/s10545-014-9749-9
   Di Meo I, 2017, GENE THER, V24, P661, DOI 10.1038/gt.2017.53
   Diebold I, 2019, MOL CELL PROBE, V44, P14, DOI 10.1016/j.mcp.2019.01.003
   Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003544
   DomÃ­nguez-GonzÃ¡lez C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Elstner M, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms222011080
   Eshaghi M, 2021, EUR J OPHTHALMOL, V31, P2064, DOI 10.1177/1120672120952344
   Fan SP, 2021, ENEUROLOGICALSCI, V24, P0
   Fan XY, 2022, NAT BIOMED ENG, V6, P339, DOI 10.1038/s41551-022-00881-7
   Fayssoil A, 2017, EUR J NEUROL, V24, P255, DOI 10.1111/ene.13176
   Finsterer J, 2018, J CLIN MED, V7, P0, DOI 10.3390/jcm7020016
   FRACKOWIAK RSJ, 1988, BRAIN, V111, P1009, DOI 10.1093/brain/111.5.1009
   Frascarelli C, 2023, FRONT GENET, V14, P0, DOI 10.3389/fgene.2023.1089956
   Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054
   Gervasoni J, 2020, GENES-BASEL, V11, P0, DOI 10.3390/genes11121522
   Giacci MK, 2015, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/52221
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Grazina MM, 2012, METHODS MOL BIOL, V837, P73, DOI 10.1007/978-1-61779-504-6_6
   Gwaltney C, 2022, J PATIENT-REP OUTCOM, V6, P0, DOI 10.1186/s41687-022-00534-y
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hathazi D, 2020, EMBO J, V39, P0, DOI 10.15252/embj.2020105364
   Hebbar M, 2017, EUR J MED GENET, V60, P533, DOI 10.1016/j.ejmg.2017.07.010
   Hemphill S, 2019, BRIT J ANAESTH, V122, P448, DOI 10.1016/j.bja.2018.12.025
   Hernandez-Voth A, 2020, BMJ OPEN RESPIR RES, V7, P0, DOI 10.1136/bmjresp-2020-000774
   Hinojosa JC, 2023, MUSCLES, V2, P75
   Hoppe K, 2017, ANASTH INTENSIVMED, V58, PS125, DOI 10.19224/ai2017.S125
   Hornby B, 2022, ORPHANET J RARE DIS, V17, P0, DOI 10.1186/s13023-022-02469-5
   Hsieh Vincent C, 2017, J. INBORN ERRORS METAB. SCREEN., V5, P0
   Ip EKK, 2022, FRONT GENET, V13, P0, DOI 10.3389/fgene.2022.692257
   Jeppesen TD, 2021, J CLIN MED, V10, P0, DOI 10.3390/jcm10081796
   Karaa A, 2023, NEUROLOGY, V101, PE238, DOI 10.1212/WNL.0000000000207402
   Karaa A, 2020, J CACHEXIA SARCOPENI, V11, P909, DOI 10.1002/jcsm.12559
   Karaa A, 2018, NEUROLOGY, V90, PE1212, DOI 10.1212/WNL.0000000000005255
   Kipper K, 2020, J CLIN MED, V9, P0, DOI 10.3390/jcm9030788
   Koene S, 2016, J INHERIT METAB DIS, V39, P705, DOI 10.1007/s10545-016-9948-7
   Koenig Mary Kay, 2023, JIMD REP, V64, P65, DOI 10.1002/jmd2.12335
   Koga Y, 2018, J NEUROL, V265, P2861, DOI 10.1007/s00415-018-9057-7
   Kyriakides T, 2010, EUR J NEUROL, V17, P767, DOI 10.1111/j.1468-1331.2010.03012.x
   Lee SB, 2019, NEUROCHEM INT, V129, P0, DOI 10.1016/j.neuint.2019.104491
   Legati A, 2017, J MED GENET, V54, P815, DOI 10.1136/jmedgenet-2017-104822
   Leslie ND, 1993, GENEREVIEWS(), V0, P0
   Levene M, 2019, J CLIN MED, V8, P0, DOI 10.3390/jcm8040457
   Lim AZ, 1993, GENEREVIEWS, V0, P0
   Lokken N, 2021, J INHERIT METAB DIS, V44, P1186, DOI 10.1002/jimd.12393
   Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087
   Lopez-Gomez C, 2021, ANN NEUROL, V90, P640, DOI 10.1002/ana.26185
   Macken WL, 2021, NAT REV NEUROL, V17, P215, DOI 10.1038/s41582-021-00455-2
   Madsen KL, 2020, NEUROLOGY, V94, PE687, DOI 10.1212/WNL.0000000000008861
   Mancuso M, 2019, DIAGNOSIS AND MANAGEMENT OF MITOCHONDRIAL DISORDERS, V0, P0, DOI DOI 10.1016/j.braindev.2012.08.006
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   Mancuso M, 2012, EXPERT OPIN PHARMACO, V13, P527, DOI 10.1517/14656566.2012.657177
   McCormick EM, 2020, HUM MUTAT, V41, P2028, DOI 10.1002/humu.24107
   Mok BY, 2022, NAT BIOTECHNOL, V40, P1378, DOI 10.1038/s41587-022-01256-8
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Montano V, 2021, ARCH BIOCHEM BIOPHYS, V697, P0, DOI 10.1016/j.abb.2020.108689
   Montano V, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000519
   Morovat A, 2017, J CLIN MED, V6, P0, DOI 10.3390/jcm6080080
   Scholle LM, 2020, GENES-BASEL, V11, P0, DOI 10.3390/genes11020212
   Munnich A, 1996, J INHERIT METAB DIS, V19, P521, DOI 10.1007/BF01799112
   Murray AJ, 2016, J PHYSIOL-LONDON, V594, P1137, DOI 10.1113/JP270079
   Nesbitt V, 2014, EUR J HUM GENET, V22, P1255, DOI 10.1038/ejhg.2014.35
   Noohi F, 2022, J LAW MED ETHICS, V50, P597, DOI 10.1017/jme.2022.98
   Ohsawa Y, 2019, J NEUROL NEUROSUR PS, V90, P529, DOI 10.1136/jnnp-2018-317964
   Okhuijsen-Kroes EJ, 2001, NEUROPEDIATRICS, V32, P183, DOI 10.1055/s-2001-17372
   Olimpio C, 2021, NEUROMUSCULAR DISORD, V31, P978, DOI 10.1016/j.nmd.2021.08.005
   Oncul U, 2021, J PEDIAT HEMATOL ONC, V43, PE592, DOI 10.1097/MPH.0000000000001806
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.107
   Guerrero-Molina MP, 2023, EUR J NEUROL, V30, P538, DOI 10.1111/ene.15626
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Pirinen E, 2020, CELL METAB, V31, P1078, DOI 10.1016/j.cmet.2020.04.008
   Porcelli S, 2016, J APPL PHYSIOL, V121, P699, DOI 10.1152/japplphysiol.00885.2015
   Protti A, 2010, CRIT CARE, V14, P0, DOI 10.1186/cc8885
   Qu CB, 2021, INT J BIOCHEM CELL B, V138, P0, DOI 10.1016/j.biocel.2021.106050
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Raymond FL, 2018, NAT REV GENET, V19, P399, DOI 10.1038/s41576-018-0022-1
   Reynaud-Dulaurier R, 2020, BRAIN, V143, P1686, DOI 10.1093/brain/awaa105
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Salehinejad MA, 2022, BRAIN BEHAV, V12, P0, DOI 10.1002/brb3.2724
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Schirris TJJ, 2015, CELL METAB, V22, P399, DOI 10.1016/j.cmet.2015.08.002
   Schoenmann N, 2023, BBA-MOL BASIS DIS, V1869, P0, DOI 10.1016/j.bbadis.2023.166769
   Schon KR, 2020, TRENDS GENET, V36, P702, DOI 10.1016/j.tig.2020.06.009
   Schrank B, 2017, NEUROMUSCULAR DISORD, V27, P473, DOI 10.1016/j.nmd.2017.02.005
   Seo KS, 2018, FRONT NEUROL, V9, P0, DOI 10.3389/fneur.2018.00552
   Silva-Pinheiro P, 2020, MOL THER-METH CLIN D, V17, P1071, DOI 10.1016/j.omtm.2020.04.026
   Spiegel R, 2014, EUR J HUM GENET, V22, P902, DOI 10.1038/ejhg.2013.269
   Steele H, 2020, EMBO MOL MED, V12, P0, DOI 10.15252/emmm.201911589
   Stefanetti RJ, 2022, NEUROLOGY, V98, PE2318, DOI 10.1212/WNL.0000000000200299
   Storgaard JH, 2022, J INHERIT METAB DIS, V45, P517, DOI 10.1002/jimd.12479
   Tachibana M, 2018, REPROD MED BIOL, V17, P421, DOI 10.1002/rmb2.12230
   Tarnopolsky MA, 2014, J CHILD NEUROL, V29, P1225, DOI 10.1177/0883073814538512
   Tinker RJ, 2021, MOL DIAGN THER, V25, P181, DOI 10.1007/s40291-020-00510-6
   Tolle I, 2023, EMBO REP, V24, P0, DOI 10.15252/embr.202255678
   Tomoda E, 2023, NUCLEIC ACIDS RES, V51, P7563, DOI 10.1093/nar/gkad139
   Tonin Y, 2014, J BIOL CHEM, V289, P13323, DOI 10.1074/jbc.M113.528968
   van de Weijer T, 2015, DIABETES, V64, P1193, DOI 10.2337/db14-0667
   van den Bersselaar LR, 2022, EUR J NEUROL, V29, P3486, DOI 10.1111/ene.15526
   Vandiver AR, 2022, MITOCHONDRION, V65, P176, DOI 10.1016/j.mito.2022.06.003
   Voet NBM, 2019, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD003907.pub5
   Wang J, 1993, GENEREVIEWS, V0, P0
   Wang W, 2023, ANN CLIN TRANSL NEUR, V10, P1035, DOI 10.1002/acn3.51787
   Zuccarini Nichole Suzzanne, 2016, J CLIN MED RES, V8, P753, DOI 10.14740/jocmr2687w
NR 124
TC 2
Z9 2
U1 12
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1933-7213
EI 1878-7479
J9 NEUROTHERAPEUTICS
JI Neurotherapeutics
PD JAN 15
PY 2024
VL 21
IS 1
BP 
EP 
DI 10.1016/j.neurot.2023.11.001
EA JAN 2024
PG 11
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA RC2N9
UT WOS:001225408900001
PM 38241155
DA 2024-11-01
ER

PT J
AU Ambrogetti, R
   Kavanagh, E
   Eltayeb, K
AF Ambrogetti, Robert
   Kavanagh, Ethan
   Eltayeb, Khalid
TI Late-onset mitochondrial encephalopathy with lactic acidosis and stroke-like episodes and the role of serial imaging
SO BMJ CASE REPORTS
LA English
DT Article
DE Neurology; Epilepsy and seizures; Neuro genetics; Genetics
ID transfer rnaleu(uur) gene; antiepileptic drugs; melas syndrome; mutation; dna; a3243g; prevalence; encephalomyopathy; diagnosis; myopathy
AB Mitochondria are essential for human metabolic function. Over 350 genetic mutations are associated with mitochondrial diseases, which are inherited in a matrilineal fashion. In mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS), defective mitochondrial function and resultant impaired cellular energy production compromise vascular perfusion in affected tissues. Early diagnostic criteria suggested the diagnosis should be considered in those under 40. However, a broader range of phenotypes are now recognised, including those that present for the first time later in life. The primary presenting feature in MELAS is a stroke-like episode invariably resulting in patients undergoing neuroradiological imaging. We present a case of a woman with a first presentation of a stroke-like episode and seizures in her 40s who was eventually diagnosed with MELAS. We detail her clinical presentation, treatment and diagnosis, emphasising the role of serial imaging in her diagnosis.
C1 [Ambrogetti, Robert] Univ Hosp Leicester NHS Trust, Internal Med, Leicester, England.
   [Kavanagh, Ethan] Univ Hosp Leicester NHS Trust, Leicester, England.
   [Eltayeb, Khalid] Univ Hosp Leicester NHS Trust, Neurol, Leicester, England.
C3 University of Leicester; University Hospitals of Leicester NHS Trust; University Hospitals of Leicester NHS Trust; University of Leicester; University of Leicester; University Hospitals of Leicester NHS Trust
RP Ambrogetti, R (corresponding author), Univ Hosp Leicester NHS Trust, Internal Med, Leicester, England.
EM robert.ambrogetti1@nhs.net
CR Coussa RG, 2021, SURV OPHTHALMOL, V66, P838, DOI 10.1016/j.survophthal.2021.02.008
   Deschauer M, 1999, NEUROMUSCULAR DISORD, V9, P305, DOI 10.1016/S0960-8966(99)00019-X
   Dickerson BC, 2005, NEW ENGL J MED, V353, P2271, DOI 10.1056/NEJMcpc059032
   Dimauro S, 2004, ANN NY ACAD SCI, V1011, P217, DOI 10.1196/annals.1293.022
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Esterhuizen K, 2019, MITOCHONDRION, V45, P38, DOI 10.1016/j.mito.2018.02.003
   Fan HC, 2021, LIFE-BASEL, V11, P0, DOI 10.3390/life11111111
   Finsterer J, 2020, AM J CASE REP, V21, P0, DOI 10.12659/AJCR.927938
   Finsterer J, 2012, EXPERT OPIN DRUG MET, V8, P71, DOI 10.1517/17425255.2012.644535
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hyslop LA, 2016, NATURE, V534, P383, DOI 10.1038/nature183030
   Imasawa T, 2023, HELIYON, V9, P0, DOI 10.1016/j.heliyon.2023.e14923
   Kanner AM, 2018, NEUROLOGY, V91, P82, DOI 10.1212/WNL.0000000000005756
   Khasminsky V, 2023, NEUROL-GENET, V9, P0, DOI 10.1212/NXG.0000000000200082
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   Li DY, 2022, FRONT GENET, V13, P0, DOI 10.3389/fgene.2022.951185
   Liu GL, 2020, J NEUROL SCI, V408, P0, DOI 10.1016/j.jns.2019.116562
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Malfatti E, 2013, NEUROLOGY, V80, P100, DOI 10.1212/WNL.0b013e31827b1a2f
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Mavraki E, 2023, EUR J HUM GENET, V31, P148, DOI 10.1038/s41431-022-01249-w
   McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ng Yi Shiau, 2019, WELLCOME OPEN RES, V4, P201, DOI 10.12688/wellcomeopenres.15599.1
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.107
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Pizzamiglio C, 2021, GENES-BASEL, V12, P0, DOI 10.3390/genes12101643
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Shen XY, 2021, NEUROSCIENCES, V26, P128, DOI 10.17712/nsj.2021.2.20200145
   Smeets Hubert J M, 2023, HANDB CLIN NEUROL, V194, P207, DOI 10.1016/B978-0-12-821751-1.00004-X
   Strandberg MC, 2020, ACTA NEUROL SCAND, V142, P323, DOI 10.1111/ane.13312
   Vossler DG, 2019, EPILEPSY CURR, V19, P83, DOI 10.1177/1535759719835353
   Wei W, 2019, SCIENCE, V364, P749, DOI 10.1126/science.aau6520
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
NR 41
TC 0
Z9 0
U1 1
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 
EI 1757-790X
J9 BMJ CASE REP
JI BMJ Case Rep.
PD FEB 15
PY 2024
VL 17
IS 2
BP 
EP 
DI 10.1136/bcr-2023-259102
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA JN3M7
UT WOS:001173809000015
PM 38417938
DA 2024-11-01
ER

PT J
AU Nogueira, C
   Pereira, C
   Silva, L
   Laranjeira, M
   Lopes, A
   Neiva, R
   Rodrigues, E
   Campos, T
   Martins, E
   Bandeira, A
   Coelho, M
   Magalhaes, M
   DamÃ¡sio, J
   Gaspar, A
   Janeiro, P
   Gomes, AL
   Ferreira, AC
   Jacinto, S
   Vieira, JP
   Diogo, L
   Santos, H
   MendonÃ§a, C
   Vilarinho, L
AF Nogueira, C.
   Pereira, C.
   Silva, L.
   Laranjeira, Mateus
   Lopes, A.
   Neiva, R.
   Rodrigues, E.
   Campos, T.
   Martins, E.
   Bandeira, A.
   Coelho, M.
   Magalhaes, M.
   Damasio, J.
   Gaspar, A.
   Janeiro, P.
   Gomes, A. Levy
   Ferreira, A. C.
   Jacinto, S.
   Vieira, J. P.
   Diogo, L.
   Santos, H.
   Mendonca, C.
   Vilarinho, L.
TI The genetic landscape of mitochondrial diseases in the next-generation sequencing era: a Portuguese cohort study
SO FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE mitochondrial diseases; next-generation sequencing; mitochondrial DNA; nuclear DNA; nuclear genes; respiratory chain; oxidative phosphorylation
ID a3243g mutation; leigh-syndrome; dna; spectrum; variants; myopathy; deletions; death
AB Introduction: Rare disorders that are genetically and clinically heterogeneous, such as mitochondrial diseases (MDs), have a challenging diagnosis. Nuclear genes codify most proteins involved in mitochondrial biogenesis, despite all mitochondria having their own DNA. The development of next-generation sequencing (NGS) technologies has revolutionized the understanding of many genes involved in the pathogenesis of MDs. In this new genetic era, using the NGS approach, we aimed to identify the genetic etiology for a suspected MD in a cohort of 450 Portuguese patients.Methods: We examined 450 patients using a combined NGS strategy, starting with the analysis of a targeted mitochondrial panel of 213 nuclear genes, and then proceeding to analyze the whole mitochondrial DNA.Results and Discussion: In this study, we identified disease-related variants in 134 (30%) analyzed patients, 88 with nuclear DNA (nDNA) and 46 with mitochondrial DNA (mtDNA) variants, most of them being pediatric patients (66%), of which 77% were identified in nDNA and 23% in mtDNA. The molecular analysis of this cohort revealed 72 already described pathogenic and 20 novel, probably pathogenic, variants, as well as 62 variants of unknown significance. For this cohort of patients with suspected MDs, the use of a customized gene panel provided a molecular diagnosis in a timely and cost-effective manner. Patients who cannot be diagnosed after this initial approach will be further selected for whole-exome sequencing.Conclusion: As a national laboratory for the study and research of MDs, we demonstrated the power of NGS to achieve a molecular etiology, expanding the mutational spectrum and proposing accurate genetic counseling in this group of heterogeneous diseases without therapeutic options.
C1 [Nogueira, C.; Silva, L.; Laranjeira, Mateus; Vilarinho, L.] Natl Inst Hlth Doutor Ricardo Jorge, Human Genet Dept, Res & Dev Unit, Lisbon, Portugal.
   [Nogueira, C.; Pereira, C.; Silva, L.; Lopes, A.; Neiva, R.; Vilarinho, L.] Natl Inst Hlth Doutor Ricardo Jorge, Human Genet Dept, Newborn Screening Metab & Genet Unit, Lisbon, Portugal.
   [Rodrigues, E.; Campos, T.] Sao Joao Hosp Univ Ctr, Inherited Metab Dis Reference Ctr, Porto, Portugal.
   [Martins, E.; Bandeira, A.; Coelho, M.] Santo Antonio Hosp Univ Ctr, Inherited Metab Dis Reference Ctr, Porto, Portugal.
   [Magalhaes, M.; Damasio, J.] Santo Antonio Hosp Univ Ctr, Neurol Dept, Porto, Portugal.
   [Gaspar, A.; Janeiro, P.] Lisboa Norte Hosp Univ Ctr, Inherited Metab Dis Reference Ctr, Lisbon, Portugal.
   [Gomes, A. Levy] Lisboa Norte Hosp Univ Ctr, Neurol Dept, Lisbon, Portugal.
   [Ferreira, A. C.; Jacinto, S.; Vieira, J. P.] Lisboa Cent Hosp Ctr, Inherited Metab Dis Reference Ctr, Lisbon, Portugal.
   [Diogo, L.] Coimbra Hosp & Univ Ctr, Inherited Metab Dis Reference Ctr, Coimbra, Portugal.
   [Santos, H.] Vila Nova de Gaia Hosp Ctr, Inherited Metab Dis Reference Ctr, Vila Nova De Gaia, Portugal.
   [Mendonca, C.] Faro Hosp & Univ Ctr, Pediat Dept, Faro, Portugal.
C3 Instituto Nacional de Saude Dr. Ricardo Jorge; Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC)
RP Vilarinho, L (corresponding author), Natl Inst Hlth Doutor Ricardo Jorge, Human Genet Dept, Res & Dev Unit, Lisbon, Portugal.; Vilarinho, L (corresponding author), Natl Inst Hlth Doutor Ricardo Jorge, Human Genet Dept, Newborn Screening Metab & Genet Unit, Lisbon, Portugal.
EM laura.vilarinho@insa.min-saude.pt
FU FCT [PTDC/DTP-PIC/2220/2014]; NORTE 2020 [NORTE-01-0246-FEDER-000014]
CR Adzhubei Ivan, 2013, CURR PROTOC HUM GENET, VChapter 7, P0, DOI 10.1002/0471142905.hg0720s76
   Alston CL, 2010, NEUROMUSCULAR DISORD, V20, P131, DOI 10.1016/j.nmd.2009.10.010
   Baldo MS, 2023, GENES-BASEL, V14, P0, DOI 10.3390/genes14081536
   Cardaioli E, 2006, NEUROMUSCULAR DISORD, V16, P26, DOI 10.1016/j.nmd.2005.11.001
   Chin J, 2014, MITOCHONDRION, V17, P34, DOI 10.1016/j.mito.2014.05.005
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Eom S, 2017, PEDIATR NEUROL, V66, P82, DOI 10.1016/j.pediatrneurol.2016.10.006
   Falk MJ, 2020, MITOCHONDRIAL DISEASE GENES COMPENDIUM: FROM GENES TO CLINICAL MANIFESTATIONS, V0, P0
   Finsterer J, 2020, MEDICINE, V99, P0, DOI 10.1097/MD.0000000000018488
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   French CE, 2019, INTENS CARE MED, V45, P627, DOI 10.1007/s00134-019-05552-x
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Gomez MAR, 2020, RNA, V26, P910, DOI 10.1261/rna.071720.119
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Houshmand M, 1996, HUM GENET, V97, P269, DOI 10.1007/BF02185750
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892
   Kotrys AV, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9010017
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Lawless C, 2020, OPEN BIOL, V10, P0, DOI 10.1098/rsob.200061
   Maresca A, 2020, J MOL MED, V98, P1467, DOI 10.1007/s00109-020-01967-y
   McCormick EM, 2020, HUM MUTAT, V41, P2028, DOI 10.1002/humu.24107
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   Nogueira C, 2019, MITOCHONDRION, V47, P309, DOI 10.1016/j.mito.2019.02.006
   Ogawa E, 2017, J INHERIT METAB DIS, V40, P685, DOI 10.1007/s10545-017-0042-6
   Papadimitriou S, 2019, P NATL ACAD SCI USA, V116, P11878, DOI 10.1073/pnas.1815601116
   Papadopoulos C, 2020, J INHERIT METAB DIS, V43, P459, DOI 10.1002/jimd.12185
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pereira Cristina, 2019, J. INBORN ERRORS METAB. SCREEN., V7, Pe20180003, DOI 10.1590/2326-4594-jiems-2018-0003
   Poulton J, 2019, NEUROMUSCULAR DISORD, V29, P725, DOI 10.1016/j.nmd.2019.08.004
   Pronicka E, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-0930-9
   Rahman J, 2018, LANCET, V391, P2560, DOI 10.1016/S0140-6736(18)30727-X
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Riley LG, 2020, GENET MED, V22, P1254, DOI 10.1038/s41436-020-0793-6
   Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242
   Rucheton B, 2020, MITOCHONDRION, V55, P64, DOI 10.1016/j.mito.2020.08.004
   Schlieben LD, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.600079
   Schon KR, 2020, TRENDS GENET, V36, P702, DOI 10.1016/j.tig.2020.06.009
   Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575
   Sevini F, 2014, EXP GERONTOL, V56, P234, DOI 10.1016/j.exger.2014.03.022
   Shen XY, 2021, NEUROSCIENCES, V26, P128, DOI 10.17712/nsj.2021.2.20200145
   Simon M, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005097
   Sobenin IA, 2013, ATHEROSCLEROSIS, V227, P283, DOI 10.1016/j.atherosclerosis.2013.01.006
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Stenton SL, 2020, EBIOMEDICINE, V56, P0, DOI 10.1016/j.ebiom.2020.102784
   SterbovÃ¡ K, 2021, NEUROGENETICS, V22, P359, DOI 10.1007/s10048-021-00659-0
   Subathra M, 2016, ANN HUM GENET, V80, P257, DOI 10.1111/ahg.12161
   SWEENEY MG, 1993, Q J MED, V86, P709
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001
   Valiente-PallejÃ  A, 2018, HUM MOL GENET, V27, P891, DOI 10.1093/hmg/ddy009
   Vilarinho L, 1999, J NEUROL SCI, V163, P168, DOI 10.1016/S0022-510X(99)00030-1
   Vilarinho L, 1997, J MED GENET, V34, P607, DOI 10.1136/jmg.34.7.607
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wild KT, 2020, AM J MED GENET A, V182, P365, DOI 10.1002/ajmg.a.61433
   Wong TS, 2023, ORPHANET J RARE DIS, V18, P0, DOI 10.1186/s13023-023-02632-6
   Yoshimi A, 2022, ORPHANET J RARE DIS, V17, P0, DOI 10.1186/s13023-022-02538-9
   Zereg E, 2020, HUM MUTAT, V41, P1394, DOI 10.1002/humu.24037
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 65
TC 3
Z9 3
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-634X
EI 
J9 FRONT CELL DEV BIOL
JI Front. Cell. Dev. Biol.
PD FEB 23
PY 2024
VL 12
IS 
BP 
EP 
DI 10.3389/fcell.2024.1331351
PG 13
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA KB4Q7
UT WOS:001177492100001
PM 38465286
DA 2024-11-01
ER

PT J
AU Gogu, AE
   Jianu, DC
   Parv, F
   Motoc, AGM
   Axelerad, A
   Stuparu, AZ
   Gogu, AA
AF Gogu, Anca Elena
   Jianu, Dragos Catalin
   Parv, Florina
   Motoc, Andrei Gheorghe Marius
   Axelerad, Any
   Stuparu, Alina Zorina
   Gogu, Andreea Alexandra
TI Case report: Clinical profile, molecular genetics, and neuroimaging findings presenting in a patient with Kearns-Sayre syndrome associated with inherited thrombophilia
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE Kearns-Sayre syndrome (KSS); inherited thrombophilia; heart conduction block; brain magnetic resonance imaging; genetic tests
ID deficiency; disease; adults; block
AB BackgroundKearns-Sayre syndrome (KSS) is classified as one of the mitochondrial DNA (mtDNA) deletion syndromes with multisystemic involvement. Additionally, the negative prognosis is associated with inherited thrombophilia, which includes the presence of homozygous Factor V G1691A Leiden mutation, MTHFR gene polymorphisms C677T and A1298C, and PAI-1 675 homozygous genotype 5G/5G.Case presentationThis case report presents a 48-year-old man with chronic progressive external ophthalmoplegia, bilateral ptosis, cerebellar ataxia, cardiovascular signs (syncope, dilated cardiomyopathy, and cardiac arrest) with electrocardiographic abnormalities (first-degree atrioventricular block and major right bundle branch block), endocrine dysfunction (short stature, growth hormone insufficiency, primary gonadal insufficiency, hypothyroidism, and secondary hyperparathyroidism), molecular genetic tests (MT-TL2 gene), and abnormal MRI brain images, thus leading to the diagnosis of KSS. The patient came back 4 weeks after the diagnosis to the emergency department with massive bilateral pulmonary embolism with syncope at onset, acute cardiorespiratory failure, deep left femoral-popliteal vein thrombophlebitis, and altered neurological status. In the intensive care unit, he received mechanical ventilation through intubation. Significant improvement was seen after 2 weeks. The patient tested positive for inherited thrombophilia and was discharged in stable conditions on a new treatment with Rivaroxaban 20 mg/day. At 6 months of follow-up, ECG-Holter monitoring and MRI brain images remained unchanged. However, after 3 months, the patient died suddenly while sleeping at home.ConclusionThe genetic tests performed on KSS patients should also include those for inherited thrombophilia. By detecting these mutations, we can prevent major complications such as cerebral venous sinus thrombosis, coronary accidents, or sudden death.
C1 [Gogu, Anca Elena; Jianu, Dragos Catalin] Victor Babes Univ Med & Pharm, Dept Neurol, Timisoara, Romania.
   [Gogu, Anca Elena; Jianu, Dragos Catalin] Victor Babes Univ Med & Pharm, Fac Med, Ctr Cognit Res Neuropsychiat Pathol Neuropsy Cog, Timisoara, Romania.
   [Parv, Florina] Victor Babes Univ Med & Pharm, Dept Cardiol, Timisoara, Romania.
   [Motoc, Andrei Gheorghe Marius] Victor Babes Univ Med & Pharm, Dept Anat & Embryol, Timisoara, Romania.
   [Axelerad, Any; Stuparu, Alina Zorina] Ovidius Univ, Gen Med Fac, Dept Neurol, Constanta, Romania.
   [Gogu, Andreea Alexandra] Victor Babes Univ Med & Pharm, Med Fac, Timisoara, Romania.
C3 Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Ovidius University; Victor Babes University of Medicine & Pharmacy, Timisoara
RP Stuparu, AZ (corresponding author), Ovidius Univ, Gen Med Fac, Dept Neurol, Constanta, Romania.
EM zorina.stroe@yahoo.com
CR Alluri RV, 2005, EUR J NEUROL, V12, P40, DOI 10.1111/j.1468-1331.2004.00938.x
   Banka S, 2011, AM J HUM GENET, V88, P216, DOI 10.1016/j.ajhg.2011.01.004
   Barrera-RamÃ­rez CF, 2005, REV ESP CARDIOL, V58, P443
   Berardo A, 2010, CURR NEUROL NEUROSCI, V10, P118, DOI 10.1007/s11910-010-0096-4
   Cerri C, 1983, MITOCHONDRIAL PATHOL, V0, P141
   CHARLES R, 1981, CIRCULATION, V63, P214, DOI 10.1161/01.CIR.63.1.214
   Clamp M, 2003, KEARNS- SAYRE PTOSIS, V0, P0
   DiMauro S, 2007, TEXTBOOK OF CLINICAL NEUROLOGY, V0, P0
   DiMauro S, 2011, GENE REVIEWS SEATTLE, V0, P0
   Fattal-Valevski A, 2000, J CHILD NEUROL, V15, P539, DOI 10.1177/088307380001500808
   Gogu AE, 2021, METABOLITES, V11, P0, DOI 10.3390/metabo11050266
   Gogu AE, 2021, BRAIN SCI, V11, P0, DOI 10.3390/brainsci11010023
   Hirano M, 2001, CURR OPIN CARDIOL, V16, P201, DOI 10.1097/00001573-200105000-00008
   Jianu DC, 2022, LIFE, V12, P717, DOI 10.3390/life12050717
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   Ramaekers VT, 2007, NEUROPEDIATRICS, V38, P184, DOI 10.1055/s-2007-991150
   Ramaekers VT, 2022, NUTRIENTS, V14, P0, DOI 10.3390/nu14153096
   Ramaekers VT, 2004, DEV MED CHILD NEUROL, V46, P843, DOI 10.1017/S0012162204001471
   Serrano M, 2010, MITOCHONDRION, V10, P429, DOI 10.1016/j.mito.2010.04.001
   Shemesh A, 2023, KEARNS- SAYRE SYNDROME, V0, P0
   Tripathi R, 2010, GENET MOL BIOL, V33, P224, DOI 10.1590/S1415-47572010005000026
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Yu M, 2016, CHINESE MED J-PEKING, V129, P1419, DOI 10.4103/0366-6999.183417
NR 25
TC 0
Z9 0
U1 3
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
EI 
J9 FRONT NEUROL
JI Front. Neurol.
PD JAN 5
PY 2024
VL 14
IS 
BP 
EP 
DI 10.3389/fneur.2023.1320757
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FF2U4
UT WOS:001144290800001
PM 38249739
DA 2024-11-01
ER

PT J
AU Phua, QH
   Ng, SY
   Soh, BS
AF Phua, Qian Hua
   Ng, Shi Yan
   Soh, Boon-Seng
TI Mitochondria: A Potential Rejuvenation Tool against Aging
SO AGING AND DISEASE
LA English
DT Review
DE aging; mitochondria; mitotherapy; lifespan; healthspan
ID caloric restriction; life-span; skeletal-muscle; biochemical adaptations; parkinsons-disease; dna mutations; transplantation; reperfusion; expression; exercise
AB Aging is a complex physiological process encompassing both physical and cognitive decline over time. This intricate process is governed by a multitude of hallmarks and pathways, which collectively contribute to the emergence of numerous age-related diseases. In response to the remarkable increase in human life expectancy, there has been a substantial rise in research focusing on the development of anti-aging therapies and pharmacological interventions. Mitochondrial dysfunction, a critical factor in the aging process, significantly impacts overall cellular health. In this extensive review, we will explore the contemporary landscape of anti-aging strategies, placing particular emphasis on the promising potential of mitotherapy as a ground-breaking approach to counteract the aging process. Moreover, we will investigate the successful application of mitochondrial transplantation in both animal models and clinical trials, emphasizing its translational potential. Finally, we will discuss the inherent challenges and future possibilities of mitotherapy within the realm of aging research and intervention.
C1 [Phua, Qian Hua; Ng, Shi Yan; Soh, Boon-Seng] ASTAR, Inst Mol & Cell Biol IMCB, Proteos, Singapore.
   [Phua, Qian Hua; Soh, Boon-Seng] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.
   [Ng, Shi Yan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore.
   [Soh, Boon-Seng] Natl Neurosci Inst, Singapore, Singapore.
   [Soh, Boon-Seng] ASTAR, 61 Biopolis Dr, Proteos 138673, Singapore.
C3 Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore; National Neuroscience Institute (NNI); Agency for Science Technology & Research (A*STAR)
RP Soh, BS (corresponding author), ASTAR, 61 Biopolis Dr, Proteos 138673, Singapore.
EM bssoh@imcb.a-star.edu.sg
FU Agency for Science, Technology and Research (Singapore); A*STAR Graduate Scholarship
CR Acquistapace A, 2011, STEM CELLS, V29, P812, DOI 10.1002/stem.632
   Amari L, 2021, FRONT MOL NEUROSCI, V14, P0, DOI 10.3389/fnmol.2021.767219
   Amartuvshin O, 2020, AGING CELL, V19, P0, DOI 10.1111/acel.13191
   Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578
   Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004
   BALDWIN KM, 1972, AM J PHYSIOL, V222, P373, DOI 10.1152/ajplegacy.1972.222.2.373
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, PE1340, DOI 10.1152/ajpendo.2001.281.6.E1340
   Berridge MV, 2017, CLIN EXP PHARMACOL P, V44, P15, DOI 10.1111/1440-1681.12764
   Blitzer D, 2020, ANN THORAC SURG, V109, P711, DOI 10.1016/j.athoracsur.2019.06.075
   Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109
   Burgstaller JP, 2015, MOL HUM REPROD, V21, P11, DOI 10.1093/molehr/gau090
   Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035
   Caicedo A, 2017, STEM CELLS INT, V2017, P0, DOI 10.1155/2017/7610414
   CantÃ³ C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022
   Chang JC, 2016, TRANSL RES, V170, P40, DOI 10.1016/j.trsl.2015.12.003
   Chen G, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.00200
   Chinnery PF, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004315
   Chistiakov DA, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/238463
   Coletta DK, 2009, DIABETOLOGIA, V52, P723, DOI 10.1007/s00125-008-1256-9
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   Cowan DB, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0160889
   Dimond R, 2015, BRIT MED BULL, V115, P173, DOI 10.1093/bmb/ldv037
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Emani SM, 2017, J THORAC CARDIOV SUR, V154, P286, DOI 10.1016/j.jtcvs.2017.02.018
   Fang EF, 2019, NAT NEUROSCI, V22, P401, DOI 10.1038/s41593-018-0332-9
   Fu AL, 2017, FRONT PHARMACOL, V8, P0, DOI 10.3389/fphar.2017.00241
   Gabbita SP, 1997, FREE RADICAL BIO MED, V23, P191, DOI 10.1016/S0891-5849(97)00043-9
   Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001
   Gollihue JL, 2017, J NEUROSCI METH, V287, P1, DOI 10.1016/j.jneumeth.2017.05.023
   Gomzikova MO, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.653322
   Greaves LC, 2012, PLOS GENET, V8, P0, DOI 10.1371/journal.pgen.1003082
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Guariento A, 2021, J THORAC CARDIOV SUR, V162, P992, DOI 10.1016/j.jtcvs.2020.10.151
   Guariento A, 2020, J THORAC CARDIOV SUR, V160, PE15, DOI 10.1016/j.jtcvs.2019.06.111
   Guo J, 2022, IUBMB LIFE, V74, P296, DOI 10.1002/iub.2585
   Han HA, 2020, J MOL MED, V98, P615, DOI 10.1007/s00109-020-01893-z
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928
   Hayashida K, 2023, BMC MED, V21, P0, DOI 10.1186/s12916-023-02759-0
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421
   HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   Jacobs RA, 2013, J APPL PHYSIOL, V114, P344, DOI 10.1152/japplphysiol.01081.2012
   Janikiewicz J, 2018, CELL DEATH DIS, V9, P0, DOI 10.1038/s41419-017-0105-5
   Jassem W, 2006, J BIOENERG BIOMEMBR, V38, P49, DOI 10.1007/s10863-006-9005-6
   Jaul Efraim, 2017, FRONT PUBLIC HEALTH, V5, P335, DOI 10.3389/fpubh.2017.00335
   Javani G, 2022, MECH AGEING DEV, V202, P0, DOI 10.1016/j.mad.2022.111632
   JI LL, 1990, AM J PHYSIOL, V258, PR918, DOI 10.1152/ajpregu.1990.258.4.R918
   Ji ZJ, 2022, J GENET GENOMICS, V49, P287, DOI 10.1016/j.jgg.2021.11.005
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kaza AK, 2017, J THORAC CARDIOV SUR, V153, P934, DOI 10.1016/j.jtcvs.2016.10.077
   Koyanagi M, 2005, CIRC RES, V96, P1039, DOI 10.1161/01.RES.0000168650.23479.0c
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Laker RC, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00520-9
   Lambert AJ, 2004, EXP GERONTOL, V39, P289, DOI 10.1016/j.exger.2003.12.009
   Lanza IR, 2012, CELL METAB, V16, P777, DOI 10.1016/j.cmet.2012.11.003
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   Lin HC, 2013, SHOCK, V39, P543, DOI 10.1097/01.shk.0000430660.63077.7f
   Lin LW, 2019, AM J TRANSPLANT, V19, P1917, DOI 10.1111/ajt.15309
   Liu JK, 2022, NAT PRODUCT BIOPROSP, V12, P0, DOI 10.1007/s13659-022-00339-y
   Liu ZH, 2022, CELL BIOSCI, V12, P0, DOI 10.1186/s13578-022-00805-7
   LÃ³pez-OtÃ­n C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Madeo F, 2019, CELL METAB, V29, P592, DOI 10.1016/j.cmet.2019.01.018
   Madreiter-Sokolowski CT, 2018, GENES-BASEL, V9, P0, DOI 10.3390/genes9030165
   MÃ¤kelÃ¤ J, 2016, NEUROPHARMACOLOGY, V102, P266, DOI 10.1016/j.neuropharm.2015.11.020
   Manoli I, 2007, TRENDS ENDOCRIN MET, V18, P190, DOI 10.1016/j.tem.2007.04.004
   Markin AM, 2021, LIFE-BASEL, V11, P0, DOI 10.3390/life11020165
   Masuzawa A, 2013, AM J PHYSIOL-HEART C, V304, PH966, DOI 10.1152/ajpheart.00883.2012
   McCully JD, 2017, MITOCHONDRION, V34, P127, DOI 10.1016/j.mito.2017.03.004
   McCully JD, 2009, AM J PHYSIOL-HEART C, V296, PH94, DOI 10.1152/ajpheart.00567.2008
   Mehlman MJ, 2004, GERONTOLOGIST, V44, P304, DOI 10.1093/geront/44.3.304
   Mehrabani S, 2020, J CACHEXIA SARCOPENI, V11, P1447, DOI 10.1002/jcsm.12611
   Mesquita A, 2010, P NATL ACAD SCI USA, V107, P15123, DOI 10.1073/pnas.1004432107
   Miliotis S, 2019, MITOCHONDRION, V48, P16, DOI 10.1016/j.mito.2019.02.002
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   Moskowitzova K, 2020, AM J PHYSIOL-LUNG C, V318, PL78, DOI 10.1152/ajplung.00221.2019
   Nakano T, 2022, COMMUN BIOL, V5, P0, DOI 10.1038/s42003-022-03719-9
   Nawaz M, 2017, FRONT MOL BIOSCI, V4, P0, DOI 10.3389/fmolb.2017.00050
   Nicolson GL, 2014, ALTERN THER HEALTH M, V20, P18
   Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728
   Nitzan K, 2019, J ALZHEIMERS DIS, V72, P587, DOI 10.3233/JAD-190853
   Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300
   Pansarasa O, 1999, FREE RADICAL BIO MED, V27, P617, DOI 10.1016/S0891-5849(99)00108-2
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Pinto M, 2013, NEUROBIOL AGING, V34, P2399, DOI 10.1016/j.neurobiolaging.2013.04.014
   Porter C, 2015, MED SCI SPORT EXER, V47, P1922, DOI 10.1249/MSS.0000000000000605
   Ramirez-Barbieri G, 2019, MITOCHONDRION, V46, P103, DOI 10.1016/j.mito.2018.03.002
   Rana A, 2017, NAT COMMUN, V8, P0, DOI 10.1038/s41467-017-00525-4
   Rizza W, 2014, AGEING RES REV, V13, P38, DOI 10.1016/j.arr.2013.11.002
   RUBY JR, 1969, J MORPHOL, V127, P307, DOI 10.1002/jmor.1051270304
   Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133
   Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011
   Serna JDC, 2020, J BIOENERG BIOMEMBR, V52, P269, DOI 10.1007/s10863-020-09838-4
   Sharma A, 2019, EMBO REP, V20, P0, DOI 10.15252/embr.201948395
   Shi XX, 2017, MITOCHONDRION, V34, P91, DOI 10.1016/j.mito.2017.02.005
   Shindyapina AV, 2022, SCI ADV, V8, P0, DOI 10.1126/sciadv.abo5482
   Sinclair KA, 2016, STEM CELL RES THER, V7, P0, DOI 10.1186/s13287-016-0354-8
   Singh A, 2021, EBIOMEDICINE, V65, P0, DOI 10.1016/j.ebiom.2021.103244
   Stephens OR, 2020, MITOCHONDRION, V54, P102, DOI 10.1016/j.mito.2020.08.002
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   Tian T, 2018, BIOMATERIALS, V150, P137, DOI 10.1016/j.biomaterials.2017.10.012
   Todd AM, 2012, GENET MOL RES, V11, P1497, DOI 10.4238/2012.May.21.6
   Tranah GJ, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-30255-6
   Tranah GJ, 2015, J GERONTOL A-BIOL, V70, P1418, DOI 10.1093/gerona/glv097
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vainshtein A, 2015, SKELET MUSCLE, V5, P0, DOI 10.1186/s13395-015-0033-y
   van der Rijt S, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.594416
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vignais ML, 2017, STEM CELLS INT, V2017, P0, DOI 10.1155/2017/6917941
   Wu SH, 2018, ADV SCI, V5, P0, DOI 10.1002/advs.201700530
   Yang XB, 2021, COMPUT STRUCT BIOTEC, V19, P3319, DOI 10.1016/j.csbj.2021.06.003
   Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y
   Yasuda K, 2006, MECH AGEING DEV, V127, P763, DOI 10.1016/j.mad.2006.07.002
   Zhang ZQ, 2019, BEHAV BRAIN RES, V356, P322, DOI 10.1016/j.bbr.2018.09.005
   Zhao ZZ, 2020, INT J BIOL SCI, V16, P849, DOI 10.7150/ijbs.40886
NR 125
TC 5
Z9 5
U1 0
U2 23
PU INT SOC AGING & DISEASE
PI FORT WORTH
PA EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA
SN 2152-5250
EI 
J9 AGING DIS
JI Aging Dis.
PD APR 15
PY 2024
VL 15
IS 2
BP 503
EP 516
DI 10.14336/AD.2023.0712
EA OCT 2023
PG 14
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA LI6V5
UT WOS:001081924800001
PM 37815912
DA 2024-11-01
ER

PT J
AU Zhao, Y
   Hou, Y
   Zhao, XT
   Liufu, TL
   Yu, M
   Zhang, W
   Xie, ZY
   Zhang, VW
   Yuan, Y
   Wang, ZX
AF Zhao, Yang
   Hou, Yue
   Zhao, Xutong
   Liufu, Tongling
   Yu, Meng
   Zhang, Wei
   Xie, Zhiying
   Zhang, Victor Wei
   Yuan, Yun
   Wang, Zhaoxia
TI The clinical, myopathological, and genetic analysis of 155 Chinese mitochondrial ophthalmoplegia patients with mitochondrial DNA single large deletions
SO MOLECULAR GENETICS & GENOMIC MEDICINE
LA English
DT Article
DE chronic progressive external ophthalmoplegia; Kearns-Sayre syndrome; mitochondrial DNA; single large-scale deletion
ID progressive external ophthalmoplegia; mutations; diagnosis; genome
AB Background: Progressive external ophthalmoplegia (PEO) is a common subtype of mitochondrial encephalomyopathy.Objective: The study aimed to investigate the relationship between mitochondrial DNA (mtDNA) abnormalities, muscle pathology, and clinical manifestations in Chinese patients with single large-scale mtDNA deletion presenting with PEO.Methods: This is a retrospective single-center study. Patients with PEO who had a single large deletion in mitochondrial DNA were included in this study. The associations were analyzed between mtDNA deletion patterns, myopathological changes, and clinical characteristics.Results: In total, 155 patients with mitochondrial PEO carrying single large-scale mtDNA mutations were enrolled, including 137 chronic progressive external ophthalmoplegia (CPEO) and 18 Kearns-Sayre syndrome (KSS) patients. The onset ages were 9.61 +/- 4.12 in KSS and 20.15 +/- 9.06 in CPEO. The mtDNA deletions ranged from 2225 bp to 9131 bp, with m.8470_13446del being the most common. The KSS group showed longer deletions than the CPEO group (p = 0.004). Additionally, a higher number of deleted genes encoding respiratory chain complex subunits (p = 0.001) and tRNA genes (p = 0.009) were also observed in the KSS group. A weak negative correlation between the mtDNA deletion size and ages of onset (p < 0.001, r = -0.369) was observed. The proportion of ragged red fibers, ragged blue fibers, and cytochrome c negative fibers did not correlate significantly with onset ages (p > 0.05). However, a higher percentage of abnormal muscle fibers corresponds to an increased prevalence of exercise intolerance, limb muscle weakness, dysphagia, and cerebellar ataxia.Conclusion: We reported a large Chinese cohort consisting of mitochondrial PEO patients with single large-scale mtDNA deletions. Our results demonstrated that the length and locations of mtDNA deletions may influence onset ages and clinical phenotypes. The severity of muscle pathology could not only indicate diagnosis but also may be associated with clinical manifestations beyond the extraocular muscles.
C1 [Zhao, Yang; Zhao, Xutong; Liufu, Tongling; Yu, Meng; Zhang, Wei; Xie, Zhiying; Yuan, Yun; Wang, Zhaoxia] Peking Univ First Hosp, Dept Neurol, Beijing 100034, Peoples R China.
   [Zhao, Yang; Zhao, Xutong; Liufu, Tongling; Yu, Meng; Zhang, Wei; Xie, Zhiying; Yuan, Yun; Wang, Zhaoxia] Beijing Key Lab Neurovasc Dis Discovery, Beijing, Peoples R China.
   [Hou, Yue] Peking Univ First Hosp, Dept Geriatr, Beijing, Peoples R China.
   [Zhao, Xutong] Beijing Jishuitan Hosp, Dept Neurol, Beijing, Peoples R China.
   [Zhang, Victor Wei] AmCare Genom Lab, Guangzhou, Peoples R China.
C3 Peking University; Peking University
RP Wang, ZX (corresponding author), Peking Univ First Hosp, Dept Neurol, Beijing 100034, Peoples R China.
EM drwangzx@163.com
FU Ministry of Science and Technology of China
CR Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   AnteneovÃ¡ N, 2020, BRAIN SCI, V10, P0, DOI 10.3390/brainsci10110766
   BjÃ¶rkman K, 2023, J MED GENET, V60, P65, DOI 10.1136/jmedgenet-2021-108006
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chinault AC, 2009, GENET MED, V11, P518, DOI 10.1097/GIM.0b013e3181abd83c
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   DRACHMAN DA, 1968, ARCH NEUROL-CHICAGO, V18, P654, DOI 10.1001/archneur.1968.00470360076008
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Heighton JN, 2019, MITOCHONDRION, V49, P227, DOI 10.1016/j.mito.2019.09.002
   Heighton JN, 2019, MITOCHONDRION, V44, P15, DOI 10.1016/j.mito.2017.12.006
   Hou Y, 2022, MOL GENET GENOM MED, V10, P0, DOI 10.1002/mgg3.1921
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Liu CS, 2006, ACTA NEUROL SCAND, V113, P334, DOI 10.1111/j.1600-0404.2006.00586.x
   LÃ³pez-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Lott MT, 2013, CURR PROTOC BIOINF, V44, P1231, DOI 10.1002/0471250953.BI0123S44
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Paramasivam A, 2016, MITOCHONDRION, V26, P81, DOI 10.1016/j.mito.2015.12.006
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707
   Reichmann H, 1996, EUR NEUROL, V36, P98, DOI 10.1159/000117217
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   RodrÃ­guez-LÃ³pez C, 2020, J MED GENET, V57, P643, DOI 10.1136/jmedgenet-2019-106649
   Rygiel KA, 2016, J PHYSIOL-LONDON, V594, P4499, DOI 10.1113/JP271212
   Sadikovic B, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0015687
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Tanji K, 2000, BRAIN PATHOL, V10, P422
   Tetsuka S, 2021, METAB BRAIN DIS, V36, P2181, DOI 10.1007/s11011-021-00772-x
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Zhang GY, 2020, FRONT NEUROL, V11, P0, DOI 10.3389/fneur.2020.00036
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 35
TC 2
Z9 2
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2324-9269
EI 
J9 MOL GENET GENOM MED
JI Mol. Genet. Genom. Med.
PD JAN 15
PY 2024
VL 12
IS 1
BP 
EP 
DI 10.1002/mgg3.2328
EA NOV 2023
PG 11
WC Genetics & Heredity
SC Genetics & Heredity
GA MW4Q6
UT WOS:001110381900001
PM 38018320
DA 2024-11-01
ER

PT J
AU Lin, HP
   Petersen, JD
   Gilsrud, AJ
   Madruga, A
   D'Silva, TM
   Huang, XP
   Shammas, MK
   Randolph, NP
   Johnson, KR
   Li, Y
   Jones, DR
   Pacold, ME
   Narendra, DP
AF Lin, Hsin-Pin
   Petersen, Jennifer D.
   Gilsrud, Alexandra J.
   Madruga, Angelo
   D'Silva, Theresa M.
   Huang, Xiaoping
   Shammas, Mario K.
   Randolph, Nicholas P.
   Johnson, Kory R.
   Li, Yan
   Jones, Drew R.
   Pacold, Michael E.
   Narendra, Derek P.
TI DELE1 maintains muscle proteostasis to promote growth and survival in mitochondrial myopathy
SO EMBO JOURNAL
LA English
DT Article; Early Access
DE Mitochondria Unfolded Protein Response (mt-UPR); Mitophagy; Mitochondrial Disorders; Mitonuclear Communication; Mitohormesis
ID integrated stress-response; protease; opa1; inactivation; deficiency; metabolism
AB Mitochondrial dysfunction causes devastating disorders, including mitochondrial myopathy, but how muscle senses and adapts to mitochondrial dysfunction is not well understood. Here, we used diverse mouse models of mitochondrial myopathy to show that the signal for mitochondrial dysfunction originates within mitochondria. The mitochondrial proteins OMA1 and DELE1 sensed disruption of the inner mitochondrial membrane and, in response, activated the mitochondrial integrated stress response (mt-ISR) to increase the building blocks for protein synthesis. In the absence of the mt-ISR, protein synthesis in muscle was dysregulated causing protein misfolding, and mice with early-onset mitochondrial myopathy failed to grow and survive. The mt-ISR was similar following disruptions in mtDNA maintenance (Tfam knockout) and mitochondrial protein misfolding (CHCHD10 G58R and S59L knockin) but heterogenous among mitochondria-rich tissues, with broad gene expression changes observed in heart and skeletal muscle and limited changes observed in liver and brown adipose tissue. Taken together, our findings identify that the DELE1 mt-ISR mediates a similar response to diverse forms of mitochondrial stress and is critical for maintaining growth and survival in early-onset mitochondrial myopathy. Mitochondrial myopathies caused by diverse mitochondrial stressors, including mitochondrial DNA (mtDNA) depletion or mitochondrial protein misfolding, activate a similar transcriptional response in muscle. This report shows that this transcriptional response is predominately mediated by the DELE1-dependent mitochondrial integrated stress response (mt-ISR) pathway and is critical for maintaining growth and survival in mouse models.DELE1 is responsible for a protective ISR in response diverse mitochondrial stressors, including mtDNA depletion and mitochondrial protein misfolding.The DELE1-dependent mt-ISR is especially critical for growth and survival in the setting of early-onset mitochondrial stress.DELE1 and OMA1 have overlapping but separable protective effects in mitochondrial myopathies.The DELE1 mt-ISR increases the building blocks for cellular protein synthesis but fails to restore OXPHOS or resolve defects in mitochondrial structure.DELE1 is required to maintain folding of newly synthesized proteins in skeletal muscle under stress. DELE1, a mitochondrial stress signal, protects striated muscle cells by suppressing the misfolding of newly translated proteins.
C1 [Lin, Hsin-Pin; Petersen, Jennifer D.; Gilsrud, Alexandra J.; Madruga, Angelo; D'Silva, Theresa M.; Huang, Xiaoping; Shammas, Mario K.; Randolph, Nicholas P.; Narendra, Derek P.] NIH, Mitochondrial Biol & Neurodegenerat Unit, Neurogenet Branch, Natl Inst Neurol Disorders & Stroke, Bethesda, MD 20892 USA.
   [Johnson, Kory R.] NIH, Bioinformat Core, Natl Inst Neurol Disorders & Stroke, Bethesda, MD 20892 USA.
   [Li, Yan] NIH, Prote Core Facil, Natl Inst Neurol Disorders & Stroke, Bethesda, MD 20892 USA.
   [Jones, Drew R.] NYU Langone Hlth, Dept Biochem & Mol Pharmacol, New York, NY USA.
   [Pacold, Michael E.] NYU Langone Hlth, Dept Radiat Oncol, New York, NY USA.
   [Pacold, Michael E.] NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); NYU Langone Medical Center; NYU Langone Medical Center; NYU Langone Medical Center
RP Narendra, DP (corresponding author), NIH, Mitochondrial Biol & Neurodegenerat Unit, Neurogenet Branch, Natl Inst Neurol Disorders & Stroke, Bethesda, MD 20892 USA.
EM derek.narendra@nih.gov
FU National Institutes of Health
CR Ahola S, 2022, CELL METAB, V34, P1875, DOI 10.1016/j.cmet.2022.08.017
   Ajroud-Driss S, 2015, NEUROGENETICS, V16, P1, DOI 10.1007/s10048-014-0421-1
   Anderson CJ, 2019, ACTA NEUROPATHOL, V138, P103, DOI 10.1007/s00401-019-01989-y
   Austin S, 2022, EMBO REP, V23, P0, DOI 10.15252/embr.202254978
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Bao XR, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.10575
   Boal RL, 2019, J CLIN ENDOCR METAB, V104, P2057, DOI 10.1210/jc.2018-00957
   Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0
   Conrad R, 2023, CELL SYST, V14, P58, DOI 10.1016/j.cels.2022.12.006
   Das I, 2015, SCIENCE, V348, P239, DOI 10.1126/science.aaa4484
   de Theije CC, 2013, AM J PHYSIOL-LUNG C, V305, PL82, DOI 10.1152/ajplung.00354.2012
   Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004
   Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009
   Ducker GS, 2016, CELL METAB, V23, P1140, DOI 10.1016/j.cmet.2016.04.016
   Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084
   Fessler E, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-29479-y
   Fessler E, 2020, NATURE, V579, P433, DOI 10.1038/s41586-020-2076-4
   Flicker D, 2019, CELL REP, V27, P1364, DOI 10.1016/j.celrep.2019.04.013
   ForsstrÃ¶m S, 2019, CELL METAB, V30, P1040, DOI 10.1016/j.cmet.2019.013.019
   Franchino CA, 2024, BRAIN, V147, P1043, DOI 10.1093/brain/awad340
   Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478
   Geeraerts SL, 2021, NAT METAB, V3, P131, DOI 10.1038/s42255-020-00329-9
   Genin EC, 2019, ACTA NEUROPATHOL, V138, P123, DOI 10.1007/s00401-019-01988-z
   Gokhin DS, 2008, J EXP BIOL, V211, P837, DOI 10.1242/jeb.014340
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Guan BJ, 2017, MOL CELL, V68, P885, DOI 10.1016/j.molcel.2017.11.007
   Guo XY, 2020, NATURE, V579, P427, DOI 10.1038/s41586-020-2078-2
   Guyenet Stephan J, 2010, J VIS EXP, V0, P0, DOI DOI 10.3791/1787
   Hamanaka RB, 2013, SCI SIGNAL, V6, P0, DOI 10.1126/scisignal.2003638
   Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738
   Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100
   Hathazi D, 2020, EMBO J, V39, P0, DOI 10.15252/embj.2020105364
   He YJ, 2010, J BIOL CHEM, V285, P9516, DOI 10.1074/jbc.M109.092429
   Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083
   HeimanPatterson TD, 1997, MUSCLE NERVE, V20, P1219, DOI 10.1002/(SICI)1097-4598(199710)20:10<1219::AID-MUS2>3.0.CO;2-F
   Huang XP, 2018, HUM MOL GENET, V27, P3881, DOI 10.1093/hmg/ddy270
   Huynh H, 2023, J MOL CELL CARDIOL, V175, P44, DOI 10.1016/j.yjmcc.2022.12.003
   Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184
   Jena J, 2023, ELIFE, V12, P0, DOI 10.7554/eLife.86452
   Kachman M, 2020, BIOINFORMATICS, V36, P1801, DOI 10.1093/bioinformatics/btz798
   Kaspar S, 2021, SCI ADV, V7, P0, DOI 10.1126/sciadv.abf0971
   Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI 10.1038/NCHEMBIO.790
   Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008
   KÃ¼hl I, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.30952
   Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Levy JL, 2023, AM J PHYSIOL-ENDOC M, V325, PE624, DOI 10.1152/ajpendo.00181.2023
   Li YJ, 2023, RESEARCH-CHINA, V6, P0, DOI 10.34133/research.0175
   Liu YT, 2020, HUM MOL GENET, V29, P1547, DOI 10.1093/hmg/ddaa077
   Luengo A, 2021, MOL CELL, V81, P691, DOI 10.1016/j.molcel.2020.12.012
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   Mick E, 2020, ELIFE, V9, P0, DOI 10.7554/eLife.49178
   Miller MJ, 2023, GEROSCIENCE, V45, P2525, DOI 10.1007/s11357-023-00772-y
   Murata D, 2020, EMBO J, V39, P0, DOI 10.15252/embj.2020105074
   Nakano H, 2021, CELL TISSUE RES, V385, P239, DOI 10.1007/s00441-021-03450-7
   Nguyen MK, 2022, HUM MOL GENET, V31, P1500, DOI 10.1093/hmg/ddab329
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Nilsson R, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4128
   Ord T, 2023, PLOS GENET, V19, P0, DOI 10.1371/journal.pgen.1011014
   Osto Corey, 2020, CURR PROTOC CELL BIOL, V89, Pe116, DOI 10.1002/cpcb.116
   Overmyer KA, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0117232
   Pachitariu M, 2022, NAT METHODS, V19, P1634, DOI 10.1038/s41592-022-01663-4
   Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195
   Patron M, 2022, EMBO J, V41, P0, DOI 10.15252/embj.2021110476
   Pirinen E, 2020, CELL METAB, V31, P1078, DOI 10.1016/j.cmet.2020.04.008
   Postnikoff SDL, 2017, MICROB CELL, V4, P368, DOI 10.15698/mic2017.11.597
   QuirÃ³s PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058
   QuirÃ³s PM, 2012, EMBO J, V31, P2117, DOI 10.1038/emboj.2012.70
   Rath S, 2021, NUCLEIC ACIDS RES, V49, PD1541, DOI 10.1093/nar/gkaa1011
   Raudvere U, 2019, NUCLEIC ACIDS RES, V47, PW191, DOI 10.1093/nar/gkz369
   Ravi Venkatraman, 2020, CURR PROTOC MOL BIOL, V133, Pe127, DOI 10.1002/cpmb.127
   Rueden CT, 2017, BMC BIOINFORMATICS, V18, P0, DOI 10.1186/s12859-017-1934-z
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI 10.1038/nmeth.2019
   Schmidt EK, 2009, NAT METHODS, V6, P275, DOI 10.1038/NMETH.1314
   Sekine Y, 2023, MOL CELL, V83, P2059, DOI 10.1016/j.molcel.2023.05.031
   Seth PP, 2010, J ORG CHEM, V75, P1569, DOI 10.1021/jo902560f
   Shammas MK, 2022, J CLIN INVEST, V132, P0, DOI 10.1172/JCI157504
   Shi XJ, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-30126-9
   Stein KC, 2022, NATURE, V601, P637, DOI 10.1038/s41586-021-04295-4
   Stein KC, 2019, J BIOL CHEM, V294, P2076, DOI 10.1074/jbc.REV118.002814
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Vincent EE, 2015, MOL CELL, V60, P195, DOI 10.1016/j.molcel.2015.08.013
   Waisman A, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-91191-6
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang Y, 2021, NATURE, V599, P136, DOI 10.1038/s41586-021-04025-w
   Wek RC, 2018, CSH PERSPECT BIOL, V10, P0, DOI 10.1101/cshperspect.a032870
   Westbrook RL, 2022, CELL REP, V38, P0, DOI 10.1016/j.celrep.2022.110320
   White RB, 2010, BMC DEV BIOL, V10, P0, DOI 10.1186/1471-213X-10-21
   Wong YL, 2019, ELIFE, V8, P0, DOI 10.7554/eLife.42940
   Yang J, 2023, NAT STRUCT MOL BIOL, V30, P1295, DOI 10.1038/s41594-023-01061-0
   Zhang L, 2022, LIFE SCI ALLIANCE, V5, P0, DOI 10.26508/lsa.202201478
   Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445
   Zhu ST, 2022, CIRCULATION, V146, P1028, DOI 10.1161/CIRCULATIONAHA.122.059594
NR 95
TC 0
Z9 0
U1 2
U2 2
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD OCT 8
PY 2024
VL 0
IS 
BP 
EP 
DI 10.1038/s44318-024-00242-x
EA OCT 2024
PG 38
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA I2D0Q
UT WOS:001328401300001
PM 39379554
DA 2024-11-01
ER

PT J
AU Li, HZ
   Zeng, FC
   Huang, CC
   Pu, QQ
   Thomas, ER
   Chen, Y
   Li, X
AF Li, Hangzhen
   Zeng, Fancai
   Huang, Cancan
   Pu, Qiqi
   Thomas, Elizabeth Rosalind
   Chen, Yan
   Li, Xiang
TI The potential role of glucose metabolism, lipid metabolism, and amino acid metabolism in the treatment of Parkinson's disease
SO CNS NEUROSCIENCE & THERAPEUTICS
LA English
DT Review
DE amino acid metabolism; glucose metabolism; lipid metabolism; Parkinson's disease
ID mitochondrial-dna deletions; pentose-phosphate pathway; alpha-synuclein; oxidative stress; substantia-nigra; fatty-acids; cholesterol-metabolism; glutamate toxicity; insulin-resistance; antidiabetic drugs
AB Purpose of ReviewParkinson's disease (PD) is a common neurodegenerative disease, which can cause progressive deterioration of motor function causing muscle stiffness, tremor, and bradykinesia. In this review, we hope to describe approaches that can improve the life of PD patients through modifications of energy metabolism. Recent FindingsThe main pathological features of PD are the progressive loss of nigrostriatal dopaminergic neurons and the production of Lewy bodies. Abnormal aggregation of & alpha;-synuclein (& alpha;-Syn) leading to the formation of Lewy bodies is closely associated with neuronal dysfunction and degeneration. The main causes of PD are said to be mitochondrial damage, oxidative stress, inflammation, and abnormal protein aggregation. Presence of abnormal energy metabolism is another cause of PD. Many studies have found significant differences between neurodegenerative diseases and metabolic decompensation, which has become a biological hallmark of neurodegenerative diseases. In this review, we highlight the relationship between abnormal energy metabolism (Glucose metabolism, lipid metabolism, and amino acid metabolism) and PD. Improvement of key molecules in glucose metabolism, fat metabolism, and amino acid metabolism (e.g., glucose-6-phosphate dehydrogenase, triglycerides, and levodopa) might be potentially beneficial in PD. Some of these metabolic indicators may serve well during the diagnosis of PD. In addition, modulation of these metabolic pathways may be a potential target for the treatment and prevention of PD.
C1 [Li, Hangzhen; Zeng, Fancai; Pu, Qiqi; Li, Xiang] Southwest Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Luzhou, Peoples R China.
   [Huang, Cancan; Chen, Yan] Southwest Med Univ, Dept Dermatol, Affiliated Hosp, Luzhou, Peoples R China.
   [Thomas, Elizabeth Rosalind] NEIGRIHMS, Dept Microbiol, Shillong, India.
   [Chen, Yan; Li, Xiang] Southwest Med Univ, Sch Basic Med Sci, Lab Biochem & Mol Biol, Luzhou 646000, Peoples R China.
C3 Southwest Medical University; Southwest Medical University; North Eastern Indira Gandhi Regional Institute of Health & Medical Sciences (NEIGRIHMS); Southwest Medical University
RP Chen, Y; Li, X (corresponding author), Southwest Med Univ, Sch Basic Med Sci, Lab Biochem & Mol Biol, Luzhou 646000, Peoples R China.
EM chenyan0216@swmu.edu.cn; lix2009@126.com
FU Science and Technology Strategic Cooperation Project of the Luzhou People's Government; Southwest Medical University [2019LZXNYDJ34]; undergraduate innovation and entrepreneurship training program [S202110632241]; Sichuan Science and Technology Program [2022YFS0623, 2023JDRC0109]
CR Abraham S, 2005, INDIAN J MED RES, V121, P111
   ÃdÃ©n E, 2011, NUTR NEUROSCI, V14, P25, DOI 10.1179/174313211X12966635733312
   Adibhatla Rao Muralikrishna, 2008, V49, V0, PP241, DOI 10.1007/978-1-4020-8831-5_9
   Alecu I, 2019, FRONT NEUROSCI-SWITZ, V13, P0, DOI 10.3389/fnins.2019.00328
   Ali Z, 2022, NEUROCHEM INT, V157, P0, DOI 10.1016/j.neuint.2022.105344
   Anandhan A, 2017, BRAIN RES BULL, V133, P12, DOI 10.1016/j.brainresbull.2017.03.009
   Anandhan A, 2017, MOL NEUROBIOL, V54, P3825, DOI 10.1007/s12035-016-9906-2
   Anis E, 2022, TRENDS ENDOCRIN MET, V33, P147, DOI 10.1016/j.tem.2021.11.005
   Ashraghi MR, 2016, RECENT PATENTS ENDOC, V10, P11, DOI 10.2174/1872214810999160628105549
   Athauda D, 2016, PROG NEUROBIOL, V145, P98, DOI 10.1016/j.pneurobio.2016.10.001
   Aubert A, 2005, P NATL ACAD SCI USA, V102, P16448, DOI 10.1073/pnas.0505427102
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bolam JP, 2012, MOVEMENT DISORD, V27, P1478, DOI 10.1002/mds.25135
   Bonvento G, 2021, CELL METAB, V33, P1546, DOI 10.1016/j.cmet.2021.07.006
   Borghammer P, 2010, BRAIN STRUCT FUNCT, V214, P303, DOI 10.1007/s00429-010-0246-0
   Bosco DA, 2006, NAT CHEM BIOL, V2, P249, DOI 10.1038/nchembio782
   Bousquet M, 2011, AGEING RES REV, V10, P453, DOI 10.1016/j.arr.2011.03.001
   Brace LE, 2016, NPJ AGING MECH DIS, V2, P0, DOI 10.1038/npjamd.2016.22
   Burks S, 2019, NEUROSCI LETT, V703, P86, DOI 10.1016/j.neulet.2019.03.015
   Butterfield DA, 2022, MOLECULES, V27, P0, DOI 10.3390/molecules27030951
   Cai R, 2019, J CLIN INVEST, V129, P4539, DOI 10.1172/JCI129987
   Camilleri A, 2014, CNS NEUROSCI THER, V20, P591, DOI 10.1111/cns.12264
   Cardoso S, 2020, INT REV NEUROBIOL, V155, P37, DOI 10.1016/bs.irn.2020.02.010
   Corona JC, 2010, J NEUROSCI RES, V88, P1943, DOI 10.1002/jnr.22357
   Cassani E, 2017, PARKINSONISM RELAT D, V42, P40, DOI 10.1016/j.parkreldis.2017.06.007
   Cerqueira NMFSA, 2016, BIOCHEMISTRY-US, V55, P5483, DOI 10.1021/acs.biochem.6b00342
   Chong MFF, 2007, P NUTR SOC, V66, P52, DOI 10.1017/S0029665107005290
   Rosa SCD, 2021, AUTOPHAGY, V17, P2257, DOI 10.1080/15548627.2020.1821548
   Dai LJ, 2021, MOL NEUROBIOL, V58, P2183, DOI 10.1007/s12035-020-02232-6
   Di Maio A, 2023, NEUROBIOL DIS, V184, P0, DOI 10.1016/j.nbd.2023.106203
   Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230
   Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003
   Dong MX, 2021, CHEM PHYS LIPIDS, V239, P0, DOI 10.1016/j.chemphyslip.2021.105112
   Dringen R, 1999, J NEUROCHEM, V72, P2523, DOI 10.1046/j.1471-4159.1999.0722523.x
   Dunn L, 2014, NEUROBIOL AGING, V35, P1111, DOI 10.1016/j.neurobiolaging.2013.11.001
   Edison P, 2013, NEUROPSYCHOPHARMACOL, V38, P938, DOI 10.1038/npp.2012.255
   Emamzadeh FN, 2018, FRONT NEUROSCI-SWITZ, V12, P0, DOI 10.3389/fnins.2018.00612
   Emamzadeh FN, 2017, J MOL NEUROSCI, V63, P165, DOI 10.1007/s12031-017-0967-0
   Eriksson I, 2017, EUR J CELL BIOL, V96, P99, DOI 10.1016/j.ejcb.2017.01.002
   Estes RE, 2021, FRONT MOL NEUROSCI, V14, P0, DOI 10.3389/fnmol.2021.788695
   Fais M, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22147630
   Fanning S, 2021, ACTA NEUROPATHOL, V141, P491, DOI 10.1007/s00401-020-02177-z
   Fanning S, 2019, MOL CELL, V73, P1001, DOI 10.1016/j.molcel.2018.11.028
   Farooqui AA, 2007, J NEUROSCI RES, V85, P1834, DOI 10.1002/jnr.21268
   Flores-Dorantes MT, 2020, FRONT NEUROSCI-SWITZ, V14, P0, DOI 10.3389/fnins.2020.00863
   Foltynie T, 2020, PROG BRAIN RES, V252, P493, DOI 10.1016/bs.pbr.2019.10.008
   Galper J, 2022, BRAIN, V145, P3472, DOI 10.1093/brain/awac176
   Gao L, 2008, J NEUROL, V255, P1850, DOI 10.1007/s00415-008-0937-0
   GarcÃ­a-Sanz P, 2021, MOVEMENT DISORD, V36, P1070, DOI 10.1002/mds.28396
   GarcÃ­a-Sanz P, 2018, AUTOPHAGY, V14, P717, DOI 10.1080/15548627.2018.1427396
   Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004
   Gibson GE, 2003, NEUROCHEM INT, V43, P129, DOI 10.1016/S0197-0186(02)00225-5
   Gimenez-Cassina A, 2009, J BIOL CHEM, V284, P3001, DOI 10.1074/jbc.M808698200
   Gonzalez-RodrÃ­guez P, 2021, NATURE, V599, P650, DOI 10.1038/s41586-021-04059-0
   Goyal MS, 2014, CELL METAB, V19, P49, DOI 10.1016/j.cmet.2013.11.020
   Graham SH, 2017, AGEING RES REV, V34, P30, DOI 10.1016/j.arr.2016.09.011
   Gregory Allison, 1993, GENEREVIEWS, V0, P0
   Guerreiro PS, 2017, NEUROMOL MED, V19, P113, DOI 10.1007/s12017-016-8435-5
   Guo XY, 2015, INT J NEUROSCI, V125, P838, DOI 10.3109/00207454.2014.979288
   Hantikainen E, 2022, EUR J EPIDEMIOL, V37, P603, DOI 10.1007/s10654-022-00863-8
   Hauser DN, 2013, NEUROBIOL DIS, V51, P35, DOI 10.1016/j.nbd.2012.10.011
   Havelund JF, 2017, METABOLITES, V7, P0, DOI 10.3390/metabo7030042
   Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000
   He Q, 2013, INT J BIOCHEM CELL B, V45, P2749, DOI 10.1016/j.biocel.2013.09.011
   Heilman PL, 2020, MOVEMENT DISORD, V35, P2028, DOI 10.1002/mds.28202
   Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881
   Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6
   Holmay MJ, 2013, CLIN NEUROPHARMACOL, V36, P103, DOI 10.1097/WNF.0b013e31829ae713
   Hong CT, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep25344
   Hu L, 2020, FRONT MOL NEUROSCI, V13, P0, DOI 10.3389/fnmol.2020.00080
   Hu YY, 2022, OXID MED CELL LONGEV, V2022, P0, DOI 10.1155/2022/1458143
   Huot P, 2013, PHARMACOL REV, V65, P171, DOI 10.1124/pr.111.005678
   Innos J, 2021, CHEM RES TOXICOL, V34, P1223, DOI 10.1021/acs.chemrestox.0c00522
   Iovino L, 2020, J PHARMACOL SCI, V144, P151, DOI 10.1016/j.jphs.2020.07.011
   Jana BA, 2019, MOL BIOL REP, V46, P957, DOI 10.1007/s11033-018-4551-7
   Janda E, 2012, MOL NEUROBIOL, V46, P639, DOI 10.1007/s12035-012-8318-1
   Jia LL, 2021, DEV CELL, V56, P2980, DOI 10.1016/j.devcel.2021.09.013
   Jiang T, 2020, TOXICOL IN VITRO, V62, P0, DOI 10.1016/j.tiv.2019.104715
   JimÃ©nez-JimÃ©nez FJ, 2014, FRONT CELL NEUROSCI, V8, P0, DOI 10.3389/fncel.2014.00369
   Jin U, 2019, EXP NEUROBIOL, V28, P554, DOI 10.5607/en.2019.28.5.554
   Julien C, 2006, NEUROCHEM INT, V48, P404, DOI 10.1016/j.neuint.2005.12.002
   Kalani K, 2018, DRUG DISCOV TODAY, V23, P1983, DOI 10.1016/j.drudis.2018.08.001
   Kim D, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0164906
   Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1
   Kinghorn KJ, 2015, BRAIN, V138, P1801, DOI 10.1093/brain/awv132
   Ko CW, 2020, NAT REV GASTRO HEPAT, V17, P169, DOI 10.1038/s41575-019-0250-7
   Korade Z, 2008, NEUROPHARMACOLOGY, V55, P1265, DOI 10.1016/j.neuropharm.2008.02.019
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kubo S, 2015, FRONT BIOSCI-LANDMRK, V20, P263, DOI 10.2741/4308
   Kuruvilla KP, 2013, J NEUROL SCI, V331, P31, DOI 10.1016/j.jns.2013.04.020
   Lei S, 2014, ACS CHEM BIOL, V9, P2032, DOI 10.1021/cb400894a
   Li X, 2021, FRONT NEUROSCI-SWITZ, V15, P0, DOI 10.3389/fnins.2021.678154
   Limbad C, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0227887
   Liu MQ, 2021, AGING DIS, V12, P2003, DOI 10.14336/AD.2021.0422
   Lu Y, 2021, INT J CLIN PRACT, V75, P0, DOI 10.1111/ijcp.13865
   LÃ¼cke C, 2006, J LIPID RES, V47, P1714, DOI 10.1194/jlr.M600003-JLR200
   Magalhaes J, 2016, HUM MOL GENET, V25, P3432, DOI 10.1093/hmg/ddw185
   Mahoney-SÃ¡nchez L, 2021, PROG NEUROBIOL, V196, P0, DOI 10.1016/j.pneurobio.2020.101890
   Manini A, 2022, AGEING RES REV, V76, P0, DOI 10.1016/j.arr.2022.101578
   Marcos AL, 2019, BBA-BIOMEMBRANES, V1861, P0, DOI 10.1016/j.bbamem.2019.05.015
   Marrs TC, 2013, CELL BIOL TOXICOL, V29, P381, DOI 10.1007/s10565-013-9259-9
   Mashima K, 2018, ASN NEURO, V10, P0, DOI 10.1177/1759091418775562
   Mazzio E, 2003, NEUROTOXICOLOGY, V24, P137, DOI 10.1016/S0161-813X(02)00110-9
   McNaught KSP, 2000, BIOCHEM PHARMACOL, V60, P979, DOI 10.1016/S0006-2952(00)00415-9
   MejÃ­as R, 2006, J NEUROSCI, V26, P4500, DOI 10.1523/JNEUROSCI.0122-06.2006
   Meng QJ, 2010, EUR J PHARMACOL, V649, P127, DOI 10.1016/j.ejphar.2010.09.046
   Meng XZ, 2015, J NEUROSCI RES, V93, P350, DOI 10.1002/jnr.23488
   Merlini E, 2022, TRENDS NEUROSCI, V45, P53, DOI 10.1016/j.tins.2021.10.014
   Mookerjee SA, 2018, J BIOL CHEM, V293, P12649, DOI 10.1074/jbc.AAC118.004855
   Morari M, 2018, J PHARMACOL EXP THER, V364, P198, DOI 10.1124/jpet.117.245100
   Mori A, 2019, P NATL ACAD SCI USA, V116, P20689, DOI 10.1073/pnas.1902958116
   Morris JK, 2010, AM J PHYSIOL-REG I, V299, PR1082, DOI 10.1152/ajpregu.00449.2010
   Nam GE, 2018, PLOS MED, V15, P0, DOI 10.1371/journal.pmed.1002640
   Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232
   Nunes VS, 2022, AGING-US, V14, P1549, DOI 10.18632/aging.203880
   Ãhman A, 2015, NEUROSCI LETT, V594, P36, DOI 10.1016/j.neulet.2015.03.051
   Orth M, 2012, CHOLESTEROL, V0, P0, DOI DOI 10.1155/2012/292598
   Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439
   Pagano G, 2018, NEUROLOGY, V90, PE1654, DOI 10.1212/WNL.0000000000005475
   Paisan-Ruiz C, 2009, ANN NEUROL, V65, P19, DOI 10.1002/ana.21415
   Palavra NC, 2021, FRONT NUTR, V8, P0, DOI 10.3389/fnut.2021.628845
   Pan PY, 2020, HUM MOL GENET, V29, P2300, DOI 10.1093/hmg/ddaa080
   Pereira CMF, 1997, FREE RADICAL BIO MED, V23, P637, DOI 10.1016/S0891-5849(97)00020-8
   Perl A, 2011, TRENDS MOL MED, V17, P395, DOI 10.1016/j.molmed.2011.01.014
   PERRY TL, 1986, NEUROSCI LETT, V67, P269, DOI 10.1016/0304-3940(86)90320-4
   PERRY TL, 1982, NEUROSCI LETT, V33, P305, DOI 10.1016/0304-3940(82)90390-1
   Pilchova I, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/6797460
   Pingale TD, 2021, J PHARM PHARMACOL, V73, P862, DOI 10.1093/jpp/rgaa063
   PisanÃ² CA, 2020, NEUROPHARMACOLOGY, V167, P0, DOI 10.1016/j.neuropharm.2020.108006
   Powers R, 2017, METABOLITES, V7, P0, DOI 10.3390/metabo7020022
   Prabhakara JPR, 2008, J NEUROCHEM, V107, P1722, DOI 10.1111/j.1471-4159.2008.05736.x
   Puchades M, 2013, J PARKINSON DIS, V3, P371, DOI 10.3233/JPD-130190
   Quansah E, 2018, MOL NEURODEGENER, V13, P0, DOI 10.1186/s13024-018-0260-x
   Quintana DD, 2020, J ALZHEIMERS DIS, V75, P119, DOI 10.3233/JAD-190964
   Rada P, 2005, NEUROSCIENCE, V134, P737, DOI 10.1016/j.neuroscience.2005.04.043
   Raj PS, 2019, FUND CLIN PHARMACOL, V33, P412, DOI 10.1111/fcp.12452
   Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884
   Reeg S, 2015, ANTIOXID REDOX SIGN, V23, P239, DOI 10.1089/ars.2014.6062
   Reeve A, 2014, AGEING RES REV, V14, P19, DOI 10.1016/j.arr.2014.01.004
   Roh JH, 2021, METAB SYNDR RELAT D, V19, P1, DOI 10.1089/met.2020.0060
   Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448
   SÃ¤Ã¤ksjÃ¤rvi K, 2015, PARKINSONISM RELAT D, V21, P1148, DOI 10.1016/j.parkreldis.2015.07.017
   Sakaue S, 2017, NPJ PARKINSONS DIS, V3, P0, DOI 10.1038/s41531-017-0014-4
   Campos SS, 2018, ARCH BIOCHEM BIOPHYS, V655, P43, DOI 10.1016/j.abb.2018.08.007
   Campos SS, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0130726
   SÃ¡nchez E, 2018, MOL NEUROBIOL, V55, P6734, DOI 10.1007/s12035-017-0846-2
   Sarkar S, 2014, NEUROTOXICOLOGY, V44, P250, DOI 10.1016/j.neuro.2014.07.006
   Saxena U, 2012, EXPERT OPIN THER TAR, V16, P351, DOI 10.1517/14728222.2012.664135
   Schmitz Y, 2013, J NEUROSCI, V33, P16778, DOI 10.1523/JNEUROSCI.3041-12.2013
   SchrÃ¶ter N, 2022, NPJ PARKINSONS DIS, V8, P0, DOI 10.1038/s41531-022-00392-x
   Schubert D, 2001, J NEUROSCI, V21, P7455, DOI 10.1523/JNEUROSCI.21-19-07455.2001
   Scigliano G, 2006, STROKE, V37, P1184, DOI 10.1161/01.STR.0000217384.03237.9c
   Shah K, 2012, INT J MOL SCI, V13, P12629, DOI 10.3390/ijms131012629
   Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598
   Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2
   SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305
   Simmering JE, 2022, MOVEMENT DISORD, V37, P2210, DOI 10.1002/mds.29184
   Simmering JE, 2021, JAMA NEUROL, V78, P407, DOI 10.1001/jamaneurol.2020.5157
   Sinclair E, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-21669-4
   SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B
   Sotiriou E, 2010, MUSCLE NERVE, V41, P707, DOI 10.1002/mus.21612
   Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036
   Subramaniam SR, 2013, PROG NEUROBIOL, V106, P17, DOI 10.1016/j.pneurobio.2013.04.004
   Sun WY, 2021, NAT CHEM BIOL, V17, P465, DOI 10.1038/s41589-020-00734-x
   Surmeier DJ, 2017, BIOCHEM BIOPH RES CO, V483, P1013, DOI 10.1016/j.bbrc.2016.08.168
   Surmeier DJ, 2017, NAT REV NEUROSCI, V18, P101, DOI 10.1038/nrn.2016.178
   Takahashi S, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22126568
   Takahashi Y, 2012, BIOCHEM BIOPH RES CO, V417, P1151, DOI 10.1016/j.bbrc.2011.12.082
   Tatton WG, 2003, ANN NEUROL, V53, PS61, DOI 10.1002/ana.10489
   Tu DZ, 2019, J NEUROINFLAMM, V16, P0, DOI 10.1186/s12974-019-1659-1
   Turri M, 2022, BBA-MOL CELL BIOL L, V1867, P0, DOI 10.1016/j.bbalip.2022.159123
   Udayar V, 2022, TRENDS NEUROSCI, V45, P184, DOI 10.1016/j.tins.2021.12.004
   Vikdahl M, 2015, EUR J CLIN NUTR, V69, P729, DOI 10.1038/ejcn.2014.259
   Vikdahl M, 2014, CLIN NUTR, V33, P1132, DOI 10.1016/j.clnu.2013.12.012
   Xicoy H, 2021, NPJ PARKINSONS DIS, V7, P0, DOI 10.1038/s41531-021-00168-9
   Xilouri M, 2016, AGEING RES REV, V32, P13, DOI 10.1016/j.arr.2016.07.001
   Yang SQ, 2020, NEUROCHEM INT, V135, P0, DOI 10.1016/j.neuint.2020.104692
   Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010
   Yang WW, 2021, MOL NEUROBIOL, V58, P603, DOI 10.1007/s12035-020-02128-5
   Ye ZC, 1999, CANCER RES, V59, P4383
   Yellen G, 2018, J CELL BIOL, V217, P2235, DOI 10.1083/jcb.201803152
   Yin F, 2023, FEBS J, V290, P1420, DOI 10.1111/febs.16344
   Zamzami N, 1996, J EXP MED, V183, P1533, DOI 10.1084/jem.183.4.1533
   Zhang QX, 2020, FRONT MOL NEUROSCI, V13, P0, DOI 10.3389/fnmol.2020.563054
NR 184
TC 7
Z9 7
U1 7
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1755-5930
EI 1755-5949
J9 CNS NEUROSCI THER
JI CNS Neurosci. Ther.
PD FEB 15
PY 2024
VL 30
IS 2
BP 
EP 
DI 10.1111/cns.14411
EA AUG 2023
PG 14
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA KB7B7
UT WOS:001047999500001
PM 37577934
DA 2024-11-01
ER

PT J
AU Kwak, H
   Lee, E
   Karki, R
AF Kwak, Hyosang
   Lee, Ein
   Karki, Rajendra
TI DNA sensors in metabolic and cardiovascular diseases: Molecular mechanisms and therapeutic prospects
SO IMMUNOLOGICAL REVIEWS
LA English
DT Review; Early Access
DE AIM2 and IFI16; cGAS-STING pathway; DNA-PK and DDX41; fatty liver and heart diseases; inflammation and cell death; obesity and diabetes
ID strand break repair; obesity-induced inflammation; of-function mutation; smooth-muscle-cells; protein-kinase; aim2 inflammasome; cpg-oligodeoxynucleotides; insulin-resistance; mitochondrial-dna; prevents obesity
AB DNA sensors generally initiate innate immune responses through the production of type I interferons. While extensively studied for host defense against invading pathogens, emerging evidence highlights the involvement of DNA sensors in metabolic and cardiovascular diseases. Elevated levels of modified, damaged, or ectopically localized self-DNA and non-self-DNA have been observed in patients and animal models with obesity, diabetes, fatty liver disease, and cardiovascular disease. The accumulation of cytosolic DNA aberrantly activates DNA signaling pathways, driving the pathological progression of these disorders. This review highlights the roles of specific DNA sensors, such as cyclic AMP-GMP synthase and stimulator of interferon genes (cGAS-STING), absent in melanoma 2 (AIM2), toll-like receptor 9 (TLR9), interferon gamma-inducible protein 16 (IFI16), DNA-dependent protein kinase (DNA-PK), and DEAD-box helicase 41 (DDX41) in various metabolic disorders. We explore how DNA signaling pathways in both immune and non-immune cells contribute to the development of these diseases. Furthermore, we discuss the intricate interplay between metabolic stress and immune responses, offering insights into potential therapeutic targets for managing metabolic and cardiovascular disorders. Understanding the mechanisms of DNA sensor signaling in these contexts provides a foundation for developing novel interventions aimed at mitigating the impact of these pervasive health issues.
C1 [Kwak, Hyosang; Karki, Rajendra] Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Seoul, South Korea.
   [Lee, Ein] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.
   [Karki, Rajendra] Nexus Inst Res & Innovat NIRI, Kathmandu, Nepal.
C3 Seoul National University (SNU); Seoul National University (SNU)
RP Karki, R (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul 08826, South Korea.
EM rkarki@snu.ac.kr
FU Seoul National University, Creative-Pioneering Researchers Program; National Research Foundation [RS-2023-00251395]
CR Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640
   Afonso MB, 2015, CLIN SCI, V129, P721, DOI 10.1042/CS20140732
   Akazawa Y, 2019, MODERN PATHOL, V32, P997, DOI 10.1038/s41379-019-0218-8
   Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391
   Al-Kafaji G, 2018, EXP THER MED, V16, P1483, DOI 10.3892/etm.2018.6319
   Alkudmani ZS, 2023, BIOLOGY-BASEL, V12, P0, DOI 10.3390/biology12111439
   Anderson AE, 2007, EUR J IMMUNOL, V37, P1548, DOI 10.1002/eji.200636562
   Andreeva L, 2017, NATURE, V549, P394, DOI 10.1038/nature23890
   Bae JH, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8040328
   Bai JL, 2020, COMMUN BIOL, V3, P0, DOI 10.1038/s42003-020-0986-1
   Bai JL, 2017, P NATL ACAD SCI USA, V114, P12196, DOI 10.1073/pnas.1708744114
   Bala S, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0096864
   Bartunek J, 2002, J AM COLL CARDIOL, V40, P1097, DOI 10.1016/S0735-1097(02)02122-8
   Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015
   BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0
   Briggs LJ, 2001, BIOCHEM J, V353, P69, DOI 10.1042/bj3530069
   BRUGUERA M, 1977, GASTROENTEROLOGY, V73, P1383
   Brunette RL, 2012, J EXP MED, V209, P1969, DOI 10.1084/jem.20121960
   Burleigh K, 2020, SCI IMMUNOL, V5, P0, DOI 10.1126/sciimmunol.aba4219
   Cao DJ, 2018, CIRCULATION, V137, P2613, DOI 10.1161/CIRCULATIONAHA.117.031046
   Cao ZJ, 2013, BBA-MOL BASIS DIS, V1832, P96, DOI 10.1016/j.bbadis.2012.08.008
   Chait A, 2020, FRONT CARDIOVASC MED, V7, P0, DOI 10.3389/fcvm.2020.00022
   Cho CS, 2018, HEPATOLOGY, V68, P1331, DOI 10.1002/hep.29742
   Chou WC, 2021, NATURE, V591, P300, DOI 10.1038/s41586-021-03231-w
   Cridland JA, 2012, BMC EVOL BIOL, V12, P0, DOI 10.1186/1471-2148-12-140
   Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845
   Csak T, 2014, LIVER INT, V34, P1402, DOI 10.1111/liv.12537
   Devi TD, 2017, AM J PATHOL, V187, P2659, DOI 10.1016/j.ajpath.2017.08.023
   Dihlmann S, 2014, MOL MED, V20, P230, DOI 10.2119/molmed.2013.00162
   Donne R, 2022, DEV CELL, V57, P1728, DOI 10.1016/j.devcel.2022.06.003
   Espejel S, 2004, EMBO REP, V5, P503, DOI 10.1038/sj.embor.7400127
   Fidler TP, 2021, NATURE, V592, P296, DOI 10.1038/s41586-021-03341-5
   Freitas DF, 2022, MOL BIOL REP, V49, P3225, DOI 10.1007/s11033-022-07157-y
   Furman D, 2019, NAT MED, V25, P1822, DOI 10.1038/s41591-019-0675-0
   Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477
   Ganz M, 2014, WORLD J GASTROENTERO, V20, P8525, DOI 10.3748/wjg.v20.i26.8525
   Gao H, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-28239-2
   Garcia-Martinez I, 2016, J CLIN INVEST, V126, P859, DOI 10.1172/JCI83885
   Gautheron J, 2014, EMBO MOL MED, V6, P1062, DOI 10.15252/emmm.201403856
   Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004
   Gong ZW, 2019, DIABETOLOGIA, V62, P2325, DOI 10.1007/s00125-019-04983-x
   Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008
   Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013
   Hamann L, 2020, IMMUN AGEING, V17, P0, DOI 10.1186/s12979-020-00176-y
   Hao B, 2018, INT J MOL MED, V41, P1365, DOI 10.3892/ijmm.2017.3346
   Hasan M, 2017, P NATL ACAD SCI USA, V114, P746, DOI 10.1073/pnas.1611113114
   Hoang AC, 2022, NAT METAB, V4, P1684, DOI 10.1038/s42255-022-00683-w
   Hong CP, 2015, OBESITY, V23, P2199, DOI 10.1002/oby.21215
   Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531
   Hu B, 2016, SCIENCE, V354, P765, DOI 10.1126/science.aaf7532
   Hu C, 2024, CELL DEATH DISCOV, V10, P0, DOI 10.1038/s41420-024-01870-2
   Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776
   Jakobsen MR, 2014, CYTOKINE GROWTH F R, V25, P649, DOI 10.1016/j.cytogfr.2014.06.004
   Jette N, 2015, PROG BIOPHYS MOL BIO, V117, P194, DOI 10.1016/j.pbiomolbio.2014.12.003
   Johnstone RW, 1998, BIOCHEMISTRY-US, V37, P11924, DOI 10.1021/bi981069a
   Kalo E, 2021, LIVERS-BASEL, V1, P147, DOI 10.3390/livers1030014
   Karki R, 2021, CELL, V184, P149, DOI 10.1016/j.cell.2020.11.025
   Karki R, 2019, NAT REV CANCER, V19, P197, DOI 10.1038/s41568-019-0123-y
   Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Kayserova J, 2014, CLIN IMMUNOL, V153, P49, DOI 10.1016/j.clim.2014.03.018
   King KR, 2017, NAT MED, V23, P1481, DOI 10.1038/nm.4428
   Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3
   Knuefermann P, 2008, CARDIOVASC RES, V78, P26, DOI 10.1093/cvr/cvn011
   KOIVISTO VA, 1989, DIABETES, V38, P641, DOI 10.2337/diabetes.38.5.641
   Kole A, 2014, CURR TOP MICROBIOL, V380, P19, DOI 10.1007/978-3-662-43492-5_2
   Kong LZ, 2023, EXP MOL MED, V55, P2320, DOI 10.1038/s12276-023-01118-6
   Konno H, 2018, CELL REP, V23, P1112, DOI 10.1016/j.celrep.2018.03.115
   Kou MY, 2023, FRONT IMMUNOL, V14, P0, DOI 10.3389/fimmu.2023.1259989
   Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113
   Kranzer K, 2000, IMMUNOLOGY, V99, P170, DOI 10.1046/j.1365-2567.2000.00964.x
   Krohn R, 2007, CIRCULATION, V116, P1812, DOI 10.1161/CIRCULATIONAHA.107.708016
   Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976
   Kumari M, 2016, J CLIN INVEST, V126, P2839, DOI 10.1172/JCI86080
   Kuznik A, 2011, J IMMUNOL, V186, P4794, DOI 10.4049/jimmunol.1000702
   Kwan HY, 2013, EUR J NUTR, V52, P1621, DOI 10.1007/s00394-012-0467-5
   Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116
   Lee KG, 2015, CELL REP, V10, P1055, DOI 10.1016/j.celrep.2015.01.039
   Leite JA, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9040959
   Li WJ, 2016, JCI INSIGHT, V1, P0, DOI 10.1172/jci.insight.87315
   Liu FY, 2019, CELL DEATH DIS, V10, P0, DOI 10.1038/s41419-019-1718-7
   Liu HY, 2018, ONCOTARGET, V9, P2887, DOI 10.18632/oncotarget.20812
   Liu L, 2022, SCI SIGNAL, V15, P0, DOI 10.1126/scisignal.abh2290
   Liu MJ, 2018, DIABETOLOGIA, V61, P2333, DOI 10.1007/s00125-018-4705-0
   Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630
   Liu X, 2015, INT J OBESITY, V39, P1548, DOI 10.1038/ijo.2015.93
   Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625
   Liu YY, 2022, RESP RES, V23, P0, DOI 10.1186/s12931-022-02171-x
   Lozano-Ruiz B, 2015, J HEPATOL, V62, P64, DOI 10.1016/j.jhep.2014.08.027
   Lu JL, 2019, FRONT IMMUNOL, V10, P0, DOI 10.3389/fimmu.2019.01173
   Lu S, 2023, FRONT IMMUNOL, V14, P0, DOI 10.3389/fimmu.2023.1052756
   Luo W, 2020, CIRCULATION, V141, P42, DOI 10.1161/CIRCULATIONAHA.119.041460
   Luther J, 2020, P NATL ACAD SCI USA, V117, P11667, DOI 10.1073/pnas.1911870117
   Ma CM, 2021, J EXP MED, V218, P0, DOI 10.1084/jem.20201796
   Macfarlane DE, 1998, J IMMUNOL, V160, P1122
   Man SM, 2015, CELL, V162, P45, DOI 10.1016/j.cell.2015.06.001
   Man SM, 2015, NAT IMMUNOL, V16, P467, DOI 10.1038/ni.3118
   Mao H, 2023, NAT METAB, V5, P1382, DOI 10.1038/s42255-023-00844-5
   Mao Y, 2017, ARTERIOSCL THROM VAS, V37, P920, DOI 10.1161/ATVBAHA.117.309017
   Markowski P, 2013, BASIC RES CARDIOL, V108, P0, DOI 10.1007/s00395-013-0376-7
   Matyszewski M, 2018, P NATL ACAD SCI USA, V115, PE1963, DOI 10.1073/pnas.1712860115
   Medunjanin S, 2015, CARDIOVASC RES, V106, P488, DOI 10.1093/cvr/cvv126
   Melki I, 2017, J ALLERGY CLIN IMMUN, V140, P543, DOI 10.1016/j.jaci.2016.10.031
   Mercer E, 2012, ARTHRITIS RES THER, V14, P0, DOI 10.1186/ar3868
   Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052
   Morrone SR, 2014, P NATL ACAD SCI USA, V111, PE62, DOI 10.1073/pnas.1313577111
   Mosler T, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-27530-y
   Murphy AJ, 2016, CELL METAB, V23, P155, DOI 10.1016/j.cmet.2015.09.024
   Nishimoto S, 2016, SCI ADV, V2, P0, DOI 10.1126/sciadv.1501332
   NÃ¶then T, 2023, ARTERIOSCL THROM VAS, V43, P300, DOI 10.1161/ATVBAHA.122.317922
   Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992
   Okude H, 2021, FRONT IMMUNOL, V11, P0, DOI 10.3389/fimmu.2020.625833
   Okuya K, 2010, J IMMUNOL, V184, P7092, DOI 10.4049/jimmunol.1000490
   Omura H, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep34756
   Oral EA, 2017, CELL METAB, V26, P157, DOI 10.1016/j.cmet.2017.06.006
   Panchanathan R, 2010, J IMMUNOL, V185, P7385, DOI 10.4049/jimmunol.1002468
   Park HW, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms5834
   Park SJ, 2017, CELL METAB, V25, P1135, DOI 10.1016/j.cmet.2017.07.005
   Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460
   Paulin N, 2018, CIRCULATION, V138, P321, DOI 10.1161/CIRCULATIONAHA.117.033098
   Pejnovic N, 2009, MOL IMMUNOL, V47, P37, DOI 10.1016/j.molimm.2008.12.032
   Petrasek J, 2013, P NATL ACAD SCI USA, V110, P16544, DOI 10.1073/pnas.1308331110
   Pham PT, 2021, EUR HEART J, V42, P4336, DOI 10.1093/eurheartj/ehab249
   Picard C, 2016, CHEST, V150, PE65, DOI 10.1016/j.chest.2016.02.682
   Pollard AE, 2019, NAT METAB, V1, P340, DOI 10.1038/s42255-019-0036-9
   Qiao JT, 2018, METABOLISM, V81, P13, DOI 10.1016/j.metabol.2017.09.010
   Qiao JT, 2022, P NATL ACAD SCI USA, V119, P0, DOI 10.1073/pnas.2101848119
   Ratsimandresy RA, 2017, CELL MOL IMMUNOL, V14, P127, DOI 10.1038/cmi.2016.35
   Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082
   Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914
   Saito Y, 2019, CELL DEATH DIFFER, V26, P470, DOI 10.1038/s41418-018-0131-6
   Sano S, 2019, JACC-BASIC TRANSL SC, V4, P684, DOI 10.1016/j.jacbts.2019.05.013
   Sestan M, 2018, IMMUNITY, V49, P164, DOI 10.1016/j.immuni.2018.05.005
   Sha S, 2021, DIABETES, V70, P504, DOI 10.2337/db20-0373
   Shang GJ, 2019, NATURE, V567, P389, DOI 10.1038/s41586-019-0998-5
   Sharma BR, 2019, EUR J IMMUNOL, V49, P1998, DOI 10.1002/eji.201848070
   Shepard CR, 2021, FRONT ENDOCRINOL, V11, P0, DOI 10.3389/fendo.2020.613639
   Shintani Y, 2014, EMBO REP, V15, P438, DOI 10.1002/embr.201337945
   Shintani Y, 2013, P NATL ACAD SCI USA, V110, P5109, DOI 10.1073/pnas.1219243110
   Singh RS, 2022, CELL REP, V39, P0, DOI 10.1016/j.celrep.2022.110856
   Smith JR, 2023, CELL REP, V42, P0, DOI 10.1016/j.celrep.2023.112805
   Alegre NS, 2020, CLIN MOL HEPATOL, V26, P216, DOI 10.3350/cmh.2019.0074
   Stadion M, 2018, DIABETOLOGIA, V61, P1167, DOI 10.1007/s00125-018-4571-9
   Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108
   Tan YS, 2015, BIOCHEM BIOPH RES CO, V466, P592, DOI 10.1016/j.bbrc.2015.09.091
   Tang P, 2021, CELL DEATH DIFFER, V28, P3022, DOI 10.1038/s41418-021-00798-9
   Ueda H, 2019, JACC-BASIC TRANSL SC, V4, P348, DOI 10.1016/j.jacbts.2019.01.002
   Umemura A, 2016, CANCER CELL, V29, P935, DOI 10.1016/j.ccell.2016.04.006
   Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279
   Varshney D, 2020, NAT REV MOL CELL BIO, V21, P459, DOI 10.1038/s41580-020-0236-x
   Vasamsetti SB, 2015, DIABETES, V64, P2028, DOI 10.2337/db14-1225
   Venkat V, 2023, GENOMICS, V115, P0, DOI 10.1016/j.ygeno.2023.110584
   Vergis N, 2017, GASTROENTEROLOGY, V152, P1068, DOI 10.1053/j.gastro.2016.12.019
   Vogel H, 2017, BMC GENOMICS, V18, P0, DOI 10.1186/s12864-017-3552-6
   Vogel H, 2012, HUM MOL GENET, V21, P3845, DOI 10.1093/hmg/dds213
   Vollmer J, 2004, EUR J IMMUNOL, V34, P251, DOI 10.1002/eji.200324032
   Wan DS, 2020, FRONT IMMUNOL, V11, P0, DOI 10.3389/fimmu.2020.00615
   Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420
   Wang LT, 2023, REDOX BIOL, V67, P0, DOI 10.1016/j.redox.2023.102893
   Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477
   Wang P, 2024, NAT COMMUN, V15, P0, DOI 10.1038/s41467-024-48611-8
   Wang XF, 2020, CELL DEATH DIS, V11, P0, DOI 10.1038/s41419-020-2296-4
   Wang XA, 2014, HEPATOLOGY, V59, P870, DOI 10.1002/hep.26751
   Wang XA, 2013, AM J PHYSIOL-ENDOC M, V305, PE485, DOI 10.1152/ajpendo.00505.2012
   Wang XY, 2019, LIFE SCI, V221, P249, DOI 10.1016/j.lfs.2019.02.035
   Wang Y, 2022, REDOX BIOL, V52, P0, DOI 10.1016/j.redox.2022.102322
   Wasko MCM, 2015, DIABETOLOGIA, V58, P2336, DOI 10.1007/s00125-015-3689-2
   Watanabe A, 2007, HEPATOLOGY, V46, P1509, DOI 10.1002/hep.21867
   Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335
   Wilson JE, 2015, NAT MED, V21, P906, DOI 10.1038/nm.3908
   Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040
   Wortmann M, 2019, INFLAMM RES, V68, P337, DOI 10.1007/s00011-019-01212-4
   Wu C, 2014, J IMMUNOL, V193, P3036, DOI 10.4049/jimmunol.1302379
   Xu L, 2021, AM J PHYSIOL-GASTR L, V320, PG1034, DOI 10.1152/ajpgi.00431.2020
   Xu S, 2024, BBA-MOL BASIS DIS, V1870, P0, DOI 10.1016/j.bbadis.2023.166930
   Xue M, 2021, LIFE SCI, V265, P0, DOI 10.1016/j.lfs.2020.118752
   Ye Z, 2021, FRONT IMMUNOL, V12, P0, DOI 10.3389/fimmu.2021.797880
   Yoo S, 1999, NUCLEIC ACIDS RES, V27, P4679, DOI 10.1093/nar/27.24.4679
   Yoshida K, 2019, CARDIOVASC RES, V115, P658, DOI 10.1093/cvr/cvy209
   Yoshida M, 2009, J MOL CELL CARDIOL, V47, P698, DOI 10.1016/j.yjmcc.2009.07.024
   Yu WJ, 2023, ACTA PHARM SIN B, V13, P4823, DOI 10.1016/j.apsb.2023.09.008
   Yu YS, 2019, J CLIN INVEST, V129, P546, DOI 10.1172/JCI121842
   Yu Z, 2023, J CLIN INVEST, V133, P0, DOI 10.1172/JCI168597
   Zhang Q, 2022, REDOX BIOL, V54, P0, DOI 10.1016/j.redox.2022.102367
   Zhang ZQ, 2013, NAT IMMUNOL, V14, P172, DOI 10.1038/ni.2492
   Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091
   Zhao BX, 2011, MOL ENDOCRINOL, V25, P1337, DOI 10.1210/me.2011-0081
   Zhao P, 2018, CELL, V172, P731, DOI 10.1016/j.cell.2018.01.007
   Zhong ZY, 2018, NATURE, V560, P198, DOI 10.1038/s41586-018-0372-z
   Zhou H, 2020, BASIC RES CARDIOL, V115, P0, DOI 10.1007/s00395-019-0773-7
   Zhou H, 2018, J PINEAL RES, V64, P0, DOI 10.1111/jpi.12450
NR 191
TC 0
Z9 0
U1 4
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0105-2896
EI 1600-065X
J9 IMMUNOL REV
JI Immunol. Rev.
PD AUG 19
PY 2024
VL 0
IS 
BP 
EP 
DI 10.1111/imr.13382
EA AUG 2024
PG 21
WC Immunology
SC Immunology
GA D0S4O
UT WOS:001293368500001
PM 39158380
DA 2024-11-01
ER

PT J
AU Lin, Y
   Wang, JY
   Ren, H
   Ma, XT
   Wang, W
   Zhao, Y
   Xu, ZH
   Liu, SW
   Wang, WQ
   Xu, XB
   Wang, B
   Zhao, DD
   Wang, DD
   Li, W
   Liu, FC
   Zhao, YY
   Lu, JQ
   Yan, CZ
   Ji, KQ
AF Lin, Yan
   Wang, Jiayin
   Ren, Hong
   Ma, Xiaotian
   Wang, Wei
   Zhao, Ying
   Xu, Zhihong
   Liu, Shuangwu
   Wang, Wenqing
   Xu, Xuebi
   Wang, Bin
   Zhao, Dandan
   Wang, Dongdong
   Li, Wei
   Liu, Fuchen
   Zhao, Yuying
   Lu, Jianqiang
   Yan, Chuanzhu
   Ji, Kunqian
TI Mitochondrial myopathy without extraocular muscle involvement: a unique clinicopathologic profile
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE Mitochondrial disorders; MiMy; PEO; MELAS; Clinicopathologic features
ID differentiation factor 15; exercise intolerance; peripheral neuropathy; mutations; disease; cohort; diagnosis; genetics
AB Objective Mitochondrial myopathy without extraocular muscles involvement (MiMy) represents a distinct form of mitochondrial disorder predominantly affecting proximal/distal or axial muscles, with its phenotypic, genotypic features, and long-term prognosis poorly understood.Methods A cross-sectional study conducted at a national diagnostic center for mitochondrial disease involved 47 MiMy patients, from a cohort of 643 mitochondrial disease cases followed up at Qilu Hospital from January 1, 2000, to January 1, 2021. We compared the clinical, pathological, and genetic features of MiMy to progressive external ophthalmoplegia (PEO) and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) patients.Results MiMy patients demonstrated a more pronounced muscle involvement syndrome, with lower 6MWT scores, higher FSS, and lower BMI compared to PEO and MELAS patients. Serum levels of creatinine kinase (CK), lactate, and growth and differentiation factor 15 (GDF15) were substantially elevated in MiMy patients. Nearly a third (31.9%) displayed signs of subclinical peripheral neuropathy, mostly axonal neuropathy. Muscle biopsies revealed that cytochrome c oxidase strong (COX-s) ragged-red fibers (RRFs) were a typical pathological feature in MiMy patients. Genetic analysis predominantly revealed mtDNA point pathogenic variants (59.6%) and less frequently single (12.8%) or multiple (4.2%) mtDNA deletions. During the follow-up, a majority (76.1%) of MiMy patients experienced stabilization or improvement after therapeutic intervention.Conclusions This study provides a comprehensive profile of MiMy through a large patient cohort, elucidating its unique clinical, genetic, and pathological features. These findings offer significant insights into the diagnostic and therapeutic management of MiMy, ultimately aiming to ameliorate patient outcomes and enhance the quality of life.
C1 [Lin, Yan; Wang, Jiayin; Wang, Wei; Zhao, Ying; Xu, Zhihong; Liu, Shuangwu; Wang, Wenqing; Wang, Bin; Zhao, Dandan; Wang, Dongdong; Li, Wei; Liu, Fuchen; Zhao, Yuying; Yan, Chuanzhu; Ji, Kunqian] Shandong Univ, Qilu Hosp, Res Inst Neuromuscular & Neurodegenerat Dis, Cheeloo Coll Med, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
   [Lin, Yan; Wang, Jiayin; Wang, Wei; Zhao, Ying; Xu, Zhihong; Liu, Shuangwu; Wang, Wenqing; Wang, Bin; Zhao, Dandan; Wang, Dongdong; Li, Wei; Liu, Fuchen; Zhao, Yuying; Yan, Chuanzhu; Ji, Kunqian] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
   [Ren, Hong] Shandong Univ Tradit Chinese Med, Dept Neurol, Affiliated Hosp, Jinan 250012, Shandong, Peoples R China.
   [Ma, Xiaotian; Yan, Chuanzhu] Shandong Univ, Qilu Hosp Qingdao, Mitochondrial Med Lab, Qingdao 266035, Shandong, Peoples R China.
   [Xu, Xuebi] Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurol, Nanbaixiang St, Wenzhou 325000, Peoples R China.
   [Lu, Jianqiang] McMaster Univ, Dept Pathol & Mol Med, Neuropathol Sect, Hamilton, ON, Canada.
   [Yan, Chuanzhu] Shandong Univ, Brain Sci Res Inst, Jinan 250012, Shandong, Peoples R China.
C3 Shandong University; Shandong University; Shandong University of Traditional Chinese Medicine; Shandong University; Wenzhou Medical University; McMaster University; Shandong University
RP Ji, KQ (corresponding author), Shandong Univ, Qilu Hosp, Res Inst Neuromuscular & Neurodegenerat Dis, Cheeloo Coll Med, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.; Ji, KQ (corresponding author), Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
EM jikunqian@email.sdu.edu.cn
FU National Key R&D Program of China [2021YFC2700904]; National Natural Science Foundation of China [82171394, 82071412, 82301590]; Shandong Provincial Postdoctoral Innovation Talent Support Program [SDBX2022061]; Natural Science Foundation of Shandong Province [ZR2023QH106]; People's Benefit Project of Science and Technology in Qingdao [20-3-4-42-nsh, 22-8-7-smjk-1-nsh]; Taishan Scholars Program of Shandong Province
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   Bermejo-Guerrero L, 2023, J CLIN MED, V12, P0, DOI 10.3390/jcm12062435
   Bin Dayel FF, 2023, BIOMEDICINES, V11, P0, DOI 10.3390/biomedicines11051485
   Boal RL, 2019, J CLIN ENDOCR METAB, V104, P2057, DOI 10.1210/jc.2018-00957
   Darin N, 2017, EUR J NEUROL, V24, P587, DOI 10.1111/ene.13249
   de la Hoz CPDF, 2021, MOL GENET METAB REP, V26, P0, DOI 10.1016/j.ymgmr.2020.100701
   Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Doughty CT, 2018, AM J MED, V131, P1010, DOI 10.1016/j.amjmed.2017.12.042
   Horvath R, 2006, NEUROLOGY, V66, P253, DOI 10.1212/01.wnl.0000194241.35115.7c
   Horvath Rita, 2023, HANDB CLIN NEUROL, V194, P99, DOI 10.1016/B978-0-12-821751-1.00014-2
   Huddar A, 2021, MITOCHONDRION, V60, P170, DOI 10.1016/j.mito.2021.08.011
   Ji KQ, 2020, J NEUROL, V267, P3319, DOI 10.1007/s00415-020-10017-z
   Karaa A, 2023, NEUROLOGY, V101, PE238, DOI 10.1212/WNL.0000000000207402
   Kim-Muller JY, 2023, CELL REP, V42, P0, DOI 10.1016/j.celrep.2022.111947
   Krag TO, 2013, MITOCHONDRION, V13, P63, DOI 10.1016/j.mito.2013.01.009
   Lehmann D, 2015, EUR J HUM GENET, V23, P1735, DOI 10.1038/ejhg.2015.73
   Lehtonen JM, 2021, J INHERIT METAB DIS, V44, P469, DOI 10.1002/jimd.12307
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Lin Y, 2021, MITOCHONDRION, V57, P1, DOI 10.1016/j.mito.2020.11.015
   Lin Y, 2020, ANN CLIN TRANSL NEUR, V7, P1204, DOI 10.1002/acn3.51104
   Lu JQ, 2021, MITOCHONDRION, V56, P52, DOI 10.1016/j.mito.2020.11.005
   Lu YY, 2017, J NEUROL SCI, V379, P137, DOI 10.1016/j.jns.2017.05.056
   Luigetti M, 2016, EUR J NEUROL, V23, P1020, DOI 10.1111/ene.12954
   Madsen KL, 2020, NEUROLOGY, V94, PE687, DOI 10.1212/WNL.0000000000008861
   Mancuso M, 2017, NEUROMUSCULAR DISORD, V27, P1126, DOI 10.1016/j.nmd.2017.08.006
   Mancuso M, 2016, NEUROMUSCULAR DISORD, V26, P272, DOI 10.1016/j.nmd.2016.02.008
   Massie R, 2010, MUSCLE NERVE, V42, P136, DOI 10.1002/mus.21649
   Meola G, 2012, J NEUROL, V259, P601, DOI 10.1007/s00415-011-6193-8
   Montano V, 2022, J NEUROL, V269, P6555, DOI 10.1007/s00415-022-11324-3
   Montano V, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000519
   Mori Masato, 2002, NIHON RINSHO, V60 Suppl 4, P302
   Morris A, 2020, NAT REV ENDOCRINOL, V16, P129, DOI 10.1038/s41574-020-0327-y
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Orsucci D, 2018, EBIOMEDICINE, V30, P3, DOI 10.1016/j.ebiom.2018.03.007
   Ost M, 2020, EMBO REP, V21, P0, DOI 10.15252/embr.201948804
   Pareyson D, 2013, LANCET NEUROL, V12, P1011, DOI 10.1016/S1474-4422(13)70158-3
   Xiao MQ, 2017, FREE RADICAL BIO MED, V111, P316, DOI 10.1016/j.freeradbiomed.2017.04.363
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Zanolini A, 2017, MOL GENET METAB REP, V10, P24, DOI 10.1016/j.ymgmr.2016.11.009
NR 44
TC 1
Z9 1
U1 2
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD FEB 15
PY 2024
VL 271
IS 2
BP 864
EP 876
DI 10.1007/s00415-023-12005-5
EA OCT 2023
PG 13
WC Clinical Neurology
SC Neurosciences & Neurology
GA IX5R7
UT WOS:001087737400002
PM 37847292
DA 2024-11-01
ER

PT J
AU Saha, D
   Kothari, S
   Kulkarni, SD
   Thambiraja, M
   Yennamalli, RM
   Das, DK
AF Saha, Debolina
   Kothari, Sonam
   Kulkarni, Shilpa Duttaprasanna
   Thambiraja, Menaka
   Yennamalli, Ragothaman M.
   Das, Dhanjit K.
TI Genetic heterogeneity and respiratory chain enzyme analysis in pediatric Indian patients with mitochondrial disorder: Report of novel variants in POLG1 gene and their functional implication using molecular dynamic simulation
SO MITOCHONDRION
LA English
DT Article
DE POLG1; Mitochondrial disorders; Respiratory chain enzyme analysis; Sanger sequencing; Molecular docking
ID dna-polymerase gamma; diseases; residue; gromacs; mutant
AB Mitochondrial disorders are a heterogeneous group of disorders caused by mutations in the mitochondrial DNA or in nuclear genes encoding the mitochondrial proteins and subunits. Polymerase Gamma (POLG) is a nuclear gene and mutation in the POLG gene are one of the major causes of inherited mitochondrial disorders. In this study, 15 pediatric patients, with a wide spectrum of clinical phenotypes were screened using blood samples (n = 15) and muscle samples (n = 4). Respiratory chain enzyme analysis in the muscle samples revealed multicomplex deficiencies with Complex I deficiency present in (1/4) patients, Complex II (2/4), Complex III (3/4) and Complex IV (2/4) patients. Multiple large deletions were observed in 4/15 patients using LR-PCR. Whole exome sequencing (WES) revealed a compound heterozygous mutation consisting of a POLG1 novel variant (NP_002684.1:p.Trp261X) and a missense variant (NP_002684.1:p. Leu304Arg) in one patient and another patient harboring a novel homozygous POLG1 variant (NP_002684.1:p. Phe750Val). These variants (NP_002684.1: p. Leu304Arg) and (NP_002684.1:p. Phe750Val) and their interactions with DNA were modelled using molecular docking and molecular dynamics (MD) simulation studies. The protein conformation was analyzed as root mean square deviation (RMSD), root mean square fluctuation (RMSF) which showed local fluctuations in the mutants compared to the wildtype. However, Solvent Accessible Surface Area (SASA) significantly increased for NP_002684.1:p.Leu304Arg and decreased in NP_002684.1:p.Phe750Val mutants. Further, Contact Order analysis indicated that the Aromatic-sulfur interactions were destabilizing in the mutants. Overall, these in-silico analysis has revealed a destabilizing mutations suggesting pathogenic variants in POLG1 gene.
C1 [Saha, Debolina; Das, Dhanjit K.] ICMR Natl Inst Res Reprod & Child Hlth, Stem Cell Biol Dept, JM St, Mumbai 400012, India.
   [Kothari, Sonam; Kulkarni, Shilpa Duttaprasanna] Bai Jerbai Wadia Hosp Children, Dept Pediat Neurol, Acharya Donde Marg, Mumbai 400012, Maharashtra, India.
   [Thambiraja, Menaka; Yennamalli, Ragothaman M.] SASTRA Deemed Univ, Sch Chem & Biotechnol, Dept Bioinformat, Thanjavur 613401, Tamil Nadu, India.
C3 Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive & Child Health (NIRRCH); Shanmugha Arts, Science, Technology & Research Academy (SASTRA)
RP Das, DK (corresponding author), ICMR Natl Inst Res Reprod & Child Hlth, Stem Cell Biol Dept, JM St, Mumbai 400012, India.; Yennamalli, RM (corresponding author), SASTRA Deemed Univ, Sch Chem & Biotechnol, Dept Bioinformat, Thanjavur 613401, Tamil Nadu, India.
EM ragothaman@scbt.sastra.edu; dasd@nirrch.res.in
FU Writing Accountability Group of India
CR Behera SK, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-86712-2
   BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   Brodkin HR, 2015, PROTEIN SCI, V24, P762, DOI 10.1002/pro.2648
   Chakrabarty S, 2021, J NEUROL, V268, P2192, DOI 10.1007/s00415-020-10390-9
   Chatterjee J, 2021, J EXP BOT, V72, P3122, DOI 10.1093/jxb/erab039
   Chinnery PF, 2021, GENEREVIEWS, V0, P1
   Deepha S, 2021, J MOL NEUROSCI, V71, P2219, DOI 10.1007/s12031-020-01765-8
   Drawz SM, 2009, BIOCHEMISTRY-US, V48, P4557, DOI 10.1021/bi9003292
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Hikmat O, 2017, GENET MED, V19, P1217, DOI 10.1038/gim.2017.35
   Kisler JE, 2010, DEV MED CHILD NEUROL, V52, P422, DOI 10.1111/j.1469-8749.2009.03605.x
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w
   Monteith WB, 2014, P NATL ACAD SCI USA, V111, P11335, DOI 10.1073/pnas.1406845111
   Nakadai M, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep18543
   Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645
   Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27
   Rader AJ, 2012, J BIOMOL STRUCT DYN, V30, P628, DOI 10.1080/07391102.2012.689696
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Sonam K, 2017, MITOCHONDRION, V32, P42, DOI 10.1016/j.mito.2016.11.002
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tchikviladze M, 2015, J NEUROL NEUROSUR PS, V86, P646, DOI 10.1136/jnnp-2013-306799
   Tina KG, 2007, NUCLEIC ACIDS RES, V35, PW473, DOI 10.1093/nar/gkm423
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014
NR 29
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI London
PA 125 London Wall, London, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAY 15
PY 2024
VL 76
IS 
BP 
EP 
DI 10.1016/j.mito.2024.101870
EA MAR 2024
PG 10
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA PT2C3
UT WOS:001216259000001
PM 38471579
DA 2024-11-01
ER

PT J
AU Hovhannisyan, Y
   Li, ZL
   Callon, D
   SuspÃ¨ne, R
   Batoumeni, V
   Canette, A
   Blanc, J
   Hocini, H
   Lefebvre, C
   El-Jahrani, N
   Kitsara, M
   L'honorÃ©, A
   Kordeli, E
   Fornes, P
   Concordet, JP
   Tachdjian, G
   Rodriguez, AM
   Vartanian, JP
   BÃ©hin, A
   Wahbi, K
   Joanne, P
   Agbulut, O
AF Hovhannisyan, Yeranuhi
   Li, Zhenlin
   Callon, Domitille
   Suspene, Rodolphe
   Batoumeni, Vivien
   Canette, Alexis
   Blanc, Jocelyne
   Hocini, Hakim
   Lefebvre, Cecile
   El-Jahrani, Nora
   Kitsara, Maria
   L'honore, Aurore
   Kordeli, Ekaterini
   Fornes, Paul
   Concordet, Jean-Paul
   Tachdjian, Gerard
   Rodriguez, Anne-Marie
   Vartanian, Jean-Pierre
   Behin, Anthony
   Wahbi, Karim
   Joanne, Pierre
   Agbulut, Onnik
TI Critical contribution of mitochondria in the development of cardiomyopathy linked to desmin mutation
SO STEM CELL RESEARCH & THERAPY
LA English
DT Article
DE Desmin; Cardiomyocytes; Stem cells; Mitochondria; iPSC; Heart failure; Dilated cardiomyopathy; Myofibrillar myopathy
ID pluripotent stem-cells; heart-failure; r-package; in-vivo; muscle; dna; transplantation; dysfunction; cytoskeleton; reperfusion
AB BackgroundBeyond the observed alterations in cellular structure and mitochondria, the mechanisms linking rare genetic mutations to the development of heart failure in patients affected by desmin mutations remain unclear due in part, to the lack of relevant human cardiomyocyte models.MethodsTo shed light on the role of mitochondria in these mechanisms, we investigated cardiomyocytes derived from human induced pluripotent stem cells carrying the heterozygous DESE439K mutation that were either isolated from a patient or generated by gene editing. To increase physiological relevance, cardiomyocytes were either cultured on an anisotropic micropatterned surface to obtain elongated and aligned cardiomyocytes, or as a cardiac spheroid to create a micro-tissue. Moreover, when applicable, results from cardiomyocytes were confirmed with heart biopsies of suddenly died patient of the same family harboring DESE439K mutation, and post-mortem heart samples from five control healthy donors.ResultsThe heterozygous DESE439K mutation leads to dramatic changes in the overall cytoarchitecture of cardiomyocytes, including cell size and morphology. Most importantly, mutant cardiomyocytes display altered mitochondrial architecture, mitochondrial respiratory capacity and metabolic activity reminiscent of defects observed in patient's heart tissue. Finally, to challenge the pathological mechanism, we transferred normal mitochondria inside the mutant cardiomyocytes and demonstrated that this treatment was able to restore mitochondrial and contractile functions of cardiomyocytes.ConclusionsThis work highlights the deleterious effects of DESE439K mutation, demonstrates the crucial role of mitochondrial abnormalities in the pathophysiology of desmin-related cardiomyopathy, and opens up new potential therapeutic perspectives for this disease.
C1 [Hovhannisyan, Yeranuhi; Li, Zhenlin; Callon, Domitille; Batoumeni, Vivien; Blanc, Jocelyne; Kitsara, Maria; L'honore, Aurore; Kordeli, Ekaterini; Rodriguez, Anne-Marie; Joanne, Pierre; Agbulut, Onnik] Sorbonne Univ, Inst Biol Paris Seine IBPS, UMR CNRS 8256, INSERM U1164,Biol Adaptat & Ageing, 7 Quai St Bernard,Case 256, F-75005 Paris, France.
   [Callon, Domitille; Fornes, Paul] Acad Hosp Reims, Dept Pathol, Reims, France.
   [Suspene, Rodolphe; Vartanian, Jean-Pierre] Univ Paris Cite, Inst Pasteur, Dept Virol, Virus & Cellular Stress Unit, Paris, France.
   [Batoumeni, Vivien] Ksilink, Strasbourg, France.
   [Canette, Alexis] Sorbonne Univ, Inst Biol Paris Seine IBPS, Serv Microscopie Elect IBPS SME, CNRS, Paris, France.
   [Hocini, Hakim; Lefebvre, Cecile; El-Jahrani, Nora] Univ Paris Est, INSERM U955, Equipe 16, Creteil, France.
   [Concordet, Jean-Paul] Museum Natl Hist Nat, INSERM U1154, CNRS, UMR7196, Paris, France.
   [Tachdjian, Gerard] Univ Paris Saclay, Hop Antoine Beclere, AP HP, Lab Cytogenet,Serv Histol Embryol Cytogenet, Clamart, France.
   [Behin, Anthony] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, Reference Ctr Muscle Dis Paris Est,Myol Inst, Paris, France.
   [Wahbi, Karim] Univ Paris Cite, Cochin Hosp, AP HP, Cardiol Dept, Paris, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm); Sorbonne Universite; Pasteur Network; Universite Paris Cite; Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Museum National d'Histoire Naturelle (MNHN); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Cochin - APHP
RP Joanne, P; Agbulut, O (corresponding author), Sorbonne Univ, Inst Biol Paris Seine IBPS, UMR CNRS 8256, INSERM U1164,Biol Adaptat & Ageing, 7 Quai St Bernard,Case 256, F-75005 Paris, France.
EM pierre.joanne@sorbonne-universite.fr; onnik.agbulut@sorbonne-universite.fr
FU Sorbonne Universite; CNRS; INSERM; Agence Nationale de la Recherche [ANR-21-CE19-0027-MoHeDis]; AFM-Telethon [22142, 20479]; Cifre PhD scholarship - Ksilink (Strasbourg); ANRT [2020/0074]; Agence Nationale de la Recherche (ANR) [ANR-21-CE19-0027] Funding Source: Agence Nationale de la Recherche (ANR)
CR Agnetti G, 2022, FEBS J, V289, P2755, DOI 10.1111/febs.15864
   Agnetti G, 2014, CARDIOVASC RES, V102, P24, DOI 10.1093/cvr/cvu003
   Agudelo D, 2017, NAT METHODS, V14, P615, DOI 10.1038/NMETH.4265
   Alam S, 2018, J AM HEART ASSOC, V7, P0, DOI 10.1161/JAHA.118.009289
   Bader GD, 2003, BMC BIOINFORMATICS, V4, P0, DOI 10.1186/1471-2105-4-2
   Barron MJ, 2005, NEUROMUSCULAR DISORD, V15, P768, DOI 10.1016/j.nmd.2005.06.018
   Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046
   BÃ©hin A, 2015, REV NEUROL-FRANCE, V171, P715, DOI 10.1016/j.neurol.2015.06.002
   Berry N, 2021, MBIO, V12, P0, DOI 10.1128/mBio.02557-21
   Billon P, 2017, MOL CELL, V67, P1068, DOI 10.1016/j.molcel.2017.08.008
   Birket MJ, 2015, CELL REP, V13, P733, DOI 10.1016/j.celrep.2015.09.025
   Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057
   Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Brodehl A, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11233906
   Brodehl A, 2019, GENES-BASEL, V10, P0, DOI 10.3390/genes10110918
   Brodehl Andreas, 2018, BIOPHYS REV, V10, P983, DOI 10.1007/s12551-018-0429-0
   Bryant JD, 2022, CURR PROTOC, V2, P0, DOI 10.1002/cpz1.372
   Butler J, 2020, J CARD FAIL, V26, P429, DOI 10.1016/j.cardfail.2020.02.001
   Capetanaki Y, 2015, CURR OPIN CELL BIOL, V32, P113, DOI 10.1016/j.ceb.2015.01.004
   Chourbagi O, 2011, EXP CELL RES, V317, P886, DOI 10.1016/j.yexcr.2011.01.013
   Dayal AA, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21218122
   Doulamis IP, 2020, EUR J CARDIO-THORAC, V57, P836, DOI 10.1093/ejcts/ezz326
   Elsnicova B, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms231912020
   Emani SM, 2017, J THORAC CARDIOV SUR, V154, P286, DOI 10.1016/j.jtcvs.2017.02.018
   Favre B, 2011, EUR J CELL BIOL, V90, P390, DOI 10.1016/j.ejcb.2010.11.013
   FornÃ¨s P, 2021, ANN PATHOL, V41, P85, DOI 10.1016/j.annpat.2020.09.008
   Fountoulakis M, 2005, J MOL CELL CARDIOL, V38, P461, DOI 10.1016/j.yjmcc.2004.12.008
   Giacomelli E, 2020, CELL STEM CELL, V26, P862, DOI 10.1016/j.stem.2020.05.004
   Guichard JL, 2017, AM J PHYSIOL-HEART C, V313, PH32, DOI 10.1152/ajpheart.00027.2017
   Guzun R, 2012, BBA-BIOMEMBRANES, V1818, P1545, DOI 10.1016/j.bbamem.2011.12.034
   Hnia K, 2015, CELL TISSUE RES, V360, P591, DOI 10.1007/s00441-014-2016-4
   Huang XY, 2022, PHARMACEUTICS, V14, P0, DOI 10.3390/pharmaceutics14122760
   Ikeda G, 2021, J AM COLL CARDIOL, V77, P1073, DOI 10.1016/j.jacc.2020.12.060
   Joanne Pierre, 2011, BIOLOGIE AUJOURD HUI, V205, P163, DOI 10.1051/jbio/2011016
   Kay L, 1997, BBA-BIOENERGETICS, V1322, P41, DOI 10.1016/S0005-2728(97)00071-6
   Kaza AK, 2017, J THORAC CARDIOV SUR, V153, P934, DOI 10.1016/j.jtcvs.2016.10.077
   Khalfi P, 2023, PLOS PATHOG, V19, P0, DOI 10.1371/journal.ppat.1011170
   Knollmann BC, 2013, CIRC RES, V112, P969, DOI 10.1161/CIRCRESAHA.112.300567
   Koblan LW, 2018, NAT BIOTECHNOL, V36, P843, DOI 10.1038/nbt.4172
   KubÃ¡nek M, 2020, J CLIN MED, V9, P0, DOI 10.3390/jcm9040937
   Kulikova O, 2021, GENES-BASEL, V12, P0, DOI 10.3390/genes12010121
   Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01
   Li HY, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0167908
   Lian XJ, 2012, P NATL ACAD SCI USA, V109, PE1848, DOI 10.1073/pnas.1200250109
   LindÃ©n M, 2001, J BIOENERG BIOMEMBR, V33, P333, DOI 10.1023/A:1010611408007
   Love MI, 2014, GENOME BIOL, V15, P0, DOI 10.1186/s13059-014-0550-8
   Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552
   Masuzawa A, 2013, AM J PHYSIOL-HEART C, V304, PH966, DOI 10.1152/ajpheart.00883.2012
   McCormick EM, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00199
   McCully JD, 2009, AM J PHYSIOL-HEART C, V296, PH94, DOI 10.1152/ajpheart.00567.2008
   Meyer JN, 2017, TOXICOLOGY, V391, P42, DOI 10.1016/j.tox.2017.07.019
   Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255
   Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283
   Mohamud Y, 2023, VIRUSES-BASEL, V15, P0, DOI 10.3390/v15020351
   Moore J, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms24054724
   Mussil B, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-39245-8
   Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054
   Ottaviani D, 2023, DEVELOPMENT, V150, P0, DOI 10.1242/dev.201103
   Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197
   Paulin D, 2004, J PATHOL, V204, P418, DOI 10.1002/path.1639
   Pautasso S, 2018, J VIROL, V92, P0, DOI 10.1128/JVI.01224-18
   Pluess Marlene, 2015, BIOPHYS REV, V7, P25, DOI 10.1007/s12551-014-0146-2
   Protonotarios A, 2021, CAN J CARDIOL, V37, P857, DOI 10.1016/j.cjca.2020.11.017
   Rainer PP, 2018, CIRC RES, V122, PE75, DOI 10.1161/CIRCRESAHA.117.312082
   Ramaccini D, 2021, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.624216
   Reipert S, 1999, EXP CELL RES, V252, P479, DOI 10.1006/excr.1999.4626
   Sabbah HN, 2020, JACC-BASIC TRANSL SC, V5, P88, DOI 10.1016/j.jacbts.2019.07.009
   Schmidt CA, 2021, J BIOL CHEM, V297, P0, DOI 10.1016/j.jbc.2021.101140
   SchrÃ¶der R, 2003, HUM MOL GENET, V12, P657, DOI 10.1093/hmg/ddg060
   Schwarz N, 2016, CELLS-BASEL, V5, P0, DOI 10.3390/cells5030030
   Seo KS, 2018, FRONT NEUROL, V9, P0, DOI 10.3389/fneur.2018.00552
   Servais L, 2020, NEUROMUSCULAR DISORD, V30, P5, DOI 10.1016/j.nmd.2019.10.008
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Singh A, 2021, EBIOMEDICINE, V65, P0, DOI 10.1016/j.ebiom.2021.103244
   Singh SR, 2018, CIRC RES, V122, P1324, DOI 10.1161/CIRCRESAHA.118.312965
   Smolina N, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165745
   Soneson Charlotte, 2015, F1000RES, V4, P1521, DOI 10.12688/f1000research.7563.2
   Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004
   Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744
   Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630
   SuspÃ¨ne R, 2005, J GEN VIROL, V86, P125, DOI 10.1099/vir.0.80426-0
   SuspÃ¨ne R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554
   SuspÃ¨ne R, 2017, NUCLEIC ACIDS RES, V45, P3231, DOI 10.1093/nar/gkx001
   SuspÃ¨ne R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108
   Thebault C, 2008, EUR J ECHOCARDIOGR, V9, P840, DOI 10.1093/ejechocard/jen189
   Thornell LE, 1997, J MOL CELL CARDIOL, V29, P2107, DOI 10.1006/jmcc.1997.0446
   Tse HF, 2013, HUM MOL GENET, V22, P1395, DOI 10.1093/hmg/dds556
   Tsui HY, 2023, SCI TRANSL MED, V15, P0, DOI 10.1126/scitranslmed.add4248
   van Meer Berend J, 2018, CURR PROTOC HUM GENET, V99, Pe67, DOI 10.1002/cphg.67
   van Opbergen CJM, 2019, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.01496
   Vignais ML, 2023, CELLS-BASEL, V12, P0, DOI 10.3390/cells12040582
   Vincent AE, 2016, NEUROMUSCULAR DISORD, V26, P691, DOI 10.1016/j.nmd.2016.08.004
   Vrabie A, 2005, ACTA NEUROPATHOL, V109, P411, DOI 10.1007/s00401-005-0980-1
   Walters AM, 2012, CIRC RES, V111, P1222, DOI 10.1161/CIRCRESAHA.112.265660
   Winter L, 2008, J CELL BIOL, V181, P903, DOI 10.1083/jcb.200710151
   Winter L, 2016, ACTA NEUROPATHOL, V132, P453, DOI 10.1007/s00401-016-1592-7
   Wu BW, 2017, CELL PHYSIOL BIOCHEM, V42, P713, DOI 10.1159/000477889
   Yamada Y, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21176365
   YÃ©pez VA, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0199938
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zhang AL, 2023, MOL THER, V31, P1468, DOI 10.1016/j.ymthe.2023.02.016
   Zhou YY, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-09234-6
NR 103
TC 2
Z9 2
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD JAN 2
PY 2024
VL 15
IS 1
BP 
EP 
DI 10.1186/s13287-023-03619-7
PG 23
WC Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA DX4F1
UT WOS:001135362700004
PM 38167524
DA 2024-11-01
ER

PT J
AU Mittur, A
   VanMeter, SA
   Orujov, E
   Glidden, P
AF Mittur, Aravind
   VanMeter, Susan A.
   Orujov, Elmar
   Glidden, Paul
TI Pharmacokinetics and Safety of a 1:1 Mixture of Doxecitine and Doxribtimine: Open-label Phase 1 Single Ascending Dose and Food Effect Studies in Healthy Adults
SO CLINICAL THERAPEUTICS
LA English
DT Article
DE Doxecitine (deoxycytidine); Doxribtimine (deoxythymidine); Pharmacokinetics; Food effect; Thymidine kinase 2 deficiency; Mitochondrial DNA depletion
ID kinase 2 deficiency; thymidine kinase; infusions
AB Purpose: Doxecitine (deoxycytidine [dC]) and doxribtimine (deoxythymidine [dT]) powder for oral solution is a 1:1 mixture consisting of equal weights 2'-deoxycytidine (dC) and 2'-deoxythymidine (dT). Doxecitine and doxribtimine (referred to as study drug) is being developed as treatment for people with thymidine kinase 2 deficiency (TK2d). TK2d is an ultra-rare mitochondrial DNA depletion and multiple deletion syndrome characterized by progressive muscle weakness and premature death. Here, we report the pharmacokinetics (PK), the effect of food, and the tolerability of 2 study drug formulations, evaluated in 2 studies (Study MT-1621-103 and Study MT-1621-105). Methods: A sequential, ascending 1:1 dose ratio was used for both studies (n = 14 healthy volunteer adult participants/study). After a 28-day (Study MT-1621-103) or 35-day (Study MT-1621-105) screening period, participants fasted overnight and sequentially received 86.6, 173.4, and 266.6 mg/kg study drug with a 48-hour PK assessment period and 48-hour washout period between doses. After 48 additional hours, participants were fed a high-fat meal and received 266.6 mg/kg study drug. Plasma and urine were collected before dosing and throughout the 48-hour PK period. dC and dT concentrations were analyzed by validated liquid chromatography mass spectrometry methods. Safety was evaluated throughout the study and at 2-week follow-up. Findings: Plasma levels of dC and dT increased rapidly and dose-dependently above endogenous levels for both formulations, with a median T-max of 1 to 2 hours under fasting conditions. Post-dose plasma dC and dT concentrations declined to nearly pre-dose (baseline) concentrations after 8 to 12 hours, suggesting rapid elimination. Peak and extent of plasma exposure (baseline-corrected C(max )and AUC0-t) tended to increase less than dose- proportionally for plasma dC and greater than dose-proportionally for plasma dT. PK variability of dC and dT was moderate-to-high ( > 30%). Administration with food delayed T-max to a median of 2 to 4 hours and increased plasma exposure: baseline-corrected plasma dC C-max and AUC0-t increased by similar to 79% to 96% and 137% to 250%, respectively, and dT C-max and AUC0-t increased by 27% to 29% and 74% to 89%, respectively, indicating a significant food effect. Renal clearance played a minor role in the elimination of systemically available intact dC and dT (Fe < 0.3%). The study drug was generally well tolerated; most frequent study-drug-related adverse events (AEs) were diarrhea (n = 4/29, 14%) and dizziness (n = 3/29, 10%). Most AEs were mild-to-moderate in severity. Implications: Doxecitine and doxribtimine are orally bioavailable in the intended clinical dose range. The PK profile supports a formulation consisting of equal doses of doxecitine and doxribtimine, a 3-times-daily dosing regimen, and administration with food.
C1 [Mittur, Aravind; VanMeter, Susan A.] UCB Biosci Inc, 4000 Paramount Pkwy,Suite 200, Morrisville, NC 27560 USA.
   [Orujov, Elmar] Aurinia Pharmaceut Inc, Rockville, MD USA.
   [Glidden, Paul] Corino Therapeut Inc, New York, NY USA.
   [Glidden, Paul] Pierrepont Therapeut Inc, New York, NY USA.
RP Mittur, A (corresponding author), UCB Biosci Inc, 4000 Paramount Pkwy,Suite 200, Morrisville, NC 27560 USA.
EM Aravind.Mittur@ucb.com
FU UCB
CR Berardo A, 2022, J NEUROMUSCULAR DIS, V9, P225, DOI 10.3233/JND-210786
   BlÃ¡zquez-Bermejo C, 2019, EBIOMEDICINE, V46, P342, DOI 10.1016/j.ebiom.2019.07.042
   Camilleri M, 2006, GASTROENTEROLOGY, V131, P640, DOI 10.1053/j.gastro.2006.03.023
   DomÃ­nguez-GonzÃ¡lez C, 2022, J NEUROL, V269, P3550, DOI 10.1007/s00415-021-10957-0
   DomÃ­nguez-GonzÃ¡lez C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   DomÃ­nguez-GonzÃ¡lez C, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1071-z
   ENSMINGER WD, 1977, CANCER RES, V37, P1857
   FDA, 2022, ASSESSING THE EFFECTS OF FOOD ON DRUGS IN INDS AND NDAS - CLINICAL PHARMACOLOGY CONSIDERATIONS GUIDANCE FOR INDUSTRY, V0, P0
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   HOWELL SB, 1981, CANCER RES, V41, P945
   Koziolek M, 2019, EUR J PHARM SCI, V134, P31, DOI 10.1016/j.ejps.2019.04.003
   Lopez-Gomez C, 2019, EBIOMEDICINE, V46, P356, DOI 10.1016/j.ebiom.2019.07.037
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev
   Mennella JA, 2008, CLIN THER, V30, P2120, DOI 10.1016/j.clinthera.2008.11.018
   Mistry P, 2017, PEDIATR DRUGS, V19, P223, DOI 10.1007/s40272-017-0223-7
   PHEAR G, 1987, P NATL ACAD SCI USA, V84, P4450, DOI 10.1073/pnas.84.13.4450
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419
   Toren D, 2016, NUCLEIC ACIDS RES, V44, PD1262, DOI 10.1093/nar/gkv1187
   Tsuruda L, 2020, NEUROMUSCULAR DISORD, V30, PS139, DOI 10.1016/j.nmd.2020.08.313
   VANGROENINGEN CJ, 1991, J NATL CANCER I, V83, P437
   Wang J, 2019, GENE REVIEWS. TK2-RELATED MITOCHONDRIAL DNA MAINTENANCE DEFECT, V0, P0
   Wang JL, 2018, MOL GENET METAB, V124, P124, DOI 10.1016/j.ymgme.2018.04.012
   ZAHARKO DS, 1979, CANCER TREAT REP, V63, P945
   ZAHARKO DS, 1979, CANCER RES, V39, P4777
   Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4
NR 28
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI BRIDGEWATER
PA 685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA
SN 0149-2918
EI 1879-114X
J9 CLIN THER
JI Clin. Ther.
PD JUL 15
PY 2024
VL 46
IS 7
BP 576
EP 587
DI 10.1016/j.clinthera.2024.06.006
EA AUG 2024
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA E4M0G
UT WOS:001302749200001
PM 39025716
DA 2024-11-01
ER

PT J
AU Lopriore, P
   Palermo, G
   Meli, A
   Bellini, G
   Benevento, E
   Montano, V
   Siciliano, G
   Mancuso, M
   Ceravolo, R
AF Lopriore, Piervito
   Palermo, Giovanni
   Meli, Adriana
   Bellini, Gabriele
   Benevento, Elena
   Montano, Vincenzo
   Siciliano, Gabriele
   Mancuso, Michelangelo
   Ceravolo, Roberto
TI Mitochondrial Parkinsonism: A Practical Guide to Genes and Clinical Diagnosis
SO MOVEMENT DISORDERS CLINICAL PRACTICE
LA English
DT Review
DE neurogenetics; primary mitochondrial diseases; parkinsonism; mitochondrial parkinsonism
ID onset spinocerebellar ataxia; dominant optic atrophy; twnk rare variants; movement-disorders; familial parkinsonism; slc25a46 mutations; spastic paraplegia; dna deletions; external ophthalmoplegia; polg1 mutations
AB BackgroundPrimary mitochondrial diseases (PMDs) are the most common inborn errors of energy metabolism, with a combined prevalence of 1 in 4300. They can result from mutations in either nuclear DNA (nDNA) or mitochondrial DNA (mtDNA). These disorders are multisystemic and mainly affect high energy-demanding tissues, such as muscle and the central nervous system (CNS). Among many clinical features of CNS involvement, parkinsonism is one of the most common movement disorders in PMDs.MethodsThis review provides a pragmatic educational overview of the most recent advances in the field of mitochondrial parkinsonism, from pathophysiology and genetic etiologies to phenotype and diagnosis.ResultsmtDNA maintenance and mitochondrial dynamics alterations represent the principal mechanisms underlying mitochondrial parkinsonism. It can be present in isolation, alongside other movement disorders or, more commonly, as part of a multisystemic phenotype. Mutations in several nuclear-encoded genes (ie, POLG, TWNK, SPG7, and OPA1) and, more rarely, mtDNA mutations, are responsible for mitochondrial parkinsonism. Progressive external opthalmoplegia and optic atrophy may guide genetic etiology identification.ConclusionA comprehensive deep-phenotyping approach is needed to reach a diagnosis of mitochondrial parkinsonism, which lacks distinctive clinical features and exemplifies the intricate genotype-phenotype interplay of PMDs.
C1 [Lopriore, Piervito; Meli, Adriana; Bellini, Gabriele; Benevento, Elena; Montano, Vincenzo; Siciliano, Gabriele; Mancuso, Michelangelo; Ceravolo, Roberto] Univ Pisa, Dept Clin & Expt Med, Unit Neurol, Pisa, Italy.
   [Palermo, Giovanni; Bellini, Gabriele; Benevento, Elena; Ceravolo, Roberto] Univ Pisa, Ctr Neurodegenerat Dis Parkinsons Dis & Movement D, Dept Clin & Expt Med, Unit Neurol, Pisa, Italy.
C3 University of Pisa; University of Pisa
RP Mancuso, M (corresponding author), Univ Pisa, Dept Clin & Expt Med, Unit Neurol, Pisa, Italy.
EM michelangelo.mancuso@unipi.it
FU Telethon-MITOCON grant [GSP16001]; EJPRD2019 project GENOMIT; Italian Ministry of University and Research [2022B9WY4A]
CR Abrams AJ, 2015, NAT GENET, V47, P926, DOI 10.1038/ng.3354
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Aloisio S, 2023, NEUROL SCI, V44, P3379, DOI 10.1007/s10072-023-07044-9
   Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Bellini G, 2021, BMC NEUROL, V21, P0, DOI 10.1186/s12883-021-02345-y
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   Billingsley KJ, 2019, NPJ PARKINSONS DIS, V5, P0, DOI 10.1038/s41531-019-0080-x
   Bitetto G, 2020, PARKINSONISM RELAT D, V74, P1, DOI 10.1016/j.parkreldis.2020.03.018
   Blesa J, 2017, EXP NEUROL, V298, P148, DOI 10.1016/j.expneurol.2017.10.002
   Bloem BR, 2021, LANCET, V397, P2284, DOI 10.1016/S0140-6736(21)00218-X
   Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209
   Bonifati V, 2007, PARKINSONISM RELAT D, V13, PS233, DOI 10.1016/S1353-8020(08)70008-7
   Borsche M, 2021, J PARKINSON DIS, V11, P45, DOI 10.3233/JPD-201981
   Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9
   Breen DP, 2020, NEUROLOGY, V95, P644, DOI 10.1212/WNL.0000000000010674
   Burke EA, 2018, CLIN GENET, V93, P712, DOI 10.1111/cge.13172
   Caporali L, 2020, ANN NEUROL, V88, P18, DOI 10.1002/ana.25723
   Caporali L, 2018, BRAIN, V141, P0, DOI 10.1093/brain/awx301
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Carelli V, 2014, NEURON, V84, P1126, DOI 10.1016/j.neuron.2014.11.022
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Charif M, 2015, FRONT GENET, V6, P0, DOI 10.3389/fgene.2015.00311
   Charlesworth G, 2016, MOVEMENT DISORD, V31, P1249, DOI 10.1002/mds.26716
   Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061
   Chumarina M, 2019, ACTA NEUROPATHOL COM, V7, P0, DOI 10.1186/s40478-019-0863-7
   Colavito D, 2017, BIOMED REP, V7, P451, DOI 10.3892/br.2017.987
   DSa K, 2023, NAT MACH INTELL, V5, P933, DOI 10.1038/s42256-023-00702-9
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z
   De la Casa-Fages B, 2019, MOVEMENT DISORD, V34, P1547, DOI 10.1002/mds.27812
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Delgado-Alvarado M, 2015, J NEUROL SCI, V350, P93, DOI 10.1016/j.jns.2015.02.011
   Di Bella D, 2010, NAT GENET, V42, P313, DOI 10.1038/ng.544
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DÃ¶lle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Elkouzi A, 2019, NAT REV NEUROL, V15, P204, DOI 10.1038/s41582-019-0155-7
   Erskine D, 2020, ACTA NEUROPATHOL, V139, P219, DOI 10.1007/s00401-019-02105-w
   Flones IH, 2018, CURR OPIN NEUROL, V31, P472, DOI 10.1097/WCO.0000000000000583
   Gaig C, 2009, MOVEMENT DISORD, V24, PS656, DOI 10.1002/mds.22672
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   Gasser T, 2009, EXPERT REV MOL MED, V11, P0, DOI 10.1017/S1462399409001148
   Ghaoui R, 2018, J NEUROL, V265, P1230, DOI 10.1007/s00415-017-8722-6
   Glasgow RIC, 2020, HUMAN MITOCHONDRIAL, V0, PP375, DOI 10.1016/B9780128196564.00015-2
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hammer MB, 2017, NEURODEGENER DIS, V17, P208, DOI 10.1159/000464445
   Henrich MT, 2023, MOL NEURODEGENER, V18, P0, DOI 10.1186/s13024-023-00676-7
   Hernandez DG, 2016, J NEUROCHEM, V139, P59, DOI 10.1111/jnc.13593
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Iannielli A, 2018, CELL REP, V22, P2066, DOI 10.1016/j.celrep.2018.01.089
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Janer A, 2016, EMBO MOL MED, V8, P1019, DOI 10.15252/emmm.201506159
   Jellinger KA, 2012, MOVEMENT DISORD, V27, P8, DOI 10.1002/mds.23795
   Johansson M, 1996, P NATL ACAD SCI USA, V93, P7258, DOI 10.1073/pnas.93.14.7258
   Jonikas M, 2018, ANN NEUROL, V83, P915, DOI 10.1002/ana.25221
   JÃ¼llig M, 2000, EUR J BIOCHEM, V267, P5466, DOI 10.1046/j.1432-1327.2000.01607.x
   Kaasinen V, 2017, ANN NEUROL, V82, P873, DOI 10.1002/ana.25103
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Klebe S, 2012, BRAIN, V135, P2980, DOI 10.1093/brain/aws240
   Li CY, 2023, MOVEMENT DISORD, V38, P708, DOI 10.1002/mds.29372
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Lynch DS, 2017, NEUROL-GENET, V3, P0, DOI 10.1212/NXG.0000000000000188
   Magri S, 2018, HUM MUTAT, V39, P2060, DOI 10.1002/humu.23658
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Mancuso M, 2008, PARKINSONISM RELAT D, V14, P381, DOI 10.1016/j.parkreldis.2007.10.001
   Mancuso Michelangelo, 2023, HANDB CLIN NEUROL, V194, P117, DOI 10.1016/B978-0-12-821751-1.00003-8
   Mancuso Michelangelo, 2008, HUMAN GENOMICS, V3, P71
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Manini A, 2022, AGEING RES REV, V76, P0, DOI 10.1016/j.arr.2022.101578
   Maresca A, 2021, BIOMOLECULES, V11, P0, DOI 10.3390/biom11040496
   Martikainen MH, 2016, JAMA NEUROL, V73, P668, DOI 10.1001/jamaneurol.2016.0355
   Martikainen MH, 2013, MITOCHONDRION, V13, P83, DOI 10.1016/j.mito.2013.01.012
   Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806
   Miguel R, 2014, CLIN NEUROL NEUROSUR, V126, P47, DOI 10.1016/j.clineuro.2014.08.020
   Montano V, 2022, J NEUROL, V269, P6555, DOI 10.1007/s00415-022-11324-3
   Montano V, 2022, J NEUROL, V269, P1413, DOI 10.1007/s00415-021-10697-1
   Morino H, 2014, NEUROLOGY, V83, P2054, DOI 10.1212/WNL.0000000000001036
   MÃ¼ller-Nedebock AC, 2021, MOVEMENT DISORD, V36, P815, DOI 10.1002/mds.28475
   Musumeci O, 2020, J TRANSL GENET GENOM, V4, P221, DOI 10.20517/JTGG.2020.22
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Orsucci D, 2011, J MOL NEUROSCI, V44, P17, DOI 10.1007/s12031-010-9488-9
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Palermo G, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms222011234
   Palin EJH, 2013, BRAIN, V136, P2379, DOI 10.1093/brain/awt160
   Parra SP, 2021, PARKINSONISM RELAT D, V93, P50, DOI 10.1016/j.parkreldis.2021.10.031
   Pedroso JL, 2018, PARKINSONISM RELAT D, V47, P88, DOI 10.1016/j.parkreldis.2017.12.004
   Percetti M, 2023, MOVEMENT DISORD, V38, P709, DOI 10.1002/mds.29373
   Percetti M, 2022, MOVEMENT DISORD, V37, P1938, DOI 10.1002/mds.29139
   Pierson TM, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002325
   Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424
   Prasuhn J, 2021, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.615461
   PRZEDBORSKI S, 1993, ANN NEUROL, V34, P715, DOI 10.1002/ana.410340515
   Qi R, 2023, SCI TRANSL MED, V15, P0, DOI 10.1126/scitranslmed.abo1557
   Remtulla S, 2019, PEDIATR NEUROL, V90, P61, DOI 10.1016/j.pediatrneurol.2018.08.007
   Ronchi D, 2018, BRAIN, V141, P0, DOI 10.1093/brain/awx302
   Sacco T, 2010, BMC NEUROSCI, V11, P0, DOI 10.1186/1471-2202-11-55
   Salgado P, 2019, MOV DISORD CLIN PRAC, V6, P174, DOI 10.1002/mdc3.12711
   Schreglmann SR, 2018, MOVEMENT DISORD, V33, P146, DOI 10.1002/mds.27174
   Senkevich K, 2022, MOVEMENT DISORD, V37, P2318, DOI 10.1002/mds.29216
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Song LY, 2012, HUM MOL GENET, V21, P5147, DOI 10.1093/hmg/dds365
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Sulaiman RA, 2017, CLIN GENET, V92, P230, DOI 10.1111/cge.12963
   Synofzik M, 2019, INT REV NEUROBIOL, V149, P277, DOI 10.1016/bs.irn.2019.10.019
   Synofzik M, 2010, MOVEMENT DISORD, V25, P2472, DOI 10.1002/mds.23307
   Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0
   Titova N, 2017, J NEURAL TRANSM, V124, P907, DOI 10.1007/s00702-016-1667-6
   Tranchant C, 2016, REV NEUROL-FRANCE, V172, P524, DOI 10.1016/j.neurol.2016.07.003
   Trinh J, 2019, MOVEMENT DISORD, V34, P133, DOI 10.1002/mds.27559
   Tzoulis C, 2016, MITOCHONDRION, V28, P33, DOI 10.1016/j.mito.2016.03.003
   Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   van Gassen KLI, 2012, BRAIN, V135, P2994, DOI 10.1093/brain/aws224
   Vandenberghe W, 2021, NEUROL-GENET, V7, P0, DOI 10.1212/NXG.0000000000000620
   Vital C, 2015, REV NEUROL-FRANCE, V171, P679, DOI 10.1016/j.neurol.2015.03.011
   Wan JJ, 2016, BRAIN, V139, P2877, DOI 10.1093/brain/aww212
   Wilcox RA, 2007, MOVEMENT DISORD, V22, P1020, DOI 10.1002/mds.21416
   Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799
   WÃ¼llner U, 2023, J NEURAL TRANSM, V130, P827, DOI 10.1007/s00702-023-02635-4
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
NR 130
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2330-1619
EI 
J9 MOV DISORD CLIN PRAC
JI MOV. DISORD. CLIN. PRACT.
PD AUG 15
PY 2024
VL 11
IS 8
BP 948
EP 965
DI 10.1002/mdc3.14148
EA JUN 2024
PG 18
WC Clinical Neurology
SC Neurosciences & Neurology
GA D0M9G
UT WOS:001257432100001
PM 38943319
DA 2024-11-01
ER

PT J
AU Fitzsimmons, CM
   Mandler, MD
   Lunger, JC
   Chan, DL
   Maligireddy, SS
   Schmiechen, AC
   Gamage, ST
   Link, C
   Jenkins, LM
   Chan, K
   Andresson, T
   Crooks, DR
   Meier, JL
   Linehan, WM
   Batista, PJ
AF Fitzsimmons, Christina M.
   Mandler, Mariana D.
   Lunger, Judith C.
   Chan, Dalen
   Maligireddy, Siddhardha S.
   Schmiechen, Alexandra C.
   Gamage, Supuni Thalalla
   Link, Courtney
   Jenkins, Lisa M.
   Chan, King
   Andresson, Thorkell
   Crooks, Daniel R.
   Meier, Jordan L.
   Linehan, W. Marston
   Batista, Pedro J.
TI Rewiring of RNA methylation by the oncometabolite fumarate in renal cell carcinoma
SO NAR CANCER
LA English
DT Article
ID messenger-rna; hereditary leiomyomatosis; succinate-dehydrogenase; mitochondrial dysfunction; sdh mutations; cancer hlrcc; tca cycle; in-vivo; hydratase; m(6)a
AB Metabolic reprogramming is a hallmark of cancer that facilitates changes in many adaptive biological processes. Mutations in the tricarboxylic acid cycle enzyme fumarate hydratase (FH) lead to fumarate accumulation and cause hereditary leiomyomatosis and renal cell cancer (HLRCC). HLRCC is a rare, inherited disease characterized by the development of non-cancerous smooth muscle tumors of the uterus and skin, and an increased risk of an aggressive form of kidney cancer. Fumarate has been shown to inhibit 2-oxoglutarate-dependent dioxygenases (2OGDDs) involved in the hydroxylation of HIF1 alpha, as well as in DNA and histone demethylation. However, the link between fumarate accumulation and changes in RNA post-transcriptional modifications has not been defined. Here, we determine the consequences of fumarate accumulation on the activity of different members of the 2OGDD family targeting RNA modifications. By evaluating multiple RNA modifications in patient-derived HLRCC cell lines, we show that mutation of FH selectively affects the levels of N6-methyladenosine (m6A), while the levels of 5-formylcytosine (f5C) in mitochondrial tRNA are unaffected. This supports the hypothesis of a differential impact of fumarate accumulation on distinct RNA demethylases. The observation that metabolites modulate specific subsets of RNA-modifying enzymes offers new insights into the intersection between metabolism and the epitranscriptome. Graphical Abstract
C1 [Fitzsimmons, Christina M.; Mandler, Mariana D.; Lunger, Judith C.; Chan, Dalen; Maligireddy, Siddhardha S.; Schmiechen, Alexandra C.; Jenkins, Lisa M.; Batista, Pedro J.] NCI, NIH, Ctr Canc Res, Lab Cell Biol, Bethesda, MD 20892 USA.
   [Gamage, Supuni Thalalla; Link, Courtney; Meier, Jordan L.] NCI, Ctr Canc Res, Chem Biol Lab, Frederick, MD 21702 USA.
   [Chan, King; Andresson, Thorkell] NCI, NIH, Res Technol Program, Prot Characterizat Lab,Frederick Natl Lab Canc Res, Frederick, MD 21701 USA.
   [Crooks, Daniel R.; Linehan, W. Marston] NCI, NIH, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Frederick National Laboratory for Cancer Research; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)
RP Batista, PJ (corresponding author), NCI, NIH, Ctr Canc Res, Lab Cell Biol, Bethesda, MD 20892 USA.
EM pedro.batista@nih.gov
FU National Cancer Institute; Center for Cancer Research (CCR) Genomics Core in Bethesda, Maryland
CR Adam J, 2013, CELL REP, V3, P1440, DOI 10.1016/j.celrep.2013.04.006
   Aguilo F, 2015, CELL STEM CELL, V17, P689, DOI 10.1016/j.stem.2015.09.005
   Akichika S, 2019, SCIENCE, V363, P141, DOI 10.1126/science.aav0080
   Akram M, 2014, CELL BIOCHEM BIOPHYS, V68, P475, DOI 10.1007/s12013-013-9750-1
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Anderson NM, 2018, PROTEIN CELL, V9, P216, DOI 10.1007/s13238-017-0451-1
   Arango D, 2018, CELL, V175, P1872, DOI 10.1016/j.cell.2018.10.030
   Arguello AE, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-31876-2
   Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003
   Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019
   Boulias K, 2019, MOL CELL, V75, P631, DOI 10.1016/j.molcel.2019.06.006
   Brunner JS, 2023, NAT REV ENDOCRINOL, V19, P134, DOI 10.1038/s41574-022-00773-5
   Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981
   Covelo-Molares H, 2021, NUCLEIC ACIDS RES, V49, P10895, DOI 10.1093/nar/gkab900
   CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y
   Crooks DR, 2021, SCI SIGNAL, V14, P0, DOI 10.1126/scisignal.abc4436
   De Sousa SMC, 2020, J ENDOCR SOC, V4, P0, DOI 10.1210/jendso/bvaa071
   Delaunay S, 2022, NATURE, V607, P593, DOI 10.1038/s41586-022-04898-5
   Dobin A, 2016, METHODS MOL BIOL, V1415, P245, DOI 10.1007/978-1-4939-3572-7_13
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112
   Fedeles BI, 2015, J BIOL CHEM, V290, P20734, DOI 10.1074/jbc.R115.656462
   Flynn RA, 2016, NAT PROTOC, V11, P273, DOI 10.1038/nprot.2016.011
   Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710
   Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417
   Gokhale NS, 2020, MOL CELL, V77, P542, DOI 10.1016/j.molcel.2019.11.007
   Grozhik AV, 2017, METHODS MOL BIOL, V1562, P55, DOI 10.1007/978-1-4939-6807-7_5
   Haag S, 2016, EMBO J, V35, P2104, DOI 10.15252/embj.201694885
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   He PC, 2021, EMBO J, V40, P0, DOI 10.15252/embj.2020105977
   Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004
   Herzog VA, 2017, NAT METHODS, V14, P1198, DOI 10.1038/NMETH.4435
   Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086
   Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017
   Islam MS, 2018, ANNU REV BIOCHEM, V87, P585, DOI 10.1146/annurev-biochem-061516-044724
   Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772
   Joberty G, 2016, ACS CHEM BIOL, V11, P2002, DOI 10.1021/acschembio.6b00080
   Justus CR, 2014, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/51046
   Kamp M, 2023, BIORXIV, V0, P0, DOI DOI 10.1101/2023.07.02.547209
   Kawarada L, 2017, NUCLEIC ACIDS RES, V45, P7401, DOI 10.1093/nar/gkx354
   Killian JK, 2013, CANCER DISCOV, V3, P648, DOI 10.1158/2159-8290.CD-13-0092
   King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594
   Kluesner MG, 2018, CRISPR J, V1, P239, DOI 10.1089/crispr.2018.0014
   Kulkarni RA, 2019, CHEMBIOCHEM, V20, P360, DOI 10.1002/cbic.201800651
   Lee H, 2019, NAT CELL BIOL, V21, P700, DOI 10.1038/s41556-019-0318-1
   LetouzÃ© E, 2013, CANCER CELL, V23, P739, DOI 10.1016/j.ccr.2013.04.018
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017
   Linehan WM, 2016, NEW ENGL J MED, V374, P135, DOI 10.1056/NEJMoa1505917
   Link CN, 2022, BIOCHEMISTRY-US, V61, P535, DOI 10.1021/acs.biochem.1c00761
   Liu C, 2023, NAT BIOTECHNOL, V41, P355, DOI 10.1038/s41587-022-01487-9
   Liu L, 2017, BMC BIOINFORMATICS, V18, P0, DOI 10.1186/s12859-017-1808-4
   Liu Y, 2019, SCIENCE, V365, P1171, DOI 10.1126/science.aax4468
   Losman JA, 2020, NAT REV CANCER, V20, P710, DOI 10.1038/s41568-020-00303-3
   Love MI, 2014, GENOME BIOL, V15, P0, DOI 10.1186/s13059-014-0550-8
   Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840
   Martin M, 2011, EMBNET.JOURNAL, V17, P10, DOI 10.14806/ej.17.1.200
   Martinez-Pastor B, 2013, CANCER DISCOV, V3, P497, DOI 10.1158/2159-8290.CD-13-0059
   Mauer J, 2019, NAT CHEM BIOL, V15, P340, DOI 10.1038/s41589-019-0231-8
   McIntyre ABR, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-63355-3
   Menko FH, 2014, FAM CANCER, V13, P637, DOI 10.1007/s10689-014-9735-2
   Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003
   Miettinen M, 2014, INT J BIOCHEM CELL B, V53, P514, DOI 10.1016/j.biocel.2014.05.033
   Miyazawa H, 2018, DEVELOPMENT, V145, P0, DOI 10.1242/dev.131110
   MÃ¼ller TA, 2018, BIOCHEM BIOPH RES CO, V495, P98, DOI 10.1016/j.bbrc.2017.10.158
   Muhar M, 2018, SCIENCE, V360, P800, DOI 10.1126/science.aao2793
   Nakano S, 2016, NAT CHEM BIOL, V12, P546, DOI 10.1038/NCHEMBIO.2099
   Olarerin-George Anthony O, 2017, BIOINFORMATICS, V33, P1563, DOI 10.1093/bioinformatics/btx002
   Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002
   Pandey RR, 2020, CELL REP, V32, P0, DOI 10.1016/j.celrep.2020.108038
   Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227
   Qu JW, 2022, J HEMATOL ONCOL, V15, P0, DOI 10.1186/s13045-022-01224-4
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Ricketts CJ, 2022, PLOS ONE, V17, P0, DOI 10.1371/journal.pone.0278108
   Safra M, 2017, NATURE, V551, P251, DOI 10.1038/nature24456
   Sandhu IS, 2015, BIOCHEM SOC T, V43, P650, DOI 10.1042/BST20150041
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI 10.1038/nmeth.2019
   Schvartzman JM, 2018, J CELL BIOL, V217, P2247, DOI 10.1083/jcb.201803061
   Sciacovelli M, 2016, NATURE, V537, P544, DOI 10.1038/nature19353
   Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022
   Sieber MH, 2017, CURR OPIN GENET DEV, V45, P58, DOI 10.1016/j.gde.2017.03.002
   Smith T, 2017, GENOME RES, V27, P491, DOI 10.1101/gr.209601.116
   Su R, 2018, CELL, V172, P90, DOI 10.1016/j.cell.2017.11.031
   Sun GX, 2021, CLIN CANCER RES, V27, P1734, DOI 10.1158/1078-0432.CCR-20-3788
   Sun HX, 2019, CELL RES, V29, P80, DOI 10.1038/s41422-018-0117-4
   Sun LD, 2016, CELL CYCLE, V15, P2647, DOI 10.1080/15384101.2016.1211214
   Supek F, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0021800
   Tandon N, 2018, BIO-PROTOCOL, V8, P0, DOI 10.21769/BioProtoc.3073
   Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849
   Tong WH, 2011, CANCER CELL, V20, P315, DOI 10.1016/j.ccr.2011.07.018
   Tsujikawa K, 2007, J CELL MOL MED, V11, P1105, DOI 10.1111/j.1582-4934.2007.00094.x
   Van Deuren V, 2020, DNA REPAIR, V96, P0, DOI 10.1016/j.dnarep.2020.102995
   Van Haute L, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms12039
   Vander Heiden MG, 2017, CELL, V168, P0, DOI 10.1016/j.cell.2016.12.039
   Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902
   Wei JB, 2018, MOL CELL, V71, P973, DOI 10.1016/j.molcel.2018.08.011
   Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200
   Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112
   Xiao Y, 2018, ANGEW CHEM INT EDIT, V57, P15995, DOI 10.1002/anie.201807942
   Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710
   Yang YF, 2012, CANCER GENET-NY, V205, P377, DOI 10.1016/j.cancergen.2012.05.001
   Yang Y, 2010, CANCER GENET CYTOGEN, V196, P45, DOI 10.1016/j.cancergencyto.2009.08.018
   Zhang CJ, 2021, SCI TRANSL MED, V13, P0, DOI 10.1126/scitranslmed.abf6045
   Zhang X, 2019, P NATL ACAD SCI USA, V116, P2919, DOI 10.1073/pnas.1820574116
   Zhang Y, 2021, MOL BIOL REP, V48, P4747, DOI 10.1007/s11033-021-06421-x
   Zhang Y, 2008, GENOME BIOL, V9, P0, DOI 10.1186/gb-2008-9-9-r137
   Zheng L, 2013, CANCER METAB, V1, P0, DOI 10.1186/2049-3002-1-12
   Zhou YY, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-09234-6
   Zuidhof HR, 2022, CANCER RES, V82, P2201, DOI 10.1158/0008-5472.CAN-21-371
NR 110
TC 4
Z9 4
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2632-8674
EI 
J9 NAR CANCER
JI NAR Cancer
PD JAN 9
PY 2024
VL 6
IS 1
BP 
EP 
DI 10.1093/narcan/zcae004
PG 20
WC Biochemistry & Molecular Biology; Oncology
SC Biochemistry & Molecular Biology; Oncology
GA HD9R0
UT WOS:001157678300001
PM 38328795
DA 2024-11-01
ER

PT J
AU Majamaa, K
   KÃ¤rppÃ¤, M
   Moilanen, JS
AF Majamaa, Kari
   Karppa, Mikko
   Moilanen, Jukka S.
TI Neurological manifestations in adult patients with the m.3243A>G variant in mitochondrial DNA
SO BMJ NEUROLOGY OPEN
LA English
DT Article
DE CLINICAL NEUROLOGY; GENETICS; META-ANALYSIS; MITOCHONDRIAL DISORDERS; SYSTEMATIC REVIEWS
ID stroke-like episodes; lactic-acidosis; peripheral neuropathy; mutation; melas; encephalopathy; prevalence; disease; a3243g; polymorphisms
AB Background The m.3243A>G variant in mitochondrial DNA (mtDNA) is the most common cause of the MELAS (Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes) syndrome usually commencing in childhood or adolescence. In adults, the variant presents with versatile and mostly neurological phenotypes, but MELAS may not be common. Objective To examine the frequency of phenotypes in adults with m.3243A>G in a population-based cohort and in a meta-analysis of reported case series. Methods We clinically examined 51 adult patients with m.3243A>G to determine the frequency of phenotypes and to analyse the contribution of variant heteroplasmy, age, sex and mtDNA haplogroup to the phenotypes. The frequencies of neurological features were also assessed in a meta-analysis on 25 published case series reporting 1314 patients. Results Sensorineural hearing impairment (HI), cognitive impairment and myopathy were the most common manifestations, whereas stroke-like episodes were infrequent. Variant heteroplasmy and age were only modest predictors of the phenotypes, although heteroplasmy correlated significantly with disability and Kaplan-Meier analysis showed progression of phenotypes with age. Male sex predicted more severe disability, whereas haplogroup UK was associated with no significant disability. Meta-analysis revealed substantial heterogeneity of phenotype frequencies and preferential inclusion of the MELAS phenotype. Discussion In adult patients with m.3243A>G sensorineural HI, cognitive impairment and myopathy are common manifestations with lifetime prevalences approaching unity. Stroke-like episodes are rare. Variant heteroplasmy, age, sex and mtDNA haplogroup contribute to the severity of the disease. Meta-analysis provided a solid estimate of the various neurological symptoms in adults with m.3243A>G.
C1 [Majamaa, Kari; Karppa, Mikko] Univ Oulu, Res Unit Clin Med, Neurol, Oulu, Finland.
   [Majamaa, Kari; Karppa, Mikko] Oulu Univ Hosp, Med Res Ctr Oulu & Neuroctr, Oulu, Finland.
   [Moilanen, Jukka S.] Univ Oulu, Res Unit Clin Med, Clin Genet, Oulu, Finland.
   [Moilanen, Jukka S.] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland.
C3 University of Oulu; University of Oulu; University of Oulu; University of Oulu
RP Majamaa, K (corresponding author), Univ Oulu, Res Unit Clin Med, Neurol, Oulu, Finland.; Majamaa, K (corresponding author), Oulu Univ Hosp, Med Res Ctr Oulu & Neuroctr, Oulu, Finland.
EM kari.majamaa@oulu.fi; mikko.karppa@oulu.fi; jukka.moilanen@oulu.fi
FU Sigrid Juselius Foundation
CR Autere J, 2004, HUM GENET, V115, P29, DOI 10.1007/s00439-004-1123-9
   Balduzzi S, 2019, EVID-BASED MENT HEAL, V22, P153, DOI 10.1136/ebmental-2019-300117
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Boggan RM, 2019, MOL GENET METAB, V128, P19, DOI 10.1016/j.ymgme.2019.09.003
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   FinnilÃ¤ S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Guy W, 1976, NATL I MENTAL HLTH R, V0, P218
   Higgins JPT, 2003, BMJ-BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394
   KÃ¤rppÃ¤ M, 2003, J NEUROL, V250, P216, DOI 10.1007/s00415-003-0981-8
   Karstens AJ, 2024, J INT NEUROPSYCH SOC, V30, P389, DOI 10.1017/S1355617723000760
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Liu GQ, 2023, BRAIN, V146, P42, DOI 10.1093/brain/awac327
   Lu YY, 2020, J NEUROL SCI, V408, P0, DOI 10.1016/j.jns.2019.116499
   Luigetti M, 2016, EUR J NEUROL, V23, P1020, DOI 10.1111/ene.12954
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Majamaa-Voltti Kirsi, 2002, BMC CARDIOVASC DISORD, V2, P12
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Martikainen MH, 2024, BMJ NEUROL OPEN, V6, P0, DOI 10.1136/bmjno-2023-000546
   Montano V, 2021, ARCH BIOCHEM BIOPHYS, V697, P0, DOI 10.1016/j.abb.2020.108689
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y
   Orsucci D, 2017, J NEUROL, V264, P1777, DOI 10.1007/s00415-017-8567-z
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Pierron D, 2008, BMC MED GENET, V9, P0, DOI 10.1186/1471-2350-9-41
   RANKIN J, 1957, SCOTT MED J, V2, P200
   Sovio U, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000409
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Torroni A, 2003, AM J HUM GENET, V72, P1005, DOI 10.1086/373936
   Uimonen S, 2001, HUM GENET, V108, P284, DOI 10.1007/s004390100475
   WHO Document Production Services, 2006, DEFINITION AND DIAGNOSIS OF DIABETES MELLITUS AND INTERMEDIATE HYPERGLYCEMIA: REPORT OF A WHO/IDF CONSULTATION, V0, P0
NR 37
TC 0
Z9 0
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 
EI 2632-6140
J9 BMJ NEUROL OPEN
JI BMJ Neurol Open
PD SEP 24
PY 2024
VL 6
IS 2
BP 
EP 
DI 10.1136/bmjno-2024-000825
PG 9
WC Clinical Neurology
SC Neurosciences & Neurology
GA H0O0B
UT WOS:001320512900001
PM 39324021
DA 2024-11-01
ER

PT J
AU Che, L
   Wu, YL
   Sheng, MW
   Xu, JA
   Yu, WL
   Weng, YQ
AF Che, Lu
   Wu, Yuli
   Sheng, Mingwei
   Xu, Jiangang
   Yu, Wenli
   Weng, Yiqi
TI Intraoperative management during liver transplantation in the child with mitochondrial depletion syndrome: A case report
SO INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS
LA English
DT Article
DE Intraoperative management; Liver transplantation; Mitochondrial depletion syndrome; Case report
ID postreperfusion syndrome; reperfusion; patient; injury; maintenance; elevation; myopathy; diseases
AB Introduction: Mitochondrial DNA depletion syndrome (MDS) is a kind of autosomal recessive genetic disorder associated with a reduction in mitochondrial DNA (mtDNA) copy number caused by mutations in nuclear genes during nucleotide synthesis, which affects the energy production of tissues and organs. Changes in hemodynamics during liver transplantation may lead to high energy-demanding organs and tissues being vulnerable. This report described the intraoperative management during liver transplantation in a child with MDS. Ultimately, the child was discharged smoothly without any complications. Presentation of the case: A five -year -old boy was diagnosed with mitochondrial depletion syndrome preoperatively and scheduled for living donor liver transplantation. The incidence of postreperfusion syndrome (PRS) could not be avoided for 30 min after opening, despite our best efforts to aggressively prevent it before opening. While ensuring hemodynamic stability, we actively prevented and adopted high-energy-demand organ protection strategies to reduce the incidence of postoperative complications. Finally, the child was discharged 28 days after the operation, and no other complications were found. Discussion: Liver transplantation can be performed for liver failure in this disease to improve the quality of life and prolong the life of patients. As this child has mitochondrial DNA depletion syndrome, the disruption of cellular energy generation caused by mitochondrial malfunction puts high-energy-demanding organs and tissues at risk during surgery. It motivates us to pay closer attention to the prevention and treatment of PRS in anesthetic management to minimize damage to the child's organs and tissues with high energy demands. Conclusions: This report describes the intraoperative management during liver transplantation in a child with mitochondrial depletion syndrome. To increase the safety of perioperative anesthesia and reduce mortality in patients with mitochondrial disease, for such patients, maintaining an acid-base balance and a stable internal environment is essential. We should also pay attention to protecting body temperature, using vasoactive drugs beforehand to lessen the incidence of PRS, and protecting high-energy-demanding organs afterward.
C1 [Che, Lu; Sheng, Mingwei; Xu, Jiangang; Yu, Wenli; Weng, Yiqi] Tianjin First Cent Hosp, Dept Anesthesiol, 24 Fukang Rd, Tianjin 300192, Peoples R China.
   [Wu, Yuli] Tianjin Med Univ, Cent Clin Coll 1, Tianjin, Peoples R China.
   [Yu, Wenli; Weng, Yiqi] Tianjin First Cent Hosp, Tianjin, Peoples R China.
C3 Tianjin Medical University; Tianjin Medical University; Tianjin Medical University
RP Xu, JA; Yu, WL; Weng, YQ (corresponding author), Tianjin First Cent Hosp, Dept Anesthesiol, 24 Fukang Rd, Tianjin 300192, Peoples R China.; Yu, WL; Weng, YQ (corresponding author), Tianjin First Cent Hosp, Tianjin, Peoples R China.
EM xjgyzx@126.com; 30817029@nankai.edu.cn; wyqhyd@126.com
FU Tianjin Key Medical Discipline (Specialty) Construction Project [TJYXZDXK-045A]; Natural Science Foundation of Tianjin [21JCYBJC01190]
CR AGGARWAL S, 1987, TRANSPLANT P, V19, P54
   AlquÃ©zar-ArbÃ© A, 2017, CRIT REV CL LAB SCI, V54, P551, DOI 10.1080/10408363.2017.1410777
   Basel D, 2020, CLIN PERINATOL, V47, P123, DOI 10.1016/j.clp.2019.10.008
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   El-Hattab AW, 2018, HUM MUTAT, V39, P461, DOI 10.1002/humu.23387
   Enns GM, 2017, CURR OPIN PEDIATR, V29, P541, DOI 10.1097/MOP.0000000000000535
   Falk MJ, 2010, CURR OPIN PEDIATR, V22, P711, DOI 10.1097/MOP.0b013e3283402e21
   Hilmi IA, 2015, BRIT J ANAESTH, V114, P919, DOI 10.1093/bja/aeu556
   Huang S, 2016, CLIN TRANSPLANT, V30, P1552, DOI 10.1111/ctr.12855
   Kassel CA, 2021, J CARDIOTHOR VASC AN, V35, P1495, DOI 10.1053/j.jvca.2020.01.056
   Nanashima A, 2001, J HEPATOBILIARY PANCREAT SURG, V8, P557, DOI 10.1007/s005340100025
   Ozacmak VH, 2007, WORLD J GASTROENTERO, V13, P538, DOI 10.3748/wjg.v13.i4.538
   Potgieter K, 2010, J NEUROPHYSIOL, V104, P742, DOI 10.1152/jn.00021.2010
   Romagnoli S, 2009, HEART LUNG VESSEL, V1, P20
   Ryu HG, 2012, LIVER TRANSPLANT, V18, P1430, DOI 10.1002/lt.23511
   Sasano N, 2007, J ANESTH, V21, P72, DOI 10.1007/s00540-006-0449-y
   Sheng MW, 2017, TRANSPLANTATION, V101, P2385, DOI 10.1097/TP.0000000000001732
   Siniscalchi A, 2016, WORLD J GASTROENTERO, V22, P1551, DOI 10.3748/wjg.v22.i4.1551
   Smith A, 2017, EUR J PEDIATR, V176, P83, DOI 10.1007/s00431-016-2813-8
   Sohrabi C, 2023, INT J SURG, V109, P1136, DOI 10.1097/JS9.0000000000000373
   Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112
   Vilchez-Monge AL, 2020, LIVER TRANSPLANT, V26, P681, DOI 10.1002/lt.25716
   Woodward EL, 2017, A A CASE REP, V8, P33, DOI 10.1213/XAA.0000000000000416
   Zhang L, 2018, ANN TRANSPL, V23, P334, DOI 10.12659/AOT.909050
NR 24
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI London
PA 125 London Wall, London, ENGLAND
SN 2210-2612
EI 
J9 INT J SURG CASE REP
JI Int. J. Surg. Case Rep.
PD MAR 15
PY 2024
VL 116
IS 
BP 
EP 
DI 10.1016/j.ijscr.2024.109432
EA MAR 2024
PG 5
WC Surgery
SC Surgery
GA NX4S3
UT WOS:001203745500001
PM 38432165
DA 2024-11-01
ER

PT J
AU Khaghani, F
   Hemmati, M
   Ebrahimi, M
   Salmaninejad, A
AF Khaghani, Faeze
   Hemmati, Mahboube
   Ebrahimi, Masoumeh
   Salmaninejad, Arash
TI Emerging Multi-Omic Approaches to the Molecular Diagnosis of Mitochondrial Disease and Available Strategies for Treatment and Prevention
SO CURRENT GENOMICS
LA English
DT Review
DE Mitochondrial disease; omics; genomic; transcriptomics; proteomics; metabolomics
ID activated protein-kinase; therapeutic strategy; quality-control; leigh-syndrome; gene-therapy; mutations; biogenesis; disorders; myopathy; exercise
AB Mitochondria are semi-autonomous organelles present in several copies within most cells in the human body that are controlled by the precise collaboration of mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) encoding mitochondrial proteins. They play important roles in numerous metabolic pathways, such as the synthesis of adenosine triphosphate (ATP), the predominant energy substrate of the cell generated through oxidative phosphorylation (OXPHOS), intracellular calcium homeostasis, metabolite biosynthesis, aging, cell cycles, and so forth. Previous studies revealed that dysfunction of these multi-functional organelles, which may arise due to mutations in either the nuclear or mitochondrial genome, leads to a diverse group of clinically and genetically heterogeneous disorders. These diseases include neurodegenerative and metabolic disorders as well as cardiac and skeletal myopathies in both adults and newborns. The plethora of phenotypes and defects displayed leads to challenges in the diagnosis and treatment of mitochondrial diseases. In this regard, the related literature proposed several diagnostic options, such as high throughput mitochondrial genomics and omics technologies, as well as numerous therapeutic options, such as pharmacological approaches, manipulating the mitochondrial genome, increasing the mitochondria content of the affected cells, and recently mitochondrial diseases transmission prevention. Therefore, the present article attempted to review the latest advances and challenges in diagnostic and therapeutic options for mitochondrial diseases.
C1 [Khaghani, Faeze] Guilan Univ Med Sci, Sch Pharm, Dept Pharmaceut Biotechnol, Rasht, Iran.
   [Khaghani, Faeze; Hemmati, Mahboube; Salmaninejad, Arash] Mashhad Univ Med Sci, Med Genet Res Ctr, Fac Med, Mashhad, Iran.
   [Ebrahimi, Masoumeh] Univ Tabriz, Sch Nat Sci, Dept Anim Biol, Tabriz, Iran.
   [Salmaninejad, Arash] Guilan Univ Med Sci, Razi Hosp, Regenerat Med Organ Procurement & Transplantat Mul, Sch Med, Rasht, Iran.
C3 Guilan University of Medical Sciences; Mashhad University of Medical Sciences; University of Tabriz; Guilan University of Medical Sciences
RP Salmaninejad, A (corresponding author), Mashhad Univ Med Sci, Med Genet Res Ctr, Fac Med, Mashhad, Iran.
EM Arash.salmany@yahoo.com
FU University of Oulu, Finland
CR Aboulmaouahib B, 2022, HUM MOL GENET, V31, P3367, DOI 10.1093/hmg/ddab312
   Aguet F, 2020, SCIENCE, V369, P1318, DOI 10.1126/science.aaz1776
   Ahmad R, 2021, INT J HEALTH SCI-IJH, V15, P1
   Aicher JK, 2020, GENET MED, V22, P1181, DOI 10.1038/s41436-020-0780-y
   Aldossary AM, 2022, SAUDI PHARM J, V30, P1065, DOI 10.1016/j.jsps.2022.05.011
   Alemany VS, 2024, J THORAC CARDIOV SUR, V167, Pe6, DOI 10.1016/j.jtcvs.2023.05.010
   Alexeyev MF, 2008, GENE THER, V15, P516, DOI 10.1038/sj.gt.2008.11
   Alshial EE, 2023, LIFE SCI, V334, P0, DOI 10.1016/j.lfs.2023.122257
   Alston CL, 2021, J PATHOL, V254, P430, DOI 10.1002/path.5641
   Alston CL, 2020, AM J HUM GENET, V106, P92, DOI 10.1016/j.ajhg.2019.12.001
   Andersen LW, 2013, MAYO CLIN PROC, V88, P1127, DOI 10.1016/j.mayocp.2013.06.012
   Anthony RM, 2021, ANIMALS-BASEL, V11, P0, DOI 10.3390/ani11051454
   Aryamvally A, 2021, J GENET COUNS, V30, P828, DOI 10.1002/jgc4.1382
   Avula S, 2014, CURR TREAT OPTION NE, V16, P0, DOI 10.1007/s11940-014-0292-7
   Bacman SR, 2007, GENE THER, V14, P1309, DOI 10.1038/sj.gt.3302981
   Bacman SR, 2020, METHOD CELL BIOL, V155, P441, DOI 10.1016/bs.mcb.2019.12.004
   Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8
   Barrera-Paez JD, 2022, TRENDS GENET, V38, P869, DOI 10.1016/j.tig.2022.04.011
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Begum AA, 2019, CURR DRUG DELIV, V16, P588, DOI 10.2174/1567201816666190529072914
   Belkadi A, 2015, P NATL ACAD SCI USA, V112, P5473, DOI 10.1073/pnas.1418631112
   Berlin S, 2020, IJC HEART VASC, V29, P0, DOI 10.1016/j.ijcha.2020.100573
   Bishop DJ, 2019, PHYSIOLOGY, V34, P56, DOI 10.1152/physiol.00038.2018
   Blanchet L, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep08035
   Boenzi S, 2018, ESSAYS BIOCHEM, V62, P443, DOI 10.1042/EBC20170111
   Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389
   Borna NN, 2019, NEUROGENETICS, V20, P9, DOI 10.1007/s10048-018-0561-9
   Bourchany A, 2017, EUR J MED GENET, V60, P595, DOI 10.1016/j.ejmg.2017.08.011
   Braun E, 2024, J MED ETHICS, V0, P0, DOI DOI 10.1136/jme-2023-109660
   Chang JC, 2024, MOL THER METH CLIN D, V32, P0, DOI 10.1016/j.omtm.2024.101193
   Chen L, 2022, FRONT CELL DEV BIOL, V10, P0, DOI 10.3389/fcell.2022.871357
   Chen X, 2021, BRIEF BIOINFORM, V22, P485, DOI 10.1093/bib/bbz159
   Chinnery PF, 2021, PRIMARY MITOCHONDRIAL DISORDERS OVERVIEW, V0, P0
   Clark MM, 2019, SCI TRANSL MED, V11, P0, DOI 10.1126/scitranslmed.aat6177
   Coene KLM, 2018, J INHERIT METAB DIS, V41, P337, DOI 10.1007/s10545-017-0131-6
   CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x
   Cummings BB, 2017, SCI TRANSL MED, V9, P0, DOI 10.1126/scitranslmed.aal5209
   De Paepe B, 2014, PHYTOTHER RES, V28, P312, DOI 10.1002/ptr.4988
   Dillon LM, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044335
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   El-Hattab AW, 2016, CELL CALCIUM, V60, P199, DOI 10.1016/j.ceca.2016.03.003
   El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223
   Emani SM, 2018, TRANSL PEDIATR, V7, P169, DOI 10.21037/tp.2018.02.02
   Esterhuizen K, 2017, MITOCHONDRION, V35, P97, DOI 10.1016/j.mito.2017.05.012
   Falabella M, 2022, NAT REV NEUROL, V18, P689, DOI 10.1038/s41582-022-00715-9
   Fan XY, 2023, AUTOPHAGY, V19, P363, DOI 10.1080/15548627.2022.2077552
   Fan XY, 2022, NAT BIOMED ENG, V6, P339, DOI 10.1038/s41551-022-00881-7
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, P884S, DOI 10.3945/ajcn.110.001917
   Ferraro NM, 2020, SCIENCE, V369, P1334, DOI 10.1126/science.aaz5900
   Ferri L, 2016, CLIN GENET, V90, P461, DOI 10.1111/cge.12756
   Filipovska A, 2013, RNA BIOL, V10, P1426, DOI 10.4161/rna.24769
   Fitzsimons PE, 2018, AM J MED GENET A, V176, P1115, DOI 10.1002/ajmg.a.38658
   Frazier AE, 2021, MED-CAMBRIDGE, V2, P49, DOI 10.1016/j.medj.2020.06.004
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gammage PA, 2016, NUCLEIC ACIDS RES, V44, P7804, DOI 10.1093/nar/gkw676
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Golubitzky A, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0026883
   Gonorazky HD, 2019, AM J HUM GENET, V104, P466, DOI 10.1016/j.ajhg.2019.01.012
   Gorman GS, 2018, LANCET, V392, P1191, DOI 10.1016/S0140-6736(18)31868-3
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Graves PR, 2002, MICROBIOL MOL BIOL R, V66, P39, DOI 10.1128/MMBR.66.1.39-63.2002
   Greenfield A, 2017, NAT BIOTECHNOL, V35, P1059, DOI 10.1038/nbt.3997
   Guarani V, 2014, MOL CELL BIOL, V34, P847, DOI 10.1128/MCB.01551-13
   Guariento A, 2021, J THORAC CARDIOV SUR, V162, P992, DOI 10.1016/j.jtcvs.2020.10.151
   Gusic M, 2021, FEBS LETT, V595, P1132, DOI 10.1002/1873-3468.14068
   Hellebrekers DMEI, 2012, HUM REPROD UPDATE, V18, P341, DOI 10.1093/humupd/dms008
   Hendel A, 2015, TRENDS BIOTECHNOL, V33, P132, DOI 10.1016/j.tibtech.2014.12.001
   Herbers E, 2019, MITOCHONDRION, V44, P85, DOI 10.1016/j.mito.2018.01.004
   Hidalgo-GutiÃ©rrez A, 2021, ANTIOXIDANTS-BASEL, V10, P0, DOI 10.3390/antiox10040520
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   Hong S, 2023, CELLS-BASEL, V12, P0, DOI 10.3390/cells12202494
   Hussain SRA, 2021, FRONT GENET, V12, P0, DOI 10.3389/fgene.2021.627050
   Ibrahim AZ, 2020, MOL GENET METAB REP, V25, P0, DOI 10.1016/j.ymgmr.2020.100645
   Jacoby E, 2022, SCI TRANSL MED, V14, P0, DOI 10.1126/scitranslmed.abo3724
   Janssen MCH, 2019, CLIN PHARMACOL THER, V105, P101, DOI 10.1002/cpt.1197
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Jo A, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/305716
   Johnson SC, 2016, ONCOTARGET, V7, P44876, DOI 10.18632/oncotarget.10381
   Kastaniotis AJ, 2021, NEUROSCIENTIST, V27, P143, DOI 10.1177/1073858420936162
   Keshavan N, 2024, J INHERIT METAB DIS, V47, P145, DOI 10.1002/jimd.12699
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Kim MB, 2018, J MED FOOD, V21, P30, DOI 10.1089/jmf.2017.3989
   Klopstock T, 2013, BRAIN, V136, P0, DOI 10.1093/brain/aws279
   Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170
   Knottnerus SJG, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165725
   Korchivaia E, 2023, BIOSYSTEMS, V223, P0, DOI 10.1016/j.biosystems.2022.104819
   Kra G, 2021, ANTIOXIDANTS-BASEL, V10, P0, DOI 10.3390/antiox10060905
   Kremer LS, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms15824
   Lake NJ, 2017, AM J HUM GENET, V101, P239, DOI 10.1016/j.ajhg.2017.07.005
   Lake NJ, 2015, J NEUROPATH EXP NEUR, V74, P482, DOI 10.1097/NEN.0000000000000195
   Landsverk ML, 2014, MOLEC GENET METAB RE, V1, P451, DOI 10.1016/j.ymgmr.2014.09.007
   Legati A, 2016, BBA-BIOENERGETICS, V1857, P1326, DOI 10.1016/j.bbabio.2016.02.022
   Li MY, 2016, TRENDS GENET, V32, P815, DOI 10.1016/j.tig.2016.10.005
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Macken William L, 2023, EXPERT REV MOL DIAGN, V23, P797, DOI 10.1080/14737159.2023.2241365
   Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270
   Maguolo A, 2020, MOL GENET METAB REP, V24, P0, DOI 10.1016/j.ymgmr.2020.100632
   Mai M, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0082459
   Marangon K, 1999, FREE RADICAL BIO MED, V27, P1114, DOI 10.1016/S0891-5849(99)00155-0
   Marini C, 2021, BIOMOLECULES, V11, P0, DOI 10.3390/biom11081231
   McArdle AJ, 2021, ARCH DIS CHILDHOOD-E, V106, P178, DOI 10.1136/archdischild-2019-317434
   McCormick E, 2013, NEUROTHERAPEUTICS, V10, P251, DOI 10.1007/s13311-012-0174-1
   McCormick EM, 2018, CURR OPIN PEDIATR, V30, P714, DOI 10.1097/MOP.0000000000000686
   Meienberg J, 2016, HUM GENET, V135, P359, DOI 10.1007/s00439-015-1631-9
   Mermigkis C, 2013, SLEEP BREATH, V17, P1129, DOI 10.1007/s11325-013-0816-5
   Mertes C, 2019, DETECTION ABERRANT S, V0, P0, DOI DOI 10.1101/2019.12.18.866830
   Mertes C, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-020-20573-7
   Miyagawa Y, 2015, P NATL ACAD SCI USA, V112, PE1632, DOI 10.1073/pnas.1423556112
   Mizuguchi T, 2019, J HUM GENET, V64, P359, DOI 10.1038/s10038-019-0569-5
   Mizuguchi Y, 2017, MITOCHONDRION, V34, P43, DOI 10.1016/j.mito.2016.12.006
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Moraes CT, 2014, TRENDS CELL BIOL, V24, P209, DOI 10.1016/j.tcb.2014.02.002
   Mu WB, 2019, GENET MED, V21, P1603, DOI 10.1038/s41436-018-0397-6
   Mutti C, 2022, BIOCHEMIST, V44, P9, DOI 10.1042/bio2022120
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Orefice NS, 2020, PHARMACEUTICS, V12, P0, DOI 10.3390/pharmaceutics12080705
   Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607
   Papatheodorou I, 2020, NUCLEIC ACIDS RES, V48, PD77, DOI 10.1093/nar/gkz947
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Pellegrino MW, 2013, BBA-MOL CELL RES, V1833, P410, DOI 10.1016/j.bbamcr.2012.02.019
   Peranteau WH, 2020, MOL DIAGN THER, V24, P135, DOI 10.1007/s40291-020-00445-y
   Pfeffer G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD004426.pub3
   Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129
   Potgieter M, 2013, NUTR REV, V71, P180, DOI 10.1111/nure.12011
   Poulton J, 2019, NEUROMUSCULAR DISORD, V29, P725, DOI 10.1016/j.nmd.2019.08.004
   Prakash R, 2021, PROG MOL BIOL TRANSL, V178, P193, DOI 10.1016/bs.pmbts.2020.12.009
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Quinzii CM, 2014, MOL SYNDROMOL, V5, P141, DOI 10.1159/000360490
   Rahman MA, 2022, FRONT PHARMACOL, V13, P0, DOI 10.3389/fphar.2022.925993
   Reisman SA, 2019, DRUG DES DEV THER, V13, P1259, DOI 10.2147/DDDT.S193889
   Rossi A, 2023, ANN SURG, V278, PE1313, DOI 10.1097/SLA.0000000000006005
   Rudolph G, 2013, J NEURO-OPHTHALMOL, V33, P30, DOI 10.1097/WNO.0b013e318272c643
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Sa BK, 2017, J MED FOOD, V20, P1047, DOI 10.1089/jmf.2017.3970
   Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013
   Salehi B, 2019, BIOMOLECULES, V9, P0, DOI 10.3390/biom9080356
   San-Millan I, 2023, ANTIOXIDANTS-BASEL, V12, P0, DOI 10.3390/antiox12040782
   Sato R, 2018, CLIN GENET, V93, P242, DOI 10.1111/cge.13068
   Sato Y, 2000, MUSCLE NERVE, V23, P1069, DOI 10.1002/1097-4598(200007)23:7<1069::AID-MUS9>3.0.CO;2-0
   Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Schaefer PM, 2022, P NATL ACAD SCI USA, V119, P0, DOI 10.1073/pnas.2200549119
   Schon KR, 2020, TRENDS GENET, V36, P702, DOI 10.1016/j.tig.2020.06.009
   Schubert MB, 2020, ORPHANET J RARE DIS, V15, P0, DOI 10.1186/s13023-020-1297-9
   Sendra L, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22020551
   Serre V, 2013, BBA-MOL BASIS DIS, V1832, P1304, DOI 10.1016/j.bbadis.2013.04.014
   Sharma H, 2020, HELIYON, V6, P0, DOI 10.1016/j.heliyon.2020.e04643
   Sharma R, 2021, J CLIN INVEST, V131, P0, DOI 10.1172/JCI136055
   Shayota BJ, 2024, NEUROTHERAPEUTICS, V21, P0, DOI 10.1016/j.neurot.2024.e00325
   Shepherd DL, 2017, J MOL CELL CARDIOL, V110, P15, DOI 10.1016/j.yjmcc.2017.06.012
   Shrader WD, 2011, BIOORG MED CHEM LETT, V21, P3693, DOI 10.1016/j.bmcl.2011.04.085
   Simon MT, 2019, MOL GENET METAB, V126, P53, DOI 10.1016/j.ymgme.2018.11.001
   Singh A, 2021, EBIOMEDICINE, V65, P0, DOI 10.1016/j.ebiom.2021.103244
   Smeets HJM, 2013, REPROD BIOMED ONLINE, V27, P599, DOI 10.1016/j.rbmo.2013.08.007
   Smeitink J, 2022, BMC NEUROL, V22, P0, DOI 10.1186/s12883-022-02685-3
   Smuts I, 2013, METABOLOMICS, V9, P379, DOI 10.1007/s11306-012-0455-z
   Somuncu B, 2022, PLOS ONE, V17, P0, DOI 10.1371/journal.pone.0268391
   Steele H, 2020, EMBO MOL MED, V12, P0, DOI 10.15252/emmm.201911589
   Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008
   Stendel C, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000393
   Stenton SL, 2020, EBIOMEDICINE, V56, P0, DOI 10.1016/j.ebiom.2020.102784
   Stenton SL, 2020, J INHERIT METAB DIS, V43, P25, DOI 10.1002/jimd.12130
   Stenton SL, 2018, ESSAYS BIOCHEM, V62, P399, DOI 10.1042/EBC20170110
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Tang JX, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21113820
   Tarnopolsky MA, 2008, ADV DRUG DELIVER REV, V60, P1561, DOI 10.1016/j.addr.2008.05.001
   Tarnopolsky MA, 2014, J CHILD NEUROL, V29, P1225, DOI 10.1177/0883073814538512
   Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972
   Tengan CH, 2017, BBA-BIOENERGETICS, V1858, P573, DOI 10.1016/j.bbabio.2017.02.009
   Thangavelu S, 2010, INDIAN JOURNAL OF PRACTICAL PEDIATRICS, V12, P181
   Thomas RH, 2022, J INHERIT METAB DIS, V45, P796, DOI 10.1002/jimd.12521
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   Tiberi J, 2023, BIOMEDICINES, V11, P0, DOI 10.3390/biomedicines11051293
   Tinker RJ, 2021, MOL DIAGN THER, V25, P181, DOI 10.1007/s40291-020-00510-6
   Tort F, 2013, MOL GENET METAB, V110, P73, DOI 10.1016/j.ymgme.2013.04.021
   Valenti D, 2022, J CLIN MED, V11, P0, DOI 10.3390/jcm11144209
   Vaughan RA, 2014, J PHYSIOL BIOCHEM, V70, P271, DOI 10.1007/s13105-013-0301-4
   Vignal C, 2018, OPHTHALMOLOGY, V125, P945, DOI 10.1016/j.ophtha.2017.12.036
   Vigne E, 2003, GENE THER, V10, P153, DOI 10.1038/sj.gt.3301845
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   Wang G, 2012, BBA-GENE REGUL MECH, V1819, P998, DOI 10.1016/j.bbagrm.2011.10.001
   Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035
   Wang LY, 2018, PHARMACOLOGY, V102, P117, DOI 10.1159/000490418
   Wang X, 2013, HUM MOL GENET, V22, P3976, DOI 10.1093/hmg/ddt251
   Watson E, 2020, J. TRANSL. GENET. GENOMICS, V4, P188, DOI 10.20517/JTGG.2020.31
   Whitaker RM, 2016, ANNU REV PHARMACOL, V56, P229, DOI 10.1146/annurev-pharmtox-010715-103155
   Wilmer MJ, 2011, BBA-MOL BASIS DIS, V1812, P643, DOI 10.1016/j.bbadis.2011.02.010
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Wu TH, 2023, SCI REP-UK, V13, P0, DOI 10.1038/s41598-023-31134-5
   Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482
   Zhang Y, 2016, BIOCHEM SOC T, V44, P1717, DOI 10.1042/BST20160071C
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505
   Zytkovicz TH, 2001, CLIN CHEM, V47, P1945
NR 198
TC 0
Z9 0
U1 3
U2 3
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
SN 1389-2029
EI 1875-5488
J9 CURR GENOMICS
JI Curr. Genomics
PD JUN 15
PY 2024
VL 25
IS 5
BP 358
EP 379
DI 10.2174/0113892029308327240612110334
EA JUN 2024
PG 22
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA F9G0T
UT WOS:001253110400001
PM 39323625
DA 2024-11-01
ER

PT J
AU Smith, KK
   Moreira, JD
   Wilson, CR
   Padera, JO
   Lamason, AN
   Xue, LY
   Gopal, DM
   Flynn, DB
   Fetterman, JL
AF Smith, Karan K.
   Moreira, Jesse D.
   Wilson, Callum R.
   Padera, June O.
   Lamason, Ashlee N.
   Xue, Liying
   Gopal, Deepa M.
   Flynn, David B.
   Fetterman, Jessica L.
TI A systematic review on the biochemical threshold of mitochondrial genetic variants
SO GENOME RESEARCH
LA English
DT Article
ID hereditary optic neuropathy; complex-i deficiency; cytochrome-b mutation; leigh-syndrome; dna mutation; missense mutation; nonsense mutation; oxidative-phosphorylation; mtdna mutation; point mutation
AB Mitochondrial DNA (mtDNA) variants cause a range of diseases from severe pediatric syndromes to aging-related conditions. The percentage of mtDNA copies carrying a pathogenic variant, variant allele frequency (VAF), must reach a threshold before a biochemical defect occurs, termed the biochemical threshold. Whether the often-cited biochemical threshold of >60% VAF is similar across mtDNA variants and cell types is unclear. In our systematic review, we sought to identify the biochemical threshold of mtDNA variants in relation to VAF by human tissue/cell type. We used controlled vocabulary terms to identify articles measuring oxidative phosphorylation (OXPHOS) complex activities in relation to VAF. We identified 76 eligible publications, describing 69, 12, 16, and 49 cases for complexes I, III, IV, and V, respectively. Few studies evaluated OXPHOS activities in diverse tissue types, likely reflective of clinical access. A number of cases with similar VAFs for the same pathogenic variant had varying degrees of residual activity of the affected complex, alluding to the presence of modifying variants. Tissues and cells with VAFs <60% associated with low complex activities were described, suggesting the possibility of a biochemical threshold of <60%. Using Kendall rank correlation tests, the VAF of the m.8993T > G variant correlated with complex V activity in skeletal muscle (tau = -0.58, P = 0.01, n = 13); however, no correlation was observed in fibroblasts (P = 0.7, n = 9). Our systematic review highlights the need to investigate the biochemical threshold over a wider range of VAFs in disease-relevant cell types to better define the biochemical threshold for specific mtDNA variants.
C1 [Smith, Karan K.; Moreira, Jesse D.; Wilson, Callum R.; Padera, June O.; Lamason, Ashlee N.; Xue, Liying; Gopal, Deepa M.; Fetterman, Jessica L.] Boston Univ Chobanian, Avedisian Sch Med, Evans Dept Med, Boston, MA 02118 USA.
   [Smith, Karan K.; Moreira, Jesse D.; Wilson, Callum R.; Padera, June O.; Lamason, Ashlee N.; Xue, Liying; Gopal, Deepa M.; Fetterman, Jessica L.] Boston Univ, Whitaker Cardiovasc Inst, Chobanian & Avedisian Sch Med, Boston, MA 02118 USA.
   [Moreira, Jesse D.] Boston Univ, Sargent Coll, Dept Hlth Sci, Programs Human Physiol, Boston, MA 02215 USA.
   [Flynn, David B.] Boston Univ, Chobanian & Avedisian Sch Med, Med Sci & Educ, Boston, MA 02118 USA.
C3 Boston University; Boston University; Boston University
RP Fetterman, JL (corresponding author), Boston Univ Chobanian, Avedisian Sch Med, Evans Dept Med, Boston, MA 02118 USA.; Fetterman, JL (corresponding author), Boston Univ, Whitaker Cardiovasc Inst, Chobanian & Avedisian Sch Med, Boston, MA 02118 USA.
FU National Heart, Lung, and Blood Institute http://dx.doi.org/10.13039/100000050 [T32 HL007224-45, K01 HL143142]; National Heart, Lung, and Blood Institute [R03 AG081053]; National Institute of Aging [17FTF33670369]; American Heart Association
CR AcÃ­n-PÃ©rez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8
   Aguilera I, 2001, J NEUROL SCI, V192, P81, DOI 10.1016/S0022-510X(01)00634-7
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   ARNAUDO E, 1992, GENE, V119, P299, DOI 10.1016/0378-1119(92)90287-Y
   Bai YD, 1998, EMBO J, V17, P4848, DOI 10.1093/emboj/17.16.4848
   Bakare AB, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms221910344
   Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015
   Bandelt HJ, 2014, J HUM GENET, V59, P66, DOI 10.1038/jhg.2013.120
   Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188
   Bateman A, 2023, NUCLEIC ACIDS RES, V51, PD523, DOI 10.1093/nar/gkac1052
   Behbehani R, 2014, BRIT J OPHTHALMOL, V98, P826, DOI 10.1136/bjophthalmol-2013-304140
   Blakely EL, 2005, FEBS J, V272, P3583, DOI 10.1111/j.1742-4658.2005.04779.x
   Blakely EL, 2005, EUR J HUM GENET, V13, P623, DOI 10.1038/sj.ejhg.5201363
   Blok MJ, 2007, J MED GENET, V44, P0, DOI 10.1136/jmg.2006.045716
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Brecht M, 2015, JIMD REP, V19, P95, DOI 10.1007/8904_2014_375
   BROWN MD, 1992, AM J HUM GENET, V51, P378
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Bruno C, 2003, MUSCLE NERVE, V28, P508, DOI 10.1002/mus.10429
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Campos Y, 2001, ANN NEUROL, V50, P409, DOI 10.1002/ana.1141
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   CarreÃ±o-Gago L, 2017, BBA-MOL BASIS DIS, V1863, P182, DOI 10.1016/j.bbadis.2016.09.002
   Carrozzo R, 2004, ACTA PAEDIATR, V93, P65, DOI 10.0180/08035320310021309
   Carrozzo R, 2004, J NEUROCHEM, V90, P490, DOI 10.1111/j.1471-4159.2004.02505.x
   Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637
   Chae JH, 2007, PEDIATR RES, V61, P622, DOI 10.1203/pdr.0b013e3180459f2d
   Chen SW, 2024, NATURE, V625, P0, DOI 10.1038/s41586-023-06045-0
   Chinnery PF, 1999, AM J MED GENET, V85, P498
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361
   Cock HR, 1999, J NEUROL SCI, V165, P10, DOI 10.1016/S0022-510X(99)00088-X
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   Dahadhah FW, 2021, ANDROLOGIA, V53, P0, DOI 10.1111/and.14139
   Danhelovska T, 2020, BMC PEDIATR, V20, P0, DOI 10.1186/s12887-020-1912-x
   DEGLIESPOSTI M, 1993, BIOCHIM BIOPHYS ACTA, V1143, P243, DOI 10.1016/0005-2728(93)90197-N
   Destiarani W, 2020, BIOINFORM BIOL INSIG, V14, P0, DOI 10.1177/1177932220978672
   Dionisi-Vici C, 1998, J INHERIT METAB DIS, V21, P2, DOI 10.1023/A:1005397227996
   Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901
   Emmanuele V, 2013, J CHILD NEUROL, V28, P236, DOI 10.1177/0883073812445787
   Formosa LE, 2018, SEMIN CELL DEV BIOL, V76, P154, DOI 10.1016/j.semcdb.2017.08.011
   Fragaki K, 2009, MITOCHONDRION, V9, P346, DOI 10.1016/j.mito.2009.06.002
   GarcÃ­a JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075
   Giachin G, 2016, FRONT MOL BIOSCI, V3, P0, DOI 10.3389/fmolb.2016.00043
   Gorman GS, 2015, CLIN SCI, V128, P895, DOI 10.1042/CS20140705
   Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050
   GutiÃ©rrez-FernÃ¡ndez J, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-17957-0
   Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910
   Haut S, 2004, EUR J HUM GENET, V12, P220, DOI 10.1038/sj.ejhg.5201132
   He JY, 2018, P NATL ACAD SCI USA, V115, P2988, DOI 10.1073/pnas.1722086115
   Herrero-Martin Maria D, 2008, HUM MUTAT, V29, PE112, DOI 10.1002/humu.20800
   Hock DH, 2020, BIOCHEM J, V477, P4085, DOI 10.1042/BCJ20190767
   HorvÃ¡th R, 2005, NEUROMUSCULAR DISORD, V15, P851, DOI 10.1016/j.nmd.2005.09.005
   HorvÃ¡th R, 2002, J MED GENET, V39, P812, DOI 10.1136/jmg.39.11.812
   HorvÃ¡th R, 2008, NEUROMUSCULAR DISORD, V18, P553, DOI 10.1016/j.nmd.2008.05.002
   Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046
   Iommarini L, 2014, HUM MOL GENET, V23, P1453, DOI 10.1093/hmg/ddt533
   Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64
   Jiang PP, 2016, HUM MOL GENET, V25, P3613, DOI 10.1093/hmg/ddw199
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   KADENBACH B, 1990, BIOCHIM BIOPHYS ACTA, V1015, P368, DOI 10.1016/0005-2728(90)90042-3
   Kadenbach B, 2015, MITOCHONDRION, V24, P64, DOI 10.1016/j.mito.2015.07.002
   Kampjut D, 2020, SCIENCE, V370, P547, DOI 10.1126/science.abc4209
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Kirby DM, 2003, ANN NEUROL, V54, P473, DOI 10.1002/ana.10687
   Kollberg G, 2005, J NEUROPATH EXP NEUR, V64, P123, DOI 10.1093/jnen/64.2.123
   Kopinski PK, 2019, P NATL ACAD SCI USA, V116, P16028, DOI 10.1073/pnas.1906896116
   Kurt Yasemin Gulcan, 2016, CHILD NEUROL OPEN, V3, P2329048X15627937, DOI 10.1177/2329048X15627937
   Lai YZ, 2023, MOL CELL, V83, P2137, DOI 10.1016/j.molcel.2023.04.029
   Lamantea E, 2002, NEUROMUSCULAR DISORD, V12, P49, DOI 10.1016/S0960-8966(01)00244-9
   Laricchia KM, 2022, GENOME RES, V32, P569, DOI 10.1101/gr.276013.121
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Legros F, 2001, EUR J HUM GENET, V9, P510, DOI 10.1038/sj.ejhg.5200678
   Leman G, 2015, INT J BIOCHEM CELL B, V65, P91, DOI 10.1016/j.biocel.2015.05.017
   Leshinsky-Silver E, 2005, BIOCHEM BIOPH RES CO, V334, P582, DOI 10.1016/j.bbrc.2005.06.134
   Li QC, 2023, FRONT CELL DEV BIOL, V11, P0, DOI 10.3389/fcell.2023.1127618
   Liu CY, 2021, MITOCHONDRION, V60, P33, DOI 10.1016/j.mito.2021.07.004
   Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268
   Lloyd RE, 2015, NEURO-ONCOLOGY, V17, P942, DOI 10.1093/neuonc/nov020
   LÃ³pez-Gallardo E, 2014, HUM MOL GENET, V23, P6191, DOI 10.1093/hmg/ddu339
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Lou XT, 2023, GENE, V860, P0, DOI 10.1016/j.gene.2023.147229
   MACKEY D, 1992, AM J HUM GENET, V51, P1218
   MAJANDER A, 1991, FEBS LETT, V292, P289, DOI 10.1016/0014-5793(91)80886-8
   Makino M, 2000, J HUM GENET, V45, P69, DOI 10.1007/s100380050014
   Malfatti E, 2007, BRAIN, V130, P1894, DOI 10.1093/brain/awm114
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   Marotta R, 2011, J CLIN NEUROSCI, V18, P290, DOI 10.1016/j.jocn.2010.06.001
   Mick E, 2020, ELIFE, V9, P0, DOI 10.7554/eLife.49178
   Miller DK, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0104879
   Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010
   Monzel AS, 2023, NAT METAB, V5, P546, DOI 10.1038/s42255-023-00783-1
   Morava E, 2006, AM J MED GENET A, V140A, P863, DOI 10.1002/ajmg.a.31194
   Mordel P, 2017, BIOCHEM BIOPH RES CO, V494, P133, DOI 10.1016/j.bbrc.2017.10.066
   MORGANHUGHES JA, 1995, BBA-MOL BASIS DIS, V1271, P135, DOI 10.1016/0925-4439(95)00020-5
   Moslemi AR, 2005, NEUROPEDIATRICS, V36, P314, DOI 10.1055/s-2005-872845
   Mourmans J, 1997, J NEUROL SCI, V149, P111, DOI 10.1016/S0022-510X(97)05379-3
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   Nsiah-Sefaa A, 2016, BIOSCIENCE REP, V36, P0, DOI 10.1042/BSR20150295
   PanadÃ©s-de Oliveira L, 2020, MITOCHONDRION, V50, P14, DOI 10.1016/j.mito.2019.10.001
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   R Core Team, 2021, R LANG ENV STAT COMP, V0, P0
   Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   Rodenburg RJ, 2016, BBA-BIOENERGETICS, V1857, P938, DOI 10.1016/j.bbabio.2016.02.012
   Ronchi D, 2011, BMC NEUROL, V11, P0, DOI 10.1186/1471-2377-11-85
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Rossignol R, 2000, BIOCHEM J, V347, P45, DOI 10.1042/0264-6021:3470045
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Ruiter EM, 2007, EUR J HUM GENET, V15, P155, DOI 10.1038/sj.ejhg.5201735
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Santorelli FM, 1996, PEDIATR RES, V39, P914, DOI 10.1203/00006450-199605000-00028
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Sasaki R, 2020, J NEUROL SCI, V408, P0, DOI 10.1016/j.jns.2019.116460
   Shaham O, 2010, P NATL ACAD SCI USA, V107, P1571, DOI 10.1073/pnas.0906039107
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Sharma R, 2021, J CLIN INVEST, V131, P0, DOI 10.1172/JCI136055
   Shen LS, 2018, HUM MUTAT, V39, P806, DOI 10.1002/humu.23422
   Shimura M, 2022, MITOCHONDRION, V63, P1, DOI 10.1016/j.mito.2021.12.005
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Signes A, 2018, ESSAYS BIOCHEM, V62, P255, DOI 10.1042/EBC20170098
   Simon DK, 2003, NEUROGENETICS, V4, P199, DOI 10.1007/s10048-003-0150-3
   Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1
   Spruijt L, 2007, ARCH NEUROL-CHICAGO, V64, P890, DOI 10.1001/archneur.64.6.890
   Spyropoulos A, 2013, JAMA NEUROL, V70, P1552, DOI 10.1001/jamaneurol.2013.4111
   Srivastava S, 2007, HUM MOL GENET, V16, P993, DOI 10.1093/hmg/ddm045
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Tang JX, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21113820
   TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tawata M, 2000, DIABETES, V49, P1269, DOI 10.2337/diabetes.49.7.1269
   Taylor RW, 2002, EUR J HUM GENET, V10, P141, DOI 10.1038/sj.ejhg.5200773
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006
   TimÃ³n-GÃ³mez A, 2018, SEMIN CELL DEV BIOL, V76, P163, DOI 10.1016/j.semcdb.2017.08.055
   TULINIUS MH, 1995, HUM GENET, V96, P290
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Ugalde C, 2007, MOL GENET METAB, V90, P10, DOI 10.1016/j.ymgme.2006.08.003
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988
   van Karnebeek CDM, 2011, DEV MED CHILD NEUROL, V53, P565, DOI 10.1111/j.1469-8749.2010.03907.x
   Varlamov DA, 2002, HUM MOL GENET, V11, P1797, DOI 10.1093/hmg/11.16.1797
   Vercellino I, 2022, NAT REV MOL CELL BIO, V23, P141, DOI 10.1038/s41580-021-00415-0
   Vercellino I, 2021, NATURE, V598, P364, DOI 10.1038/s41586-021-03927-z
   Verny C, 2011, MITOCHONDRION, V11, P70, DOI 10.1016/j.mito.2010.07.006
   Vilarinho L, 2000, PEDIATR NEUROL, V22, P29, DOI 10.1016/S0887-8994(99)00113-7
   Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686
   von Kleist-Retzow JC, 1998, AM J HUM GENET, V63, P428, DOI 10.1086/301957
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398
   Wang W, 2021, NEUROMUSCULAR DISORD, V31, P558, DOI 10.1016/j.nmd.2021.02.020
   Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224
   Wolz W, 1997, GENOMICS, V45, P438, DOI 10.1006/geno.1997.4937
   Xu MT, 2021, FRONT GENET, V12, P0, DOI 10.3389/fgene.2021.638749
   Xu T, 2015, MICROB CELL, V2, P105, DOI 10.15698/mic2015.04.197
   Yi Jason Tae, 2023, SCI REP, V13, P20413, DOI 10.1038/s41598-023-47314-2
   YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699
   Yu XL, 2021, NEUROL SCI, V42, P5123, DOI 10.1007/s10072-021-05155-9
   Yu-Wai-Man Patrick, 2011, TAIWAN J OPHTHALMOL, V1, P12
   Zhang JJ, 2018, HUM MOL GENET, V27, P1999, DOI 10.1093/hmg/ddy107
   Zong S, 2018, CELL RES, V28, P1026, DOI 10.1038/s41422-018-0071-1
NR 170
TC 1
Z9 1
U1 3
U2 4
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1088-9051
EI 1549-5469
J9 GENOME RES
JI Genome Res.
PD MAR 15
PY 2024
VL 34
IS 3
BP 341
EP 365
DI 10.1101/gr.278200.123
PG 25
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity
GA PN6S0
UT WOS:001214802400001
PM 38627095
DA 2024-11-01
ER

PT J
AU Joyce, E
   Ali, M
   Richard, G
   Kelly, S
   Martin, F
   Conlon, PJ
   Whelehan, A
   Ng, YS
   Lefter, S
AF Joyce, Eimear
   Ali, Mohib
   Richard, Georgia
   Kelly, Siobhan
   Martin, Fiachra
   Conlon, Peter J.
   Whelehan, Anna
   Ng, Yi Shiau
   Lefter, Stela
TI Adult presentation of a rare mitochondrial tRNA Val gene mutation-an expanding clinical phenotype
SO EUROPEAN JOURNAL OF NEUROLOGY
LA English
DT Article
DE late onset mitochondrial disorder; m.1659T > C; MT-TV gene variant
AB Background and purpose Late-onset mitochondrial disorders are diagnostically challenging with significant heterogeneity in disease presentation. A case is reported of a 67-year-old gentleman who presented with a 3-month history of seizures, recurrent encephalopathy, ataxia and weight loss, preceded by recent initiation of haemodialysis for end-stage chronic kidney disease. Methods Extensive work-up including serological, cerebrospinal fluid, magnetic resonance imaging and electroencephalography was performed. Whole exome sequencing and muscle biopsy confirmed the diagnosis. Results Magnetic resonance imaging brain demonstrated a single non-enhancing T2 fluid attenuated inversion recovery hyperintense cortical/subcortical signal change in the right temporal lobe and cerebellar atrophy. Given the subacute presentation of uncertain aetiology, he was empirically treated for autoimmune/paraneoplastic encephalitis. Despite radiological resolution of the cortical abnormality 2 weeks later, there was no clinical improvement. Further collateral history unveiled a mildly ataxic gait and longstanding hearing loss suggestive of a genetic cause. Whole exome sequencing revealed a likely pathogenic, heteroplasmic mitochondrial DNA variant in the MT-TV gene, m.1659T>C, present at higher levels of heteroplasmy in muscle (91%) compared to other mitotic tissues. A high fat/protein diet and multivitamins including co-enzyme Q10 were commenced. Treatment of the nutritional deficiency and avoidance of intermittent fasting due to unreliable oral intake secondary to encephalopathy probably contributed to the clinical improvement seen over the ensuing few months, with resolution of his encephalopathy and return to his baseline gait and weight. Conclusion An adult case is reported with an acute neurological presentation mimicking encephalitis, caused by a heteroplasmic m.1659T>C MT-TV variant, previously reported once in a child who displayed a different clinical phenotype.
C1 [Joyce, Eimear; Ali, Mohib; Richard, Georgia; Lefter, Stela] Beaumont Hosp, Dept Neurol, Dublin, Ireland.
   [Kelly, Siobhan] Sligo Univ Hosp, Dept Neurol, Sligo, Ireland.
   [Martin, Fiachra] Beaumont Hosp, Dept Plast Surg, Dublin, Ireland.
   [Conlon, Peter J.] Beaumont Hosp, Dept Nephrol & Transplantat, Dublin, Ireland.
   [Whelehan, Anna] Beaumont Hosp, Dept Neurophysiol, Dublin, Ireland.
   [Ng, Yi Shiau] Newcastle Univ, Translat & Clin Res Inst, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, England.
   [Ng, Yi Shiau] Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Serv Rare Mitochondrial Dis, Newcastle Upon Tyne, England.
C3 Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust
RP Lefter, S (corresponding author), Beaumont Hosp, Dept Neurol, Dublin, Ireland.
EM stelalefter2@beaumont.ie
CR Blakely EL, 2004, J NEUROL SCI, V225, P99, DOI 10.1016/j.jns.2004.07.007
   Forny P, 2021, NEUROL-GENET, V7, P0, DOI 10.1212/NXG.0000000000000597
   Ng YS, 2022, BRAIN, V145, P542, DOI 10.1093/brain/awab353
   Ng Yi Shiau, 2019, WELLCOME OPEN RES, V4, P201, DOI 10.12688/wellcomeopenres.15599.1
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
NR 5
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-5101
EI 1468-1331
J9 EUR J NEUROL
JI Eur. J. Neurol.
PD OCT 15
PY 2024
VL 31
IS 10
BP 
EP 
DI 10.1111/ene.16405
EA JUL 2024
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA G6L3K
UT WOS:001264984000001
PM 38973423
DA 2024-11-01
ER

PT J
AU Iu, ECY
   So, H
   Chan, CB
AF Iu, Elsie Chit Yu
   So, Ho
   Chan, Chi Bun
TI Mitochondrial defects in sporadic inclusion body myositis-causes and consequences
SO FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
LA English
DT Review
DE mitochondria; myositis; muscle; pathogenesis; pyroptosis; necroptosis
ID amyloid precursor protein; oxidative dna-damage; skeletal-muscle; inflammatory myopathy; pathogenic significance; abnormality; stress; expression; accumulation; autophagy
AB Sporadic inclusion body myositis (sIBM) is a distinct subcategory of Idiopathic Inflammatory Myopathies (IIM), characterized by unique pathological features such as muscle inflammation, rimmed vacuoles, and protein aggregation within the myofibers. Although hyperactivation of the immune system is widely believed as the primary cause of IIM, it is debated whether non-immune tissue dysfunction might contribute to the disease's onset as patients with sIBM are refractory to conventional immunosuppressant treatment. Moreover, the findings that mitochondrial dysfunction can elicit non-apoptotic programmed cell death and the subsequent immune response further support this hypothesis. Notably, abnormal mitochondrial structure and activities are more prominent in the muscle of sIBM than in other types of IIM, suggesting the presence of defective mitochondria might represent an overlooked contributor to the disease onset. The large-scale mitochondrial DNA deletion, aberrant protein aggregation, and slowed organelle turnover have provided mechanistic insights into the genesis of impaired mitochondria in sIBM. This article reviews the disease hallmarks of sIBM, the plausible contributors of mitochondrial damage in the sIBM muscle, and the immunological responses associated with mitochondrial perturbations. Additionally, the potential application of mitochondrial-targeted chemicals as a new treatment strategy to sIBM is explored and discussed.
C1 [Iu, Elsie Chit Yu; Chan, Chi Bun] Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China.
   [So, Ho] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.
C3 University of Hong Kong; Chinese University of Hong Kong
RP Chan, CB (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China.
EM chancb@hku.hk
FU HKU Seed Fund for Basic Research; Hong Kong Health and Medical Research Fund [HMRF21222301]
CR Andreux PA, 2019, NAT METAB, V1, P595, DOI 10.1038/s42255-019-0073-4
   Askanas V, 1996, P NATL ACAD SCI USA, V93, P1314, DOI 10.1073/pnas.93.3.1314
   Askanas V, 1998, ARCH NEUROL-CHICAGO, V55, P915, DOI 10.1001/archneur.55.7.915
   Askanas V, 2008, ACTA NEUROPATHOL, V116, P583, DOI 10.1007/s00401-008-0449-0
   Askanas V, 2015, BBA-MOL BASIS DIS, V1852, P633, DOI 10.1016/j.bbadis.201409.005
   Askanas V, 2012, J NEUROPATH EXP NEUR, V71, P680, DOI 10.1097/NEN.0b013e31826183c8
   Bhatt PS, 2019, NEUROMUSCULAR DISORD, V29, P242, DOI 10.1016/j.nmd.2019.02.001
   Boncompagni S, 2012, J BIOL CHEM, V287, P20534, DOI 10.1074/jbc.M112.359588
   Britson KA, 2022, SCI TRANSL MED, V14, P0, DOI 10.1126/scitranslmed.abi9196
   Cacciottolo M, 2013, NEUROPATH APPL NEURO, V39, P750, DOI 10.1111/nan.12038
   ÃanakÃ§i CF, 2006, J PERIODONTOL, V77, P1894, DOI 10.1902/jop.2006.060108
   CantÃ³-Santos J, 2023, ANTIOXIDANTS-BASEL, V12, P0, DOI 10.3390/antiox12081639
   CantÃ³-Santos J, 2023, J CACHEXIA SARCOPENI, V14, P964, DOI 10.1002/jcsm.13178
   CatalÃ¡n-GarcÃ­a M, 2020, J CLIN MED, V9, P0, DOI 10.3390/jcm9051446
   CatalÃ¡n-GarcÃ­a M, 2015, MOL MED, V21, P817, DOI 10.2119/molmed.2015.00168
   CatalÃ¡n-GarcÃ­a M, 2016, CLIN SCI, V130, P1741, DOI 10.1042/CS20160080
   Chen SF, 2018, APOPTOSIS, V23, P299, DOI 10.1007/s10495-018-1455-x
   Ching JK, 2013, AUTOPHAGY, V9, P2115, DOI 10.4161/auto.26150
   Coudert JD, 2022, CLIN TRANSL IMMUNOL, V11, P0, DOI 10.1002/cti2.1416
   Damian L, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23137358
   Danieli MG, 2023, AUTOIMMUN REV, V22, P0, DOI 10.1016/j.autrev.2023.103308
   De Bleecker JL, 2001, ACTA NEUROPATHOL, V101, P572
   De Paepe B, 2019, BIOMOLECULES, V9, P0, DOI 10.3390/biom9010015
   Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006
   Di Leo V, 2023, BIOCHEM J, V480, P1767, DOI 10.1042/BCJ20220233
   Diederichsen LP, 2023, MUSCLE NERVE, V68, P73, DOI 10.1002/mus.27841
   DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602
   Faitg J, 2024, CALCIFIED TISSUE INT, V114, P53, DOI 10.1007/s00223-023-01145-5
   Favaro G, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-10226-9
   FrÃ©ret M, 2013, AM J PATHOL, V183, P893, DOI 10.1016/j.ajpath.2013.06.003
   Fyhr IM, 1998, ANN NEUROL, V43, P127, DOI 10.1002/ana.410430123
   Gang Q, 2016, NEUROBIOL AGING, V47, P0, DOI 10.1016/j.neurobiolaging.2016.07.024
   GarcÃ­a-Villalba R, 2022, MOL NUTR FOOD RES, V66, P0, DOI 10.1002/mnfr.202101019
   Goebels N, 1996, J CLIN INVEST, V97, P2905, DOI 10.1172/JCI118749
   Gonzalez Chapa Jorge Armando, 2024, CLIN EXP RHEUMATOL, V42, P394, DOI 10.55563/clinexprheumatol/5lfq5x
   Gonzalez-Chapa JA, 2023, RAMBAM MAIMONIDES ME, V14, P0, DOI 10.5041/RMMJ.10493
   Greenberg MVC, 2019, NAT REV MOL CELL BIO, V20, P590, DOI 10.1038/s41580-019-0159-6
   Greenberg SA, 2005, NEUROLOGY, V65, P1782, DOI 10.1212/01.wnl.0000187124.92826.20
   Greenberg SA, 2019, NAT REV RHEUMATOL, V15, P257, DOI 10.1038/s41584-019-0186-x
   GÃ¼ttsches AK, 2017, ANN NEUROL, V81, P227, DOI 10.1002/ana.24847
   Gunawardena H, 2009, RHEUMATOLOGY, V48, P607, DOI 10.1093/rheumatology/kep078
   Hall DT, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708307
   Hedberg-Oldfors C, 2021, BRAIN PATHOL, V31, P0, DOI 10.1111/bpa.12931
   Hiniker A, 2016, J NEUROPATH EXP NEUR, V75, P239, DOI 10.1093/jnen/nlv023
   Horvath R, 1998, J NEUROPATH EXP NEUR, V57, P396, DOI 10.1097/00005072-199805000-00003
   Huntley ML, 2019, LAB INVEST, V99, P1041, DOI 10.1038/s41374-019-0233-x
   Irazoki A, 2023, NAT COMMUN, V14, P0, DOI 10.1038/s41467-022-35732-1
   Ito A, 2022, J CACHEXIA SARCOPENI, V13, P1864, DOI 10.1002/jcsm.12988
   Jang S, 2019, NAT STRUCT MOL BIOL, V26, P695, DOI 10.1038/s41594-019-0261-7
   Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje
   Jiang Q, 2020, OXID MED CELL LONGEV, V2020, P0, DOI 10.1155/2020/8837893
   Joaquim M, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.572182
   Johnson GA, 2023, FRONT NEUROSCI-SWITZ, V17, P0, DOI 10.3389/fnins.2023.1202167
   Joshi PR, 2014, J CLIN NEUROSCI, V21, P1959, DOI 10.1016/j.jocn.2014.05.051
   Jou C, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms231911002
   Kamiya M, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-021-27875-4
   Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015
   Khoo T, 2023, NAT REV RHEUMATOL, V19, P695, DOI 10.1038/s41584-023-01033-0
   Koo JH, 2019, GERONTOLOGY, V65, P240, DOI 10.1159/000494723
   Landfeldt Erik, 2015, J NEUROMUSCUL DIS, V2, P63, DOI 10.3233/JND-140053
   Lee DY, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms242216542
   Lightfoot AP, 2015, ANN RHEUM DIS, V74, P1340, DOI 10.1136/annrheumdis-2014-207172
   Lindgren U, 2015, NEUROMUSCULAR DISORD, V25, P281, DOI 10.1016/j.nmd.2014.12.010
   Liu D, 2021, RHEUMATOLOGY, V60, P2177, DOI 10.1093/rheumatology/keaa473
   LJUNGMAN M, 1992, MOL CARCINOGEN, V5, P264, DOI 10.1002/mc.2940050406
   Lodi R, 1998, BRAIN, V121, P2119, DOI 10.1093/brain/121.11.2119
   Lu JQ, 2020, J NEUROL SCI, V413, P0, DOI 10.1016/j.jns.2020.116816
   Lu YY, 2023, THERANOSTICS, V13, P736, DOI 10.7150/thno.79876
   Luan PL, 2021, SCI TRANSL MED, V13, P0, DOI 10.1126/scitranslmed.abb0319
   LÃ¼nemann JD, 2007, ANN NEUROL, V61, P476, DOI 10.1002/ana.21115
   Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5
   Marchi S, 2023, NAT REV IMMUNOL, V23, P159, DOI 10.1038/s41577-022-00760-x
   Marek-Iannucci S, 2021, JCI INSIGHT, V6, P0, DOI 10.1172/jci.insight.151981
   Mavroudis Ioannis, 2021, J CLIN NEUROMUSCUL DIS, V23, P31, DOI 10.1097/CND.0000000000000353
   McCord B, 2023, SCI REP-UK, V13, P0, DOI 10.1038/s41598-023-42824-5
   Mccord B, 2023, MEDIAT INFLAMM, V2023, P0, DOI 10.1155/2023/9018470
   Miller FW, 2018, NAT REV RHEUMATOL, V14, P255, DOI 10.1038/nrrheum.2018.48
   Moriya K, 2001, CANCER RES, V61, P4365
   Moslemi AR, 1997, HUM MUTAT, V10, P381, DOI 10.1002/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I
   Nicot AS, 2014, AUTOPHAGY, V10, P1036, DOI 10.4161/auto.28479
   Nogalska A, 2010, AM J PATHOL, V177, P1377, DOI 10.2353/ajpath.2010.100050
   Oddis CV, 2016, J INTERN MED, V280, P63, DOI 10.1111/joim.12511
   Oikawa Y, 2020, PLOS ONE, V15, P0, DOI 10.1371/journal.pone.0231064
   Oldfors A, 2006, NEUROLOGY, V66, PS49, DOI 10.1212/01.wnl.0000192127.63013.8d
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   OlivÃ© M, 2008, NEUROPATH APPL NEURO, V34, P76, DOI 10.1111/j.1365-2990.2007.00864.x
   OlivÃ© M, 2009, J NEUROPATH EXP NEUR, V68, P262, DOI 10.1097/NEN.0b013e3181996d8f
   Papadimas GK, 2019, RHEUMATOL INT, V39, P1459, DOI 10.1007/s00296-019-04314-8
   Papadopoulos C, 2017, EMBO J, V36, P135, DOI 10.15252/embj.201695148
   Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191
   Peng QL, 2022, ARTHRITIS RHEUMATOL, V74, P1048, DOI 10.1002/art.42071
   PÃ©rez-Torres I, 2017, INT J MOL SCI, V18, P0, DOI 10.3390/ijms18102098
   Phillips MCL, 2020, FRONT NEUROL, V11, P0, DOI 10.3389/fneur.2020.582402
   Picca A, 2023, NAT METAB, V5, P2047, DOI 10.1038/s42255-023-00930-8
   Pruitt JN, 1996, ANN NEUROL, V39, P139, DOI 10.1002/ana.410390122
   Qiu XF, 2018, CELL DEATH DIFFER, V25, P821, DOI 10.1038/s41418-018-0075-x
   Rinnenthal JL, 2014, NEUROMUSCULAR DISORD, V24, P151, DOI 10.1016/j.nmd.2013.11.004
   Romani M, 2021, CELL REP, V34, P0, DOI 10.1016/j.celrep.2020.108660
   Rostamzadeh F, 2024, BIOMED PHARMACOTHER, V170, P0, DOI 10.1016/j.biopha.2023.116020
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Rygiel KA, 2016, NUCLEIC ACIDS RES, V44, P5313, DOI 10.1093/nar/gkw382
   Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132
   Sachdev R, 2018, MOL NEUROBIOL, V55, P8355, DOI 10.1007/s12035-018-0997-9
   Salam S, 2022, CLIN EXP RHEUMATOL, V40, P384, DOI 10.55563/clinexprheumatol/r625rm
   Schmidt J, 2008, BRAIN, V131, P1228, DOI 10.1093/brain/awn053
   Sharma BR, 2021, NAT IMMUNOL, V22, P550, DOI 10.1038/s41590-021-00886-5
   Shelly S, 2021, NEUROLOGY, V96, PE2653, DOI 10.1212/WNL.0000000000012004
   Shelton GD, 2019, J NEUROMUSCULAR DIS, V6, P485, DOI 10.3233/JND-190421
   Skolka MP, 2023, CURR OPIN RHEUMATOL, V35, P404, DOI 10.1097/BOR.0000000000000958
   Snedden AM, 2022, CLIN EXP RHEUMATOL, V40, P414, DOI 10.55563/clinexprheumatol/pp0oso
   Sorriento D, 2021, FRONT PHYSIOL, V12, P0, DOI 10.3389/fphys.2021.660068
   Sulaimon LA, 2022, ADV. REDOX RES, V0, P0, DOI DOI 10.1016/J.ARRES.2022.100037
   Suzuki N, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1122-5
   Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074
   Tanboon J, 2020, CURR OPIN NEUROL, V33, P590, DOI 10.1097/WCO.0000000000000855
   Tawara N, 2017, ANN NEUROL, V81, P512, DOI 10.1002/ana.24919
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Terracciano C, 2008, FREE RADICAL BIO MED, V45, P773, DOI 10.1016/j.freeradbiomed.2008.05.030
   Tsamis KI, 2022, CRIT REV CL LAB SCI, V59, P219, DOI 10.1080/10408363.2021.2000584
   Tsuruta Y, 2002, ACTA NEUROPATHOL, V103, P59, DOI 10.1007/s004010100428
   Urbina-Varela R, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21207704
   Weihl CC, 2015, NEUROMUSCULAR DISORD, V25, P289, DOI 10.1016/j.nmd.2014.12.009
   Winkler M, 2021, J NEUROPATH EXP NEUR, V80, P1060, DOI 10.1093/jnen/nlab101
   Xiao WS, 2020, ANTIOXID REDOX SIGN, V32, P1330, DOI 10.1089/ars.2019.7803
   Yamashita S, 2023, J NEUROL NEUROSUR PS, V94, P1018, DOI 10.1136/jnnp-2023-331474
   Yang ZT, 2018, NAT CELL BIOL, V20, P186, DOI 10.1038/s41556-017-0022-y
   Yu CH, 2020, CELL, V183, P636, DOI 10.1016/j.cell.2020.09.020
   Zeng R, 2022, NEUROTHERAPEUTICS, V19, P911, DOI 10.1007/s13311-022-01220-z
   Zhang ZL, 2022, SIGNAL TRANSDUCT TAR, V7, P0, DOI 10.1038/s41392-022-01252-z
   Zhao YF, 2022, SCI REP-UK, V12, P0, DOI 10.1038/s41598-022-09943-x
   Zubair AS, 2023, FRONT NEUROL, V14, P0, DOI 10.3389/fneur.2023.1146015
NR 131
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-634X
EI 
J9 FRONT CELL DEV BIOL
JI Front. Cell. Dev. Biol.
PD MAY 14
PY 2024
VL 12
IS 
BP 
EP 
DI 10.3389/fcell.2024.1403463
PG 11
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA SB4L9
UT WOS:001231986100001
PM 38808223
DA 2024-11-01
ER

PT J
AU Yazdani, M
AF Yazdani, Mazyar
TI Cellular and Molecular Responses to Mitochondrial DNA Deletions in Kearns-Sayre Syndrome: Some Underlying Mechanisms
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE Reactive Oxygen Species (ROS); Myelin Vacuolation; Autophagy; Apoptosis; Oligodendrocyte; Lipid raft
ID progressive external ophthalmoplegia; myelin-associated glycoprotein; reactive oxygen; neurodegenerative diseases; tissue distribution; energy demand; mtdna; neuropathology; mutations; apoptosis
AB Kearns-Sayre syndrome (KSS) is a rare multisystem mitochondrial disorder. It is caused by mitochondrial DNA (mtDNA) rearrangements, mostly large-scale deletions of 1.1-10 kb. These deletions primarily affect energy supply through impaired oxidative phosphorylation and reduced ATP production. This impairment gives rise to dysfunction of several tissues, in particular those with high energy demand like brain and muscles. Over the past decades, changes in respiratory chain complexes and energy metabolism have been emphasized, whereas little attention has been paid to other reports on ROS overproduction, protein synthesis inhibition, myelin vacuolation, demyelination, autophagy, apoptosis, and involvement of lipid raft and oligodendrocytes in KSS. Therefore, this paper draws attention towards these relatively underemphasized findings that might further clarify the pathologic cascades following deletions in the mtDNA.
C1 [Yazdani, Mazyar] Oslo Univ Hosp, Dept Med Biochem, Rikshosp, N-0027 Oslo, Norway.
C3 University of Oslo; National Hospital Norway
RP Yazdani, M (corresponding author), Oslo Univ Hosp, Dept Med Biochem, Rikshosp, N-0027 Oslo, Norway.
EM mazyar.yazdani.edu@gmail.com
CR Ajoolabady A, 2021, CLIN EXP PHARMACOL P, V48, P943, DOI 10.1111/1440-1681.13500
   Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014
   ALLEN RJ, 1983, ANN NEUROL, V13, P679, DOI 10.1002/ana.410130620
   Amador MD, 2018, J INHERIT METAB DIS, V41, P447, DOI 10.1007/s10545-017-0134-3
   ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Atkinson JB, 2009, MODERN SURG PATHOLOG, V0, P2069
   BALL EH, 1982, P NATL ACAD SCI-BIOL, V79, P123, DOI 10.1073/pnas.79.1.123
   Barkovich AJ, 2000, AM J NEURORADIOL, V21, P1099
   Berardo A, 2010, CURR NEUROL NEUROSCI, V10, P118, DOI 10.1007/s11910-010-0096-4
   BERENBAUM F, 1990, NEUROLOGY, V40, P193, DOI 10.1212/WNL.40.1.193
   Berio A, 2017, PEDIAT MED CHIR, V39, P0
   Betts J, 2004, NEUROCHEM RES, V29, P505, DOI 10.1023/B:NERE.0000014821.07269.8d
   BRESOLIN N, 1987, ANN NEUROL, V21, P564, DOI 10.1002/ana.410210607
   Brown GK, 2005, J INHERIT METAB DIS, V28, P393, DOI 10.1007/s10545-005-7051-6
   Brown GK, 1996, J INHERIT METAB DIS, V19, P553, DOI 10.1007/BF01799116
   CHEN X, 1995, AM J HUM GENET, V57, P239
   Chertkof J, 2020, OPHTHALMIC GENET, V41, P497, DOI 10.1080/13816810.2020.1799416
   Cisneros A, 2021, J STUD RES, V10, P0
   CLARKE A, 1990, J MED GENET, V27, P451, DOI 10.1136/jmg.27.7.451
   Collins BE, 1997, J BIOL CHEM, V272, P1248, DOI 10.1074/jbc.272.2.1248
   CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Dailah HG, 2022, MOLECULES, V27, P0, DOI 10.3390/molecules27217207
   Deigner HP, 2000, EXPERT OPIN INV DRUG, V9, P747, DOI 10.1517/13543784.9.4.747
   Delcarlo M, 2006, AM J PHYSIOL-CELL PH, V290, PC802, DOI 10.1152/ajpcell.00214.2005
   Duncan ID, 2016, EXP NEUROL, V283, P452, DOI 10.1016/j.expneurol.2016.04.002
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   Finsterer J, 2020, CASE REP NEUROL MED, V2020, P0, DOI 10.1155/2020/7368527
   George KS, 2012, TOXICOL APPL PHARM, V259, P311, DOI 10.1016/j.taap.2012.01.007
   Gibson BW, 2005, INT J BIOCHEM CELL B, V37, P927, DOI 10.1016/j.biocel.2004.11.013
   Giussani P, 2021, J NEUROCHEM, V156, P403, DOI 10.1111/jnc.15133
   Goldstein A, 1993, GENEREVIEWS((R)), V0, P0
   Goldstein A, 2019, MITOCHONDRIAL DNA DE, V0, P0
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grigalioniene K, 2023, MOL GENET GENOM MED, V11, P0, DOI 10.1002/mgg3.2059
   GUENTHARD J, 1995, ARCH DIS CHILD, V72, P223, DOI 10.1136/adc.72.3.223
   Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007
   Guo WT, 2020, SEMIN CELL DEV BIOL, V99, P133, DOI 10.1016/j.semcdb.2019.07.010
   Gustafson MA, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0221829
   Hamano T, 2012, NEUROBIOL AGING, V33, P2306, DOI 10.1016/j.neurobiolaging.2011.10.020
   Hardwick JP, 2014, GCT, V1, P0
   HARVEY JN, 1992, CLIN ENDOCRINOL, V37, P97, DOI 10.1111/j.1365-2265.1992.tb02289.x
   Hastings N, 2022, CELL TRANSPLANT, V31, P0, DOI 10.1177/09636897221105499
   Heiman P, 2022, SCI REP-UK, V12, P0, DOI 10.1038/s41598-022-07076-9
   Holloman CM, 2013, CASE REP, V2013, P0
   HYLAND K, 1988, NEUROLOGY, V38, P459, DOI 10.1212/WNL.38.3.459
   Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026
   Inoue K, 1999, ANN NEUROL, V46, P313, DOI 10.1002/1531-8249(199909)46:3<313::AID-ANA6>3.0.CO;2-7
   Jacoby E, 2021, NPJ REGEN MED, V6, P0, DOI 10.1038/s41536-021-00167-7
   James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x
   Jou MJ, 2005, ANN NY ACAD SCI, V1042, P221, DOI 10.1196/annals.1338.024
   Kandel J, 2017, J R SOC INTERFACE, V14, P0, DOI 10.1098/rsif.2017.0071
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1
   Kennedy PGE, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23147584
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282
   Kleinle S, 1997, HUM GENET, V100, P643, DOI 10.1007/s004390050567
   Komen JC, 2014, BRIT J PHARMACOL, V171, P1818, DOI 10.1111/bph.12413
   Kontou M, 2009, BIOL CHEM, V390, P575, DOI 10.1515/BC.2009.058
   Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911
   Lackner LL, 2013, CURR OPIN CELL BIOL, V25, P471, DOI 10.1016/j.ceb.2013.02.011
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   Lax NZ, 2012, ARCH NEUROL-CHICAGO, V69, P490, DOI 10.1001/archneurol.2011.2167
   Lee CM, 1999, ONCOGENE, V18, P2997, DOI 10.1038/sj.onc.1202786
   Lee HG, 2022, NAT REV DRUG DISCOV, V21, P339, DOI 10.1038/s41573-022-00390-x
   Li WL, 2021, AGING DIS, V12, P2096, DOI 10.14336/AD.2021.0416
   Lightowlers RN, 2020, EMBO REP, V21, P0, DOI 10.15252/embr.202050964
   Liu F, 2002, FEBS LETT, V512, P101, DOI 10.1016/S0014-5793(02)02228-7
   LÃ³pez-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Maceluch Jaros Aw, 2006, PEDIATR ENDOCRINOL REV, V4, P117
   Madan S, 2022, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.781933
   Mandelkow EM, 2012, CSH PERSPECT MED, V2, P0, DOI 10.1101/cshperspect.a006247
   MARTENS ME, 1988, ANN NEUROL, V24, P630, DOI 10.1002/ana.410240507
   Mayorga L, 2016, MITOCHONDRIAL DNA A, V27, P2864, DOI 10.3109/19401736.2015.1053132
   Meske V, 2003, EUR J NEUROSCI, V17, P93, DOI 10.1046/j.1460-9568.2003.02433.x
   Mokranjac D, 2009, BBA-MOL CELL RES, V1793, P33, DOI 10.1016/j.bbamcr.2008.06.021
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1995, MUSCLE NERVE, V0, PS150
   Moroni I, 2002, NEUROPEDIATRICS, V33, P79, DOI 10.1055/s-2002-32372
   MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315
   Nadeem Arsalan, 2023, ENEUROLOGICALSCI, V30, P100448, DOI 10.1016/j.ensci.2023.100448
   Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409
   NIH, 2020, FACT SHEET HLTH PROF, V0, P0
   Nissanka N, 2018, FEBS LETT, V592, P728, DOI 10.1002/1873-3468.12956
   Obeid R, 2006, FEBS LETT, V580, P2994, DOI 10.1016/j.febslet.2006.04.088
   Obeid R, 2007, CLIN CHEM, V53, P1129, DOI 10.1373/clinchem.2006.085241
   OBERMAIERKUSSER B, 1990, BIOCHEM BIOPH RES CO, V169, P1007, DOI 10.1016/0006-291X(90)91994-4
   OLDFORS A, 1990, ACTA NEUROPATHOL, V80, P541, DOI 10.1007/BF00294616
   Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003
   Park H, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21093369
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328
   PohjoismÃ¤ki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   POULTON J, 1994, HUM MOL GENET, V3, P947, DOI 10.1093/hmg/3.6.947
   POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23
   POULTON J, 1995, MUSCLE NERVE, V0, PS154
   Prigione A, 2007, AGING CELL, V6, P619, DOI 10.1111/j.1474-9726.2007.00323.x
   Prolo LM, 2009, J NEUROSCI, V29, P15355, DOI 10.1523/JNEUROSCI.3005-09.2009
   Quntanilla RA, 2020, CURR NEUROPHARMACOL, V18, P1076, DOI 10.2174/1570159X18666200525020259
   Raine CS, 1999, ANN NEUROL, V46, P144, DOI 10.1002/1531-8249(199908)46:2<144::AID-ANA3>3.0.CO;2-K
   Redza-Dutordoir M, 2021, BBA-MOL CELL RES, V1868, P0, DOI 10.1016/j.bbamcr.2021.119041
   Redza-Dutordoir M, 2016, BBA-MOL CELL RES, V1863, P2977, DOI 10.1016/j.bbamcr.2016.09.012
   REICHMANN H, 1993, ACTA NEUROPATHOL, V85, P679, DOI 10.1007/BF00334681
   Rius R, 2019, GENET MED, V21, P2823, DOI 10.1038/s41436-019-0568-0
   Rose MR, 1998, ARCH NEUROL-CHICAGO, V55, P17, DOI 10.1001/archneur.55.1.17
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROTIG A, 1991, GENOMICS, V10, P502, DOI 10.1016/0888-7543(91)90342-C
   Ruiz-Pesini E, 2010, MITOMAP HUMAN MITOCH, V0, P0
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Ryzhkova AI, 2018, THER CLIN RISK MANAG, V14, P1933, DOI 10.2147/TCRM.S154863
   Sabella-JimÃ©nez V, 2020, MOL GENET GENOM MED, V8, P0, DOI 10.1002/mgg3.1509
   SaldaÃ±a-MartÃ­nez A, 2019, GENE, V688, P171, DOI 10.1016/j.gene.2018.11.085
   Salvador CL, 2023, PEDIATR NEUROL, V0, P0
   Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Scrivo A, 2018, LANCET NEUROL, V17, P802, DOI 10.1016/S1474-4422(18)30238-2
   Sequiera GL, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10030568
   SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24
   Shemesh A, 2022, MARGOLIN KEARNS SAYR, V0, P0
   Simoes-Costa M, 2013, GENOME RES, V23, P1069, DOI 10.1101/gr.157586.113
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408
   Smith KJ, 1999, BRAIN PATHOL, V9, P69
   SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Srivastava A, 2021, STEM CELL RES, V53, P0, DOI 10.1016/j.scr.2021.102283
   Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, P0, DOI 10.3389/fncel.2014.00314
   Stefano GB, 2022, CELL MOL NEUROBIOL, V42, P99, DOI 10.1007/s10571-021-01117-z
   Stefano GB, 2016, BIOMED REP, V4, P259, DOI 10.3892/br.2016.590
   Steinfeld R, 2009, AM J HUM GENET, V85, P354, DOI 10.1016/j.ajhg.2009.08.005
   Szalardy L, 2016, FOLIA NEUROPATHOL, V54, P9, DOI 10.5114/fn.2016.58911
   Szalardy L, 2013, NEURODEGENER DIS, V12, P177, DOI 10.1159/000346267
   Tang YY, 2000, MOL BIOL CELL, V11, P1471, DOI 10.1091/mbc.11.4.1471
   Tanji K, 1999, J NEUROL SCI, V166, P64, DOI 10.1016/S0022-510X(99)00114-8
   Tanji K, 2001, SEMIN CELL DEV BIOL, V12, P429, DOI 10.1006/scdb.2001.0280
   Tatton WG, 1999, BBA-BIOENERGETICS, V1410, P195, DOI 10.1016/S0005-2728(98)00167-4
   Tonska K, 2012, GENE, V506, P161, DOI 10.1016/j.gene.2012.06.081
   Valiente-PallejÃ  A, 2022, EBIOMEDICINE, V76, P0, DOI 10.1016/j.ebiom.2022.103815
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vidal RL, 2014, TRENDS PHARMACOL SCI, V35, P39, DOI 10.1016/j.tips.2014.09.002
   Vielhaber S, 2000, MUSCLE FIBRES APPL S, V0, P0
   Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100
   Vogel H, 2001, J NEUROPATH EXP NEUR, V60, P217, DOI 10.1093/jnen/60.3.217
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wang XH, 2021, FRONT NEUROL, V12, P0, DOI 10.3389/fneur.2021.749244
   Yazdani M, 2015, TOXICOL IN VITRO, V30, P578, DOI 10.1016/j.tiv.2015.08.010
   YORIFUJI S, 1985, J NEUROL SCI, V71, P65, DOI 10.1016/0022-510X(85)90037-1
   Yoshimi A, 2022, ORPHANET J RARE DIS, V17, P0, DOI 10.1186/s13023-022-02538-9
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118
   Zhang L, 2018, CIRCULATION, V137, P1374, DOI 10.1161/CIRCULATIONAHA.117.031139
   Zhu Q, 2022, BMC OPHTHALMOL, V22, P0, DOI 10.1186/s12886-021-02224-7
NR 160
TC 1
Z9 1
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD AUG 15
PY 2024
VL 61
IS 8
BP 5665
EP 5679
DI 10.1007/s12035-024-03938-7
EA JAN 2024
PG 15
WC Neurosciences
SC Neurosciences & Neurology
GA YV3A9
UT WOS:001142024400001
PM 38224444
DA 2024-11-01
ER

PT J
AU Hidalgo-Gutierrez, A
   Shintaku, J
   Ramon, J
   Barriocanal-Casado, E
   Pesini, A
   Saneto, RP
   Garrabou, G
   Milisenda, JC
   Matas-Garcia, A
   Gort, L
   Ugarteburu, O
   Gu, Y
   Koganti, L
   Wang, T
   Tadesse, S
   Meneri, M
   Sciacco, M
   Wang, S
   Tanji, K
   Horwitz, MS
   Dorschner, MO
   Mansukhani, M
   Comi, GP
   Ronchi, D
   Marti, R
   Ribes, A
   Tort, F
   Hirano, M
AF Hidalgo-Gutierrez, Agustin
   Shintaku, Jonathan
   Ramon, Javier
   Barriocanal-Casado, Eliana
   Pesini, Alba
   Saneto, Russell P.
   Garrabou, Gloria
   Milisenda, Jose Cesar
   Matas-Garcia, Ana
   Gort, Laura
   Ugarteburu, Olatz
   Gu, Yue
   Koganti, Lahari
   Wang, Tian
   Tadesse, Saba
   Meneri, Megi
   Sciacco, Monica
   Wang, Shuang
   Tanji, Kurenai
   Horwitz, Marshall S.
   Dorschner, Michael O.
   Mansukhani, Mahesh
   Comi, Giacomo Pietro
   Ronchi, Dario
   Marti, Ramon
   Ribes, Antonia
   Tort, Frederic
   Hirano, Michio
TI Guanylate Kinase 1 Deficiency: A Novel and Potentially Treatable Mitochondrial DNA Depletion/Deletions Disease
SO ANNALS OF NEUROLOGY
LA English
DT Article; Early Access
ID thymidine kinase; depletion; purine; supplementation; monophosphate; pharmacology; forodesine
AB Objective: Mitochondrial DNA (mtDNA) depletion/deletions syndrome (MDDS) comprises a group of diseases caused by primary autosomal defects of mtDNA maintenance. Our objective was to study the etiology of MDDS in 4 patients who lack pathogenic variants in known genetic causes. Methods: Whole exome sequencing of the probands was performed to identify pathogenic variants. We validated the mitochondrial defect by analyzing mtDNA, mitochondrial dNTP pools, respiratory chain activities, and GUK1 activity. To confirm pathogenicity of GUK1 deficiency, we expressed 2 GUK1 isoforms in patient cells. Results: We identified biallelic GUK1 pathogenic variants in all 4 probands who presented with ptosis, ophthalmoparesis, and myopathic proximal limb weakness, as well as variable hepatopathy and altered T-lymphocyte profiles. Muscle biopsies from all probands showed mtDNA depletion, deletions, or both, as well as reduced activities of mitochondrial respiratory chain enzymes. GUK1 encodes guanylate kinase, originally identified as a cytosolic enzyme. Long and short isoforms of GUK1 exist. We observed that the long isoform is intramitochondrial and the short is cytosolic. In probands' fibroblasts, we noted decreased GUK1 activity causing unbalanced mitochondrial dNTP pools and mtDNA depletion in both replicating and quiescent fibroblasts indicating that GUK1 deficiency impairs de novo and salvage nucleotide pathways. Proband fibroblasts treated with deoxyguanosine and/or forodesine, a purine phosphatase inhibitor, ameliorated mtDNA depletion, indicating potential pharmacological therapies. Interpretation: Primary GUK1 deficiency is a new and potentially treatable cause of MDDS. The cytosolic isoform of GUK1 may contribute to the T-lymphocyte abnormality, which has not been observed in other MDDS disorders. ANN NEUROL 2024
C1 [Hidalgo-Gutierrez, Agustin; Shintaku, Jonathan; Barriocanal-Casado, Eliana; Pesini, Alba; Tadesse, Saba; Hirano, Michio] Columbia Univ, Irving Med Ctr, Dept Neurol, New York, NY USA.
   [Ramon, Javier; Garrabou, Gloria; Milisenda, Jose Cesar; Matas-Garcia, Ana; Gort, Laura; Ugarteburu, Olatz; Marti, Ramon; Ribes, Antonia; Tort, Frederic] Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid, Spain.
   [Ramon, Javier; Marti, Ramon] Autonomous Univ Barcelona, Vall dHebron Res Inst, Barcelona, Spain.
   [Saneto, Russell P.] Seattle Childrens Hosp, Seattle, WA USA.
   [Garrabou, Gloria; Milisenda, Jose Cesar; Matas-Garcia, Ana] Univ Barcelona UB, Fac Med & Hlth Sci, Inherited Metab Dis & Muscle Disorders Lab, Cellex IDIBAPS, Barcelona, Spain.
   [Milisenda, Jose Cesar; Matas-Garcia, Ana] Hosp Clin Barcelona, Dept Internal Med, Barcelona, Spain.
   [Gort, Laura; Ugarteburu, Olatz; Ribes, Antonia; Tort, Frederic] Hosp Clin Barcelona, IDIBAPS, Dept Biochem & Mol Genet, Sect Inborn Errors Metab IBC, Barcelona, Spain.
   [Gu, Yue; Koganti, Lahari; Tanji, Kurenai; Mansukhani, Mahesh] Columbia Univ, Irving Med Ctr, Dept Pathol & Cell Biol, New York, NY USA.
   [Wang, Tian; Wang, Shuang] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA.
   [Meneri, Megi; Comi, Giacomo Pietro; Ronchi, Dario] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Milan, Italy.
   [Meneri, Megi; Comi, Giacomo Pietro; Ronchi, Dario] IRCCS Fdn CaGranda Osped Maggiore Policlin, Neurol Unit, Milan, Italy.
   [Sciacco, Monica] IRCCS Fdn CaGranda Osped Maggiore Policlin, Neuromuscular & Rare Dis Unit, Milan, Italy.
   [Horwitz, Marshall S.; Dorschner, Michael O.] Univ Washington, Dept Lab Med & Pathol, Seattle, WA USA.
C3 Columbia University; NewYork-Presbyterian Hospital; Instituto de Salud Carlos III; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Seattle Children's Hospital; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; NewYork-Presbyterian Hospital; Columbia University; Columbia University; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Washington; University of Washington Seattle
RP Hirano, M (corresponding author), Columbia Univ, Irving Med Ctr, 630 West 168th St,P&S 4-423, New York, NY 10032 USA.
EM ah3591@cumc.columbia.edu; jonathan.shintaku@gmail.com; javier.ramon@vhir.org; eb3471@cumc.columbia.edu; ap4072@cumc.columbia.edu; russ.saneto@seattlechildrens.org; GARRABOU@clinic.cat; JCMILISE@clinic.cat; ANMATAS@clinic.cat; lgort@clinic.cat; ougarteburu@gmail.com; yg2537@cumc.columbia.edu; lk2776@cumc.columbia.edu; tw2697@cumc.columbia.edu; st300@cumc.columbia.edu; megimeneri@gmail.com; monica.sciacco@policlinico.mi.it; sw2206@cumc.columbia.edu; kt8@cumc.columbia.edu; horwitz@uw.edu; mod@uw.edu; mm322@cumc.columbia.edu; giacomo.comi@unimi.it; dario.ronchi@gmail.com; ramon.marti@vhir.org; ARIBES@clinic.cat; FTORT@recerca.clinic.cat; mh29@columbia.edu
FU Department of Defense Focused Program [W81XWH2010807]; Marie S. Curie Global Fellowship within the European Union research and innovation framework programme Horizon Europe; Shuman Mitochondrial Disease Fund; Geof Barker; NIH [U54 NS078059, P01 HD32062]; Marriott Mitochondrial Disease Clinic Research Fund from the J. Willard and Alice S. Marriott Foundation; Arturo Estopinan TK2 Research Fund; Nicholas Nunno Foundation; JDM Fund for Mitochondrial Research; Fundacion Alfonso Martin Escudero; Spanish Instituto de Salud Carlos III [PI21/00554]; Catalan Fundacio La Marato de TV3 [202020]; European Union; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [SGR 1428, SGR 01423]; CERCA Programme/Generalitat de Catalunya; PNC "Hub Life Science - Diagnostica Avanzata" [PNC-E3-2022-23683266]; SEQMD project (IRCCS Ca Granda Ospedale Maggiore Policlinico); Italian Ministry of Education and Research (MUR) "Dipartimenti di Eccellenza Program 2023-2027" - Department of Pathophysiology and Transplantation, University of Milan; Associazione Centro Dino Ferrari; Italian Ministry of Health - Current research IRCCS Ca' Granda Ospedale Maggiore Policlinico;  [PI19/01310];  [PI22/00856];  [ER20P2AC737]; U.S. Department of Defense (DOD) [W81XWH2010807] Funding Source: U.S. Department of Defense (DOD)
CR AGARWAL RP, 1971, BIOCHEM PHARMACOL, V20, P1341, DOI 10.1016/0006-2952(71)90261-9
   Alexander SPH, 2021, BRIT J PHARMACOL, V178, PS412, DOI 10.1111/bph.15543
   Amtmann D, 2023, MITOCHONDRION, V68, P1, DOI 10.1016/j.mito.2022.10.003
   [Anonymous], 2019, AN OPENLABEL STUDY OF CONTINUATION TREATMENT WITH COMBINATION PYRIMIDINE NUCLEOSIDES IN PATIENTS WITH TK2 DEFICIENCY (2019) CLINICAL TRIAL, V0, P0
   [Anonymous], 2018, TREATMENT OF TK2 DEFICIENCY WITH THYMIDINE AND DEOXYCYTIDINE (2018) CLINICAL TRIAL (IDENTIFICATION NO. NCT03639701), V0, P0
   Balakrishnan K, 2010, BLOOD, V116, P886, DOI 10.1182/blood-2010-02-272039
   Bantia S, 2001, INT IMMUNOPHARMACOL, V1, P1199, DOI 10.1016/S1567-5769(01)00056-X
   Basel D, 2020, CLIN PERINATOL, V47, P123, DOI 10.1016/j.clp.2019.10.008
   Berardo A, 2022, J NEUROMUSCULAR DIS, V9, P225, DOI 10.3233/JND-210786
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   BlÃ¡zquez-Bermejo C, 2019, EBIOMEDICINE, V46, P342, DOI 10.1016/j.ebiom.2019.07.042
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bulst S, 2012, MOL GENET METAB, V107, P95, DOI 10.1016/j.ymgme.2012.04.022
   CÃ¡mara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Carvalho G, 2022, ANTIOXID REDOX SIGN, V36, P885, DOI 10.1089/ars.2021.0091
   Cheng J, 2023, SCIENCE, V381, P1303, DOI 10.1126/science.adg7492
   Di Noia MA, 2014, J BIOL CHEM, V289, P33137, DOI 10.1074/jbc.M114.610808
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   DomÃ­nguez-GonzÃ¡lez C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Gandhi V, 2007, SEMIN ONCOL, V34, PS8, DOI 10.1053/j.seminoncol.2007.11.003
   GonzÃ¡lez-GarcÃ­a P, 2022, REDOX BIOL, V55, P0, DOI 10.1016/j.redox.2022.102403
   Hible G, 2006, BIOCHIMIE, V88, P1157, DOI 10.1016/j.biochi.2006.04.002
   Hidalgo-Gutierrez A, 2021, BIOMEDICINES, V9, P0, DOI 10.3390/biomedicines9101457
   Hidalgo-GutiÃ©rrez A, 2019, EMBO MOL MED, V11, P0, DOI 10.15252/emmm.201809466
   Hirano Michio, 2023, HANDB CLIN NEUROL, V194, P9, DOI 10.1016/B978-0-12-821751-1.00018-X
   Iino M, 2022, ANN HEMATOL, V101, P2351, DOI 10.1007/s00277-022-04898-5
   Ionescu MI, 2019, PROTEIN J, V38, P120, DOI 10.1007/s10930-019-09811-0
   Khan N, 2019, J BIOL CHEM, V294, P11920, DOI 10.1074/jbc.RA119.009251
   Landoni JC, 2018, BIOL METHODS PROTOCOLS, V3, P0
   Lane AN, 2015, NUCLEIC ACIDS RES, V43, P2466, DOI 10.1093/nar/gkv047
   LÃ³pez-GÃ³mez C, 2022, NEUROMUSCULAR DISORD, V32, P609, DOI 10.1016/j.nmd.2022.05.008
   Lopez-Gomez C, 2019, EBIOMEDICINE, V46, P356, DOI 10.1016/j.ebiom.2019.07.037
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   MARKERT M L, 1991, IMMUNODEFICIENCY REVIEWS, V3, P45
   Minton K, 2023, NAT REV GENET, V24, P804, DOI 10.1038/s41576-023-00668-9
   Morgenstern M, 2021, CELL METAB, V33, P2464, DOI 10.1016/j.cmet.2021.11.001
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Panayiotou C, 2014, INT J BIOCHEM CELL B, V49, P75, DOI 10.1016/j.biocel.2014.01.014
   Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100
   RamÃ³n J, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22126447
   Rath S, 2021, NUCLEIC ACIDS RES, V49, PD1541, DOI 10.1093/nar/gkaa1011
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Shintaku J, 2022, J CLIN INVEST, V132, P0, DOI 10.1172/JCI145660
   Somech R, 2013, IMMUNOL RES, V56, P150, DOI 10.1007/s12026-012-8380-9
   Sommerville EW, 2020, CLIN GENET, V97, P276, DOI 10.1111/cge.13652
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Topalis D, 2007, FEBS J, V274, P3704, DOI 10.1111/j.1742-4658.2007.05902.x
   Wang L, 2010, NUCLEOS NUCLEOT NUCL, V29, P370, DOI 10.1080/15257771003729732
   Wang LY, 2016, NUCLEOS NUCLEOT NUCL, V35, P578, DOI 10.1080/15257770.2015.1125001
NR 50
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD SEP 4
PY 2024
VL 0
IS 
BP 
EP 
DI 10.1002/ana.27071
EA SEP 2024
PG 16
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA E8R7F
UT WOS:001305622000001
PM 39230499
DA 2024-11-01
ER

PT J
AU Adiba, M
   Rahman, M
   Akter, H
   Rahman, MM
   Uddin, M
   Ebihara, A
   Nabi, AHMN
AF Adiba, Maisha
   Rahman, Molie
   Akter, Hosneara
   Rahman, Md Mizanur
   Uddin, Mohammed
   Ebihara, Akio
   Nabi, A. H. M. Nurun
TI Mutational landscape of mitochondrial cytochrome <i>b</i> and its flanking tRNA genes associated with increased mitochondrial DNA copy number and disease risk in children with autism
SO GENE REPORTS
LA English
DT Article
DE ASD; Autism; Cytochrome b; Lactic acid; Ammonia; SNP; Copy number variation
ID protein; muscle; sites; tool
AB Autism, the severe form of Autism Spectrum Disorder (ASD), is a genetically heterogeneous wide spectrum of impairments characterized by social dysfunction, restricted contact, and communication. Out of 80 children (aged 3 to 10 years) enrolled, 50 were diagnosed with autism (according to M-CHAT-R), while the remaining 30 were healthy children. Lactic acid and ammonia levels were measured using an autoanalyzer and children with autism had significantly higher levels than controls. The Cytb and its adjacent tRNA genes for glutamine, threonine, and proline (MT-TE, MT-TT, MT-TP) were amplified by PCR, purified, and sequenced by Sanger sequencing. A total of 57 variants (19 non-synonymous and 31 synonymous SNPs in Cytb, and seven tRNA gene variants) were identified and Cytb-specific mtDNA copy numbers were determined. There was no significant association between any Cytb variants and disease outcomes, but three of them (15067T>C, 15202C>T, 15262T>C) were linked to higher lactic acid levels and two (14753C>T, 15262T>C) to higher ammonia levels. When docked with Cytb ligands PEE, Heme1, and Heme2, 15341T>C and 15773G>A had the most detrimental impact on protein structure, with higher RMSD than the reference protein complexes. The mtDNA copy number was significantly higher in children with autism than in healthy children, although after adjusting confounding factors the difference was found to be insignificant. Out of two detrimental variants, 15341T>C, along with two additional variants, 15049C>T and 15796T>C, were found to be associated with an increased Cytb-specific mtDNA copy number. Additionally, synonymous SNPs showed codon-usage variations (RSCU). Although no association of variants in Cytb and its adjacent tRNA gene was found with autism, a cluster of variants has been found to affect protein structure and translation rate (as indicated by alteration of RSCU values), which may impair normal activity of electron transport chain (ETC) which is reflected by the significant change in lactic acid and ammonia levels. Children with autism showed increased mtDNA copy number to compensate the impact of these mutational consequences. In conclusion, the electron transport chain complexes should be investigated further in a large sample size to strengthen this finding.
C1 [Adiba, Maisha; Rahman, Molie; Akter, Hosneara; Nabi, A. H. M. Nurun] Univ Dhaka, Dept Biochem & Mol Biol, Lab Populat Genet, Dhaka 1000, Bangladesh.
   [Akter, Hosneara; Uddin, Mohammed] NeuroGen Childrens Healthcare, Genet & Genom Med Ctr, Dhaka, Bangladesh.
   [Rahman, Md Mizanur] Rajshahi Med Coll, Dept Microbiol, Rajshahi, Bangladesh.
   [Uddin, Mohammed] Mohammed Bin Rashid Univ Med & Hlth Sci, Coll Med, Dubai, U Arab Emirates.
   [Uddin, Mohammed] GenomeArc Inc, Cellular Intelligence Ci Lab, Toronto, ON, Canada.
   [Ebihara, Akio] Gifu Univ, United Grad Sch Agr Sci, Lab Appl Biochem, 1-1 Yanagido, Gifu 5011193, Japan.
C3 University of Dhaka; Rajshahi Medical College; Gifu University
RP Nabi, AHMN (corresponding author), Univ Dhaka, Dept Biochem & Mol Biol, Lab Populat Genet, Dhaka 1000, Bangladesh.
EM nabi@du.ac.bd
FU Ministry of Science and Technology, Government of the Peoples' Republic of Bangladesh; Dhaka University Neuroscience Research Center; United Graduate School of Agricultural Science, Gifu University, Japan
CR Afruza Rownock, 2014, J GENOMICS, V2, P45, DOI 10.7150/jgen.5193
   Al-Kafaji G, 2018, EXP THER MED, V16, P1483, DOI 10.3892/etm.2018.6319
   Arun S, 2016, CURR NEUROPHARMACOL, V14, P143, DOI 10.2174/1570159X13666150703154541
   Autism Spectrum, 2021, AUTISM GENETICS, V0, P1
   Barja G, 1999, J BIOENERG BIOMEMBR, V31, P347, DOI 10.1023/A:1005427919188
   Brandon MC, 2009, HUM MUTAT, V30, P1, DOI 10.1002/humu.20801
   Charman T, 2013, CHILD ADOL MENT H-UK, V18, P52, DOI 10.1111/j.1475-3588.2012.00664.x
   Chlebowski C, 2013, PEDIATRICS, V131, PE1121, DOI 10.1542/peds.2012-1525
   Davuluri G, 2016, J PHYSIOL-LONDON, V594, P7341, DOI 10.1113/JP272796
   DEGLIESPOSTI M, 1993, BIOCHIM BIOPHYS ACTA, V1143, P243, DOI 10.1016/0005-2728(93)90197-N
   Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1
   Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01
   Frye RE, 2011, PEDIATR RES, V69, P41R, DOI 10.1203/PDR.0b013e318212f16b
   Grabrucker Andreas M, 2012, FRONT PSYCHIATRY, V3, P118, DOI 10.3389/fpsyt.2012.00118
   Griffiths KK, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/4314025
   Gu F, 2013, TRANSL PSYCHIAT, V3, P0, DOI 10.1038/tp.2013.68
   Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050
   Hashem S, 2020, TRANSL PSYCHIAT, V10, P0, DOI 10.1038/s41398-020-00921-3
   Heo L, 2013, NUCLEIC ACIDS RES, V41, PW384, DOI 10.1093/nar/gkt458
   Hildenbeutel M, 2014, J CELL BIOL, V205, P511, DOI 10.1083/jcb.201401009
   Hyman SL, 2020, IDENTIFICATION, V0, P0
   Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945
   Karimi P, 2017, J RES MED SCI, V22, P0, DOI 10.4103/1735-1995.200272
   Keightley JA, 2000, AM J HUM GENET, V67, P1400, DOI 10.1086/316900
   Kim HJ, 2012, BBA-MOL CELL RES, V1823, P1604, DOI 10.1016/j.bbamcr.2012.04.008
   Kim Y, 2011, GENETICS, V189, P213, DOI 10.1534/genetics.111.130203
   Klausen MS, 2019, PROTEINS, V87, P520, DOI 10.1002/prot.25674
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221
   Mandrekar JN, 2010, J THORAC ONCOL, V5, P1315, DOI 10.1097/JTO.0b013e3181ec173d
   Miles JH, 2011, GENET MED, V13, P278, DOI 10.1097/GIM.0b013e3181ff67ba
   Park HR, 2016, EXP NEUROBIOL, V25, P1, DOI 10.5607/en.2016.25.1.1
   Pejaver V, 2017, MUTPRED2: INFERRING THE MOLECULAR AND PHENOTYPIC IMPACT OF AMINO ACID VARIANTS, V0, P0, DOI DOI 10.1101/134981
   Phillips JC, 2020, J CHEM PHYS, V153, P0, DOI 10.1063/5.0014475
   Picard M, 2021, MITOCHONDRION, V60, P1, DOI 10.1016/j.mito.2021.06.010
   Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136
   Saha SK, 2019, META GENE, V19, P23, DOI 10.1016/j.mgene.2018.10.004
   SARASTE M, 1984, FEBS LETT, V166, P367, DOI 10.1016/0014-5793(84)80114-3
   Sharma SR, 2018, PHARMACOL THERAPEUT, V190, P91, DOI 10.1016/j.pharmthera.2018.05.007
   SolÃ© X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268
   Son D, 2021, STEM CELL RES, V54, P0, DOI 10.1016/j.scr.2021.102392
   Sonney S, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005867
   Vahia VN, 2013, INDIAN J PSYCHIAT, V55, P220, DOI 10.4103/0019-5545.117131
   Venselaar H, 2010, BMC BIOINFORMATICS, V11, P0, DOI 10.1186/1471-2105-11-548
   WEISS H, 1987, BIOCHEM SOC T, V15, P100, DOI 10.1042/bst0150100
   Weitlauf AS, 2015, J DEV BEHAV PEDIATR, V36, P497, DOI 10.1097/DBP.0000000000000194
   Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012
   Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224
   WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yan YM, 2017, NUCLEIC ACIDS RES, V45, PW365, DOI 10.1093/nar/gkx407
   Yoo H, 2015, EXP NEUROBIOL, V24, P257, DOI 10.5607/en.2015.24.4.257
   Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524
NR 53
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 
EI 2452-0144
J9 GENE REP
JI Gene Rep.
PD JUN 15
PY 2024
VL 35
IS 
BP 
EP 
DI 10.1016/j.genrep.2024.101895
EA FEB 2024
PG 17
WC Genetics & Heredity
SC Genetics & Heredity
GA NA6H7
UT WOS:001197752100001
DA 2024-11-01
ER

PT J
AU Senol, HB
   Soydemir, D
   Polat, AI
   Aydin, A
   Hiz, AS
   Yis, U
AF Senol, Hueseyin Bahadir
   Soydemir, Didem
   Polat, Ayse Ipek
   Aydin, Adem
   Hiz, Ayse Semra
   Yis, Uluc
TI An Unusual Presentation of Leber Hereditary Optic Neuropathy-Plus Case Caused by a Novel <i>DNAJC30</i> Variant
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article; Early Access
DE exome sequencing; idiopathic intracranial hypertension; Leber hereditary optic neuropathy; neuromyelitis optica spectrum disorder; ventriculoperitoneal shunt
ID mitochondrial-dna mutation; neuromyelitis-optica
AB Leber hereditary optic neuropathy (LHON) is characterized by vision loss due to the degeneration of retinal ganglion cells. LHON-Plus refers to LHON with additional extraocular findings. Neurological conditions observed in LHON-Plus include seizures, encephalopathy, movement disorders, neuropathy, and myopathy. Herein, we present a case with atypical LHON-Plus caused by a novel DNAJC30 disease-causing gene variant. A 15-year-old boy presented with acute headache, and blurred and decreased vision in both eyes. Although initial evaluation pointed toward idiopathic intracranial hypertension, the subsequent diagnostic process revealed unusual features like area postrema syndrome and T2 hyperintensity in brain magnetic resonance imaging. Consequently, antibody-negative neuromyelitis optica spectrum disorder (NMOSD) was diagnosed and treatment was commenced. Recurrent episodes of elevated intracranial pressure necessitated the insertion of a ventriculoperitoneal shunt. Exome sequencing (ES) revealed a novel homozygous variant in the DNAJC30 gene 2 years after symptom onset. Atypical LHON presentations due to nuclear gene mutations may mimic other neuroinflammatory conditions like NMOSD, necessitating thorough clinical evaluation and genetic testing. ES plays a crucial role in diagnosing complex neurological cases, enabling the identification of novel genetic variants associated with LHON and related disorders.
C1 [Senol, Hueseyin Bahadir; Soydemir, Didem; Polat, Ayse Ipek; Aydin, Adem; Hiz, Ayse Semra; Yis, Uluc] Dokuz Eylul Univ, Fac Med, Dept Pediat Neurol, Izmir, Turkiye.
C3 Dokuz Eylul University
RP Senol, HB (corresponding author), Dokuz Eylul Univ, Fac Med, Dept Pediat Neurol, Izmir, Turkiye.
EM huseyinbahadirsenol@gmail.com
CR Bhatti MT, 1999, J NEURO-OPHTHALMOL, V19, P28
   Birnbaum FA, 2021, J NEURO-OPHTHALMOL, V41, PE715, DOI 10.1097/WNO.0000000000001151
   Bittner F, 2019, JAMA NEUROL, V76, P227, DOI 10.1001/jamaneurol.2018.3207
   Cunha AM, 2021, INT MED CASE REP J, V14, P163, DOI 10.2147/IMCRJ.S303460
   Dujmovic I, 2016, MULT SCLER J, V22, P393, DOI 10.1177/1352458515590649
   Gerber S, 2021, GENES-BASEL, V12, P0, DOI 10.3390/genes12040521
   Gerber S, 2017, J MED GENET, V54, P346, DOI 10.1136/jmedgenet-2016-104212
   Ghezzi A, 2004, NEUROL SCI, V25, PS380, DOI 10.1007/s10072-004-0347-8
   Goldberg I, 1992, OPHTHALMOLOGY CLINICS OF NORTH AMERICA| OPHTHALMOLOGY CLINICS OF NORTH AMERICA, V4, P916
   Lenaers G, 2023, BRAIN, V146, P3156, DOI 10.1093/brain/awad131
   Magrinelli F, 2022, MOV DISORD CLIN PRAC, V9, P218, DOI 10.1002/mdc3.13398
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   McClelland CM, 2011, J NEURO-OPHTHALMOL, V31, P265, DOI 10.1097/WNO.0b013e318225247b
   Myrgorodska O, 2022, CESK SLOV OFTALMOL, V2, P1001, DOI 10.31348/2022/18
   NEWMAN NJ, 1993, ARCH NEUROL-CHICAGO, V50, P540, DOI 10.1001/archneur.1993.00540050082021
   NIKOSKELAINEN EK, 1995, J NEUROL NEUROSUR PS, V59, P160, DOI 10.1136/jnnp.59.2.160
   Shemesh A, 2002, LEBER HEREDITARY OPTIC NEUROPATHY (LHON), V0, P0
   Shiraishi W, 2014, MULT SCLER J, V20, P258, DOI 10.1177/1352458513513057
   Simao LM, 2012, ARQ BRAS OFTALMOL, V75, P280, DOI 10.1590/S0004-27492012000400013
   Skorczyk-Werner A, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms242417496
   Stenton SL, 2022, BRAIN, V145, P1624, DOI 10.1093/brain/awac052
   Stenton Sarah L, 2021, J CLIN INVEST, V131, P0, DOI 10.1172/JCI138267
   Sundaramurthy S, 2021, GRAEF ARCH CLIN EXP, V259, P2461, DOI 10.1007/s00417-020-04993-1
   Sunshine A, 2023, NEUROLOGY, V101, PE2585, DOI 10.1212/WNL.0000000000207979
   Whiteley W, 2006, NEUROLOGY, V67, P1690, DOI 10.1212/01.wnl.0000242704.60275.e9
   Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729
   Yu-Wai-Man P, 2014, EYE, V28, P521, DOI 10.1038/eye.2014.37
   Yu-Wai-Man P, 2016, ACTA NEUROPATHOL, V132, P789, DOI 10.1007/s00401-016-1625-2
   Zawadzka M, 2022, CLIN GENET, V102, P438, DOI 10.1111/cge.14196
NR 29
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD OCT 15
PY 2024
VL 0
IS 
BP 
EP 
DI 10.1002/ajmg.a.63902
EA OCT 2024
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA J0W6S
UT WOS:001334364800001
PM 39404442
DA 2024-11-01
ER

PT J
AU Aaltio, J
   Euro, L
   Tynninen, O
   Vu, HS
   Ni, M
   Deberardinis, RJ
   Suomalainen, A
   Isohanni, P
AF Aaltio, Juho
   Euro, Liliya
   Tynninen, Olli
   Vu, Hieu S.
   Ni, Min
   Deberardinis, Ralph J.
   Suomalainen, Anu
   Isohanni, Pirjo
TI Niacin supplementation in a child with novel <i>MTTN</i> variant m.5670A&gt;G causing early onset mitochondrial myopathy and NAD<SUP>+</SUP> deficiency
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE MTTN; tRNA-Asn; Mitochondrial myopathy; NAD plus deficiency; Niacin; Niacin supplementation
ID mutation
AB Myopathy is a common manifestation in mitochondrial disorders, but the pathomechanisms are still insufficiently studied in children. Here, we report a severe, progressive mitochondrial myopathy in a four-year-old child, who died at eight years. He developed progressive loss of muscle strength with nocturnal hypoventilation and dilated cardiomyopathy. Skeletal muscle showed ragged red fibers and severe combined respiratory chain deficiency. Mitochondrial DNA sequencing revealed a novel m.5670A>G mutation in mitochondrial tRNA(Asn) (MTTN) with 88 % heteroplasmy in muscle. The proband also had systemic NAD(+) deficiency but rescuing this with the NAD(+) precursor niacin did not stop disease progression. Targeted metabolomics revealed an overall shift of metabolism towards controls after niacin supplementation, with normalized tryptophan metabolites and lipid-metabolic markers, but most amino acids did not respond to niacin therapy. To conclude, we report a new MTTN mutation, secondary NAD(+) deficiency in childhood-onset mitochondrial myopathy with metabolic but meager clinical response to niacin supplementation. (c) 2024 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
C1 [Aaltio, Juho; Euro, Liliya; Suomalainen, Anu; Isohanni, Pirjo] Univ Helsinki, Res Programs Unit, Stem Cells & Metab Res, Helsinki, Finland.
   [Tynninen, Olli] Helsinki Univ Hosp, Dept Pathol, Helsinki, Finland.
   [Tynninen, Olli] Univ Helsinki, Helsinki, Finland.
   [Vu, Hieu S.; Ni, Min; Deberardinis, Ralph J.] Univ Texas Southwestern Med Ctr Dallas, Childrens Med Ctr Res Inst, Dallas, TX USA.
   [Deberardinis, Ralph J.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX USA.
   [Suomalainen, Anu] Helsinki Univ Hosp, HUS Diagnost Ctr, Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, HiLife, Helsinki, Finland.
   [Isohanni, Pirjo] Univ Helsinki, Childrens Hosp, Pediat Res Ctr, Child Neurol, Helsinki, Finland.
   [Isohanni, Pirjo] Helsinki Univ Hosp, Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital
RP Aaltio, J (corresponding author), Univ Helsinki, Res Programs Unit, Stem Cells & Metab Res, Helsinki, Finland.
EM juho.aaltio@helsinki.fi
CR Bruno C, 2011, BIOCHEM BIOPH RES CO, V412, P518, DOI 10.1016/j.bbrc.2011.06.155
   Coulbault L, 2005, BIOCHEM BIOPH RES CO, V329, P1152, DOI 10.1016/j.bbrc.2005.02.083
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   GÃ¶tz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Hathazi D, 2020, EMBO J, V39, P0, DOI 10.15252/embj.2020105364
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   Krall AS, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms11457
   Lapatto HAK, 2023, SCI ADV, V9, P0, DOI 10.1126/sciadv.add5163
   Lorenz R, 2011, ALGORITHM MOL BIOL, V6, P0, DOI 10.1186/1748-7188-6-26
   Meulemans A, 2006, ARCH NEUROL-CHICAGO, V63, P1194, DOI 10.1001/archneur.63.8.1194
   Pang ZQ, 2021, NUCLEIC ACIDS RES, V49, PW388, DOI 10.1093/nar/gkab382
   Pirinen E, 2020, CELL METAB, V31, P1078, DOI 10.1016/j.cmet.2020.04.008
   Ronchi D, 2012, EUR J HUM GENET, V20, P357, DOI 10.1038/ejhg.2011.238
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Sonney S, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005867
   Visuttijai K, 2021, ACTA NEUROL SCAND, V143, P103, DOI 10.1111/ane.13339
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27
   Zereg E, 2020, HUM MUTAT, V41, P1394, DOI 10.1002/humu.24037
NR 20
TC 0
Z9 0
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD OCT 15
PY 2024
VL 43
IS 
BP 14
EP 19
DI 10.1016/j.nmd.2024.07.005
EA AUG 2024
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA E2N1T
UT WOS:001301411800001
PM 39173541
DA 2024-11-01
ER

PT J
AU Namani, S
   Kavetsky, K
   Lin, CY
   Maharjan, S
   Gamper, HB
   Li, NS
   Piccirilli, JA
   Hou, YM
   Drndic, M
AF Namani, Srilahari
   Kavetsky, Kyril
   Lin, Chih-Yuan
   Maharjan, Sunita
   Gamper, Howard B.
   Li, Nan-Sheng
   Piccirilli, Joseph A.
   Hou, Ya-Ming
   Drndic, Marija
TI Unraveling RNA Conformation Dynamics in Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episode Syndrome with Solid-State Nanopores
SO ACS NANO
LA English
DT Article
DE nanopore; MELAS; tRNA conformation; silicon nitride; m(1)G9 methylation; mitochondrialtRNA
ID molecule mass-spectrometry; transfer rnaleu(uur) gene; single-stranded-dna; salt; encephalopathy; translocation; myopathy; mutation; stability; nucleotide
AB This study investigates transfer ribonucleic acid (tRNA) conformational dynamics in the context of MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) using solid-state silicon nitride (SiN) nanopore technology. SiN nanopores in thin membranes with specific dimensions exhibit high signal resolution, enabling real-time and single-molecule electronic detection of tRNA conformational changes. We focus on human mitochondrial tRNALeu(UAA) (mt-Leu(UAA)) that decodes Leu codons UUA/UUG (UUR) during protein synthesis on the mt-ribosome. The single A14G substitution in mt-Leu(UAA) is the major cause of MELAS disease. Measurements of current blockades and dwell times reveal distinct conformational dynamics of the wild-type (WT) and the A14G variant of mt-Leu(UAA) in response to the conserved post-transcriptional m(1)G9 methylation. While the m(1)G9-modified WT transcript adopts a more stable structure relative to the unmodified transcript, the m(1)G9-modified MELAS transcript adopts a less stable structure relative to the unmodified transcript. Notably, these differential features were observed at 0.4 M KCl, but not at 3 M KCl, highlighting the importance of experimental settings that are closer to physiological conditions. This work demonstrates the feasibility of the nanopore platform to discern tRNA molecules that differ by a single-nucleotide substitution or by a single methylation event, providing an important step forward to explore changes in the conformational dynamics of other RNA molecules in human diseases.
C1 [Namani, Srilahari; Lin, Chih-Yuan; Drndic, Marija] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.
   [Kavetsky, Kyril] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.
   [Maharjan, Sunita; Gamper, Howard B.; Hou, Ya-Ming] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.
   [Li, Nan-Sheng; Piccirilli, Joseph A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA.
   [Piccirilli, Joseph A.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA.
C3 University of Pennsylvania; University of Pennsylvania; Jefferson University; University of Chicago; University of Chicago
RP Drndic, M (corresponding author), Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.; Hou, YM (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.
EM ya-ming.hou@jefferson.edu; drndic@physics.upenn.edu
FU NIH Opportunity Fund grant "Probing RNA conformational dynamics through a solid-state nanopore with sub-100 nanosecond time resolution" from the Technology Development Coordinating Center (TDCC) [U24 HG011735]; NIH [R21 HG011120, R21 HG-12395, R35 GM149336]; NSF [NNCI-1542153]; NSF through the University of Pennsylvania Materials Research Science and Engineering Center (MRSEC) [DMR-1720530]
CR Al-Hashimi HM, 2008, CURR OPIN STRUC BIOL, V18, P321, DOI 10.1016/j.sbi.2008.04.004
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Baaken G, 2011, ACS NANO, V5, P8080, DOI 10.1021/nn202670z
   Bakshloo MA, 2023, ACS CHEM NEUROSCI, V14, P2517, DOI 10.1021/acschemneuro.3c00164
   Bakshloo MA, 2022, J AM CHEM SOC, V144, P2716, DOI 10.1021/jacs.1c11758
   Bandarkar P, 2020, BIOPHYS J, V118, P1612, DOI 10.1016/j.bpj.2020.01.030
   Bezrukov SM, 2000, J MEMBRANE BIOL, V174, P1, DOI 10.1007/s002320001026
   Bhatta A, 2021, NAT STRUCT MOL BIOL, V28, P713, DOI 10.1038/s41594-021-00637-y
   Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101
   Boskovic F, 2022, NAT CHEM, V14, P1258, DOI 10.1038/s41557-022-01037-5
   Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106
   Chau C, 2022, ACS NANO, V16, P20075, DOI 10.1021/acsnano.2c08312
   Chien CC, 2019, ACS NANO, V13, P10545, DOI 10.1021/acsnano.9b04626
   Chou YC, 2021, J CHEM PHYS, V154, P0, DOI 10.1063/5.0044227
   Chou YC, 2020, ACS NANO, V14, P6715, DOI 10.1021/acsnano.9b09964
   Erxleben DA, 2024, ANAL CHEM, V96, P1606, DOI 10.1021/acs.analchem.3c04387
   Ettedgui J, 2016, J AM CHEM SOC, V138, P7228, DOI 10.1021/jacs.6b02917
   Fan HC, 2021, LIFE-BASEL, V11, P0, DOI 10.3390/life11111111
   Fechter P, 1998, FEBS LETT, V436, P99, DOI 10.1016/S0014-5793(98)01096-5
   Firnkes M, 2010, NANO LETT, V10, P2162, DOI 10.1021/nl100861c
   Fischer NM, 2018, NUCLEIC ACIDS RES, V46, P4872, DOI 10.1093/nar/gky221
   Fologea D, 2005, NANO LETT, V5, P1734, DOI 10.1021/nl051063o
   Fuller CW, 2016, P NATL ACAD SCI USA, V113, P5233, DOI 10.1073/pnas.1601782113
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Halverson KM, 2005, J BIOL CHEM, V280, P34056, DOI 10.1074/jbc.M507928200
   Helm M, 1999, BIOCHEMISTRY-US, V38, P13338, DOI 10.1021/bi991061g
   Helm M, 1998, NUCLEIC ACIDS RES, V26, P1636, DOI 10.1093/nar/26.7.1636
   Henley RY, 2016, PROG MOL BIOL TRANSL, V139, P73, DOI 10.1016/bs.pmbts.2015.10.020
   Henley RY, 2016, NANO LETT, V16, P138, DOI 10.1021/acs.nanolett.5b03331
   Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013
   Hopkins JF, 2009, NUCLEIC ACIDS RES, V37, P6205, DOI 10.1093/nar/gkp646
   Ishimura R, 2014, SCIENCE, V345, P455, DOI 10.1126/science.1249749
   Ivankin A, 2014, ACS NANO, V8, P10774, DOI 10.1021/nn504551d
   Kasianowicz JJ, 2008, HDB BIOSENSORSAND BI, V0, P0
   Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770
   Kasianowicz JJ, 2001, ANAL CHEM, V73, P2268, DOI 10.1021/ac000958c
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kim HD, 2002, P NATL ACAD SCI USA, V99, P4284, DOI 10.1073/pnas.032077799
   Klein DJ, 2004, RNA, V10, P1366, DOI 10.1261/rna.7390804
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   Koculi E, 2007, J AM CHEM SOC, V129, P2676, DOI 10.1021/ja068027r
   Kumar S, 2012, SCI REP-UK, V2, P0, DOI 10.1038/srep00684
   Larkin J, 2014, BIOPHYS J, V106, P696, DOI 10.1016/j.bpj.2013.12.025
   Lin CY, 2022, NANO LETT, V22, P8719, DOI 10.1021/acs.nanolett.2c03546
   Liu K, 2014, ACS NANO, V8, P2504, DOI 10.1021/nn406102h
   Lott MT, 2013, CURR PROTOC BIOINF, V44, P1231, DOI 10.1002/0471250953.BI0123S44
   Maharjan Sunita, 2023, BIORXIV, V0, P0, DOI DOI 10.1101/2023.12.09.569632
   Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171
   McDermott JJ, 2018, PLOS ONE, V13, P0, DOI 10.1371/journal.pone.0209713
   McLaughlin S, 1977, CURR TOP MEMBR TRANS, V9, P71
   Owczarzy R, 2008, BIOCHEMISTRY-US, V47, P5336, DOI 10.1021/bi702363u
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pia S, 2022, MELAS SYNDROME, V0, P0
   Reiner JE, 2010, P NATL ACAD SCI USA, V107, P12080, DOI 10.1073/pnas.1002194107
   Reinhard L, 2017, NUCLEIC ACIDS RES, V45, P12469, DOI 10.1093/nar/gkx902
   Reinhard L, 2015, NUCLEIC ACIDS RES, V43, P5664, DOI 10.1093/nar/gkv481
   Robertson JWF, 2007, P NATL ACAD SCI USA, V104, P8207, DOI 10.1073/pnas.0611085104
   Rosenstein JK, 2012, NAT METHODS, V9, P487, DOI 10.1038/nmeth.1932
   Rozevsky Y, 2020, ACS NANO, V14, P13964, DOI 10.1021/acsnano.0c06375
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Schibel AEP, 2010, J AM CHEM SOC, V132, P17992, DOI 10.1021/ja109501x
   Schneider GF, 2010, NANO LETT, V10, P3163, DOI 10.1021/nl102069z
   Sethi K, 2021, ACS NANO, V15, P8474, DOI 10.1021/acsnano.0c10887
   Smeets RMM, 2006, NANO LETT, V6, P89, DOI 10.1021/nl052107w
   Soni N, 2022, ACS NANO, V16, P11405, DOI 10.1021/acsnano.2c05391
   Suzuki T, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-18068-6
   Tan ZJ, 2011, BIOPHYS J, V101, P176, DOI 10.1016/j.bpj.2011.05.050
   Tan ZJ, 2006, BIOPHYS J, V90, P1175, DOI 10.1529/biophysj.105.070904
   Tian FJ, 2023, P NATL ACAD SCI USA, V120, P0, DOI 10.1073/pnas.2218425120
   Vaidyanathan S, 2023, ANAL CHEM, V95, P9892, DOI 10.1021/acs.analchem.3c00855
   Venta K, 2013, ACS NANO, V7, P4629, DOI 10.1021/nn4014388
   Vilardo E, 2012, NUCLEIC ACIDS RES, V40, P11583, DOI 10.1093/nar/gks910
   Voigts-Hoffmann F, 2007, J AM CHEM SOC, V129, P13382, DOI 10.1021/ja075520+
   Waduge P, 2017, ACS NANO, V11, P5706, DOI 10.1021/acsnano.7b01212
   Wang YJ, 2020, RNA, V26, P470, DOI 10.1261/rna.073882.119
   Wanunu M, 2011, ACS NANO, V5, P9345, DOI 10.1021/nn203764j
   Wanunu M, 2011, J AM CHEM SOC, V133, P486, DOI 10.1021/ja107836t
   Wanunu M, 2010, NAT NANOTECHNOL, V5, P807, DOI 10.1038/NNANO.2010.202
   WILLIAMS AP, 1989, BIOCHEMISTRY-US, V28, P4283, DOI 10.1021/bi00436a025
   Woodson SA, 2009, METHOD ENZYMOL, V469, P189, DOI 10.1016/S0076-6879(09)69009-1
   Xia ZH, 2022, PROTEOMICS, V22, P0, DOI 10.1002/pmic.202100071
   Yao HT, 2023, ALGORITHM MOL BIOL, V18, P0, DOI 10.1186/s13015-023-00236-0
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Ying YL, 2022, NAT NANOTECHNOL, V17, P1136, DOI 10.1038/s41565-022-01193-2
   Yusko EC, 2017, NAT NANOTECHNOL, V12, P360, DOI 10.1038/NNANO.2016.267
   Zahid OK, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep29565
NR 88
TC 1
Z9 1
U1 8
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD JUN 21
PY 2024
VL 18
IS 26
BP 17240
EP 17250
DI 10.1021/acsnano.4c04625
EA JUN 2024
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA XG9T7
UT WOS:001253168700001
PM 38906834
DA 2024-11-01
ER

PT J
AU Cha, JH
   Lee, SH
   Yun, Y
   Choi, WH
   Koo, H
   Jung, SH
   Chae, HB
   Lee, DH
   Lee, SJ
   Jo, DH
   Kim, JH
   Song, JJ
   Chae, JH
   Lee, JH
   Park, J
   Kang, JY
   Bae, S
   Lee, SY
AF Cha, Ju Hyuen
   Lee, Seok-Hoon
   Yun, Yejin
   Choi, Won Hoon
   Koo, Hansol
   Jung, Sung Ho
   Chae, Ho Byung
   Lee, Dae Hee
   Lee, Seok Jae
   Jo, Dong Hyun
   Kim, Jeong Hun
   Song, Jae-Jin
   Chae, Jong-Hee
   Lee, Jun Ho
   Park, Jiho
   Kang, Jin Young
   Bae, Sangsu
   Lee, Sang-Yeon
TI Discovery of novel disease-causing mutation in <i>SSBP1 </i>and its correction using adenine base editor to improve mitochondrial function
SO MOLECULAR THERAPY NUCLEIC ACIDS
LA English
DT Article
ID mobility shift assay; genomic dna; replication; protein; model
AB Mutations in nuclear genes regulating mitochondrial DNA (mtDNA) replication are associated with mtDNA depletion syndromes. Using whole-genome sequencing, we identified fi ed a heterozygous mutation (c.272G>A:p.Arg91Gln) in single-stranded DNA-binding protein 1 (SSBP1), a crucial protein involved in mtDNA replisome. The proband manifested symptoms including sensorineural deafness, congenital cataract, optic atrophy, macular dystrophy, and myopathy. This mutation impeded multimer formation and DNA-binding affinity, leading to reduced efficiency of mtDNA replication, altered mitochondria dynamics, and compromised mitochondrial function. To correct this mutation, we tested two adenine base editor (ABE) variants on patient-derived fi broblasts. One variant, NG-Cas9-based ABE8e (NG-ABE8e), showed higher editing efficacy (<= 30%) and enhanced mitochondrial replication and function, despite off-target editing frequencies; however, risks from bystander editing were limited due to silent mutations and off-target sites in non-translated regions. The other variant, NG-Cas9-based ABE8eWQ (NG-ABE8eWQ), had a safer therapeutic profile with very few off-target effects, but this came at the cost of lower editing efficacy (<= 10% editing). Despite this, NG-ABE8eWQedited cells still restored replication and improved mtDNA copy number, which in turn recovery of compromised mitochondrial function. Taken together, base editing-based gene therapies may be a promising treatment for mitochondrial diseases, including those associated with SSBP1 mutations.
C1 [Cha, Ju Hyuen; Lee, Seok-Hoon; Yun, Yejin; Choi, Won Hoon; Jung, Sung Ho; Chae, Ho Byung; Lee, Jun Ho; Park, Jiho; Kang, Jin Young; Bae, Sangsu; Lee, Sang-Yeon] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea.
   [Lee, Seok-Hoon; Bae, Sangsu; Lee, Sang-Yeon] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.
   [Cha, Ju Hyuen; Lee, Seok-Hoon; Yun, Yejin; Choi, Won Hoon; Koo, Hansol; Bae, Sangsu] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea.
   [Lee, Dae Hee] CTCELLS Inc, Daejeon, South Korea.
   [Lee, Seok Jae; Kim, Jeong Hun] Seoul Natl Univ Hosp, Clin Res Inst, Fight Angiogenesis Related Blindness FARB Lab, Seoul, South Korea.
   [Lee, Seok Jae; Kim, Jeong Hun] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.
   [Jo, Dong Hyun] Seoul Natl Univ, Coll Med, Dept Anat & Cell Biol, Seoul, South Korea.
   [Song, Jae-Jin] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Otorhinolaryngol, Seongnam, South Korea.
   [Chae, Jong-Hee; Lee, Sang-Yeon] Seoul Natl Univ Hosp, Dept Genom Med, Seoul, South Korea.
   [Park, Jiho; Kang, Jin Young] Korea Adv Inst Sci & Technol, Dept Chem, Daejeon 34141, South Korea.
   [Bae, Sangsu] Seoul Natl Univ, Coll Med, Med Res Ctr, Genom Med Inst, Seoul, South Korea.
   [Lee, Sang-Yeon] Seoul Natl Univ, Med Res Ctr, Sensory Organ Res Inst, Seoul, South Korea.
C3 Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University (SNU)
RP Bae, S; Lee, SY (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea.; Bae, S; Lee, SY (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.
EM sbae7@snu.ac.kr; maru4843@hanmail.net
FU National Research Foundation (NRF) of Korea [2022R1C1C1003147, 2021M3A9H3015389, SRC-NRF2022R1A5A102641311]; Korean Fund for Regenerative Medicine (KFRM) [RS-2024-00332601]; SNUH Kun-hee Lee Child Cancer & Rare Disease Project [FP-2022-00001-004]; SNU Medicine grant [800-20230428]; KAIST UP Program
CR Amorim JA, 2022, NAT REV ENDOCRINOL, V18, P243, DOI 10.1038/s41574-021-00626-7
   Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048
   Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126
   Capps GJ, 2003, J THEOR BIOL, V221, P565, DOI 10.1006/jtbi.2003.3207
   Chaudhry A, 2020, AM J PHYSIOL-ENDOC M, V318, PE87, DOI 10.1152/ajpendo.00457.2019
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   Del Dotto V, 2020, J CLIN INVEST, V130, P108, DOI 10.1172/JCI128514
   Dunbar CE, 2018, SCIENCE, V359, P175, DOI 10.1126/science.aan4672
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Eustaquio T, 2018, EXP CELL RES, V373, P164, DOI 10.1016/j.yexcr.2018.10.009
   Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644
   Gupta R, 2023, NATURE, V620, P0, DOI 10.1038/s41586-023-06426-5
   Gustafson MA, 2021, DNA REPAIR, V107, P0, DOI 10.1016/j.dnarep.2021.103212
   Gustafson MA, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0221829
   Haapaniemi E, 2018, NAT MED, V24, P927, DOI 10.1038/s41591-018-0049-z
   Han KH, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0161756
   Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249
   Hwang GH, 2021, METHODS MOL BIOL, V2162, P23, DOI 10.1007/978-1-0716-0687-2_2
   Hwang GH, 2018, BMC BIOINFORMATICS, V19, P0, DOI 10.1186/s12859-018-2585-4
   Jeong YK, 2021, NAT BIOTECHNOL, V39, P1426, DOI 10.1038/s41587-021-00943-2
   Jiang LY, 2023, MOL THER, V31, P934, DOI 10.1016/j.ymthe.2023.02.001
   Jiang M, 2021, SCI ADV, V7, P0, DOI 10.1126/sciadv.abf8631
   Jo DH, 2023, MOL THER-NUCL ACIDS, V31, P16, DOI 10.1016/j.omtn.2022.11.021
   Kim HS, 2019, NAT BIOTECHNOL, V37, P1145, DOI 10.1038/s41587-019-0254-4
   Kim N, 2024, NAT BIOTECHNOL, V42, P0, DOI 10.1038/s41587-023-01792-x
   Kingwell K, 2022, NAT REV DRUG DISCOV, V21, P545, DOI 10.1038/d41573-022-00124-z
   Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044
   Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192
   Kullar PJ, 2018, BRAIN, V141, P55, DOI 10.1093/brain/awx295
   Kurt IC, 2021, NAT BIOTECHNOL, V39, P41, DOI 10.1038/s41587-020-0609-x
   Lee SY, 2020, DIAGNOSTICS, V10, P0, DOI 10.3390/diagnostics10090672
   Liu HT, 2008, BMC BIOTECHNOL, V8, P0, DOI 10.1186/1472-6750-8-91
   Novotny MV, 2023, BIORXIV, V0, P0, DOI DOI 10.1101/2023.07.28.551015
   OSullivan JDB, 2023, HEARING RES, V428, P0, DOI 10.1016/j.heares.2022.108660
   Piro-MÃ©gy C, 2020, J CLIN INVEST, V130, P143, DOI 10.1172/JCI128513
   Pla-Martin D, 2019, PLOS GENET, V15, P0, DOI 10.1371/journal.pgen.1008140
   Ream JA, 2016, ANAL BIOCHEM, V511, P36, DOI 10.1016/j.ab.2016.07.027
   Rees HA, 2018, NAT REV GENET, V19, P770, DOI 10.1038/s41576-018-0059-1
   Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Richter MF, 2020, NAT BIOTECHNOL, V38, P883, DOI 10.1038/s41587-020-0453-z
   Rusecka J, 2018, J APPL GENET, V59, P43, DOI 10.1007/s13353-017-0424-3
   Russell OM, 2020, CELL, V181, P168, DOI 10.1016/j.cell.2020.02.051
   Sabouny R, 2021, J CELL SCI, V134, P0, DOI 10.1242/jcs.258944
   Scheibye-Knudsen M, 2015, TRENDS CELL BIOL, V25, P158, DOI 10.1016/j.tcb.2014.11.002
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI 10.1038/nmeth.2019
   Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899
   Srivastava S, 2019, METABOLITES, V9, P0, DOI 10.3390/metabo9120301
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tong HW, 2023, NAT BIOTECHNOL, V41, P1080, DOI 10.1038/s41587-022-01595-6
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Vangipuram M, 2013, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/3779
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015
   Wojtaszek JL, 2023, NUCLEIC ACIDS RES, V51, P9716, DOI 10.1093/nar/gkad679
   Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153
   Zuccaro MV, 2020, CELL, V183, P1650, DOI 10.1016/j.cell.2020.10.025
NR 59
TC 0
Z9 0
U1 5
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2162-2531
EI 
J9 MOL THER NUCL ACIDS
JI Mol. Ther. Nucl. Acids
PD SEP 10
PY 2024
VL 35
IS 3
BP 
EP 
DI 10.1016/j.omtn.2024.102257
EA JUL 2024
PG 15
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA YH4K7
UT WOS:001267582500001
PM 39104869
DA 2024-11-01
ER

PT J
AU Sprason, C
   Tucker, T
   Clancy, D
AF Sprason, Charlotte
   Tucker, Trudy
   Clancy, David
TI MtDNA deletions and aging
SO FRONTIERS IN AGING
LA English
DT Review
DE aging; mitochondria; mitochondrial DNA deletions; mitochondrial DNA; mitochondrial dysfunction
ID mitochondrial-dna-deletion; point mutations; maternal inheritance; skeletal-muscle; direct repeats; human brain; disease; accumulation; mechanisms; genome
AB Aging is the major risk factor in most of the leading causes of mortality worldwide, yet its fundamental causes mostly remain unclear. One of the clear hallmarks of aging is mitochondrial dysfunction. Mitochondria are best known for their roles in cellular energy generation, but they are also critical biosynthetic and signaling organelles. They also undergo multiple changes with organismal age, including increased genetic errors in their independent, circular genome. A key group of studies looking at mice with increased mtDNA mutations showed that premature aging phenotypes correlated with increased deletions but not point mutations. This generated an interest in mitochondrial deletions as a potential fundamental cause of aging. However, subsequent studies in different models have yielded diverse results. This review summarizes the research on mitochondrial deletions in various organisms to understand their possible roles in causing aging while identifying the key complications in quantifying deletions across all models.
C1 [Sprason, Charlotte; Tucker, Trudy; Clancy, David] Univ Lancaster, Biomed & Life Sci, Lancaster, England.
C3 Lancaster University
RP Clancy, D (corresponding author), Univ Lancaster, Biomed & Life Sci, Lancaster, England.
EM d.clancy@lancaster.ac.uk
CR Abascal F, 2021, NATURE, V593, P405, DOI 10.1038/s41586-021-03477-4
   Alexe G, 2007, HUM GENET, V121, P347, DOI 10.1007/s00439-007-0330-6
   Allio R, 2017, MOL BIOL EVOL, V34, P2762, DOI 10.1093/molbev/msx197
   Ameur A, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002028
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Arai T, 2003, AGING CLIN EXP RES, V15, P1
   Arbeithuber B, 2020, PLOS BIOL, V18, P0, DOI 10.1371/journal.pbio.3000745
   Austad SN, 2016, CELL METAB, V23, P1022, DOI 10.1016/j.cmet.2016.05.019
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bilal E, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0002421
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Bratic A, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms9808
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Camus MF, 2012, CURR BIOL, V22, P1717, DOI 10.1016/j.cub.2012.07.018
   Cassano P, 2004, ANN NY ACAD SCI, V1019, P269, DOI 10.1196/annals.1297.045
   Chen Z, 2019, J GENET GENOMICS, V46, P201, DOI 10.1016/j.jgg.2019.03.009
   Cheng YW, 2019, RESPIR MED CASE REP, V28, P0, DOI 10.1016/j.rmcr.2019.100901
   Chevigny N, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21010328
   Chocron ES, 2019, BBA-MOL BASIS DIS, V1865, P285, DOI 10.1016/j.bbadis.2018.09.035
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Dabravolski SA, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23147863
   Dattani S, 2023, OUR WORLD IN DATA, V0, P0
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Filograna R, 2019, SCI ADV, V5, P0, DOI 10.1126/sciadv.aav9824
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   Gao J, 2016, CLIN LAB, V62, P689, DOI 10.7754/Clin.Lab.2015.150837
   Gemmell NJ, 2004, TRENDS ECOL EVOL, V19, P238, DOI 10.1016/j.tree.2004.02.002
   Gems D, 2021, AGEING RES REV, V70, P0, DOI 10.1016/j.arr.2021.101407
   Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Haroon S, 2018, CELL REP, V22, P3115, DOI 10.1016/j.celrep.2018.02.099
   Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Jiang M, 2017, CELL METAB, V26, P429, DOI 10.1016/j.cmet.2017.07.003
   Kauppila TES, 2018, P NATL ACAD SCI USA, V115, PE9620, DOI 10.1073/pnas.1721683115
   Khaidakov M, 2006, MECH AGEING DEV, V127, P808, DOI 10.1016/j.mad.2006.07.008
   Kowald A, 2013, AGING CELL, V12, P728, DOI 10.1111/acel.12098
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kraytsberg Y, 2009, AGING CELL, V8, P502, DOI 10.1111/j.1474-9726.2009.00484.x
   Lareau CA, 2021, NAT BIOTECHNOL, V39, P451, DOI 10.1038/s41587-020-0645-6
   Latorre-Pellicer A, 2019, CELL METAB, V30, P1120, DOI 10.1016/j.cmet.2019.09.007
   Lax NZ, 2011, NEUROSCIENTIST, V17, P645, DOI 10.1177/1073858411385469
   Lee William, 2023, NAT GENET, V55, P1632, DOI 10.1038/s41588-023-01505-9
   Liang P, 1997, DIABETES, V46, P920, DOI 10.2337/diabetes.46.5.920
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Liu Y, 2021, MOL THER-NUCL ACIDS, V23, P657, DOI 10.1016/j.omtn.2020.12.017
   LÃ³pez-Otin C, 2023, CELL, V186, P243, DOI 10.1016/j.cell.2022.11.001
   Ludwig LS, 2019, CELL, V176, P1325, DOI 10.1016/j.cell.2019.01.022
   Lujan SA, 2020, GENOME BIOL, V21, P0, DOI 10.1186/s13059-020-02138-5
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Maeda R, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-67686-z
   Matam K, 2014, MOL GENET GENOMICS, V289, P533, DOI 10.1007/s00438-014-0828-2
   Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974
   MELOV S, 1994, NUCLEIC ACIDS RES, V22, P1075, DOI 10.1093/nar/22.6.1075
   Melov S, 1999, NEUROBIOL AGING, V20, P565, DOI 10.1016/S0197-4580(99)00092-5
   Mikhailova A, 2019, BIORXIV, V0, PP603282, DOI 10.1101/603282
   Nagarajan-Radha V, 2020, PHILOS T R SOC B, V375, P0, DOI 10.1098/rstb.2019.0178
   Nido GS, 2018, NEUROBIOL AGING, V63, P120, DOI 10.1016/j.neurobiolaging.2017.10.024
   Rojansky R, 2016, ELIFE, V5, P0, DOI 10.7554/eLife.17896
   Ross JM, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep06569
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Rygiel KA, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep09906
   Samstag CL, 2018, PLOS GENET, V14, P0, DOI 10.1371/journal.pgen.1007805
   Sanchez-Contreras M, 2022, FRONT AGING-LAUSANNE, V2, P0, DOI 10.3389/fragi.2021.805126
   Sato M, 2013, BBA-MOL CELL RES, V1833, P1979, DOI 10.1016/j.bbamcr.2013.03.010
   Shokolenko Inna N, 2014, WORLD J EXP MED, V4, P46
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Valentine CC, 2020, P NATL ACAD SCI USA, V117, P33414, DOI 10.1073/pnas.2013724117
   Vandiver AR, 2022, MITOCHONDRION, V65, P176, DOI 10.1016/j.mito.2022.06.003
   Vecoli C, 2020, MUTAT RES-REV MUTAT, V784, P0, DOI 10.1016/j.mrrev.2020.108309
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Williams SL, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003990
   Xirocostas ZA, 2020, BIOL LETTERS, V16, P0, DOI 10.1098/rsbl.2019.0867
   Yui R, 2006, MUTAT RES-FUND MOL M, V594, P155, DOI 10.1016/j.mrfmmm.2005.08.003
   Yui R, 2003, GENES GENET SYST, V78, P245
NR 84
TC 0
Z9 0
U1 2
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 2673-6217
J9 FRONT AGING-LAUSANNE
JI Front. Aging
PD FEB 15
PY 2024
VL 5
IS 
BP 
EP 
DI 10.3389/fragi.2024.1359638
PG 13
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA JM6Z0
UT WOS:001173637000001
PM 38425363
DA 2024-11-01
ER

PT J
AU Somasundaram, I
   Jain, SM
   Blot-Chabaud, M
   Pathak, S
   Banerjee, A
   Rawat, S
   Sharma, NR
   Duttaroy, AK
AF Somasundaram, Indumathi
   Jain, Samatha M.
   Blot-Chabaud, Marcel
   Pathak, Surajit
   Banerjee, Antara
   Rawat, Sonali
   Sharma, Neeta Raj
   Duttaroy, Asim K.
TI Mitochondrial dysfunction and its association with age-related disorders
SO FRONTIERS IN PHYSIOLOGY
LA English
DT Review
DE mitochondrial dysfunction; mitochondrial DNA; ROS production; chromosomal aberrations; mitophagy
ID skeletal-muscle mitochondrial; oxidative stress; life-span; cellular senescence; antioxidant enzymes; dna mutations; apoptosis; autophagy; disease; health
AB Aging is a complex process that features a functional decline in many organelles. Various factors influence the aging process, such as chromosomal abnormalities, epigenetic changes, telomere shortening, oxidative stress, and mitochondrial dysfunction. Mitochondrial dysfunction significantly impacts aging because mitochondria regulate cellular energy, oxidative balance, and calcium levels. Mitochondrial integrity is maintained by mitophagy, which helps maintain cellular homeostasis, prevents ROS production, and protects against mtDNA damage. However, increased calcium uptake and oxidative stress can disrupt mitochondrial membrane potential and permeability, leading to the apoptotic cascade. This disruption causes increased production of free radicals, leading to oxidative modification and accumulation of mitochondrial DNA mutations, which contribute to cellular dysfunction and aging. Mitochondrial dysfunction, resulting from structural and functional changes, is linked to age-related degenerative diseases. This review focuses on mitochondrial dysfunction, its implications in aging and age-related disorders, and potential anti-aging strategies through targeting mitochondrial dysfunction. The figure shows the effect of mitochondrial dysfunction and mitophagy on stem cells leading to aging.
C1 [Somasundaram, Indumathi] Kolhapur Inst Technol Coll Engn, Biotechnol Engn, Dept Biotechnol Engn, Kolhapur, India.
   [Jain, Samatha M.; Pathak, Surajit; Banerjee, Antara] Chettinad Hosp & Res Inst, Chettinad Acad Res & Educ, Fac Allied Hlth Sci, Dept Biotechnol, Chennai, India.
   [Blot-Chabaud, Marcel] Aix Marseille Univ, C2VN, Marseille, France.
   [Rawat, Sonali] All India Inst Med Sci, DBT Ctr Excellence Stem Cell Res, Stem Cell Facil, New Delhi, India.
   [Sharma, Neeta Raj] Lovely Profess Univ, Sch Bioengn & Biosci, Phagwara, India.
   [Duttaroy, Asim K.] Univ Oslo, Inst Basic Med Sci, Fac Med, Dept Nutr, Oslo, Norway.
C3 Aix-Marseille Universite; All India Institute of Medical Sciences (AIIMS) New Delhi; Lovely Professional University; University of Oslo
RP Somasundaram, I (corresponding author), Kolhapur Inst Technol Coll Engn, Biotechnol Engn, Dept Biotechnol Engn, Kolhapur, India.; Pathak, S (corresponding author), Chettinad Hosp & Res Inst, Chettinad Acad Res & Educ, Fac Allied Hlth Sci, Dept Biotechnol, Chennai, India.; Duttaroy, AK (corresponding author), Univ Oslo, Inst Basic Med Sci, Fac Med, Dept Nutr, Oslo, Norway.
EM a.k.duttaroy@medisin.uio.no; drindumathisomasundaram@gmail.com; drsurajitpathak@care.edu.in
CR Agil A, 2015, J PINEAL RES, V59, P70, DOI 10.1111/jpi.12241
   Alberts B, 2002, MOLECULAR BIOLOGY OF THE CELL, V4th ed, P0
   Andreux PA, 2019, NAT METAB, V1, P595, DOI 10.1038/s42255-019-0073-4
   [Anonymous], 2020, WORLD POPULATION AGEING 2019. REPORT ST/ESA/SER.A/444), V0, P0
   Atayik MC, 2022, BIOGERONTOLOGY, V23, P401, DOI 10.1007/s10522-022-09973-y
   Bakula D, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.00239
   BalcÃ¡zar M, 2020, FRONT BIOENG BIOTECH, V8, P0, DOI 10.3389/fbioe.2020.00919
   Balmik AA, 2018, J ALZHEIMERS DIS, V62, P1481, DOI 10.3233/JAD-170900
   Bar-Ziv R, 2020, EMBO REP, V21, P0, DOI 10.15252/embr.202050094
   Basu A, 2022, PHARMACOL THERAPEUT, V230, P0, DOI 10.1016/j.pharmthera.2021.107943
   Benz CC, 2008, NAT REV CANCER, V8, P875, DOI 10.1038/nrc2522
   Bernardini JP, 2017, ONCOGENE, V36, P1315, DOI 10.1038/onc.2016.302
   Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005
   Boos F, 2020, TRENDS CELL BIOL, V30, P241, DOI 10.1016/j.tcb.2019.12.003
   BOWLING AC, 1995, LIFE SCI, V56, P1151, DOI 10.1016/0024-3205(95)00055-B
   Bratic A, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms9808
   Bratic I, 2010, BBA-BIOENERGETICS, V1797, P961, DOI 10.1016/j.bbabio.2010.01.004
   Bravo-San Pedro JM, 2017, CIRC RES, V120, P1812, DOI 10.1161/CIRCRESAHA.117.311082
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Burtscher J, 2023, AGING CELL, V22, P0, DOI 10.1111/acel.13770
   Byun HO, 2012, EXP CELL RES, V318, P1808, DOI 10.1016/j.yexcr.2012.04.012
   Camell CD, 2021, SCIENCE, V373, P0, DOI 10.1126/science.abe4832
   Camplejohn RS, 2003, BRIT J CANCER, V88, P487, DOI 10.1038/sj.bjc.6600767
   Pelegay EC, 2019, ADV EXP MED BIOL, V1134, P89, DOI 10.1007/978-3-030-12668-1_5
   Cedikova M, 2016, PHYSIOL RES, V65, PS519, DOI 10.33549/physiolres.933538
   Chapman J, 2019, FEBS LETT, V593, P1566, DOI 10.1002/1873-3468.13498
   CHATTERJEE A, 1967, TETRAHEDRON, V23, P1769, DOI 10.1016/S0040-4020(01)82575-8
   Chen G, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.00200
   Chen HS, 2015, MOL CELL, V59, P719, DOI 10.1016/j.molcel.2015.07.011
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chistiakov DA, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/238463
   Cho SJ, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms24087628
   Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076
   Cloonan SM, 2020, EUR RESPIR REV, V29, P0, DOI 10.1183/16000617.0165-2020
   Cohen AA, 2018, BBA-MOL BASIS DIS, V1864, P2680, DOI 10.1016/j.bbadis.2017.05.028
   Conte M, 2019, J GERONTOL A-BIOL, V74, P600, DOI 10.1093/gerona/gly153
   Costello MJ, 2013, EXP EYE RES, V116, P141, DOI 10.1016/j.exer.2013.08.017
   Crane JD, 2010, J GERONTOL A-BIOL, V65, P119, DOI 10.1093/gerona/glp179
   Cui Hang, 2012, J SIGNAL TRANSDUCT, V2012, P646354, DOI 10.1155/2012/646354
   Davalli P, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/2389523
   Decout A, 2021, NAT REV IMMUNOL, V21, P548, DOI 10.1038/s41577-021-00524-z
   Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031
   Dziechciaz M, 2014, ANN AGR ENV MED, V21, P835, DOI 10.5604/12321966.1129943
   Eberle J, 2008, CURR GENOMICS, V9, P409, DOI 10.2174/138920208785699571
   Edgar D, 2009, AGING-US, V1, P1028, DOI 10.18632/aging.100109
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Evangelou K, 2023, PHYSIOL REV, V103, P0, DOI 10.1152/physrev.00007.2022
   Fivenson EM, 2017, NEUROCHEM INT, V109, P202, DOI 10.1016/j.neuint.2017.02.007
   Ganley IG, 2022, J CELL SCI, V135, P0, DOI 10.1242/jcs.259748
   Gioscia-Ryan RA, 2016, AGING-US, V8, P2897, DOI 10.18632/aging.101099
   Greaves LC, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004620
   Greenhalgh DG, 1998, INT J BIOCHEM CELL B, V30, P1019, DOI 10.1016/S1357-2725(98)00058-2
   Hoshino A, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3308
   Indo HP, 2015, J CLIN BIOCHEM NUTR, V56, P1, DOI 10.3164/jcbn.14-42
   Iwashita M, 2007, EUR J PHARMACOL, V570, P38, DOI 10.1016/j.ejphar.2007.05.073
   Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759
   Jiang YH, 2020, FRONT PHARMACOL, V11, P0, DOI 10.3389/fphar.2020.00512
   JimÃ©nez-Loygorri JI, 2024, NAT COMMUN, V15, P0, DOI 10.1038/s41467-024-45044-1
   Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Khan N, 2013, ANTIOXID REDOX SIGN, V19, P151, DOI 10.1089/ars.2012.4901
   Kietzmann T, 2017, BRIT J PHARMACOL, V174, P1533, DOI 10.1111/bph.13792
   Kizhakekuttu TJ, 2010, CARDIOVASC THER, V28, Pe20, DOI 10.1111/j.1755-5922.2010.00137.x
   Kopustinskiene DM, 2021, PHARMACEUTICS, V13, P0, DOI 10.3390/pharmaceutics13020129
   Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793
   Kowaltowski AJ, 2000, BRAZ J MED BIOL RES, V33, P241, DOI 10.1590/S0100-879X2000000200014
   Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024
   Kurosaka K, 2003, J IMMUNOL, V171, P4672, DOI 10.4049/jimmunol.171.9.4672
   Kwak S, 2014, INFLAMM RES, V63, P779, DOI 10.1007/s00011-014-0750-4
   Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486
   Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009
   Lee SM, 2012, BIOGERONTOLOGY, V13, P525, DOI 10.1007/s10522-012-9397-0
   Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200
   Lemasters JJ, 2005, GASTROENTEROLOGY, V129, P351, DOI 10.1053/j.gastro.2005.06.006
   Levine B, 2019, CELL, V176, P11, DOI 10.1016/j.cell.2018.09.048
   Li Z, 2021, BIOGERONTOLOGY, V22, P165, DOI 10.1007/s10522-021-09910-5
   Liao ZH, 2021, BIOMEDICINES, V9, P0, DOI 10.3390/biomedicines9121769
   Liu JP, 2014, CLIN EXP PHARMACOL P, V41, P445, DOI 10.1111/1440-1681.12247
   Liu L, 2002, AGING CELL, V1, P40, DOI 10.1046/j.1474-9728.2002.00004.x
   Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x
   LÃ³pez-OtÃ­n C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842
   Madreiter-Sokolowski CT, 2018, GENES-BASEL, V9, P0, DOI 10.3390/genes9030165
   Mahmoud YI, 2016, BIOTECH HISTOCHEM, V91, P86, DOI 10.3109/10520295.2015.1076578
   Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139
   Markovic ZS, 2011, J MOL MODEL, V17, P2575, DOI 10.1007/s00894-010-0942-y
   Martini H, 2023, FEBS J, V290, P1186, DOI 10.1111/febs.16361
   Marycz K, 2016, OXID MED CELL LONGEV, V2016, P0, DOI 10.1155/2016/4710326
   Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011
   Mitchell SJ, 2015, ANNU REV ANIM BIOSCI, V3, P283, DOI 10.1146/annurev-animal-022114-110829
   Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149
   Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08
   Molenaars M, 2020, CELL METAB, V31, P549, DOI 10.1016/j.cmet.2020.01.011
   Mondello C, 2010, SUBCELL BIOCHEM, V50, P307, DOI 10.1007/978-90-481-3471-7_16
   Morita M, 2017, MOL CELL, V67, P922, DOI 10.1016/j.molcel.2017.08.013
   Morita M, 2015, CELL CYCLE, V14, P473, DOI 10.4161/15384101.2014.991572
   Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001
   Mortensen M, 2010, CELL CYCLE, V9, P1901, DOI 10.4161/cc.9.10.11603
   Mottis A, 2019, SCIENCE, V366, P827, DOI 10.1126/science.aax3768
   Nehlin JO, 2023, ADV PROTEIN CHEM STR, V136, P217, DOI 10.1016/bs.apcsb.2023.02.020
   Nicolson GL, 2017, BBA-BIOMEMBRANES, V1859, P1704, DOI 10.1016/j.bbamem.2017.04.013
   Nicolson GL, 2014, ALTERN THER HEALTH M, V20, P18
   Nilsson MI, 2019, BIOLOGY-BASEL, V8, P0, DOI 10.3390/biology8020040
   Nissanka N, 2018, FEBS LETT, V592, P728, DOI 10.1002/1873-3468.12956
   Norat P, 2020, NPJ REGEN MED, V5, P0, DOI 10.1038/s41536-020-00107-x
   Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169
   Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2
   Palomera-Avalos V, 2017, MOL NEUROBIOL, V54, P1661, DOI 10.1007/s12035-016-9770-0
   PapÃ¡ckovÃ¡ Z, 2014, PHYSIOL RES, V63, P409, DOI 10.33549/physiolres.932684
   Paraskevaidi M, 2017, MUTAGENESIS, V32, P335, DOI 10.1093/mutage/gew058
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Passos JF, 2010, MOL SYST BIOL, V6, P0, DOI 10.1038/msb.2010.5
   PÃ©rez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x
   Pollack M, 2001, J GERONTOL A-BIOL, V56, PB475, DOI 10.1093/gerona/56.11.B475
   Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003
   Rai SN, 2020, MOL NEUROBIOL, V57, P3075, DOI 10.1007/s12035-020-01945-y
   Ramos ES, 2019, PLOS GENET, V15, P0, DOI 10.1371/journal.pgen.1008085
   Ravindran J, 2011, APOPTOSIS, V16, P145, DOI 10.1007/s10495-010-0554-0
   Rinnerthaler M, 2015, BIOMOLECULES, V5, P545, DOI 10.3390/biom5020545
   Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow
   Ross JM, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep06569
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Roy M, 2015, CURR OPIN CELL BIOL, V33, P111, DOI 10.1016/j.ceb.2015.02.001
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Saccon TD, 2021, J GERONTOL A-BIOL, V76, P1895, DOI 10.1093/gerona/glab002
   Salabei JK, 2013, REDOX BIOL, V1, P542, DOI 10.1016/j.redox.2013.10.011
   Sato M, 2013, BBA-MOL CELL RES, V1833, P1979, DOI 10.1016/j.bbamcr.2013.03.010
   Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006
   Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y
   Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445
   Shao YD, 2022, FRONT PHARMACOL, V13, P0, DOI 10.3389/fphar.2022.937502
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Shum LC, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0155709
   Sonawane SK, 2019, ARCH BIOCHEM BIOPHYS, V675, P0, DOI 10.1016/j.abb.2019.108119
   Srivastava S, 2017, GENES-BASEL, V8, P0, DOI 10.3390/genes8120398
   Stancu Andreea L, 2015, DISCOVERIES (CRAIOVA), V3, Pe53, DOI 10.15190/d.2015.45
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Tan DX, 2016, INT J MOL SCI, V17, P0, DOI 10.3390/ijms17122124
   Taniguchi H, 2016, J CLIN ENDOCR METAB, V101, P190, DOI 10.1210/jc.2015-3308
   Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598
   Tower J, 2015, AGEING RES REV, V23, P90, DOI 10.1016/j.arr.2015.04.002
   Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TURK PW, 1995, CARCINOGENESIS, V16, P1253, DOI 10.1093/carcin/16.5.1253
   Tzameli I, 2012, TRENDS ENDOCRIN MET, V23, P417, DOI 10.1016/j.tem.2012.07.008
   van der Rijt S, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.594416
   van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Wall CE, 2019, CELL REP, V29, P3280, DOI 10.1016/j.celrep.2019.10.130
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wang J, 2020, ANGIOGENESIS, V23, P299, DOI 10.1007/s10456-020-09720-2
   Wang L, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-74102-z
   Wang R, 2021, SPECTROCHIM ACTA A, V253, P0, DOI 10.1016/j.saa.2021.119605
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Wu Y, 2022, FRONT ENDOCRINOL, V12, P0, DOI 10.3389/fendo.2021.808120
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Yan LJ, 2014, REDOX BIOL, V2, P165, DOI 10.1016/j.redox.2014.01.002
   Yang SS, 2020, MOL CELL BIOCHEM, V467, P1, DOI 10.1007/s11010-019-03667-9
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753
   Yoon YS, 2003, J BIOL CHEM, V278, P51577, DOI 10.1074/jbc.M308489200
   Youm YH, 2016, P NATL ACAD SCI USA, V113, P1026, DOI 10.1073/pnas.1514511113
   Yousefzadeh MJ, 2018, EBIOMEDICINE, V36, P18, DOI 10.1016/j.ebiom.2018.09.015
   Zhang HB, 2018, DEVELOPMENT, V145, P0, DOI 10.1242/dev.143420
   Zhang H, 2019, AM J PHYSIOL-ENDOC M, V316, PE829, DOI 10.1152/ajpendo.00439.2018
   Zhou ZX, 2022, AGEING RES REV, V81, P0, DOI 10.1016/j.arr.2022.101702
   Zhu JH, 2013, AUTOPHAGY, V9, P1663, DOI 10.4161/auto.24135
   Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287
   Zimmermann A, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.656201
   Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013
NR 176
TC 0
Z9 0
U1 9
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 1664-042X
J9 FRONT PHYSIOL
JI Front. Physiol.
PD JUL 2
PY 2024
VL 15
IS 
BP 
EP 
DI 10.3389/fphys.2024.1384966
PG 13
WC Physiology
SC Physiology
GA YU9K5
UT WOS:001271115000001
PM 39015222
DA 2024-11-01
ER

PT J
AU Dong, HB
   Guo, W
   Yue, RC
   Sun, XG
   Zhou, ZX
AF Dong, Haibo
   Guo, Wei
   Yue, Ruichao
   Sun, Xinguo
   Zhou, Zhanxiang
TI Nuclear Nicotinamide Adenine Dinucleotide Deficiency by Nmnat1 Deletion Impaired Hepatic Insulin Signaling, Mitochondrial Function, and Hepatokine Expression in Mice Fed a High-Fat Diet
SO LABORATORY INVESTIGATION
LA English
DT Article
DE glucose metabolism; hepatokines; insulin resistance; mitochondrial dysfunction; metabolic syndrome; NAD plus
ID metabolic syndrome; nad(+) metabolism; liver; disease; pathophysiology; biosynthesis; sirtuins; muscle; sirt1
AB Metabolic syndrome (MetS) is a worldwide challenge that is closely associated with obesity, nonalcoholic liver disease, insulin resistance, and type 2 diabetes. Boosting nicotinamide adenine dinucleotide (NAD+) presents great potential in preventing MetS. However, the function of nuclear NAD+ in the development of MetS remains poorly understood. In this study, hepatocyte-specific Nmnat1 knockout mice were used to determine a possible link between nuclear NAD+ and high-fat diet (HFD)-induced MetS. We found that Nmnat1 knockout significantly reduced hepatic nuclear NAD+ levels but did not exacerbate HFD-induced obesity and hepatic triglycerides accumulation. Interestingly, loss of Nmnat1 caused insulin resistance. Further analysis revealed that Nmnat1 deletion promoted gluconeogenesis but inhibited glycogen synthesis in the liver. Moreover, Nmnat1 deficiency induced mitochondrial dysfunction by decreasing mitochondrial DNA (mtDNA)-encoded complexes I and IV, suppressing mtDNA replication and mtRNA transcription and reducing mtDNA copy number. In addition, Nmnat1 depletion affected the expression of hepatokines in the liver, particularly downregulating the expression of follistatin. These findings highlight the importance of nuclear NAD+ in maintaining insulin sensitivity and provide insights into the mechanisms underlying HFD-induced insulin resistance. (c) 2024 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights reserved.
C1 [Dong, Haibo; Guo, Wei; Yue, Ruichao; Sun, Xinguo; Zhou, Zhanxiang] Univ N Carolina, Ctr Translat Biomed Res, North Carolina Res Campus, Kannapolis, NC 27412 USA.
   [Zhou, Zhanxiang] Univ N Carolina, Dept Nutr, Greensboro, NC 27412 USA.
C3 University of North Carolina; University of North Carolina; University of North Carolina Greensboro
RP Zhou, ZX (corresponding author), Univ N Carolina, Ctr Translat Biomed Res, North Carolina Res Campus, Kannapolis, NC 27412 USA.; Zhou, ZX (corresponding author), Univ N Carolina, Dept Nutr, Greensboro, NC 27412 USA.
EM z_zhou@uncg.edu
FU National Institutes of Health [R01AA018844, R01AA020212]
CR Amjad S, 2021, MOL METAB, V49, P0, DOI 10.1016/j.molmet.2021.101195
   Arenillas JF, 2007, STROKE, V38, P2196, DOI 10.1161/STROKEAHA.106.480004
   Cambronne XA, 2020, TRENDS BIOCHEM SCI, V45, P858, DOI 10.1016/j.tibs.2020.05.010
   CantÃ³ C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023
   Carafa V, 2016, CLIN EPIGENETICS, V8, P0, DOI 10.1186/s13148-016-0224-3
   Charni-Natan M, 2020, STAR PROTOC, V1, P0, DOI 10.1016/j.xpro.2020.100086
   Covarrubias AJ, 2021, NAT REV MOL CELL BIO, V22, P119, DOI 10.1038/s41580-020-00313-x
   Dall M, 2021, J BIOL CHEM, V297, P0, DOI 10.1016/j.jbc.2021.101388
   Ding RB, 2017, INT J BIOL SCI, V13, P852, DOI 10.7150/ijbs.19370
   Dong HB, 2021, CELL MOL GASTROENTER, V12, P793, DOI 10.1016/j.jcmgh.2021.05.013
   Eblimit A, 2018, EXP EYE RES, V173, P32, DOI 10.1016/j.exer.2018.04.010
   Elhassan YS, 2017, J ENDOCR SOC, V1, P816, DOI 10.1210/js.2017-00092
   Ennequin G, 2019, AM J PHYSIOL-ENDOC M, V317, PE11, DOI 10.1152/ajpendo.00433.2018
   Fan L, 2020, J DIABETES INVEST, V11, P1403, DOI 10.1111/jdi.13303
   Frederick DW, 2015, J BIOL CHEM, V290, P1546, DOI 10.1074/jbc.M114.579565
   Gao P, 2014, J MOL MED, V92, P347, DOI 10.1007/s00109-013-1111-4
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Han XQ, 2019, J CACHEXIA SARCOPENI, V10, P1241, DOI 10.1002/jcsm.12474
   Holper L, 2019, NEUROPSYCHOPHARMACOL, V44, P837, DOI 10.1038/s41386-018-0090-0
   Iqbal T, 2022, BIOCHEM BIOPH RES CO, V636, P89, DOI 10.1016/j.bbrc.2022.10.072
   Jensen-Cody SO, 2021, MOL METAB, V44, P0, DOI 10.1016/j.molmet.2020.101138
   Kane AE, 2018, CIRC RES, V123, P868, DOI 10.1161/CIRCRESAHA.118.312498
   Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791
   Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472
   Meex RCR, 2017, NAT REV ENDOCRINOL, V13, P508, DOI 10.1038/nrendo.2017.56
   Mukherjee S, 2017, HEPATOLOGY, V65, P616, DOI 10.1002/hep.28912
   Nassir F, 2016, WORLD J GASTROENTERO, V22, P10084, DOI 10.3748/wjg.v22.i46.10084
   North BJ, 2004, GENOME BIOL, V5, P0, DOI 10.1186/gb-2004-5-5-224
   Rochlani Y, 2017, THER ADV CARDIO DIS, V11, P215, DOI 10.1177/1753944717711379
   Roden M, 2008, WIEN MED WOCHENSCHR, V158, P558, DOI 10.1007/s10354-008-0595-y
   Saklayen MG, 2018, CURR HYPERTENS REP, V20, P0, DOI 10.1007/s11906-018-0812-z
   Sangwung P, 2020, ENDOCRINOLOGY, V161, P0, DOI 10.1210/endocr/bqaa017
   Sergi D, 2019, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.00532
   Stott NL, 2020, NUTRIENTS, V12, P0, DOI 10.3390/nu12123650
   Stromsdorfer KL, 2016, CELL REP, V16, P1851, DOI 10.1016/j.celrep.2016.07.027
   Takamura T, 2008, OBESITY, V16, P2601, DOI 10.1038/oby.2008.419
   Tao RY, 2018, NAT MED, V24, P1058, DOI 10.1038/s41591-018-0048-0
   Tong JL, 2022, DIABET METAB SYND OB, V15, P3285, DOI 10.2147/DMSO.S380053
   Trammell SAJ, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep26933
   Wang LF, 2017, LIPIDS HEALTH DIS, V16, P0, DOI 10.1186/s12944-017-0464-z
   Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528
   Xiao WS, 2018, ANTIOXID REDOX SIGN, V28, P251, DOI 10.1089/ars.2017.7216
   Yang Y, 2016, BBA-PROTEINS PROTEOM, V1864, P1787, DOI 10.1016/j.bbapap.2016.06.014
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Zhou CC, 2016, BRIT J PHARMACOL, V173, P2352, DOI 10.1111/bph.13513
NR 45
TC 3
Z9 3
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0023-6837
EI 1530-0307
J9 LAB INVEST
JI Lab. Invest.
PD MAR 15
PY 2024
VL 104
IS 3
BP 
EP 
DI 10.1016/j.labinv.2024.100329
EA FEB 2024
PG 10
WC Medicine, Research & Experimental; Pathology
SC Research & Experimental Medicine; Pathology
GA LH4W8
UT WOS:001185895600001
PM 38237740
DA 2024-11-01
ER

PT J
AU TauchmannovÃ¡, K
   PecinovÃ¡, A
   Houstek, J
   Mracek, T
AF Tauchmannova, Katerina
   Pecinova, Alena
   Houstek, Josef
   Mracek, Tomas
TI Variability of Clinical Phenotypes Caused by Isolated Defects of Mitochondrial ATP Synthase
SO PHYSIOLOGICAL RESEARCH
LA English
DT Review
DE Mitochondrial diseases; ATP synthase; Nuclear DNA; Mitochondrial DNA; TMEM70
ID complex-v deficiency; hereditary spastic paraplegia; neurogenic muscle weakness; cytochrome-c-oxidase; onset leigh-syndrome; dna t8993g mutation; aciduria type-iv; retinitis-pigmentosa; 3-methylglutaconic aciduria; 6 gene
AB Disorders of ATP synthase, the key enzyme in mitochondrial energy supply, belong to the most severe metabolic diseases, manifesting as early-onset mitochondrial encephalocardiomyopathies. Since ATP synthase subunits are encoded by both mitochondrial and nuclear DNA, pathogenic variants can be found in either genome. In addition, the biogenesis of ATP synthase requires several assembly factors, some of which are also hotspots for pathogenic variants. While variants of MT-ATP6 and TMEM70 represent the most common cases of mitochondrial and nuclear DNA mutations respectively, the advent of nextgeneration sequencing has revealed new pathogenic variants in a number of structural genes and TMEM70, sometimes with truly reported cases and discuss biochemical mechanisms, through enzyme biogenesis and function.
C1 [Tauchmannova, Katerina; Pecinova, Alena; Houstek, Josef; Mracek, Tomas] Czech Acad Sci, Inst Physiol, Lab Bioenerget, Prague, Czech Republic.
C3 Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences
RP Mracek, T (corresponding author), Czech Acad Sci, Inst Physiol, Lab Bioenerget, Prague, Czech Republic.
EM tomas.mracek@fgu.cas.cz
FU National Institute for Research of Metabolic and Cardiovascular Diseases [LX22NPO5104]; European Union - Next Generation EU; Czech Science Foundation [GACR 21-18993S]; Czech Health Research Council [NU21-07-00550]; Institute of Physiology of the Czech Academy of Sciences [RVO:67985823]
CR Abicht A, 2018, MOL GENET GENOM MED, V6, P1188, DOI 10.1002/mgg3.500
   Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P4211, DOI 10.1167/iovs.06-0295
   Adema AY, 2016, NETH J MED, V74, P455
   Akagi M, 2002, NEUROMUSCULAR DISORD, V12, P53, DOI 10.1016/S0960-8966(01)00242-5
   Al-Kafaji G, 2022, PLOS ONE, V17, P0, DOI 10.1371/journal.pone.0263606
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Ardissone A, 2023, EUR J NEUROL, V30, P2079, DOI 10.1111/ene.15814
   Atay Z, 2013, GENE, V515, P197, DOI 10.1016/j.gene.2012.11.044
   AurÃ© K, 2013, NEUROLOGY, V81, P1810, DOI 10.1212/01.wnl.0000436067.43384.0b
   Baban A, 2020, AM J MED GENET A, V182, P64, DOI 10.1002/ajmg.a.61383
   Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177
   Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   Barca E, 2018, HUM MOL GENET, V27, P3305, DOI 10.1093/hmg/ddy231
   Bardakjian T, 2019, J NEUROMUSCULAR DIS, V6, P385, DOI 10.3233/JND-190400
   Bergs PMJ, 2022, MOL GENET METAB, V135, P102, DOI 10.1016/j.ymgme.2021.12.010
   Berhe S, 2018, HAEMATOLOGICA, V103, PE561, DOI 10.3324/haematol.2018.199109
   Blanco-Grau A, 2013, GENES BRAIN BEHAV, V12, P812, DOI 10.1111/gbb.12089
   Braczynski AK, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/462592
   Brambilla A, 2020, ORPHANET J RARE DIS, V15, P0, DOI 10.1186/s13023-020-01466-w
   Brum M, 2014, CASE REP NEUROL MED, V2014, P0, DOI 10.1155/2014/701761
   Bugiardini E, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000381
   Burrage LC, 2014, MOL GENET METAB, V113, P207, DOI 10.1016/j.ymgme.2014.06.004
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   Cameron JM, 2011, MITOCHONDRION, V11, P191, DOI 10.1016/j.mito.2010.09.008
   Campos Y, 1997, NEUROLOGY, V49, P595, DOI 10.1212/WNL.49.2.595
   Capiau S, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11030489
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Carroll CJ, 2014, BRIT J PHARMACOL, V171, P1837, DOI 10.1111/bph.12469
   Carroll J, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2100558118
   Carrozzo R, 2001, NEUROLOGY, V56, P687, DOI 10.1212/WNL.56.5.687
   Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637
   Catteruccia M, 2014, MOL GENET METAB, V111, P353, DOI 10.1016/j.ymgme.2014.01.001
   Childs AM, 2007, NEUROPEDIATRICS, V38, P313, DOI 10.1055/s-2008-1065355
   Chinnery PF, 2000, BRAIN, V123, P82, DOI 10.1093/brain/123.1.82
   CizkovÃ¡ A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Claeys KG, 2016, MUSCLE NERVE, V54, P328, DOI 10.1002/mus.25125
   CortÃ©s-HernÃ¡ndez P, 2007, J BIOL CHEM, V282, P1051, DOI 10.1074/jbc.M606828200
   Craig K, 2007, J MED GENET, V44, P797, DOI 10.1136/jmg.2007.052902
   DAurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   Dautant A, 2018, FRONT PHYSIOL, V9, P0, DOI 10.3389/fphys.2018.00329
   Dawod PGA, 2020, GENES-BASEL, V11, P0, DOI 10.3390/genes11091037
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   de Mello AH, 2018, LIFE SCI, V192, P26, DOI 10.1016/j.lfs.2017.11.019
   Del Dotto V, 2024, INT J MOL SCI, V25, P0, DOI 10.3390/ijms25042239
   DEMEIRLEIR L, 1995, PEDIATR NEUROL, V13, P242, DOI 10.1016/0887-8994(95)00184-H
   DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319
   DIMAURO S, 1976, J NEUROL SCI, V27, P217, DOI 10.1016/0022-510X(76)90063-0
   DiMauro S, 2007, BIOSCIENCE REP, V27, P125, DOI 10.1007/s10540-007-9041-4
   DiMauro S, 2011, J INHERIT METAB DIS, V34, P261, DOI 10.1007/s10545-010-9082-x
   Diodato D, 2015, JIMD REP, V15, P71, DOI 10.1007/8904_2014_300
   Duno M, 2013, GENE, V515, P372, DOI 10.1016/j.gene.2012.12.066
   Vazquez-Memije ME, 2009, J CELL BIOCHEM, V106, P878, DOI 10.1002/jcb.22055
   Fragaki K, 2019, MOL GENET METAB REP, V21, P0, DOI 10.1016/j.ymgmr.2019.100543
   FRYER A, 1994, ARCH DIS CHILD, V71, P419, DOI 10.1136/adc.71.5.419
   Galber C, 2021, LIFE-BASEL, V11, P0, DOI 10.3390/life11040325
   Ganapathi M, 2022, J INHERIT METAB DIS, V45, P996, DOI 10.1002/jimd.12526
   Ganetzky RD, 2019, HUM MUTAT, V40, P499, DOI 10.1002/humu.23723
   Ganetzky RD, 2022, NEW ENGL J MED, V387, P1395, DOI 10.1056/NEJMoa2202949
   Gilbert DL, 2009, MOVEMENT DISORD, V24, P364, DOI 10.1002/mds.22363
   Giorgio V, 2019, BRIT J PHARMACOL, V176, P4247, DOI 10.1111/bph.14513
   Green DW, 2000, BBA-BIOENERGETICS, V1458, P343, DOI 10.1016/S0005-2728(00)00085-2
   Harrington JS, 2023, PHYSIOL REV, V103, P2349, DOI 10.1152/physrev.00058.2021
   He JY, 2018, P NATL ACAD SCI USA, V115, P2988, DOI 10.1073/pnas.1722086115
   He JY, 2017, P NATL ACAD SCI USA, V114, P3409, DOI 10.1073/pnas.1702357114
   HejzlarovÃ¡ K, 2015, BIOCHEM J, V466, P601, DOI 10.1042/BJ20141462
   Hirono K, 2019, CLIN CASE REP, V7, P553, DOI 10.1002/ccr3.2050
   HOLME E, 1992, PEDIATR RES, V32, P731, DOI 10.1203/00006450-199212000-00022
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Honzik T, 2013, MOL GENET METAB, V108, P102, DOI 10.1016/j.ymgme.2012.11.002
   Honzik T, 2012, J INHERIT METAB DIS, V35, P749, DOI 10.1007/s10545-011-9440-3
   HonzÃ­k T, 2010, ARCH DIS CHILD, V95, P296, DOI 10.1136/adc.2009.168096
   Houstek J, 1999, HUM MOL GENET, V8, P1967
   HOUSTEK J, 1995, BBA-MOL BASIS DIS, V1271, P349, DOI 10.1016/0925-4439(95)00063-A
   Hu CP, 2020, EUR J MED GENET, V63, P0, DOI 10.1016/j.ejmg.2020.103898
   Imai A, 2016, INT J CARDIOL, V207, P203, DOI 10.1016/j.ijcard.2016.01.026
   Imai-Okazaki A, 2019, INT J CARDIOL, V279, P115, DOI 10.1016/j.ijcard.2019.01.017
   Isohanni P, 2018, NEUROGENETICS, V19, P49, DOI 10.1007/s10048-018-0537-9
   Jackson CB, 2017, EUR J MED GENET, V60, P345, DOI 10.1016/j.ejmg.2017.04.006
   Jesina P, 2004, BIOCHEM J, V383, P561, DOI 10.1042/BJ20040407
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Jonckheere AI, 2013, BRAIN, V136, P1544, DOI 10.1093/brain/awt086
   Jonckheere AI, 2011, MITOCHONDRION, V11, P954, DOI 10.1016/j.mito.2011.08.012
   Jones DE, 2021, CLIN CHIM ACTA, V522, P96, DOI 10.1016/j.cca.2021.08.016
   Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2
   Knight KM, 2020, MITOCHONDRION, V55, P8, DOI 10.1016/j.mito.2020.08.009
   Kobayashi R, 2020, P NATL ACAD SCI USA, V117, P1447, DOI 10.1073/pnas.1909407117
   KovalcÃ­kovÃ¡ J, 2019, FASEB J, V33, P14103, DOI 10.1096/fj.201900685RR
   KÃ¼hlbrandt W, 2019, ANNU REV BIOCHEM, V88, P515, DOI 10.1146/annurev-biochem-013118-110903
   Kumar M, 2010, MOL VIS, V16, P782
   KytÃ¶vuori L, 2016, J NEUROL, V263, P2188, DOI 10.1007/s00415-016-8249-2
   Lai YZ, 2023, MOL CELL, V83, P2137, DOI 10.1016/j.molcel.2023.04.029
   LAMMINEN T, 1995, AM J HUM GENET, V56, P1238
   Larson AA, 2019, MITOCHONDRION, V44, P58, DOI 10.1016/j.mito.2018.01.001
   Lemoine S, 2018, AM J KIDNEY DIS, V71, P754, DOI 10.1053/j.ajkd.2017.09.020
   Li Y, 2017, PLOS COMPUT BIOL, V13, P0, DOI 10.1371/journal.pcbi.1005653
   Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40
   Lines MA, 2021, EUR J HUM GENET, V29, P1719, DOI 10.1038/s41431-021-00956-0
   LÃ³pez-Gallardo E, 2009, J MED GENET, V46, P64, DOI 10.1136/jmg.2008.060616
   LÃ³pez-Gallardo E, 2014, HUM MOL GENET, V23, P6191, DOI 10.1093/hmg/ddu339
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Mackay L, 2023, AM J MED GENET A, V191, P1366, DOI 10.1002/ajmg.a.63131
   Magner M, 2015, J INHERIT METAB DIS, V38, P417, DOI 10.1007/s10545-014-9774-8
   Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254
   Mkaouar-Rebai E, 2009, PEDIATR NEUROL, V40, P437, DOI 10.1016/j.pediatrneurol.2009.01.004
   Morava E, 2006, AM J MED GENET A, V140A, P863, DOI 10.1002/ajmg.a.31194
   Mordel P, 2017, BIOCHEM BIOPH RES CO, V494, P133, DOI 10.1016/j.bbrc.2017.10.066
   Mori M, 2014, JIMD REP, V17, P47, DOI 10.1007/8904_2014_332
   Moslemi AR, 2005, NEUROPEDIATRICS, V36, P314, DOI 10.1055/s-2005-872845
   Nasca A, 2023, BRAIN, V146, P2730, DOI 10.1093/brain/awad068
   Neilson DE, 2022, MOVEMENT DISORD, V37, P375, DOI 10.1002/mds.28821
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Ng YS, 2019, ANN NEUROL, V86, P310, DOI 10.1002/ana.25525
   Nolte D, 2021, J NEUROL, V268, P4866, DOI 10.1007/s00415-021-10607-5
   Ogawa E, 2017, J INHERIT METAB DIS, V40, P685, DOI 10.1007/s10545-017-0042-6
   OlÃ¡hovÃ¡ M, 2018, AM J HUM GENET, V102, P494, DOI 10.1016/j.ajhg.2018.01.020
   Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561
   Panosyan FB, 2017, MUSCLE NERVE, V55, P922, DOI 10.1002/mus.25453
   Panwala TF, 2022, PEDIATR NEUROL, V130, P7, DOI 10.1016/j.pediatrneurol.2022.02.007
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   PASTORES GM, 1994, AM J MED GENET, V50, P265, DOI 10.1002/ajmg.1320500310
   Pfeffer G, 2012, J NEUROL NEUROSUR PS, V83, P883, DOI 10.1136/jnnp-2012-302568
   Piekutowska-Abramczuk D, 2018, METAB BRAIN DIS, V33, P191, DOI 10.1007/s11011-017-0122-1
   Pinke G, 2020, NAT STRUCT MOL BIOL, V27, P1077, DOI 10.1038/s41594-020-0503-8
   Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d
   Porto FBO, 2001, AM J OPHTHALMOL, V132, P935, DOI 10.1016/S0002-9394(01)01187-4
   Prasun P, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165838
   PUDDU P, 1993, BRIT J OPHTHALMOL, V77, P84, DOI 10.1136/bjo.77.2.84
   Rabier D, 1998, J INHERIT METAB DIS, V21, P216, DOI 10.1023/A:1005391300203
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   RantamÃ¤ki MT, 2005, ANN NEUROL, V58, P337, DOI 10.1002/ana.20555
   Ribas GS, 2022, CELL MOL NEUROBIOL, V42, P2593, DOI 10.1007/s10571-021-01156-6
   Ronchi D, 2011, BIOCHEM BIOPH RES CO, V412, P245, DOI 10.1016/j.bbrc.2011.07.076
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rucheton B, 2020, MITOCHONDRION, V55, P64, DOI 10.1016/j.mito.2020.08.004
   Sallevelt SCEH, 2017, J MED GENET, V54, P114, DOI 10.1136/jmedgenet-2016-103876
   Saneto RP, 2010, MITOCHONDRION, V10, P567, DOI 10.1016/j.mito.2010.05.006
   Santorelli FM, 1997, NEUROLOGY, V49, P270, DOI 10.1212/WNL.49.1.270
   Sarajlija A, 2017, CONGENIT ANOM, V57, P64, DOI 10.1111/cga.12194
   Scaglia Fernando, 2002, BMC PEDIATR, V2, P12, DOI 10.1186/1471-2431-2-12
   Seneca S, 1996, J INHERIT METAB DIS, V19, P115, DOI 10.1007/BF01799407
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   Shchelochkov OA, 2010, MOL GENET METAB, V101, P282, DOI 10.1016/j.ymgme.2010.07.012
   Sikorska M, 2009, MUSCLE NERVE, V40, P381, DOI 10.1002/mus.21355
   Sperl W, 2006, NEUROMUSCULAR DISORD, V16, P821, DOI 10.1016/j.nmd.2006.08.008
   Spiegel R, 2011, J MED GENET, V48, P177, DOI 10.1136/jmg.2010.084608
   Spikes TE, 2020, P NATL ACAD SCI USA, V117, P23519, DOI 10.1073/pnas.2013998117
   Staretz-Chacham O, 2019, AM J MED GENET A, V179, P1293, DOI 10.1002/ajmg.a.61138
   Stendel C, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000393
   Stenton SL, 2020, EBIOMEDICINE, V56, P0, DOI 10.1016/j.ebiom.2020.102784
   Stojanovic V, 2013, J PEDIATR ENDOCR MET, V26, P151, DOI 10.1515/jpem-2012-0291
   Synofzik M, 2012, EUR J NEUROL, V19, Pe114, DOI 10.1111/j.1468-1331.2012.03812.x
   Takada R, 2020, BRAIN DEV-JPN, V42, P69, DOI 10.1016/j.braindev.2019.08.006
   TATUCH Y, 1992, AM J HUM GENET, V50, P852
   Tatuch Yuriy, 1994, EUROPEAN JOURNAL OF HUMAN GENETICS, V2, P35
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Theunissen TEJ, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00400
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   Torraco A, 2012, NEUROGENETICS, V13, P375, DOI 10.1007/s10048-012-0343-8
   Tort F, 2011, CLIN GENET, V80, P297, DOI 10.1111/j.1399-0004.2011.01650.x
   Tsao CY, 2001, J CHILD NEUROL, V16, P533, DOI 10.1177/088307380101600716
   Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16
   Varadi M, 2022, NUCLEIC ACIDS RES, V50, PD439, DOI 10.1093/nar/gkab1061
   VÃ¡zquez-Memije ME, 1998, J INHERIT METAB DIS, V21, P829, DOI 10.1023/A:1005418718299
   Verny C, 2011, MITOCHONDRION, V11, P70, DOI 10.1016/j.mito.2010.07.006
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Walsh N, 2024, J MED GENET, V61, P207, DOI 10.1136/jmg-2023-109488
   Wang YM, 2007, J BIOL CHEM, V282, P8228, DOI 10.1074/jbc.M609635200
   Wang ZG, 2001, J BIOL CHEM, V276, P30773, DOI 10.1074/jbc.M104133200
   Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149
   Waterham HR, 2023, GENET MED, V25, P0, DOI 10.1016/j.gim.2023.100944
   Wei YP, 2018, J NEUROL, V265, P2388, DOI 10.1007/s00415-018-9014-5
   Wen SZ, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep36313
   Wittig I, 2010, BBA-BIOENERGETICS, V1797, P1004, DOI 10.1016/j.bbabio.2010.02.021
   Wong LJC, 2020, HUM MUTAT, V41, P1783, DOI 10.1002/humu.24082
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Wortmann SB, 2013, J INHERIT METAB DIS, V36, P923, DOI 10.1007/s10545-012-9580-0
   Wortmann SB, 2009, BRAIN, V132, P136, DOI 10.1093/brain/awn296
   Yaribeygi H, 2020, OXID MED CELL LONGEV, V2020, P0, DOI 10.1155/2020/8609213
   Yu JL, 2020, J CLIN INVEST, V130, P4935, DOI 10.1172/JCI134965
   Yu XL, 2018, CHINESE MED J-PEKING, V131, P2705, DOI 10.4103/0366-6999.245265
   Zech M, 2022, ANN NEUROL, V91, P225, DOI 10.1002/ana.26293
   Zhang HX, 2018, ESSAYS BIOCHEM, V62, P225, DOI 10.1042/EBC20170096
   Zigman T, 2021, J PEDIATR ENDOCR MET, V34, P389, DOI 10.1515/jpem-2020-0396
NR 186
TC 0
Z9 0
U1 2
U2 2
PU ACAD SCIENCES CZECH REPUBLIC, INST PHYSIOLOGY
PI PRAGUE 4
PA VIDENSKA 1083, PRAGUE 4 142 20, CZECH REPUBLIC
SN 0862-8408
EI 1802-9973
J9 PHYSIOL RES
JI Physiol. Res.
PD AUG 15
PY 2024
VL 73
IS 
BP S243
EP S278
DI 10.33549/physiolres.935407
PG 36
WC Physiology
SC Physiology
GA D3O3L
UT WOS:001295308400014
PM 39016153
DA 2024-11-01
ER

PT J
AU Pawlowski, W
   Reszec-Gielazyn, J
   Cechowska-Pasko, M
   Urban, B
   Bakunowicz-Lazarczyk, A
AF Pawlowski, Wojciech
   Reszec-Gielazyn, Joanna
   Cechowska-Pasko, Marzanna
   Urban, Beata
   Bakunowicz-Lazarczyk, Alina
TI A Preliminary Study of the Occurrence of Genetic Changes in mtDNA in the Muscles in Children Treated for Strabismus
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE mtDNA; extraocular muscles; strabismus; ANT1
ID tendon axonal profiles; medial rectus muscles; extraocular-muscles; expression; infantile; ant1
AB Background: The dysregulation of extraocular muscles (EOMs) in the strabismus may be partly due to modification in the mitochondrial DNA (mtDNA). Currently, little is known about changes occurring in mtDNA of EOMs in patients with strabismus, therefore the aim of our study was to analyze if there are any changes occurring in the mitochondrial DNA of extraocular muscles in children that underwent strabismus surgery in our clinic. Methods: MtDNA was isolated from the tissue material using the Qiagen kit. Assessment of mtDNA mutations was performed by next-generation sequencing (NGS) using the Illumina MiSeq protocol. Results: The examination revealed the presence of atrophic changes in muscle fibers. NGS evaluation revealed a dominant genetic mutation in the ANT1 gene in 12 of the 15 patients examined. Conclusions: The presented results constitute the beginning of research on changes in mtDNA occurring in the muscles of children with strabismus surgery. Further studies are necessary in the context of resolving the transcriptomic differences between strabismic and non-strabismic EOMs. Better understanding of the molecular genetics of strabismus will lead to improved knowledge of the disease mechanisms and ultimately to a more effective treatment.
C1 [Pawlowski, Wojciech; Urban, Beata; Bakunowicz-Lazarczyk, Alina] Med Univ Bialystok, Dept Pediat Ophthalmol & Strabismus, PL-15089 Bialystok, Poland.
   [Reszec-Gielazyn, Joanna] Med Univ Bialystok, Dept Med Pathomorphol, PL-15296 Bialystok, Poland.
   [Cechowska-Pasko, Marzanna] Med Univ Bialystok, Dept Pharmaceut Biochem, PL-15089 Bialystok, Poland.
C3 Medical University of Bialystok; Medical University of Bialystok; Medical University of Bialystok
RP Bakunowicz-Lazarczyk, A (corresponding author), Med Univ Bialystok, Dept Pediat Ophthalmol & Strabismus, PL-15089 Bialystok, Poland.; Cechowska-Pasko, M (corresponding author), Med Univ Bialystok, Dept Pharmaceut Biochem, PL-15089 Bialystok, Poland.
EM wojciech.pawlowski@umb.edu.pl; joanna.reszec-gielazyn@umb.edu.pl; marzanna.cechowska-pasko@umb.edu.pl; beata.urban@umb.edu.pl; alina.bakunowicz-lazarczyk@umb.edu.pl
CR Altick AL, 2012, INVEST OPHTH VIS SCI, V53, P5168, DOI 10.1167/iovs.12-9785
   Antunes-Foschini RS, 2008, INVEST OPHTH VIS SCI, V49, P215, DOI 10.1167/iovs.07-0507
   Arbogast S, 2022, REDOX BIOL, V56, P0, DOI 10.1016/j.redox.2022.102450
   Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7
   CORSI M, 1990, OPHTHALMOLOGICA, V200, P154, DOI 10.1159/000310097
   Coyne LP, 2019, MITOCHONDRION, V49, P46, DOI 10.1016/j.mito.2019.06.001
   DOMENICILOMBARDO L, 1992, OPHTHALMOLOGICA, V205, P29, DOI 10.1159/000310308
   Fischer MD, 2005, PHYSIOL GENOMICS, V22, P283, DOI 10.1152/physiolgenomics.00158.2004
   Janbaz AH, 2014, INVEST OPHTH VIS SCI, V55, P5151, DOI 10.1167/iovs.14-14316
   Jung SK, 2015, GRAEF ARCH CLIN EXP, V253, P551, DOI 10.1007/s00417-014-2794-0
   Khan AO, 2011, MOL VIS, V17, P1997
   Kim SH, 2008, EYE, V22, P1076, DOI 10.1038/eye.2008.133
   Kim SH, 2006, ACTA OPHTHALMOL SCAN, V84, P182, DOI 10.1111/j.1600-0420.2005.00556.x
   Kitada Mizue, 2003, STRABISMUS, V11, P145, DOI 10.1076/stra.11.3.145.16647
   Li J, 2001, ZHONGHUA YAN KE ZA ZHI, V37, P200
   Liu Gui-xiang, 2007, ZHONGHUA YAN KE ZA ZHI, V43, P618
   MARTINEZ AJ, 1980, ARCH OPHTHALMOL-CHIC, V98, P533
   Michaelides M, 2004, J MED GENET, V41, P641, DOI 10.1136/jmg.2004.021667
   Park Sung-Eun, 2009, KOREAN J OPHTHALMOL, V23, P93, DOI 10.3341/kjo.2009.23.2.93
   Sharer JD, 2005, IUBMB LIFE, V57, P607, DOI 10.1080/15216540500217735
   Simoncini Costanza, 2017, ACTA MYOL, V36, P25
   Wright KW, 1995, PEDIATRIC OPHTHALMOLOGY AND STRABISMUS, V0, P96
   Yamane T, 2003, ACTA MED OKAYAMA, V57, P199
   Yu CY, 2005, NEUROMUSCULAR DISORD, V15, P17, DOI 10.1016/j.nmd.2004.10.002
   Zhu YJ, 2013, MOL MED REP, V7, P217, DOI 10.3892/mmr.2012.1149
   Zuo Xu-hong, 2012, ZHONGHUA YAN KE ZA ZHI, V48, P794
NR 27
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD JUL 15
PY 2024
VL 13
IS 14
BP 
EP 
DI 10.3390/jcm13144041
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA ZS8I7
UT WOS:001277368700001
PM 39064081
DA 2024-11-01
ER

PT J
AU Mavillard, F
   Guerra-Castellano, A
   Guerrero-GÃ³mez, D
   Rivas, E
   Cantero, G
   Servian-Morilla, E
   Folland, C
   Ravenscroft, G
   MartÃ­n, MA
   Miranda-Vizuete, A
   Cabrera-Serrano, M
   Diaz-Moreno, I
   Paradas, C
AF Mavillard, Fabiola
   Guerra-Castellano, Alejandra
   Guerrero-Gomez, David
   Rivas, Eloy
   Cantero, Gloria
   Servian-Morilla, Emilia
   Folland, Chiara
   Ravenscroft, Gianina
   Martin, Miguel A.
   Miranda-Vizuete, Antonio
   Cabrera-Serrano, Macarena
   Diaz-Moreno, Irene
   Paradas, Carmen
TI A splice-altering homozygous variant in COX18 causes severe sensory-motor neuropathy with oculofacial apraxia
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE Encephaloneuropathy; Complex IV; COX18; Missplicing; Mitochondria; Supercomplex
ID cytochrome-c-oxidase; sco2 mutation; maturation; rna; phosphorylation; mitochondria; deficiency; prediction; insights; muscle
AB Cytochrome-c oxidase (COX) is part of the mitochondrial complex IV (CIV). COX deficiency is usually associated with tRNA variants, and less frequently with variants in COX assembly factors. Mutations in COX subunits encoded by mitochondrial DNA and nuclear DNA are rare, likely because most of them are associated to very severe phenotypes with early lethality. COX18, an assembly factor of CIV, has long been analyzed as a potential cause of mitochondrial disease. To date, only one patient has been identified carrying a homozygous missense variant in COX18, associated with neonatal encephalo-cardiomyopathy and axonal sensory neuropathy. Here, we describe a 40-year-old patient, asymptomatic until 7 months of age, who presented with progressive muscle weakness resembling spinal muscle atrophy type-2, associated with oculofacial apraxia and dysarthric speech. Electrophysiology analysis highlighted a severe sensory-motor neuropathy. Muscle biopsy showed striking and diffuse decreases of COX staining and a substantial reduction of CIV activity. Muscle biopsy showed no raggedred fibers, although ultrastructural mitochondrial alterations were evident. A novel homozygous variant (c.598G>A), located in the last nucleotide of exon 3, was detected in COX18 by whole-exome sequencing, which affected the splicing donor site, as demonstrated by cDNA-seq. The patient fibroblasts express a truncated form of COX18 (COX18 Delta 112-240) capable of assembling CIV and CIV-involving supercomplexes. However, CIV activity was decreased. COX18 full-length (COX18-fl) overexpression partially rescued CIV activity in the patient fibroblasts. The rescue of the null CIV activity in COX18-KO-HEK293 cells by overexpressing of COX18 Delta 112-240 was significantly lower than in cells with COX18-fl. In addition, cox-18 downregulation in C. elegans resulted in slow growth and, diminished reduced motility phenotypes and as well as severe fragmentation of the mitochondrial network. Our case expands the phenotypes associated with COX18 variants and supports the pathogenic role of COX18 as the cause of a severe encephaloneuropathy syndrome.
C1 [Mavillard, Fabiola; Cantero, Gloria; Servian-Morilla, Emilia; Cabrera-Serrano, Macarena; Paradas, Carmen] Univ Seville, Hosp Virgen Rocio, CSIC, Inst Biomed Sevilla IBIS,Neuromuscular Unit,Neurol, Seville, Spain.
   [Mavillard, Fabiola; Cantero, Gloria; Servian-Morilla, Emilia; Cabrera-Serrano, Macarena; Paradas, Carmen] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Seville, Spain.
   [Guerra-Castellano, Alejandra; Diaz-Moreno, Irene] Univ Seville, Inst Invest Quim, CSIC, Seville, Spain.
   [Miranda-Vizuete, Antonio] Univ Seville, Hosp Virgen Rocio, Inst Biomed Sevilla IBIS, Redox Homeostasis Grp,CSIC, Seville, Spain.
   [Rivas, Eloy] Hosp Univ Virgen Rocio, Dept Neuropathol, Seville, Spain.
   [Folland, Chiara; Ravenscroft, Gianina] Univ Western Australia, Harry Perkins Inst Med Res, Ctr Med Res, Nedlands, WA 6009, Australia.
   [Martin, Miguel A.] Hosp 12 Octubre, Hlth Res Inst Imas12, Mitochondrial & Neuromuscular Disorders Grp, Madrid, Spain.
   [Martin, Miguel A.] Inst Salud Carlos III, Biomed Network Res Ctr Rare Dis CIBERER, Madrid, Spain.
C3 Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Instituto de Salud Carlos III; CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-USE - Instituto de Investigaciones Quimicas (IIQ); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Virgen del Rocio University Hospital; Harry Perkins Institute of Medical Research; University of Western Australia; Hospital Universitario 12 de Octubre; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona
RP Paradas, C (corresponding author), Univ Seville, Hosp Virgen Rocio, CSIC, Inst Biomed Sevilla IBIS,Neuromuscular Unit,Neurol, Seville, Spain.; Diaz-Moreno, I (corresponding author), Univ Seville, Inst Invest Quim, CSIC, Seville, Spain.
EM idiazmoreno@us.es; cparadas@us.es
FU Instituto de Salud Carlos III [FIS PI19-01497]; Consejeria de Salud y Familia, Junta de Andalucia and Programa Operativo Fondo Social Europeo de Andalucia [2014-2020 (RH0046- 2020), C1-0003-2022]; FP7 WeNMR [261572]; H2020 West -Life [675858, 777536, 101017567, INFN-LNL-2, IN2P3-CPPM]; NIKHEF; US Open Science Grid; Spanish Government [PGC2018-096049-B-I00]; FEDER/Ministerio de Ciencia e Innovaci [<acute accent>, PID2021-126663NB-I00, MCIN/AEI/10.13039/501100011033]; ERDF A way of making Europe; European Regional Development Fund (FEDER); Andalusian Government [BIO-198]; Ram <acute accent> on Areces Foundation [2021-2024]; European Research Network in Neuromuscular Diseases (EURO-NMD)
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Arnold S, 1997, EUR J BIOCHEM, V249, P350, DOI 10.1111/j.1432-1033.1997.t01-1-00350.x
   Bourens M, 2017, J BIOL CHEM, V292, P7774, DOI 10.1074/jbc.M117.778514
   Bourens M, 2014, HUM MOL GENET, V23, P2901, DOI 10.1093/hmg/ddu003
   Brand MD, 2013, BRIT J DERMATOL, V169, P1, DOI 10.1111/bjd.12208
   Brischigliaro M, 2021, BBA-BIOENERGETICS, V1862, P0, DOI 10.1016/j.bbabio.2020.148335
   Brix N, 2019, NEONATOLOGY, V116, P290, DOI 10.1159/000499488
   Casarin A, 2012, ORPHANET J RARE DIS, V7, P0, DOI 10.1186/1750-1172-7-21
   Cerqua C, 2018, BBA-BIOENERGETICS, V1859, P244, DOI 10.1016/j.bbabio.2018.01.004
   Chakravorty S, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-73219-5
   Chalmers RM, 1999, BBA-BIOENERGETICS, V1410, P147, DOI 10.1016/S0005-2728(98)00163-7
   Choi Y, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0046688
   Cogliati S, 2018, J MOL BIOL, V430, P4849, DOI 10.1016/j.jmb.2018.09.016
   DÃ­az-Quintana A, 2020, OXID MED CELL LONGEV, V2020, P0, DOI 10.1155/2020/6813405
   Dong HL, 2021, BRAIN, V144, P2457, DOI 10.1093/brain/awab135
   Doss S, 2014, J NEUROL, V261, P207, DOI 10.1007/s00415-013-7177-7
   Elliott LE, 2012, GENETICS, V190, P559, DOI 10.1534/genetics.111.135665
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Fornuskova D, 2010, BIOCHEM J, V428, P363, DOI 10.1042/BJ20091714
   Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478
   Gandre Shilpa, 2007, METHODS MOL BIOL, V372, P485, DOI 10.1007/978-1-59745-365-3_34
   GÃ³mez LA, 2009, ARCH BIOCHEM BIOPHYS, V490, P30, DOI 10.1016/j.abb.2009.08.002
   Guerra-Castellano A, 2018, P NATL ACAD SCI USA, V115, P7955, DOI 10.1073/pnas.1806833115
   Guerra-Castellano A, 2015, CHEM-EUR J, V21, P15004, DOI 10.1002/chem.201502019
   Gurgel-Giannetti J, 2013, JAMA NEUROL, V70, P258, DOI 10.1001/jamaneurol.2013.595
   Hell K, 2000, J BIOL CHEM, V275, P4571, DOI 10.1074/jbc.275.7.4571
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Huynh Mai-Loan, 2009, V519, V0, PP507, DOI 10.1007/978-1-59745-281-6_34
   Jett KA, 2018, J BIOL CHEM, V293, P4644, DOI 10.1074/jbc.R117.816132
   Jian XQ, 2014, NUCLEIC ACIDS RES, V42, P13534, DOI 10.1093/nar/gku1206
   Kastritis PL, 2013, J R SOC INTERFACE, V10, P0, DOI 10.1098/rsif.2012.0835
   Leary SC, 2013, HUM MUTAT, V34, P1366, DOI 10.1002/humu.22385
   Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
   NyvltovÃ¡ E, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-31413-1
   Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003
   Otero MG, 2019, ANN CLIN TRANSL NEUR, V6, P154, DOI 10.1002/acn3.661
   Pacheu-Grau D, 2015, CELL METAB, V21, P823, DOI 10.1016/j.cmet.2015.04.012
   PeÃ±a-Chilet M, 2021, NUCLEIC ACIDS RES, V49, PD1130, DOI 10.1093/nar/gkaa794
   Rebelo AP, 2018, BRAIN, V141, P662, DOI 10.1093/brain/awx369
   Ronchi D, 2023, EUR J HUM GENET, V31, P1414, DOI 10.1038/s41431-023-01433-6
   Sacconi S, 2009, J HUM GENET, V54, P419, DOI 10.1038/jhg.2009.36
   SchÃ¤gger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2
   Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890
   Shihab HA, 2015, BIOINFORMATICS, V31, P1536, DOI 10.1093/bioinformatics/btv009
   Signes A, 2018, ESSAYS BIOCHEM, V62, P255, DOI 10.1042/EBC20170098
   Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012
   Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2
   Sirey TM, 2016, BIOCHEM SOC T, V44, P1491, DOI 10.1042/BST20160100
   Stiernagle Theresa, 2006, WORMBOOK, V0, P1
   Tarnopolsky MA, 2004, AM J MED GENET A, V125A, P310, DOI 10.1002/ajmg.a.20466
   TimÃ³n-GÃ³mez A, 2018, SEMIN CELL DEV BIOL, V76, P163, DOI 10.1016/j.semcdb.2017.08.055
   Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272
   van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014
   Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275
   Yoshida S, 2013, P NATL ACAD SCI USA, V110, PE1604, DOI 10.1073/pnas.1220659110
NR 57
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD OCT 15
PY 2024
VL 1870
IS 7
BP 
EP 
DI 10.1016/j.bbadis.2024.167330
EA JUL 2024
PG 13
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA YI7E3
UT WOS:001267918400001
PM 38960055
DA 2024-11-01
ER

PT J
AU Spinazzola, A
   Perez-Rodriguez, D
   Jezek, J
   Holt, IJ
AF Spinazzola, Antonella
   Perez-Rodriguez, Diego
   Jezek, Jan
   Holt, Ian J.
TI Mitochondrial DNA competition: starving out the mutant genome
SO TRENDS IN PHARMACOLOGICAL SCIENCES
LA English
DT Review
ID random genetic drift; glutamine-metabolism; skeletal-muscle; quality-control; optic atrophy; mtdna; deletions; heteroplasmy; segregation; mutations
AB High levels of pathogenic mitochondrial DNA (mtDNA) variants lead to severe genetic diseases, and the accumulation of such mutants may also contribute to common disorders. Thus, selecting against these mutants is a major goal in mitochondrial medicine. Although mutant mtDNA can drift randomly, mounting evidence indicates that active forces play a role in the selection for and against mtDNA variants. The underlying mechanisms are beginning to be clarified, and recent studies suggest that metabolic cues, including fuel availability, contribute to shaping mtDNA heteroplasmy. In the context of pathological mtDNAs, remodeling of nutrient metabolism supports mitochondria with deleterious mtDNAs and enables them to outcompete functional variants owing to a replicative advantage. The elevated nutrient requirement represents a mutant Achilles' heel because small molecules that restrict nutrient consumption or interfere with nutrient sensing can purge cells of deleterious mtDNAs and restore mitochondrial respiration. These advances herald the dawn of a new era of small-molecule therapies to counteract pathological mtDNAs.
C1 [Spinazzola, Antonella; Perez-Rodriguez, Diego; Jezek, Jan; Holt, Ian J.] UCL, Queen Sq Inst Neurol, Dept Clin & Movement Neurosci, Royal Free Campus, London NW3 2PF, England.
   [Holt, Ian J.] Biodonostia Hlth Res Inst, San Sebastian 20014, Spain.
   [Holt, Ian J.] IKERBASQUE, Basque Fdn Sci, Bilbao 48013, Spain.
   [Holt, Ian J.] Minist Econ & Competitiveness, Inst Carlos III, Ctr Networked Biomed Res Neurodegenerat Dis, CIBERNED, Madrid 28031, Spain.
   [Holt, Ian J.] Univ Basque Country, Barrio Sarriena S-N, Leioa 48940, Bilbao, Spain.
C3 University of London; University College London; Instituto de Investigacion Sanitaria Biogipuzkoa; Basque Foundation for Science; Spanish Ministry of Economy & Competitiveness; CIBERNED; University of Basque Country
RP Spinazzola, A; Holt, IJ (corresponding author), UCL, Queen Sq Inst Neurol, Dept Clin & Movement Neurosci, Royal Free Campus, London NW3 2PF, England.; Holt, IJ (corresponding author), Biodonostia Hlth Res Inst, San Sebastian 20014, Spain.; Holt, IJ (corresponding author), IKERBASQUE, Basque Fdn Sci, Bilbao 48013, Spain.; Holt, IJ (corresponding author), Minist Econ & Competitiveness, Inst Carlos III, Ctr Networked Biomed Res Neurodegenerat Dis, CIBERNED, Madrid 28031, Spain.; Holt, IJ (corresponding author), Univ Basque Country, Barrio Sarriena S-N, Leioa 48940, Bilbao, Spain.
EM a.spinazzola@ucl.ac.uk; ian.holt@biodonostia.org
FU UK Medical Research Council [MR/X002365/1]; Muscular Dystrophy UK [17GRO-PG24-0184-1]; Lily Foundation; CHAMP Foundation; Brain Research UK [202021-26]; Carlos III Health Program (ISCIII) [2018111043]; Pas Vasco Department of Health [2018222031, PI17/00380];  [PI20/00096]
CR Aiestaran-Zelaia I, 2022, SCI REP-UK, V12, P0, DOI 10.1038/s41598-022-10168-1
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Arroyo JD, 2016, CELL METAB, V24, P875, DOI 10.1016/j.cmet.2016.08.017
   Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bhatt AN, 2022, BMC INFECT DIS, V22, P0, DOI 10.1186/s12879-022-07642-6
   Bhatt AN, 2022, LIFE SCI, V295, P0, DOI 10.1016/j.lfs.2022.120411
   BLANC H, 1980, P NATL ACAD SCI-BIOL, V77, P3942, DOI 10.1073/pnas.77.7.3942
   Bojkova D, 2020, NATURE, V583, P469, DOI 10.1038/s41586-020-2332-7
   Borella R, 2019, MOLECULES, V24, P0, DOI 10.3390/molecules24224097
   Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035
   Burgstaller JP, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04797-2
   Burr SP, 2023, CELL, V186, P1212, DOI 10.1016/j.cell.2023.01.034
   Burt A, 2006, GENES CONFLICT BIOL, V0, P0
   Cannino G, 2012, J BIOL CHEM, V287, P38729, DOI 10.1074/jbc.M112.386060
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen QY, 2018, CELL METAB, V27, P1007, DOI 10.1016/j.cmet.2018.03.002
   Chen Z, 2020, J CELL BIOL, V219, P0, DOI 10.1083/jcb.201905160
   Chiang ACY, 2019, CURR BIOL, V29, P4330, DOI 10.1016/j.cub.2019.10.060
   Chiaravalli M, 2016, J AM SOC NEPHROL, V27, P1958, DOI 10.1681/ASN.2015030231
   Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311
   Chung CY, 2022, TRENDS CELL BIOL, V32, P391, DOI 10.1016/j.tcb.2021.10.005
   Chung CY, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-26746-2
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   Clerc I, 2019, NAT METAB, V1, P717, DOI 10.1038/s42255-019-0084-1
   Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023
   de Zeeuw D, 2013, NEW ENGL J MED, V369, P2492, DOI 10.1056/NEJMoa1306033
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562
   DurÃ¡n RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043
   Durigon R, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708550
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Falabella M, 2022, NAT REV NEUROL, V18, P689, DOI 10.1038/s41582-022-00715-9
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Floros VI, 2018, NAT CELL BIOL, V20, P144, DOI 10.1038/s41556-017-0017-8
   Frezza C, 2017, INTERFACE FOCUS, V7, P0, DOI 10.1098/rsfs.2016.0100
   Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791
   Gaude E, 2018, MOL CELL, V69, P581, DOI 10.1016/j.molcel.2018.01.034
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Gitschlag BL, 2020, ELIFE, V9, P0, DOI 10.7554/eLife.56686
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   Gomes LC, 2011, CELL CYCLE, V10, P2635, DOI 10.4161/cc.10.16.17002
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Gray MW, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a011403
   Gupta R, 2023, NATURE, V620, P0, DOI 10.1038/s41586-023-06426-5
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Hill JH, 2014, NAT GENET, V46, P389, DOI 10.1038/ng.2920
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 1997, HUM MOL GENET, V6, P1251, DOI 10.1093/hmg/6.8.1251
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Hudson G, 2013, NEUROLOGY, V80, P2042, DOI 10.1212/WNL.0b013e318294b434
   HyvÃ¤rinen AK, 2007, NUCLEIC ACIDS RES, V35, P6458, DOI 10.1093/nar/gkm676
   Ignatenko O, 2020, LIFE SCI ALLIANCE, V3, P0, DOI 10.26508/lsa.202000797
   Jakubke C, 2021, SCI ADV, V7, P0, DOI 10.1126/sciadv.abi8886
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472
   Jokinen R, 2010, PLOS GENET, V6, P0, DOI 10.1371/journal.pgen.1001161
   Kandul NP, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13100
   Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037
   Keshavan N, 2024, J INHERIT METAB DIS, V47, P145, DOI 10.1002/jimd.12699
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Kim M, 2022, TRENDS CANCER, V8, P1046, DOI 10.1016/j.trecan.2022.08.001
   Kopinski PK, 2019, P NATL ACAD SCI USA, V116, P16028, DOI 10.1073/pnas.1906896116
   Latorre-Pellicer A, 2019, CELL METAB, V30, P1120, DOI 10.1016/j.cmet.2019.09.007
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   Le S, 2021, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/62756
   Lee JY, 2014, J CELL SCI, V127, P4954, DOI 10.1242/jcs.157321
   Lee JJ, 2018, J CELL BIOL, V217, P1613, DOI 10.1083/jcb.201801044
   Lehtinen SK, 2000, GENETICS, V154, P363
   Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374
   Leiter I, 2019, NEUROBIOL DIS, V130, P0, DOI 10.1016/j.nbd.2019.104510
   Lewis SC, 2016, SCIENCE, V353, P0, DOI 10.1126/science.aaf5549
   Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001
   Li MK, 2016, GENOME RES, V26, P417, DOI 10.1101/gr.203216.115
   Lickfett S, 2022, STAR PROTOC, V3, P0, DOI 10.1016/j.xpro.2022.101567
   Lieber T, 2019, NATURE, V570, P380, DOI 10.1038/s41586-019-1213-4
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Ma HS, 2016, NAT GENET, V48, P798, DOI 10.1038/ng.3587
   Ma HS, 2014, NAT GENET, V46, P393, DOI 10.1038/ng.2919
   Malena A, 2016, AUTOPHAGY, V12, P2098, DOI 10.1080/15548627.2016.1226734
   Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281
   MartÃ­nez-Reyes I, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-019-13668-3
   McWilliams TG, 2018, CELL METAB, V27, P439, DOI 10.1016/j.cmet.2017.12.008
   Medeiros TC, 2018, J CELL BIOL, V217, P1601, DOI 10.1083/jcb.201801168
   Minor RK, 2010, TOXICOL APPL PHARM, V243, P332, DOI 10.1016/j.taap.2009.11.025
   Scholle LM, 2020, GENES-BASEL, V11, P0, DOI 10.3390/genes11020212
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Palozzi JM, 2022, CELL METAB, V34, P1809, DOI 10.1016/j.cmet.2022.10.005
   Pantic B, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-26829-0
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Picard M, 2022, CELL METAB, V34, P1620, DOI 10.1016/j.cmet.2022.10.008
   Picard M, 2014, P NATL ACAD SCI USA, V111, PE4033, DOI 10.1073/pnas.1414028111
   Podrini C, 2018, COMMUN BIOL, V1, P0, DOI 10.1038/s42003-018-0200-x
   Raez LE, 2013, CANCER CHEMOTH PHARM, V71, P523, DOI 10.1007/s00280-012-2045-1
   Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108
   Ramos ES, 2019, PLOS GENET, V15, P0, DOI 10.1371/journal.pgen.1008085
   Rath S, 2021, NUCLEIC ACIDS RES, V49, PD1541, DOI 10.1093/nar/gkaa1011
   Rebolledo-Jaramillo B, 2014, P NATL ACAD SCI USA, V111, P15474, DOI 10.1073/pnas.1409328111
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Rowe I, 2013, NAT MED, V19, P488, DOI 10.1038/nm.3092
   Sanchez-Contreras M, 2023, ELIFE, V12, P0, DOI 10.7554/eLife.83395
   Schrepfer E, 2016, MOL CELL, V61, P683, DOI 10.1016/j.molcel.2016.02.022
   Shanske S, 2002, AM J HUM GENET, V71, P679, DOI 10.1086/342482
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Silva-Pinheiro P, 2023, NAT BIOMED ENG, V7, P692, DOI 10.1038/s41551-022-00968-1
   Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Stein M, 2010, PROSTATE, V70, P1388, DOI 10.1002/pros.21172
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Terse PS, 2016, INT J TOXICOL, V35, P284, DOI 10.1177/1091581815624397
   Thorburn DR, 1993, GENEREVIEWS, V0, P0
   Tostes K, 2022, AUTOPHAGY, V18, P2397, DOI 10.1080/15548627.2022.2038501
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Valle-Casuso JC, 2019, CELL METAB, V29, P611, DOI 10.1016/j.cmet.2018.11.015
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Lechuga-Vieco AV, 2020, SCI ADV, V6, P0, DOI 10.1126/sciadv.aba5345
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wang FL, 2018, CELL METAB, V28, P463, DOI 10.1016/j.cmet.2018.08.012
   Wei W, 2019, SCIENCE, V364, P749, DOI 10.1126/science.aau6520
   WOODWARD GE, 1954, CANCER RES, V14, P599
   Xi HB, 2011, CANCER CHEMOTH PHARM, V67, P899, DOI 10.1007/s00280-010-1391-0
   Yang QY, 2022, NAT CELL BIOL, V24, P181, DOI 10.1038/s41556-021-00840-5
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
   Zhang HX, 2021, SCI ADV, V7, P0, DOI 10.1126/sciadv.abi5657
   Zhang Y, 2019, MOL CELL, V73, P1127, DOI 10.1016/j.molcel.2019.01.013
NR 133
TC 1
Z9 1
U1 1
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0165-6147
EI 1873-3735
J9 TRENDS PHARMACOL SCI
JI Trends Pharmacol. Sci.
PD MAR 15
PY 2024
VL 45
IS 3
BP 225
EP 242
DI 10.1016/j.tips.2024.01.011
EA MAR 2024
PG 18
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA PL4S4
UT WOS:001214226700001
PM 38402076
DA 2024-11-01
ER

PT J
AU Shelton, GD
   Mickelson, JR
   Friedenberg, SG
   Cullen, JN
   Mehra, JM
   Guo, LT
   Minor, KM
AF Shelton, G. Diane
   Mickelson, James R.
   Friedenberg, Steven G.
   Cullen, Jonah N.
   Mehra, Jaya M.
   Guo, Ling T.
   Minor, Katie M.
TI Multi-Allelic Mitochondrial DNA Deletions in an Adult Dog with Chronic Weakness, Exercise Intolerance and Lactic Acidemia
SO ANIMALS
LA English
DT Article
DE canine; muscle; myopathy; whole-genome sequencing (WGS); variant analysis
ID mutation; gene; identification; muscle; myopathy; disease
AB Simple Summary Mitochondrial diseases in people are a heterogeneous group of genetically, biochemically, and clinically diverse disorders caused by defects in the metabolic pathways of oxidation phosphorylation (OXPHOS) and ATP production. While infrequently described in dogs, mitochondrial diseases may be more common than is currently known. Both the nuclear and mitochondrial genomes encode components of the enzyme complexes of the OXPHOS system, resulting in the genetic bases of mitochondrial diseases being transmitted in a Mendelian fashion, maternally, or as sporadic diseases. The pathogenicity is further complicated by heteroplasmy, with several different mitochondrial genomes existing within a given cell. A major challenge in the diagnosis of mitochondrial diseases is the clinical heterogeneity, with multi-system diseases affecting three or more organs and characteristically affecting tissues with high energy demands such as the central nervous system, skeletal muscle, eye and heart. Novel clinical syndromes have been reported in association with mitochondrial dysfunction and many patients can be misdiagnosed. The advent of next-generation sequencing has resulted in the discovery of new pathogenetic variants and has become the standard for the diagnosis of mitochondrial disease. Here, we describe an adult dog with a chronic myopathy associated with a mitochondrial deletion disorder.Abstract (1) Background: An adult dog was presented to a board-certified veterinary neurologist for evaluation of chronic weakness, exercise intolerance and lactic acidemia. (2) Methods: A mitochondrial myopathy was diagnosed based on the histological and histochemical phenotype of numerous COX-negative muscle fibers. Whole-genome sequencing established the presence of multiple extended deletions in the mitochondrial DNA (mtDNA), with the highest prevalence between the 1-11 kb positions of the approximately 16 kb mitochondrial chromosome. Such findings are typically suggestive of an underlying nuclear genome variant affecting mitochondrial replication, repair, or metabolism. (3) Results: Numerous variants in the nuclear genome unique to the case were identified in the whole-genome sequence data, and one, the insertion of a DYNLT1 retrogene, whose parent gene is a regulator of the mitochondrial voltage-dependent anion channel (VDAC), was considered a plausible causal variant. (4) Conclusions: Here, we add mitochondrial deletion disorders to the spectrum of myopathies affecting adult dogs.
C1 [Shelton, G. Diane; Guo, Ling T.] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA.
   [Mickelson, James R.] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.
   [Friedenberg, Steven G.; Cullen, Jonah N.; Minor, Katie M.] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA.
   [Mehra, Jaya M.] VCA Anim Care Ctr Sonoma Cty, Rohnert Pk, CA 94928 USA.
C3 University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities
RP Shelton, GD (corresponding author), Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA.
EM gshelton@health.ucsd.edu; micke001@umn.edu; fried255@umn.edu; cull0084@umn.edu; jaya.mehra@vca.com; liguo@health.ucsd.edu; minork@umn.edu
FU NIH Special Emphasis Research Career Award in Pathology and Comparative Medicine by the Division of Comparative Medicine, Office of Research Infrastructure Programs [1 K01OD027058]
CR Ahmed ST, 2018, NEUROTHERAPEUTICS, V15, P943, DOI 10.1007/s13311-018-00674-4
   Baranowska I, 2009, PLOS GENET, V5, P0, DOI 10.1371/journal.pgen.1000499
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Cameron JM, 2007, MOL GENET METAB, V90, P15, DOI 10.1016/j.ymgme.2006.09.011
   Christen M, 2024, SCI REP-UK, V14, P0, DOI 10.1038/s41598-024-53314-7
   Cullen JN, 2023, G3-GENES GENOM GENET, V13, P0, DOI 10.1093/g3journal/jkad117
   Dickinson PJ, 2002, VET CLIN N AM-SMALL, V32, P63, DOI 10.1016/S0195-5616(03)00080-9
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   DrÃ¶gemÃ¼ller M, 2020, GENES-BASEL, V11, P0, DOI 10.3390/genes11101215
   Dubowitz V, 2007, MUSCLE BIOPSY: A PRACTICAL APPROACH, V0, P0
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   Emmanuele V, 2022, MOL GENET METAB, V136, P125, DOI 10.1016/j.ymgme.2022.05.001
   Fang YD, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0028052
   Glass EN, 2002, VET CLIN N AM-SMALL, V32, P1, DOI 10.1016/S0195-5616(03)00078-0
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Huang L, 2023, MOL MED, V29, P0, DOI 10.1186/s10020-023-00663-0
   Kirby DM, 2004, J MED GENET, V41, P784, DOI 10.1136/jmg.2004.020537
   Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356
   Lepori V, 2018, G3-GENES GENOM GENET, V8, P1545, DOI 10.1534/g3.118.200084
   Li FY, 2006, NEUROBIOL DIS, V21, P35, DOI 10.1016/j.nbd.2005.06.009
   Meadows JRS, 2023, GENOME BIOL, V24, P0, DOI 10.1186/s13059-023-03023-7
   Meurs KM, 2019, GENES-BASEL, V10, P0, DOI 10.3390/genes10020168
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Naghdi S, 2016, BBA-MOL CELL RES, V1863, P2503, DOI 10.1016/j.bbamcr.2016.04.020
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.107
   Parker HG, 2009, SCIENCE, V325, P995, DOI 10.1126/science.1173275
   Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308
   Rygiel KA, 2016, J PHYSIOL-LONDON, V594, P4499, DOI 10.1113/JP271212
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Schwarzer C, 2002, INT J BIOCHEM CELL B, V34, P1059, DOI 10.1016/S1357-2725(02)00026-2
   Shelton GD, 2019, J NEUROMUSCULAR DIS, V6, P485, DOI 10.3233/JND-190421
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   Solovyev VV, 2010, METHODS MOL BIOL, V674, P57, DOI 10.1007/978-1-60761-854-6_5
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tkaczyk-Wlizlo A, 2022, MITOCHONDRION, V63, P72, DOI 10.1016/j.mito.2022.02.001
   Varughese JT, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10071737
   Vernau KM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0057195
   VIJAYASARATHY C, 1994, COMP BIOCHEM PHYS A, V109, P887, DOI 10.1016/0300-9629(94)90236-4
   Volpi L, 2011, MUSCULOSKELET SURG, V95, P59, DOI 10.1007/s12306-011-0096-9
   Wang C, 2021, COMMUN BIOL, V4, P0, DOI 10.1038/s42003-021-01698-x
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 45
TC 1
Z9 1
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2076-2615
EI 
J9 ANIMALS-BASEL
JI Animals
PD JUL 15
PY 2024
VL 14
IS 13
BP 
EP 
DI 10.3390/ani14131946
PG 15
WC Agriculture, Dairy & Animal Science; Veterinary Sciences; Zoology
SC Agriculture; Veterinary Sciences; Zoology
GA YP6C2
UT WOS:001269717600001
PM 38998058
DA 2024-11-01
ER

PT J
AU Bartman, S
   Coppotelli, G
   Ross, JM
AF Bartman, Sydney
   Coppotelli, Giuseppe
   Ross, Jaime M.
TI Mitochondrial Dysfunction: A Key Player in Brain Aging and Diseases
SO CURRENT ISSUES IN MOLECULAR BIOLOGY
LA English
DT Review
DE mitochondria; mitochondrial dysfunction; aging; neurodegenerative diseases
ID oxidative stress; parkinsons-disease; alzheimers-disease; mouse model; caloric restriction; cytochrome-c; huntingtons-disease; transgenic model; skeletal-muscle; dna mutations
AB Mitochondria are thought to have become incorporated within the eukaryotic cell approximately 2 billion years ago and play a role in a variety of cellular processes, such as energy production, calcium buffering and homeostasis, steroid synthesis, cell growth, and apoptosis, as well as inflammation and ROS production. Considering that mitochondria are involved in a multitude of cellular processes, mitochondrial dysfunction has been shown to play a role within several age-related diseases, including cancers, diabetes (type 2), and neurodegenerative diseases, although the underlying mechanisms are not entirely understood. The significant increase in lifespan and increased incidence of age-related diseases over recent decades has confirmed the necessity to understand the mechanisms by which mitochondrial dysfunction impacts the process of aging and age-related diseases. In this review, we will offer a brief overview of mitochondria, along with structure and function of this important organelle. We will then discuss the cause and consequence of mitochondrial dysfunction in the aging process, with a particular focus on its role in inflammation, cognitive decline, and neurodegenerative diseases, such as Huntington's disease, Parkinson's disease, and Alzheimer's disease. We will offer insight into therapies and interventions currently used to preserve or restore mitochondrial functioning during aging and neurodegeneration.
C1 [Bartman, Sydney; Coppotelli, Giuseppe; Ross, Jaime M.] Univ Rhode Isl, George & Anne Ryan Inst Neurosci, Kingston, RI 02881 USA.
   [Bartman, Sydney; Coppotelli, Giuseppe; Ross, Jaime M.] Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA.
C3 University of Rhode Island; University of Rhode Island
RP Coppotelli, G; Ross, JM (corresponding author), Univ Rhode Isl, George & Anne Ryan Inst Neurosci, Kingston, RI 02881 USA.; Coppotelli, G; Ross, JM (corresponding author), Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA.
EM gcoppotelli@uri.edu; jaime_ross@uri.edu
FU National Institute on Aging
CR Abramov AY, 2004, J NEUROSCI, V24, P565, DOI 10.1523/JNEUROSCI.4042-03.2004
   Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005
   Ahn CS, 2015, CANCER METAB, V3, P0, DOI 10.1186/s40170-015-0128-2
   Aidt Frederik Heurlin, 2013, PLOS CURR, V5, P0, DOI 10.1371/currents.hd.d8917b4862929772c5a2f2a34ef1c201
   Aleyasin H, 2010, P NATL ACAD SCI USA, V107, P3186, DOI 10.1073/pnas.0914876107
   Allen JA, 2006, ENDOCRINOLOGY, V147, P3924, DOI 10.1210/en.2005-1204
   Amadoro G, 2014, FRONT AGING NEUROSCI, V6, P0, DOI 10.3389/fnagi.2014.00018
   Amartuvshin O, 2020, AGING CELL, V19, P0, DOI 10.1111/acel.13191
   Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104
   Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7
   Andriollo-Sanchez M, 2005, EUR J CLIN NUTR, V59, PS58, DOI 10.1038/sj.ejcn.1602300
   Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085
   Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81
   Ayala A, 2014, OXID MED CELL LONGEV, V2014, P0, DOI 10.1155/2014/360438
   Ayyub SA, 2020, RNA BIOL, V17, P165, DOI 10.1080/15476286.2019.1690099
   Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974
   Banerjee R, 2009, BBA-MOL BASIS DIS, V1792, P651, DOI 10.1016/j.bbadis.2008.11.007
   Bang E, 2022, J NEUROSCI, V42, P1020, DOI 10.1523/JNEUROSCI.1442-21.2021
   Banoth B, 2018, TRANSL RES, V202, P52, DOI 10.1016/j.trsl.2018.07.014
   Bar-Yaacov D, 2012, BBA-GENE REGUL MECH, V1819, P1107, DOI 10.1016/j.bbagrm.2011.10.008
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819
   Barzilai N, 2016, CELL METAB, V23, P1060, DOI 10.1016/j.cmet.2016.05.011
   Beal MF, 2010, NATURE, V466, PS8, DOI 10.1038/466S8a
   Becanovic K, 2021, NPJ AGING MECH DIS, V7, P0, DOI 10.1038/s41514-021-00079-2
   Berridge MJ, 2017, J PHYSIOL-LONDON, V595, P6825, DOI 10.1113/JP274887
   Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004
   Branch SY, 2016, J NEUROSCI, V36, P4026, DOI 10.1523/JNEUROSCI.1395-15.2016
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Breuer ME, 2012, J INHERIT METAB DIS, V35, P193, DOI 10.1007/s10545-011-9375-8
   Brown GC, 2015, EMBO REP, V16, P137, DOI 10.15252/embr.201439518
   Brown MR, 2004, J BIOENERG BIOMEMBR, V36, P401, DOI 10.1023/B:JOBB.0000041775.10388.23
   BUCANA CD, 1974, TISSUE CELL, V6, P85, DOI 10.1016/0040-8166(74)90024-X
   Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035
   Burtscher J, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21155412
   Businaro Rita, 2012, CURR GERONTOL GERIATR RES, V2012, P986823, DOI 10.1155/2012/986823
   Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040
   Castellani R, 2002, J NEUROSCI RES, V70, P357, DOI 10.1002/jnr.10389
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chang PS, 2022, FRONT AGING NEUROSCI, V14, P0, DOI 10.3389/fnagi.2022.910289
   Chaung WW, 2012, INT J MOL MED, V30, P199, DOI 10.3892/ijmm.2012.959
   Chen C, 2019, BIOLOGY-BASEL, V8, P0, DOI 10.3390/biology8020038
   Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873
   Chen KQ, 2017, J AUTOIMMUN, V85, P64, DOI 10.1016/j.jaut.2017.06.012
   Chen LZ, 2019, AGING-US, V11, P10242, DOI 10.18632/aging.102451
   Chiareli RA, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.665795
   Chmielewski PP, 2020, BIOGERONTOLOGY, V21, P125, DOI 10.1007/s10522-019-09839-w
   Cho J, 2011, EXP GERONTOL, V46, P331, DOI 10.1016/j.exger.2010.08.010
   Choe YM, 2023, ALZHEIMERS RES THER, V15, P0, DOI 10.1186/s13195-023-01293-8
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003
   Colak E, 2017, J CLIN BIOCHEM NUTR, V60, P100, DOI 10.3164/jcbn.16-30
   Colizzi C, 2019, ALZH DEMENT-TRCI, V5, P184, DOI 10.1016/j.trci.2018.09.002
   Collin F, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20102407
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   Coppotelli G, 2016, INT J MOL SCI, V17, P0, DOI 10.3390/ijms17050711
   CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Crouser ED, 2009, CRIT CARE MED, V37, P2000, DOI 10.1097/CCM.0b013e3181a001ae
   Damiano M, 2010, BBA-MOL BASIS DIS, V1802, P52, DOI 10.1016/j.bbadis.2009.07.012
   Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044
   Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034
   de Barcelos IP, 2019, BIOLOGY-BASEL, V8, P0, DOI 10.3390/biology8020028
   de Cabo R, 2019, NEW ENGL J MED, V381, P2541, DOI 10.1056/NEJMra1905136
   de Oliveira LG, 2021, FRONT IMMUNOL, V12, P0, DOI 10.3389/fimmu.2021.624919
   Deota S, 2023, CELL METAB, V35, P150, DOI 10.1016/j.cmet.2022.12.006
   Deshwal S, 2020, ANNU REV BIOCHEM, V89, P501, DOI 10.1146/annurev-biochem-062917-012739
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Dharmalingam Mala, 2011, INDIAN J ENDOCRINOL METAB, V15, P9, DOI 10.4103/2230-8210.77571
   Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961
   Dias GP, 2021, MOL PSYCHIATR, V26, P6365, DOI 10.1038/s41380-021-01102-4
   Diaz F, 2010, BBA-MOL BASIS DIS, V1802, P100, DOI 10.1016/j.bbadis.2009.07.013
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Ding L, 2015, INT J MOL SCI, V16, P10870, DOI 10.3390/ijms160510870
   Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119
   Dixit S, 2017, FREE RADICAL BIO MED, V112, P515, DOI 10.1016/j.freeradbiomed.2017.08.021
   Djordjevic J, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9061541
   Dubey A, 1996, ARCH BIOCHEM BIOPHYS, V333, P189, DOI 10.1006/abbi.1996.0380
   Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x
   Dumont M, 2011, J ALZHEIMERS DIS, V27, P211, DOI 10.3233/JAD-2011-110209
   Duncan T, 2017, STEM CELL RES THER, V8, P0, DOI 10.1186/s13287-017-0567-5
   Edgar D, 2009, AGING-US, V1, P1028, DOI 10.18632/aging.100109
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296
   elsevier, 1900, V1ST, V0, P0
   Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546
   ESTERBAUER H, 1990, MUTAT RES, V238, P223, DOI 10.1016/0165-1110(90)90014-3
   Faitg J, 2019, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.00420
   Fakouri NB, 2019, BIOLOGY-BASEL, V8, P0, DOI 10.3390/biology8020035
   Femminella GD, 2019, TRIALS, V20, P0, DOI 10.1186/s13063-019-3259-x
   Finch CE, 2000, CHANCE DEV AGING, V0, P0
   Finkbeiner S, 2011, CSH PERSPECT BIOL, V3, P0, DOI 10.1101/cshperspect.a007476
   Firenzuoli F, 2007, EVID-BASED COMPL ALT, V4, P37, DOI 10.1093/ecam/nem096
   Flones IH, 2018, ACTA NEUROPATHOL, V135, P409, DOI 10.1007/s00401-017-1794-7
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Furukawa K, 2019, FRONT PLANT SCI, V10, P0, DOI 10.3389/fpls.2019.01479
   Fusco D, 2007, CLIN INTERV AGING, V2, P377
   Galter D, 2010, GENES BRAIN BEHAV, V9, P173, DOI 10.1111/j.1601-183X.2009.00542.x
   GarcÃ­a ML, 2013, J NEUROL SCI, V330, P18, DOI 10.1016/j.jns.2013.03.019
   Garcia S, 2018, AGING CELL, V17, P0, DOI 10.1111/acel.12707
   Gentile F, 2017, AIMS GENET, V4, P103, DOI 10.3934/genet.2017.2.103
   Ghosh S, 2011, DIABETES, V60, P2051, DOI 10.2337/db11-0121
   Giacomello M, 2020, NAT REV MOL CELL BIO, V21, P204, DOI 10.1038/s41580-020-0210-7
   Golpich M, 2017, CNS NEUROSCI THER, V23, P5, DOI 10.1111/cns.12655
   Gombault A, 2013, FRONT IMMUNOL, V3, P0, DOI 10.3389/fimmu.2012.00414
   GOODRICK CL, 1990, MECH AGEING DEV, V55, P69, DOI 10.1016/0047-6374(90)90107-Q
   GÃ¶tz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200
   Gray MW, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a011403
   Grazioli S, 2018, FRONT IMMUNOL, V9, P0, DOI 10.3389/fimmu.2018.00832
   Grimolizzi F, 2018, HAEMATOLOGICA, V103, P1586, DOI 10.3324/haematol.2018.196097
   GrÃ¼newald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007
   Gudden J, 2021, NUTRIENTS, V13, P0, DOI 10.3390/nu13093166
   Guo C, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep32581
   Hall AM, 2012, BRAIN RES BULL, V88, P3, DOI 10.1016/j.brainresbull.2011.11.017
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hauser DN, 2015, ENEURO, V2, P0, DOI 10.1523/ENEURO.0075-14.2015
   Hawkins KE, 2019, WORLD J STEM CELLS, V11, P236, DOI 10.4252/wjsc.v11.i5.236
   Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008
   Henderson ST, 2020, J ALZHEIMERS DIS, V75, P547, DOI 10.3233/JAD-191302
   Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3
   Holbrook JA, 2021, FRONT PHARMACOL, V12, P0, DOI 10.3389/fphar.2021.643254
   Holtze S, 2021, FRONT MOL BIOSCI, V8, P0, DOI 10.3389/fmolb.2021.660959
   Hsieh PC, 2019, BRAIN BEHAV, V9, P0, DOI 10.1002/brb3.1281
   Huang YD, 2014, NEUROBIOL DIS, V72, P3, DOI 10.1016/j.nbd.2014.08.025
   Iqbal S, 2013, MUSCLE NERVE, V48, P963, DOI 10.1002/mus.23838
   Jang YC, 2009, EXP GERONTOL, V44, P256, DOI 10.1016/j.exger.2008.12.006
   Jeppesen TD, 2020, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.00349
   Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Khatoon R, 2019, NEUROSCI LETT, V711, P0, DOI 10.1016/j.neulet.2019.134376
   Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Konopka AR, 2014, J GERONTOL A-BIOL, V69, P371, DOI 10.1093/gerona/glt107
   Kriebel M, 2020, FRONT MOL NEUROSCI, V13, P0, DOI 10.3389/fnmol.2020.00043
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kulic L, 2011, NEUROBIOL AGING, V32, P1827, DOI 10.1016/j.neurobiolaging.2009.10.014
   Kulkarni AS, 2018, AGING CELL, V17, P0, DOI 10.1111/acel.12723
   Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976
   Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000
   Laberge RM, 2013, CELL DEATH DIS, V4, P0, DOI 10.1038/cddis.2013.199
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0
   Lasserre JP, 2015, DIS MODEL MECH, V8, P509, DOI 10.1242/dmm.020438
   Lawless C, 2020, OPEN BIOL, V10, P0, DOI 10.1098/rsob.200061
   Leduc-Gaudet JP, 2015, ONCOTARGET, V6, P17923, DOI 10.18632/oncotarget.4235
   Lei YJ, 2021, SCI ADV, V7, P0, DOI 10.1126/sciadv.abe7548
   LERNER AB, 1958, J AM CHEM SOC, V80, P2587, DOI 10.1021/ja01543a060
   Levine MS, 2004, TRENDS NEUROSCI, V27, P691, DOI 10.1016/j.tins.2004.08.008
   Li Jia Yi, 2005, NEURORX, V2, P447, DOI 10.1602/neurorx.2.3.447
   Li ZX, 2023, EUR J PHARM BIOPHARM, V182, P41, DOI 10.1016/j.ejpb.2022.11.022
   Liraz O, 2013, MOL NEURODEGENER, V8, P0, DOI 10.1186/1750-1326-8-16
   Liu ZW, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/2525967
   LÃ³pez-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014
   LÃ³pez-Otin C, 2023, CELL, V186, P243, DOI 10.1016/j.cell.2022.11.001
   LÃ³pez-OtÃ­n C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   MACAYA A, 1994, P NATL ACAD SCI USA, V91, P8117, DOI 10.1073/pnas.91.17.8117
   Madsen PM, 2017, J NEUROSCI, V37, P10185, DOI 10.1523/JNEUROSCI.1378-17.2017
   Maekawa H, 2019, CELL REP, V29, P1261, DOI 10.1016/j.celrep.2019.09.050
   Manczak M, 2005, J NEUROCHEM, V92, P494, DOI 10.1111/j.1471-4159.2004.02884.x
   Marchi S, 2023, NAT REV IMMUNOL, V23, P159, DOI 10.1038/s41577-022-00760-x
   Markaki M, 2017, AUTOPHAGY: CANCER, V0, P0
   MartÃ­n M, 2000, J PINEAL RES, V28, P242, DOI 10.1034/j.1600-079X.2000.280407.x
   Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3
   Masters Alina, 2014, BRAIN DISORD THER, V4, P0
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   Mattar JM, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23073921
   Matthews RT, 1998, P NATL ACAD SCI USA, V95, P8892, DOI 10.1073/pnas.95.15.8892
   Mattison JA, 2017, NAT COMMUN, V8, P0, DOI 10.1038/ncomms14063
   Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432
   Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   McClean PL, 2014, NEUROPHARMACOLOGY, V76, P57, DOI 10.1016/j.neuropharm.2013.08.005
   Melzer D, 2020, NAT REV GENET, V21, P88, DOI 10.1038/s41576-019-0183-6
   Mhyre Timothy R, 2012, SUBCELL BIOCHEM, V65, P389, DOI 10.1007/978-94-007-5416-4_16
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Montava-Garriga L, 2020, J MOL BIOL, V432, P206, DOI 10.1016/j.jmb.2019.06.032
   Mor DE, 2020, P NATL ACAD SCI USA, V117, P26438, DOI 10.1073/pnas.2009838117
   Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006
   Mullin S, 2013, MOL NEUROBIOL, V47, P587, DOI 10.1007/s12035-013-8394-x
   MUNSCHER C, 1993, FEBS LETT, V317, P27, DOI 10.1016/0014-5793(93)81484-H
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799
   Narendra DP, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000298
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, PR1244, DOI 10.1152/ajpregu.00226.2004
   Nilsson MI, 2019, BIOLOGY-BASEL, V8, P0, DOI 10.3390/biology8020040
   Nilsson MI, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0210863
   Niu X, 2007, EXP CELL RES, V313, P3924, DOI 10.1016/j.yexcr.2007.05.029
   Nopoulos PC, 2016, DIALOGUES CLIN NEURO, V18, P91
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3
   Oettinghaus B, 2016, CELL DEATH DIFFER, V23, P18, DOI 10.1038/cdd.2015.39
   Oliveira JMA, 2007, J NEUROCHEM, V101, P241, DOI 10.1111/j.1471-4159.2006.04361.x
   Oliveira JMA, 2006, J NEUROSCI, V26, P11174, DOI 10.1523/JNEUROSCI.3004-06.2006
   Omodei D, 2011, FEBS LETT, V585, P1537, DOI 10.1016/j.febslet.2011.03.015
   Onyango IG, 2016, AGING DIS, V7, P201, DOI 10.14336/AD.2015.1007
   Papa S, 2012, ADV EXP MED BIOL, V942, P3, DOI 10.1007/978-94-007-2869-1_1
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Park JS, 2018, CURR NEUROL NEUROSCI, V18, P0, DOI 10.1007/s11910-018-0829-3
   Park JS, 2014, HUM MOL GENET, V23, P2802, DOI 10.1093/hmg/ddt623
   Partridge L, 2010, PHILOS T R SOC B, V365, P147, DOI 10.1098/rstb.2009.0222
   Peng Y, 2010, J NEUROSCI, V30, P8180, DOI 10.1523/JNEUROSCI.0340-10.2010
   Perluigi M, 2010, J NEUROSCI RES, V88, P3498, DOI 10.1002/jnr.22500
   Peters R, 2006, POSTGRAD MED J, V82, P84, DOI 10.1136/pgmj.2005.036665
   Picca A, 2017, INT J MOL SCI, V18, P0, DOI 10.3390/ijms18050933
   Pizzino G, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/8416763
   Pizzuto M, 2020, TRENDS CELL BIOL, V30, P892, DOI 10.1016/j.tcb.2020.09.004
   Pullerits R, 2005, RHEUMATOLOGY, V44, P32, DOI 10.1093/rheumatology/keh406
   Pyo JO, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3300
   Qian S, 1998, NEURON, V20, P611, DOI 10.1016/S0896-6273(00)80999-X
   Qin WP, 2009, ARCH NEUROL-CHICAGO, V66, P352, DOI 10.1001/archneurol.2008.588
   Qiu Chengxuan, 2009, DIALOGUES CLIN NEUROSCI, V11, P111
   Quintana FJ, 2005, J IMMUNOL, V175, P2777, DOI 10.4049/jimmunol.175.5.2777
   QuirÃ³s PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984
   Rabin JS, 2019, JAMA NEUROL, V76, P1203, DOI 10.1001/jamaneurol.2019.1879
   Raoof M, 2010, J TRAUMA, V68, P1328, DOI 10.1097/TA.0b013e3181dcd28d
   Rattray I, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0084726
   Rebrin I, 2007, BRAIN RES, V1127, P10, DOI 10.1016/j.brainres.2006.10.040
   Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002
   Reddy PH, 2008, NEUROMOL MED, V10, P291, DOI 10.1007/s12017-008-8044-z
   Reddy PH, 2009, BRAIN RES REV, V61, P33, DOI 10.1016/j.brainresrev.2009.04.001
   Reimers C D, 2012, J AGING RES, V2012, P243958, DOI 10.1155/2012/243958
   Ricca C, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19061672
   Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763
   Romero-Garcia S, 2019, INT J ONCOL, V54, P1155, DOI 10.3892/ijo.2019.4696
   Ross JM, 2024, BIOMOLECULES, V14, P0, DOI 10.3390/biom14020162
   Ross JM, 2019, AGING CELL, V18, P0, DOI 10.1111/acel.13029
   Ross JM, 2015, INT J MOL SCI, V16, P19458, DOI 10.3390/ijms160819458
   Ross JM, 2014, SCI REP-UK, V4, P0, DOI 10.1038/srep06569
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6
   Roy J, 2022, FRONT NEUROENDOCRIN, V65, P0, DOI 10.1016/j.yfrne.2022.100986
   Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657
   Ruetenik A, 2015, BBA-BIOENERGETICS, V1847, P1434, DOI 10.1016/j.bbabio.2015.05.005
   Salim S, 2017, J PHARMACOL EXP THER, V360, P201, DOI 10.1124/jpet.116.237503
   Sams Eleanor Catherine, 2021, NEURONAL SIGNAL, V5, PNS20210008, DOI 10.1042/NS20210008
   Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029
   Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858
   Scarffe LA, 2014, TRENDS NEUROSCI, V37, P315, DOI 10.1016/j.tins.2014.03.004
   Schmukler E, 2020, CELL DEATH DIS, V11, P0, DOI 10.1038/s41419-020-02776-4
   Scott L, 2022, J NEUROSCI, V42, P9263, DOI 10.1523/JNEUROSCI.0545-22.2022
   SebastiÃ¡n D, 2016, EMBO J, V35, P1677, DOI 10.15252/embj.201593084
   Sharifi-Rad M, 2020, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.00694
   Sharma P, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8020100
   Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   Shin SJ, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20123030
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Sikora E, 2021, FRONT AGING NEUROSCI, V13, P0, DOI 10.3389/fnagi.2021.646924
   Simon DK, 2004, NEUROBIOL AGING, V25, P71, DOI 10.1016/S0197-4580(03)00037-X
   Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169
   Snezhkina AV, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/6175804
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Son HG, 2019, AGING CELL, V18, P0, DOI 10.1111/acel.12853
   SOONG NW, 1992, NAT GENET, V2, P318
   Spindler M, 2009, NEUROPSYCH DIS TREAT, V5, P597
   Srivastava S, 2017, GENES-BASEL, V8, P0, DOI 10.3390/genes8120398
   Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025
   Stauch KL, 2014, AGING-US, V6, P320, DOI 10.18632/aging.100657
   Stefano GB, 2017, ADV EXP MED BIOL, V982, P577, DOI 10.1007/978-3-319-55330-6_30
   Sterky FH, 2012, HUM MOL GENET, V21, P1078, DOI 10.1093/hmg/ddr537
   Strobbe D, 2018, FRONT MOL NEUROSCI, V11, P0, DOI 10.3389/fnmol.2018.00068
   Stuart Jeffrey A, 2014, LONGEV HEALTHSPAN, V3, P4, DOI 10.1186/2046-2395-3-4
   Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814
   Swerdlow RH, 2014, BBA-MOL BASIS DIS, V1842, P1219, DOI 10.1016/j.bbadis.2013.09.010
   Tan DX, 2016, INT J MOL SCI, V17, P0, DOI 10.3390/ijms17122124
   Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986
   TELLEZNAGEL I, 1974, J NEUROPATH EXP NEUR, V33, P308, DOI 10.1097/00005072-197404000-00008
   Terock J, 2022, PSYCHIAT RES-NEUROIM, V327, P0, DOI 10.1016/j.pscychresns.2022.111558
   Tezze C, 2017, CELL METAB, V25, P1374, DOI 10.1016/j.cmet.2017.04.021
   TÃ¶nnies E, 2017, J ALZHEIMERS DIS, V57, P1105, DOI 10.3233/JAD-161088
   Tordjman S, 2017, CURR NEUROPHARMACOL, V15, P434, DOI 10.2174/1570159X14666161228122115
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vaittinen M, 2023, DIABETES RES CLIN PR, V199, P0, DOI 10.1016/j.diabres.2023.110635
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011072
   Van Raamsdonk JM, 2007, BRAIN RES BULL, V72, P124, DOI 10.1016/j.brainresbull.2006.10.018
   VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X
   Varela-LÃ³pez A, 2016, MOLECULES, V21, P0, DOI 10.3390/molecules21030373
   Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369
   Wan M, 2014, ATHEROSCLEROSIS, V235, P592, DOI 10.1016/j.atherosclerosis.2014.05.913
   Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015
   Wang XL, 2012, HUM MOL GENET, V21, P1931, DOI 10.1093/hmg/dds003
   Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105
   Wang ZT, 2023, ZOOL RES, V44, P559, DOI 10.24272/j.issn.2095-8137.2022.406
   Warby SC, 2009, AM J HUM GENET, V84, P351, DOI 10.1016/j.ajhg.2009.02.003
   Waziry R, 2023, NATURE AGING, V3, P248, DOI 10.1038/s43587-022-00357-y
   Weber D, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/1401452
   Webster SJ, 2013, ALZHEIMERS RES THER, V5, P0, DOI 10.1186/alzrt182
   WEI YH, 1992, MUTAT RES, V275, P145, DOI 10.1016/0921-8734(92)90019-L
   Weidling I, 2019, BIOLOGY-BASEL, V8, P0, DOI 10.3390/biology8020039
   Weinrich TW, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-48383-y
   Wenceslau CF, 2016, PULM PHARMACOL THER, V37, P49, DOI 10.1016/j.pupt.2016.02.005
   Wenceslau CF, 2015, AM J PHYSIOL-HEART C, V308, PH768, DOI 10.1152/ajpheart.00779.2014
   Wenz Tina, 2011, J AGING RES, V2011, P810619, DOI 10.4061/2011/810619
   Wescott AP, 2019, NAT METAB, V1, P975, DOI 10.1038/s42255-019-0126-8
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   Will Y, 2019, BIOLOGY-BASEL, V8, P0, DOI 10.3390/biology8020032
   Will Y, 2014, EXPERT OPIN DRUG MET, V10, P1061, DOI 10.1517/17425255.2014.939628
   Wimalawansa S, 2012, SRI LANKA J. DIABETES ENDOCRINOL. METAB, V2, P73, DOI 10.4038/sjdem.v2i2.4776
   Wimalawansa SJ, 2019, BIOLOGY-BASEL, V8, P0, DOI 10.3390/biology8020030
   Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013
   Wu JB, 2013, J IMMUNOL, V190, P3590, DOI 10.4049/jimmunol.1200860
   Wu YB, 2019, MITOCHONDRION, V49, P35, DOI 10.1016/j.mito.2019.07.003
   Xu Y, 2020, AUTOPHAGY, V16, P3, DOI 10.1080/15548627.2019.1603547
   Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106
   Yuan Y, 2018, FRONT COMPUT NEUROSC, V12, P0, DOI 10.3389/fncom.2018.00079
   Zeng XS, 2018, ASN NEURO, V10, P0, DOI 10.1177/1759091418777438
   Zhang HJ, 2022, FRONT PHARMACOL, V13, P0, DOI 10.3389/fphar.2022.1077249
   Zhang HQ, 2017, FREE RADICAL BIO MED, V111, P219, DOI 10.1016/j.freeradbiomed.2016.11.032
   Zhang XD, 2016, ELIFE, V5, P0, DOI 10.7754/eLife.13374
   Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663
   Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013
NR 319
TC 5
Z9 5
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1467-3037
EI 1467-3045
J9 CURR ISSUES MOL BIOL
JI Curr. Issues Mol. Biol.
PD MAR 15
PY 2024
VL 46
IS 3
BP 1987
EP 2026
DI 10.3390/cimb46030130
PG 40
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA MD1W8
UT WOS:001191607700001
PM 38534746
DA 2024-11-01
ER

PT J
AU Prasun, P
   Kohli, U
AF Prasun, Pankaj
   Kohli, Utkarsh
TI Making a case for mitochondria in hypertrophic cardiomyopathy
SO FUTURE CARDIOLOGY
LA English
DT Article
DE cardiomyopathy; gene panel; hypertrophic cardiomyopathy; mitochondria; mitochondrial DNA
AB Hypertrophic cardiomyopathy (HCM) is a well-known manifestation of inherited mitochondrial disease. Still, currently available gene panels do not include mitochondrial genome sequencing. Mitochondrial dysfunction plays a very important role in the pathogenesis of HCM, whether tested positive or negative by the currently available gene panels for HCM. Mitochondrial DNA variations may act as modifiers of disease manifestation in genotype-positive individuals. In genotype-negative individuals, it may be the primary driver of pathogenesis. A recent study has demonstrated that mitochondrial dysfunction is correlated with septal hypertrophy in genotype-negative HCM, which can be amenable to mitochondria-targeted therapy. It is important to consider mitochondrial genome sequencing as part of the genetic evaluation of HCM. Plain language summary: Hypertrophic cardiomyopathy or 'thick heart' is a common heart problem that can lead to abnormal heart rhythm and even heart failure. In older adults, it is often due to high blood pressure that causes the heart to pump against high resistance and hence becoming thick. However, it can occur without high blood pressure, often in young individuals with underlying heart muscle disease. Sometimes, there are many individuals in a family with thick hearts. In these instances, it is likely genetic. The individual may have a faulty gene related to heart muscle function causing the heart to become thick as an adaptation to inefficient heart muscle function. Mitochondria are tiny organelles inside our cells that make energy. When there is mitochondrial damage, heart muscles cannot generate energy efficiently. This can lead to a thick heart as well. Hence, it is important to test mitochondrial genes along with the heart muscle genes to find the cause of thick heart when it is unexplained, or a genetic cause is suspected.
C1 [Prasun, Pankaj; Kohli, Utkarsh] West Virginia Univ Med, Dept Pediat, Morgantown, WV 26506 USA.
RP Prasun, P (corresponding author), West Virginia Univ Med, Dept Pediat, Morgantown, WV 26506 USA.
EM Pankaj.prasun@hsc.wvu.edu
CR Chiang S, 2018, NEUROCHEM INT, V117, P35, DOI 10.1016/j.neuint.2017.08.002
   Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017
   Gruner C, 2013, CIRC-CARDIOVASC GENE, V6, P19, DOI 10.1161/CIRCGENETICS.112.963363
   Kargaran PK, 2020, J CLIN MED, V9, P0, DOI 10.3390/jcm9082349
   Kuno T, 2017, CASE REP CARDIOL, V2017, P0, DOI 10.1155/2017/9473917
   Lioncino M, 2022, HEART FAIL CLIN, V18, P51, DOI 10.1016/j.hfc.2021.07.003
   Nollet EE, 2023, EUR HEART J, V44, P1170, DOI 10.1093/eurheartj/ehad028
   Ommen SR, 2021, J THORAC CARDIOV SUR, V162, PE23, DOI 10.1016/j.jtcvs.2021.04.001
   Ranjbarvaziri S, 2021, CIRCULATION, V144, P1714, DOI 10.1161/CIRCULATIONAHA.121.053575
   Sabater-Molina M, 2018, CLIN GENET, V93, P3, DOI 10.1111/cge.13027
   Seneca S, 2005, AM J MED GENET A, V137A, P170, DOI 10.1002/ajmg.a.30854
   Sequeira V, 2019, FEBS LETT, V593, P1616, DOI 10.1002/1873-3468.13496
   Takeda A, 2021, J CLIN PATHOL, V74, P365, DOI 10.1136/jclinpath-2020-206801
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Veitia RA, 2019, CLIN GENET, V95, P542, DOI 10.1111/cge.13496
NR 15
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1479-6678
EI 1744-8298
J9 FUTUR CARDIOL
JI Futur. Cardiol.
PD MAR 11
PY 2024
VL 20
IS 4
BP 179
EP 182
DI 10.1080/14796678.2024.2360355
EA JUN 2024
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA ZN9U5
UT WOS:001242837600001
PM 39049772
DA 2024-11-01
ER

PT J
AU Matsumoto, S
   Uchiumi, T
   Noda, N
   Ueyanagi, Y
   Hotta, T
   Kang, DC
AF Matsumoto, Shinya
   Uchiumi, Takeshi
   Noda, Nozomi
   Ueyanagi, Yasushi
   Hotta, Taeko
   Kang, Dongchon
TI Droplet digital polymerase chain reaction to measure heteroplasmic m.3243A&gt;G mitochondrial mutations
SO LABORATORY MEDICINE
LA English
DT Article
DE droplet digital PCR; mitochondrial DNA; m; 3243A > G; heteroplasmy; mitochondrial disease; peripheral blood
ID a3243g mutation; lactic-acidosis; point mutation; dna; accurate; muscle; pcr; encephalomyopathy; quantitation; deafness
AB Objective Different mitochondrial DNA genotypes can coexist in a cell population as well as in a single cell, a condition known as heteroplasmy. Here, we accurately determined the heteroplasmy levels of the m.3243A>G mutation, which is the most frequently identified mutation in patients with mitochondrial diseases, using droplet digital polymerase chain reaction (ddPCR). Methods The m.3243A>G heteroplasmy levels in artificial heteroplasmy controls mixed with various proportions of wild-type and mutant plasmids were measured using ddPCR, PCR-restriction fragment length polymorphism, and Sanger sequencing. The m.3243A>G heteroplasmy levels in DNA, extracted from the peripheral blood of patients with suspected mitochondrial disease and healthy subjects, were determined using ddPCR. Results The accuracy of the ddPCR method was high. The lower limit of detection was 0.1%, which indicated its higher sensitivity compared with other methods. The m.3243A>G heteroplasmy levels in peripheral blood, measured using ddPCR, correlated inversely with age at the time of analysis. The m.3243A>G mutation may be overlooked in the peripheral blood-derived DNA of elderly people, as patients >60 years of age have heteroplasmy levels <10%, which is difficult to detect using methods other than the highly sensitive ddPCR. Conclusion ddPCR may be considered an accurate and sensitive method for measuring m.3243 A>G heteroplasmy levels of mitochondrial DNA.
C1 [Matsumoto, Shinya; Uchiumi, Takeshi; Noda, Nozomi; Ueyanagi, Yasushi; Hotta, Taeko] Kyushu Univ Hosp, Dept Clin Chem & Lab Med, Fukuoka, Japan.
   [Uchiumi, Takeshi; Kang, Dongchon] Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, Fukuoka, Japan.
   [Uchiumi, Takeshi] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Fukuoka, Japan.
C3 Kyushu University; Kyushu University; Kyushu University
RP Matsumoto, S (corresponding author), Kyushu Univ Hosp, Dept Clin Chem & Lab Med, Fukuoka, Japan.
EM matsumoto.shinya.544@m.kyushu-u.ac.jp
CR Biggin A, 2005, MOL GENET METAB, V84, P61, DOI 10.1016/j.ymgme.2004.09.011
   CIAFALONI E, 1991, NEUROLOGY, V41, P1663, DOI 10.1212/WNL.41.10.1663
   Dubeau F, 2000, ANN NEUROL, V47, P179, DOI 10.1002/1531-8249(200002)47:2<179::AID-ANA7>3.0.CO;2-Z
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Hudecova I, 2015, CLIN BIOCHEM, V48, P948, DOI 10.1016/j.clinbiochem.2015.03.015
   Ji KQ, 2020, J NEUROL, V267, P3319, DOI 10.1007/s00415-020-10017-z
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   Liou CW, 2001, DIABETES RES CLIN PR, V54, PS39, DOI 10.1016/S0168-8227(01)00334-5
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   Murdock DG, 2000, NUCLEIC ACIDS RES, V28, P4350, DOI 10.1093/nar/28.21.4350
   Newkirk JE, 1997, DIABETIC MED, V14, P457, DOI 10.1002/(SICI)1096-9136(199706)14:6<457::AID-DIA372>3.3.CO;2-N
   Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955
   Rong EG, 2018, BIOMED RES INT, V2018, P0, DOI 10.1155/2018/1286480
   Sho SN, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0170897
   Smith ML, 1997, J CLIN ENDOCR METAB, V82, P2826, DOI 10.1210/jc.82.9.2826
   Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8
   Sunde K, 2016, MOL GENET METAB REP, V9, P94, DOI 10.1016/j.ymgmr.2016.11.002
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Suzuki Y, 1997, J NEUROL SCI, V145, P49, DOI 10.1016/S0022-510X(96)00239-0
   tHart LM, 1996, HUM MUTAT, V7, P193
   Uimonen S, 2001, HUM GENET, V108, P284, DOI 10.1007/s004390100475
   Urata M, 2004, CLIN CHEM, V50, P2045, DOI 10.1373/clinchem.2004.033761
   Urata M, 1998, CLIN CHEM, V44, P2088
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   Wachsmuth M, 2016, PLOS GENET, V12, P0, DOI 10.1371/journal.pgen.1005939
   Whale AS, 2012, NUCLEIC ACIDS RES, V40, P0, DOI 10.1093/nar/gks203
   Yan JB, 2014, J MOL DIAGN, V16, P431, DOI 10.1016/j.jmoldx.2014.03.005
   Yang MG, 2021, FRONT ENDOCRINOL, V12, P0, DOI 10.3389/fendo.2021.728043
   Ye W, 2017, ANAL BIOANAL CHEM, V409, P2727, DOI 10.1007/s00216-017-0217-x
NR 34
TC 2
Z9 2
U1 1
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0007-5027
EI 1943-7730
J9 LAB MED
JI Lab. Med.
PD MAR 7
PY 2024
VL 55
IS 2
BP 227
EP 233
DI 10.1093/labmed/lmad063
EA JUL 2023
PG 7
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA KB5F5
UT WOS:001030281400001
PM 37478467
DA 2024-11-01
ER

PT J
AU Gomes, TMB
   Vincent, AE
   Menger, KE
   Stewart, JB
   Nicholls, TJ
AF Gomes, Tiago M. Bernardino
   Vincent, Amy E.
   Menger, Katja E.
   Stewart, James B.
   Nicholls, Thomas J.
TI Mechanisms and pathologies of human mitochondrial DNA replication and deletion formation
SO BIOCHEMICAL JOURNAL
LA English
DT Review
ID mouse l-cells; progressive external ophthalmoplegia; topoisomerase iii-alpha; large-scale deletions; marie-tooth disease; polymerase-gamma; binding-protein; rna-polymerase; transcription factor; skeletal-muscle
AB Human mitochondria possess a multi-copy circular genome, mitochondrial DNA (mtDNA), that is essential for cellular energy metabolism. The number of copies of mtDNA per cell, and their integrity, are maintained by nuclear-encoded mtDNA replication and repair machineries. Aberrant mtDNA replication and mtDNA breakage are believed to cause deletions within mtDNA. The genomic location and breakpoint sequences of these deletions show similar patterns across various inherited and acquired diseases, and are also observed during normal ageing, suggesting a common mechanism of deletion formation. However, an ongoing debate over the mechanism by which mtDNA replicates has made it difficult to develop clear and testable models for how mtDNA rearrangements arise and propagate at a molecular and cellular level. These deletions may impair energy metabolism if present in a high proportion of the mtDNA copies within the cell, and can be seen in primary mitochondrial diseases, either in sporadic cases or caused by autosomal variants in nuclear-encoded mtDNA maintenance genes. These mitochondrial diseases have diverse genetic causes and multiple modes of inheritance, and show notoriously broad clinical heterogeneity with complex tissue specificities, which further makes establishing genotype-phenotype relationships challenging. In this review, we aim to cover our current understanding of how the human mitochondrial genome is replicated, the mechanisms by which mtDNA replication and repair can lead to mtDNA instability in the form of large-scale rearrangements, how rearranged mtDNAs subsequently accumulate within cells, and the pathological consequences when this occurs.
C1 [Gomes, Tiago M. Bernardino; Vincent, Amy E.] Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, Newcastle Upon Tyne NE2 4HH, England.
   [Gomes, Tiago M. Bernardino; Vincent, Amy E.; Menger, Katja E.; Stewart, James B.; Nicholls, Thomas J.] Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, England.
   [Gomes, Tiago M. Bernardino] Newcastle Tyne Hosp NHS Fdn Trust, NHS England Highly Specialised Serv Rare Mitochond, Newcastle Upon Tyne NE2 4HH, England.
   [Menger, Katja E.; Stewart, James B.; Nicholls, Thomas J.] Newcastle Univ, Biosci Inst, Fac Med Sci, Newcastle Upon Tyne NE2 4HH, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK
RP Nicholls, TJ (corresponding author), Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, England.; Nicholls, TJ (corresponding author), Newcastle Univ, Biosci Inst, Fac Med Sci, Newcastle Upon Tyne NE2 4HH, England.
EM thomas.nicholls@newcastle.ac.uk
CR Agaronyan K, 2015, SCIENCE, V347, P548, DOI 10.1126/science.aaa0986
   Ahmed N, 2015, INT J MOL SCI, V16, P18054, DOI 10.3390/ijms160818054
   Al-Behadili A, 2018, NUCLEIC ACIDS RES, V46, P9471, DOI 10.1093/nar/gky708
   Al-Gadi IS, 2018, J ENDOCR SOC, V2, P361, DOI 10.1210/js.2017-00434
   Al-Hussaini A, 2014, J PEDIATR-US, V164, P553, DOI 10.1016/j.jpeds.2013.10.082
   ALBERTINI AM, 1982, CELL, V29, P319, DOI 10.1016/0092-8674(82)90148-9
   Alonzo JR, 2018, J BIOL CHEM, V293, P20285, DOI 10.1074/jbc.RA118.004788
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Antes A, 2010, NUCLEIC ACIDS RES, V38, P6466, DOI 10.1093/nar/gkq493
   Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348
   Bailey LJ, 2017, BIOCHEM SOC T, V45, P513, DOI 10.1042/BST20160162
   Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   Baines HL, 2014, MECH AGEING DEV, V139, P22, DOI 10.1016/j.mad.2014.06.003
   Basu S, 2020, PLOS GENET, V16, P0, DOI 10.1371/journal.pgen.1009242
   Bayona-Bafaluy MP, 2005, P NATL ACAD SCI USA, V102, P14392, DOI 10.1073/pnas.0502896102
   Bedford E, 1997, P NATL ACAD SCI USA, V94, P479, DOI 10.1073/pnas.94.2.479
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Berardo A, 2022, J NEUROMUSCULAR DIS, V9, P225, DOI 10.3233/JND-210786
   BERK AJ, 1974, J MOL BIOL, V86, P801, DOI 10.1016/0022-2836(74)90355-6
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   Bharti SK, 2014, J BIOL CHEM, V289, P29975, DOI 10.1074/jbc.M114.567073
   Bianchi J, 2013, MOL CELL, V52, P566, DOI 10.1016/j.molcel.2013.10.035
   Bizard AH, 2020, J BIOL CHEM, V295, P7138, DOI 10.1074/jbc.REV120.008286
   BOGENHAGEN D, 1978, J MOL BIOL, V119, P49, DOI 10.1016/0022-2836(78)90269-3
   Bombelli F, 2014, JAMA NEUROL, V71, P1036, DOI 10.1001/jamaneurol.2014.629
   Bonnen PE, 2013, AM J HUM GENET, V93, P773, DOI 10.1016/j.ajhg.2013.09.003
   Borsche M, 2024, CEREBELLUM, V23, P479, DOI 10.1007/s12311-023-01557-x
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Brown TA, 2002, NUCLEIC ACIDS RES, V30, P2004, DOI 10.1093/nar/30.9.2004
   Brzezniak LK, 2011, RNA BIOL, V8, P616, DOI 10.4161/rna.8.4.15393
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Buchaklian AH, 2012, MOL GENET METAB, V107, P92, DOI 10.1016/j.ymgme.2012.04.019
   Bugiardini E, 2017, NEUROL-GENET, V3, P0, DOI 10.1212/NXG.0000000000000149
   Burr SP, 2018, DEV GROWTH DIFFER, V60, P21, DOI 10.1111/dgd.12420
   Campbell G, 2014, HUM MOL GENET, V23, P4612, DOI 10.1093/hmg/ddu176
   CarreÃ±o-Gago L, 2019, FRONT GENET, V10, P0, DOI 10.3389/fgene.2019.00576
   Carrodeguas JA, 2002, J BIOL CHEM, V277, P50008, DOI 10.1074/jbc.M207030200
   Carrodeguas JA, 1999, MOL CELL BIOL, V19, P4039
   Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8
   Carrozzo R, 2016, J INHERIT METAB DIS, V39, P243, DOI 10.1007/s10545-015-9894-9
   Cejka P, 2021, ANNU REV GENET, V55, P285, DOI 10.1146/annurev-genet-071719-020312
   Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1
   Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x
   CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351
   CHANG DD, 1987, EMBO J, V6, P409, DOI 10.1002/j.1460-2075.1987.tb04770.x
   Chapman J, 2020, LIFE-BASEL, V10, P0, DOI 10.3390/life10090164
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen T, 2011, J HUM GENET, V56, P689, DOI 10.1038/jhg.2011.97
   Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7
   Chung KW, 2006, BRAIN, V129, P2103, DOI 10.1093/brain/awl174
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Cluett TJ, 2018, NUCLEIC ACIDS RES, V46, P10771, DOI 10.1093/nar/gky852
   Constantinou A, 2001, CELL, V104, P259, DOI 10.1016/S0092-8674(01)00210-0
   Conti F, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms242316746
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Dalla Rosa I, 2017, J BIOL CHEM, V292, P20162, DOI 10.1074/jbc.M117.815241
   Dalla Rosa I, 2014, J BIOL CHEM, V289, P18595, DOI 10.1074/jbc.M114.555367
   Damas J, 2014, NUCLEIC ACIDS RES, V42, PD1261, DOI 10.1093/nar/gkt982
   DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Doimo M, 2023, NUCLEIC ACIDS RES, V51, P7392, DOI 10.1093/nar/gkad535
   DÃ¶lle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Dong DW, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-677
   Dosekova P, 2020, EUR J MED GENET, V63, P0, DOI 10.1016/j.ejmg.2019.103821
   DUNBAR DR, 1993, HUM MOL GENET, V2, P1619, DOI 10.1093/hmg/2.10.1619
   Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88
   Durham SE, 2006, NEUROLOGY, V67, P502, DOI 10.1212/01.wnl.0000227961.55640.2f
   El-Hattab AW, 2018, HUM MUTAT, V39, P461, DOI 10.1002/humu.23387
   El-Hattab AW, 2017, HUM MUTAT, V38, P1649, DOI 10.1002/humu.23341
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Erdinc D, 2023, EMBO MOL MED, V15, P0, DOI 10.15252/emmm.202216775
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Farr CL, 1999, J BIOL CHEM, V274, P14779, DOI 10.1074/jbc.274.21.14779
   Farruggia P, 2016, JIMD REP, V26, P37, DOI 10.1007/8904_2015_470
   Fellman V, 2011, SEMIN FETAL NEONAT M, V16, P222, DOI 10.1016/j.siny.2011.05.002
   Ferreira CR, 2021, J INHERIT METAB DIS, V44, P164, DOI 10.1002/jimd.12348
   Finsterer J, 2018, BIOMED REP, V9, P119, DOI 10.3892/br.2018.1115
   Finsterer J, 2018, NEUROPEDIATRICS, V49, P231, DOI 10.1055/s-0037-1609039
   Finsterer J, 2017, THER ADV GASTROENTER, V10, P142, DOI 10.1177/1756283X16666806
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   Frascarelli C, 2023, FRONT GENET, V14, P0, DOI 10.3389/fgene.2023.1089956
   Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   FRIDLENDER B, 1972, P NATL ACAD SCI USA, V69, P452, DOI 10.1073/pnas.69.2.452
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   FustÃ© JM, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004832
   FustÃ© JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001
   Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773
   GarcÃ­a-GÃ³mez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465
   GILLUM AM, 1979, J MOL BIOL, V135, P353, DOI 10.1016/0022-2836(79)90441-8
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   Glastad RC, 2023, PLOS COMPUT BIOL, V19, P0, DOI 10.1371/journal.pcbi.1010953
   GonzÃ¡lez-del Angel A, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.01049
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Govers LP, 2021, PEDIATR NEPHROL, V36, P9, DOI 10.1007/s00467-019-04404-6
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   GRAY H, 1992, J BIOL CHEM, V267, P5835
   Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476
   Greaves LC, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004620
   GREENLEAF AL, 1986, P NATL ACAD SCI USA, V83, P3391, DOI 10.1073/pnas.83.10.3391
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402
   HagstrÃ¶m E, 2014, NUCLEIC ACIDS RES, V42, P1111, DOI 10.1093/nar/gkt969
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Hangas A, 2022, NUCLEIC ACIDS RES, V50, P8733, DOI 10.1093/nar/gkac660
   Hangas A, 2018, NUCLEIC ACIDS RES, V46, P9625, DOI 10.1093/nar/gky793
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Hikmat O, 2017, GENET MED, V19, P1217, DOI 10.1038/gim.2017.35
   Hillen HS, 2017, CELL, V171, P1072, DOI 10.1016/j.cell.2017.10.036
   Holmes JB, 2015, P NATL ACAD SCI USA, V112, P9334, DOI 10.1073/pnas.1503653112
   Holt IJ, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a012971
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603
   Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013
   HOWELL N, 1983, SOMAT CELL GENET, V9, P1, DOI 10.1007/BF01544045
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506
   Imasawa T, 2022, KIDNEY INT REP, V7, P580, DOI 10.1016/j.ekir.2021.12.028
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Insalata F, 2022, P NATL ACAD SCI USA, V119, P0, DOI 10.1073/pnas.2122073119
   Itoh Y, 2021, SCIENCE, V371, P846, DOI 10.1126/science.abe0763
   JAEKEN J, 1984, NEUROPEDIATRICS, V15, P165, DOI 10.1055/s-2008-1052362
   Jeedigunta SP, 2021, ANNU REV GENOM HUM G, V22, P55, DOI 10.1146/annurev-genom-121420-081805
   Jiang M, 2021, SCI ADV, V7, P0, DOI 10.1126/sciadv.abf8631
   Jiang S, 2019, EMBO REP, V20, P0, DOI 10.15252/embr.201948101
   Jiang WJ, 2021, BBA-MOL BASIS DIS, V1867, P0, DOI 10.1016/j.bbadis.2021.166106
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   KASAMATSU H, 1971, P NATL ACAD SCI USA, V68, P2252, DOI 10.1073/pnas.68.9.2252
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kaur P, 2018, NUCLEIC ACIDS RES, V46, P11287, DOI 10.1093/nar/gky875
   Kazama T, 2008, PLANT J, V55, P619, DOI 10.1111/j.1365-313X.2008.03529.x
   Keshavan N, 2018, ESSAYS BIOCHEM, V62, P423, DOI 10.1042/EBC20170108
   KISS T, 1992, EMBO J, V11, P3737, DOI 10.1002/j.1460-2075.1992.tb05459.x
   KISS T, 1992, CELL, V70, P11, DOI 10.1016/0092-8674(92)90528-K
   Koenig MK, 2017, NEUROLOGY, V88, P1919, DOI 10.1212/WNL.0000000000003936
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257
   Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   KOSKINEN T, 1994, MUSCLE NERVE, V17, P509, DOI 10.1002/mus.880170507
   Kowald A, 2018, GENES-BASEL, V9, P0, DOI 10.3390/genes9030126
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Krasich R, 2017, FRONT BIOSCI-LANDMRK, V22, P692, DOI 10.2741/4510
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   Lawless C, 2020, OPEN BIOL, V10, P0, DOI 10.1098/rsob.200061
   Lax NZ, 2017, NEUROPATH APPL NEURO, V43, P102, DOI 10.1111/nan.12333
   Lee DY, 1998, J BIOL CHEM, V273, P30614, DOI 10.1074/jbc.273.46.30614
   Lee DY, 1997, GENE DEV, V11, P582, DOI 10.1101/gad.11.5.582
   Lehmann D, 2019, NUCLEIC ACIDS RES, V47, P7430, DOI 10.1093/nar/gkz472
   Li W, 1998, P NATL ACAD SCI USA, V95, P1010, DOI 10.1073/pnas.95.3.1010
   Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918
   LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024
   LlauradÃ³ A, 2023, CLIN GENET, V103, P492, DOI 10.1111/cge.14287
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   LÃ¶nnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   LÃ³pez-Gallardo E, 2009, MITOCHONDRION, V9, P314, DOI 10.1016/j.mito.2009.04.005
   Low RL, 2003, EUR J BIOCHEM, V270, P4173, DOI 10.1046/j.1432-1033.2003.03814.x
   Lujan SA, 2020, GENOME BIOL, V21, P0, DOI 10.1186/s13059-020-02138-5
   Ma Y, 2021, FRONT NEUROL, V12, P0, DOI 10.3389/fneur.2021.757518
   Macao B, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8303
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Manea EM, 2009, J PEDIAT HEMATOL ONC, V31, P947, DOI 10.1097/MPH.0b013e3181bbc4ef
   Manini A, 2022, FRONT GENET, V13, P0, DOI 10.3389/fgene.2022.906667
   MARTENS PA, 1979, J MOL BIOL, V135, P327, DOI 10.1016/0022-2836(79)90440-6
   Martin CA, 2018, AM J HUM GENET, V103, P221, DOI 10.1016/j.ajhg.2018.07.001
   MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4
   Mathews CK, 2007, FASEB J, V21, P2294, DOI 10.1096/fj.06-7977rev
   Matic S, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-03552-x
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Menger KE, 2022, NUCLEIC ACIDS RES, V50, P11154, DOI 10.1093/nar/gkac857
   Menger KE, 2021, OPEN BIOL, V11, P0, DOI 10.1098/rsob.210168
   Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001
   Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051
   Minczuk M, 2011, NUCLEIC ACIDS RES, V39, P4284, DOI 10.1093/nar/gkq1224
   Misic J, 2022, NUCLEIC ACIDS RES, V50, P8749, DOI 10.1093/nar/gkac661
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MONTOYA J, 1982, P NATL ACAD SCI-BIOL, V79, P7195, DOI 10.1073/pnas.79.23.7195
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MORAES CT, 1995, MUSCLE NERVE, V0, PS150
   Moretton A, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0176795
   Morozov YI, 2014, NUCLEIC ACIDS RES, V42, P3884, DOI 10.1093/nar/gkt1356
   Muraki K, 1997, J INHERIT METAB DIS, V20, P697, DOI 10.1023/A:1005378527077
   Nasca A, 2017, ORPHANET J RARE DIS, V12, P0, DOI 10.1186/s13023-017-0641-1
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   Ng YS, 2022, BRAIN, V145, P542, DOI 10.1093/brain/awab353
   Nicholls TJ, 2018, MOL CELL, V69, P9, DOI 10.1016/j.molcel.2017.11.033
   Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nishino I, 2001, NEUROMUSCULAR DISORD, V11, P7, DOI 10.1016/S0960-8966(00)00159-0
   Nissanka N, 2019, TRENDS GENET, V35, P235, DOI 10.1016/j.tig.2019.01.001
   Nissanka N, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04895-1
   OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0
   OJALA D, 1981, J MOL BIOL, V150, P303, DOI 10.1016/0022-2836(81)90454-X
   Orsucci D, 2017, J NEUROL, V264, P1777, DOI 10.1007/s00415-017-8567-z
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Peeva V, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-04131-w
   Persson Ã, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-08673-5
   Peter BJ, 1998, CELL, V94, P819, DOI 10.1016/S0092-8674(00)81740-7
   Pham XH, 2006, J BIOL CHEM, V281, P24647, DOI 10.1074/jbc.M602429200
   Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014
   Phowthongkum P, 2017, NEUROMUSCULAR DISORD, V27, P616, DOI 10.1016/j.nmd.2017.03.013
   Pipis M, 2020, BRAIN, V143, P3589, DOI 10.1093/brain/awaa323
   Pitceathly RDS, 2012, NEUROMUSCULAR DISORD, V22, P577, DOI 10.1016/j.nmd.2012.03.009
   PohjoismÃ¤ki JLO, 2011, MITOCHONDRION, V11, P630, DOI 10.1016/j.mito.2011.04.002
   PohjoismÃ¤ki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029
   Pommier Y, 2022, NAT REV MOL CELL BIO, V23, P407, DOI 10.1038/s41580-022-00452-3
   Posse V, 2019, PLOS GENET, V15, P0, DOI 10.1371/journal.pgen.1007781
   Posse V, 2017, J BIOL CHEM, V292, P2637, DOI 10.1074/jbc.M116.751008
   Posse V, 2015, NUCLEIC ACIDS RES, V43, P2615, DOI 10.1093/nar/gkv105
   POULTON J, 1989, LANCET, V1, P236
   Prasad R, 2017, DNA REPAIR, V60, P77, DOI 10.1016/j.dnarep.2017.10.011
   Primiano G, 2022, NEUROL-GENET, V8, P0, DOI 10.1212/NXG.0000000000200007
   Qian YF, 2017, J BIOL CHEM, V292, P13068, DOI 10.1074/jbc.M117.791392
   RADLOFF R, 1967, P NATL ACAD SCI USA, V57, P1514, DOI 10.1073/pnas.57.5.1514
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Ramos ES, 2019, PLOS GENET, V15, P0, DOI 10.1371/journal.pgen.1008085
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Remtulla S, 2019, PEDIATR NEUROL, V90, P61, DOI 10.1016/j.pediatrneurol.2018.08.007
   Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196
   Richter-Dennerlein R, 2016, CELL, V167, P471, DOI 10.1016/j.cell.2016.09.003
   ROBBERSON DL, 1974, P NATL ACAD SCI USA, V71, P4447, DOI 10.1073/pnas.71.11.4447
   ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737
   Rocha EBD, 2023, NEUROMUSCULAR DISORD, V33, P692, DOI 10.1016/j.nmd.2023.06.004
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   ROTIG A, 1992, AM J HUM GENET, V50, P364
   Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Rusecka J, 2018, J APPL GENET, V59, P43, DOI 10.1007/s13353-017-0424-3
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Saha LK, 2024, CELL CYCLE, V23, P115, DOI 10.1080/15384101.2024.2314440
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060
   Sarfallah A, 2021, EMBO J, V40, P0, DOI 10.15252/embj.2021107988
   Schaefer AM, 2013, MOL CELL ENDOCRINOL, V379, P2, DOI 10.1016/j.mce.2013.06.004
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Schreier HK, 2022, GENES-BASEL, V13, P0, DOI 10.3390/genes13050879
   SebastiÃ¡n D, 2017, TRENDS MOL MED, V23, P201, DOI 10.1016/j.molmed.2017.01.003
   Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064
   SENGERS RCA, 1975, J PEDIATR-US, V86, P873, DOI 10.1016/S0022-3476(75)80217-4
   Shi YH, 2012, P NATL ACAD SCI USA, V109, P16510, DOI 10.1073/pnas.1119738109
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794
   Singh B, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0140409
   Sobek S, 2013, NUCLEIC ACIDS RES, V41, P9848, DOI 10.1093/nar/gkt768
   Solano A, 2003, J MED GENET, V40, P0, DOI 10.1136/jmg.40.7.e86
   SOONG NW, 1992, NAT GENET, V2, P318
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2024, TRENDS PHARMACOL SCI, V45, P225, DOI 10.1016/j.tips.2024.01.011
   Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001
   Suzuki Y, 2010, MOL CELL BIOL, V30, P5123, DOI 10.1128/MCB.00619-10
   Sykora P, 2017, MOL CELL BIOL, V37, P0, DOI 10.1128/MCB.00237-17
   Szczesny RJ, 2013, NUCLEIC ACIDS RES, V41, P3144, DOI 10.1093/nar/gkt029
   Tadi SK, 2016, MOL BIOL CELL, V27, P223, DOI 10.1091/mbc.E15-05-0260
   Takamatsu C, 2002, EMBO REP, V3, P451, DOI 10.1093/embo-reports/kvf099
   Tan BG, 2024, NAT REV MOL CELL BIO, V25, P119, DOI 10.1038/s41580-023-00661-4
   Tan BG, 2022, MOL CELL, V82, P3646, DOI 10.1016/j.molcel.2022.08.011
   Tang YY, 2000, MOL BIOL CELL, V11, P1471, DOI 10.1091/mbc.11.4.1471
   TAPPER DP, 1981, J BIOL CHEM, V256, P5109
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Ticci C, 2021, J CLIN MED, V10, P0, DOI 10.3390/jcm10102063
   TIRANTI V, 1993, GENE, V126, P219, DOI 10.1016/0378-1119(93)90370-I
   Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615
   Tranchant C, 2016, REV NEUROL-FRANCE, V172, P524, DOI 10.1016/j.neurol.2016.07.003
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tuppen HAL, 2023, METHODS MOL BIOL, V2615, P443, DOI 10.1007/978-1-0716-2922-2_29
   Uhler JP, 2016, NUCLEIC ACIDS RES, V44, P5861, DOI 10.1093/nar/gkw468
   Uhler JP, 2015, DNA REPAIR, V34, P28, DOI 10.1016/j.dnarep.2015.07.003
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vandiver AR, 2023, AGING CELL, V22, P0, DOI 10.1111/acel.13842
   Vandiver AR, 2022, MITOCHONDRION, V65, P176, DOI 10.1016/j.mito.2022.06.003
   VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x
   Vara R, 2023, J INHERIT METAB DIS, V46, P634, DOI 10.1002/jimd.12633
   Vincent AE, 2018, ANN NEUROL, V84, P289, DOI 10.1002/ana.25288
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a021220
   Walter MC, 2010, J NEUROL, V257, P1517, DOI 10.1007/s00415-010-5565-9
   Wang HY, 2022, FRONT CARDIOVASC MED, V8, P0, DOI 10.3389/fcvm.2021.808115
   Wang Y, 2002, P NATL ACAD SCI USA, V99, P12114, DOI 10.1073/pnas.192449499
   Wanrooij PH, 2012, NUCLEIC ACIDS RES, V40, P10334, DOI 10.1093/nar/gks802
   Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634
   Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105
   Wanrooij S, 2012, EMBO REP, V13, P1130, DOI 10.1038/embor.2012.161
   Whittaker RG, 2015, ANN NEUROL, V78, P949, DOI 10.1002/ana.24525
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Wisnovsky S, 2018, ACS CHEM BIOL, V13, P900, DOI 10.1021/acschembio.8b00072
   Wisnovsky S, 2016, NAT CHEM BIOL, V12, P567, DOI 10.1038/nchembio.2102
   Woodbridge P, 2013, INTERN MED J, V43, P150, DOI 10.1111/j.1445-5994.2012.02847.x
   Wu CHW, 2023, MOL GENET METAB, V139, P0, DOI 10.1016/j.ymgme.2023.107626
   XU BJ, 1995, MOL CELL BIOL, V15, P580, DOI 10.1128/MCB.15.1.580
   Xu BJ, 1996, EMBO J, V15, P3135, DOI 10.1002/j.1460-2075.1996.tb00676.x
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Yan B, 2022, GENOME RES, V32, P162, DOI 10.1101/gr.275784.121
   Yanagihara I, 2001, J PEDIATR-US, V139, P452, DOI 10.1067/mpd.2001.116296
   Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153
   Yang J, 2010, J BIOL CHEM, V285, P21426, DOI 10.1074/jbc.M110.123216
   Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9
   Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   Yoshimi A, 2022, ORPHANET J RARE DIS, V17, P0, DOI 10.1186/s13023-022-02538-9
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zeviani M, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23010210
   ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7
   Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998
   Zhang HL, 2008, BIOCHEMISTRY-US, V47, P11196, DOI 10.1021/bi800774b
   Zhang HL, 2014, NUCLEIC ACIDS RES, V42, P7259, DOI 10.1093/nar/gku384
   Zhu XF, 2022, CELL, V185, P2309, DOI 10.1016/j.cell.2022.05.006
   Zollo O, 2012, P NATL ACAD SCI USA, V109, P6508, DOI 10.1073/pnas.1118594109
   Zorkau M, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2008778118
NR 348
TC 0
Z9 0
U1 2
U2 2
PU PORTLAND PRESS LTD
PI LONDON
PA 1ST FLR, 10 QUEEN STREET PLACE, LONDON, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD JUN 15
PY 2024
VL 481
IS 11
BP 683
EP 715
DI 10.1042/BCJ20230262
PG 33
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA SQ1P4
UT WOS:001235827100001
PM 38804971
DA 2024-11-01
ER

PT J
AU Reiter, L
   Niehoff, N
   Weiland, D
   Helbig, D
   Eming, SA
   Krieg, T
   Etich, J
   Brachvogel, B
   Wiesner, RJ
   Knuever, J
AF Reiter, Lena
   Niehoff, Nadine
   Weiland, Daniela
   Helbig, Doris
   Eming, Sabine A.
   Krieg, Thomas
   Etich, Julia
   Brachvogel, Bent
   Wiesner, Rudolf J.
   Knuever, Jana
TI Mitochondrial DNA mutations attenuate Bleomycin-induced dermal fibrosis by inhibiting differentiation into myofibroblasts
SO MATRIX BIOLOGY
LA English
DT Article
DE Mitochondrial DNA; Twinkle helicase; Skin fibrosis; alpha-Smooth-muscle-actin; Myofibroblasts; Differentiation
ID collagen-lattices; mast-cells; skin; fibroblasts; deletions; mechanisms; mitophagy; exposure; promotes; marker
AB Post-mitotic, non-proliferative dermal fibroblasts have crucial functions in maintenance and restoration of tissue homeostasis. They are involved in essential processes such as wound healing, pigmentation and hair growth, but also tumor development and aging-associated diseases. These processes are energetically highly demanding and error prone when mitochondrial damage occurs. However, mitochondrial function in fibroblasts and the influence of mitochondrial dysfunction on fibroblast-specific demands are still unclear. To address these questions, we created a mouse model in which accelerated cell-specific mitochondrial DNA (mtDNA) damage accumulates. We crossed mice carrying a dominant-negative mutant of the mitochondrial replicative helicase Twinkle (RosaSTOP system) with mice that express fibroblast-specific Cre Recombinase (Collagen1A2 CreERT) ERT ) which can be activated by Tamoxifen (TwinkleFIBRO). FIBRO ). Thus, we are able to induce mtDNA deletions and duplications in specific cells, a process which resembles the physiological aging process in humans, where this damage accumulates in all tissues. Upon proliferation in vitro, , Tamoxifen induced Twinkle fibroblasts deplete most of their mitochondrial DNA which, although not disturbing the stoichiometry of the respiratory chain complexes, leads to reduced ROS production and mitochondrial membrane potential as well as an anti-inflammatory and anti-fibrotic profile of the cells. In Sodium Azide treated wildtype fibroblasts, without a functioning respiratory chain, we observe the opposite, a rather pro-inflammatory and pro-fibrotic signature. Upon accumulation of mitochondrial DNA mutations in vivo the TwinkleFIBRO FIBRO mice are protected from fibrosis development induced by intradermal Bleomycin injections. This is due to dampened differentiation of the dermal fibroblasts into alpha- smooth-muscle-actin positive myofibroblasts in TwinkleFIBRO FIBRO mice. We thus provide evidence for striking differences of the impact that mtDNA mutations have in contrast to blunted mitochondrial function in dermal fibroblasts and skin homeostasis. These data contribute to improved understanding of mitochondrial function and dysfunction in skin and provide mechanistic insight into potential targets to treat skin fibrosis in the future.
C1 [Reiter, Lena; Niehoff, Nadine; Weiland, Daniela; Wiesner, Rudolf J.] Univ Cologne, Inst Vegetat Physiol, Ctr Physiol & Pathophysiol, D-50931 Cologne, Germany.
   [Weiland, Daniela] Univ Cologne, Inst Virol, Fac Med, Lab Expt Immunol, D-50931 Cologne, Germany.
   [Helbig, Doris; Eming, Sabine A.; Krieg, Thomas; Knuever, Jana] Univ Cologne, Fac Med, Dept Dermatol & Venereol, D-50937 Cologne, Germany.
   [Helbig, Doris; Eming, Sabine A.; Krieg, Thomas; Knuever, Jana] Univ Cologne, Univ Hosp Cologne, D-50937 Cologne, Germany.
   [Eming, Sabine A.; Krieg, Thomas; Brachvogel, Bent; Wiesner, Rudolf J.] Univ Cologne, Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany.
   [Eming, Sabine A.; Krieg, Thomas; Brachvogel, Bent; Wiesner, Rudolf J.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respons, D-50931 Cologne, Germany.
   [Eming, Sabine A.] Univ Cologne, Inst Zool, Dev Biol Unit, D-50674 Cologne, Germany.
   [Krieg, Thomas] Univ Cologne, Med Fac, Translat Matrix Biol, D-50931 Cologne, Germany.
   [Etich, Julia; Brachvogel, Bent] Univ Cologne, Fac Med, Dept Pediat & Adolescent Med, Expt Neonatol, D-50931 Cologne, Germany.
   [Etich, Julia; Brachvogel, Bent] Univ Cologne, Univ Hosp Cologne, D-50931 Cologne, Germany.
C3 University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne
RP Knuever, J (corresponding author), Univ Cologne, Fac Med, Dept Dermatol & Venereol, D-50937 Cologne, Germany.
EM jana.naetlitz@uk-koeln.de
FU Koeln Fortune program/Faculty of Medicine/University of Cologne [254/2022]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [FOR2722-BR2304/12-1-407146744, ET144/3-2384170921, BR2304/7-1-207342459]
CR Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345
   Birch-Machin MA, 1998, J INVEST DERMATOL, V110, P149, DOI 10.1046/j.1523-1747.1998.00099.x
   Blagov AV, 2024, FRONT PHARMACOL, V15, P0, DOI 10.3389/fphar.2024.1378335
   Bubb K, 2021, J BIOL CHEM, V297, P0, DOI 10.1016/j.jbc.2021.101224
   Cantanhede IG, 2022, FRONT IMMUNOL, V13, P0, DOI 10.3389/fimmu.2022.1004949
   Chu XG, 2019, FRONT IMMUNOL, V10, P0, DOI 10.3389/fimmu.2019.02431
   Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   Forrester SJ, 2018, CIRC RES, V122, P877, DOI 10.1161/CIRCRESAHA.117.311401
   ForsstrÃ¶m S, 2019, CELL METAB, V30, P1040, DOI 10.1016/j.cmet.2019.013.019
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Huang JW, 2022, SEMIN CELL DEV BIOL, V128, P137, DOI 10.1016/j.semcdb.2022.02.027
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Insalata F, 2022, P NATL ACAD SCI USA, V119, P0, DOI 10.1073/pnas.2122073119
   Johnson BZ, 2020, BIOMEDICINES, V8, P0, DOI 10.3390/biomedicines8050101
   Karan KR, 2022, J MOL MED, V100, P963, DOI 10.1007/s00109-022-02206-2
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Krishnan KJ, 2004, J INVEST DERMATOL, V123, P1020, DOI 10.1111/j.0022-202X.2004.23457.x
   Larson-Casey JL, 2016, IMMUNITY, V44, P582, DOI 10.1016/j.immuni.2016.01.001
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Leman G, 2022, J INVEST DERMATOL, V142, P2623, DOI 10.1016/j.jid.2022.01.035
   Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356
   Majora M, 2009, AM J PATHOL, V175, P1019, DOI 10.2353/ajpath.2009.080832
   Mauro-Lizcano M, 2015, AUTOPHAGY, V11, P833, DOI 10.1080/15548627.2015.1034403
   Meng FR, 2021, MOL BIOL REP, V48, P7153, DOI 10.1007/s11033-021-06707-0
   Mia MM, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0091559
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Oexner RR, 2020, INVEST OPHTH VIS SCI, V61, P0, DOI 10.1167/iovs.61.12.14
   Pickles S, 2018, CURR BIOL, V28, PR170, DOI 10.1016/j.cub.2018.01.004
   Plikus MV, 2021, CELL, V184, P3852, DOI 10.1016/j.cell.2021.06.024
   Plikus MV, 2021, EXP DERMATOL, V30, P4, DOI 10.1111/exd.14257
   Ray AJ, 2000, J INVEST DERMATOL, V115, P674, DOI 10.1046/j.1523-1747.2000.00092.x
   Rigau AR, 2021, METHODS MOL BIOL, V2299, P371, DOI 10.1007/978-1-0716-1382-5_25
   Rinkevich Y, 2015, SCIENCE, V348, P0, DOI 10.1126/science.aaa2151
   Rombold S, 2008, PHOTODERMATOL PHOTO, V24, P19, DOI 10.1111/j.1600-0781.2008.00328.x
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Sawant M, 2021, WOUND REPAIR REGEN, V29, P515, DOI 10.1111/wrr.12950
   Sen A, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-34205-9
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Sturm G, 2023, COMMUN BIOL, V6, P0, DOI 10.1038/s42003-022-04303-x
   Sturm G, 2022, SCI DATA, V9, P0, DOI 10.1038/s41597-022-01852-y
   Tigges J, 2014, MECH AGEING DEV, V138, P26, DOI 10.1016/j.mad.2014.03.004
   Tomer D, 2018, DEV BIOL, V434, P48, DOI 10.1016/j.ydbio.2017.11.009
   van der Veer WM, 2009, BURNS, V35, P15, DOI 10.1016/j.burns.2008.06.020
   Wang YY, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms24043257
   Weiland D, 2018, J INVEST DERMATOL, V138, P132, DOI 10.1016/j.jid.2017.08.019
   Weiskirchen R, 2019, MOL ASPECTS MED, V65, P2, DOI 10.1016/j.mam.2018.06.003
   Wiley CD, 2021, NAT METAB, V3, P1290, DOI 10.1038/s42255-021-00483-8
   Willenborg S, 2021, CELL METAB, V33, P2398, DOI 10.1016/j.cmet.2021.10.004
   Willenborg S, 2014, J INVEST DERMATOL, V134, P2005, DOI 10.1038/jid.2014.12
   Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386
   Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807
   Xian HX, 2021, IMMUNITY, V54, P1463, DOI 10.1016/j.immuni.2021.05.004
   Yamamoto T, 2000, IMMUNOLOGY, V99, P435, DOI 10.1046/j.1365-2567.2000.00973.x
   Zhang K, 2022, ELIFE, V11, P0, DOI 10.7554/eLife.68598
   Zheng B, 2002, AM J PATHOL, V160, P1609, DOI 10.1016/S0002-9440(10)61108-X
   Zhou X, 2022, ARTHRITIS RHEUMATOL, V74, P871, DOI 10.1002/art.42033
   Zouboulis CC, 2011, CLIN DERMATOL, V29, P3, DOI 10.1016/j.clindermatol.2010.07.001
NR 59
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0945-053X
EI 1569-1802
J9 MATRIX BIOL
JI Matrix Biol.
PD SEP 15
PY 2024
VL 132
IS 
BP 72
EP 86
DI 10.1016/j.matbio.2024.07.002
EA JUL 2024
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA ZK0J6
UT WOS:001275071500001
PM 39009171
DA 2024-11-01
ER

PT J
AU Izumi, R
   Ikeda, K
   Niihori, T
   Suzuki, N
   Shirota, M
   Funayama, R
   Nakayama, K
   Warita, H
   Tateyama, M
   Aoki, Y
   Aoki, M
AF Izumi, Rumiko
   Ikeda, Kensuke
   Niihori, Tetsuya
   Suzuki, Naoki
   Shirota, Matsuyuki
   Funayama, Ryo
   Nakayama, Keiko
   Warita, Hitoshi
   Tateyama, Maki
   Aoki, Yoko
   Aoki, Masashi
TI Nuclear pore pathology underlying multisystem proteinopathy type 3-related inclusion body myopathy
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Article
ID distal myopathy; nucleocytoplasmic transport; missense mutation; n-cam; expression; hnrnpa1
AB Objective Multisystem proteinopathy type 3 (MSP3) is an inherited, pleiotropic degenerative disorder caused by a mutation in heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1), which can affect the muscle, bone, and/or nervous system. This study aimed to determine detailed histopathological features and transcriptomic profile of HNRNPA1-mutated skeletal muscles to reveal the core pathomechanism of hereditary inclusion body myopathy (hIBM), a predominant phenotype of MSP3.Methods Histopathological analyses and RNA sequencing of HNRNPA1-mutated skeletal muscles harboring a c.940G > A (p.D314N) mutation (NM_031157) were performed, and the results were compared with those of HNRNPA1-unlinked hIBM and control muscle tissues.Results RNA sequencing revealed aberrant alternative splicing events that predominantly occurred in myofibril components and mitochondrial respiratory complex. Enrichment analyses identified the nuclear pore complex (NPC) and nucleocytoplasmic transport as suppressed pathways. These two pathways were linked by the hub genes NUP50, NUP98, NUP153, NUP205, and RanBP2. In immunohistochemistry, these nucleoporin proteins (NUPs) were mislocalized to the cytoplasm and aggregated mostly with TAR DNA-binding protein 43 kDa and, to a lesser extent, with hnRNPA1. Based on ultrastructural observation, irregularly shaped myonuclei with deep invaginations were frequently observed in atrophic fibers, consistent with the disorganization of NPCs. Additionally, regarding the expression profiles of overall NUPs, reduced expression of NUP98, NUP153, and RanBP2 was shared with HNRNPA1-unlinked hIBMs.Interpretation The shared subset of altered NUPs in amyotrophic lateral sclerosis (ALS), as demonstrated in prior research, HNRNPA1-mutated, and HNRNPA1-unlinked hIBM muscle tissues may provide evidence regarding the underlying common nuclear pore pathology of hIBM, ALS, and MSP.
C1 [Izumi, Rumiko; Ikeda, Kensuke; Suzuki, Naoki; Warita, Hitoshi; Aoki, Masashi] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Japan.
   [Izumi, Rumiko; Niihori, Tetsuya; Aoki, Yoko] Tohoku Univ, Grad Sch Med, Dept Med Genet, Sendai, Japan.
   [Shirota, Matsuyuki] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Sendai, Japan.
   [Funayama, Ryo; Nakayama, Keiko] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Div Cell Proliferat, Sendai, Japan.
   [Tateyama, Maki] Natl Hosp Org, Iwate Hosp, Ichinoseki, Japan.
   [Aoki, Masashi] Tohoku Univ, Grad Sch Med, Dept Neurol, 1-1 Seiryo machi,Aoba ku, Sendai 9808574, Japan.
C3 Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University
RP Aoki, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Neurol, 1-1 Seiryo machi,Aoba ku, Sendai 9808574, Japan.
EM aokim@med.tohoku.ac.jp
FU Grant-in-Aid for Early-Career Scientists from Japan Society for the Promotion of Science (JSPS); Biomedical Research Core of Tohoku University Graduate School of Medicine
CR Beijer D, 2021, JCI INSIGHT, V6, P0, DOI 10.1172/jci.insight.148363
   Chompoopong P, 2022, NEUROMUSCULAR DISORD, V32, P521, DOI 10.1016/j.nmd.2022.03.009
   Chou CC, 2018, NAT NEUROSCI, V21, P228, DOI 10.1038/s41593-017-0047-3
   COVAULT J, 1985, P NATL ACAD SCI USA, V82, P4544, DOI 10.1073/pnas.82.13.4544
   Coyne AN, 2021, SCI TRANSL MED, V13, P0, DOI 10.1126/scitranslmed.abe1923
   Coyne AN, 2020, NEURON, V107, P1124, DOI 10.1016/j.neuron.2020.06.027
   Eftekharzadeh B, 2018, NEURON, V99, P925, DOI 10.1016/j.neuron.2018.07.039
   Pereira PE, 2023, ACTA NEUROPATHOL, V145, P793, DOI 10.1007/s00401-023-02565-1
   Gasset-Rosa F, 2017, NEURON, V94, P48, DOI 10.1016/j.neuron.2017.03.027
   Gosztonyi G, 2001, MICROSC RES TECHNIQ, V55, P187, DOI 10.1002/jemt.1170
   Grassano M, 2022, J NEUROL NEUROSUR PS, V93, P1190, DOI 10.1136/jnnp-2022-328931
   Hachiya N, 2021, MOL NEUROBIOL, V58, P983, DOI 10.1007/s12035-020-02168-x
   Hackman P, 2021, NEUROL-GENET, V7, P0, DOI 10.1212/NXG.0000000000000632
   Han M, 2019, HUM MUTAT, V40, P310, DOI 10.1002/humu.23691
   Han XC, 2022, ANN CLIN TRANSL NEUR, V9, P1910, DOI 10.1002/acn3.51682
   HÃ¶hn A, 2013, REDOX BIOL, V1, P140, DOI 10.1016/j.redox.2013.01.006
   Izumi R, 2015, NEUROL-GENET, V1, P0, DOI 10.1212/NXG.0000000000000023
   Janin A, 2017, ORPHANET J RARE DIS, V12, P0, DOI 10.1186/s13023-017-0698-x
   Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922
   Koike Y, 2023, PLOS BIOL, V21, P0, DOI 10.1371/journal.pbio.3002028
   Kottlors M, 2010, J NEUROL SCI, V291, P79, DOI 10.1016/j.jns.2009.12.008
   Li C, 2016, NUCLEUS-PHILA, V7, P430, DOI 10.1080/19491034.2016.1238997
   Li YI, 2018, NAT GENET, V50, P151, DOI 10.1038/s41588-017-0004-9
   Lin YC, 2021, NAT NEUROSCI, V24, P1077, DOI 10.1038/s41593-021-00859-9
   Liu Q, 2016, NEUROLOGY, V87, P1763, DOI 10.1212/WNL.0000000000003256
   Liu XY, 2015, J NEUROCHEM, V133, P187, DOI 10.1111/jnc.13069
   LOVE MI, 2014, GENOME BIOL, V15, P0, DOI 10.1186/S13059-014-0550-8
   Lussi YC, 2011, MOL BIOL CELL, V22, P1080, DOI 10.1091/mbc.E10-05-0463
   Ma XR, 2022, NATURE, V603, P124, DOI 10.1038/s41586-022-04424-7
   MÃ¼ller TJ, 2014, ANN NEUROL, V76, P669, DOI 10.1002/ana.24255
   Naruse H, 2018, NEUROBIOL AGING, V61, P0, DOI 10.1016/j.neurobiolaging.2017.08.030
   Raices M, 2012, NAT REV MOL CELL BIO, V13, P687, DOI 10.1038/nrm3461
   Senderek J, 2009, AM J HUM GENET, V84, P511, DOI 10.1016/j.ajhg.2009.03.006
   Shijo T, 2018, J NEUROSCI RES, V96, P222, DOI 10.1002/jnr.24127
   Smythe C, 2000, EMBO J, V19, P3918, DOI 10.1093/emboj/19.15.3918
   Suzuki N, 2005, MUSCLE NERVE, V32, P812, DOI 10.1002/mus.20417
   TÃ¶pf A, 2020, GENET MED, V22, P1478, DOI 10.1038/s41436-020-0840-3
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Xie ZR, 2021, CURR PROTOC, V1, P0, DOI 10.1002/cpz1.90
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973
NR 41
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
EI 
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD MAR 15
PY 2024
VL 11
IS 3
BP 577
EP 592
DI 10.1002/acn3.51977
EA DEC 2023
PG 16
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA NC7L8
UT WOS:001134328700001
PM 38158701
DA 2024-11-01
ER

PT J
AU GÃ¼lec, Ã
   Gedikbasi, A
   Sahin, G
   Toksoy, G
   Duramaz, A
   Uyguner, ZO
AF Gulec, Cagri
   Gedikbasi, Asuman
   Sahin, Gokcen
   Toksoy, Guven
   Duramaz, Altug
   Uyguner, Zehra Oya
TI HETEROPLASMY-ASSOCIATED MITOCHONDRIAL DNA VARIANTS IN HUMAN BLOOD AND SKELETAL MUSCLE SAMPLES
SO JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
LA English
DT Article
DE Mitochondrial heteroplasmy; MT-TL1; MT-TL2; MTRNR2; MT-TM; MT-TI; MT-TF
ID mutations; sequence
AB Objective: Mitochondrial heteroplasmy, a recognized trait in eukaryotic cells, plays a pivotal role in complex disorders like mito-chondrial diseases. High-throughput sequencing has improved precision in detecting low-level heteroplasmy and can identify ultra-low-level variants (<1%) associated with heteroplasmy attributes. We aimed to investigate potential genetic and demographic factors associated with heteroplasmy levels in mito-chondrial variants by analyzing both blood and muscle tissues in individuals, regardless of their phenotypes.Material and Methods: High-throughput sequencing was con-ducted on the mitochondrial genomes of 10 individuals, with an equal gender distribution. Variants with heteroplasmy ratios both ranging from 5% to 95% and out of this range were used for statistical analysis.Result: A total of 194 heteroplasmic variants were identified, of which 13 displayed lower heteroplasmy ratios in both blood and skeletal muscle samples from females, while the mitochondrial control region (D-Loop) exhibited higher ratios.Conclusion: The study findings confirm the correlation between the m.10398A>G variant and mitochondrial heteroplasmy levels, consistent with prior research. Additionally, we identified the m.1811A>G variant in MT-RNR2 and the m.12308A>G variant in MT-TL2, both associated with higher heteroplasmy. Conversely, the m.582T>C variant in MT-TF, m.3260A>G in MT-TL1, m.3302A>G in MT-TL1, m.4409T>C in MT-TM, and m.4267A>G in MT-TI were linked to lower heteroplasmy, all involving transition-type alterations. Furthermore, our study hinted at a potential age-related threshold for variant accumulation in the control region. Future studies, involving larger cohorts and advanced expression analysis methods, will further contribute to the validation and enhancement of these findings.
C1 [Gulec, Cagri; Toksoy, Guven; Uyguner, Zehra Oya] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, Istanbul, Turkiye.
   [Gedikbasi, Asuman] Istanbul Univ, Inst Child Hlth, Dept Pediat Basic Sci, Istanbul, Turkiye.
   [Sahin, Gokcen] Istanbul Univ, Inst Hlth Sci, Dept Genet, Istanbul, Turkiye.
   [Duramaz, Altug] Univ Hlth Sci, Bakirkoy Dr Sadi Konuk Applicat & Res Ctr, Dept Orthoped & Traumatol, Istanbul, Turkiye.
C3 Istanbul University; Istanbul University; Istanbul University; University of Health Sciences Turkey
RP Uyguner, ZO (corresponding author), Istanbul Univ, Istanbul Fac Med, Dept Med Genet, Istanbul, Turkiye.
EM o.uyguner@istanbul.edu.tr
FU Scientific Research Projects Coordination Unit of Istanbul University [TYL-2019-33447, TDK-2018-32544]
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   Avital G, 2012, HUM MOL GENET, V21, P4214, DOI 10.1093/hmg/dds245
   Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024
   Clayton D A, 2000, HUM REPROD, V15 Suppl 2, P11
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Diroma MA, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-S3-S2
   Frederiksen AL, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.039339
   Frezza C, 2017, INTERFACE FOCUS, V7, P0, DOI 10.1098/rsfs.2016.0100
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Gupta R, 2023, NATURE, V620, P0, DOI 10.1038/s41586-023-06426-5
   He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802
   Imasawa T, 2023, HELIYON, V9, P0, DOI 10.1016/j.heliyon.2023.e14923
   Kaneva K, 2020, MITOCHONDRION, V51, P97, DOI 10.1016/j.mito.2020.01.006
   Kennedy SR, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003794
   Laaksonen J, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-020-79931-6
   Larman TC, 2012, P NATL ACAD SCI USA, V109, P14087, DOI 10.1073/pnas.1211502109
   Lee HY, 2006, ANN HUM GENET, V70, P59, DOI 10.1111/j.1529-8817.2005.00217.x
   Legati A, 2023, METHODS MOL BIOL, V2615, P381, DOI 10.1007/978-1-0716-2922-2_26
   LEITITIS JU, 1987, ACTA PAEDIATR SCAND, V76, P789, DOI 10.1111/j.1651-2227.1987.tb10566.x
   Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014
   Lorca R, 2023, J CLIN MED, V12, P0, DOI 10.3390/jcm12062133
   Mullin NK, 2023, JCI INSIGHT, V8, P0, DOI 10.1172/jci.insight.165937
   Nandakumar P, 2021, SCI ADV, V7, P0, DOI 10.1126/sciadv.abe7520
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Rovcanin B, 2020, EXP EYE RES, V201, P0, DOI 10.1016/j.exer.2020.108277
   Samuels DC, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003929
   Smullen M, 2023, SCI REP-UK, V13, P0, DOI 10.1038/s41598-023-37541-y
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092
   Trinh J, 2023, BRAIN, V146, P2753, DOI 10.1093/brain/awac464
   Wang YQ, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-30805-7
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
NR 36
TC 0
Z9 0
U1 1
U2 4
PU ISTANBUL UNIV, FAC MEDICINE, PUBL OFF
PI ISTANBUL
PA ISTANBUL UNIV, ISTANBUL TIP FAK DEKANLIGI, YAYUNCILIK BIRIMI, TURGUT OZAL CAD CAPA FATIH, PK, ISTANBUL, 34093, Turkiye
SN 
EI 1305-6441
J9 J ISTANB FAC MED
JI J. Istanb. Fac. Med.
PD JUN 15
PY 2024
VL 87
IS 1
BP 1
EP 10
DI 10.26650/IUITFD.1394708
EA JAN 2024
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA GU2V8
UT WOS:001150201400001
DA 2024-11-01
ER

PT J
AU Dombi, E
   Marinaki, T
   Spingardi, P
   Millar, V
   Hadjichristou, N
   Carver, J
   Johnston, IG
   Fratter, C
   Poulton, J
AF Dombi, Eszter
   Marinaki, Tony
   Spingardi, Paolo
   Millar, Val
   Hadjichristou, Nastasia
   Carver, Janet
   Johnston, Iain G.
   Fratter, Carl
   Poulton, Joanna
TI Nucleoside supplements as treatments for mitochondrial DNA depletion syndrome
SO FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE mitochondrial DNA; mitochondrial DNA depletion syndrome; high-content imaging; nucleoside bypass therapy; heavy isotope labelling mass spectroscopy; alpers syndrome; POLG; TWNK
ID in-vitro supplementation; thymidine kinase; dntp pools; replication; defects; metabolism; therapy
AB Introduction: In mitochondrial DNA (mtDNA) depletion syndrome (MDS), patients cannot maintain sufficient mtDNA for their energy needs. MDS presentations range from infantile encephalopathy with hepatopathy (Alpers syndrome) to adult chronic progressive external ophthalmoplegia. Most are caused by nucleotide imbalance or by defects in the mtDNA replisome. There is currently no curative treatment available. Nucleoside therapy is a promising experimental treatment for TK2 deficiency, where patients are supplemented with exogenous deoxypyrimidines. We aimed to explore the benefits of nucleoside supplementation in POLG and TWNK deficient fibroblasts.Methods: We used high-content fluorescence microscopy with software-based image analysis to assay mtDNA content and membrane potential quantitatively, using vital dyes PicoGreen and MitoTracker Red CMXRos respectively. We tested the effect of 15 combinations (A, T, G, C, AT, AC, AG, CT, CG, GT, ATC, ATG, AGC, TGC, ATGC) of deoxynucleoside supplements on mtDNA content of fibroblasts derived from four patients with MDS (POLG1, POLG2, DGUOK, TWNK) in both a replicating (10% dialysed FCS) and quiescent (0.1% dialysed FCS) state. We used qPCR to measure mtDNA content of supplemented and non-supplemented fibroblasts following mtDNA depletion using 20 mu M ddC and after 14- and 21-day recovery in a quiescent state.Results: Nucleoside treatments at 200 mu M that significantly increased mtDNA content also significantly reduced the number of cells remaining in culture after 7 days of treatment, as well as mitochondrial membrane potential. These toxic effects were abolished by reducing the concentration of nucleosides to 50 mu M. In POLG1 and TWNK cells the combination of ATGC treatment increased mtDNA content the most after 7 days in non-replicating cells. ATGC nucleoside combination significantly increased the rate of mtDNA recovery in quiescent POLG1 cells following mtDNA depletion by ddC.Conclusion: High-content imaging enabled us to link mtDNA copy number with key read-outs linked to patient wellbeing. Elevated G increased mtDNA copy number but severely impaired fibroblast growth, potentially by inhibiting purine synthesis and/or causing replication stress. Combinations of nucleosides ATGC, T, or TC, benefited growth of cells harbouring POLG mutations. These combinations, one of which reflects a commercially available preparation, could be explored further for treatment of POLG patients.
C1 [Dombi, Eszter; Carver, Janet; Poulton, Joanna] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford, England.
   [Marinaki, Tony] Guys & St Thomas Hospitals, Dept Biochem Sci, Purine Res Lab, London, England.
   [Spingardi, Paolo] Univ Oxford, Ludwig Inst Canc Res, Nuffield Dept Med, Med Sci Div, Oxford, England.
   [Millar, Val] Univ Oxford, Target Discovery Inst, Ctr Med Discovery, Nuffield Dept Med, Oxford, England.
   [Hadjichristou, Nastasia] Arch Makarios III Hosp, Dept Paediat, Nicosia, Cyprus.
   [Johnston, Iain G.] Univ Bergen, Dept Math, Bergen, Norway.
   [Johnston, Iain G.] Univ Bergen, Computat Biol Unit, Bergen, Norway.
   [Fratter, Carl] Oxford Univ Hosp NHS Fdn Trust, Oxford Genet Labs, Oxford, England.
C3 University of Oxford; Guy's & St Thomas' NHS Foundation Trust; Ludwig Institute for Cancer Research; University of Oxford; University of Oxford; University of Bergen; University of Bergen; Oxford University Hospitals NHS Foundation Trust
RP Poulton, J (corresponding author), Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford, England.
EM joanna.poulton@wrh.ox.ac.uk
FU Medical Research Council10.13039/501100000265
CR Amtmann D, 2023, MITOCHONDRION, V68, P1, DOI 10.1016/j.mito.2022.10.003
   Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   Batiuk TD, 2001, AM J PHYSIOL-CELL PH, V281, PC1776, DOI 10.1152/ajpcell.2001.281.6.C1776
   BlÃ¡zquez-Bermejo C, 2019, FASEB J, V33, P7168, DOI 10.1096/fj.201801591R
   Bradshaw PC, 2005, AM J PHYSIOL-CELL PH, V288, PC989, DOI 10.1152/ajpcell.00530.2004
   Bulst S, 2012, MOL GENET METAB, V107, P95, DOI 10.1016/j.ymgme.2012.04.022
   Bulst S, 2009, HUM MOL GENET, V18, P1590, DOI 10.1093/hmg/ddp074
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Diot A, 2015, PHARMACOL RES, V100, P24, DOI 10.1016/j.phrs.2015.07.014
   DomÃ­nguez-GonzÃ¡lez C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   FrÃ¶lich S, 2020, CYTOM PART A, V97, P378, DOI 10.1002/cyto.a.23988
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   GonzÃ¡lez-Vioque E, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002035
   HÃ¥kansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200
   HÃ¤mÃ¤lÃ¤inen RH, 2019, NAT METAB, V1, P958, DOI 10.1038/s42255-019-0120-1
   Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372
   KELLEY WN, 1975, ARTHRITIS RHEUM-US, V18, P673, DOI 10.1002/art.1780180706
   Lane AN, 2015, NUCLEIC ACIDS RES, V43, P2466, DOI 10.1093/nar/gkv047
   Lodge T, 2017, NEUROMUSCULAR DISORD, V27, P0
   Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Mortiboys H, 2006, INFLUENCE OF MITOCHONDRIAL ENERGY METABOLISM ON CELLULAR FUNCTION: IMPLICATIONS FOR NEUROMETABOLIC AND NEURODEGENERATIVE DISEASES, V0, P0
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443
   Pai CC, 2017, GENES-BASEL, V8, P0, DOI 10.3390/genes8020057
   Pinheiro J, 2022, R PACKAGE VERSION 3.1-160, V0, P0
   R Core Team, 2021, R LANG ENV STAT COMP, V0, P0
   RÃ¶tig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009
   Roy S, 2018, ELIFE, V7, P0, DOI 10.7554/eLife.31723
   S K, 2021, R PACKAGE VERSION 0.9.1, V0, P0
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Saada A, 2008, MOL GENET METAB, V95, P169, DOI 10.1016/j.ymgme.2008.07.007
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112
   Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215
   Wickham H, 2016, GGPLOT2: ELEGANT GRAPHICS FOR DATA ANALYSIS, V0, P0, DOI DOI 10.1007/978-3-319-24277-4
   Wickham H BJ, 2023, R PACKAGE VERSION 1.4.2, V0, P0
NR 41
TC 1
Z9 1
U1 6
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-634X
EI 
J9 FRONT CELL DEV BIOL
JI Front. Cell. Dev. Biol.
PD APR 2
PY 2024
VL 12
IS 
BP 
EP 
DI 10.3389/fcell.2024.1260496
PG 17
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA OM4L6
UT WOS:001207676700001
PM 38665433
DA 2024-11-01
ER

PT J
AU Li, Y
   Zhang, HH
   Yu, CJ
   Dong, XL
   Yang, FH
   Wang, MJ
   Wen, ZY
   Su, MH
   Li, B
   Yang, LN
AF Li, Ya
   Zhang, Huhu
   Yu, Chunjuan
   Dong, Xiaolei
   Yang, Fanghao
   Wang, Mengjun
   Wen, Ziyuan
   Su, Mohan
   Li, Bing
   Yang, Lina
TI New Insights into Mitochondria in Health and Diseases
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE mitochondrial; bioenergetics; ROS; aging; mtDNA; mutations; mitochondrial dysfunction; mitochondrial targeted therapy
ID complex i deficiency; parkinsons-disease; oxidative stress; permeability transition; membrane transition; alzheimers-disease; alpha-synuclein; mitofusin 2; dysfunction; dna
AB Mitochondria are a unique type of semi-autonomous organelle within the cell that carry out essential functions crucial for the cell's survival and well-being. They are the location where eukaryotic cells carry out energy metabolism. Aside from producing the majority of ATP through oxidative phosphorylation, which provides essential energy for cellular functions, mitochondria also participate in other metabolic processes within the cell, such as the electron transport chain, citric acid cycle, and beta-oxidation of fatty acids. Furthermore, mitochondria regulate the production and elimination of ROS, the synthesis of nucleotides and amino acids, the balance of calcium ions, and the process of cell death. Therefore, it is widely accepted that mitochondrial dysfunction is a factor that causes or contributes to the development and advancement of various diseases. These include common systemic diseases, such as aging, diabetes, Parkinson's disease, and cancer, as well as rare metabolic disorders, like Kearns-Sayre syndrome, Leigh disease, and mitochondrial myopathy. This overview outlines the various mechanisms by which mitochondria are involved in numerous illnesses and cellular physiological activities. Additionally, it provides new discoveries regarding the involvement of mitochondria in both disorders and the maintenance of good health.
C1 [Li, Ya; Zhang, Huhu; Yu, Chunjuan; Dong, Xiaolei; Yang, Fanghao; Wang, Mengjun; Wen, Ziyuan; Su, Mohan; Li, Bing; Yang, Lina] Qingdao Univ, Basic Med Coll, Dept Genet & Cell Biol, Qingdao 266071, Peoples R China.
C3 Qingdao University
RP Yang, LN (corresponding author), Qingdao Univ, Basic Med Coll, Dept Genet & Cell Biol, Qingdao 266071, Peoples R China.
EM liyaemail2022@163.com; ts_zhh2580@163.com; 17861281992@163.com; dongxiaoleiqd@163.com; yfhao1996@163.com; wangmj90405@163.com; 13287377676@163.com; smh13731390822@163.com; libing_516@qdu.edu.cn; yanglina@qdu.edu.cn
FU National Natural Science Foundation of China [81803895]; Shandong Province Natural Science Foundation [ZR2021YQ57]; China Postdoctoral Science Foundation [2020M682131, 2021T140357]
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Angelova PR, 2018, FEBS LETT, V592, P692, DOI 10.1002/1873-3468.12964
   Argueti-Ostrovsky S, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10092438
   Aubert G, 2013, BBA-MOL CELL RES, V1833, P840, DOI 10.1016/j.bbamcr.2012.08.015
   Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   Baglivo M, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms241612580
   Balsa E, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-16423-1
   Barrea L, 2022, CRIT REV FOOD SCI, V62, P1800, DOI 10.1080/10408398.2020.1847030
   BARTH E, 1992, J MOL CELL CARDIOL, V24, P669, DOI 10.1016/0022-2828(92)93381-S
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Birk AV, 2013, J AM SOC NEPHROL, V24, P1250, DOI 10.1681/ASN.2012121216
   Blaszczyk JW, 2020, METABOLITES, V10, P0, DOI 10.3390/metabo10110450
   Brown DA, 2017, NAT REV CARDIOL, V14, P238, DOI 10.1038/nrcardio.2016.203
   Browne SE, 1999, BRAIN PATHOL, V9, P147
   Cejudo P, 2005, MUSCLE NERVE, V32, P342, DOI 10.1002/mus.20368
   Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162
   Christoffersen BO, 2022, OBESITY, V30, P841, DOI 10.1002/oby.23374
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Compagnoni GM, 2020, MOL NEUROBIOL, V57, P2959, DOI 10.1007/s12035-020-01926-1
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   de Laat P, 2015, NETH J MED, V73, P30
   de Laat P, 2013, OPHTHALMOLOGY, V120, P2684, DOI 10.1016/j.ophtha.2013.05.013
   Debray FG, 2007, CLIN CHEM, V53, P916, DOI 10.1373/clinchem.2006.081166
   Diaz F, 2011, SEMIN FETAL NEONAT M, V16, P197, DOI 10.1016/j.siny.2011.05.004
   Eckert GP, 2013, NEUROCHEM INT, V62, P595, DOI 10.1016/j.neuint.2013.02.014
   Efremov RG, 2011, CURR OPIN STRUC BIOL, V21, P532, DOI 10.1016/j.sbi.2011.07.002
   Finsterer J, 2001, ACTA MED AUST, V28, P152, DOI 10.1046/j.1563-2571.2001.01036.x
   Flores K, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23116205
   Fromenty B, 2023, J HEPATOL, V78, P415, DOI 10.1016/j.jhep.2022.09.020
   Fu WY, 2019, ACS CHEM NEUROSCI, V10, P872, DOI 10.1021/acschemneuro.8b00402
   Garcia I, 2017, FRONT BIOSCI-LANDMRK, V22, P710, DOI 10.2741/4511
   Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419
   GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Giovannini L, 2017, NUTRITION, V34, P82, DOI 10.1016/j.nut.2016.09.008
   Haas RH, 2007, MITOCHONDRION, V7, PS136, DOI 10.1016/j.mito.2007.03.008
   Hage R, 2021, FRONT NEUROL, V12, P0, DOI 10.3389/fneur.2021.651639
   Harrington JS, 2023, PHYSIOL REV, V103, P2349, DOI 10.1152/physrev.00058.2021
   Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005
   HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Hong YM, 2020, AGING CELL, V19, P0, DOI 10.1111/acel.13128
   Hoppins S, 2011, MOL CELL, V41, P150, DOI 10.1016/j.molcel.2010.11.030
   Horvath R, 2008, NEUROTHERAPEUTICS, V5, P558, DOI 10.1016/j.nurt.2008.07.002
   Hu TT, 2023, METABOLISM, V146, P0, DOI 10.1016/j.metabol.2023.155658
   Huang DH, 2020, J CELL MOL MED, V24, P5850, DOI 10.1111/jcmm.15256
   HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0
   Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078
   Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989
   Javadov S, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9051177
   Jin P, 2022, EMBO MOL MED, V14, P0, DOI 10.15252/emmm.202216082
   Jin P, 2022, J HEMATOL ONCOL, V15, P0, DOI 10.1186/s13045-022-01313-4
   Karanjia R, 2024, OPHTHALMOLOGY, V131, P422, DOI 10.1016/j.ophtha.2023.10.033
   Kawakita E, 2021, MOL CANCER RES, V19, P61, DOI 10.1158/1541-7786.MCR-20-0115
   Khoo TK, 2013, NEUROLOGY, V80, P276, DOI 10.1212/WNL.0b013e31827deb74
   Klemmensen MM, 2024, NEUROTHERAPEUTICS, V21, P0, DOI 10.1016/j.neurot.2023.10.002
   Kwong JQ, 2015, CELL METAB, V21, P206, DOI 10.1016/j.cmet.2014.12.001
   Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3
   Leavitt BR, 2020, JAMA NEUROL, V77, P764, DOI 10.1001/jamaneurol.2020.0299
   Lee IC, 2021, ANTIOXIDANTS-BASEL, V10, P0, DOI 10.3390/antiox10121950
   Liu CY, 2022, EMBO MOL MED, V14, P0, DOI 10.15252/emmm.202215851
   Liu Y, 2023, INT J BIOL SCI, V19, P897, DOI 10.7150/ijbs.81609
   Lopriore P, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms232113216
   Malpartida AB, 2021, TRENDS BIOCHEM SCI, V46, P329, DOI 10.1016/j.tibs.2020.11.007
   Marchi S, 2023, NAT REV IMMUNOL, V23, P159, DOI 10.1038/s41577-022-00760-x
   Marin SE, 2013, GENE, V516, P162, DOI 10.1016/j.gene.2012.12.024
   Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006
   McCormick EM, 2023, ANN NEUROL, V94, P696, DOI 10.1002/ana.26716
   Morton H, 2021, FREE RADICAL BIO MED, V172, P652, DOI 10.1016/j.freeradbiomed.2021.07.013
   Moslehi J, 2012, CIRC RES, V110, P1226, DOI 10.1161/CIRCRESAHA.111.246868
   Nakamura K, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23073587
   Narasimhaiah R, 2005, CEREB CORTEX, V15, P696, DOI 10.1093/cercor/bhh171
   Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Ojuka EO, 2003, FASEB J, V17, P675, DOI 10.1096/fj.02-0951com
   OKANE MJ, 1992, BRIT J CLIN PHARMACO, V33, P451, DOI 10.1111/j.1365-2125.1992.tb04067.x
   Okuno D, 2011, J BIOCHEM, V149, P655, DOI 10.1093/jb/mvr049
   Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884
   Parikh S, 2013, MITOCHONDRION, V13, P681, DOI 10.1016/j.mito.2013.09.003
   Perry JB, 2019, J MOL CELL CARDIOL, V135, P160, DOI 10.1016/j.yjmcc.2019.08.010
   Picca A, 2018, NAT REV CARDIOL, V15, P543, DOI 10.1038/s41569-018-0059-z
   Pinti MV, 2019, AM J PHYSIOL-ENDOC M, V316, PE268, DOI 10.1152/ajpendo.00314.2018
   Postuma RB, 2012, MOVEMENT DISORD, V27, P617, DOI 10.1002/mds.24996
   Prakoso D, 2022, TRENDS PHARMACOL SCI, V43, P940, DOI 10.1016/j.tips.2022.04.005
   Read AD, 2021, REDOX BIOL, V47, P0, DOI 10.1016/j.redox.2021.102164
   Ribeiro RF, 2018, FREE RADICAL BIO MED, V117, P18, DOI 10.1016/j.freeradbiomed.2018.01.012
   Rusek M, 2019, INT J MOL SCI, V20, P0, DOI 10.3390/ijms20163892
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Schubert MB, 2020, ORPHANET J RARE DIS, V15, P0, DOI 10.1186/s13023-020-1297-9
   Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741
   Shi YF, 2019, NATURE, V567, P341, DOI 10.1038/s41586-019-0993-x
   Sirk D, 2007, J NEUROCHEM, V103, P1989, DOI 10.1111/j.1471-4159.2007.04907.x
   Slone J, 2020, NPJ GENOM MED, V5, P0, DOI 10.1038/s41525-020-0116-5
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004
   Subramaniam SR, 2013, PROG NEUROBIOL, V106, P17, DOI 10.1016/j.pneurobio.2013.04.004
   Sun LF, 2017, P NATL ACAD SCI USA, V114, PE476, DOI 10.1073/pnas.1618657114
   Szeto HH, 2014, BRIT J PHARMACOL, V171, P2029, DOI 10.1111/bph.12461
   Tabrizi SJ, 2022, LANCET NEUROL, V21, P645, DOI 10.1016/S1474-4422(22)00121-1
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Takeda K, 2021, COMMUN BIOL, V4, P0, DOI 10.1038/s42003-021-01720-2
   Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457
   Twarowski B, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms24076518
   Upadhayay S, 2024, PHARMACOL REP, V76, P693, DOI 10.1007/s43440-024-00619-z
   Vasan K, 2020, CELL METAB, V32, P341, DOI 10.1016/j.cmet.2020.06.019
   Wang XJ, 2018, ANN INTERN MED, V169, PITC65, DOI 10.7326/AITC201811060
   Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009
   Wesol-Kucharska D, 2021, CHILDREN-BASEL, V8, P0, DOI 10.3390/children8070532
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Wu YT, 2023, HEARING RES, V438, P0, DOI 10.1016/j.heares.2023.108876
   Xia WM, 2024, NAT METAB, V6, P273, DOI 10.1038/s42255-024-00978-0
   Xiao HP, 2020, CELL, V180, P968, DOI 10.1016/j.cell.2020.02.012
   Xourafa G, 2024, NAT REV ENDOCRINOL, V20, P27, DOI 10.1038/s41574-023-00898-1
   Xu DC, 2023, SIGNAL TRANSDUCT TAR, V8, P0, DOI 10.1038/s41392-023-01353-3
   Xu XX, 2022, CELL STEM CELL, V29, P840, DOI 10.1016/j.stem.2022.03.003
   Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547
   Yu-Wai-Man P, 2016, AM J HUM GENET, V98, P1271, DOI 10.1016/j.ajhg.2016.05.015
   Yu-Wai-Man P, 2020, SCI TRANSL MED, V12, P0, DOI 10.1126/scitranslmed.aaz7423
   Zhang TQ, 2023, BIOMED PHARMACOTHER, V165, P0, DOI 10.1016/j.biopha.2023.114706
   Zhang ZR, 2017, J EXP MED, V214, P2671, DOI 10.1084/jem.20162040
   Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663
   Zweers H, 2018, JPEN-PARENTER ENTER, V42, P581, DOI 10.1177/0148607117699792
NR 127
TC 0
Z9 0
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD SEP 15
PY 2024
VL 25
IS 18
BP 
EP 
DI 10.3390/ijms25189975
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA H5Q6P
UT WOS:001323989800001
PM 39337461
DA 2024-11-01
ER

PT J
AU Saunders, C
   Longman, C
   Gorman, G
   James, K
   Oliwa, A
   Petty, R
   Snadden, L
   Farrugia, ME
AF Saunders, Charlie
   Longman, Cheryl
   Gorman, Grainne
   James, Kelly
   Oliwa, Agata
   Petty, Richard
   Snadden, Lesley
   Farrugia, Maria Elena
TI The West of Scotland Cohort of Mitochondrial Individuals with the m.3243A>G Variant: Variations in Phenotypes and Predictors of Disease Severity
SO JOURNAL OF NEUROMUSCULAR DISEASES
LA English
DT Article
DE Epidemiology; mitochondrial conditions; mitochondrial DNA; m.3243A>G; multidisciplinary team
ID stroke-like episodes; lactic-acidosis; m.3243a-greater-than-g mutation; clinical-features; dna mutations; melas; heteroplasmy; prevalence; a3243g; encephalomyopathy
AB Background: The m.3243A>G variant is the commonest mitochondrial (mt) DNA pathogenic variant and a frequent cause of mitochondrial disease. Individuals present with a variety of clinical manifestations from diabetes to neurological events resembling strokes. Due to this, patients are commonly cared for by a multidisciplinary team. Objectives: This project aimed to identify patients with confirmed mt.3243A>G-related mitochondrial disease attending the Muscle Clinic at Queen Elizabeth University Hospital in Glasgow. We explored potential correlates between clinical phenotypes and mtDNA heteroplasmy levels, HbA1c levels, body mass index, and specific clinical manifestations. We investigated if there were discrepancies between non-neurological speciality labelling in clinical records and individuals' phenotypes. Methods: Data were gathered from theWest of Scotland electronic records. Phenotypes were ascertained by a clinician with expertise in mitochondrial disorders. Statistical analyses were applied to study relationships between tissue heteroplasmy, HbA1c and clinical phenotypes including body mass index (BMI). Results: Forty-six individuals were identified from 31 unrelated pedigrees. Maternally inherited diabetes and deafness was the prominent syndromic phenotype (48%). A significant association was found between overall number of symptoms and bowel dysmotility (p < 0.01). HbA1c was investigated as a predictor of severity with potential association seen. Although used widely as a prognosticator, neither corrected blood nor urine mtDNAheteroplasmy levels were associated with increased number of symptoms. In 74.1% of records, syndromic phenotypes were incorrectly used by non-neurological specialities. Conclusions: This m.3243 A> G patient cohort present with marked clinical heterogeneity. Urine and blood heteroplasmy levels are not reliable predictors of disease severity. HbA1c may be a novel predictor of disease severity with further research required to investigate this association. We infer that prognosis may be worse in patients with low BMIs and in those with bowel dysmotility. These results underscore a multidisciplinary approach and highlight a problem with inaccurate use of the existing nomenclature.
C1 [Saunders, Charlie; Petty, Richard; Farrugia, Maria Elena] Queen Elizabeth Univ Hosp, Inst Neurol Sci, Neurol Dept, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland.
   [Longman, Cheryl; Oliwa, Agata; Snadden, Lesley] Queen Elizabeth Univ Hosp, West Scotland Reg Genet Serv, Genet Dept, Glasgow, Lanark, Scotland.
   [Gorman, Grainne] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [James, Kelly] Univ Glasgow, Dept Geog & Earth Sci, Glasgow, Lanark, Scotland.
   [Gorman, Grainne] Univ Glasgow, Coll Med Vet & Life Sci, Sch Med, Glasgow, Lanark, Scotland.
   [Saunders, Charlie] Univ Hosp Crosshouse, Stroke Dept, Kilmarnock KA2 0BE, Scotland.
   [Oliwa, Agata] Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Snadden, Lesley] Aberdeen Royal Infirm, Dept Genet, Aberdeen AB25 2ZN, Scotland.
C3 University of Glasgow; Queen Elizabeth University Hospital (QEUH); Queen Elizabeth University Hospital (QEUH); Newcastle University - UK; University of Glasgow; University of Glasgow; Newcastle University - UK; University of Aberdeen
RP Farrugia, ME (corresponding author), Queen Elizabeth Univ Hosp, Inst Neurol Sci, Neurol Dept, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland.
EM mariaelena.farrugia@ggc.scot.nhs.uk
CR Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   de Laat P, 2019, MOL GENET GENOM MED, V7, P0, DOI 10.1002/mgg3.523
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Dvorakova V, 2016, MOL GENET METAB, V118, P288, DOI 10.1016/j.ymgme.2016.06.003
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   El-Hattab AW, 2014, MITOCHONDRION, V18, P63, DOI 10.1016/j.mito.2014.07.008
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Farrugia ME, 2018, J NEUROMUSCUL DIS, V5, PS128, DOI 10.3233/JND-
   Fayssoil A, 2017, EUR J NEUROL, V24, P255, DOI 10.1111/ene.13176
   Finsterer J, 2020, AM J CASE REP, V21, P0, DOI 10.12659/AJCR.927938
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Hanna MG, 1998, J NEUROL NEUROSUR PS, V65, P512, DOI 10.1136/jnnp.65.4.512
   Hou Y, 2019, PLOS ONE, V14, P0, DOI 10.1371/journal.pone.0219628
   Koene S, 2014, NEUROLOGY, V83, P125, DOI 10.1212/WNL.0000000000000578
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   Lindroos MM, 2009, DIABETES, V58, P543, DOI 10.2337/db08-0981
   Liu GL, 2020, J NEUROL SCI, V408, P0, DOI 10.1016/j.jns.2019.116562
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Mavraki E, 2023, EUR J HUM GENET, V31, P148, DOI 10.1038/s41431-022-01249-w
   Mehrazin M, 2009, AM J MED GENET A, V149A, P584, DOI 10.1002/ajmg.a.32703
   Narbonne H, 2004, DIABETES METAB, V30, P61, DOI 10.1016/S1262-3636(07)70090-3
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ng YS, 2022, BRAIN, V145, P542, DOI 10.1093/brain/awab353
   Ng Yi Shiau, 2019, WELLCOME OPEN RES, V4, P201, DOI 10.12688/wellcomeopenres.15599.1
   Ng YS, 2016, ANN NEUROL, V80, P686, DOI 10.1002/ana.24736
   Ng YS, 2016, EUR HEART J, V37, P2552, DOI 10.1093/eurheartj/ehv306
   Papadopoulos C, 2020, J INHERIT METAB DIS, V43, P459, DOI 10.1002/jimd.12185
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915
   Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532
   Poulsen NS, 2020, MITOCHONDRION, V50, P35, DOI 10.1016/j.mito.2019.10.005
   R Core Team, 2020, R: A LANGUAGE AND ENVIRONMENT FOR STATISTICAL COMPUTING, V0, P0
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
   Yang MG, 2021, FRONT ENDOCRINOL, V12, P0, DOI 10.3389/fendo.2021.728043
   Yee ML, 2018, ENDOCRINOL DIAB META, V0, P0, DOI DOI 10.1530/EDM-18-0091
NR 43
TC 0
Z9 0
U1 1
U2 1
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 2214-3599
EI 2214-3602
J9 J NEUROMUSCULAR DIS
JI J. Neuromusc. Dis.
PD JUN 15
PY 2024
VL 11
IS 1
BP 179
EP 189
DI 10.3233/JND-230166
PG 11
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA IP8F2
UT WOS:001167617500015
PM 38108361
DA 2024-11-01
ER

PT J
AU Ali, MA
   Gioscia-Ryan, R
   Yang, DL
   Sutton, NR
   Tyrrell, DJ
AF Ali, Md Akkas
   Gioscia-Ryan, Rachel
   Yang, Dongli
   Sutton, Nadia R.
   Tyrrell, Daniel J.
TI Cardiovascular aging: spotlight on mitochondria
SO AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
LA English
DT Review
DE aging; cardiovascular; metabolism; mitochondria; senescence
ID smooth-muscle contraction; oxygen species production; myocardial fatty-acid; oxidative stress; life-span; endothelial dysfunction; dna mutations; hydrogen-peroxide; vascular inflammation; premature senescence
AB Mitochondria are cellular organelles critical for ATP production and are particularly relevant to cardiovascular diseases including heart failure, atherosclerosis, ischemia-reperfusion injury, and cardiomyopathies. With advancing age, even in the absence of clinical disease, mitochondrial homeostasis becomes disrupted (e.g., redox balance, mitochondrial DNA damage, oxidative metabolism, and mitochondrial quality control). Mitochondrial dysregulation leads to the accumulation of damaged and dysfunctional mitochondria, producing excessive reactive oxygen species and perpetuating mitochondrial dysfunction. In addition, mitochondrial DNA, cardiolipin, and N-formyl peptides are potent activators of cell-intrinsic and -extrinsic inflammatory pathways. These age-related mitochondrial changes contribute to the development of cardiovascular diseases. This review covers the impact of aging on mitochondria and links these mechanisms to therapeutic implications for age-associated cardiovascular diseases.
C1 [Ali, Md Akkas; Tyrrell, Daniel J.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.
   [Gioscia-Ryan, Rachel] Univ Michigan, Dept Anesthesiol, Michigan Med, Ann Arbor, MI USA.
   [Yang, Dongli; Sutton, Nadia R.] Vanderbilt Univ, Div Cardiovasc Med, Med Ctr, Nashville, TN USA.
   [Sutton, Nadia R.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN USA.
C3 University of Alabama System; University of Alabama Birmingham; University of Michigan System; University of Michigan; Vanderbilt University; Vanderbilt University
RP Tyrrell, DJ (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.
EM danieltyrrell@uabmc.edu
FU National Institute on Aging [R00AG068309, K76AG064426]
CR Abe J, 2023, CIRC RES, V133, P25, DOI 10.1161/CIRCRESAHA.122.322017
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Ait-Aissa K, 2022, FUNCTION, V3, P0, DOI 10.1093/function/zqac043
   Ait-Aissa K, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-43761-y
   Ait-Aissa K, 2019, FRONT CARDIOVASC MED, V6, P0, DOI 10.3389/fcvm.2019.00031
   Amorim JA, 2022, NAT REV ENDOCRINOL, V18, P243, DOI 10.1038/s41574-021-00626-7
   BÃ¤r C, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms6863
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89
   Bikomeye JC, 2022, AM J PHYSIOL-HEART C, V323, PH702, DOI 10.1152/ajpheart.00231.2022
   Nguyen BY, 2019, BRIT J PHARMACOL, V176, P4302, DOI 10.1111/bph.14431
   Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106
   Bolduc V, 2013, AM J PHYSIOL-HEART C, V305, PH620, DOI 10.1152/ajpheart.00624.2012
   Borges DGF, 2023, PEERJ, V11, P0, DOI 10.7717/peerj.14571
   Brand MD, 2013, BRIT J DERMATOL, V169, P1, DOI 10.1111/bjd.12208
   Brandes RP, 2014, HYPERTENSION, V64, P924, DOI 10.1161/HYPERTENSIONAHA.114.03575
   Brozovich FV, 2016, PHARMACOL REV, V68, P476, DOI 10.1124/pr.115.010652
   Cavinato C, 2021, MECH AGEING DEV, V196, P0, DOI 10.1016/j.mad.2021.111471
   Chaib S, 2022, NAT MED, V28, P1556, DOI 10.1038/s41591-022-01923-y
   Chang AR, 2020, PHYSIOL REV, V100, P145, DOI 10.1152/physrev.00030.2018
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chatterjee S, 2021, MOL THER, V29, P1395, DOI 10.1016/j.ymthe.2020.12.035
   Che D, 2002, DAKAR MED, V47, P18
   Chen CJ, 2013, BIOCHEM BIOPH RES CO, V430, P798, DOI 10.1016/j.bbrc.2012.11.066
   Chen DX, 2002, J NEUROCHEM, V81, P1273, DOI 10.1046/j.1471-4159.2002.00916.x
   Chen MS, 2022, CARDIOVASC RES, V118, P1173, DOI 10.1093/cvr/cvab161
   Cherubini A, 2005, CURR PHARM DESIGN, V11, P2017, DOI 10.2174/1381612054065783
   CHETSANGA CJ, 1976, LIFE SCI, V18, P1405, DOI 10.1016/0024-3205(76)90357-X
   Childs BG, 2021, NATURE AGING, V1, P698, DOI 10.1038/s43587-021-00089-5
   Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659
   Chimenti C, 2003, CIRC RES, V93, P604, DOI 10.1161/01.RES.0000093985.76901.AF
   Choi RH, 2021, NAT REV CARDIOL, V18, P701, DOI 10.1038/s41569-021-00536-1
   Chowdhury A, 2023, EMBO MOL MED, V15, P0, DOI 10.15252/emmm.202317399
   Chrissobolis S, 2014, J HYPERTENS, V32, P1815, DOI 10.1097/HJH.0000000000000259
   Clark L C Jr, 1967, ALA J MED SCI, V4, P337
   Clark L C Jr, 1979, BIRTH DEFECTS ORIG ARTIC SER, V15, P33
   CLARK LC, 1953, J APPL PHYSIOL, V6, P189, DOI 10.1152/jappl.1953.6.3.189
   Collins AR, 2009, CIRC RES, V104, Pe42, DOI 10.1161/CIRCRESAHA.108.188771
   Colpani Ornella, 2019, VASC BIOL, V1, PH75, DOI 10.1530/VB-19-0017
   Corbi G, 2019, OXID MED CELL LONGEV, V2019, P0, DOI 10.1155/2019/7049237
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   Craige SM, 2015, FREE RADICAL BIO MED, V89, P1, DOI 10.1016/j.freeradbiomed.2015.07.004
   Dai Dao-Fu, 2014, LONGEV HEALTHSPAN, V3, P6, DOI 10.1186/2046-2395-3-6
   Dai DF, 2011, J AM COLL CARDIOL, V58, P73, DOI 10.1016/j.jacc.2010.12.044
   Dai DF, 2009, TRENDS CARDIOVAS MED, V19, P213, DOI 10.1016/j.tcm.2009.12.004
   Dai SH, 2014, INT J MOL MED, V34, P1159, DOI 10.3892/ijmm.2014.1876
   Dikalova AE, 2020, CIRC RES, V126, P439, DOI 10.1161/CIRCRESAHA.119.315767
   Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376
   Dookun E, 2020, AGING CELL, V19, P0, DOI 10.1111/acel.13249
   Dorn GW, 2010, J CARDIOVASC TRANSL, V3, P374, DOI 10.1007/s12265-010-9174-x
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861
   Duicu OM, 2013, CAN J PHYSIOL PHARM, V91, P593, DOI 10.1139/cjpp-2012-0422
   Eisenberg T, 2016, NAT MED, V22, P1428, DOI 10.1038/nm.4222
   Elorza AA, 2021, FRONT CELL DEV BIOL, V9, P0, DOI 10.3389/fcell.2021.625020
   Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508
   Ferrara N, 2008, REJUV RES, V11, P139, DOI 10.1089/rej.2007.0576
   Foote K, 2018, AGING CELL, V17, P0, DOI 10.1111/acel.12773
   Franco A, 2016, NATURE, V540, P74, DOI 10.1038/nature20156
   Frustaci A, 2000, CIRC RES, V87, P1123, DOI 10.1161/01.RES.87.12.1123
   Gabisonia K, 2022, AM J PHYSIOL-HEART C, V322, PH769, DOI 10.1152/ajpheart.00659.2021
   Gao YZ, 2014, AM J PHYSIOL-HEART C, V307, PH1252, DOI 10.1152/ajpheart.00392.2014
   GarcÃ­a-GÃ³mez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025
   George CRP, 2003, J NEPHROL, V16, P949
   Ghyczy M, 2001, BRIT J NUTR, V85, P409, DOI 10.1079/BJN2000274
   Giannitsi S, 2019, JRSM CARDIOVASC DIS, V8, P0, DOI 10.1177/2048004019843047
   Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301
   Giorgi C, 2018, INT REV CEL MOL BIO, V340, P209, DOI 10.1016/bs.ircmb.2018.05.006
   Gioscia-Ryan RA, 2018, J APPL PHYSIOL, V124, P1194, DOI 10.1152/japplphysiol.00670.2017
   Gioscia-Ryan RA, 2014, J PHYSIOL-LONDON, V592, P2549, DOI 10.1113/jphysiol.2013.268680
   Gire V, 2015, CELL CYCLE, V14, P297, DOI 10.1080/15384101.2014.1000134
   Goszcz Katarzyna, 2015, FRONT CARDIOVASC MED, V2, P29, DOI 10.3389/fcvm.2015.00029
   Grivennikova VG, 2010, BBA-BIOENERGETICS, V1797, P939, DOI 10.1016/j.bbabio.2010.02.013
   HajnÃ³czky G, 2005, ALCOHOL CLIN EXP RES, V29, P693, DOI 10.1097/01.ALC.0000163493.45344.7A
   Han Y, 2022, AM J PHYSIOL-HEART C, V323, PH538, DOI 10.1152/ajpheart.00244.2022
   He HM, 2022, CIRC RES, V131, P562, DOI 10.1161/CIRCRESAHA.122.321227
   Heggermont WA, 2017, CIRCULATION, V136, P747, DOI 10.1161/CIRCULATIONAHA.116.024171
   HernÃ¡ndez-Corbacho MJ, 2017, BBA-MOL CELL BIOL L, V1862, P56, DOI 10.1016/j.bbalip.2016.09.019
   Hicks S, 2013, AM J PHYSIOL-HEART C, V304, PH903, DOI 10.1152/ajpheart.00567.2012
   Hohensinner PJ, 2016, BBA-MOL CELL RES, V1863, P360, DOI 10.1016/j.bbamcr.2015.11.034
   Hoshino A, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3308
   Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293
   Hsu YJ, 2017, INT J CARDIOL, V228, P543, DOI 10.1016/j.ijcard.2016.11.247
   Hu C, 2022, AGING DIS, V13, P103, DOI 10.14336/AD.2021.0927
   Huang TT, 2000, J GERONTOL A-BIOL, V55, P0
   Huang W, 2022, FRONT IMMUNOL, V13, P0, DOI 10.3389/fimmu.2022.859231
   Hughes WE, 2021, ARTERIOSCL THROM VAS, V41, P446, DOI 10.1161/ATVBAHA.120.314944
   Hyyti OM, 2010, AM J PHYSIOL-HEART C, V299, PH868, DOI 10.1152/ajpheart.00931.2009
   Jalilov AS, 2016, ACS APPL MATER INTER, V8, P15086, DOI 10.1021/acsami.6b03502
   Jezek J, 2018, ANTIOXIDANTS-BASEL, V7, P0, DOI 10.3390/antiox7010013
   Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje
   Kandul NP, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13100
   Karnewar S, 2022, ATHEROSCLEROSIS, V356, P28, DOI 10.1016/j.atherosclerosis.2022.07.012
   Karwi QG, 2018, FRONT CARDIOVASC MED, V5, P0, DOI 10.3389/fcvm.2018.00068
   Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439
   Khavinson V, 2023, CELLS-BASEL, V12, P0, DOI 10.3390/cells12010106
   Kim S, 2020, FREE RADICAL BIO MED, V150, P161, DOI 10.1016/j.freeradbiomed.2020.02.017
   Kim SJ, 2012, CELL METAB, V16, P274, DOI 10.1016/j.cmet.2012.06.012
   Kirkman DL, 2021, AM J PHYSIOL-HEART C, V320, PH2080, DOI 10.1152/ajpheart.00917.2020
   Konior A, 2014, ANTIOXID REDOX SIGN, V20, P2794, DOI 10.1089/ars.2013.5607
   Kowalczyk P, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms222413384
   Kubli Dieter A, 2013, COMMUN INTEGR BIOL, V6, Pe24511, DOI 10.4161/cib.24511
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kumar S, 2018, CRIT REV BIOCHEM MOL, V53, P311, DOI 10.1080/10409238.2018.1458071
   Kumar S, 2017, TRENDS BIOCHEM SCI, V42, P499, DOI 10.1016/j.tibs.2017.05.008
   Kunovac A, 2020, AM J PHYSIOL-HEART C, V319, PH282, DOI 10.1152/ajpheart.00026.2020
   Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911
   Laflamme K, 2006, FASEB J, V20, P1245, DOI 10.1096/fj.05-4702fje
   Lakatta EG, 2003, CIRCULATION, V107, P490, DOI 10.1161/01.CIR.0000048894.99865.02
   Lakshmanan LN, 2018, AGING CELL, V17, P0, DOI 10.1111/acel.12814
   LaRocca TJ, 2014, EXP GERONTOL, V58, P78, DOI 10.1016/j.exger.2014.07.008
   LaRocca TJ, 2013, MECH AGEING DEV, V134, P314, DOI 10.1016/j.mad.2013.04.004
   Lebrecht D, 2003, CIRCULATION, V108, P2423, DOI 10.1161/01.CIR.0000093196.59829.DF
   Lee I, 2021, ANTIOXIDANTS-BASEL, V10, P0, DOI 10.3390/antiox10111645
   Lee I, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-57673-9
   Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x
   Lesnefsky EJ, 2016, CIRC RES, V118, P1593, DOI 10.1161/CIRCRESAHA.116.307505
   Leverve Xavier, 2007, NOVARTIS FOUND SYMP, V280, P108
   Lewis-McDougall FC, 2019, AGING CELL, V18, P0, DOI 10.1111/acel.12931
   Li ZH, 2012, METHODS MOL BIOL, V837, P63, DOI 10.1007/978-1-61779-504-6_5
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268
   Lopaschuk GD, 2021, CIRC RES, V128, P1487, DOI 10.1161/CIRCRESAHA.121.318241
   Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009
   LOPASCHUK GD, 1992, CARDIOVASC RES, V26, P1172, DOI 10.1093/cvr/26.12.1172
   Lozhkin A, 2017, J MOL CELL CARDIOL, V102, P10, DOI 10.1016/j.yjmcc.2016.12.004
   Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115
   Maejima Y, 2008, AGING CELL, V7, P125, DOI 10.1111/j.1474-9726.2007.00358.x
   Manoj P, 2023, AM J PHYSIOL-HEART C, V324, PH259, DOI 10.1152/ajpheart.00618.2022
   Marcus JM, 2018, FRONT NEUROSCI-SWITZ, V12, P0, DOI 10.3389/fnins.2018.00799
   MARTIN GM, 1977, AM J PATHOL, V89, P513
   MartÃ­nez-JimÃ©nez MI, 2015, DNA REPAIR, V29, P127, DOI 10.1016/j.dnarep.2015.02.013
   Martino E, 2022, ANTIOXIDANTS-BASEL, V11, P0, DOI 10.3390/antiox11081611
   Matsushima S, 2015, AM J PHYSIOL-HEART C, V309, PH1375, DOI 10.1152/ajpheart.00053.2015
   Matsuura TR, 2023, CIRC RES, V132, P882, DOI 10.1161/CIRCRESAHA.123.321872
   Mejia Edgard M, 2014, CARDIOVASCULAR & HEMATOLOGICAL DISORDERS - DRUG TARGETS, V14, P98
   Mengozzi A, 2022, CIRC RES, V131, P476, DOI 10.1161/CIRCRESAHA.122.320888
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   Miller FJ, 2020, CIRC RES, V126, P453, DOI 10.1161/CIRCRESAHA.120.316567
   Mitchell W, 2022, ELIFE, V11, P0, DOI 10.7554/eLife.75531
   Mitry MA, 2020, AM J PHYSIOL-CELL PH, V318, PC380, DOI 10.1152/ajpcell.00073.2019
   Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149
   Miwa S, 2022, J CLIN INVEST, V132, P0, DOI 10.1172/JCI158447
   Mladenov M, 2023, ANTIOXIDANTS-BASEL, V12, P0, DOI 10.3390/antiox12051126
   Mohamed SA, 2006, EXP GERONTOL, V41, P508, DOI 10.1016/j.exger.2006.03.014
   Mohanta SK, 2014, CIRC RES, V114, P1772, DOI 10.1161/CIRCRESAHA.114.301137
   Mone P, 2022, HYPERTENSION, V79, P1633, DOI 10.1161/HYPERTENSIONAHA.122.19586
   Monette JS, 2011, PHARMACOL RES, V63, P23, DOI 10.1016/j.phrs.2010.09.007
   Montalvo RN, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms24097689
   Moon SK, 2001, AM J PHYSIOL-HEART C, V280, PH2779, DOI 10.1152/ajpheart.2001.280.6.H2779
   Moreau R, 2004, BIOCHEM BIOPH RES CO, V325, P48, DOI 10.1016/j.bbrc.2004.10.011
   Morra EA, 2019, FREE RADICAL BIO MED, V130, P174, DOI 10.1016/j.freeradbiomed.2018.10.406
   Murray KO, 2023, AM J PHYSIOL-HEART C, V325, PH187, DOI 10.1152/ajpheart.00270.2023
   Narendra D, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a011338
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Newman LE, 2023, ANNU REV BIOCHEM, V92, P299, DOI 10.1146/annurev-biochem-032620-104401
   Valcarcel-Ares MN, 2012, J GERONTOL A-BIOL, V67, P821, DOI 10.1093/gerona/glr229
   Oldham WM, 2015, CELL METAB, V22, P291, DOI 10.1016/j.cmet.2015.06.021
   Ong SB, 2013, ANTIOXID REDOX SIGN, V19, P400, DOI 10.1089/ars.2012.4777
   Pan W, 2021, CELL DEATH DISCOV, V7, P0, DOI 10.1038/s41420-021-00546-5
   PARADIES G, 1993, ARCH GERONTOL GERIAT, V16, P263, DOI 10.1016/0167-4943(93)90037-I
   Park JH, 2016, FEBS LETT, V590, P924, DOI 10.1002/1873-3468.12061
   Pasdois P, 2011, BIOCHEM J, V436, P493, DOI 10.1042/BJ20101957
   Patel KHK, 2022, AM J PHYSIOL-HEART C, V322, PH129, DOI 10.1152/ajpheart.00565.2021
   PÃ©rez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x
   PÃ©rez-Torres I, 2017, INT J MOL SCI, V18, P0, DOI 10.3390/ijms18102098
   Piao S, 2021, BIOMEDICINES, V9, P0, DOI 10.3390/biomedicines9010052
   Picca A, 2018, NAT REV CARDIOL, V15, P543, DOI 10.1038/s41569-018-0059-z
   Pillai VB, 2010, CARDIOVASC RES, V88, P250, DOI 10.1093/cvr/cvq250
   Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380
   PRICE GB, 1971, SCIENCE, V171, P917, DOI 10.1126/science.171.3974.917
   Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044
   Rajasekaran NS, 2011, ANTIOXID REDOX SIGN, V14, P957, DOI 10.1089/ars.2010.3587
   Rakovic A, 2013, J BIOL CHEM, V288, P2223, DOI 10.1074/jbc.M112.391680
   Ralser Markus, 2007, J BIOL, V6, P10
   Redgrave RE, 2023, NPJ AGING, V9, P0, DOI 10.1038/s41514-023-00113-5
   Ren SC, 2022, AGING DIS, V13, P1015, DOI 10.14336/AD.2021.1204
   RodrÃ­guez-Calvo R, 2007, J GERONTOL A-BIOL, V62, P1326, DOI 10.1093/gerona/62.12.1326
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rossman MJ, 2020, CLIN SCI, V134, P1491, DOI 10.1042/CS20190559
   Rossman MJ, 2018, HYPERTENSION, V71, P1056, DOI 10.1161/HYPERTENSIONAHA.117.10787
   Russomanno G, 2017, IMMUN AGEING, V14, P0, DOI 10.1186/s12979-017-0088-1
   Saheera S, 2021, AM J PHYSIOL-HEART C, V320, PH1749, DOI 10.1152/ajpheart.00925.2020
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Satoh Akiko, 2011, HANDB EXP PHARMACOL, V206, P125, DOI 10.1007/978-3-642-21631-2_7
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   SchrÃ¶der K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054
   SchÃ¼rmann C, 2015, EUR HEART J, V36, P3447, DOI 10.1093/eurheartj/ehv460
   SenthilKumar G, 2022, AM J PHYSIOL-HEART C, V323, PH1167, DOI 10.1152/ajpheart.00566.2022
   Shaji CA, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-018-36769-3
   Shanmugam G, 2020, ANTIOXID REDOX SIGN, V32, P1293, DOI 10.1089/ars.2019.7808
   Shi J, 2020, AM J PHYSIOL-HEART C, V319, PH613, DOI 10.1152/ajpheart.00220.2020
   SIMIONESCU N, 1986, AM J PATHOL, V123, P109
   Simon-Chica A, 2023, AM J PHYSIOL-HEART C, V325, PH475, DOI 10.1152/ajpheart.00184.2023
   Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Song MS, 2017, CELL METAB, V26, P872, DOI 10.1016/j.cmet.2017.09.023
   Stanhewicz AE, 2018, AM J PHYSIOL-HEART C, V315, PH1569, DOI 10.1152/ajpheart.00396.2018
   Suda M, 2024, CIRC J, V88, P277, DOI 10.1253/circj.CJ-23-0657
   SULKIN NM, 1967, J GERONTOL, V22, P485
   Sykora P, 2017, MOL CELL BIOL, V37, P0, DOI 10.1128/MCB.00237-17
   Szczesny B, 2010, MECH AGEING DEV, V131, P330, DOI 10.1016/j.mad.2010.03.009
   Tahrir FG, 2019, J CELL PHYSIOL, V234, P8122, DOI 10.1002/jcp.27597
   Tan YC, 2016, ACTA BIOCH BIOPH SIN, V48, P145, DOI 10.1093/abbs/gmv121
   TatarkovÃ¡ Z, 2011, PHYSIOL RES, V60, P281, DOI 10.33549/physiolres.932019
   Tello K, 2023, CARDIOVASC RES, V119, P1891, DOI 10.1093/cvr/cvad108
   Theurey P, 2018, GENES-BASEL, V9, P0, DOI 10.3390/genes9010022
   Thompson AM, 2014, AM J PHYSIOL-HEART C, V307, PH533, DOI 10.1152/ajpheart.00871.2013
   Tirichen H, 2021, FRONT PHYSIOL, V12, P0, DOI 10.3389/fphys.2021.627837
   Torregrosa-MuÃ±umer R, 2017, P NATL ACAD SCI USA, V114, P11398, DOI 10.1073/pnas.1705367114
   Touyz RM, 2018, CARDIOVASC RES, V114, P529, DOI 10.1093/cvr/cvy023
   Tracy EP, 2022, AM J PHYSIOL-HEART C, V323, PH749, DOI 10.1152/ajpheart.00311.2022
   Tracy EP, 2022, AM J PHYSIOL-HEART C, V322, PH647, DOI 10.1152/ajpheart.00674.2021
   Tranah GJ, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-30255-6
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tseng AHH, 2013, FREE RADICAL BIO MED, V63, P222, DOI 10.1016/j.freeradbiomed.2013.05.002
   Tyrrell DJ, 2022, ARTERIOSCL THROM VAS, V42, P1060, DOI 10.1161/ATVBAHA.122.317643
   Tyrrell DJ, 2020, J AM HEART ASSOC, V9, P0, DOI 10.1161/JAHA.120.017820
   Tyrrell DJ, 2021, NAT REV CARDIOL, V18, P58, DOI 10.1038/s41569-020-0431-7
   Tyrrell DJ, 2020, CIRC RES, V126, P298, DOI 10.1161/CIRCRESAHA.119.315644
   Ungvari Z, 2011, AM J PHYSIOL-HEART C, V301, PH363, DOI 10.1152/ajpheart.01134.2010
   Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103
   van der Velden J, 2018, CARDIOVASC RES, V114, P1273, DOI 10.1093/cvr/cvy147
   van Kuijk K, 2023, CARDIOVASC RES, V119, P1509, DOI 10.1093/cvr/cvad016
   VÃ¡squez-Trincado C, 2016, J PHYSIOL-LONDON, V594, P509, DOI 10.1113/JP271301
   Vendrov AE, 2017, J AM HEART ASSOC, V6, P0, DOI 10.1161/JAHA.117.006775
   Vendrov AE, 2015, ANTIOXID REDOX SIGN, V23, P1389, DOI 10.1089/ars.2014.6221
   Vessey DA, 2009, OXID MED CELL LONGEV, V2, P146, DOI 10.4161/oxim.2.3.8622
   Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang HD, 2010, CAN J PHYSIOL PHARM, V88, P177, DOI 10.1139/Y10-015
   Wang JL, 2015, CIRCULATION, V132, P1909, DOI 10.1161/CIRCULATIONAHA.115.016457
   Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388
   Watson SR, 2021, AM J PHYSIOL-HEART C, V320, PH52, DOI 10.1152/ajpheart.00420.2020
   Wei W, 2017, CELL RES, V27, P898, DOI 10.1038/cr.2017.68
   West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975
   Wilson C, 2023, FUNCTION, V4, P0, DOI 10.1093/function/zqac063
   Wilson N, 2023, TRENDS CELL BIOL, V33, P788, DOI 10.1016/j.tcb.2023.02.004
   Winder NR, 2021, AM J PHYSIOL-HEART C, V320, PH424, DOI 10.1152/ajpheart.00696.2020
   Wisnovsky S, 2018, ACS CHEM BIOL, V13, P900, DOI 10.1021/acschembio.8b00072
   Wisnovsky S, 2016, NAT CHEM BIOL, V12, P567, DOI 10.1038/nchembio.2102
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Xu SP, 2014, REDOX BIOL, V2, P642, DOI 10.1016/j.redox.2014.04.004
   Yapryntseva MA, 2022, FRONT CELL DEV BIOL, V10, P0, DOI 10.3389/fcell.2022.947357
   Yousefzadeh MJ, 2021, NATURE, V594, P100, DOI 10.1038/s41586-021-03547-7
   Yousefzadeh MJ, 2018, EBIOMEDICINE, V36, P18, DOI 10.1016/j.ebiom.2018.09.015
   Yu EPK, 2017, ARTERIOSCL THROM VAS, V37, P2322, DOI 10.1161/ATVBAHA.117.310042
   Yu HZ, 2019, MED SCI MONITOR, V25, P4137, DOI 10.12659/MSM.913240
   Zha YW, 2022, FRONT CARDIOVASC MED, V9, P0, DOI 10.3389/fcvm.2022.910580
   Zhang D, 2005, AM J PHYSIOL-HEART C, V288, PH2476, DOI 10.1152/ajpheart.00670.2004
   Zhang RY, 2017, BMC GENOMICS, V18, P0, DOI 10.1186/s12864-017-4287-0
   Zhang YM, 2014, FREE RADICAL BIO MED, V71, P208, DOI 10.1016/j.freeradbiomed.2014.03.018
   Zhou X, 2014, CELL DEATH DIS, V5, P0, DOI 10.1038/cddis.2014.530
   Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445
NR 256
TC 4
Z9 4
U1 11
U2 20
PU AMER PHYSIOLOGICAL SOC
PI Rockville
PA 6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES
SN 0363-6135
EI 1522-1539
J9 AM J PHYSIOL-HEART C
JI Am. J. Physiol.-Heart Circul. Physiol.
PD FEB 15
PY 2024
VL 326
IS 2
BP H317
EP H333
DI 10.1152/ajpheart.00632.2023
PG 17
WC Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology; Physiology
GA GV5Y6
UT WOS:001155473500001
PM 38038719
DA 2024-11-01
ER

PT J
AU Ozlu, C
   Messahel, S
   Minassian, B
   Kayani, S
AF Ozlu, Can
   Messahel, Souad
   Minassian, Berge
   Kayani, Saima
TI Mitochondrial encephalopathies and myopathies: Our tertiary center's experience
SO EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
LA English
DT Article
DE Mitochondrial disease; Encephalopathy; Myopathy; Cohort; Mitochondrial gene mutation
ID antiepileptic drugs; dysfunction; disease; deficiency
AB Mitochondrial diseases have a heterogeneous phenotype and can result from mutations in the mitochondrial or nuclear genomes, constituting a diagnostically and therapeutically challenging group of disorders. We report our center's experience with mitochondrial encephalopathies and myopathies with a cohort of 50 genetically and phenotypically diverse patients followed in the Neurology clinic over the last ten years. Seventeen patients had mitochondrial DNA mutations, presented over a wide range of ages with seizures, feeding difficulties, extraocular movements abnormalities, and had high rates of stroke-like episodes and regression. Twenty-seven patients had nuclear DNA mutations, presented early in life with feeding difficulty, failure-to-thrive, and seizures, and had high proportions of developmental delay, wheelchair dependence, spine abnormalities and dystonia. In six patients, a mutation could not be identified, but they were included for having mitochondrial disease confirmed by histopathology, enzyme analysis and clinical features. These patients had similar characteristics to patients with nuclear DNA mutations, suggesting missed underlying mutations in the nuclear genome. Management was variable among patients, but outcomes were universally poor with severe disability in all cases. Therapeutic entryways through elucidation of disease pathways and remaining unknown genes are acutely needed.
C1 [Ozlu, Can; Minassian, Berge; Kayani, Saima] Univ Texas Southwestern Med Ctr, Dallas, TX 75390 USA.
   [Ozlu, Can; Minassian, Berge; Kayani, Saima] Childrens Med Ctr, Dallas, TX USA.
   [Messahel, Souad] Elpida Therapeut, Encino, CA USA.
C3 University of Texas System; University of Texas Southwestern Medical Center Dallas
RP Kayani, S (corresponding author), Univ Texas Southwestern Med Ctr, Dallas, TX 75390 USA.
EM saima.kayani@utsouthwestern.edu
CR Abate M, 2020, SEMIN CELL DEV BIOL, V98, P139, DOI 10.1016/j.semcdb.2019.05.022
   Almannai M, 2021, FRONT MOL NEUROSCI, V14, P0, DOI 10.3389/fnmol.2021.682780
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrieux P, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms222111338
   Ardissone A, 2023, EUR J NEUROL, V30, P2079, DOI 10.1111/ene.15814
   Baker MJ, 2022, OPEN BIOL, V12, P0, DOI 10.1098/rsob.220274
   Barca E, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000402
   Belal S, 2022, BIOMEDICINES, V10, P0, DOI 10.3390/biomedicines10071665
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Brandao SR, 2021, ARCH PHYSIOL BIOCHEM, V127, P210, DOI 10.1080/13813455.2019.1628065
   Busanello ENB, 2010, NEUROCHEM INT, V56, P948, DOI 10.1016/j.neuint.2010.04.002
   Cervellati C, 2015, BBA-MOL BASIS DIS, V1852, P2066, DOI 10.1016/j.bbadis.2015.07.014
   Cicaloni V, 2020, FREE RADICAL BIO MED, V155, P37, DOI 10.1016/j.freeradbiomed.2020.05.014
   Crivellari I, 2021, ARCH BIOCHEM BIOPHYS, V700, P0, DOI 10.1016/j.abb.2021.108790
   De Vries MC, 2020, J INHERIT METAB DIS, V43, P800, DOI 10.1002/jimd.12196
   Eisner V, 2018, NAT CELL BIOL, V20, P755, DOI 10.1038/s41556-018-0133-0
   El-Hattab Ayman W, 2017, J. INBORN ERRORS METAB. SCREEN., V5, Pe160051, DOI 10.1177/2326409817697399
   Emmanuele V, 2022, MOL GENET METAB, V136, P125, DOI 10.1016/j.ymgme.2022.05.001
   Finsterer J, 2020, PEDIATR NEUROL, V110, P25, DOI 10.1016/j.pediatrneurol.2020.03.009
   Finsterer J, 2018, BRAIN DEV-JPN, V40, P366, DOI 10.1016/j.braindev.2017.08.002
   Finsterer J, 2017, HANDB EXP PHARMACOL, V240, P473, DOI 10.1007/164_2016_2
   Gold WA, 2014, MITOCHONDRION, V15, P10, DOI 10.1016/j.mito.2014.02.012
   Goldstein A, 1993, GENEREVIEWS((R)), V0, P0
   Gough SM, 2021, FRONT NUTR, V8, P0, DOI 10.3389/fnut.2021.782657
   Guo L, 2020, DNA CELL BIOL, V39, P1449, DOI 10.1089/dna.2019.5010
   Koga Y, 2018, J NEUROL, V265, P2861, DOI 10.1007/s00415-018-9057-7
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lim AZ, 2022, ANN NEUROL, V91, P117, DOI 10.1002/ana.26260
   Liu SW, 2022, J PEDIATR-US, V241, P154, DOI 10.1016/j.jpeds.2021.09.052
   Lopriore P, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms232113216
   Monzel AS, 2023, NAT METAB, V5, P546, DOI 10.1038/s42255-023-00783-1
   Morio B, 2021, CELL CALCIUM, V94, P0, DOI 10.1016/j.ceca.2020.102336
   Ni M, 2019, CELL REP, V27, P1376, DOI 10.1016/j.celrep.2019.04.005
   Orsucci D, 2021, J CLIN MED, V10, P0, DOI 10.3390/jcm10061249
   Parikh S, 2017, GENET MED, V19, P0, DOI 10.1038/gim.2017.107
   Rashid J, 2020, PEDIATR DRUGS, V22, P279, DOI 10.1007/s40272-020-00384-5
   Rogac M, 2021, BALK J MED GENET, V24, P5, DOI 10.2478/bjmg-2021-0019
   Roginski AC, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165682
   Saffari A, 2017, J INHERIT METAB DIS, V40, P631, DOI 10.1007/s10545-017-0048-0
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Shaito A, 2023, CURR NEUROPHARMACOL, V21, P1184, DOI 10.2174/1570159X20666221012122855
   SIEKEVITZ P, 1957, SCI AM, V197, P131, DOI 10.1038/scientificamerican0757-131
   Steele H, 2020, EMBO MOL MED, V12, P0, DOI 10.15252/emmm.201911589
   Stefanetti RJ, 2022, NEUROLOGY, V98, PE2318, DOI 10.1212/WNL.0000000000200299
   Stowe RC, 2018, AM J MED GENET A, V176, P1184, DOI 10.1002/ajmg.a.38654
   Sun C, 2022, MOL GENET GENOM MED, V10, P0, DOI 10.1002/mgg3.1943
   Tarnopolsky MA, 2008, ADV DRUG DELIVER REV, V60, P1561, DOI 10.1016/j.addr.2008.05.001
   Tetsuka S, 2021, METAB BRAIN DIS, V36, P2181, DOI 10.1007/s11011-021-00772-x
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Tragni V, 2022, MOLECULES, V27, P0, DOI 10.3390/molecules27113494
   Valero T, 2014, CURR PHARM DESIGN, V20, P5507, DOI 10.2174/138161282035140911142118
   Velez-Bartolomei F, 1993, GENEREVIEWS, V0, P0
   Vento JM, 2013, NEUROTHERAPEUTICS, V10, P243, DOI 10.1007/s13311-012-0173-2
   Wajner M, 2016, BIOSCIENCE REP, V36, P0, DOI 10.1042/BSR20150240
   Wang ZH, 2022, MITOCHONDRION, V65, P80, DOI 10.1016/j.mito.2022.05.002
   Wesol-Kucharska D, 2021, CHILDREN-BASEL, V8, P0, DOI 10.3390/children8070532
   Xiao CR, 2020, AM J MED GENET A, V182, P2426, DOI 10.1002/ajmg.a.61786
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Youle RJ, 2019, SCIENCE, V365, P655, DOI 10.1126/science.aaw9855
   Zhang XQ, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms222011253
NR 60
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER SCI LTD
PI London
PA 125 London Wall, London, ENGLAND
SN 1090-3798
EI 1532-2130
J9 EUR J PAEDIATR NEURO
JI Eur. J. Paediatr. Neurol.
PD MAY 15
PY 2024
VL 50
IS 
BP 31
EP 40
DI 10.1016/j.ejpn.2024.03.005
EA APR 2024
PG 10
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA QS6H4
UT WOS:001222893900001
PM 38583367
DA 2024-11-01
ER

PT J
AU Mhlanga-Mutangadura, T
   Bullock, G
   Cerda-Gonzalez, S
   Katz, ML
AF Mhlanga-Mutangadura, Tendai
   Bullock, Garrett
   Cerda-Gonzalez, Sofia
   Katz, Martin L.
TI Neuronal Ceroid Lipofuscinosis in a Mixed-Breed Dog with a Splice Site Variant in <i>CLN6</i>
SO GENES
LA English
DT Article
DE neurodegeneration; lysosomal storage; mitochondrial subunit c protein; lipofuscin; fluorescence; whole genome sequencing; electron microscopy
ID lysosomal storage disease; synthase subunit c; nonsense mutation; batten-disease; gene; spectrum; ncl; expression; sequence; deletion
AB A 23-month-old neutered male dog of unknown ancestry presented with a history of progressive neurological signs that included anxiety, cognitive impairment, tremors, seizure activity, ataxia, and pronounced visual impairment. The clinical signs were accompanied by global brain atrophy. Due to progression in the severity of disease signs, the dog was euthanized at 26 months of age. An examination of the tissues collected at necropsy revealed dramatic intracellular accumulations of autofluorescent inclusions in the brain, retina, and cardiac muscle. The inclusions were immunopositive for subunit c of mitochondrial ATP synthase, and their ultrastructural appearances were similar to those of lysosomal storage bodies that accumulate in some neuronal ceroid lipofuscinosis (NCL) diseases. The dog also exhibited widespread neuroinflammation. Based on these findings, the dog was deemed likely to have suffered from a form of NCL. A whole genome sequence analysis of the proband's DNA revealed a homozygous C to T substitution that altered the intron 3-exon 4 splice site of CLN6. Other mutations in CLN6 cause NCL diseases in humans and animals, including dogs. The CLN6 protein was undetectable with immunolabeling in the tissues of the proband. Based on the clinical history, fluorescence and electron-microscopy, immunohistochemistry, and molecular genetic findings, the disorder in this dog was classified as an NCL resulting from the absence of the CLN6 protein. Screening the dog's genome for a panel of breed-specific polymorphisms indicated that its ancestry included numerous breeds, with no single breed predominating. This suggests that the CLN6 disease variant is likely to be present in other mixed-breed dogs and at least some ancestral breeds, although it is likely to be rare since other cases have not been reported to date.
C1 [Mhlanga-Mutangadura, Tendai; Bullock, Garrett; Katz, Martin L.] Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Canine Genet Lab, Columbia, MO 65211 USA.
   [Cerda-Gonzalez, Sofia] MedVet Chicago, Chicago, IL 60618 USA.
   [Katz, Martin L.] Univ Missouri, Sch Med, Dept Ophthalmol, Neurodegenerat Dis Res Lab, Columbia, MO 65212 USA.
C3 University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia
RP Katz, ML (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Canine Genet Lab, Columbia, MO 65211 USA.; Katz, ML (corresponding author), Univ Missouri, Sch Med, Dept Ophthalmol, Neurodegenerat Dis Res Lab, Columbia, MO 65212 USA.
EM tendai@missouri.edu; gebkd2@missouri.edu; sofia.cerda-gonzalez@medvet.com; katzm@health.missouri.edu
FU American Kennel Club Canine Health Foundation [02604]; U.S. National Institutes of Health [S10 OD032246, EY031674]; Orthopedic Foundation for Animals; National Science Foundation [2138259, 2138286, 2138307, 2137603, 2138296]
CR Abitbol M, 2010, P NATL ACAD SCI USA, V107, P14775, DOI 10.1073/pnas.0914206107
   Ashwini A, 2016, MOL GENET METAB, V118, P326, DOI 10.1016/j.ymgme.2016.05.008
   Awano T, 2006, MOL GENET METAB, V87, P341, DOI 10.1016/j.ymgme.2005.11.005
   Awano T, 2006, MOL GENET METAB, V89, P254, DOI 10.1016/j.ymgme.2006.02.016
   Bajaj L, 2020, J CLIN INVEST, V130, P4118, DOI 10.1172/JCl130955
   Bathke J, 2021, BMC BIOINFORMATICS, V22, P0, DOI 10.1186/s12859-021-04317-y
   Beck-WÃ¶dl S, 2018, ACTA NEUROPATHOL COM, V6, P0, DOI 10.1186/s40478-018-0646-6
   Best HL, 2021, J NEUROCHEM, V157, P764, DOI 10.1111/jnc.15285
   Bouhouche A, 2013, INDIAN J PEDIATR, V80, P694, DOI 10.1007/s12098-012-0889-3
   Bullock G, 2023, GENES-BASEL, V14, P0, DOI 10.3390/genes14091746
   Bullock G, 2022, GENE, V830, P0, DOI 10.1016/j.gene.2022.146513
   Butz ES, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2019.165571
   Cao Y, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0017118
   Chin JJ, 2019, MOL GENET METAB, V126, P188, DOI 10.1016/j.ymgme.2018.12.001
   Das AM, 1999, MOL GENET METAB, V66, P349, DOI 10.1006/mgme.1999.2811
   Farias FHG, 2011, NEUROBIOL DIS, V42, P468, DOI 10.1016/j.nbd.2011.02.009
   FEARNLEY IM, 1990, BIOCHEM J, V268, P751, DOI 10.1042/bj2680751
   Gilliam D, 2015, MOL GENET METAB, V115, P101, DOI 10.1016/j.ymgme.2015.04.001
   Guo JY, 2019, MOL GENET METAB REP, V21, P0, DOI 10.1016/j.ymgmr.2019.100521
   Guo JY, 2015, BMC VET RES, V10, P0, DOI 10.1186/s12917-014-0181-z
   Guo J, 2014, MOL GENET METAB, V112, P302, DOI 10.1016/j.ymgme.2014.05.014
   Hansen FM, 2023, LIFE SCI ALLIANCE, V7, P0, DOI 10.26508/lsa.202302147
   Heine C, 2003, BIOCHEM J, V376, P369, DOI 10.1042/BJ20030598
   Heine C, 2007, MOL MEMBR BIOL, V24, P74, DOI 10.1080/09687860600967317
   Hirz M, 2017, MOL GENET METAB, V120, P269, DOI 10.1016/j.ymgme.2016.12.007
   Hughes SM, 2001, ELECTROPHORESIS, V22, P1785, DOI 10.1002/1522-2683(200105)22:9<1785::AID-ELPS1785>3.0.CO;2-L
   Hulbert AJ, 2006, J COMP PHYSIOL B, V176, P93, DOI 10.1007/s00360-005-0025-z
   KaminiÃ³w K, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23105729
   Katz ML, 2017, NEUROBIOL DIS, V108, P277, DOI 10.1016/j.nbd.2017.08.017
   Katz ML, 2011, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2011/198042
   Katz ML, 2005, BIOCHEM BIOPH RES CO, V327, P541, DOI 10.1016/j.bbrc.2004.12.038
   Keller SH, 2024, GENES-BASEL, V15, P0, DOI 10.3390/genes15020246
   Kolicheski A, 2017, J VET INTERN MED, V31, P149, DOI 10.1111/jvim.14632
   Kolicheski A, 2016, J VET INTERN MED, V30, P1149, DOI 10.1111/jvim.13971
   Kominami E, 1995, NEUROCHEM RES, V20, P1305, DOI 10.1007/BF00992505
   Kousi M, 2012, HUM MUTAT, V33, P42, DOI 10.1002/humu.21624
   Lingaas F, 2018, ANIM GENET, V49, P52, DOI 10.1111/age.12629
   MARTINUS RD, 1991, VET RES COMMUN, V15, P85, DOI 10.1007/BF00405140
   Matsumoto A, 2019, BRAIN DEV-JPN, V41, P726, DOI 10.1016/j.braindev.2019.04.009
   Melville SA, 2005, GENOMICS, V86, P287, DOI 10.1016/j.ygeno.2005.06.005
   Mole SE, 2011, THE NEURONAL CEROID LIPOFUSCINOSES (BATTEN DISEASE), V2nd, P0
   Mole SE, 2004, EXP CELL RES, V298, P399, DOI 10.1016/j.yexcr.2004.04.042
   Morgan BR, 2014, J NEUROSCI RES, V92, P531, DOI 10.1002/jnr.23332
   Naseri N, 2021, CLIN GENET, V99, P111, DOI 10.1111/cge.13829
   Nathanson J, 2013, AM J MED GENET A, V161A, P473, DOI 10.1002/ajmg.a.35736
   Onodera M, 2021, CLIN CHIM ACTA, V523, P191, DOI 10.1016/j.cca.2021.09.021
   Palmer DN, 2013, BBA-MOL BASIS DIS, V1832, P1882, DOI 10.1016/j.bbadis.2013.05.014
   PALMER DN, 1989, ADV EXP MED BIOL, V266, P211
   PALMER DN, 1992, AM J MED GENET, V42, P561, DOI 10.1002/ajmg.1320420428
   Panjeshahi S, 2023, HUM GENET, V142, P1001, DOI 10.1007/s00439-023-02556-y
   Pezzini F, 2011, BIOCHEM BIOPH RES CO, V416, P159, DOI 10.1016/j.bbrc.2011.11.016
   Rus CM, 2023, SCI REP-UK, V13, P0, DOI 10.1038/s41598-023-45789-7
   Rus CM, 2022, ORPHANET J RARE DIS, V17, P0, DOI 10.1186/s13023-022-02288-8
   Sadeesh EM, 2023, MOL BIOL REP, V50, P5255, DOI 10.1007/s11033-023-08416-2
   Sanders DN, 2010, MOL GENET METAB, V100, P349, DOI 10.1016/j.ymgme.2010.04.009
   Sato R, 2016, BRAIN DEV-JPN, V38, P852, DOI 10.1016/j.braindev.2016.04.007
   Schmutz I, 2019, MOL GENET METAB, V127, P95, DOI 10.1016/j.ymgme.2018.11.015
   Sharp JD, 2003, HUM MUTAT, V22, P35, DOI 10.1002/humu.10227
   Shiro Y, 2021, BIOMED RES-TOKYO, V42, P129, DOI 10.2220/biomedres.42.129
   Sun GL, 2018, BMC MED GENET, V19, P0, DOI 10.1186/s12881-018-0690-x
   Tanner AJ, 1996, BIOCHEM MOL MED, V57, P1, DOI 10.1006/bmme.1996.0001
   Teixeira CAF, 2006, BBA-MOL BASIS DIS, V1762, P637, DOI 10.1016/j.bbadis.2006.06.002
   Teixeira CA, 2003, HUM MUTAT, V21, P502, DOI 10.1002/humu.10207
   Tuermer A, 2021, PROTEOMICS, V21, P0, DOI 10.1002/pmic.202100043
   Villani NA, 2019, MOL GENET METAB, V127, P107, DOI 10.1016/j.ymgme.2019.04.003
   Wheeler RB, 2002, AM J HUM GENET, V70, P537, DOI 10.1086/338708
   Yamashita A, 2020, BIOCHEM BIOPH RES CO, V525, P883, DOI 10.1016/j.bbrc.2020.03.019
   Yamashita A, 2017, BIOCHEM BIOPH RES CO, V487, P917, DOI 10.1016/j.bbrc.2017.05.002
NR 68
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD JUN 15
PY 2024
VL 15
IS 6
BP 
EP 
DI 10.3390/genes15060661
PG 21
WC Genetics & Heredity
SC Genetics & Heredity
GA WW2S8
UT WOS:001257849400001
PM 38927597
DA 2024-11-01
ER

PT J
AU Pontifex, CS
   Zaman, M
   Fanganiello, RD
   Shutt, TE
   Pfeffer, G
AF Pontifex, Carly S.
   Zaman, Mashiat
   Fanganiello, Roberto D.
   Shutt, Timothy E.
   Pfeffer, Gerald
TI Valosin-Containing Protein (VCP): A Review of Its Diverse Molecular Functions and Clinical Phenotypes
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE valosin-containing protein; multisystem proteinopathy; genetic diagnosis; genotype-phenotype correlation; autophagy; mitophagy; lysophagy; stress granules; ERAD; cell cycle control; DNA damage response; apoptosis; SUMOylation; ubiquitination; skeletal muscle; osteoclast; neuron
ID mitochondrial quality-control; endoplasmic-reticulum stress; dna-replication termination; aaa-atpase; multisystem proteinopathy; frontotemporal dementia; paget-disease; damaged mitochondria; autophagic flux; repair pathway
AB In this review we examine the functionally diverse ATPase associated with various cellular activities (AAA-ATPase), valosin-containing protein (VCP/p97), its molecular functions, the mutational landscape of VCP and the phenotypic manifestation of VCP disease. VCP is crucial to a multitude of cellular functions including protein quality control, endoplasmic reticulum-associated degradation (ERAD), autophagy, mitophagy, lysophagy, stress granule formation and clearance, DNA replication and mitosis, DNA damage response including nucleotide excision repair, ATM- and ATR-mediated damage response, homologous repair and non-homologous end joining. VCP variants cause multisystem proteinopathy, and pathology can arise in several tissue types such as skeletal muscle, bone, brain, motor neurons, sensory neurons and possibly cardiac muscle, with the disease course being challenging to predict.
C1 [Pontifex, Carly S.; Zaman, Mashiat; Shutt, Timothy E.; Pfeffer, Gerald] Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB T2N 1N4, Canada.
   [Zaman, Mashiat; Shutt, Timothy E.; Pfeffer, Gerald] Univ Calgary, Alberta Child Hlth Res Inst, Cumming Sch Med, Dept Med Genet, Calgary, AB T2N 1N4, Canada.
   [Zaman, Mashiat; Shutt, Timothy E.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada.
   [Fanganiello, Roberto D.] Univ Laval, Fac Sci & Engn, Quebec City, PQ G1V 0A6, Canada.
   [Pfeffer, Gerald] Heritage Med Res Bldg 155,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.
C3 University of Calgary; University of Calgary; University of Calgary; Laval University
RP Pfeffer, G (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB T2N 1N4, Canada.; Pfeffer, G (corresponding author), Univ Calgary, Alberta Child Hlth Res Inst, Cumming Sch Med, Dept Med Genet, Calgary, AB T2N 1N4, Canada.; Pfeffer, G (corresponding author), Heritage Med Res Bldg 155,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.
EM cspontif@ucalgary.ca; mashiat.zaman1@ucalgary.ca; robertofanganiello@gmail.com; timothy.shutt@ucalgary.ca; gerald.pfeffer@ucalgary.ca
CR Abramzon Y, 2012, NEUROBIOL AGING, V33, P0, DOI 10.1016/j.neurobiolaging.2012.04.005
   Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188
   Anversa P, 1998, CIRC RES, V83, P1, DOI 10.1161/01.RES.83.1.1
   Arhzaouy K, 2019, AUTOPHAGY, V15, P1082, DOI 10.1080/15548627.2019.1569933
   Ash PEA, 2014, BRAIN RES, V1584, P52, DOI 10.1016/j.brainres.2014.05.052
   Badadani M, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0013183
   Bartolome F, 2013, NEURON, V78, P57, DOI 10.1016/j.neuron.2013.02.028
   Bastola P, 2017, CELL DEATH DISCOV, V3, P0, DOI 10.1038/cddiscovery.2017.65
   Bastola P, 2016, MOL ONCOL, V10, P1559, DOI 10.1016/j.molonc.2016.09.005
   Bayraktar O, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0164864
   Bento AC, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-30963-z
   Bergink S, 2013, NAT CELL BIOL, V15, P526, DOI 10.1038/ncb2729
   Blythe EE, 2019, STRUCTURE, V27, P1820, DOI 10.1016/j.str.2019.09.011
   Blythe EE, 2017, P NATL ACAD SCI USA, V114, PE4380, DOI 10.1073/pnas.1706205114
   Boock V, 2023, CURR OPIN NEUROL, V36, P432, DOI 10.1097/WCO.0000000000001184
   Borowik AK, 2022, FUNCTION, V4, P0, DOI 10.1093/function/zqac059
   Braakman I, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a013201
   Braun RJ, 2006, J BIOL CHEM, V281, P25757, DOI 10.1074/jbc.M513699200
   Cao XL, 2020, AGING CELL, V19, P0, DOI 10.1111/acel.13136
   Chang YC, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1001288
   Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029
   Chen JS, 2021, CELLS-BASEL, V10, P0, DOI 10.3390/cells10071789
   Chen X, 2018, CONNECT TISSUE RES, V59, P99, DOI 10.1080/03008207.2017.1290085
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Cheng C, 2022, J TRANSL MED, V20, P0, DOI 10.1186/s12967-021-03186-6
   Ching JK, 2013, HUM MOL GENET, V22, P1167, DOI 10.1093/hmg/dds524
   Chou TF, 2014, J MOL BIOL, V426, P2886, DOI 10.1016/j.jmb.2014.05.022
   Cooney I, 2019, SCIENCE, V365, P502, DOI 10.1126/science.aax0486
   Cramer AAW, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-20058-7
   Custer SK, 2010, HUM MOL GENET, V19, P1741, DOI 10.1093/hmg/ddq050
   Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056
   Dalal S, 2001, CELL, V104, P5, DOI 10.1016/S0092-8674(01)00186-6
   De Brito OM, 2008, ANTIOXID REDOX SIGN, V10, P621, DOI 10.1089/ars.2007.1934
   DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972
   Denton D, 2019, CELL DEATH DIFFER, V26, P605, DOI 10.1038/s41418-018-0252-y
   DeSelm CJ, 2011, DEV CELL, V21, P966, DOI 10.1016/j.devcel.2011.08.016
   Dewar JM, 2015, NATURE, V525, P345, DOI 10.1038/nature14887
   Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041
   Du YJ, 2021, MOL BIOL CELL, V32, P1474, DOI 10.1091/mbc.E21-03-0097
   Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200
   Fang L, 2015, FRONT CELL NEUROSCI, V9, P0, DOI 10.3389/fncel.2015.00016
   Feely SME, 2011, NEUROLOGY, V76, P1690, DOI 10.1212/WNL.0b013e31821a441e
   FernÃ¡ndez-SÃ¡iz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49
   Finkelstein Y, 2010, CLIN TOXICOL, V48, P407, DOI 10.3109/15563650.2010.495348
   Forman MS, 2006, J NEUROPATH EXP NEUR, V65, P571, DOI 10.1097/00005072-200606000-00005
   Franz A, 2011, MOL CELL, V44, P85, DOI 10.1016/j.molcel.2011.08.028
   FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443
   Fujita K, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms2828
   Galarreta A, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22168796
   Garvin AJ, 2019, GENE DEV, V33, P333, DOI 10.1101/gad.321125.118
   Gomez-Suaga P, 2022, AGING CELL, V21, P0, DOI 10.1111/acel.13549
   Gonzalez AE, 2020, FRONT CELL DEV BIOL, V8, P0, DOI 10.3389/fcell.2020.00256
   Gonzalez MA, 2014, BRAIN, V137, P2897, DOI 10.1093/brain/awu224
   Guo X, 2017, BBA-MOL BASIS DIS, V1863, P552, DOI 10.1016/j.bbadis.2016.11.026
   Gupta M, 2019, FRONT NEUROL, V10, P0, DOI 10.3389/fneur.2019.00553
   He JS, 2014, J BIOL CHEM, V289, P27278, DOI 10.1074/jbc.M114.589812
   Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021
   Hewitt G, 2016, AUTOPHAGY, V12, P1917, DOI 10.1080/15548627.2016.1210368
   Hong CJ, 2016, BRAIN RES, V1649, P166, DOI 10.1016/j.brainres.2016.02.048
   Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041
   Inano S, 2017, MOL CELL, V66, P622, DOI 10.1016/j.molcel.2017.04.022
   Isono M, 2017, CELL REP, V18, P520, DOI 10.1016/j.celrep.2016.12.042
   Ivanov P, 2019, CSH PERSPECT BIOL, V11, P0, DOI 10.1101/cshperspect.a032813
   Izawa T, 2017, CELL, V171, P890, DOI 10.1016/j.cell.2017.10.002
   Jerath Nivedita U, 2015, CASE REP GENET, V2015, P239167, DOI 10.1155/2015/239167
   Jiang N, 2013, CELL DEATH DIS, V4, P0, DOI 10.1038/cddis.2013.171
   Ju JS, 2010, AUTOPHAGY, V6, P929, DOI 10.4161/auto.6.7.12785
   Ju JS, 2010, AUTOPHAGY, V6, P283, DOI 10.4161/auto.6.2.11063
   Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115
   Kim H, 2021, MATERIALS, V14, P0, DOI 10.3390/ma14113019
   Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029
   Kim YS, 2023, EUR J NEUROL, V30, P2583, DOI 10.1111/ene.15824
   Kimonis VE, 2008, AM J MED GENET A, V146A, P745, DOI 10.1002/ajmg.a.31862
   Kimonis VE, 2008, BBA-MOL BASIS DIS, V1782, P744, DOI 10.1016/j.bbadis.2008.09.003
   Kimura Y, 2013, GENES CELLS, V18, P1131, DOI 10.1111/gtc.12103
   Kirby AE, 2021, NEUROL-GENET, V7, P0, DOI 10.1212/NXG.0000000000000595
   Klar J, 2013, HUM MUTAT, V34, P572, DOI 10.1002/humu.22282
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Koerver L, 2019, EMBO REP, V20, P0, DOI 10.15252/embr.201948014
   Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034
   Korb M, 2022, ORPHANET J RARE DIS, V17, P0, DOI 10.1186/s13023-022-02172-5
   Korb MK, 2021, MUSCLE NERVE, V63, P442, DOI 10.1002/mus.27097
   Koyano F, 2019, EMBO REP, V20, P0, DOI 10.15252/embr.201947728
   Kravic B, 2020, AUTOPHAGY, V16, P179, DOI 10.1080/15548627.2019.1687217
   Kwon OC, 2017, AM J MED, V130, P583, DOI 10.1016/j.amjmed.2016.12.006
   Lee JH, 2010, EMBO J, V29, P574, DOI 10.1038/emboj.2009.372
   Lee Y, 2018, J CLIN INVEST, V128, P1164, DOI 10.1172/JCI97103
   Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200
   Li ZD, 2016, DNA REPAIR, V38, P94, DOI 10.1016/j.dnarep.2015.11.019
   Livingstone M, 2005, CANCER RES, V65, P7533, DOI 10.1158/0008-5472.CAN-04-3729
   Llambi F, 2016, CELL, V165, P421, DOI 10.1016/j.cell.2016.02.026
   Luijsterburg MS, 2012, CURR OPIN CELL BIOL, V24, P439, DOI 10.1016/j.ceb.2012.03.008
   Mah-Som AY, 2023, AM J HUM GENET, V110, P1959, DOI 10.1016/j.ajhg.2023.10.007
   Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040
   Majera D, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9020469
   Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x
   Markovinovic A, 2022, J CELL SCI, V135, P0, DOI 10.1242/jcs.248534
   MÃ¥rtensson CU, 2019, NATURE, V569, P679, DOI 10.1038/s41586-019-1227-y
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   McLelland GL, 2018, AUTOPHAGY, V14, P1658, DOI 10.1080/15548627.2018.1505154
   McLelland GL, 2018, ELIFE, V7, P0, DOI 10.7554/eLife.32866
   McMillan EM, 2014, BIOCHEM J, V462, P267, DOI 10.1042/BJ20140312
   Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367
   Mei L, 2021, BIOCHEM SOC T, V49, P2133, DOI 10.1042/BST20210161
   Mengus C, 2022, AUTOPHAGY, V18, P171, DOI 10.1080/15548627.2021.1922982
   Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831
   Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181
   Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579
   Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010
   Montalbano M, 2020, NEUROBIOL DIS, V146, P0, DOI 10.1016/j.nbd.2020.105130
   Mori-Konya C, 2009, GENES CELLS, V14, P483, DOI 10.1111/j.1365-2443.2009.01286.x
   Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395
   MÃ¼ller JMM, 2007, BIOCHEM BIOPH RES CO, V354, P459, DOI 10.1016/j.bbrc.2006.12.206
   Nadeau ME, 2015, BMC CANCER, V15, P0, DOI 10.1186/s12885-015-1489-1
   Nalbandian A, 2015, MITOCHONDRION, V22, P1, DOI 10.1016/j.mito.2015.02.004
   Nalbandian A, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0046308
   Nalbandian A, 2013, MUSCLE NERVE, V47, P260, DOI 10.1002/mus.23522
   Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9
   Nightingale H, 2014, BMJ-BRIT MED J, V348, P0, DOI 10.1136/bmj.g459
   Niu ZY, 2018, FRONT NEUROL, V9, P0, DOI 10.3389/fneur.2018.00147
   Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778
   Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017
   Papadopoulos C, 2020, J MOL BIOL, V432, P231, DOI 10.1016/j.jmb.2019.08.010
   Papadopoulos C, 2017, EMBO J, V36, P135, DOI 10.15252/embj.201695148
   ParÃ© MF, 2017, BBA-MOL CELL RES, V1864, P708, DOI 10.1016/j.bbamcr.2016.12.015
   Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3
   Pfeffer G, 2022, GENES-BASEL, V13, P0, DOI 10.3390/genes13060963
   Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911
   Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004
   Puumalainen MR, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms4695
   Qi L, 2017, TRENDS CELL BIOL, V27, P430, DOI 10.1016/j.tcb.2016.12.002
   Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002
   Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5
   Reddy S V, 2001, REV ENDOCR METAB DISORD, V2, P195
   Regensburger M, 2017, NEUROLOGY, V89, P746, DOI 10.1212/WNL.0000000000004240
   Roberts TM, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep28166
   Roy B, 2023, ANN CLIN TRANSL NEUR, V10, P686, DOI 10.1002/acn3.51760
   Seguin SJ, 2014, CELL DEATH DIFFER, V21, P1838, DOI 10.1038/cdd.2014.103
   Shao JY, 2020, MOL CELL ONCOL, V7, P0, DOI 10.1080/23723556.2020.1796179
   Shih YT, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms11020
   Singh AN, 2019, EMBO J, V38, P0, DOI 10.15252/embj.2019102361
   Sonneville R, 2017, NAT CELL BIOL, V19, P468, DOI 10.1038/ncb3500
   Spina S, 2013, EUR J NEUROL, V20, P251, DOI 10.1111/j.1468-1331.2012.03831.x
   Steffen J, 2017, MOL BIOL CELL, V28, P600, DOI 10.1091/mbc.E16-07-0545
   Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042
   Strifler G, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0166682
   Szurman-Zubrzycka M, 2019, FRONT PLANT SCI, V10, P0, DOI 10.3389/fpls.2019.01299
   Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013
   Taylor JP, 2015, NEUROLOGY, V85, P658, DOI 10.1212/WNL.0000000000001862
   Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014
   Turakhiya A, 2018, MOL CELL, V70, P906, DOI 10.1016/j.molcel.2018.04.021
   Uchiyama K, 2005, J BIOCHEM, V137, P115, DOI 10.1093/jb/mvi028
   van den Boom J, 2016, MOL CELL, V64, P189, DOI 10.1016/j.molcel.2016.08.037
   Wang B, 2019, MOL CELL, V74, P742, DOI 10.1016/j.molcel.2019.03.027
   Wang FL, 2021, CANCERS, V13, P0, DOI 10.3390/cancers13205076
   Wang G, 2004, CELL RES, V14, P303, DOI 10.1038/sj.cr.7290375
   Wang KZQ, 2018, ENEURO, V5, P0, DOI 10.1523/ENEURO.0466-18.2018
   Wang T, 2016, J BIOL CHEM, V291, P14373, DOI 10.1074/jbc.M116.729343
   Wang ZH, 2016, HUM MOL GENET, V25, P1946, DOI 10.1093/hmg/ddw067
   Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332
   Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426
   Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327
   WÃ³jcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432
   Wolozin B, 2019, NAT REV NEUROSCI, V20, P649, DOI 10.1038/s41583-019-0222-5
   Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748
   Yablonka-Reuveni Z, 2006, DEV DYNAM, V235, P203, DOI 10.1002/dvdy.20602
   Yeo BK, 2016, MOL BRAIN, V9, P0, DOI 10.1186/s13041-016-0212-8
   Zhang T, 2017, ELIFE, V6, P0, DOI 10.7554/eLife.17834
   Zhao YG, 2021, NAT REV MOL CELL BIO, V22, P733, DOI 10.1038/s41580-021-00392-4
   Zhou CH, 2012, AUTOPHAGY, V8, P1215, DOI 10.4161/auto.20284
   Zhu CG, 2020, CELL REP, V31, P0, DOI 10.1016/j.celrep.2020.107745
NR 171
TC 1
Z9 1
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUN 15
PY 2024
VL 25
IS 11
BP 
EP 
DI 10.3390/ijms25115633
PG 23
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA UB9U2
UT WOS:001245727000001
PM 38891822
DA 2024-11-01
ER

PT J
AU Nesterova, VV
   Babenkova, PI
   Brezgunova, AA
   Samoylova, NA
   Sadovnikova, IS
   Semenovich, DS
   Andrianova, NV
   Gureev, AP
   Plotnikov, EY
AF Nesterova, Veronika V.
   Babenkova, Polina I.
   Brezgunova, Anna A.
   Samoylova, Natalia A.
   Sadovnikova, Irina S.
   Semenovich, Dmitry S.
   Andrianova, Nadezda V.
   Gureev, Artem P.
   Plotnikov, Egor Y.
TI Differences in the Effect of Beta-Hydroxybutyrate on the Mitochondrial Biogenesis, Oxidative Stress and Inflammation Markers in Tissues from Young and Old Rats
SO BIOCHEMISTRY-MOSCOW
LA English
DT Article
DE aging; beta-hydroxybutyrate; ketogenic diet; mitochondria; mitochondrial DNA; oxidative stress
ID ketogenic diet; expression; accumulation; deletions; protein
AB One of the therapeutic approaches to age-related diseases is modulation of body cell metabolism through certain diets or their pharmacological mimetics. The ketogenic diet significantly affects cell energy metabolism and functioning of mitochondria, which has been actively studied in various age-related pathologies. Here, we investigated the effect of the ketogenic diet mimetic beta-hydroxybutyrate (BHB) on the expression of genes regulating mitochondrial biogenesis (Ppargc1a, Nrf1, Tfam), quality control (Sqstm1), functioning of the antioxidant system (Nfe2l2, Gpx1, Gpx3, Srxn1, Txnrd2, Slc6a9, Slc7a11), and inflammatory response (Il1b, Tnf, Ptgs2, Gfap) in the brain, lungs, heart, liver, kidneys, and muscles of young and old rats. We also analyzed mitochondrial DNA (mtDNA) copy number, accumulation of mtDNA damage, and levels of oxidative stress based on the concentration of reduced glutathione and thiobarbituric acid-reactive substances (TBARS). In some organs, aging disrupted mitochondrial biogenesis and functioning of cell antioxidant system, which was accompanied by the increased oxidative stress and inflammation. Administration of BHB for 2 weeks had different effects on the organs of young and old rats. In particular, BHB upregulated expression of genes coding for proteins associated with the mitochondrial biogenesis and antioxidant system, especially in the liver and muscles of young (but not old) rats. At the same time, BHB contributed to the reduction of TBARS in the kidneys of old rats. Therefore, our study has shown that administration of ketone bodies significantly affected gene expression in organs, especially in young rats, by promoting mitochondrial biogenesis, improving the functioning of the antioxidant defense system, and partially reducing the level of oxidative stress. However, these changes were much less pronounced in old animals.
C1 [Nesterova, Veronika V.; Babenkova, Polina I.; Samoylova, Natalia A.; Sadovnikova, Irina S.; Gureev, Artem P.] Voronezh State Univ, Voronezh 394018, Russia.
   [Brezgunova, Anna A.; Semenovich, Dmitry S.; Andrianova, Nadezda V.; Plotnikov, Egor Y.] Lomonosov Moscow State Univ, Belozersky Inst Phys Chem Biol, Moscow 119991, Russia.
   [Gureev, Artem P.] Voronezh State Univ Engn Technol, Voronezh 394036, Russia.
C3 Voronezh State University; Lomonosov Moscow State University; Voronezh State University of Engineering Technologies
RP Plotnikov, EY (corresponding author), Lomonosov Moscow State Univ, Belozersky Inst Phys Chem Biol, Moscow 119991, Russia.
EM plotnikov@belozersky.msu.ru
FU Russian Science Foundation [21-75-30009]
CR Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81
   Bank C, 2000, BIOCHEM BIOPH RES CO, V279, P595, DOI 10.1006/bbrc.2000.3951
   Edwards JG, 2009, MITOCHONDRION, V9, P31, DOI 10.1016/j.mito.2008.11.004
   Fang YD, 2021, KIDNEY INT, V100, P1037, DOI 10.1016/j.kint.2021.06.031
   Feng J, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms232315166
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   Goshtasbi H, 2022, NEUROCHEM INT, V153, P0, DOI 10.1016/j.neuint.2021.105268
   Gregory John W, 2009, V15, V0, PP59, DOI 10.1159/000207610
   Gureev AP, 2024, INT J MOL SCI, V25, P0, DOI 10.3390/ijms25115710
   Gureev AP, 2022, FEBS J, V289, P5697, DOI 10.1111/febs.16451
   Gureev AP, 2019, FRONT GENET, V10, P0, DOI 10.3389/fgene.2019.00435
   Han YM, 2020, EXP MOL MED, V52, P548, DOI 10.1038/s12276-020-0415-z
   Harrington JS, 2023, PHYSIOL REV, V103, P2349, DOI 10.1152/physrev.00058.2021
   HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2
   Hoppe T, 2020, GENETICS, V215, P889, DOI 10.1534/genetics.120.301283
   Huang TY, 2021, AM J PHYSIOL-ENDOC M, V320, PE1053, DOI 10.1152/ajpendo.00410.2020
   Ivannikova Ekaterina V, 2022, PROBLEMY ENDOKRINOLOGII, V68, P49, DOI 10.14341/probl12724
   Jin LW, 2023, FASEB J, V37, P0, DOI 10.1096/fj.202301254R
   Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI 10.1042/BSE0470069
   Kim DH, 2019, AGING-US, V11, P1283, DOI 10.18632/aging.101838
   Komaravelli N, 2015, FREE RADICAL BIO MED, V88, P391, DOI 10.1016/j.freeradbiomed.2015.05.043
   Koronowski KB, 2021, CELL REP, V36, P0, DOI 10.1016/j.celrep.2021.109487
   Kumar A, 2022, CURR NEUROPHARMACOL, V20, P2034, DOI 10.2174/1570159X20666220420130109
   Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002
   Lee AK, 2020, AGING DIS, V11, P777, DOI 10.14336/AD.2019.0926
   Li Y, 2021, ACS CHEM NEUROSCI, V12, P1219, DOI 10.1021/acschemneuro.1c00046
   Lima T, 2022, NATURE AGING, V2, P199, DOI 10.1038/s43587-022-00191-2
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Loshchenova PS, 2015, BIOCHEMISTRY-MOSCOW+, V80, P596, DOI 10.1134/S0006297915050120
   Lu YY, 2023, THERANOSTICS, V13, P736, DOI 10.7150/thno.79876
   Luo SL, 2022, INT IMMUNOPHARMACOL, V111, P0, DOI 10.1016/j.intimp.2022.109101
   Makievskaya CI, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms24032576
   Martins R, 2016, AGING CELL, V15, P196, DOI 10.1111/acel.12427
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   Newman JC, 2017, ANNU REV NUTR, V37, P51, DOI 10.1146/annurev-nutr-071816-064916
   Newman JC, 2014, DIABETES RES CLIN PR, V106, P173, DOI 10.1016/j.diabres.2014.08.009
   Nissanka N, 2019, TRENDS GENET, V35, P235, DOI 10.1016/j.tig.2019.01.001
   Nissanka N, 2018, FEBS LETT, V592, P728, DOI 10.1002/1873-3468.12956
   Norwitz NG, 2019, FRONT NUTR, V6, P0, DOI 10.3389/fnut.2019.00063
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Pal S, 2016, SCI ADV, V2, P0, DOI 10.1126/sciadv.1600584
   Pan A, 2022, NAT COMMUN, V13, P0, DOI 10.1038/s41467-022-28044-x
   Patsoukis N, 2004, ANAL BIOANAL CHEM, V378, P1783, DOI 10.1007/s00216-004-2525-1
   Rojas-Morales P, 2020, REDOX BIOL, V29, P0, DOI 10.1016/j.redox.2019.101395
   Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y
   Sharma P, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8020100
   Shi XX, 2014, CELL PHYSIOL BIOCHEM, V33, P920, DOI 10.1159/000358664
   Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166
   Shippy DC, 2020, J NEUROINFLAMM, V17, P0, DOI 10.1186/s12974-020-01948-5
   Son JM, 2019, BMB REP, V52, P13, DOI 10.5483/BMBRep.2019.52.1.300
   Wang L, 2021, NUTRIENTS, V13, P0, DOI 10.3390/nu13103420
   Wei S, 2022, FRONT MOL BIOSCI, V9, P0, DOI 10.3389/fmolb.2022.823602
   Whitehall Julia C, 2023, SUBCELL BIOCHEM, V102, P77, DOI 10.1007/978-3-031-21410-3_4
   Yan CJ, 2019, CELLS-BASEL, V8, P0, DOI 10.3390/cells8040379
   Zinovkina LA, 2018, BIOCHEMISTRY-MOSCOW+, V83, P233, DOI 10.1134/S0006297918030045
   Zorov DB, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1115, DOI 10.1134/S0006297907100094
NR 56
TC 0
Z9 0
U1 2
U2 2
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 0006-2979
EI 1608-3040
J9 BIOCHEMISTRY-MOSCOW+
JI Biochem.-Moscow
PD JUL 15
PY 2024
VL 89
IS 7
BP 1336
EP 1348
DI 10.1134/S0006297924070149
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA C5W6S
UT WOS:001290074400003
PM 39218029
DA 2024-11-01
ER

PT J
AU Ceballos, F
   Serrano-Lorenzo, P
   Bermejo-Guerrero, L
   BlÃ¡zquez, A
   Quesada-Espinosa, JF
   Amigo, J
   Minguez, P
   Ayuso, C
   GarcÃ­a-ArumÃ­, E
   Muelas, N
   Jaijo, T
   Nascimento, A
   GalÃ¡n-Rodriguez, B
   Paradas, C
   Arenas, J
   Carracedo, A
   MartÃ­, R
   MartÃ­n, MA
   DomÃ­nguez-GonzÃ¡lez, C
AF Ceballos, Francisco
   Serrano-Lorenzo, Pablo
   Bermejo-Guerrero, Laura
   Blazquez, Alberto
   Quesada-Espinosa, Juan F.
   Amigo, Jorge
   Minguez, Pablo
   Ayuso, Carmen
   Garcia-Arumi, Elena
   Muelas, Nuria
   Jaijo, Teresa
   Nascimento, Andres
   Galan-Rodriguez, Beatriz
   Paradas, Carmen
   Arenas, Joaquin
   Carracedo, Angel
   Marti, Ramon
   Martin, Miguel A.
   Dominguez-Gonzalez, Cristina
TI Clinical and Genetic Analysis of Patients With TK2 Deficiency
SO NEUROLOGY-GENETICS
LA English
DT Article
ID mitochondrial-dna depletion; thymidine kinase 2; one word; mutations; maintenance; homozygosity; association; myopathy; spectrum; defects
AB ObjectivesThymidine kinase 2 deficiency (TK2d) is a rare autosomal recessive disorder that stems from a perturbation of the mitochondrial DNA maintenance. Nucleoside treatment has recently shown promise as a disease-modifying therapy. TK2d was initially associated with rapidly progressive fatal myopathy in children featuring mitochondrial DNA depletion. Subsequently, less severe variants of the disease were described, with onset of symptoms during adolescence or adulthood and associated with the presence of multiple mtDNA deletions. These less severe phenotypes have been reported in only 15% of the approximately 120 patients described worldwide. However, some reports suggest that these juvenile and adult-onset presentations may be more common. The objective of this study was to describe the clinical phenotype in a sample of patients from Spain.MethodsThis study includes 53 patients harboring biallelic TK2 pathogenic variants, compiling data retrospectively from 7 Spanish centers. We analyzed allele frequency, investigated the most recent common ancestor of core haplotypes, and used the Runs of Homozygosity approach to investigate variant coalescence.ResultsSymptom onset distribution revealed that 32 patients (60%) experienced symptoms beyond 12 years of age. Approximately 30% of patients died of respiratory insufficiency, while 56% of surviving patients needed mechanical ventilation. Genetic analysis identified 16 distinct variants in TK2. Two variants, p.Lys202del and p.Thr108Met, exhibited significantly higher prevalence in the Spanish population than that reported in gnomAD database (86-fold and 13-fold, respectively). These variants are estimated to have originated approximately 16.8 generations ago for p.Thr108Met and 95.2 generations ago for p.Lys202del within the Spanish population, with the increase in frequency attributed to various forms of inbreeding. In late-onset cases, 46.9% carried the p.Lys202del variant.DiscussionThe higher frequency of TK2d in Spain can be partially attributed to the increased prevalence of 2 variants and consanguinity. Notably, in 60% of the cohort, the disease was late-onset, emphasizing the potential underdiagnosis of this subgroup of patients in other regions. Raising awareness of this potentially treatable disorder is of utmost importance because early interventions can significantly affect the quality of life and survival of affected individuals.
C1 [Ceballos, Francisco; Serrano-Lorenzo, Pablo; Blazquez, Alberto; Amigo, Jorge; Minguez, Pablo; Ayuso, Carmen; Garcia-Arumi, Elena; Muelas, Nuria; Jaijo, Teresa; Nascimento, Andres; Arenas, Joaquin; Carracedo, Angel; Marti, Ramon; Martin, Miguel A.; Dominguez-Gonzalez, Cristina] Hosp Res Inst imas12, Spanish Network Biomed Res Rare Dis CIBERER, Madrid, Spain.
   [Serrano-Lorenzo, Pablo; Blazquez, Alberto; Arenas, Joaquin; Martin, Miguel A.; Dominguez-Gonzalez, Cristina] Hosp Res Inst imas12, Mitochondrial & Neuromuscular Res Group?12 Octubre, Madrid, Spain.
   [Bermejo-Guerrero, Laura] Hosp 12 Octubre, Neurol Dept, Neuromuscular Disorders Unit, Madrid, Spain.
   [Quesada-Espinosa, Juan F.; Martin, Miguel A.] Hosp Univ 12 Octubre, Genet Dept, Madrid, Spain.
   [Amigo, Jorge; Carracedo, Angel] Fdn Publ Galega Med Xen FPGMX, Santiago, Spain.
   [Amigo, Jorge; Carracedo, Angel] Santiago de Compostela Res Inst IDIS, Genet Grp, Santiago De Compostela, Spain.
   [Amigo, Jorge; Carracedo, Angel] Santiago de Compostela Univ USC, Res Ctr Mol Med & Chron Dis CIMUS, Med Xen Grp, Santiago De Compostela, Spain.
   [Minguez, Pablo; Ayuso, Carmen] Fdn Jimenez Diaz Univ Hosp, Dept Genet & Genom, Inst Invest Sanitaria, Madrid, Spain.
   [Minguez, Pablo] Univ Autonoma Madrid IIS FJD, Fdn Jimenez Diaz Univ Hosp, Hlth Res Inst, Bioinformat Unit, Madrid, Spain.
   [Garcia-Arumi, Elena] ValldHebron Univ Hosp, Dept Clin & Mol Genet, Barcelona, Spain.
   [Garcia-Arumi, Elena; Marti, Ramon] Univ Autonoma Barcelona, Vall dHebron Res Inst VHIR, Res Grp Neuromuscular & Mitochondrial Disorders, Barcelona, Spain.
   [Muelas, Nuria] Hosp Univ & Politecn La Fe, Dept Neurol, Neuromuscular Unit, Neuromuscular & Ataxias Res Grp, Valencia, Spain.
   [Jaijo, Teresa] Hosp Univ & Politecn Fe Valencia, Dept Genet, Valencia, Spain.
   [Nascimento, Andres] St Joan de Deu Hosp, St Joan de Deu Res Inst, Neurol Dept, Neuromuscular Unit, Barcelona, Spain.
   [Galan-Rodriguez, Beatriz; Paradas, Carmen] Hosp U Virgen del Rocio, Neurol Dept, Neuromuscular Disorders Unit, Inst Biomed Sevilla, Seville, Spain.
   [Paradas, Carmen] Spanish Network Biomed Res Neurodegenerat Dis CIBE, Madrid, Spain.
C3 CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; Universidade de Santiago de Compostela; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital Universitari i Politecnic La Fe; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS)
RP MartÃ­n, MA; DomÃ­nguez-GonzÃ¡lez, C (corresponding author), Hosp Res Inst imas12, Spanish Network Biomed Res Rare Dis CIBERER, Madrid, Spain.
FU Instituto de Salud Carlos III, (ISCIII); Ministerio de Ciencia e Innovacion (Madrid, Spain); European Regional Development Fund "A way to make Europe" [PI22/01587, PI19/01772, PI21/00381]
CR Abouelhoda M, 2016, GENOME BIOL, V17, P0, DOI 10.1186/s13059-016-1102-1
   Alkuraya FS, 2010, GENET MED, V12, P765, DOI 10.1097/GIM.0b013e3181fbfcc4
   Alston CL, 2013, NEUROLOGY, V81, P2051, DOI 10.1212/01.wnl.0000436931.94291.e6
   Ashley N, 2007, HUM MOL GENET, V16, P1400, DOI 10.1093/hmg/ddm090
   BÃ©hin A, 2012, NEUROLOGY, V78, P644, DOI 10.1212/WNL.0b013e318248df2b
   Bray SM, 2010, P NATL ACAD SCI USA, V107, P16222, DOI 10.1073/pnas.1004381107
   Bychkov IO, 2021, MITOCHONDRION, V57, P205, DOI 10.1016/j.mito.2021.01.004
   Ceballos FC, 2022, FRONT IMMUNOL, V13, P0, DOI 10.3389/fimmu.2022.925558
   Ceballos FC, 2019, HUM GENET, V138, P1123, DOI 10.1007/s00439-019-02045-1
   Ceballos FC, 2018, NAT REV GENET, V19, P220, DOI 10.1038/nrg.2017.109
   Chanprasert S, 2013, MOL GENET METAB, V110, P153, DOI 10.1016/j.ymgme.2013.07.009
   de la Hoz CPDF, 2021, MOL GENET METAB REP, V26, P0, DOI 10.1016/j.ymgmr.2020.100701
   DomÃ­nguez-GonzÃ¡lez C, 2022, NEUROMUSCULAR DISORD, V32, P728, DOI 10.1016/j.nmd.2022.07.399
   DomÃ­nguez-GonzÃ¡lez C, 2022, J NEUROL, V269, P3550, DOI 10.1007/s00415-021-10957-0
   DomÃ­nguez-GonzÃ¡lez C, 2021, ORPHANET J RARE DIS, V16, P0, DOI 10.1186/s13023-021-02030-w
   Dominguez-Gonzalez C, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-66940-8
   DomÃ­nguez-GonzÃ¡lez C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   DomÃ­nguez-GonzÃ¡lez C, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1071-z
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Florian RT, 2019, NAT COMMUN, V10, P0, DOI 10.1038/s41467-019-12763-9
   Gandolfo LC, 2014, GENETICS, V197, P1315, DOI 10.1534/genetics.114.164616
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   JACQUARD A, 1975, THEOR POPUL BIOL, V7, P338, DOI 10.1016/0040-5809(75)90024-6
   Laine-MenÃ©ndez S, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22115598
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Nothnagel M, 2010, HUM MOL GENET, V19, P2927, DOI 10.1093/hmg/ddq198
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Pagnamenta AT, 2021, BRAIN, V144, P584, DOI 10.1093/brain/awaa420
   Palamara PF, 2012, AM J HUM GENET, V91, P809, DOI 10.1016/j.ajhg.2012.08.030
   Paradas C, 2013, NEUROLOGY, V80, P504, DOI 10.1212/WNL.0b013e31827f0ff7
   Park YH, 2020, NAT IMMUNOL, V21, P857, DOI 10.1038/s41590-020-0705-6
   Provine WB, 2004, GENETICS, V167, P1041
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   RodrÃ­guez-LÃ³pez C, 2020, J MED GENET, V57, P643, DOI 10.1136/jmedgenet-2019-106649
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Salman DO, 2022, FRONT GENET, V13, P0, DOI 10.3389/fgene.2022.1029947
   Slatkin M, 2004, AM J HUM GENET, V75, P282, DOI 10.1086/423146
   TEMPLETON AR, 1994, EXS, V68, P91
   Tulinius M, 2005, NEUROMUSCULAR DISORD, V15, P412, DOI 10.1016/j.nmd.2005.03.010
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Urtizberea JA, 2023, GENES-BASEL, V14, P0, DOI 10.3390/genes14050954
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Wang JL, 2018, MOL GENET METAB, V124, P124, DOI 10.1016/j.ymgme.2018.04.012
   Wang L, 1999, FEBS LETT, V443, P170, DOI 10.1016/S0014-5793(98)01711-6
   Wang LY, 2022, NUCLEOS NUCLEOT NUCL, V41, P264, DOI 10.1080/15257770.2021.2001005
   Weir BS, 2012, PHILOS SCI, V79, P637, DOI 10.1086/667904
   Wills C, 2007, J HERED, V98, P382, DOI 10.1093/JHERED/ESM035
NR 50
TC 0
Z9 0
U1 2
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2376-7839
EI 
J9 NEUROL-GENET
JI Neurol.-Genet.
PD APR 15
PY 2024
VL 10
IS 2
BP 
EP 
DI 10.1212/NXG.0000000000200138
PG 13
WC Genetics & Heredity; Clinical Neurology
SC Genetics & Heredity; Neurosciences & Neurology
GA E6T5H
UT WOS:001304310900001
PM 38544965
DA 2024-11-01
ER

PT J
AU Lu, JL
   Dai, YC
   Ji, KQ
   Peng, GX
   Li, H
   Yan, CZ
   Shen, B
   Zhou, XL
AF Lu, Jia-Li
   Dai, Yichen
   Ji, Kunqian
   Peng, Gui-Xin
   Li, Hong
   Yan, Chuanzhu
   Shen, Bin
   Zhou, Xiao-Long
TI Taurine hypomodification underlies mitochondrial tRNA<SUP>Trp</SUP>-related genetic diseases
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article; Early Access
ID transfer-rna modification; wobble modification deficiency; gtp-binding protein; hypertrophic cardiomyopathy; modification defect; lactic-acidosis; 1st position; mutation; mnme; myopathy
AB Escherichia coli MnmE and MnmG form a complex (EcMnmEG), generating transfer RNA (tRNA) 5-carboxymethylaminomethyluridine (cmnm(5)U) modification. Both cmnm(5)U and equivalent 5-taurinomethyluridine (tau m(5)U, catalyzed by homologous GTPBP3 and MTO1) are found at U34 in several human mitochondrial tRNAs (hmtRNAs). Certain mitochondrial DNA (mtDNA) mutations, including m.3243A > G in tRNA(Leu)(UUR) and m.8344A > G in tRNA(Lys), cause genetic diseases, partially due to tau m(5)U hypomodification. However, whether other mtDNA variants in different tRNAs cause a defect in tau m(5)U biogenesis remains unknown. Here, we purified naturally assembled EcMnmEG from E. coli. Notably, EcMnmEG was able to incorporate both cmnm(5)U and tau m(5)U into hmtRNA(Trp) (encoded by MT-TW), providing a valuable basis for directly monitoring the effects of mtDNA mutations on U34 modification. In vitro, several clinical hmtRNA(Trp) pathogenic mutations caused U34 hypomodification. A patient harboring an m.5541C > T mutation exhibited hmtRNA(Trp) tau m(5)U hypomodification. Moreover, using mtDNA base editing, we constructed two cell lines carrying m.5532G > A or m.5545C > T mutations, both of which exhibited hmtRNA(Trp) tau m(5)U hypomodification. Taurine supplementation improved mitochondrial translation in patient cells. Our findings describe the third hmtRNA species with mutation-related tau m(5)U-hypomodification and provide new insights into the pathogenesis and intervention strategy for hmtRNA(Trp)-related genetic diseases.
C1 [Lu, Jia-Li; Peng, Gui-Xin; Zhou, Xiao-Long] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci,Key Lab RNA Innova, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.
   [Dai, Yichen; Shen, Bin] Nanjing Med Univ, Womens Hosp, Nanjing Women & Childrens Healthcare Hosp, Ctr Global Hlth,Gusu Sch,State Key Lab Reprod Med, 101 Long Mian Ave, Nanjing 211166, Peoples R China.
   [Ji, Kunqian; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Res Inst Neuromuscular & Neurodegenerat Dis, 107 West Wenhua Rd, Jinan 250012, Peoples R China.
   [Ji, Kunqian; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Peoples R China.
   [Li, Hong] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, Core Facil Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Qilu Hosp Qingdao, Mitochondrial Med Lab, 758 Hefei Rd, Qingdao 266035, Peoples R China.
   [Zhou, Xiao-Long] Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Life Sci, Key Lab Syst Hlth Sci Zhejiang Prov, 1 Xiangshan Sub-Lane, Hangzhou 310024, Peoples R China.
C3 Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Center for Excellence in Molecular Cell Science, CAS; Nanjing Medical University; Shandong University; Shandong University; Chinese Academy of Sciences; Center for Excellence in Molecular Cell Science, CAS; Shandong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS
RP Zhou, XL (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci,Key Lab RNA Innova, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.; Shen, B (corresponding author), Nanjing Med Univ, Womens Hosp, Nanjing Women & Childrens Healthcare Hosp, Ctr Global Hlth,Gusu Sch,State Key Lab Reprod Med, 101 Long Mian Ave, Nanjing 211166, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Res Inst Neuromuscular & Neurodegenerat Dis, 107 West Wenhua Rd, Jinan 250012, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp Qingdao, Mitochondrial Med Lab, 758 Hefei Rd, Qingdao 266035, Peoples R China.; Zhou, XL (corresponding author), Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Life Sci, Key Lab Syst Hlth Sci Zhejiang Prov, 1 Xiangshan Sub-Lane, Hangzhou 310024, Peoples R China.
EM czyan@sdu.edu.cn; binshen@njmu.edu.cn; xlzhou@sibcb.ac.cn
FU National Key Research and Development Program of China [2021YFA1300800]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB0570000]; Natural Science Foundation of China [32271300, 32371546]; Committee of Science and Technology in Shanghai [22ZR1481300, 22JC1400503]; CAS Project for Young Scientists in Basic Research [YSBR-075]
CR Agris PF, 2008, EMBO REP, V9, P629, DOI 10.1038/embor.2008.104
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Anitori R, 2005, MOL GENET METAB, V84, P176, DOI 10.1016/j.ymgme.2004.10.003
   Asano K, 2018, NUCLEIC ACIDS RES, V46, P1565, DOI 10.1093/nar/gky068
   Baric I, 2013, EUR J HUM GENET, V21, P871, DOI 10.1038/ejhg.2012.272
   BASAVAPPA R, 1991, EMBO J, V10, P3105, DOI 10.1002/j.1460-2075.1991.tb07864.x
   Becker L, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0114918
   Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Bommisetti P, 2023, J AM CHEM SOC, V145, P26947, DOI 10.1021/jacs.3c10182
   Bommisetti P, 2022, J BIOL CHEM, V298, P0, DOI 10.1016/j.jbc.2022.102548
   Cappannini A, 2023, NUCLEIC ACIDS RES, V0, P0, DOI DOI 10.1093/nar/gkad1083
   Chen DN, 2019, NUCLEIC ACIDS RES, V47, P5341, DOI 10.1093/nar/gkz218
   de CrÃ©cy-Lagard V, 2021, TRENDS MICROBIOL, V29, P41, DOI 10.1016/j.tim.2020.06.010
   Dey R, 2000, NEUROMUSCULAR DISORD, V10, P488, DOI 10.1016/S0960-8966(00)00125-5
   Herrero-MartÃ­n MD, 2010, J NEUROL NEUROSUR PS, V81, P471, DOI 10.1136/jnnp.2009.173831
   Duan HC, 2024, NAT COMMUN, V15, P0, DOI 10.1038/s41467-024-45166-6
   Fakruddin M, 2018, CELL REP, V22, P482, DOI 10.1016/j.celrep.2017.12.051
   Fislage M, 2014, NUCLEIC ACIDS RES, V42, P5978, DOI 10.1093/nar/gku213
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   GiegÃ© R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017
   Giege R, 2023, NUCLEIC ACIDS RES, V51, P1528, DOI 10.1093/nar/gkad007
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guo JY, 2021, CELL DISCOV, V7, P0, DOI 10.1038/s41421-021-00307-9
   HANNA MG, 1995, AM J HUM GENET, V56, P1026
   Hatakeyama H, 2015, ACTA NEUROPATHOL COM, V3, P0, DOI 10.1186/s40478-015-0227-x
   Huang MH, 2023, SCI BULL, V68, P2094, DOI 10.1016/j.scib.2023.08.002
   Ji KQ, 2022, J MED GENET, V59, P79, DOI 10.1136/jmedgenet-2020-107323
   Kazuhito T, 2020, J BIOCHEM, V168, P435, DOI 10.1093/jb/mvaa098
   Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Kopajtich R, 2014, AM J HUM GENET, V95, P708, DOI 10.1016/j.ajhg.2014.10.017
   Kurata S, 2008, J BIOL CHEM, V283, P18801, DOI 10.1074/jbc.M800233200
   Lambert IH, 2015, ACTA PHYSIOL, V213, P191, DOI 10.1111/apha.12365
   Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002
   Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200
   Maniura-Weber K, 2004, EUR J HUM GENET, V12, P509, DOI 10.1038/sj.ejhg.5201185
   Meyer S, 2008, J MOL BIOL, V380, P532, DOI 10.1016/j.jmb.2008.04.072
   Meyer S, 2009, PLOS BIOL, V7, P0, DOI 10.1371/journal.pbio.1000212
   Meyer S, 2009, J MOL BIOL, V392, P910, DOI 10.1016/j.jmb.2009.07.004
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Moukadiri I, 2009, NUCLEIC ACIDS RES, V37, P7177, DOI 10.1093/nar/gkp762
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   Ohsawa Y, 2019, J NEUROL NEUROSUR PS, V90, P529, DOI 10.1136/jnnp-2018-317964
   Osawa T, 2009, STRUCTURE, V17, P713, DOI 10.1016/j.str.2009.03.013
   Peng GX, 2021, NUCLEIC ACIDS RES, V49, P2816, DOI 10.1093/nar/gkab104
   PÃ¼tz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407
   Richter U, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-06471-z
   Rikimaru M, 2012, INTERNAL MED, V51, P3351, DOI 10.2169/internalmedicine.51.7529
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, PD823, DOI 10.1093/nar/gkl927
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Scrima A, 2005, EMBO J, V24, P23, DOI 10.1038/sj.emboj.7600507
   Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171
   Shi R, 2009, J BACTERIOL, V191, P7614, DOI 10.1128/JB.00650-09
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Silvestri G, 2000, NEUROLOGY, V54, P1693, DOI 10.1212/WNL.54.8.1693
   Singh P, 2023, SCIENCE, V380, P0, DOI 10.1126/science.abn9257
   Sissler M, 2004, RNA, V10, P841, DOI 10.1261/rna.5267604
   Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656
   Suzuki T, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-18068-6
   Suzuki T, 2021, NAT REV MOL CELL BIO, V22, P375, DOI 10.1038/s41580-021-00342-0
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Suzuki T, 2011, WIRES RNA, V2, P376, DOI 10.1002/wrna.65
   Tulinius M, 2003, NEUROPEDIATRICS, V34, P87
   Wang M, 2013, BIOCHEM J, V453, P455, DOI 10.1042/BJ20130294
   Wang Y, 2020, SCI CHINA LIFE SCI, V63, P1227, DOI 10.1007/s11427-019-1619-x
   Wang Y, 2018, NUCLEIC ACIDS RES, V46, P4662, DOI 10.1093/nar/gky243
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
   Wolff P, 2020, RNA, V26, P1957, DOI 10.1261/rna.077537.120
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5
   Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794
   Yim L, 2006, NUCLEIC ACIDS RES, V34, P5892, DOI 10.1093/nar/gkl752
   YOKOYAMA S, 1985, P NATL ACAD SCI USA, V82, P4905, DOI 10.1073/pnas.82.15.4905
   Zhang QH, 2021, NUCLEIC ACIDS RES, V49, P4689, DOI 10.1093/nar/gkab228
   Zheng WQ, 2023, P NATL ACAD SCI USA, V120, P0, DOI 10.1073/pnas.2309714120
NR 75
TC 0
Z9 0
U1 3
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD OCT 9
PY 2024
VL 0
IS 
BP 
EP 
DI 10.1093/nar/gkae854
EA OCT 2024
PG 17
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA I6N4W
UT WOS:001331406100001
PM 39380483
DA 2024-11-01
ER

PT J
AU Kleefeld, F
   Horvath, R
   Pinal-Fernandez, I
   Mammen, AL
   Casal-Dominguez, M
   Hathazi, D
   Melchert, S
   Hahn, K
   Sickmann, A
   Muselmann-Genschow, C
   Hentschel, A
   Preusse, C
   Roos, A
   Schoser, B
   Stenzel, W
AF Kleefeld, Felix
   Horvath, Rita
   Pinal-Fernandez, Iago
   Mammen, Andrew L.
   Casal-Dominguez, Maria
   Hathazi, Denisa
   Melchert, Sarah
   Hahn, Katrin
   Sickmann, Albert
   Muselmann-Genschow, Claudia
   Hentschel, Andreas
   Preusse, Corinna
   Roos, Andreas
   Schoser, Benedikt
   Stenzel, Werner
TI Multi-level profiling unravels mitochondrial dysfunction in myotonic dystrophy type 2
SO ACTA NEUROPATHOLOGICA
LA English
DT Article
DE Myotonic dystrophy type 2; Proximal myotonic myopathy; Mitochondrial dysfunction
ID mutation; taco1; deletions; myopathy
AB Myotonic dystrophy type 2 (DM2) is an autosomal-dominant multisystemic disease with a core manifestation of proximal muscle weakness, muscle atrophy, myotonia, and myalgia. The disease-causing CCTG tetranucleotide expansion within the CNBP gene on chromosome 3 leads to an RNA-dominated spliceopathy, which is currently untreatable. Research exploring the pathophysiological mechanisms in myotonic dystrophy type 1 has resulted in new insights into disease mechanisms and identified mitochondrial dysfunction as a promising therapeutic target. It remains unclear whether similar mechanisms underlie DM2 and, if so, whether these might also serve as potential therapeutic targets. In this cross-sectional study, we studied DM2 skeletal muscle biopsy specimens on proteomic, molecular, and morphological, including ultrastructural levels in two separate patient cohorts consisting of 8 (explorative cohort) and 40 (confirmatory cohort) patients. Seven muscle biopsy specimens from four female and three male DM2 patients underwent proteomic analysis and respiratory chain enzymology. We performed bulk RNA sequencing, immunoblotting of respiratory chain complexes, mitochondrial DNA copy number determination, and long-range PCR (LR-PCR) to study mitochondrial DNA deletions on six biopsies. Proteomic and transcriptomic analyses revealed a downregulation of essential mitochondrial proteins and their respective RNA transcripts, namely of subunits of respiratory chain complexes I, III, and IV (e.g., mt-CO1, mt-ND1, mt-CYB, NDUFB6) and associated translation factors (TACO1). Light microscopy showed mitochondrial abnormalities (e.g., an age-inappropriate amount of COX-deficient fibers, subsarcolemmal accumulation) in most biopsy specimens. Electron microscopy revealed widespread ultrastructural mitochondrial abnormalities, including dysmorphic mitochondria with paracrystalline inclusions. Immunofluorescence studies with co-localization of autophagy (p62, LC-3) and mitochondrial marker proteins (TOM20, COX-IV), as well as immunohistochemistry for mitophagy marker BNIP3 indicated impaired mitophagic flux. Immunoblotting and LR-PCR did not reveal significant differences between patients and controls. In contrast, mtDNA copy number measurement showed a reduction of mtDNA copy numbers in the patient group compared to controls. This first multi-level study of DM2 unravels thus far undescribed functional and structural mitochondrial abnormalities. However, the molecular link between the tetranucleotide expansion and mitochondrial dysfunction needs to be further elucidated.
C1 [Kleefeld, Felix; Melchert, Sarah; Hahn, Katrin] Charite Univ Med Berlin, Dept Neurol, Charitepl 1, D-10117 Berlin, Germany.
   [Kleefeld, Felix; Hahn, Katrin; Muselmann-Genschow, Claudia; Preusse, Corinna; Stenzel, Werner] Free Univ Berlin, Humboldt Univ Berlin, BIH, Charitepl 1, D-10117 Berlin, Germany.
   [Horvath, Rita; Hathazi, Denisa] Univ Cambridge, Dept Clin Neurosci, Cambridge, England.
   [Pinal-Fernandez, Iago; Mammen, Andrew L.; Casal-Dominguez, Maria] NIAMSD, Muscle Dis Unit, NIH, Bethesda, MD 20892 USA.
   [Pinal-Fernandez, Iago; Mammen, Andrew L.; Casal-Dominguez, Maria] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Melchert, Sarah] Free Univ Berlin, Humboldt Univ Berlin, Charitepl 1, D-10117 Berlin, Germany.
   [Sickmann, Albert; Hentschel, Andreas] Leibniz Inst Analyt Wissensch ISAS eV, D-44139 Dortmund, Germany.
   [Muselmann-Genschow, Claudia; Preusse, Corinna; Stenzel, Werner] Charite Univ Med Berlin, Dept Neuropathol, Charitepl 1, D-10117 Berlin, Germany.
   [Preusse, Corinna] Charite Univ Med Berlin, Dept Neuropediat, Augustenburger Pl 1, D-13353 Berlin, Germany.
   [Preusse, Corinna] Humboldt Univ, Freie Univ Berlin, BIH, Augustenburger Pl 1, D-13353 Berlin, Germany.
   [Roos, Andreas] Univ Duisburg Essen, Univ Childrens Hosp, Pediat Neurol, Fac Med, Essen, Germany.
   [Roos, Andreas] Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada.
   [Schoser, Benedikt] Ludwig Maximilians Univ Munchen, Friedrich Baur Inst, Dept Neurol, Munich, Germany.
C3 Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Johns Hopkins University; Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Berlin Institute of Health; Berlin Institute of Health; Free University of Berlin; University of Duisburg Essen; University of Ottawa; Children's Hospital of Eastern Ontario; University of Munich
RP Stenzel, W (corresponding author), Charite Univ Med Berlin, Dept Neuropathol, Charitepl 1, D-10117 Berlin, Germany.
EM Werner.Stenzel@charite.de
FU Deutsche Gesellschaft fuer Muskelkranke e.V. [KI 3/2]
CR Chartier A, 2015, PLOS GENET, V11, P0, DOI 10.1371/journal.pgen.1005092
   Chen T, 2011, J HUM GENET, V56, P689, DOI 10.1038/jhg.2011.97
   FISCHER JC, 1986, EUR J PEDIATR, V144, P441, DOI 10.1007/BF00441735
   GarcÃ­a-Puga M, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23052901
   GarcÃ­a-Puga M, 2020, AGING-US, V12, P6260, DOI 10.18632/aging.103022
   Gramegna LL, 2018, NEUROMUSCULAR DISORD, V28, P144, DOI 10.1016/j.nmd.2017.10.007
   Gu X, 2021, STAR PROTOC, V2, P0, DOI 10.1016/j.xpro.2020.100245
   Hathazi D, 2020, EMBO J, V39, P0, DOI 10.15252/embj.2020105364
   HorvÃ¡th R, 2003, J MED GENET, V40, P752, DOI 10.1136/jmg.40.10.752
   Johnson NE, 2021, NEUROLOGY, V96, PE1045, DOI 10.1212/WNL.0000000000011425
   Koehorst E, 2020, J CLIN MED, V9, P0, DOI 10.3390/jcm9123939
   Li Y, 2022, CELL DEATH DIS, V13, P0, DOI 10.1038/s41419-021-04469-y
   Meola Giovanni, 2020, ACTA MYOL, V39, P222, DOI 10.36185/2532-1900-026
   Nguyen CDL, 2023, J NEUROL, V270, P3138, DOI 10.1007/s00415-023-11633-1
   Oktay Y, 2020, J NEUROMUSCULAR DIS, V7, P301, DOI 10.3233/JND-200510
   Ophuis RJAO, 2009, PLOS ONE, V4, P0, DOI 10.1371/journal.pone.0008024
   Pinal-Fernandez I, 2020, ANN RHEUM DIS, V79, P1234, DOI 10.1136/annrheumdis-2019-216599
   Preusse C, 2016, ACTA NEUROPATHOL COM, V4, P0, DOI 10.1186/s40478-016-0308-5
   Preusse C, 2012, AM J PATHOL, V181, P2161, DOI 10.1016/j.ajpath.2012.08.033
   Rusconi F, 2010, NEUROBIOL DIS, V38, P273, DOI 10.1016/j.nbd.2010.01.017
   SAHASHI K, 1992, GERONTOLOGY, V38, P18
   Seeger J, 2010, NEUROMUSCULAR DISORD, V20, P720, DOI 10.1016/j.nmd.2010.06.017
   Suominen T, 2011, EUR J HUM GENET, V19, P776, DOI 10.1038/ejhg.2011.23
   Todorow V, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22168607
   Udd B, 2019, NEUROMUSCULAR DISORD, V29, P483, DOI 10.1016/j.nmd.2019.03.002
   Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390
   Wong KT, 1996, NEUROMUSCULAR DISORD, V6, P163, DOI 10.1016/0960-8966(95)00039-9
   Yamada T, 2019, AUTOPHAGY, V15, P2012, DOI 10.1080/15548627.2019.1643185
NR 28
TC 2
Z9 2
U1 4
U2 6
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0001-6322
EI 1432-0533
J9 ACTA NEUROPATHOL
JI Acta Neuropathol.
PD JUN 15
PY 2024
VL 147
IS 1
BP 
EP 
DI 10.1007/s00401-023-02673-y
PG 12
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA FL3Q7
UT WOS:001145910400002
PM 38240888
DA 2024-11-01
ER

PT J
AU Rustamov, J
   Rustamov, Z
   Mohamad, MS
   Zaki, N
   Al Tenaiji, A
   Al Harbi, M
   Al Jasmi, F
AF Rustamov, Jaloliddin
   Rustamov, Zahiriddin
   Mohamad, Mohd Saberi
   Zaki, Nazar
   Al Tenaiji, Amal
   Al Harbi, Mariam
   Al Jasmi, Fatma
TI An expert rule-based approach for identifying infantile-onset Pompe disease patients using retrospective electronic health records
SO SCIENTIFIC REPORTS
LA English
DT Article
DE Pompe disease; Infantile onset Pompe disease; Electronic health records; Expert rule-based screening; PowerBI; Dashboard analytics
ID respiratory-failure; diagnosis
AB Pompe disease (OMIM #232300), a rare genetic disorder, leads to glycogen buildup in the body due to an enzyme deficiency, particularly harming the heart and muscles. Infantile-onset Pompe disease (IOPD) requires urgent treatment to prevent mortality, but the unavailability of these methods often delays diagnosis. Our study aims to streamline IOPD diagnosis in the UAE using electronic health records (EHRs) for faster, more accurate detection and timely treatment initiation. This study utilized electronic health records from the Abu Dhabi Healthcare Company (SEHA) healthcare network in the UAE to develop an expert rule-based screening approach operationalized through a dashboard. The study encompassed six diagnosed IOPD patients and screened 93,365 subjects. Expert rules were formulated to identify potential high-risk IOPD patients based on their age, particular symptoms, and creatine kinase levels. The proposed approach was evaluated using accuracy, sensitivity, and specificity. The proposed approach accurately identified five true positives, one false negative, and four false positive IOPD cases. The false negative case involved a patient with both Pompe disease and congenital heart disease. The focus on CHD led to the overlooking of Pompe disease, exacerbated by no measurement of creatine kinase. The false positive cases were diagnosed with Mitochondrial DNA depletion syndrome 12-A (SLC25A4 gene), Immunodeficiency-71 (ARPC1B mutation), Niemann-Pick disease type C (NPC1 gene mutation leading to frameshift), and Group B Streptococcus meningitis. The proposed approach of integrating expert rules with a dashboard facilitated efficient data visualization and automated patient screening, which aids in the early detection of Pompe disease. Future studies are encouraged to investigate the application of machine learning methodologies to enhance further the precision and efficiency of identifying patients with IOPD.
C1 [Rustamov, Jaloliddin; Al Jasmi, Fatma] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Genet & Genom, Al Ain, U Arab Emirates.
   [Rustamov, Zahiriddin; Zaki, Nazar] United Arab Emirates Univ, Coll Informat Technol, Dept Comp Sci & Software Engn, Al Ain, U Arab Emirates.
   [Rustamov, Zahiriddin; Zaki, Nazar; Al Jasmi, Fatma] United Arab Emirates Univ, ASPIRE Precis Med Res Inst Abu Dhabi, Al Ain, U Arab Emirates.
   [Al Tenaiji, Amal] Sheikh Khalifa Med City, Dept Pediat, Abu Dhabi, U Arab Emirates.
   [Al Harbi, Mariam] SEHA Corp Med & Clin Affairs, Res Dept, Abu Dhabi, U Arab Emirates.
   [Al Jasmi, Fatma] Tawam Hosp, Dept Pediat, Al Ain, U Arab Emirates.
   [Mohamad, Mohd Saberi] United Arab Emirates Univ, Coll Med & Hlth Sci, Hlth Data Sci Lab, Al Ain, U Arab Emirates.
   [Mohamad, Mohd Saberi] Multimedia Univ, Fac Engn & Technol, Ctr Engn Computat Intelligence, Melaka, Malaysia.
C3 United Arab Emirates University; United Arab Emirates University; United Arab Emirates University; United Arab Emirates University; Multimedia University
RP Rustamov, J; Al Jasmi, F (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Genet & Genom, Al Ain, U Arab Emirates.; Al Jasmi, F (corresponding author), United Arab Emirates Univ, ASPIRE Precis Med Res Inst Abu Dhabi, Al Ain, U Arab Emirates.; Al Jasmi, F (corresponding author), Tawam Hosp, Dept Pediat, Al Ain, U Arab Emirates.
EM 700043175@uaeu.ac.ae; aljasmif@uaeu.ac.ae
FU Sanofi; ASPIRE, the technology program management pillar of Abu Dhabi's Advanced Technology Research Council (ATRC); ASPIRE Precision Medicine Research Institute Abu Dhabi (ASPIREPMRIAD) [VRI-20-10];  [21M142]
CR Al Hassnan Z, 2022, ORPHANET J RARE DIS, V17, P0, DOI 10.1186/s13023-022-02545-w
   Al Jasmi F, 2015, BMC NEUROL, V15, P0, DOI 10.1186/s12883-015-0412-3
   Al-Hassnan Z, 2023, ORPHANET J RARE DIS, V18, P0, DOI 10.1186/s13023-023-02967-0
   Al-Jasmi FA, 2016, JIMD REP, V28, P127, DOI 10.1007/8904_2015_512
   Alonso-PÃ©rez J, 2020, MED CLIN-BARCELONA, V154, P80, DOI 10.1016/j.medcli.2019.03.036
   Ansong AK, 2006, GENET MED, V8, P297, DOI 10.1097/01.gim.0000195896.04069.5f
   Bay LB, 2019, ARCH ARGENT PEDIATR, V117, P271, DOI 10.5546/aap.2019.eng.271
   Bembi B, 2003, J INHERIT METAB DIS, V26, P675, DOI 10.1023/B:BOLI.0000005618.76542.ed
   Case LE, 2007, PEDIATR RADIOL, V37, P437, DOI 10.1007/s00247-007-0428-y
   Chien YH, 2013, PEDIATR NEONATOL, V54, P219, DOI 10.1016/j.pedneo.2013.03.009
   Crossen K, 2022, INT J NEONAT SCREEN, V8, P0, DOI 10.3390/ijns8030043
   Fukuda T, 2006, ANN NEUROL, V59, P700, DOI 10.1002/ana.20807
   Howell RR, 2006, GENET MED, V8, P289, DOI 10.1097/01.gim.0000204462.42910.b8
   Kishnani PS, 2023, GENET MED, V25, P0, DOI 10.1016/j.gim.2022.10.010
   Kishnani PS, 2006, J PEDIATR-US, V148, P671, DOI 10.1016/j.jpeds.2005.11.033
   Kishnani PS, 2006, GENET MED, V8, P267, DOI 10.1097/01.gim.0000218152.87434.f3
   Kishnani PS, 2006, J PEDIATR-US, V149, P89, DOI 10.1016/j.jpeds.2006.02.035
   Lin SM, 2023, FRONT NEUROL, V14, P0, DOI 10.3389/fneur.2023.1108222
   Mellies U, 2005, NEUROLOGY, V64, P1465, DOI 10.1212/01.WNL.0000158682.85052.C0
   Mellies U, 2001, NEUROLOGY, V57, P1290, DOI 10.1212/WNL.57.7.1290
   Richardson JS, 2021, GENET MED, V23, P758, DOI 10.1038/s41436-020-01038-0
   Rustamov J, 2023, SUSTAINABILITY-BASEL, V15, P0, DOI 10.3390/su15107782
   Sawada T, 2021, ORPHANET J RARE DIS, V16, P0, DOI 10.1186/s13023-021-02146-z
   Stevens D, 2022, CURR TREAT OPTION NE, V24, P573, DOI 10.1007/s11940-022-00736-1
   Talukdar J, 2023, ARTIFICIAL INTELLIGENCE IN HEALTHCARE INDUSTRY, V0, PP145, DOI 10.1007/978-981-99-3157-68
   van den Hout HMP, 2003, PEDIATRICS, V112, P332, DOI 10.1542/peds.112.2.332
   van der Ploeg AT, 2008, LANCET, V372, P1342, DOI 10.1016/S0140-6736(08)61555-X
   Zaki N, 2009, BMC BIOINFORMATICS, V10, P0, DOI 10.1186/1471-2105-10-150
   Zhao YY, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1054-0
NR 29
TC 0
Z9 0
U1 0
U2 0
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
EI 
J9 SCI REP-UK
JI Sci Rep
PD SEP 14
PY 2024
VL 14
IS 1
BP 
EP 
DI 10.1038/s41598-024-72259-5
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA H3M6P
UT WOS:001322516400034
PM 39277702
DA 2024-11-01
ER

PT J
AU Celik, D
   Campisi, M
   Cannella, L
   Pavanello, S
AF Celik, Dilek
   Campisi, Manuela
   Cannella, Luana
   Pavanello, Sofia
TI The effect of low birth weight as an intrauterine exposure on the early onset of sarcopenia through possible molecular pathways
SO JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
LA English
DT Review
DE Clock genes; DOHaD; Epigenetic; Genome-wide study; Low birth weight; Sarcopenia
ID developmental origins; skeletal-muscle; body-composition; growth restriction; oxidative stress; grip strength; early-life; disease; health; fetal
AB Sarcopenia, a musculoskeletal disease characterized by the progressive loss of skeletal muscle mass, strength, and physical performance, presents significant challenges to global public health due to its adverse effects on mobility, morbidity, mortality, and healthcare costs. This comprehensive review explores the intricate connections between sarcopenia and low birth weight (LBW), emphasizing the developmental origins of health and disease (DOHaD) hypothesis, inflammatory processes (inflammaging), mitochondrial dysfunction, circadian rhythm disruptions, epigenetic mechanisms, and genetic variations revealed through genome-wide studies (GWAS). A systematic search strategy was developed using PubMed to identify relevant English-language publications on sarcopenia, LBW, DOHaD, inflammaging, mitochondrial dysfunction, circadian disruption, epigenetic mechanisms, and GWAS. The publications consist of 46.2% reviews, 21.2% cohort studies, 4.8% systematic reviews, 1.9% cross-sectional studies, 13.4% animal studies, 4.8% genome-wide studies, 5.8% epigenome-wide studies, and 1.9% book chapters. The review identified key factors contributing to sarcopenia development, including the DOHaD hypothesis, LBW impact on muscle mass, inflammaging, mitochondrial dysfunction, the influence of clock genes, the role of epigenetic mechanisms, and genetic variations revealed through GWAS. The DOHaD theory suggests that LBW induces epigenetic alterations during foetal development, impacting long-term health outcomes, including the early onset of sarcopenia. LBW correlates with reduced muscle mass, grip strength, and lean body mass in adulthood, increasing the risk of sarcopenia. Chronic inflammation (inflammaging) and mitochondrial dysfunction contribute to sarcopenia, with LBW linked to increased oxidative stress and dysfunction. Disrupted circadian rhythms, regulated by genes such as BMAL1 and CLOCK, are associated with both LBW and sarcopenia, impacting lipid metabolism, muscle mass, and the ageing process. Early-life exposures, including LBW, induce epigenetic modifications like DNA methylation (DNAm) and histone changes, playing a pivotal role in sarcopenia development. Genome-wide studies have identified candidate genes and variants associated with lean body mass, muscle weakness, and sarcopenia, providing insights into genetic factors contributing to the disorder. LBW emerges as a potential early predictor of sarcopenia development, reflecting the impact of intrauterine exposures on long-term health outcomes. Understanding the complex interplay between LBW with inflammaging, mitochondrial dysfunction, circadian disruption, and epigenetic factors is essential for elucidating the pathogenesis of sarcopenia and developing targeted interventions. Future research on GWAS and the underlying mechanisms of LBW-associated sarcopenia is warranted to inform preventive strategies and improve public health outcomes.
C1 [Celik, Dilek] Univ Padua, Dept Pharmceut & Pharmacol Sci, Padua, Italy.
   [Campisi, Manuela; Cannella, Luana; Pavanello, Sofia] Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Padua, Italy.
   [Pavanello, Sofia] Univ Hosp Padova, Padua, Italy.
C3 University of Padua; University of Padua; University of Padua; Azienda Ospedaliera - Universita di Padova
RP Pavanello, S (corresponding author), Univ Hosp Padova, Padua, Italy.
EM manuela.campisi@unipd.it; luana.cannella@phd.unipd.it; sofia.pavanello@unipd.it
FU European Union's Horizon 2020 research [101034319]; European Union's Horizon 2020 research and innovation programme under the Marie Sklstrok;odowska-Curie; European Union; Marie Curie Actions (MSCA) [101034319] Funding Source: Marie Curie Actions (MSCA)
CR AntuÃ±a E, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms232315039
   Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x
   Barker DJP, 2004, ACTA PAEDIATR, V93, P26, DOI 10.1080/08035320410022730
   Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235
   Beauchamp B, 2015, INT J OBESITY, V39, P702, DOI 10.1038/ijo.2014.120
   Bellanti F, 2021, BIOLOGY-BASEL, V10, P0, DOI 10.3390/biology10010031
   Bianchi ME, 2022, FRONT MED-LAUSANNE, V8, P0, DOI 10.3389/fmed.2021.793990
   Bianco-Miotto T, 2017, J DEV ORIG HLTH DIS, V8, P513, DOI 10.1017/S2040174417000733
   Bielemann RM, 2016, NUTRITION, V32, P228, DOI 10.1016/j.nut.2015.08.014
   Boengler K, 2017, J CACHEXIA SARCOPENI, V8, P349, DOI 10.1002/jcsm.12178
   Cannataro R, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22189724
   Castrogiovanni P, 2017, JOURNAL OF FUNCTIONAL MORPHOLOGY AND KINESIOLOGY, V2, P30, DOI 10.3390/jfmk2030030
   Cech DJ, 2012, FUNCTIONAL MOVEMENT, V0, P129
   Chen WD, 2014, BIOCHEM BIOPH RES CO, V451, P408, DOI 10.1016/j.bbrc.2014.07.138
   Chen YY, 2021, J INFLAMM RES, V14, P2019, DOI 10.2147/JIR.S313085
   Choi YI, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-48161-w
   Choi Y, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21093106
   Christian CJ, 2020, AGING CELL, V19, P0, DOI 10.1111/acel.13223
   Costello PM, 2008, J PHYSIOL-LONDON, V586, P2371, DOI 10.1113/jphysiol.2008.150987
   Cruz-Jentoft AJ, 2019, LANCET, V393, P2636, DOI 10.1016/S0140-6736(19)31138-9
   da Rocha AL, 2022, SCI REP-UK, V12, P0, DOI 10.1038/s41598-022-24277-4
   Dalle S, 2017, FRONT PHYSIOL, V8, P0, DOI 10.3389/fphys.2017.01045
   Dodds R, 2012, J DEV ORIG HEALTH DIS, V3, P0, DOI 10.1017/S204017441100081X
   Dodds R, 2012, J NUTR HEALTH AGING, V16, P609, DOI 10.1007/s12603-012-0053-9
   Jimenez-Gutierrez GE, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11152359
   Eriksson JG, 2016, ANN MED, V48, P456, DOI 10.1080/07853890.2016.1193786
   Fall CHD, 2019, PHILOS T R SOC B, V374, P0, DOI 10.1098/rstb.2018.0123
   Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2
   Gao HB, 2020, EXP CELL RES, V397, P0, DOI 10.1016/j.yexcr.2020.112348
   Gensous N, 2019, FRONT PHYSIOL, V10, P0, DOI 10.3389/fphys.2019.00996
   Goyal D, 2019, J ENDOCRINOL, V242, PT105, DOI 10.1530/JOE-19-0009
   Guarner-Lans V, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21041203
   Gustafsson PE, 2010, BMC PUBLIC HEALTH, V10, P0, DOI 10.1186/1471-2458-10-346
   Hales CN, 2003, DIABETOLOGIA, V46, P1013, DOI 10.1007/s00125-003-1131-7
   Hemmeryckx B, 2011, OBESITY, V19, P659, DOI 10.1038/oby.2010.266
   Hildreth JR, 2022, J DEV ORIG HLTH DIS, V14, P1
   Hiona A, 2010, PLOS ONE, V5, P0, DOI 10.1371/journal.pone.0011468
   Hoffman DJ, 2021, PHYSIOL REV, V101, P739, DOI 10.1152/physrev.00002.2020
   Hsu CN, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21062232
   Inskip HM, 2007, J INTERN MED, V262, P368, DOI 10.1111/j.1365-2796.2007.01812.x
   Iozzo P, 2014, OBESITY FACTS, V7, P130, DOI 10.1159/000362656
   Irazoki A, 2022, AGING CELL, V21, P0, DOI 10.1111/acel.13583
   Jones G, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-20918-w
   Jones G, 2020, J GERONTOL A-BIOL, V75, P301, DOI 10.1093/gerona/glz042
   Kamper RS, 2021, J CACHEXIA SARCOPENI, V12, P1641, DOI 10.1002/jcsm.12832
   Kaur S, 2020, BMC PREGNANCY CHILDB, V20, P0, DOI 10.1186/s12884-020-2797-2
   Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206
   Kondratov RV, 2009, AGING-US, V1, P979, DOI 10.18632/aging.100113
   Kubota T, 2016, ENVIRON EPIGENETICS, V2, P0, DOI 10.1093/eep/dvw017
   Leduc-Gaudet JP, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22158179
   Lee H, 2021, J CACHEXIA SARCOPENI, V12, P1925, DOI 10.1002/jcsm.12794
   Lekkas D, 2019, AUTON NEUROSCI-BASIC, V219, P0, DOI 10.1016/j.autneu.2019.05.001
   Li CW, 2019, J CACHEXIA SARCOPENI, V10, P586, DOI 10.1002/jcsm.12417
   Li S, 2022, EBIOMEDICINE, V77, P0, DOI 10.1016/j.ebiom.2022.103927
   Liu XG, 2009, AM J HUM GENET, V84, P418, DOI 10.1016/j.ajhg.2009.02.004
   Lu AT, 2019, AGING-US, V11, P5895, DOI 10.18632/aging.102173
   Lu AT, 2019, AGING-US, V11, P303, DOI 10.18632/aging.101684
   Madden RA, 2021, EPIGENETICS-US, V16, P783, DOI 10.1080/15592294.2020.1827713
   Malhan D, 2023, NPJ MICROGRAVITY, V9, P0, DOI 10.1038/s41526-023-00273-4
   Marzetti E, 2013, INT J BIOCHEM CELL B, V45, P2288, DOI 10.1016/j.biocel.2013.06.024
   McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x
   Mendez N, 2016, ENDOCRINOLOGY, V157, P4654, DOI 10.1210/en.2016-1282
   Meng SJ, 2010, INT J MOL SCI, V11, P1509, DOI 10.3390/ijms11041509
   Moore SE, 2016, J DEV ORIG HLTH DIS, V7, P123, DOI 10.1017/S2040174415007199
   Nakano Y, 2020, J ATHEROSCLER THROMB, V27, P397, DOI 10.5551/jat.RV17039
   Nebendahl C, 2016, J NUTR BIOCHEM, V29, P41, DOI 10.1016/j.jnutbio.2015.10.017
   Newsome CA, 2003, DIABETIC MED, V20, P339, DOI 10.1046/j.1464-5491.2003.00871.x
   Nishikawa H, 2021, NUTRIENTS, V13, P0, DOI 10.3390/nu13103519
   Nishikawa H, 2021, INT J MOL MED, V48, P0, DOI 10.3892/ijmm.2021.4989
   Ogawa S, 2016, INFLAMM REGEN, V36, P0, DOI 10.1186/s41232-016-0022-5
   Oke SL, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22136986
   Parisi F, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22041732
   Parsons E, 2022, J DEV ORIG HLTH DIS, V14, P1
   Patel HP, 2012, J GERONTOL A-BIOL, V67, P82, DOI 10.1093/gerona/glr020
   Patel HP, 2010, BMC GERIATR, V10, P0, DOI 10.1186/1471-2318-10-43
   Petermann-Rocha F, 2020, MATURITAS, V133, P60, DOI 10.1016/j.maturitas.2020.01.004
   Peterson MD, 2023, J CACHEXIA SARCOPENI, V14, P108, DOI 10.1002/jcsm.13110
   Ran S, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-61406-3
   Ridgway CL, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0017955
   Risnes KR, 2011, INT J EPIDEMIOL, V40, P647, DOI 10.1093/ije/dyq267
   RodrÃ­guez-RodrÃ­guez P, 2018, FRONT PHYSIOL, V9, P0, DOI 10.3389/fphys.2018.00602
   Saito Y, 2021, FRONT PHARMACOL, V12, P0, DOI 10.3389/fphar.2021.739510
   Saver AA, 2004, AM J CLIN NUTR, V80, P199
   Sayer AA, 2010, J DEV ORIG HLTH DIS, V1, P150, DOI 10.1017/S2040174410000097
   Sayer AA, 2005, EARLY HUM DEV, V81, P735, DOI 10.1016/j.earlhumdev.2005.07.003
   Sayer AA, 2004, J GERONTOL A-BIOL, V59, P930, DOI 10.1093/gerona/59.9.M930
   Sayer AA, 1998, AGE AGEING, V27, P579, DOI 10.1093/ageing/27.5.579
   Sayer AA, 2022, AGE AGEING, V51, P0, DOI 10.1093/ageing/afac220
   Sharples AP, 2016, AGING CELL, V15, P603, DOI 10.1111/acel.12486
   Shimba S, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0025231
   Stein AD, 2019, DIABETOLOGIA, V62, P1773, DOI 10.1007/s00125-019-4930-1
   Tanaka Y, 2005, HYPERTENS RES, V28, P529, DOI 10.1291/hypres.28.529
   Tarry-Adkins JL, 2016, DIS MODEL MECH, V9, P1221, DOI 10.1242/dmm.026591
   Voisin S, 2021, J CACHEXIA SARCOPENI, V12, P1064, DOI 10.1002/jcsm.12741
   Wada K, 2008, CIRC J, V72, P757, DOI 10.1253/circj.72.757
   Wadhwa PD, 2009, SEMIN REPROD MED, V27, P358, DOI 10.1055/s-0029-1237424
   Westbury LD, 2023, J CACHEXIA SARCOPENI, V14, P565, DOI 10.1002/jcsm.13160
   WHO, 2014, LOW BIRTH WEIGHT POLICY BRIEF, V0, P0
   Woo J, 2014, AGE, V36, P0, DOI 10.1007/s11357-014-9711-7
   Wu X, 2009, INT J OBESITY, V33, P971, DOI 10.1038/ijo.2009.137
   Wu Y, 2020, METABOLITES, V10, P0, DOI 10.3390/metabo10060235
   Yang QM, 2022, AGING DIS, V13, P801, DOI 10.14336/AD.2021.1107
   Yildirim RM, 2022, BIOMEDICINES, V10, P0, DOI 10.3390/biomedicines10102539
   YlihÃ¤rsilÃ¤ H, 2007, INT J OBESITY, V31, P1392, DOI 10.1038/sj.ijo.0803612
NR 104
TC 1
Z9 1
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2190-5991
EI 2190-6009
J9 J CACHEXIA SARCOPENI
JI J. Cachexia Sarcopenia Muscle
PD JUN 15
PY 2024
VL 15
IS 3
BP 770
EP 780
DI 10.1002/jcsm.13455
EA MAR 2024
PG 11
WC Geriatrics & Gerontology; Medicine, General & Internal
SC Geriatrics & Gerontology; General & Internal Medicine
GA TR5H1
UT WOS:001193263300001
PM 38553412
DA 2024-11-01
ER

PT J
AU Ishikawa, K
   Miyata, D
   Hattori, S
   Tani, H
   Kuriyama, T
   Wei, FY
   Miyakawa, T
   Nakada, K
AF Ishikawa, Kaori
   Miyata, Daiki
   Hattori, Satoko
   Tani, Haruna
   Kuriyama, Takayoshi
   Wei, Fan-Yan
   Miyakawa, Tsuyoshi
   Nakada, Kazuto
TI Accumulation of mitochondrial DNA with a point mutation in tRNALeu(UUR) gene induces brain dysfunction in mice
SO PHARMACOLOGICAL RESEARCH
LA English
DT Article
DE Mitochondrial DNA; Brain dysfunction; MtDNA tRNALeu(UUR); Prepulse inhibition; Environmental factors; Memory
ID a3302g mutation; generation; schizophrenia; diseases; models; mtdna
AB Brain functions are mediated via the complex interplay between several complex factors, and hence, identifying the underlying cause of an abnormality within a certain brain region can be challenging. In mitochondrial disease, abnormalities in brain function are thought to be attributed to accumulation of mitochondrial DNA (mtDNA) with pathogenic mutations; however, only few previous studies have directly demonstrated that accumulation of mutant mtDNA induced abnormalities in brain function. Herein, we examined the effects of mtDNA mutations on brain function via behavioral analyses using a mouse model with an A2748G point mutation in mtDNA tRNALeu(UUR). Our results revealed that mice with a high percentage of mutant mtDNA showed a characteristic trend toward reduced prepulse inhibition and memory-dependent test performance, similar to that observed in psychiatric disorders, such as schizophrenia; however, muscle strength and motor coordination were not markedly affected. Upon examining the hippocampus and frontal lobes of the brain, mitochondrial morphology was abnormal, and the brain weight was slightly reduced. These results indicate that the predominant accumulation of a point mutation in the tRNALeu(UUR) gene may affect brain functions, particularly the coordination of sensory and motor functions and memory processes. These abnormalities probably caused by both direct effects of accumulation of the mutant mtDNA in neuronal cells and indirect effects via changes of systemic extracellular environments. Overall, these findings will lead to a better understanding of the pathogenic mechanism underlying this complex disease and facilitate the development of optimal treatment methods.
C1 [Ishikawa, Kaori; Nakada, Kazuto] Univ Tsukuba, Inst Life & Environm Sci, Tsukuba, Japan.
   [Miyata, Daiki; Kuriyama, Takayoshi; Miyakawa, Tsuyoshi] Univ Tsukuba, Grad Sch Sci & Technol, Degree Programs Life & Earth Sci, Tsukuba, Japan.
   [Hattori, Satoko] Fujita Hlth Univ, Ctr Med Sci, Div Syst Med Sci, Toyoake, Japan.
   [Hattori, Satoko] Aichi Med Univ, Res Creat Support Ctr, Nagakute, Japan.
   [Tani, Haruna; Wei, Fan-Yan] Tohoku Univ, Inst Dev Aging & Canc, Dept Mod Biol & Med, Sendai, Japan.
C3 University of Tsukuba; University of Tsukuba; Fujita Health University; Aichi Medical University; Tohoku University
RP Ishikawa, K; Nakada, K (corresponding author), Univ Tsukuba, Inst Life & Environm Sci, Tsukuba, Japan.
EM k_ishikawa@biol.tsukuba.ac.jp; knakada@biol.tsukuba.ac.jp
FU Japan Society for the Promotion of Science (JSPS) [23H04951, 22H02536, 23K23801]; Japan Science and Technology Agency (JST) [JPMJFR204M]; AMED-CREST Japan Agency for Medical Research and Development (AMED) [JP23gm1110006]; Grant-in-Aid for Scientific Research on Innovative Areas (Platform of Advanced Animal Model Support) [22H04922]; Promotion of Distinctive Joint Research Center Program Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan [JPMXP0621467949]
CR Ball M, 1993, GENEREVIEWS, V0, P0
   Ballhausen D, 2010, J INHERIT METAB DIS, V33, PS219, DOI 10.1007/s10545-010-9098-2
   Borsche M, 2024, CEREBELLUM, V23, P479, DOI 10.1007/s12311-023-01557-x
   CarlÃ©n M, 2017, SCIENCE, V358, P478, DOI 10.1126/science.aan8868
   Ding Y, 2016, REPROD SCI, V23, P228, DOI 10.1177/1933719115602777
   Goto M, 2014, BRAIN DEV-JPN, V36, P180, DOI 10.1016/j.braindev.2013.03.001
   Goto Y, 2001, J INHERIT METAB DIS, V24, P181, DOI 10.1023/A:1010366917652
   Hutchison WM, 2005, ARCH NEUROL-CHICAGO, V62, P1920, DOI 10.1001/archneur.62.12.1920
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Ishikawa K, 2021, PHARMACOL RES, V163, P0, DOI 10.1016/j.phrs.2020.105246
   Ishikawa K, 2019, J NEUROSCI, V39, P1588, DOI 10.1523/JNEUROSCI.2139-18.2018
   Kang HC, 2013, BRAIN DEV-JPN, V35, P757, DOI 10.1016/j.braindev.2013.01.006
   Kanungo S, 2018, ANN TRANSL MED, V6, P0, DOI 10.21037/atm.2018.12.13
   Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005
   KOLB B, 1974, J COMP PHYSIOL PSYCH, V87, P772, DOI 10.1037/h0036970
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Lim K, 2024, BMB REP, V57, P19, DOI 10.5483/BMBRep.2023-0224
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0
   Nakajima Ryuichi, 2019, NEUROPSYCHOPHARMACOLOGY REPORTS, V39, P223, DOI 10.1002/npr2.12073
   Ogasawara E, 2020, PHARMACOL RES, V160, P0, DOI 10.1016/j.phrs.2020.105204
   Shimizu A, 2014, P NATL ACAD SCI USA, V111, P3104, DOI 10.1073/pnas.1318109111
   SHOFFNER JM, 1993, AM J HUM GENET, V53, P949
   Shoji H, 2012, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/3300
   Sugawara A, 2006, COMPARATIVE MED, V56, P31
   Swerdlow NR, 2008, PSYCHOPHARMACOLOGY, V199, P331, DOI 10.1007/s00213-008-1072-4
   Swerdlow NR, 2006, ARCH GEN PSYCHIAT, V63, P1325, DOI 10.1001/archpsyc.63.12.1325
   Takao K, 2013, NEUROPSYCHOPHARMACOL, V38, P1409, DOI 10.1038/npp.2013.38
   Takao Keizo, 2006, J VIS EXP, V0, PP104, DOI 10.3791/104
   Tanaka D, 2008, MOL BRAIN, V1, P0, DOI 10.1186/1756-6606-1-21
   Tani H, 2022, NUCLEIC ACIDS RES, V50, P9382, DOI 10.1093/nar/gkac699
   van den Bosch BJC, 2004, NEUROMUSCULAR DISORD, V14, P683, DOI 10.1016/j.nmd.2004.06.004
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WATMOUGH NJ, 1990, J CLIN INVEST, V85, P177, DOI 10.1172/JCI114409
   YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458
   Yokota M, 2010, FEBS LETT, V584, P3943, DOI 10.1016/j.febslet.2010.07.048
   Zehavi Y, 2021, METAB BRAIN DIS, V36, P581, DOI 10.1007/s11011-021-00671-1
   Zsurka G, 2015, LANCET NEUROL, V14, P956, DOI 10.1016/S1474-4422(15)00148-9
NR 38
TC 0
Z9 0
U1 0
U2 0
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-6618
EI 1096-1186
J9 PHARMACOL RES
JI Pharmacol. Res.
PD OCT 15
PY 2024
VL 208
IS 
BP 
EP 
DI 10.1016/j.phrs.2024.107374
EA AUG 2024
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA E9U8R
UT WOS:001306388900001
PM 39197713
DA 2024-11-01
ER

PT J
AU Shin, HJ
   Na, JH
   Lee, YM
AF Shin, Hui Jin
   Na, Ji-Hoon
   Lee, Young-Mock
TI A case of exacerbated encephalopathy with stroke-like episodes and lactic acidosis triggered by metformin in a patient with MELAS
SO NEUROLOGICAL SCIENCES
LA English
DT Article
DE MELAS syndrome; DNA, Mitochondrial; Metformin; Seizures; Point mutation
AB Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is a maternally inherited multisystemic disorder caused by mutations in mitochondrial DNA that result in cellular energy deficiency. MELAS affects the most metabolically active organs, including the brain, skeletal muscles, cochlea, retina, heart, kidneys, and pancreas. As a result, about 85% of carriers of m.3243A > G, the most common mutation in MELAS, develop diabetes by the age of 70. Although metformin is the most widely prescribed drug for diabetes, its usefulness in mitochondrial dysfunction remains controversial. Here, we present the case of a 32-year-old Korean patient diagnosed with MELAS who presented with exacerbated stroke-like episodes and lactic acidosis triggered by metformin.
C1 [Shin, Hui Jin; Na, Ji-Hoon; Lee, Young-Mock] Yonsei Univ, Gangnam Severance Hosp, Dept Pediat, Coll Med, 211 Eonju Ro, Seoul 06273, South Korea.
C3 Yonsei University; Yonsei University Health System
RP Na, JH (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Dept Pediat, Coll Med, 211 Eonju Ro, Seoul 06273, South Korea.
EM jhnamd83@yuhs.ac
CR Chen Wan-Ting, 2019, ACTA NEUROL TAIWAN, V28(2), P46
   Crowley MJ, 2016, METFORMIN USE IN PATIENTS WITH HISTORICAL CONTRAINDICATIONS OR PRECAUTIONS, V0, P0
   Fontaine E, 2018, FRONT ENDOCRINOL, V9, P0, DOI 10.3389/fendo.2018.00753
   Graham GG, 2011, CLIN PHARMACOKINET, V50, P81, DOI 10.2165/11534750-000000000-00000
   Kim NH, 2021, ANN INTERN MED, V174, P124, DOI 10.7326/L20-0292
   Lin WH, 2022, FRONT NEUROL, V13, P0, DOI 10.3389/fneur.2022.863047
   Maassen JA, 2005, ANN MED, V37, P213, DOI 10.1080/07853890510007188
   Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270
   Murakami K, 2023, J STROKE CEREBROVASC, V32, P0, DOI 10.1016/j.jstrokecerebrovasdis.2023.107080
   Tong HF, 2022, J DIABETES COMPLICAT, V36, P0, DOI 10.1016/j.jdiacomp.2021.108111
NR 10
TC 2
Z9 2
U1 1
U2 1
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1590-1874
EI 1590-3478
J9 NEUROL SCI
JI Neurol. Sci.
PD MAY 15
PY 2024
VL 45
IS 5
BP 2337
EP 2339
DI 10.1007/s10072-024-07343-9
EA JAN 2024
PG 3
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA PX0S3
UT WOS:001148986200003
PM 38265537
DA 2024-11-01
ER

PT J
AU Kang, YL
   Hepojoki, J
   Maldonado, RS
   Mito, T
   Terzioglu, M
   Manninen, T
   Kant, R
   Singh, S
   Othman, A
   Verma, R
   Uusimaa, J
   Wartiovaara, K
   Kareinen, L
   Zamboni, N
   Nyman, TA
   Paetau, A
   Kipar, A
   Vapalahti, O
   Suomalainen, A
AF Kang, Yilin
   Hepojoki, Jussi
   Maldonado, Rocio Sartori
   Mito, Takayuki
   Terzioglu, Muegen
   Manninen, Tuula
   Kant, Ravi
   Singh, Sachin
   Othman, Alaa
   Verma, Rohit
   Uusimaa, Johanna
   Wartiovaara, Kirmo
   Kareinen, Lauri
   Zamboni, Nicola
   Nyman, Tuula Anneli
   Paetau, Anders
   Kipar, Anja
   Vapalahti, Olli
   Suomalainen, Anu
TI Ancestral allele of DNA polymerase gamma modifies antiviral tolerance
SO NATURE
LA English
DT Article
ID cryo-em; citrate synthase; phylogenetic analysis; sierpinski triangles; algorithms; symmetry; muscle; forms
AB Mitochondria are critical modulators of antiviral tolerance through the release of mitochondrial RNA and DNA (mtDNA and mtRNA) fragments into the cytoplasm after infection, activating virus sensors and type-I interferon (IFN-I) response 1-4 . The relevance of these mechanisms for mitochondrial diseases remains understudied. Here we investigated mitochondrial recessive ataxia syndrome (MIRAS), which is caused by a common European founder mutation in DNA polymerase gamma (POLG1) 5 . Patients homozygous for the MIRAS variant p.W748S show exceptionally variable ages of onset and symptoms 5 , indicating that unknown modifying factors contribute to disease manifestation. We report that the mtDNA replicase POLG1 has a role in antiviral defence mechanisms to double-stranded DNA and positive-strand RNA virus infections (HSV-1, TBEV and SARS-CoV-2), and its p.W748S variant dampens innate immune responses. Our patient and knock-in mouse data show that p.W748S compromises mtDNA replisome stability, causing mtDNA depletion, aggravated by virus infection. Low mtDNA and mtRNA release into the cytoplasm and a slow IFN response in MIRAS offer viruses an early replicative advantage, leading to an augmented pro-inflammatory response, a subacute loss of GABAergic neurons and liver inflammation and necrosis. A population databank of around 300,000 Finnish individuals 6 demonstrates enrichment of immunodeficient traits in carriers of the POLG1 p.W748S mutation. Our evidence suggests that POLG1 defects compromise antiviral tolerance, triggering epilepsy and liver disease. The finding has important implications for the mitochondrial disease spectrum, including epilepsy, ataxia and parkinsonism. The POLG1 mutation p.W748S, which is associated with mitochondrial recessive ataxia syndrome, dampens innate immune responses by compromising mtDNA replisome stability, and this explains why a viral infection can trigger the development of the disease and contribute to its variable clinical manifestation.
C1 [Kang, Yilin; Maldonado, Rocio Sartori; Mito, Takayuki; Terzioglu, Muegen; Manninen, Tuula; Verma, Rohit; Wartiovaara, Kirmo; Paetau, Anders; Suomalainen, Anu] Univ Helsinki, Fac Med, Stem Cell & Metab Res Program Unit, Res Program Unit, Helsinki, Finland.
   [Hepojoki, Jussi; Kant, Ravi; Kareinen, Lauri; Vapalahti, Olli] Univ Helsinki, Fac Med, Dept Virol, Helsinki, Finland.
   [Hepojoki, Jussi; Kipar, Anja] Univ Zurich, Inst Vet Pathol, Vetsuisse Fac, Lab Anim Model Pathol, Zurich, Switzerland.
   [Kant, Ravi; Kareinen, Lauri; Kipar, Anja; Vapalahti, Olli] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland.
   [Kant, Ravi] Med Univ Gdansk, Inst Maritime & Trop Med, Dept Trop Parasitol, Gdansk, Poland.
   [Singh, Sachin; Nyman, Tuula Anneli] Univ Oslo, Inst Clin Med, Dept Immunol, Oslo, Oslo, Norway.
   [Singh, Sachin; Nyman, Tuula Anneli] Rikshosp Oslo, Oslo, Norway.
   [Othman, Alaa; Zamboni, Nicola] Swiss Fed Inst Technol, Swiss Multiom Ctr, Zurich, Switzerland.
   [Uusimaa, Johanna] Univ Oulu, Med Res Ctr, Res Unit Clin Med, Oulu, Finland.
   [Uusimaa, Johanna] Oulu Univ Hosp, Dept Pediat & Adolescent Med, Unit Child Neurol, Oulu, Finland.
   [Wartiovaara, Kirmo; Paetau, Anders; Vapalahti, Olli; Suomalainen, Anu] Helsinki Univ Hosp, HUS Diagnost, Helsinki, Finland.
   [Kareinen, Lauri] Finnish Food Safety Author, Helsinki, Finland.
   [Paetau, Anders] Univ Helsinki, Fac Med, Dept Pathol, Helsinki, Finland.
   [Suomalainen, Anu] Univ Helsinki, HiLife, Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; University of Zurich; University of Helsinki; Fahrenheit Universities; Medical University Gdansk; University of Oslo; University of Oslo; National Hospital Norway; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Oulu; University of Oulu; University of Helsinki; Helsinki University Central Hospital; Finnish Food Authority; University of Helsinki; University of Helsinki
RP Suomalainen, A (corresponding author), Univ Helsinki, Fac Med, Stem Cell & Metab Res Program Unit, Res Program Unit, Helsinki, Finland.; Suomalainen, A (corresponding author), Helsinki Univ Hosp, HUS Diagnost, Helsinki, Finland.; Suomalainen, A (corresponding author), Univ Helsinki, HiLife, Helsinki, Finland.
EM anu.wartiovaara@helsinki.fi
FU Research Council of Norway INFRASTRUKTUR-program [295910]; Swiss initiative on Personalized Health and Related Technology by the ETH Domain; Jane and Aatos Erkko Foundation; Academy of Finland; Sigrid Juselius Foundation; University of Helsinki; Helsinki University Hospital; European Molecular Biology Organization's postdoctoral fellowship; POLG foundation; Business Finland
CR Abraham Mark James, 2015, SOFTWAREX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001
   Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Ahnert SE, 2015, SCIENCE, V350, P0, DOI 10.1126/science.aaa2245
   Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453
   Azpeitia E, 2021, SCIENCE, V373, P192, DOI 10.1126/science.abg5999
   Baneyx F, 2014, CURR OPIN BIOTECH, V28, P39, DOI 10.1016/j.copbio.2013.11.001
   Bepler T, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-18952-1
   Biyani N, 2017, J STRUCT BIOL, V198, P124, DOI 10.1016/j.jsb.2017.03.007
   Broddrick JT, 2016, P NATL ACAD SCI USA, V113, PE8344, DOI 10.1073/pnas.1613446113
   Clerico Eugenia M, 2007, METHODS MOL BIOL, V362, P155
   Du JX, 2013, NEUROCOMPUTING, V116, P150, DOI 10.1016/j.neucom.2012.03.028
   East NJ, 2022, PROTEIN SCI, V31, P0, DOI 10.1002/pro.4510
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459
   Garcia-Seisdedos H, 2017, NATURE, V548, P244, DOI 10.1038/nature23320
   Gonzato G, 2000, GEOPHYS J INT, V142, P108, DOI 10.1046/j.1365-246x.2000.00133.x
   Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105
   GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086
   Grant T, 2018, ELIFE, V7, P0, DOI 10.7554/eLife.35383
   Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Halley JM, 2004, ECOL LETT, V7, P254, DOI 10.1111/j.1461-0248.2004.00568.x
   Hasunuma T, 2018, METAB ENG, V48, P109, DOI 10.1016/j.ymben.2018.05.013
   Hopkins JB, 2017, J APPL CRYSTALLOGR, V50, P1545, DOI 10.1107/S1600576717011438
   Husain A, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-85405-0
   James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X
   Jiang ZL, 2020, ISCIENCE, V23, P0, DOI 10.1016/j.isci.2020.101064
   Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kanamori E, 2015, BIOPHYS PHYSICOBIOL, V12, P47, DOI 10.2142/biophysico.12.0_47
   KARPUSAS M, 1990, BIOCHEMISTRY-US, V29, P2213, DOI 10.1021/bi00461a002
   Kempkes SN, 2019, NAT PHYS, V15, P127, DOI 10.1038/s41567-018-0328-0
   Kidmose RT, 2019, IUCRJ, V6, P526, DOI 10.1107/S2052252519007619
   Kieffer J, 2022, J SYNCHROTRON RADIAT, V29, P1318, DOI 10.1107/S1600577522007238
   Laniado J, 2020, P NATL ACAD SCI USA, V117, P31817, DOI 10.1073/pnas.2015183117
   Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067
   Li C, 2021, J AM CHEM SOC, V143, P14417, DOI 10.1021/jacs.1c05949
   Li C, 2017, J AM CHEM SOC, V139, P13749, DOI 10.1021/jacs.7b05720
   Mandelbrot BB, 1982, FRACTAL GEOMETRY NAT, V0, PP1, DOI 10.1119/1.13295
   Mangan NM, 2016, P NATL ACAD SCI USA, V113, PE5354, DOI 10.1073/pnas.1525145113
   Marty MT, 2015, ANAL CHEM, V87, P4370, DOI 10.1021/acs.analchem.5b00140
   Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Mo YP, 2019, J AM CHEM SOC, V141, P11378, DOI 10.1021/jacs.9b04815
   Moore KR, 2019, FRONT MICROBIOL, V10, P0, DOI 10.3389/fmicb.2019.01612
   Nguyen NT, 2001, BIOCHEMISTRY-US, V40, P13177, DOI 10.1021/bi010408o
   PagÃ¨s G, 2020, METHODS MOL BIOL, V2165, P245, DOI 10.1007/978-1-0716-0708-4_14
   Pillai AS, 2022, PROTEIN SCI, V31, P0, DOI 10.1002/pro.4449
   Pillai AS, 2020, NATURE, V581, P480, DOI 10.1038/s41586-020-2292-y
   Pinevich A, 2012, FRONT MICROBIOL, V3, P0, DOI 10.3389/fmicb.2012.00173
   Punjani A, 2017, NAT METHODS, V14, P290, DOI 10.1038/NMETH.4169
   Sarkar R, 2020, J AM CHEM SOC, V142, P5526, DOI 10.1021/jacs.0c01168
   Scheres SHW, 2014, ELIFE, V3, P0, DOI 10.7554/eLife.03665
   Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010
   Schirrmeister BE, 2011, BMC EVOL BIOL, V11, P0, DOI 10.1186/1471-2148-11-45
   Scholl J, 2020, MOL MICROBIOL, V114, P292, DOI 10.1111/mmi.14512
   Sendker FL, 2024, V1 EDMOND, V0, P0, DOI DOI 10.17617/3.KNEQIR
   Shang J, 2015, NAT CHEM, V7, P389, DOI 10.1038/NCHEM.2211
   Sierpinski W, 1915, CR HEBD ACAD SCI, V160, P302
   SRERE PA, 1963, ACTA CHEM SCAND, V17, P129, DOI 10.3891/acta.chem.scand.17s-0129
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Talatahari S, 2021, ARTIF INTELL REV, V54, P917, DOI 10.1007/s10462-020-09867-w
   Tan YZ, 2017, NAT METHODS, V14, P793, DOI 10.1038/NMETH.4347
   TARBOTON DG, 1988, WATER RESOUR RES, V24, P1317, DOI 10.1029/WR024i008p01317
   Tully MD, 2021, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/61578
   Wagner T, 2019, COMMUN BIOL, V2, P0, DOI 10.1038/s42003-019-0437-z
   Wang YF, 2019, CHEMPHYSCHEM, V20, P2262, DOI 10.1002/cphc.201900258
   Welkie DG, 2019, TRENDS MICROBIOL, V27, P231, DOI 10.1016/j.tim.2018.11.002
   WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97
   Yang J, 2010, BIOTECHNIQUES, V49, P817, DOI 10.2144/000113520
   Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088
   Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003
   Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193
NR 75
TC 3
Z9 3
U1 10
U2 11
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD APR 25
PY 2024
VL 628
IS 8009
BP 
EP 
DI 10.1038/s41586-024-07260-z
PG 32
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA SK8N7
UT WOS:001234439100023
PM 38570685
DA 2024-11-01
ER

PT J
AU Cai, H
   Li, LM
   Zhang, M
   Zhou, YY
   Li, P
AF Cai, Hao
   Li, Li-Min
   Zhang, Miao
   Zhou, Yuying
   Li, Pan
TI Case report: Late-onset MELAS syndrome with mtDNA 5783G&gt;A mutation diagnosed by urinary sediment genetic testing
SO FRONTIERS IN GENETICS
LA English
DT Article
DE MELAS; late-onset; MT-TC; m.5783G > A; urinary sediment
ID stroke-like-episodes; mitochondrial-myopathy; lactic-acidosis; clinical-features; a3243g mutation; encephalopathy; tissue
AB Background: Patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) usually present with multisystemic dysfunction with a wide range of clinical manifestations. When the tests for common mitochondrial DNA (mtDNA) point mutations are negative and the mtDNA defects hypothesis remains, urine epithelial cells can be used to screen the mitochondrial genome for unknown mutations to confirm the diagnosis. Case presentation: A 66-year-old Chinese woman presented with symptoms of MELAS and was initially misdiagnosed with acute encephalitis at another institution. Although genetic analysis of blood lymphocyte DNA was negative, brain imaging, including magnetic resonance imaging, magnetic resonance spectroscopy, and clinical and laboratory findings, were all suggestive of MELAS. Finally, the patient was eventually diagnosed with MELAS with the mtDNA 5783G>A mutation in the MT-TC gene with a urinary sediment genetic test. Conclusion: This case report expands the genetic repertoire associated with MELAS syndrome and highlights the importance that full mtDNA sequencing should be warranted beside the analysis of classical variants when a mitochondrial disorder is highly suspected. Furthermore, urine sediment genetic testing has played a crucial role in the diagnosis of MELAS.
C1 [Cai, Hao; Zhang, Miao; Zhou, Yuying; Li, Pan] Tianjin Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China.
   [Cai, Hao; Zhang, Miao; Zhou, Yuying; Li, Pan] Tianjin Huanhu Hosp, Tianjin Neurosurg Inst, Tianjin Key Lab Cerebral Vasc & Neurodegenerat Dis, Tianjin, Peoples R China.
   [Cai, Hao; Zhang, Miao; Zhou, Yuying; Li, Pan] Tianjin Med Univ, Clin Coll Neurol Neurosurg & Neurorehabil, Tianjin, Peoples R China.
   [Cai, Hao; Zhang, Miao; Zhou, Yuying; Li, Pan] Tianjin Univ, Tianjin Huanhu Hosp, Huanhu Hosp, Tianjin, Peoples R China.
   [Li, Li-Min] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin, Peoples R China.
   [Li, Li-Min] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Tianjin, Peoples R China.
C3 Tianjin Medical University; Tianjin University; Tianjin Medical University; Tianjin Medical University
RP Li, P (corresponding author), Tianjin Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China.; Li, P (corresponding author), Tianjin Huanhu Hosp, Tianjin Neurosurg Inst, Tianjin Key Lab Cerebral Vasc & Neurodegenerat Dis, Tianjin, Peoples R China.; Li, P (corresponding author), Tianjin Med Univ, Clin Coll Neurol Neurosurg & Neurorehabil, Tianjin, Peoples R China.; Li, P (corresponding author), Tianjin Univ, Tianjin Huanhu Hosp, Huanhu Hosp, Tianjin, Peoples R China.
EM doc_panpan@163.com
FU Tianjin Health Research Project [TJWJ 2022QN008]; Tianjin Key Medical Discipline (Specialty) Construction Project [TJYXZDXK-052B]; Tianjin Health Industry High level Talent Training Project (Young Medical Emerging Talents) [TJSQNYXXR-D2-107]
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Baker K, 2018, BRAIN, V141, P2576, DOI 10.1093/brain/awy209
   Feigenbaum A, 2006, AM J MED GENET A, V140A, P2216, DOI 10.1002/ajmg.a.31436
   Frederiksen AL, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.039339
   GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   GOTO Y, 1995, MUSCLE NERVE, V0, PS107
   Gropman A, 2004, AM J MED GENET A, V124A, P377, DOI 10.1002/ajmg.a.20456
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kawazoe T, 2022, INTERNAL MED, V61, P547, DOI 10.2169/internalmedicine.7767-21
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Lareau CA, 2021, NAT BIOTECHNOL, V39, P451, DOI 10.1038/s41587-020-0645-6
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   Lorenzoni PJ, 2015, ARQ NEURO-PSIQUIAT, V73, P959
   Ma YN, 2009, MITOCHONDRION, V9, P139, DOI 10.1016/j.mito.2009.01.004
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873
   Marotta R, 2009, J CLIN NEUROSCI, V16, P1223, DOI 10.1016/j.jocn.2008.11.012
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   Meng FL, 2022, NUCLEIC ACIDS RES, V50, P9453, DOI 10.1093/nar/gkac720
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Tarnopolsky MA, 2004, AM J MED GENET A, V124A, P372, DOI 10.1002/ajmg.a.20449
   Walker MA, 2020, NEW ENGL J MED, V383, P1556, DOI 10.1056/NEJMoa2001265
   Yokota M, 2015, HUM MOL GENET, V24, P4698, DOI 10.1093/hmg/ddv201
NR 26
TC 0
Z9 0
U1 4
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD MAY 31
PY 2024
VL 15
IS 
BP 
EP 
DI 10.3389/fgene.2024.1367716
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA UH2H3
UT WOS:001247095200001
PM 38881794
DA 2024-11-01
ER

PT J
AU Ali, A
   Esmaeil, A
   Behbehani, R
AF Ali, Ali
   Esmaeil, Ali
   Behbehani, Raed
TI Mitochondrial Chronic Progressive External Ophthalmoplegia
SO BRAIN SCIENCES
LA English
DT Review
DE chronic progressive external ophthalmoplegia; CPEO; mitochondrial diseases
ID nucleotide translocator 1; alpha-lipoic acid; leigh-syndrome; dna depletion; liver-transplantation; diagnostic-criteria; mtdna replication; melas syndrome; mutations; deficiency
AB Background: Chronic progressive external ophthalmoplegia (CPEO) is a rare disorder that can be at the forefront of several mitochondrial diseases. This review overviews mitochondrial CPEO encephalomyopathies to enhance accurate recognition and diagnosis for proper management. Methods: This study is conducted based on publications and guidelines obtained by selective review in PubMed. Randomized, double-blind, placebo-controlled trials, Cochrane reviews, and literature meta-analyses were particularly sought. Discussion: CPEO is a common presentation of mitochondrial encephalomyopathies, which can result from alterations in mitochondrial or nuclear DNA. Genetic sequencing is the gold standard for diagnosing mitochondrial encephalomyopathies, preceded by non-invasive tests such as fibroblast growth factor-21 and growth differentiation factor-15. More invasive options include a muscle biopsy, which can be carried out after uncertain diagnostic testing. No definitive treatment option is available for mitochondrial diseases, and management is mainly focused on lifestyle risk modification and supplementation to reduce mitochondrial load and symptomatic relief, such as ptosis repair in the case of CPEO. Nevertheless, various clinical trials and endeavors are still at large for achieving beneficial therapeutic outcomes for mitochondrial encephalomyopathies. Key Messages: Understanding the varying presentations and genetic aspects of mitochondrial CPEO is crucial for accurate diagnosis and management.
C1 [Ali, Ali; Esmaeil, Ali; Behbehani, Raed] Ibn Sina Hosp, Al Bahar Ophthalmol Ctr, Neuroophthalmol Unit, Kuwait 70035, Kuwait.
RP Behbehani, R (corresponding author), Ibn Sina Hosp, Al Bahar Ophthalmol Ctr, Neuroophthalmol Unit, Kuwait 70035, Kuwait.
EM ali.moh.behbahani@gmail.com; ali.moh.esmaeil@gmail.com; rsbehbehani@gmail.com
CR Ahn J, 2008, BRIT J OPHTHALMOL, V92, P1685, DOI 10.1136/bjo.2008.144816
   Airhart SE, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0186459
   Al-Enezi M, 2008, MIDDLE EAST AFR J OP, V15, P81, DOI 10.4103/0974-9233.51998
   Alonzo JR, 2018, J BIOL CHEM, V293, P20285, DOI 10.1074/jbc.RA118.004788
   Alves CAPF, 2020, ANN NEUROL, V88, P218, DOI 10.1002/ana.25789
   Ardissone A, 2021, ORPHANET J RARE DIS, V16, P0, DOI 10.1186/s13023-021-02029-3
   Argudo JM, 2022, CUREUS J MED SCIENCE, V14, P0, DOI 10.7759/cureus.32709
   Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   Balasubramaniam S, 2020, J. TRANSL. GENET. GENOMICS, V4, P285, DOI 10.20517/jtgg.2020.34
   Berardo A, 2022, J NEUROMUSCULAR DIS, V9, P225, DOI 10.3233/JND-210786
   Bermejo-Guerrero L, 2022, J CLIN MED, V11, P0, DOI 10.3390/jcm11010022
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Bonora E, 2021, BRAIN, V144, P1451, DOI 10.1093/brain/awab056
   Borsche M, 2024, CEREBELLUM, V23, P479, DOI 10.1007/s12311-023-01557-x
   Brecht M, 2015, JIMD REP, V19, P95, DOI 10.1007/8904_2014_375
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Bugiardini E, 2017, NEUROL-GENET, V3, P0, DOI 10.1212/NXG.0000000000000149
   Caporali L, 2018, BRAIN, V141, P0, DOI 10.1093/brain/awx301
   Cardaioli E, 2010, NEUROL SCI, V31, P491, DOI 10.1007/s10072-010-0225-5
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Cejudo P, 2005, MUSCLE NERVE, V32, P342, DOI 10.1002/mus.20368
   Chang XL, 2020, MEDICINE, V99, P0, DOI 10.1097/MD.0000000000018634
   Chatfield KC, 2019, JACC-BASIC TRANSL SC, V4, P147, DOI 10.1016/j.jacbts.2018.12.005
   Chatzistefanou KI, 2019, INT OPHTHALMOL, V39, P213, DOI 10.1007/s10792-017-0781-2
   Cheng WQ, 2022, FRONT NEUROL, V13, P0, DOI 10.3389/fneur.2022.843386
   Ciesielski GL, 2016, METHODS MOL BIOL, V1351, P211, DOI 10.1007/978-1-4939-3040-1_16
   Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763
   Davis RL, 2016, NEUROLOGY, V86, P2010, DOI 10.1212/WNL.0000000000002705
   de Barcelos IP, 2019, CURR OPIN NEUROL, V32, P715, DOI 10.1097/WCO.0000000000000743
   de Haas R, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-09417-5
   Parada-Garza JD, 2020, NEUROMUSCULAR DISORD, V30, P590, DOI 10.1016/j.nmd.2020.04.008
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Dimmock DP, 2008, LIVER TRANSPLANT, V14, P1480, DOI 10.1002/lt.21556
   DomÃ­nguez-GonzÃ¡lez C, 2022, J NEUROL, V269, P3550, DOI 10.1007/s00415-021-10957-0
   DomÃ­nguez-GonzÃ¡lez C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Echaniz-Laguna A, 2012, J MED GENET, V49, P146, DOI 10.1136/jmedgenet-2011-100504
   El-Hattab AW, 2018, HUM MUTAT, V39, P461, DOI 10.1002/humu.23387
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab AW, 2016, MOL GENET METAB, V117, P407, DOI 10.1016/j.ymgme.2016.01.010
   El-Hattab AW, 2012, MOL GENET METAB, V107, P247, DOI 10.1016/j.ymgme.2012.06.018
   El-Hattab AW, 2010, MOL GENET METAB, V99, P300, DOI 10.1016/j.ymgme.2009.10.003
   Erdinc D, 2023, EMBO MOL MED, V15, P0, DOI 10.15252/emmm.202216775
   Esmaeil Ali, 2022, FRONT OPHTHALMOL (LAUSANNE), V2, P1077395, DOI 10.3389/fopht.2022.1077395
   Faraci M, 2007, BONE MARROW TRANSPL, V39, P563, DOI 10.1038/sj.bmt.1705638
   Fava Antonietta, 2013, J NEURODEGENER DIS, V2013, P454253, DOI 10.1155/2013/454253
   Feichtinger RG, 2017, AM J HUM GENET, V101, P525, DOI 10.1016/j.ajhg.2017.08.015
   Filosto M, 2018, J CLIN MED, V7, P0, DOI 10.3390/jcm7110389
   Finsterer Josef, 2023, J CLIN NEUROMUSCUL DIS, V24, P140, DOI 10.1097/CND.0000000000000422
   Finsterer J, 2022, CUREUS J MED SCIENCE, V14, P0, DOI 10.7759/cureus.22716
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   Finsterer J, 2017, BIOMED REP, V6, P487, DOI 10.3892/br.2017.892
   Gedikbasi A, 2023, FRONT GENET, V14, P0, DOI 10.3389/fgene.2023.1191159
   Gimenes AC, 2015, BRAZ J MED BIOL RES, V48, P354, DOI 10.1590/1414-431X20143467
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   Gorman GS, 2015, JAMA NEUROL, V72, P106, DOI 10.1001/jamaneurol.2014.1753
   Grabhorn E, 2014, LIVER TRANSPLANT, V20, P464, DOI 10.1002/lt.23830
   Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659
   Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226
   Han J, 2015, BRIT J OPHTHALMOL, V99, P528, DOI 10.1136/bjophthalmol-2014-305704
   Hanisch F, 2015, J NEUROL NEUROSUR PS, V86, P630, DOI 10.1136/jnnp-2013-306748
   Hikmat O, 2020, J INHERIT METAB DIS, V43, P726, DOI 10.1002/jimd.12211
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Hornby B, 2022, ORPHANET J RARE DIS, V17, P0, DOI 10.1186/s13023-022-02469-5
   Hung KM, 2017, BBA-MOL BASIS DIS, V1863, P406, DOI 10.1016/j.bbadis.2016.11.017
   Jacinto S, 2021, FRONT CELL NEUROSCI, V15, P0, DOI 10.3389/fncel.2021.641264
   Jacoby E, 2018, BLOOD, V132, P0, DOI 10.1182/blood-2018-99-113773
   Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje
   Jennifer MS, 2020, ANN NONINVAS ELECTRO, V25, P0, DOI 10.1111/anec.12681
   Jeppesen TD, 2020, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.00349
   Kang YX, 2017, ANDROLOGIA, V49, P0, DOI 10.1111/and.12711
   Katsanos KH, 2001, DIS ESOPHAGUS, V14, P63, DOI 10.1111/j.1442-2050.2001.00152.x
   Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kawamata H, 2011, HUM MOL GENET, V20, P2964, DOI 10.1093/hmg/ddr200
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Keshavan N, 2020, GENET MED, V22, P199, DOI 10.1038/s41436-019-0613-z
   Khan NA, 2015, INDIAN J MED RES, V141, P13
   Kistol D, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms24021597
   Klumpe I, 2016, J MOL MED, V94, P645, DOI 10.1007/s00109-016-1413-4
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lapatto HAK, 2023, SCI ADV, V9, P0, DOI 10.1126/sciadv.add5163
   Latvala T, 2002, GRAEF ARCH CLIN EXP, V240, P795, DOI 10.1007/s00417-002-0555-y
   Lee H, 2018, ANTIOXIDANTS-BASEL, V7, P0, DOI 10.3390/antiox7120186
   Lee J, 2009, BBA-BIOENERGETICS, V1787, P364, DOI 10.1016/j.bbabio.2009.01.014
   Lenaers G, 2012, ORPHANET J RARE DIS, V7, P0, DOI 10.1186/1750-1172-7-46
   Li JA, 2021, FRONT NEUROL, V12, P0, DOI 10.3389/fneur.2021.675816
   Li YW, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0174437
   Liu JK, 2008, NEUROCHEM RES, V33, P194, DOI 10.1007/s11064-007-9403-0
   LlauradÃ³ A, 2023, CLIN GENET, V103, P492, DOI 10.1111/cge.14287
   Mancuso M, 2005, ARCH NEUROL-CHICAGO, V62, P745, DOI 10.1001/archneur.62.5.745
   Mani S, 2019, J NEUROL SCI, V404, P91, DOI 10.1016/j.jns.2019.07.007
   Manini A, 2022, FRONT GENET, V13, P0, DOI 10.3389/fgene.2022.906667
   MarcÃ©-Grau A, 2019, J INHERIT METAB DIS, V42, P581, DOI 10.1002/jimd.12125
   Marchet S, 2020, HUM MUTAT, V41, P1745, DOI 10.1002/humu.24081
   Maricich SM, 2015, NEUROMUSCULAR DISORDERS OF INFANCY, V0, P0
   MartÃ­ R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179
   Misic J, 2022, NUCLEIC ACIDS RES, V50, P8749, DOI 10.1093/nar/gkac661
   Montano V, 2019, CASE REP NEUROL MED, V2019, P0, DOI 10.1155/2019/5918632
   Neergheen Viruna, 2017, J. INBORN ERRORS METAB. SCREEN., V5, P0
   Ng YS, 2021, ENDOCR REV, V43, P583, DOI 10.1210/endrev/bnab036
   Ng Yi Shiau, 2019, WELLCOME OPEN RES, V4, P201, DOI 10.12688/wellcomeopenres.15599.1
   Ogawa E, 2017, J INHERIT METAB DIS, V40, P685, DOI 10.1007/s10545-017-0042-6
   OLSON W, 1972, ARCH NEUROL-CHICAGO, V26, P193, DOI 10.1001/archneur.1972.00490090019001
   Orsucci Daniele, 2019, DRUGS CONTEXT, V8, P212588, DOI 10.7573/dic.212588
   Ortiz Alvaro, 2017, INT J RETINA VITREOUS, V3, P24, DOI 10.1186/s40942-017-0077-8
   Pek NMQ, 2019, CELL DEATH DIS, V10, P0, DOI 10.1038/s41419-019-2036-9
   PÃ©rez-Cruz E, 2022, ENDOCRINOL DIAB NUTR, V69, P144, DOI 10.1016/j.endinu.2021.03.004
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   Pineda M, 2006, ANN NEUROL, V59, P394, DOI 10.1002/ana.20746
   Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231
   Quijada-Fraile P, 2014, ORPHANET J RARE DIS, V9, P0, DOI 10.1186/s13023-014-0217-2
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rajabi MT, 2014, IRAN J NEUROL, V13, P185
   Ramaekers VT, 2007, NEUROPEDIATRICS, V38, P184, DOI 10.1055/s-2007-991150
   Reddy Jyothi Muni, 2019, SUDAN J PAEDIATR, V19, P161, DOI 10.24911/SJP.106-1534158413
   RESKENIELSEN E, 1976, ACTA OPHTHALMOL, V54, P553
   Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488
   Rocha EBD, 2023, NEUROMUSCULAR DISORD, V33, P692, DOI 10.1016/j.nmd.2023.06.004
   Romagnoli M, 2020, ANN CLIN TRANSL NEUR, V7, P590, DOI 10.1002/acn3.51026
   Ronchi D, 2020, FRONT GENET, V11, P0, DOI 10.3389/fgene.2020.00860
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Rusecka J, 2018, J APPL GENET, V59, P43, DOI 10.1007/s13353-017-0424-3
   Sabbah HN, 2022, HEART FAIL REV, V27, P1911, DOI 10.1007/s10741-021-10177-8
   Saini Arushi Gahlot, 2021, AUTOPS CASE REP, V11, Pe2021334, DOI 10.4322/acr.2021.334
   Schaefer PM, 2022, MOL METAB, V64, P0, DOI 10.1016/j.molmet.2022.101560
   Seed LM, 2022, MOL GENET GENOM MED, V10, P0, DOI 10.1002/mgg3.1955
   Seitun S, 2016, CASE REP CARDIOL, V2016, P0, DOI 10.1155/2016/1490181
   Seo KS, 2018, FRONT NEUROL, V9, P0, DOI 10.3389/fneur.2018.00552
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Shemesh A, 2023, STATPEARLS, V0, P0
   Shintaku J, 2022, J CLIN INVEST, V132, P0, DOI 10.1172/JCI145660
   Shoeleh C, 2023, CUREUS J MED SCIENCE, V15, P0, DOI 10.7759/cureus.33963
   Slone J, 2018, J GENET GENOMICS, V45, P71, DOI 10.1016/j.jgg.2017.11.008
   Sofou K, 2018, J MED GENET, V55, P21, DOI 10.1136/jmedgenet-2017-104891
   Sommerville EW, 2020, CLIN GENET, V97, P276, DOI 10.1111/cge.13652
   Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110
   Sulaimon LA, 2022, ADV. REDOX RES, V0, P0, DOI DOI 10.1016/J.ARRES.2022.100037
   Sun MG, 2019, ORBIT-ABINGDON, V38, P342, DOI 10.1080/01676830.2018.1445760
   Szczesny RJ, 2013, NUCLEIC ACIDS RES, V41, P3144, DOI 10.1093/nar/gkt029
   Takata A, 2011, GENOME BIOL, V12, P0, DOI 10.1186/gb-2011-12-9-r92
   Tsygankova PG, 2019, J INHERIT METAB DIS, V42, P918, DOI 10.1002/jimd.12142
   Uhler JP, 2016, NUCLEIC ACIDS RES, V44, P5861, DOI 10.1093/nar/gkw468
   Uusimaa J, 2014, EUR J HUM GENET, V22, P184, DOI 10.1038/ejhg.2013.112
   Vadhul Raghav, 2019, DIGIT J OPHTHALMOL, V25, P59, DOI 10.5693/djo.02.2019.09.001
   van Tienen F, 2019, STEM CELL RES THER, V10, P0, DOI 10.1186/s13287-019-1510-8
   Virmani MA, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23052717
   Watson E, 2020, J. TRANSL. GENET. GENOMICS, V4, P188, DOI 10.20517/JTGG.2020.31
   Weiduschat N, 2014, NEUROLOGY, V82, P798, DOI 10.1212/WNL.0000000000000169
   Wong WK, 2022, MOV DISORD CLIN PRAC, V9, PS32, DOI 10.1002/mdc3.13538
   Wu G, 2023, NEUROLOGIST, V28, P190, DOI 10.1097/NRL.0000000000000457
   Yang MG, 2021, FRONT ENDOCRINOL, V12, P0, DOI 10.3389/fendo.2021.728043
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Ying YQ, 2022, FRONT GENET, V13, P0, DOI 10.3389/fgene.2022.802402
   Yoshida T, 2013, INTERNAL MED, V52, P1389, DOI 10.2169/internalmedicine.52.0188
   Yu M, 2016, CHINESE MED J-PEKING, V129, P2519, DOI 10.4103/0366-6999.191855
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2014, INVEST OPHTH VIS SCI, V55, P0
   Zaidi AA, 2019, P NATL ACAD SCI USA, V116, P25172, DOI 10.1073/pnas.1906331116
   Zaidman I, 2021, PEDIATR BLOOD CANCER, V68, P0, DOI 10.1002/pbc.28926
   Zelissen R, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms24032679
   Zeng T, 2020, BMC PEDIATR, V20, P0, DOI 10.1186/s12887-020-02309-0
   ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0
   Zhang HX, 2018, ESSAYS BIOCHEM, V62, P225, DOI 10.1042/EBC20170096
   Zhang HL, 2020, ELIFE, V9, P0, DOI 10.7554/eLife.60827
   Zhao H, 2017, INT J BIOCHEM CELL B, V87, P86, DOI 10.1016/j.biocel.2017.04.002
   Zhao LL, 2019, ENZYMES, V45, P311, DOI 10.1016/bs.enz.2019.08.004
   Zhao Y, 2024, MOL GENET GENOM MED, V12, P0, DOI 10.1002/mgg3.2328
   ZINTZ R, 1967, OPHTHALMOLOGICA, V153, P439, DOI 10.1159/000305086
   Zweers H, 2021, ORPHANET J RARE DIS, V16, P0, DOI 10.1186/s13023-021-01927-w
NR 172
TC 0
Z9 0
U1 3
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2076-3425
J9 BRAIN SCI
JI Brain Sci.
PD FEB 15
PY 2024
VL 14
IS 2
BP 
EP 
DI 10.3390/brainsci14020135
PG 26
WC Neurosciences
SC Neurosciences & Neurology
GA JI2Y9
UT WOS:001172483500001
PM 38391710
DA 2024-11-01
ER

PT J
AU Lewis, M
   Voelkel, N
   Kadri, F
AF Lewis, Michael
   Voelkel, Norbert
   Kadri, Ferdous
TI Pathobiology of Pulmonary Arterial Hypertension
SO CURRENT RESPIRATORY MEDICINE REVIEWS
LA English
DT Review
DE Pulmonary artery endothelial cells; pulmonary artery smooth muscle cells; intimal hyperplasia; medial hypertrophy; plexiform lesions; inflammation; immune dysfunction; TGF beta; BMP; mutations; growth factors; channelopathy; Warburg phenomenon; mitochondrial dysfunction; hypoxia; estrogen paradox; DNA damage; senescence; drug-induced PAH; cancer hypothesis
ID smooth-muscle-cells; right-ventricular function; to-mesenchymal transition; microvascular endothelial-cells; serotonin-reuptake inhibitors; growth-factor; dna-damage; adventitial fibroblasts; prevents progression; insulin-resistance
AB Pulmonary Arterial Hypertension (PAH) is a progressive disease associated with occlusive pulmonary arterial remodeling of vessels < 500 mu m for which there is no cure. Even in the era of PAH-specific combination therapies, aberrant lung pathology and progressive right ventricular (RV) dysfunction occur, culminating in a median survival of 6.2 years, according to the latest data in the treatment era. While better than a median survival from symptom onset of 2.8 years prior to PAH-specific therapies, it is still poor. Thus, there is an urgent need to move the opportunities forward for meaningful treatment strategies. Clearly, a better understanding of the highly complex pathobiology of PAH is needed if we are to achieve new and novel treatment strategies. This is especially so if we are to pursue a more personalized treatment approach to PAH in light of the multitude of pathobiological abnormalities described in PAH, which likely culminate in a final common pathway for PAH development. In this State-of-the-Art review, we provide comprehensive insights into the complex pathobiology of PAH to provide understanding and insights for the practicing clinician. We review the pathology of PAH and the cells involved and their impact in driving pathological abnormalities (pulmonary artery endothelial cells, smooth muscle cells, fibroblasts and pericytes) as well as the role of the extracellular matrix. Inflammation and immune dysfunction are considered important drivers of PAH and are comprehensively discussed. Another pathway relates to TGF beta/ bone morphogenic protein (BMP) imbalance, which is highlighted, as well as a new novel agent, sotatercept that impacts this imbalance. Genetic factors underlying heritable PAH (HPAH) are addressed, as well as epigenetic influences. Other important pathways highlighted include growth factor signaling, ion channels/channelopathy, hypoxia signaling pathways, and altered metabolism and mitochondrial dysfunction. We also address the "estrogen paradox", whereby PAH is more common in women but more severe in men. The basis for drug-induced PAH is discussed, including the new methamphetamine epidemic. We briefly provide insights into DNA damage and senescence factors in pathobiology and highlight commonalities between PAH and cancer pathobiology. Furthermore, we provide concluding insights for the treating physician. In conclusion, we need to pose the right questions to motivate novel and effective treatment strategies for the management of PAH based on pathobiological principles and understanding.
C1 [Lewis, Michael; Kadri, Ferdous] Cedars Sinai Med Ctr, Pulm Crit Care Div, Los Angeles, CA USA.
   [Lewis, Michael] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA USA.
   [Voelkel, Norbert] Univ Amsterdam, Pulm Div, Med Ctr, Amsterdam, Netherlands.
C3 Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Amsterdam
RP Voelkel, N (corresponding author), Univ Amsterdam, Pulm Div, Med Ctr, Amsterdam, Netherlands.
EM nfvoelkel@gmail.com
CR Abenhaim L, 1996, NEW ENGL J MED, V335, P609, DOI 10.1056/NEJM199608293350901
   Aldabbous L, 2016, ARTERIOSCL THROM VAS, V36, P2078, DOI 10.1161/ATVBAHA.116.307634
   Amsellem V, 2014, CIRCULATION, V130, P880, DOI 10.1161/CIRCULATIONAHA.114.010757
   Anderson L, 2010, AM J PHYSIOL-REG I, V298, PR833, DOI 10.1152/ajpregu.00534.2009
   Andruska A, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19092499
   Angelini DJ, 2009, AM J PHYSIOL-LUNG C, V296, PL582, DOI 10.1152/ajplung.90526.2008
   Antigny F, 2016, CIRCULATION, V133, P1371, DOI 10.1161/CIRCULATIONAHA.115.020951
   Archer SL, 2004, CIRC RES, V95, P308, DOI 10.1161/01.RES.0000137173.42723.fb
   Archer SL, 2008, AM J PHYSIOL-HEART C, V294, PH570, DOI 10.1152/ajpheart.01324.2007
   Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098
   Arends SJ, 2013, CLIN EXP IMMUNOL, V174, P433, DOI 10.1111/cei.12166
   Austin ED, 2012, CIRC-CARDIOVASC GENE, V5, P336, DOI 10.1161/CIRCGENETICS.111.961888
   Balabanian K, 2002, AM J RESP CRIT CARE, V165, P1419, DOI 10.1164/rccm.2106007
   Barnes PJ, 2019, AM J RESP CRIT CARE, V200, P556, DOI 10.1164/rccm.201810-1975TR
   Bertero T, 2016, J CLIN INVEST, V126, P3313, DOI 10.1172/JCI86387
   Bertero T, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep18277
   Best DH, 2014, CHEST, V145, P231, DOI 10.1378/chest.13-2366
   Bockmeyer CL, 2012, J HEART LUNG TRANSPL, V31, P764, DOI 10.1016/j.healun.2012.03.010
   Bohnen MS, 2018, CIRC-GENOM PRECIS ME, V11, P0, DOI 10.1161/CIRCGEN.118.002087
   Bonnet S, 2007, P NATL ACAD SCI USA, V104, P11418, DOI 10.1073/pnas.0610467104
   Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008
   Bordron A, 1998, J CLIN INVEST, V101, P2029, DOI 10.1172/JCI2261
   Boucherat O, 2015, EUR RESPIR J, V46, P1167, DOI 10.1183/13993003.00798-2015
   Brittain EL, 2020, J AM HEART ASSOC, V9, P0, DOI 10.1161/JAHA.120.018349
   Budhiraja R, 2004, CIRCULATION, V109, P159, DOI 10.1161/01.CIR.0000102381.57477.50
   Burton VJ, 2011, BLOOD, V117, P333, DOI 10.1182/blood-2010-05-285973
   Carvalho D, 1996, J CLIN INVEST, V97, P111, DOI 10.1172/JCI118377
   Chalmers SJ, 2021, PULM CIRC, V10, P2045894020933081
   Chambers CD, 2006, NEW ENGL J MED, V354, P579, DOI 10.1056/NEJMoa052744
   Chaouat A, 2004, THORAX, V59, P446, DOI 10.1136/thx.2003.11890
   Chelladurai P, 2012, EUR RESPIR J, V40, P766, DOI 10.1183/09031936.00209911
   Chen PI, 2017, JCI INSIGHT, V2, P0, DOI 10.1172/jci.insight.90427
   Cheng XY, 2019, HYPERTENSION, V74, P733, DOI 10.1161/HYPERTENSIONAHA.119.13458
   Cheron C, 2021, EUR RESPIR REV, V30, P0, DOI 10.1183/16000617.0330-2020
   Chettimada S, 2015, AM J PHYSIOL-LUNG C, V308, PL287, DOI 10.1152/ajplung.00229.2014
   Chien S, 2008, ANN BIOMED ENG, V36, P554, DOI 10.1007/s10439-007-9426-3
   Claessen G, 2015, J AM HEART ASSOC, V4, P0, DOI 10.1161/JAHA.114.001602
   Cober ND, 2022, HYPERTENSION, V79, P1580, DOI 10.1161/HYPERTENSIONAHA.122.18261
   Cogolludo A, 2006, CIRC RES, V98, P931, DOI 10.1161/01.RES.0000216858.04599.e1
   Cohen-Kaminsky S, 2014, DRUG DISCOV TODAY, V19, P1251, DOI 10.1016/j.drudis.2014.04.007
   Cool CD, 2020, AM J PHYSIOL-LUNG C, V318, PL1115, DOI 10.1152/ajplung.00476.2019
   Courboulin Audrey, 2011, RESPIR RES, V12, P128, DOI 10.1186/1465-9921-12-128
   Culley MK, 2022, CIRC RES, V130, P928, DOI 10.1161/CIRCRESAHA.121.319815
   Culley MK, 2021, J CLIN INVEST, V131, P0, DOI 10.1172/JCI136459
   Cunningham CM, 2022, AM J RESP CRIT CARE, V206, P186, DOI 10.1164/rccm.202110-2309OC
   Dahal BK, 2010, AM J RESP CRIT CARE, V181, P158, DOI 10.1164/rccm.200811-1682OC
   DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343
   Davies RJ, 2012, AM J PHYSIOL-LUNG C, V302, PL604, DOI 10.1152/ajplung.00309.2011
   de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004
   Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059
   Denver N, 2020, PULM CIRC, V10, P0, DOI 10.1177/2045894020908783
   Dhalla IA, 2012, CHEST, V141, P348, DOI 10.1378/chest.11-0426
   Dib H, 2012, EUR RESPIR J, V39, P1405, DOI 10.1183/09031936.00181410
   Din S, 2009, VASC PHARMACOL, V51, P344, DOI 10.1016/j.vph.2009.09.001
   DorfmÃ¼ller P, 2007, HUM PATHOL, V38, P893, DOI 10.1016/j.humpath.2006.11.022
   DorfmÃ¼ller P, 2003, SARCOIDOSIS VASC DIF, V20, P9
   DorfmÃ¼ller P, 2002, AM J RESP CRIT CARE, V165, P534, DOI 10.1164/rccm.2012112
   Drake KM, 2011, AM J RESP CRIT CARE, V184, P1400, DOI 10.1164/rccm.201106-1130OC
   Eddahibi S, 2001, RESP RES, V3, P0, DOI 10.1186/rr181
   Eddahibi S, 2002, J LAB CLIN MED, V139, P194, DOI 10.1067/mlc.2002.122181
   El Kasmi KC, 2014, J IMMUNOL, V193, P597, DOI 10.4049/jimmunol.1303048
   Evans JDW, 2016, LANCET RESP MED, V4, P129, DOI 10.1016/S2213-2600(15)00544-5
   Eyries M, 2014, NAT GENET, V46, P65, DOI 10.1038/ng.2844
   Fan Y, 2020, AM J RESP CRIT CARE, V202, P1283, DOI 10.1164/rccm.201909-1884OC
   Federici C, 2015, AM J RESP CRIT CARE, V192, P219, DOI 10.1164/rccm.201411-2128OC
   Fessel JP, 2013, PULM CIRC, V3, P564, DOI 10.1086/674312
   Fijalkowska I, 2010, AM J PATHOL, V176, P1130, DOI 10.2353/ajpath.2010.090832
   Frid MG, 2020, AM J RESP CRIT CARE, V201, P224, DOI 10.1164/rccm.201903-0591OC
   Frump AL, 2023, AM J RESP CELL MOL, V68, P341, DOI 10.1165/rcmb.2022-0224LE
   Frump AL, 2021, J CLIN INVEST, V131, P0, DOI 10.1172/JCI129433
   Goldenberg NM, 2019, AM J RESP CRIT CARE, V199, P1566, DOI 10.1164/rccm.201808-1597LE
   Golembeski SA, 2005, CHEST, V128, P572S, DOI 10.1378/chest.128.6_suppl.572S-a
   GrÃ¤f S, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-03672-4
   Granton J, 2015, CIRC RES, V117, P645, DOI 10.1161/CIRCRESAHA.114.305951
   Guignabert C, 2005, CIRCULATION, V111, P2812, DOI 10.1161/CIRCULATIONAHA.104.524926
   Hagen M, 2007, AM J PHYSIOL-LUNG C, V292, PL1473, DOI 10.1152/ajplung.00197.2006
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Hansmann G, 2007, CIRCULATION, V115, P1275, DOI 10.1161/CIRCULATIONAHA.106.663120
   Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015
   Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231
   Hashimoto-Kataoka T, 2015, P NATL ACAD SCI USA, V112, PE2677, DOI 10.1073/pnas.1424774112
   Hassoun PM, 2021, NEW ENGL J MED, V385, P2361, DOI 10.1056/NEJMra2000348
   Hassoun PM, 2009, J AM COLL CARDIOL, V54, PS10, DOI 10.1016/j.jacc.2009.04.006
   Hautefort A, 2015, CHEST, V147, P1610, DOI 10.1378/chest.14-1678
   HEATH D, 1958, CIRCULATION, V18, P533, DOI 10.1161/01.CIR.18.4.533
   Hemnes AR, 2019, JCI INSIGHT, V4, P0, DOI 10.1172/jci.insight.123611
   Hemnes AR, 2017, EUR RESPIR REV, V26, P0, DOI 10.1183/16000617.0093-2017
   Hendriks PM, 2022, PULM CIRC, V12, P0, DOI 10.1002/pul2.12137
   Hester J, 2020, COMPR PHYSIOL, V10, P125, DOI 10.1002/cphy.c190011
   Hlavaty A, 2022, BRIT J CLIN PHARMACO, V88, P5227, DOI 10.1111/bcp.15436
   Hoeper MM, 2023, NEW ENGL J MED, V388, P1478, DOI 10.1056/NEJMoa2213558
   Hoeper MM, 2013, CIRCULATION, V127, P1128, DOI 10.1161/CIRCULATIONAHA.112.000765
   Hoffmann J, 2011, EUR RESPIR J, V37, P1400, DOI 10.1183/09031936.00043310
   Hoffmann J, 2015, AM J PHYSIOL-LUNG C, V308, PL1002, DOI 10.1152/ajplung.00383.2014
   Hong ZG, 2017, AM J RESP CRIT CARE, V195, P515, DOI 10.1164/rccm.201604-0814OC
   Hopper RK, 2016, CIRCULATION, V133, P1783, DOI 10.1161/CIRCULATIONAHA.115.020617
   Huertas A, 2020, CARDIOVASC RES, V116, P885, DOI 10.1093/cvr/cvz308
   Huertas A, 2012, EUR RESPIR J, V40, P895, DOI 10.1183/09031936.00159911
   Humbert M, 2021, NEW ENGL J MED, V384, P1204, DOI 10.1056/NEJMoa2024277
   Humbert M, 2019, EUR RESPIR J, V53, P0, DOI 10.1183/13993003.01887-2018
   Hunter KS, 2011, COMPR PHYSIOL, V1, P1413, DOI 10.1002/cphy.c100005
   Iqbal M, 2001, POULTRY SCI, V80, P656, DOI 10.1093/ps/80.5.656
   Itoh A, 2003, RESPIROLOGY, V8, P467, DOI 10.1046/j.1440-1843.2003.00491.x
   Izikki M, 2009, J CLIN INVEST, V119, P512, DOI 10.1172/JCI35070
   Jacobs W, 2014, CHEST, V145, P1230, DOI 10.1378/chest.13-1291
   Johnson JA, 2012, AM J PHYSIOL-LUNG C, V302, PL474, DOI 10.1152/ajplung.00202.2011
   Jones PL, 1996, CIRC RES, V79, P1131, DOI 10.1161/01.RES.79.6.1131
   Jones RJ, 2022, AM J RESP CRIT CARE, V206, P81, DOI 10.1164/rccm.202108-1919OC
   Kawut SM, 2011, CIRCULATION, V123, P2542, DOI 10.1161/CIRCULATIONAHA.110.985515
   Kim YM, 2011, AM J PATHOL, V179, P1560, DOI 10.1016/j.ajpath.2011.05.051
   Klein M, 2008, CIRCULATION, V118, P2081, DOI 10.1161/CIRCULATIONAHA.108.779751
   Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226
   Larkin EK, 2012, AM J RESP CRIT CARE, V186, P892, DOI 10.1164/rccm.201205-0886OC
   Larsen KO, 2011, AM J PHYSIOL-LUNG C, V301, PL50, DOI 10.1152/ajplung.00048.2010
   Le Hiress M, 2015, AM J RESP CRIT CARE, V192, P983, DOI 10.1164/rccm.201402-0322OC
   Le Payec J, 2010, AM J RESP CRIT CARE, V181, P1285, DOI 10.1164/rccm.200909-1331PP
   Lechartier B, 2022, CHEST, V161, P219, DOI 10.1016/j.chest.2021.08.040
   Lee JG, 2009, INVEST OPHTH VIS SCI, V50, P2067, DOI 10.1167/iovs.08-3135
   Lewis MI, 2023, ALPHA STUDY PULMONAR, V0, P0
   Li ML, 2014, AM J RESP CELL MOL, V50, P1118, DOI 10.1165/rcmb.2013-0349OC
   Liang SX, 2022, BIOMEDICINES, V10, P0, DOI 10.3390/biomedicines10020341
   Liu AP, 2014, AM J PHYSIOL-HEART C, V307, PH273, DOI 10.1152/ajpheart.00758.2013
   Liu LM, 2022, CLIN EXP PHARMACOL P, V49, P1042, DOI 10.1111/1440-1681.13696
   Liu XD, 2014, J THORAC DIS, V6, P497, DOI 10.3978/j.issn.2072-1439.2014.03.27
   Long L, 2015, NAT MED, V21, P777, DOI 10.1038/nm.3877
   Long L, 2013, CIRC RES, V112, P1159, DOI 10.1161/CIRCRESAHA.111.300483
   Low AT, 2015, HAEMATOLOGICA, V100, PE244, DOI 10.3324/haematol.2014.120816
   Ma L, 2013, NEW ENGL J MED, V369, P351, DOI 10.1056/NEJMoa1211097
   Machado RD, 2015, HUM MUTAT, V36, P1113, DOI 10.1002/humu.22904
   Machado RD, 2000, GENOMICS, V68, P220, DOI 10.1006/geno.2000.6291
   Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848
   Masri FA, 2008, CTS-CLIN TRANSL SCI, V1, P99, DOI 10.1111/j.1752-8062.2008.00035.x
   Mathai SC, 2012, HEART FAIL CLIN, V8, P413, DOI 10.1016/j.hfc.2012.04.001
   McClenaghan C, 2019, HYPERTENSION, V74, P14, DOI 10.1161/HYPERTENSIONAHA.119.12992
   McMurtry MS, 2004, CIRC RES, V95, P830, DOI 10.1161/01.RES.0000145360.16770.9f
   Meloche J, 2015, CIRC RES, V117, P525, DOI 10.1161/CIRCRESAHA.115.307004
   Meloche J, 2014, CIRCULATION, V129, P786, DOI 10.1161/CIRCULATIONAHA.113.006167
   Michelakis ED, 2002, CIRCULATION, V105, P244, DOI 10.1161/hc0202.101974
   Michelakis ED, 2017, SCI TRANSL MED, V9, P0, DOI 10.1126/scitranslmed.aao4583
   Middleton R, 2021, AM J RESP CRIT CARE, V203, P0
   Middleton RC, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0183557
   Mirsaeidi Mehdi, 2016, TANAFFOS, V15, P44
   Montani D, 2016, EUR RESPIR J, V47, P1518, DOI 10.1183/13993003.00026-2016
   Morrell NW, 2019, EUR RESPIR J, V53, P0, DOI 10.1183/13993003.01899-2018
   Moudgil R, 2006, MICROCIRCULATION, V13, P615, DOI 10.1080/10739680600930222
   MuÃ±oz LE, 2010, AUTOIMMUN REV, V10, P38, DOI 10.1016/j.autrev.2010.08.015
   Nasim MT, 2011, HUM MUTAT, V32, P1385, DOI 10.1002/humu.21605
   Nave AH, 2014, ARTERIOSCL THROM VAS, V34, P1446, DOI 10.1161/ATVBAHA.114.303534
   Noureddine H, 2011, CIRC RES, V109, P543, DOI 10.1161/CIRCRESAHA.111.241299
   Ntokou A, 2021, JCI INSIGHT, V6, P0, DOI 10.1172/jci.insight.139067
   Olivetta E, 2003, J IMMUNOL, V170, P1716, DOI 10.4049/jimmunol.170.4.1716
   Olschewski A, 2006, CIRC RES, V98, P1072, DOI 10.1161/01.RES.0000219677.12988.e9
   Olschewski A, 2017, EUR RESPIR J, V50, P0, DOI 10.1183/13993003.00754-2017
   Owen NE, 2020, EBIOMEDICINE, V56, P0, DOI 10.1016/j.ebiom.2020.102794
   Palasset TL, 2021, ANN AM THORAC SOC, V18, P1306, DOI 10.1513/AnnalsATS.202008-913OC
   Patterson KC, 2006, ANN INTERN MED, V145, P152, DOI 10.7326/0003-4819-145-2-200607180-00020
   Perros F, 2007, EUR RESPIR J, V29, P937, DOI 10.1183/09031936.00104706
   Perros F, 2008, AM J RESP CRIT CARE, V178, P81, DOI 10.1164/rccm.200707-1037OC
   Perros F, 2012, AM J RESP CRIT CARE, V185, P311, DOI 10.1164/rccm.201105-0927OC
   Pietra GG, 2004, J AM COLL CARDIOL, V43, P25S, DOI 10.1016/j.jacc.2004.02.033
   PIETRA GG, 1989, CIRCULATION, V80, P1198, DOI 10.1161/01.CIR.80.5.1198
   Pogoriler JE, 2012, HISTOPATHOLOGY, V61, P597, DOI 10.1111/j.1365-2559.2012.04246.x
   Price LC, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0075415
   Prins KW, 2018, J HEART LUNG TRANSPL, V37, P376, DOI 10.1016/j.healun.2017.08.011
   Pugh ME, 2011, J HEART LUNG TRANSPL, V30, P904, DOI 10.1016/j.healun.2011.02.016
   Pullamsetti SS, 2012, AM J RESP CRIT CARE, V185, P409, DOI 10.1164/rccm.201106-1093OC
   Qian J, 2015, HYPERTENSION, V66, P1227, DOI 10.1161/HYPERTENSIONAHA.115.06370
   RABINOVITCH M, 1980, HUM PATHOL, V11, P499
   Rabinovitch M, 2014, CIRC RES, V115, P165, DOI 10.1161/CIRCRESAHA.113.301141
   Rai PR, 2008, AM J RESP CRIT CARE, V178, P558, DOI 10.1164/rccm.200709-1369PP
   Ramirez RL, 2018, CURR OPIN PULM MED, V24, P416, DOI 10.1097/MCP.0000000000000513
   Ranchoux B, 2015, CIRCULATION, V131, P1006, DOI 10.1161/CIRCULATIONAHA.114.008750
   Ranchoux B, 2015, AM J PATHOL, V185, P356, DOI 10.1016/j.ajpath.2014.10.021
   Raychaudhuri B, 1999, AM J RESP CELL MOL, V21, P311, DOI 10.1165/ajrcmb.21.3.3611
   Redel-Traub G, 2022, BIOMOLECULES, V12, P0, DOI 10.3390/biom12101341
   Renard S, 2016, CHEST, V149, PE69, DOI 10.1016/j.chest.2015.09.018
   Ricard N, 2014, CIRCULATION, V129, P1586, DOI 10.1161/CIRCULATIONAHA.113.007469
   RITCHIE M, 1993, J AM COLL CARDIOL, V22, P1170, DOI 10.1016/0735-1097(93)90433-2
   Ross DJ, 2012, J HEART LUNG TRANSPL, V31, P865, DOI 10.1016/j.healun.2012.04.008
   Rother N, 2015, FRONT IMMUNOL, V6, P0, DOI 10.3389/fimmu.2015.00610
   Rothman AMK, 2016, J CLIN INVEST, V126, P2495, DOI 10.1172/JCI83361
   Sakao S, 2005, FASEB J, V19, P1178, DOI 10.1096/fj.04-3261fje
   Savale L, 2009, RESP RES, V10, P0, DOI 10.1186/1465-9921-10-6
   Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838
   Schulman LL, 1996, TRANSPLANTATION, V62, P622, DOI 10.1097/00007890-199609150-00014
   Schweitzer F, 2019, AIDS RES HUM RETROV, V35, P63, DOI 10.1089/AID.2018.0132
   Shah NP, 2015, AM J HEMATOL, V90, P1060, DOI 10.1002/ajh.24174
   Sharma S, 2020, GENES-BASEL, V11, P0, DOI 10.3390/genes11101224
   Shimoda LA, 2020, PHYSIOLOGY, V35, P222, DOI 10.1152/physiol.00039.2019
   Shu T, 2021, FRONT CARDIOVASC MED, V8, P0, DOI 10.3389/fcvm.2021.680109
   Southgate L, 2020, NAT REV CARDIOL, V17, P85, DOI 10.1038/s41569-019-0242-x
   Souza R, 2006, THORAX, V61, P736, DOI 10.1136/thx.2006.064097
   Spiekerkoetter E, 2017, EUR RESPIR J, V50, P0, DOI 10.1183/13993003.02449-2016
   Stacher E, 2012, AM J RESP CRIT CARE, V186, P261, DOI 10.1164/rccm.201201-0164OC
   Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014
   Stenmark KR, 2016, CIRCULATION, V133, P1734, DOI 10.1161/CIRCULATIONAHA.116.022479
   Stenmark Kurt R, 2012, PULM CIRC, V2, P3, DOI 10.4103/2045-8932.94817
   Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, PL1013, DOI 10.1152/ajplung.00217.2009
   Swietlik EM, 2021, CIRC-GENOM PRECIS ME, V14, P0, DOI 10.1161/CIRCGEN.120.003155
   Tamby MC, 2006, EUR RESPIR J, V28, P799, DOI 10.1183/09031936.06.00152705
   Tamby MC, 2005, THORAX, V60, P765, DOI 10.1136/thx.2004.029082
   Tamosiuniene R, 2011, CIRC RES, V109, P867, DOI 10.1161/CIRCRESAHA.110.236927
   Tang HY, 2018, JACC-BASIC TRANSL SC, V3, P744, DOI 10.1016/j.jacbts.2018.08.009
   Teichert-Kuliszewska K, 2006, CIRC RES, V98, P209, DOI 10.1161/01.RES.0000200180.01710.e6
   Tello K, 2020, AM J RESP CRIT CARE, V202, P1042, DOI 10.1164/rccm.202003-0807LE
   Terrier B, 2008, AM J RESP CRIT CARE, V177, P1128, DOI 10.1164/rccm.200707-1015OC
   Thenappan T, 2018, AM J PHYSIOL-HEART C, V315, PH1322, DOI 10.1152/ajpheart.00136.2018
   Tian W, 2013, SCI TRANSL MED, V5, P0, DOI 10.1126/scitranslmed.3006674
   Tielemans B, 2019, DRUG DISCOV TODAY, V24, P703, DOI 10.1016/j.drudis.2018.12.001
   Toby IT, 2010, AM J PHYSIOL-LUNG C, V298, PL600, DOI 10.1152/ajplung.00122.2009
   TODOROVICHHUNTER L, 1992, AM REV RESPIR DIS, V146, P213, DOI 10.1164/ajrccm/146.1.213
   Tofovic SP, 2010, J CARDIOVASC PHARM, V56, P696, DOI 10.1097/FJC.0b013e3181f9ea8d
   Tonelli Adriano R, 2012, PULM CIRC, V2, P214, DOI 10.4103/2045-8932.97607
   Trembath RC, 2001, NEW ENGL J MED, V345, P325, DOI 10.1056/NEJM200108023450503
   Trip P, 2013, EUR RESPIR J, V42, P1575, DOI 10.1183/09031936.00184412
   Tuder RM, 1998, J LAB CLIN MED, V132, P16, DOI 10.1016/S0022-2143(98)90020-8
   TUDER RM, 1994, AM J PATHOL, V144, P275
   Tuder RM, 2013, J AM COLL CARDIOL, V62, PD4, DOI 10.1016/j.jacc.2013.10.025
   Upton PD, 2013, EXP PHYSIOL, V98, P1262, DOI 10.1113/expphysiol.2012.069104
   van de Veerdonk MC, 2015, CHEST, V147, P1063, DOI 10.1378/chest.14-0701
   van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068
   Van der Feen DE, 2019, AM J RESP CRIT CARE, V200, P910, DOI 10.1164/rccm.201812-2275OC
   van der Feen DE, 2019, AM J RESP CELL MOL, V61, P11, DOI 10.1165/rcmb.2018-0329TR
   Vengethasamy L, 2016, PFLUG ARCH EUR J PHY, V468, P1969, DOI 10.1007/s00424-016-1899-1
   Ventetuolo CE, 2016, AM J RESP CRIT CARE, V193, P1168, DOI 10.1164/rccm.201509-1785OC
   WAGENVOORT CA, 1970, J PATHOL, V101, P0
   Wang DR, 2014, CIRC RES, V114, P67, DOI 10.1161/CIRCRESAHA.114.301633
   Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98
   West J, 2020, PULM CIRC, V10, P0, DOI 10.1177/2045894019856483
   West J, 2013, EUR RESPIR J, V41, P861, DOI 10.1183/09031936.00030312
   Xu WL, 2021, ANNU REV PHYSIOL, V83, P551, DOI 10.1146/annurev-physiol-031620-123956
   Xu WL, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-55053-6
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yang SZ, 2012, AM J PHYSIOL-LUNG C, V302, PL521, DOI 10.1152/ajplung.00316.2011
   Yeager ME, 2001, CIRC RES, V88, P0
   Yu YRA, 2020, J IMMUNOL, V204, P1474, DOI 10.4049/jimmunol.1900239
   Yuan K, 2015, AM J PATHOL, V185, P69, DOI 10.1016/j.ajpath.2014.09.013
   Yuan XJ, 1998, LANCET, V351, P726, DOI 10.1016/S0140-6736(05)78495-6
   Zamanian RT, 2009, EUR RESPIR J, V33, P318, DOI 10.1183/09031936.00000508
   Zamanian RT, 2021, AM J RESP CRIT CARE, V204, P209, DOI 10.1164/rccm.202009-3481OC
   Zhang H, 2017, CIRCULATION, V136, P2468, DOI 10.1161/CIRCULATIONAHA.117.028069
   Zhang S, 2003, AM J PHYSIOL-LUNG C, V285, PL740, DOI 10.1152/ajplung.00284.2002
   Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157672.70560.7b
   Zhao YD, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0088727
   Zhu N, 2018, CIRC-GENOM PRECIS ME, V11, P0, DOI 10.1161/CIRCGEN.117.001887
NR 245
TC 0
Z9 0
U1 0
U2 0
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
SN 1573-398X
EI 1875-6387
J9 CURR RESPIR MED REV
JI Curr. Respir. Med. Rev.
PD JUN 15
PY 2024
VL 20
IS 2
BP 127
EP 155
DI 10.2174/011573398X266579240226064718
EA MAR 2024
PG 29
WC Respiratory System
SC Respiratory System
GA YW0N0
UT WOS:001189816100001
DA 2024-11-01
ER

PT J
AU Yu, XJ
   Li, S
   Guo, QX
   Leng, JH
   Ding, Y
AF Yu, Xuejiao
   Li, Sheng
   Guo, Qinxian
   Leng, Jianhang
   Ding, Yu
TI The Association Between Mitochondrial tRNA<SUP>Glu </SUP>Variants and Hearing Loss: A Case-Control Study
SO PHARMACOGENOMICS & PERSONALIZED MEDICINE
LA English
DT Article
DE deafness; mitochondrial tRNA(Glu) variants; pediatrics; tRNA metabolism
ID complete nucleotide-sequence; transfer-rna mutations; dna mutations; deafness; genes; expression; phylogeny; myopathy; nuclear; roles
AB Purpose: This study aimed to examine the frequencies of mt-tRNA(Glu) variants in 180 pediatric patients with non-syndromic hearing loss (NSHL) and 100 controls.<br /> Methods: Sanger sequencing was performed to screen for mt-tRNA(Glu) variants. These mitochondrial DNA (mtDNA) pathogenic mutations were further assessed using phylogenetic conservation and haplogroup analyses. We also traced the origins of the family history of probands carrying potential pathogenic mtDNA mutations. Mitochondrial functions including mtDNA content, ATP and reactive oxygen species (ROS) were examined in cells derived from patients carrying the mt-tRNA(Glu) A14692G and CO1/tRNA(Ser(UCN)) G7444A variants and controls.<br /> Results: We identified four possible pathogenic variants: m.T14709C, m.A14683G, m.A14692G and m.A14693G, which were found in NSHL patients but not in controls. Genetic counseling suggested that one child with the m.A14692G variant had a family history of NSHL. Sequence analysis of mtDNA suggested the presence of the CO1/tRNA(Ser(UCN)) G7444A and mt-tRNA(Glu) A14692G variants. Molecular analysis suggested that, compared with the controls, patients with these variants exhibited much lower mtDNA copy numbers, ATP production, whereas ROS levels increased (p< 0.05 for all), suggesting that the m.A14692G and m.G7444A variants led to mitochondrial dysfunction.<br /> Conclusion: mt-tRNA(Glu) variants are important risk factors for NSHL.
C1 [Yu, Xuejiao] Wenzhou Med Univ, Quzhou Affiliated Hosp, Quzhou Peoples Hosp, Dept Clin Lab, Quzhou 324000, Zhejiang, Peoples R China.
   [Li, Sheng] Wenzhou Med Univ, Quzhou Peoples Hosp, Dept Otolaryngol, Quzhou Affiliated Hosp, Quzhou 324000, Zhejiang, Peoples R China.
   [Guo, Qinxian; Leng, Jianhang; Ding, Yu] Hangzhou First Peoples Hosp, Cent Lab, Hangzhou 310006, Zhejiang, Peoples R China.
C3 Wenzhou Medical University; Wenzhou Medical University
RP Yu, XJ (corresponding author), Wenzhou Med Univ, Quzhou Affiliated Hosp, Quzhou Peoples Hosp, Dept Clin Lab, Quzhou 324000, Zhejiang, Peoples R China.; Ding, Y (corresponding author), Hangzhou First Peoples Hosp, Cent Lab, Hangzhou 310006, Zhejiang, Peoples R China.
EM ajkc5701@163.com; dingyu_zj@126.com
FU Ministry of Public Health of Zhejiang Province [2021RC022]; Quzhou Bureau of Science and Technology [2022K51]
CR AllnÃ©r O, 2011, RNA, V17, P2177, DOI 10.1261/rna.029231.111
   An ST, 2018, INT J CLIN EXP MED, V11, P269
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7
   Bitner-Glindzicz M, 2002, BRIT MED BULL, V63, P73, DOI 10.1093/bmb/63.1.73
   Cui Y, 2018, MOL MED REP, V18, P5159, DOI 10.3892/mmr.2018.9519
   Ding Y, 2022, J CLIN MED, V11, P0, DOI 10.3390/jcm11216431
   Ding Y, 2022, GENES-BASEL, V13, P0, DOI 10.3390/genes13101794
   Ding Y, 2019, CURR MOL MED, V19, P136, DOI 10.2174/1566524019666190308121552
   Ding Y, 2019, ENDOCR J, V66, P81, DOI 10.1507/endocrj.EJ18-0308
   Ding Y, 2018, GENE, V642, P299, DOI 10.1016/j.gene.2017.11.049
   Ding Y, 2017, AM J TRANSL RES, V9, P2984
   Ding Y, 2013, BIOCHEM GENET, V51, P588, DOI 10.1007/s10528-013-9589-6
   Ding Y, 2009, J GENET GENOMICS, V36, P241, DOI 10.1016/S1673-8527(08)60111-3
   Ebrahimkhani Somayeh, 2021, IRAN J OTORHINOLARYNGOL, V33, P79, DOI 10.22038/ijorl.2020.45196.2483
   Finsterer J, 2005, INT J PEDIATR OTORHI, V69, P621, DOI 10.1016/j.ijporl.2004.12.002
   GADALETA G, 1989, J MOL EVOL, V28, P497, DOI 10.1007/BF02602930
   Gaignard P, 2013, JIMD REP, V11, P117, DOI 10.1007/8904_2013_230
   Gao YJ, 2022, FRONT GENET, V13, P0, DOI 10.3389/fgene.2022.797124
   Grasbon-Frodl EM, 1999, NEUROGENETICS, V2, P121, DOI 10.1007/s100480050063
   Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868
   Hawk MA, 2018, J BIOL CHEM, V293, P7531, DOI 10.1074/jbc.TM117.000260
   Ibrahim I, 2018, MUTAT RES-FUND MOL M, V810, P39, DOI 10.1016/j.mrfmmm.2018.03.003
   Jafarlou F, 2021, INT J PREVENTIVE MED, V12, P0, DOI 10.4103/ijpvm.IJPVM_270_20
   Jeng JY, 2008, J CELL BIOCHEM, V103, P347, DOI 10.1002/jcb.21625
   Jia ZD, 2022, NUCLEIC ACIDS RES, V50, P9368, DOI 10.1093/nar/gkac698
   Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130
   Levin L, 2013, GENOME BIOL EVOL, V5, P876, DOI 10.1093/gbe/evt058
   Liu Q, 2015, MOL MED REP, V12, P8176, DOI 10.3892/mmr.2015.4484
   Luo LF, 2013, GENE, V520, P79, DOI 10.1016/j.gene.2013.03.041
   Marinelli JP, 2022, LANCET HEALTH LONGEV, V3, PE817, DOI 10.1016/S2666-7568(22)00241-0
   McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004
   Memon AA, 2022, ANTIOXID REDOX SIGN, V37, P1168, DOI 10.1089/ars.2022.0100
   Meng FL, 2022, NUCLEIC ACIDS RES, V50, P9453, DOI 10.1093/nar/gkac720
   Meulemans A, 2007, EUR J PAEDIATR NEURO, V11, P17, DOI 10.1016/j.ejpn.2006.10.004
   Moassass F, 2018, INT J PEDIATR OTORHI, V113, P110, DOI 10.1016/j.ijporl.2018.07.028
   Mutai H, 2017, BMC MED GENET, V18, P0, DOI 10.1186/s12881-017-0389-4
   Perucca-Lostanlen D, 2002, BBA-MOL BASIS DIS, V1588, P210, DOI 10.1016/S0925-4439(02)00167-9
   Rayess HM, 2015, AM J OTOLARYNG, V36, P7, DOI 10.1016/j.amjoto.2014.08.010
   ROE BA, 1985, J BIOL CHEM, V260, P9759
   Saoji M, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22116066
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   van Oven M, 2009, HUM MUTAT, V30, PE386, DOI 10.1002/humu.20921
   Wang M, 2016, J BIOL CHEM, V291, P21029, DOI 10.1074/jbc.M116.739482
   Xue L, 2019, MITOCHONDRION, V46, P370, DOI 10.1016/j.mito.2018.10.001
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yu XJ, 2022, J CLIN LAB ANAL, V36, P0, DOI 10.1002/jcla.24298
   Zheng J, 2020, MITOCHONDRION, V52, P163, DOI 10.1016/j.mito.2020.03.005
   Zheng J, 2012, MITOCHONDRION, V12, P406, DOI 10.1016/j.mito.2012.04.001
   Zhou YG, 2019, MOL GENET GENOM MED, V7, P0, DOI 10.1002/mgg3.537
NR 51
TC 0
Z9 0
U1 0
U2 2
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 
EI 1178-7066
J9 PHARMACOGEN PERS MED
JI Pharmacogn. Pers. Med.
PD JUN 15
PY 2024
VL 17
IS 
BP 77
EP 89
DI 10.2147/PGPM.S441281
PG 13
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA MP2M3
UT WOS:001194761000001
PM 38562431
DA 2024-11-01
ER

PT J
AU Moustaine, MO
   Azemour, Z
   Mohammed, F
   Benlanda, O
   Nassik, H
   Karkouri, M
AF Moustaine, Moulay O.
   Azemour, Zakaria
   Mohammed, Frarchi
   Benlanda, Othman
   Nassik, Hicham
   Karkouri, Mehdi
TI Management of Ptosis in Kearns-Sayre Syndrome: A Case Report and Literature Review
SO ARCHIVES OF PLASTIC SURGERY-APS
LA English
DT Article
DE Kearns-Sayre syndrome; ptosis; chronic progressive external ophthalmoplegia; Frontal suspension
ID mitochondrial-dna; patient
AB Kearns-Sayre syndrome (KSS) is a rare mitochondrial disease that affects young adults, due to a deletion of mitochondrial DNA and characterized by the triad: age of onset lower than 20 years, chronic progressive external ophthalmoplegia, and an atypical pigmentary retinopathy. It is also characterized by other endocrine, neurological, and especially cardiac impairment with a very high risk of cardiac complications during surgical procedures under all types of anesthesia. We report a case of KSS revealed by severe bilateral ptosis and confirmed by a muscle biopsy with "ragged red fibers." The ptosis was surgically managed by cautious Frontal suspension under local anesthesia "Frontal nerve block." Through this case, we discuss challenges in the management of KSS patients.
C1 [Moustaine, Moulay O.; Azemour, Zakaria; Mohammed, Frarchi] Ibn Zohr Univ, CHU Souss Massa, Dept Ophthalmol, Fac Med & Pharm, Agadir, Morocco.
   [Benlanda, Othman; Nassik, Hicham] Ibn Zohr Univ, CHU Souss Massa, Dept Anesthesia Resuscitat, Fac Med & Pharm, Agadir, Morocco.
   [Karkouri, Mehdi] Hassan II Univ, CHU Ibn Rochd, Gen Lab Pathol Anat, Fac Med & Pharm, Casablanca, Morocco.
C3 Ibn Zohr University of Agadir; University Hospital of Agadir; Ibn Zohr University of Agadir; University Hospital of Agadir; Hassan II University of Casablanca; Ibn Rochd University Hospital Center of Casablanca
RP Moustaine, MO (corresponding author), Ibn Zohr Univ, UHC Souss Massa, Fac Med & Pharm Agadir, Ophthalmol Dept, Agadir, Morocco.
EM o.moustaine@uiz.ac.ma
CR Berardo A, 2010, CURR NEUROL NEUROSCI, V10, P118, DOI 10.1007/s11910-010-0096-4
   Ãakmak BM, 2013, J CLIN ANAL MED, V4, P155, DOI 10.4328/JCAM.643
   Calzavacca Paolo, 2011, CASE REP ANESTHESIOL, V2011, P806086, DOI 10.1155/2011/806086
   Capkova M, 2002, CAS LEK CESK, V141, P51
   Choi C, 2000, YONSEI MED J, V41, P676, DOI 10.3349/ymj.2000.41.5.676
   Gaboune L, 2012, J FR OPHTALMOL, V35, P0, DOI 10.1016/j.jfo.2012.06.010
   Isashiki Y, 1998, ACTA OPHTHALMOL SCAN, V76, P6, DOI 10.1034/j.1600-0420.1998.760103.x
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   KITOH T, 1995, ANESTH ANALG, V80, P1240, DOI 10.1097/00000539-199506000-00030
   Laloi-Michelin M, 2006, DIABETES METAB, V32, P182, DOI 10.1016/S1262-3636(07)70267-7
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   Serna JT, 2021, REV ESP ANEST REANIM, V68, P232, DOI 10.1016/j.redar.2020.04.007
   Shemesh A, 2022, KEARNS SAYRE SYNDROME, V0, P0
   Tsang SH, 2018, ADV EXP MED BIOL, V1085, P161, DOI 10.1007/978-3-319-95046-4_30
   Weitgasser L, 2015, ARCH PLAST SURG-APS, V42, P214, DOI 10.5999/aps.2015.42.2.214
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 17
TC 0
Z9 0
U1 1
U2 1
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 2234-6163
EI 2234-6171
J9 ARCH PLAST SURG-APS
JI Arch. Plast. Surg.-APS
PD MAR 15
PY 2024
VL 51
IS 02
BP 182
EP 186
DI 10.1055/a-2207-7587
PG 5
WC Surgery
SC Surgery
GA NC9C9
UT WOS:001198357800015
PM 38596148
DA 2024-11-01
ER

PT J
AU Saad, FA
   Saad, JF
   Siciliano, G
   Merlini, L
   Angelini, C
AF Saad, Fawzy A.
   Saad, Jasen F.
   Siciliano, Gabriele
   Merlini, Luciano
   Angelini, Corrado
TI Duchenne Muscular Dystrophy Gene Therapy
SO CURRENT GENE THERAPY
LA English
DT Review
DE Duchene muscular dystrophy; microdystrophin; pharmacophore; adeno-associated virus; exon skipping; CRISPR/Cas gene editing; gene therapy; gene drugs; genetic drugs; genomic drugs
ID point mutations; full-length; mouse model; dmd gene; mitochondrial dysfunction; glycoprotein complex; missense mutation; exon; muscle; expression
AB Duchenne and Becker muscular dystrophies are allelic X-linked recessive neuromuscular diseases affecting both skeletal and cardiac muscles. Therefore, owing to their single X chromosome, the affected boys receive pathogenic gene mutations from their unknowing carrier mothers. Current pharmacological drugs are palliative that address the symptoms of the disease rather than the genetic cause imbedded in the Dystrophin gene DNA sequence. Therefore, alternative therapies like gene drugs that could address the genetic cause of the disease at its root are crucial, which include gene transfer/implantation, exon skipping, and gene editing. Presently, it is possible through genetic reprogramming to engineer AAV vectors to deliver certain therapeutic cargos specifically to muscle or other organs regardless of their serotype. Similarly, it is possible to direct the biogenesis of exosomes to carry gene editing constituents or certain therapeutic cargos to specific tissue or cell type like brain and muscle. While autologous exosomes are immunologically inert, it is possible to camouflage AAV capsids, and lipid nanoparticles to evade the immune system recognition. In this review, we highlight current opportunities for Duchenne muscular dystrophy gene therapy, which has been known thus far as an incurable genetic disease. This article is a part of Gene Therapy of Rare Genetic Diseases thematic issue.
C1 [Saad, Fawzy A.] Univ Padua, Sch Med, Dept Biol, Via Trieste 75, I-35121 Padua, Italy.
   [Saad, Fawzy A.; Saad, Jasen F.] Saad Pharmaceut, Dept Gene Therapy, Tornimae 7-26, EE-10145 Tallinn, Estonia.
   [Siciliano, Gabriele] Pisa Univ, Sch Med, Dept Clin & Expt Med, Pisa, Italy.
   [Merlini, Luciano] Bologna Univ, Sch Med, Dept Biomed & Neuromotor Sci, I-40126 Bologna, Italy.
   [Angelini, Corrado] Padova Univ, Sch Med, Dept Neurosci, Padua, Italy.
C3 University of Padua; University of Pisa; University of Bologna; University of Padua
RP Saad, FA (corresponding author), Univ Padua, Sch Med, Dept Biol, Via Trieste 75, I-35121 Padua, Italy.; Saad, FA (corresponding author), Saad Pharmaceut, Dept Gene Therapy, Tornimae 7-26, EE-10145 Tallinn, Estonia.
EM fa_saad@yahoo.co.uk
FU Italian Ministry of Foreign Affairs
CR Aartsma-Rus A, 2006, MOL THER, V14, P401, DOI 10.1016/j.ymthe.2006.02.022
   Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918
   Amoasii L, 2018, SCIENCE, V362, P86, DOI 10.1126/science.aau1549
   Amoasii L, 2017, SCI TRANSL MED, V9, P0, DOI 10.1126/scitranslmed.aan8081
   Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104
   Angelini C, 2007, MUSCLE NERVE, V36, P424, DOI 10.1002/mus.20812
   Anthony K, 2011, BRAIN, V134, P3544, DOI 10.1093/brain/awr291
   Anzalone AV, 2019, NATURE, V576, P149, DOI 10.1038/s41586-019-1711-4
   Aoki Y, 2013, BIOMED RES INT, V2013, P0, DOI 10.1155/2013/402369
   Baskin B, 2009, NEUROMUSCULAR DISORD, V19, P189, DOI 10.1016/j.nmd.2008.11.003
   BÃ©roud C, 2007, HUM MUTAT, V28, P196, DOI 10.1002/humu.20428
   Bladen CL, 2015, HUM MUTAT, V36, P395, DOI 10.1002/humu.22758
   Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182
   Buckon Cathleen, 2016, PLOS CURR, V8, P0, DOI 10.1371/currents.md.1ced64dff945f8958221fddcd4ee60b0
   Cau M, 1998, HUM MUTAT, V12, P70
   Cencic R, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0109213
   Chemello F, 2021, SCI ADV, V7, P0, DOI 10.1126/sciadv.abg4910
   Chen PJ, 2021, CELL, V184, P5635, DOI 10.1016/j.cell.2021.09.018
   Chicoine LG, 2014, MOL THER, V22, P338, DOI 10.1038/mt.2013.244
   Cirak S, 2012, MOL THER, V20, P462, DOI 10.1038/mt.2011.248
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Cotten Matt, 1993, CURRENT OPINION IN BIOTECHNOLOGY, V4, P705, DOI 10.1016/0958-1669(93)90053-Y
   Dallas SL, 2013, ENDOCR REV, V34, P658, DOI 10.1210/er.2012-1026
   Donovan JM, 2017, J CLIN PHARMACOL, V57, P627, DOI 10.1002/jcph.842
   Duchenne, 1867, BR MED J, V2, P541
   Echigoya Y, 2018, J PERS MED, V8, P0, DOI 10.3390/jpm8040041
   Eid A, 2018, BIOCHEM J, V475, P1955, DOI 10.1042/BCJ20170793
   ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0
   Fabb SA, 2002, HUM MOL GENET, V11, P733, DOI 10.1093/hmg/11.7.733
   Ferreiro V, 2009, MUSCLE NERVE, V39, P239, DOI 10.1002/mus.21193
   Finkel RS, 2021, NEUROMUSCULAR DISORD, V31, P385, DOI 10.1016/j.nmd.2021.02.001
   Flanigan KM, 2009, HUM MUTAT, V30, P1657, DOI 10.1002/humu.21114
   GALVAGNI F, 1994, HUM GENET, V94, P83, DOI 10.1007/BF02272848
   Gapinske M, 2018, GENOME BIOL, V19, P0, DOI 10.1186/s13059-018-1482-5
   Gherardi S, 2017, BBA-GENE REGUL MECH, V1860, P1138, DOI 10.1016/j.bbagrm.2017.08.010
   Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044
   Ginjaar HB, 2000, J NEUROL, V247, P524, DOI 10.1007/s004150070151
   Guiraud S, 2017, CURR OPIN PHARMACOL, V34, P36, DOI 10.1016/j.coph.2017.04.002
   Hagan M, 2018, MED HYPOTHESES, V110, P97, DOI 10.1016/j.mehy.2017.11.009
   Hampton T, 2020, JAMA-J AM MED ASSOC, V323, P405, DOI 10.1001/jama.2019.21827
   HEALD A, 1994, NEUROLOGY, V44, P2388, DOI 10.1212/WNL.44.12.2388
   Heier Christopher R, 2019, LIFE SCI ALLIANCE, V2, P0, DOI 10.26508/lsa.201800186
   Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4382, DOI 10.1210/en.140.10.4382
   Ikezawa M, 1999, HUM MUTAT, V13, P170, DOI 10.1002/(SICI)1098-1004(1999)13:2<170::AID-HUMU12>3.0.CO;2-7
   Ilyinskii PO, 2021, MOL THER-METH CLIN D, V22, P279, DOI 10.1016/j.omtm.2021.06.015
   Incitti T, 2010, MOL THER, V18, P1675, DOI 10.1038/mt.2010.123
   Jiang JJ, 2018, FETAL PEDIATR PATHOL, V37, P1, DOI 10.1080/15513815.2017.1369201
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Kemaladewi DU, 2011, BMC MED GENOMICS, V4, P0, DOI 10.1186/1755-8794-4-36
   KILIMANN MW, 1992, HUM GENET, V89, P253
   KOENIG M, 1989, AM J HUM GENET, V45, P498
   KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6
   Kourakis S, 2021, ORPHANET J RARE DIS, V16, P0, DOI 10.1186/s13023-021-01758-9
   Lasa A, 1997, HUM MUTAT, V9, P473
   Lau Cia-Hin, 2017, F1000RES, V6, P2153, DOI 10.12688/f1000research.11243.1
   Lee K, 2017, NAT BIOMED ENG, V1, P889, DOI 10.1038/s41551-017-0137-2
   LENK U, 1993, HUM MOL GENET, V2, P1877, DOI 10.1093/hmg/2.11.1877
   Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013
   Li YC, 2021, GENOME BIOL, V22, P0, DOI 10.1186/s13059-021-02458-0
   Long CZ, 2018, SCI ADV, V4, P0, DOI 10.1126/sciadv.aap9004
   Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725
   Loperfido M, 2016, NUCLEIC ACIDS RES, V44, P744, DOI 10.1093/nar/gkv1464
   LOVE DR, 1991, J MED GENET, V28, P860, DOI 10.1136/jmg.28.12.860
   Malerba A, 2012, MOL THER-NUCL ACIDS, V1, P0, DOI 10.1038/mtna.2012.54
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Manzur AY, 2008, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD003725.pub3
   Matthews E, 2016, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD003725.pub4
   Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198
   Mendell JR, 2016, CELL RES, V26, P513, DOI 10.1038/cr.2016.28
   Merlini Luciano, 2020, ACTA MYOL, V39, P200, DOI 10.36185/2532-1900-023
   Merlini L, 2014, NEUROMUSCULAR DISORD, V24, P546, DOI 10.1016/j.nmd.2014.03.009
   Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736
   Min YL, 2019, ANNU REV MED, V70, P239, DOI 10.1146/annurev-med-081117-010451
   Mirza F, 2015, EUR J ENDOCRINOL, V173, PR131, DOI 10.1530/EJE-15-0118
   Mizobe Y, 2018, METHODS MOL BIOL, V1828, P275, DOI 10.1007/978-1-4939-8651-4_17
   Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9
   Mori-Yoshimura Madoka, 2018, J NEUROMUSCUL DIS, V5, P193, DOI 10.3233/JND-170225
   MOSTACCIUOLO ML, 1993, NEUROEPIDEMIOLOGY, V12, P326, DOI 10.1159/000110334
   Nakamura A, 2017, J HUM GENET, V62, P459, DOI 10.1038/jhg.2016.152
   Nakamura A, 2016, J HUM GENET, V61, P663, DOI 10.1038/jhg.2016.28
   Nakamura A, 2008, J CLIN NEUROSCI, V15, P757, DOI 10.1016/j.jocn.2006.12.012
   Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143
   Novak JS, 2021, J NEUROMUSCULAR DIS, V8, PS383, DOI 10.3233/JND-210696
   Olson EN, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2004840117
   Ousterout DG, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms7244
   Pellegrini C, 2013, J CELL PHYSIOL, V228, P1323, DOI 10.1002/jcp.24290
   Percesepe A, 2005, PRENATAL DIAG, V25, P1011, DOI 10.1002/pd.1238
   Pereira RC, 2002, BONE, V30, P685, DOI 10.1016/S8756-3282(02)00687-7
   PRIOR TW, 1993, HUM MOL GENET, V2, P311, DOI 10.1093/hmg/2.3.311
   Rando TA, 2007, BBA-MOL BASIS DIS, V1772, P263, DOI 10.1016/j.bbadis.2006.07.009
   Rees HA, 2018, NAT REV GENET, V19, P770, DOI 10.1038/s41576-018-0059-1
   ROBERTS RG, 1992, P NATL ACAD SCI USA, V89, P2331, DOI 10.1073/pnas.89.6.2331
   Rodino-Klapac LR, 2009, MUSCLE NERVE, V39, P283, DOI 10.1002/mus.21244
   Ryu SM, 2018, NAT BIOTECHNOL, V36, P536, DOI 10.1038/nbt.4148
   SAAD FA, 1993, HUM MUTAT, V2, P314, DOI 10.1002/humu.1380020413
   Saad FA, 1998, AM J MED GENET, V80, P99, DOI 10.1002/(SICI)1096-8628(19981102)80:2<99::AID-AJMG1>3.0.CO;2-L
   Saad FA, 1997, HUM MUTAT, V9, P188, DOI 10.1002/(SICI)1098-1004(1997)9:2<188::AID-HUMU15>3.3.CO;2-J
   SAAD FA, 1994, NEUROMUSCULAR DISORD, V4, P335, DOI 10.1016/0960-8966(94)90069-8
   Saad Fawzy, 1992, HUMAN MOLECULAR GENETICS, V1, P345, DOI 10.1093/hmg/1.5.345
   Saad FA, 2020, ANN NY ACAD SCI, V1462, P37, DOI 10.1111/nyas.14231
   Sakata RC, 2020, NAT BIOTECHNOL, V38, P865, DOI 10.1038/s41587-020-0509-0
   Schiavone M, 2017, PHARMACOL RES, V125, P122, DOI 10.1016/j.phrs.2017.09.001
   Schreiber A, 2018, DEV MED CHILD NEUROL, V60, P185, DOI 10.1111/dmcn.13590
   Scott JM, 2002, NEUROMUSCULAR DISORD, V12, PS23, DOI 10.1016/S0960-8966(02)00078-0
   Shah D, 2008, INDIAN PEDIATR, V45, P401
   Sitnik R, 1997, HUM MUTAT, V10, P217
   Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177
   Taglia Antonella, 2015, ACTA MYOL, V34, P9
   Tanihata J, 2018, BIOCHEM BIOPH RES CO, V505, P51, DOI 10.1016/j.bbrc.2018.09.039
   Tiepolo T, 2009, BRIT J PHARMACOL, V157, P1045, DOI 10.1111/j.1476-5381.2009.00316.x
   Todeschini A, 2016, NEUROMUSCULAR DISORD, V26, P662, DOI 10.1016/j.nmd.2016.08.007
   Tuffery S, 1996, EUR J HUM GENET, V4, P143
   Tuffery-Giraud S, 2009, HUM MUTAT, V30, P934, DOI 10.1002/humu.20976
   van den Bergen JC, 2014, J NEUROL NEUROSUR PS, V85, P92, DOI 10.1136/jnnp-2012-304729
   Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993
   Wang JZ, 2017, BRAIN DEV-JPN, V39, P547, DOI 10.1016/j.braindev.2017.03.024
   Wang Y, 2020, BMC MED GENET, V21, P0, DOI 10.1186/s12881-020-01157-0
   Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799
   WELLS DJ, 1995, HUM MOL GENET, V4, P1245, DOI 10.1093/hmg/4.8.1245
   WILTON SD, 1993, AM J MED GENET, V46, P563, DOI 10.1002/ajmg.1320460521
   Wilton-Clark H, 2022, GENES-BASEL, V13, P0, DOI 10.3390/genes13020257
   Wissing ER, 2010, NEUROMUSCULAR DISORD, V20, P753, DOI 10.1016/j.nmd.2010.06.016
   Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192
   Yang JL, 2009, ACTA BIOCH BIOPH SIN, V41, P1053, DOI 10.1093/abbs/gmp080
   Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469
   Yazaki M, 1999, EUR NEUROL, V42, P145, DOI 10.1159/000008089
   Young Courtney S, 2017, J NEUROMUSCUL DIS, V4, P139, DOI 10.3233/JND-170218
   Yue YP, 2003, CIRCULATION, V108, P1626, DOI 10.1161/01.CIR.0000089371.11664.27
   Zhang Y, 2020, SCI ADV, V6, P0, DOI 10.1126/sciadv.aay6812
   Zhu JF, 2013, INT J MOL MED, V32, P1166, DOI 10.3892/ijmm.2013.1498
   Zimowski JG, 2021, J APPL GENET, V62, P289, DOI 10.1007/s13353-020-00605-0
   Zulian A, 2014, FRONT AGING NEUROSCI, V6, P0, DOI 10.3389/fnagi.2014.00324
   Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081
NR 133
TC 2
Z9 2
U1 11
U2 18
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
SN 1566-5232
EI 1875-5631
J9 CURR GENE THER
JI Curr. Gene Ther.
PD JUN 15
PY 2024
VL 24
IS 1
BP 
EP 
DI 10.2174/1566523223666221118160932
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA HC6H6
UT WOS:001157326100004
PM 36411557
DA 2024-11-01
ER

PT J
AU LÃ©garÃ©, VP
   Harji, ZA
   Rampal, CJ
   Antonicka, H
   Gurberg, TJN
   Persia, O
   Rodriguez, EC
   Shoubridge, EA
   Armstrong, GAB
AF Legare, Virginie Petel
   Harji, Ziyaan A.
   Rampal, Christian J.
   Antonicka, Hana
   Gurberg, Tyler J. N.
   Persia, Olivia
   Rodriguez, Esteban C.
   Shoubridge, E. A.
   Armstrong, Gary A. B.
TI CHCHD10<SUP>P80L</SUP> knock-in zebrafish display a mild ALS-like phenotype
SO EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE Als; Zebrafish; Motor neuron; CHCHD10; Neurodegeneration; Knock-in mutation; Mitochondria
ID amyotrophic-lateral-sclerosis; differential expression analysis; frontotemporal dementia; mutation; disease; model; ftld
AB Mutations in the nuclear-encoded mitochondrial gene CHCHD10 have been observed in patients with a spectrum of diseases that include amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). To investigate the pathogenic nature of disease-associated variants of CHCHD10 we generated a zebrafish knock-in (KI) model expressing the orthologous ALS-associated CHCHD10(P80L) variant (zebrafish: Chchd10(P83L)). Larval chchd10(P83L/ P83L) fish displayed reduced Chchd(10) protein expression levels, motor impairment, reduced survival and abnormal neuromuscular junctions (NMJ). These deficits were not accompanied by changes in transcripts involved in the integrated stress response (ISR), phenocopying previous findings in our knockout (chchd10(- /-) ). Adult, 11-month old chchd10(P83L/P83L) zebrafish, displayed smaller slow- and fast-twitch muscle cell crosssectional areas compared to wild type zebrafish muscle cells. Motoneurons in the spinal cord of chchd10(P83L/ P83L) zebrafish displayed similar cross-sectional areas to that of wild type motor neurons and significantly fewer motor neurons were observed when compared to chchd2(- /-) adult spinal cords. Bulk RNA sequencing using whole spinal cords of 7-month old fish revealed transcriptional changes associated with neuroinflammation, apoptosis, amino acid metabolism and mt-DNA inflammatory response in our chchd10(P83L/P83L) model. The findings presented here, suggest that the CHCHD10(P80L )variant confers an ALS-like phenotype when expressed in zebrafish.
C1 [Legare, Virginie Petel; Harji, Ziyaan A.; Rampal, Christian J.; Gurberg, Tyler J. N.; Persia, Olivia; Rodriguez, Esteban C.; Armstrong, Gary A. B.] McGill Univ, Montreal Neurol Inst, Fac Med, Dept Neurol & Neurosurg, Montreal, PQ, Canada.
   [Antonicka, Hana; Shoubridge, E. A.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 2B4, Canada.
C3 McGill University; McGill University
RP Armstrong, GAB (corresponding author), McGill Univ, Montreal Neurol Inst, Fac Med, Dept Neurol & Neurosurg, Montreal, PQ, Canada.
EM gary.armstrong@mcgill.ca
FU Canadian Institutes of Health Research [420108, 133530]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2018-05603]; Canadian Foundation for Innovation and Rare Diseases: Models & Mechanisms Network grant
CR Ajroud-Driss S, 2015, NEUROGENETICS, V16, P1, DOI 10.1007/s10048-014-0421-1
   Anderson CJ, 2019, ACTA NEUROPATHOL, V138, P103, DOI 10.1007/s00401-019-01989-y
   Armstrong GAB, 2013, HUM MOL GENET, V22, P4282, DOI 10.1093/hmg/ddt278
   Armstrong GAB, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0150188
   Auranen M, 2015, NEUROL-GENET, V1, P0, DOI 10.1212/NXG.0000000000000003
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004
   BÃ©land LC, 2020, BRAIN COMMUN, V2, P0, DOI 10.1093/braincomms/fcaa124
   Benedetti L, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep24515
   BoillÃ©e S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103
   Burstein SR, 2018, HUM MOL GENET, V27, P160, DOI 10.1093/hmg/ddx397
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, PD1251, DOI 10.1093/nar/gkv1003
   Cavallaro G, 2010, MOL BIOSYST, V6, P2459, DOI 10.1039/c0mb00058b
   Consortium PMAS, 2018, CHCHD10 VARIANTS IN AMYOTROPHIC LATERAL SCLEROSIS: WHERE IS THE EVIDENCE?, V84, P110
   Correia AS, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0140248
   Cozzolino M, 2012, PROG NEUROBIOL, V97, P54, DOI 10.1016/j.pneurobio.2011.06.003
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dupuis L, 2004, NEURODEGENER DIS, V1, P245, DOI 10.1159/000085063
   Fryer AL, 2021, FRONT NEUROSCI-SWITZ, V15, P0, DOI 10.3389/fnins.2021.621501
   Fu JJ, 2022, J NEUROINFLAMM, V19, P0, DOI 10.1186/s12974-022-02446-6
   Funayama M, 2015, LANCET NEUROL, V14, P274, DOI 10.1016/S1474-4422(14)70266-2
   Genin EC, 2019, ACTA NEUROPATHOL, V138, P123, DOI 10.1007/s00401-019-01988-z
   Gilbert MJH, 2014, EXP GERONTOL, V50, P106, DOI 10.1016/j.exger.2013.11.013
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Huang XP, 2018, HUM MOL GENET, V27, P3881, DOI 10.1093/hmg/ddy270
   Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110
   Jin M, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-62756-8
   Keith JL, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000394
   Kumar S, 2021, CELL RES, V31, P379, DOI 10.1038/s41422-020-00461-x
   Legare VP, 2023, DEV NEUROBIOL, V83, P54, DOI 10.1002/dneu.22909
   Legare VP, 2022, COMP BIOCHEM PHYS B, V261, P0, DOI 10.1016/j.cbpb.2022.110756
   Lehmer C, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708558
   Lin MM, 2022, ACTA PHARMACOL SIN, V43, P2439, DOI 10.1038/s41401-022-00879-6
   Liscic RM, 2008, EUR J NEUROL, V15, P772, DOI 10.1111/j.1468-1331.2008.02195.x
   Liu J, 2017, FRONT IMMUNOL, V8, P0, DOI 10.3389/fimmu.2017.01005
   Liu XD, 2021, ACTA NEUROPATHOL COM, V9, P0, DOI 10.1186/s40478-021-01133-6
   Liu YT, 2020, HUM MOL GENET, V29, P1547, DOI 10.1093/hmg/ddaa077
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lomen-Hoerth C, 2003, NEUROLOGY, V60, P1094, DOI 10.1212/01.WNL.0000055861.95202.8D
   Lomen-Hoerth C, 2002, NEUROLOGY, V59, P1077, DOI 10.1212/WNL.59.7.1077
   Mackenzie IRA, 2005, J NEUROPATH EXP NEUR, V64, P730, DOI 10.1097/01.jnen.0000174335.27708.0a
   Matsui H, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-23452-x
   McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042
   McCauley ME, 2019, ACTA NEUROPATHOL, V137, P715, DOI 10.1007/s00401-018-1933-9
   Mendelsohn BA, 2008, DEV DYNAM, V237, P1780, DOI 10.1002/dvdy.21581
   Modjtahedi N, 2016, TRENDS BIOCHEM SCI, V41, P245, DOI 10.1016/j.tibs.2015.12.004
   Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI 10.1038/NMETH.3543
   Motwani M, 2019, NAT REV GENET, V20, P657, DOI 10.1038/s41576-019-0151-1
   Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971
   PenttilÃ¤ S, 2015, ANN NEUROL, V77, P163, DOI 10.1002/ana.24319
   Perrone F, 2017, NEUROBIOL AGING, V51, P0, DOI 10.1016/j.neurobiolaging.2016.12.008
   Purandare N, 2018, J BIOL CHEM, V293, P6517, DOI 10.1074/jbc.RA117.001073
   Rentzos M, 2010, ACTA NEUROL SCAND, V122, P425, DOI 10.1111/j.1600-0404.2010.01333.x
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Roman W, 2018, SEMIN CELL DEV BIOL, V82, P51, DOI 10.1016/j.semcdb.2017.11.005
   Ronchi D, 2015, BRAIN, V138, PE372, DOI 10.1093/brain/awu384
   Sayles NM, 2022, CELL REP, V38, P0, DOI 10.1016/j.celrep.2022.110475
   Shammas MK, 2023, BIOCHEM SOC T, V51, P797, DOI 10.1042/BST20221365
   Shammas MK, 2022, J CLIN INVEST, V132, P0, DOI 10.1172/JCI157504
   Shpilka T, 2018, NAT REV MOL CELL BIO, V19, P109, DOI 10.1038/nrm.2017.110
   Smith EF, 2019, NEUROSCI LETT, V710, P0, DOI 10.1016/j.neulet.2017.06.052
   Straub IR, 2021, HUM MOL GENET, V30, P687, DOI 10.1093/hmg/ddab078
   Straub IR, 2018, HUM MOL GENET, V27, P178, DOI 10.1093/hmg/ddx393
   Strecker R, 2011, COMP BIOCHEM PHYS C, V153, P318, DOI 10.1016/j.cbpc.2010.12.002
   Vejnar Charles E, 2016, COLD SPRING HARB PROTOC, V2016, P0, DOI 10.1101/pdb.prot086850
   Westerfield M, 1995, THE ZEBRAFISH BOOK: A GUIDE FOR THE LABORATORY USE OF ZEBRAFISH (BRACHYDANIO RERIO), V0, P0
   Woulfe J, 2001, ACTA NEUROPATHOL, V102, P94
   Xia W, 2022, CELL REGEN, V11, P0, DOI 10.1186/s13619-022-00111-0
   Xiao TT, 2017, MOL NEUROBIOL, V54, P5243, DOI 10.1007/s12035-016-0056-3
   Xiao YT, 2020, HUM MOL GENET, V29, P1784, DOI 10.1093/hmg/ddz154
   Yu CH, 2020, CELL, V183, P636, DOI 10.1016/j.cell.2020.09.020
   Zhang M, 2015, BRAIN, V138, P0, DOI 10.1093/brain/awv082
NR 75
TC 0
Z9 0
U1 1
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4886
EI 1090-2430
J9 EXP NEUROL
JI Exp. Neurol.
PD DEC 15
PY 2024
VL 382
IS 
BP 
EP 
DI 10.1016/j.expneurol.2024.114945
EA SEP 2024
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA G7A4P
UT WOS:001318120200001
PM 39260590
DA 2024-11-01
ER

PT J
AU Pasqualotto, BA
   Nelson, A
   Deheshi, S
   Sheldon, CA
   Vogl, AW
   Rintoul, GL
AF Pasqualotto, Bryce A.
   Nelson, Alexa
   Deheshi, Samineh
   Sheldon, Claire A.
   Vogl, A. Wayne
   Rintoul, Gordon L.
TI Impaired mitochondrial morphological plasticity and failure of mitophagy associated with the G11778A mutation of LHON
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE LHON; Mitochondrial morphology; Mitophagy; G11778A; Galactose
ID hereditary optic neuropathy; linked mechanical-activity; single living cells; dna copy number; complex-i; skeletal-muscle; oxidative-phosphorylation; ultrastructural bases; dynamics; bioenergetics
AB Mitochondrial dynamics were examined in human dermal fibroblasts biopsied from a confirmed Leber's Hereditary Optic Neuropathy (LHON) patient with a homoplasmic G11778A mutation of the mitochondrial genome. Expression of the G11778A mutation did not impart any discernible difference in mitochondrial network morphology using widefield fluorescence microscopy. However, at the ultrastructural level, cells expressing this mutation exhibited an impairment of mitochondrial morphological plasticity when forced to utilize oxidative phosphorylation (OXPHOS) by transition to glucose -free, galactose -containing media. LHON fibroblasts also displayed a transient increase in mitophagy upon transition to galactose media. These results provide new insights into the consequences of the G11778A mutation of LHON and the pathological mechanisms underlying this disease.
C1 [Pasqualotto, Bryce A.; Nelson, Alexa; Deheshi, Samineh; Rintoul, Gordon L.] Simon Fraser Univ, Ctr Cell Biol Dev & Dis, Burnaby, BC, Canada.
   [Pasqualotto, Bryce A.; Nelson, Alexa; Deheshi, Samineh; Rintoul, Gordon L.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada.
   [Sheldon, Claire A.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC, Canada.
   [Vogl, A. Wayne] Univ British Columbia, Life Sci Inst, Vancouver, BC, Canada.
   [Vogl, A. Wayne] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC, Canada.
C3 Simon Fraser University; Simon Fraser University; University of British Columbia; University of British Columbia; University of British Columbia
RP Rintoul, GL (corresponding author), Simon Fraser Univ, Ctr Cell Biol Dev & Dis, Burnaby, BC, Canada.; Rintoul, GL (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada.
EM gordon_rintoul@sfu.ca
FU Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2017- 06498, RGPIN-2018-03727]; Simon Fraser University Graduate Fellowships; Canadian Foundation for Innovation; British Columbia Knowledge Development Fund (GLR); President's Research Grant Fund (GLR) from Simon Fraser University
CR Agier V, 2012, BBA-MOL BASIS DIS, V1822, P1570, DOI 10.1016/j.bbadis.2012.07.002
   Arena ET, 2011, INFECT IMMUN, V79, P4392, DOI 10.1128/IAI.05478-11
   Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829
   Baba K, 2020, HISTOCHEM CELL BIOL, V153, P199, DOI 10.1007/s00418-019-01842-z
   Bahr T, 2020, BBA-MOL BASIS DIS, V1866, P0, DOI 10.1016/j.bbadis.2020.165743
   Bakare AB, 2021, FRONT PHYSIOL, V12, P0, DOI 10.3389/fphys.2021.693734
   Barboni P, 2005, OPHTHALMOLOGY, V112, P120, DOI 10.1016/j.ophtha.2004.06.034
   Bayguinov Peter O, 2018, CURR PROTOC CYTOM, V85, Pe39, DOI 10.1002/cpcy.39
   Beretta S, 2004, BRAIN, V127, P2183, DOI 10.1093/brain/awh258
   Bianco Angelica, 2018, BMC RES NOTES, V11, P911, DOI 10.1186/s13104-018-4025-y
   Bianco A, 2017, INVEST OPHTH VIS SCI, V58, P2193, DOI 10.1167/iovs.16-20389
   Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015
   Brown MD, 1999, J NEUROL SCI, V165, P1, DOI 10.1016/S0022-510X(99)00087-8
   Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200
   Carta A, 2005, BRIT J OPHTHALMOL, V89, P825, DOI 10.1136/bjo.2004.060590
   Cheng XT, 2018, J CELL BIOL, V217, P3127, DOI 10.1083/jcb.201711083
   Cock HR, 1999, J NEUROL SCI, V165, P10, DOI 10.1016/S0022-510X(99)00088-X
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Cretin E, 2021, EMBO MOL MED, V13, P0, DOI 10.15252/emmm.202013579
   Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200
   Dai Y, 2014, HUM MOL GENET, V23, P637, DOI 10.1093/hmg/ddt450
   Danese A, 2022, CELL REP, V40, P0, DOI 10.1016/j.celrep.2022.111124
   Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080
   Dolman NJ, 2013, AUTOPHAGY, V9, P1653, DOI 10.4161/auto.24001
   Dombi E, 2016, NEUROLOGY, V86, P1921, DOI 10.1212/WNL.0000000000002688
   Dott W, 2014, REDOX BIOL, V2, P224, DOI 10.1016/j.redox.2013.12.028
   Eisner V, 2018, NAT CELL BIOL, V20, P755, DOI 10.1038/s41556-018-0133-0
   Emperador S, 2018, FRONT NEUROSCI-SWITZ, V12, P0, DOI 10.3389/fnins.2018.00061
   Evans CS, 2020, J MOL BIOL, V432, P240, DOI 10.1016/j.jmb.2019.06.031
   Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007
   FalcÃ³n-PÃ©rez JM, 2005, J CELL SCI, V118, P5243, DOI 10.1242/jcs.02633
   Fan XY, 2010, FREE RADICAL BIO MED, V49, P1646, DOI 10.1016/j.freeradbiomed.2010.08.024
   Fenton AR, 2021, CURR OPIN CELL BIOL, V68, P28, DOI 10.1016/j.ceb.2020.08.014
   Fiedorczuk K, 2018, TRENDS CELL BIOL, V28, P835, DOI 10.1016/j.tcb.2018.06.006
   Fiszer-Kierzkowska A, 2011, BMC MOL BIOL, V12, P0, DOI 10.1186/1471-2199-12-27
   Floreani M, 2005, FEBS J, V272, P1124, DOI 10.1111/j.1742-4658.2004.04542.x
   Ghelli A, 2008, INVEST OPHTH VIS SCI, V49, P671, DOI 10.1167/iovs.07-0880
   Giacomello M, 2020, NAT REV MOL CELL BIO, V21, P204, DOI 10.1038/s41580-020-0210-7
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   Giordano C, 2011, BRAIN, V134, P220, DOI 10.1093/brain/awq276
   Gu YL, 2022, COMMUN BIOL, V5, P0, DOI 10.1038/s42003-022-03632-1
   Guillery O, 2008, NEUROMUSCULAR DISORD, V18, P319, DOI 10.1016/j.nmd.2007.12.008
   HACKENBROCK CR, 1968, J CELL BIOL, V37, P345, DOI 10.1083/jcb.37.2.345
   HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269
   HACKENBROCK CR, 1971, J CELL BIOL, V51, P123, DOI 10.1083/jcb.51.1.123
   Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95
   Hofhaus G, 1996, J BIOL CHEM, V271, P13155, DOI 10.1074/jbc.271.22.13155
   Howell N, 2003, AM J HUM GENET, V72, P1460, DOI 10.1086/375537
   Hudson Gavin, 2008, EXPERT OPIN MED DIAGN, V2, P789, DOI 10.1517/17530059.2.7.789
   Iannetti EF, 2016, NAT PROTOC, V11, P1693, DOI 10.1038/nprot.2016.094
   Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106
   Iqbal S, 2014, AM J PHYSIOL-CELL PH, V306, PC1176, DOI 10.1152/ajpcell.00017.2014
   Iworima DG, 2016, MOL CELL NEUROSCI, V72, P22, DOI 10.1016/j.mcn.2015.12.014
   Jankauskaite E, 2020, J APPL GENET, V61, P195, DOI 10.1007/s13353-020-00550-y
   Jankauskaite E, 2017, MITOCHONDRION, V32, P19, DOI 10.1016/j.mito.2016.11.006
   Kageyama Y, 2014, EMBO J, V33, P2798, DOI 10.15252/embj.201488658
   KERRISON JB, 1995, OPHTHALMOLOGY, V102, P1509
   Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451
   Kirches E, 2011, CURR GENOMICS, V12, P44, DOI 10.2174/138920211794520150
   Kirkman MA, 2009, INVEST OPHTH VIS SCI, V50, P3112, DOI 10.1167/iovs.08-3166
   Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417
   Kodron A, 2019, ACTA BIOCHIM POL, V66, P427, DOI 10.18388/abp.2019_2837
   Koopman WJH, 2007, AM J PHYSIOL-CELL PH, V293, PC22, DOI 10.1152/ajpcell.00194.2006
   Koopman WJH, 2008, METHODS, V46, P304, DOI 10.1016/j.ymeth.2008.09.018
   Koopman WJH, 2006, CYTOM PART A, V69A, P1, DOI 10.1002/cyto.a.20198
   Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V289, PC881, DOI 10.1152/ajpcell.00104.2005
   Korsten A, 2010, BBA-BIOENERGETICS, V1797, P197, DOI 10.1016/j.bbabio.2009.10.003
   Kremers GJ, 2009, NAT METHODS, V6, P355, DOI 10.1038/nmeth.1319
   Kuznetsov AV, 2009, INT J BIOCHEM CELL B, V41, P1928, DOI 10.1016/j.biocel.2009.03.007
   Leduc-Gaudet JP, 2015, ONCOTARGET, V6, P17923, DOI 10.18632/oncotarget.4235
   Lemasters JJ, 2014, REDOX BIOL, V2, P749, DOI 10.1016/j.redox.2014.06.004
   Li ZZ, 2019, J CELL PHYSIOL, V234, P21166, DOI 10.1002/jcp.28719
   Liang M, 2022, HUM MOL GENET, V31, P3299, DOI 10.1093/hmg/ddac109
   Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x
   Mannella CA, 2006, BBA-MOL CELL RES, V1763, P542, DOI 10.1016/j.bbamcr.2006.04.006
   Mannella CA, 2008, ANN NY ACAD SCI, V1147, P171, DOI 10.1196/annals.1427.020
   Maresca A, 2013, MOL CELL NEUROSCI, V55, P62, DOI 10.1016/j.mcn.2012.08.004
   Misgeld T, 2017, NEURON, V96, P651, DOI 10.1016/j.neuron.2017.09.055
   Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877
   Montava-Garriga L, 2020, J MOL BIOL, V432, P206, DOI 10.1016/j.jmb.2019.06.032
   MorÃ¡n M, 2010, BBA-MOL BASIS DIS, V1802, P443, DOI 10.1016/j.bbadis.2010.02.001
   Napoli E, 2017, BIOCHEM J, V474, P3887, DOI 10.1042/BCJ20170632
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Newman NJ, 2020, J NEURO-OPHTHALMOL, V40, P547, DOI 10.1097/WNO.0000000000001045
   ORourke AR, 2018, FEBS J, V285, P481, DOI 10.1111/febs.14367
   Olichow A, 2007, J CELL PHYSIOL, V211, P423, DOI 10.1002/jcp.20950
   Onishi M, 2021, EMBO J, V40, P0, DOI 10.15252/embj.2020104705
   Pasqualotto BA, 2024, EXP CELL RES, V439, P0, DOI 10.1016/j.yexcr.2024.114075
   Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011
   Picard M, 2013, AM J PHYSIOL-REG I, V304, PR393, DOI 10.1152/ajpregu.00584.2012
   Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012
   Pickles S, 2018, CURR BIOL, V28, PR170, DOI 10.1016/j.cub.2018.01.004
   Pinho SA, 2022, FEBS J, V289, P5198, DOI 10.1111/febs.16413
   Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003
   Rafelski SM, 2013, BMC BIOL, V11, P0, DOI 10.1186/1741-7007-11-71
   REITZER LJ, 1979, J BIOL CHEM, V254, P2669
   Ren MD, 2022, FRONT CELL DEV BIOL, V10, P0, DOI 10.3389/fcell.2022.867175
   Sadun A A, 2000, TRANS AM OPHTHALMOL SOC, V98, P223
   Sanchez MIGL, 2020, MITOCHONDRION, V54, P113, DOI 10.1016/j.mito.2020.07.003
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI 10.1038/nmeth.2019
   Schoeler S, 2007, NEUROBIOL DIS, V25, P536, DOI 10.1016/j.nbd.2006.10.014
   Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578
   Sharma LK, 2019, HUM MOL GENET, V28, P422, DOI 10.1093/hmg/ddy354
   Smirnov VM, 2020, J NEURO-OPHTHALMOL, V40, P569, DOI 10.1097/WNO.0000000000001083
   STONE EM, 1990, ARCH OPHTHALMOL-CHIC, V108, P1417, DOI 10.1001/archopht.1990.01070120065030
   Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104
   Swedlow JR, 2013, METHOD CELL BIOL, V114, P407, DOI 10.1016/B978-0-12-407761-4.00017-8
   Takashima A, 2001, CURR PROTOC CELL BIOL, VChapter 2, P0, DOI 10.1002/0471143030.cb0201s00
   Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779
   Valente AJ, 2019, ADV EXP MED BIOL, V1158, P183, DOI 10.1007/978-981-13-8367-0_10
   Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001
   Van Laar VS, 2013, NEUROBIOL DIS, V51, P43, DOI 10.1016/j.nbd.2012.05.015
   Vernay A, 2017, P NATL ACAD SCI USA, V114, P8277, DOI 10.1073/pnas.1706643114
   Villa E, 2018, TRENDS CELL BIOL, V28, P882, DOI 10.1016/j.tcb.2018.07.004
   Villa E, 2017, CELL REP, V20, P2846, DOI 10.1016/j.celrep.2017.08.087
   Voets AM, 2012, BBA-BIOENERGETICS, V1817, P1971, DOI 10.1016/j.bbabio.2012.07.001
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2017, HANDB EXP PHARMACOL, V240, P339, DOI 10.1007/164_2017_2
   Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431
   Wu YR, 2018, EXP CELL RES, V363, P299, DOI 10.1016/j.yexcr.2018.01.020
   Yoshii SR, 2015, BBA-MOL CELL RES, V1853, P2797, DOI 10.1016/j.bbamcr.2015.01.013
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   Yu-Wai-Man P, 2017, MITOCHONDRION, V36, P36, DOI 10.1016/j.mito.2017.01.004
   Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   Zeviani M, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23010210
   Zhang JJ, 2021, INVEST OPHTH VIS SCI, V62, P0, DOI 10.1167/iovs.62.9.38
   Zhang JJ, 2018, HUM MOL GENET, V27, P1999, DOI 10.1093/hmg/ddy107
   Zinchuk Vadim, 2014, CURR PROTOC CELL BIOL, V62, P0, DOI 10.1002/0471143030.cb0419s62
NR 132
TC 0
Z9 0
U1 1
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD AUG 20
PY 2024
VL 721
IS 
BP 
EP 
DI 10.1016/j.bbrc.2024.150119
EA MAY 2024
PG 16
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA TS0F5
UT WOS:001243123800001
PM 38768545
DA 2024-11-01
ER

PT J
AU Vincent, AE
   Chen, C
   Gomes, TB
   Di Leo, V
   Laalo, T
   Pabis, K
   Capaldi, R
   Marusich, MF
   McDonald, D
   Filby, A
   Fuller, A
   Urban, DL
   Zierz, S
   Deschauer, M
   Turnbull, D
   Reeve, AK
   Lawless, C
AF Vincent, Amy E.
   Chen, Chun
   Gomes, Tiago Bernardino
   Di Leo, Valeria
   Laalo, Tuomas
   Pabis, Kamil
   Capaldi, Rodrick
   Marusich, Michael F.
   McDonald, David
   Filby, Andrew
   Fuller, Andrew
   Urban, Diana Lehmann
   Zierz, Stephan
   Deschauer, Marcus
   Turnbull, Doug
   Reeve, Amy K.
   Lawless, Conor
TI A stagewise response to mitochondrial dysfunction in mitochondrial DNA maintenance disorders
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE Myopathy; Cell signalling; OXPHOS; Mitochondrial DNA deletion; Mitochondrial disease
ID progressive external ophthalmoplegia; mutations; replication; deletions; twinkle; fibers; genome
AB Mitochondrial DNA (mtDNA) deletions which clonally expand in skeletal muscle of patients with mtDNA maintenance disorders, impair mitochondrial oxidative phosphorylation dysfunction. Previously we have shown that these mtDNA deletions arise and accumulate in perinuclear mitochondria causing localised mitochondrial dysfunction before spreading through the muscle fibre. We believe that mito-nuclear signalling is a key contributor in the accumulation and spread of mtDNA deletions, and that knowledge of how muscle fibres respond to mitochondrial dysfunction is key to our understanding of disease mechanisms. To understand the contribution of mito-nuclear signalling to the spread of mitochondrial dysfunction, we use imaging mass cytometry. We characterise the levels of mitochondrial Oxidative Phosphorylation proteins alongside a mitochondrial mass marker, in a cohort of patients with mtDNA maintenance disorders. Our expanded panel included protein markers of key signalling pathways, allowing us to investigate cellular responses to different combinations of oxidative phosphorylation dysfunction and ragged red fibres. We find combined Complex I and IV deficiency to be most common. Interestingly, in fibres deficient for one or more complexes, the remaining complexes are often upregulated beyond the increase of mitochondrial mass typically observed in ragged red fibres. We further find that oxidative phosphorylation deficient fibres exhibit an increase in the abundance of proteins involved in proteostasis, e.g. HSP60 and LONP1, and regulation of mitochondrial metabolism (including oxidative phosphorylation and proteolysis, e.g. PHB1). Our analysis suggests that the cellular response to mitochondrial dysfunction changes depending on the combination of deficient oxidative phosphorylation complexes in each fibre.
C1 [Vincent, Amy E.; Gomes, Tiago Bernardino; Di Leo, Valeria; Pabis, Kamil; Turnbull, Doug; Reeve, Amy K.; Lawless, Conor] Newcastle Univ, Clin & Translat Res Inst, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, England.
   [Vincent, Amy E.; Gomes, Tiago Bernardino; Lawless, Conor] Newcastle Univ, Fac Med Sci, NIHR Biomed Res Ctr, Newcastle Upon Tyne, England.
   [Vincent, Amy E.] Newcastle Univ, Clin & Translat Res Inst, Fac Med Sci, John Walton Muscular Dystrophy Res Ctr, Newcastle Upon Tyne, England.
   [Chen, Chun] Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Biosci Inst, Newcastle Upon Tyne, England.
   [Laalo, Tuomas] Univ Helsinki, Fac Med, Stem Cells & Metab Res Program, Helsinki, Finland.
   [Capaldi, Rodrick] Cellstate Biosci, Tucson, AZ USA.
   [Marusich, Michael F.] mAbDx Inc, Eugene, OR USA.
   [McDonald, David; Filby, Andrew; Fuller, Andrew] Newcastle Univ, Biosci Inst, Innovat Methodol & Applicat Res Theme, Newcastle Upon Tyne, England.
   [McDonald, David; Filby, Andrew; Fuller, Andrew] Newcastle Univ, Fac Med Sci, Flow Cytometry Core Facil, Newcastle Upon Tyne, England.
   [Urban, Diana Lehmann] Ulm Univ, Dept Neurol, Ulm, Germany.
   [Zierz, Stephan] Martin Luther Univ Halle Wittenberg, Dept Neurol, Halle, Saale, Germany.
   [Deschauer, Marcus] Tech Univ Munich, Dept Neurol, Munich, Germany.
   [Vincent, Amy E.] Newcastle Univ, Med Sch, 4th Floor Cookson Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Helsinki; Newcastle University - UK; Newcastle University - UK; Ulm University; Martin Luther University Halle Wittenberg; Technical University of Munich; Newcastle University - UK
RP Vincent, AE (corresponding author), Newcastle Univ, Med Sch, 4th Floor Cookson Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, England.
EM amy.vincent@newcastle.ac.uk
FU Henry Wellcome Postdoctoral Fellowship [215888/Z/19/Z]; NIHR Newcastle Biomedical Research Centre; MJFF grant [15707]; PDUK grant [G-2003]
CR Bankhead P, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-17204-5
   Bourges I, 2004, BIOCHEM J, V383, P491, DOI 10.1042/BJ20040256
   Cardamone MD, 2018, MOL CELL, V69, P757, DOI 10.1016/j.molcel.2018.01.037
   Chen C, 2023, NPJ PARKINSONS DIS, V9, P0, DOI 10.1038/s41531-023-00564-3
   Chen C, 2021, NPJ PARKINSONS DIS, V7, P0, DOI 10.1038/s41531-021-00182-x
   DeBerardinis RJ, 2016, SCI ADV, V2, P0, DOI 10.1126/sciadv.1600200
   EGGER J, 1981, ARCH DIS CHILD, V56, P741, DOI 10.1136/adc.56.10.741
   Giesen C, 2014, NAT METHODS, V11, P417, DOI 10.1038/NMETH.2869
   Gitschlag BL, 2016, CELL METAB, V24, P91, DOI 10.1016/j.cmet.2016.06.008
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146
   Lehmann D, 2019, NUCLEIC ACIDS RES, V47, P7430, DOI 10.1093/nar/gkz472
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Mito T, 2022, CELL METAB, V34, P197, DOI 10.1016/j.cmet.2021.12.017
   Murgia M, 2019, CELL REP, V29, P3825, DOI 10.1016/j.celrep.2019.11.055
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444
   Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019
   R Core Team, 2021, R LANG ENV STAT COMP, V0, P0
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   Rocha MC, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep15037
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Scrucca L, 2016, R J, V8, P289
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vincent AE, 2018, ANN NEUROL, V84, P289, DOI 10.1002/ana.25288
   Warren C, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-70885-3
   Yaku K, 2018, FRONT ONCOL, V8, P0, DOI 10.3389/fonc.2018.00622
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
NR 35
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD JUN 15
PY 2024
VL 1870
IS 5
BP 
EP 
DI 10.1016/j.bbadis.2024.167131
EA APR 2024
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA RG3Q8
UT WOS:001226479000001
PM 38521420
DA 2024-11-01
ER

PT J
AU Zhao, Y
   Zhao, XT
   Ji, KQ
   Wang, JL
   Zhao, YY
   Lin, J
   Gang, Q
   Yu, M
   Yuan, Y
   Jiang, HS
   Sun, C
   Fang, F
   Yan, CZ
   Wang, ZX
AF Zhao, Yang
   Zhao, Xutong
   Ji, Kunqian
   Wang, Junling
   Zhao, Yuying
   Lin, Jie
   Gang, Qiang
   Yu, Meng
   Yuan, Yun
   Jiang, Haishan
   Sun, Chong
   Fang, Fang
   Yan, Chuanzhu
   Wang, Zhaoxia
TI The clinical and genetic spectrum of mitochondrial diseases in China: A multicenter retrospective cross-sectional study
SO CLINICAL GENETICS
LA English
DT Article; Early Access
DE genotype; heterogeneity; mitochondrial diseases; phenotype
ID hereditary optic neuropathy; dna; mutations; cohort; prevalence; children; single; melas; leigh; progression
AB Mitochondrial diseases (MtDs) present diverse clinical phenotypes, yet large-scale studies are hindered by their rarity. This retrospective, multicenter study, conducted across five Chinese hospitals' neurology departments from 2009 to 2019, aimed to address this gap. Nationwide, 1351 patients were enrolled, with a median onset age of 14.0 (18.5) years. The predominant phenotype was mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) (45.0%). Mitochondrial DNA (mtDNA) mutations were prevalent (87.4%), with m.3243A>G being the most common locus (48.7%). Meanwhile, POLG mutations in nuclear DNA (nDNA) accounted for 16.5%. Comparative analysis based on age groups (with a cut-off at 14 years) revealed the highest prevalence of MELAS, with Leigh syndrome (LS) and chronic progressive external ophthalmoplegia (CPEO) being the second most common phenotypes in junior and senior groups, respectively. Notably, the most commonly mutated nuclear genes varied across age groups. In conclusion, MELAS predominated in this Chinese MtD cohort, underscored by m.3243A>G and POLG as principal mtDNA mutations and pathogenic nuclear genes. The phenotypic and genotypic disparities observed among different age cohorts highlight the complex nature of MtDs.
C1 [Zhao, Yang; Zhao, Xutong; Gang, Qiang; Yu, Meng; Yuan, Yun; Wang, Zhaoxia] Peking Univ First Hosp, Dept Neurol, Beijing, Peoples R China.
   [Ji, Kunqian; Zhao, Yuying; Yan, Chuanzhu] Shandong Univ, Dept Neurol, Qilu Hosp, 107 West Wenhua Rd, Jinan 250012, Peoples R China.
   [Wang, Junling; Fang, Fang] Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Dept Neurol, 56 Nanlishi Rd, Beijing 100045, Peoples R China.
   [Wang, Junling] Zhengzhou Univ, Dept Pediat, Affiliated Hosp 3, Zhengzhou, Peoples R China.
   [Lin, Jie; Sun, Chong] Fudan Univ, Dept Neurol, Huashan Hosp, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China.
   [Jiang, Haishan] Southern Med Univ, Nanfang Hosp, Dept Neurol, 1838 North Guangzhou Ave, Guangzhou 510515, Peoples R China.
   [Wang, Zhaoxia] Peking Univ First Hosp, Dept Neurol, Beijing Key Lab Neurovasc Dis Discovery, 8 Xishiku St, Beijing 100034, Peoples R China.
C3 Peking University; Shandong University; Capital Medical University; Zhengzhou University; Fudan University; Southern Medical University - China
RP Yan, CZ (corresponding author), Shandong Univ, Dept Neurol, Qilu Hosp, 107 West Wenhua Rd, Jinan 250012, Peoples R China.; Fang, F (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Dept Neurol, 56 Nanlishi Rd, Beijing 100045, Peoples R China.; Sun, C (corresponding author), Fudan Univ, Dept Neurol, Huashan Hosp, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China.; Jiang, HS (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Neurol, 1838 North Guangzhou Ave, Guangzhou 510515, Peoples R China.; Wang, ZX (corresponding author), Peking Univ First Hosp, Dept Neurol, Beijing Key Lab Neurovasc Dis Discovery, 8 Xishiku St, Beijing 100034, Peoples R China.
EM jianghs@smu.edu.cn; 08301010238@fudan.edu.cn; fangfang@bch.com.cn; chuanzhuyan@163.com; drwangzx@163.com
FU National High Level Hospital Clinical Research Funding (High Quality Clinical Research Project of Peking University First Hospital) [2023HQ03]; R&D Program of Beijing Municipal Education Commission [BS20210103]; National Natural Science Foundation of China [LHGJ20220525]; R&D Program of Beijing Municipal Education Commission [KZ202210025033]
CR Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   AnteneovÃ¡ N, 2020, BRAIN SCI, V10, P0, DOI 10.3390/brainsci10110766
   Arpa J, 2003, MUSCLE NERVE, V28, P690, DOI 10.1002/mus.10507
   Barca E, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000402
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Fang F, 2017, SCI CHINA LIFE SCI, V60, P746, DOI 10.1007/s11427-017-9080-y
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Hou Y, 2022, MOL GENET GENOM MED, V10, P0, DOI 10.1002/mgg3.1921
   Hu CP, 2020, EUR J MED GENET, V63, P0, DOI 10.1016/j.ejmg.2020.103898
   Hunter MF, 2011, PEDIATR NEUROL, V45, P311, DOI 10.1016/j.pediatrneurol.2011.07.008
   Ji YC, 2019, HUM MOL GENET, V28, P1515, DOI 10.1093/hmg/ddy450
   Jiang PP, 2015, INVEST OPHTH VIS SCI, V56, P4778, DOI 10.1167/iovs.14-16158
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Lin Y, 2024, J NEUROL, V271, P864, DOI 10.1007/s00415-023-12005-5
   Lu YY, 2017, J NEUROL SCI, V379, P137, DOI 10.1016/j.jns.2017.05.056
   Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015
   MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0
   Ng YS, 2022, BRAIN, V145, P542, DOI 10.1093/brain/awab353
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Ogasawara Y, 2005, BLOOD, V106, P3271, DOI 10.1182/blood-2005-01-0150
   Ogawa E, 2020, J INHERIT METAB DIS, V43, P819, DOI 10.1002/jimd.12218
   Orsucci D, 2021, J CLIN MED, V10, P0, DOI 10.3390/jcm10061249
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409
   Shi YQ, 2022, MITOCHONDRION, V62, P139, DOI 10.1016/j.mito.2021.11.006
   Stendel C, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000393
   Stenton SL, 2022, ANN NEUROL, V91, P466, DOI 10.1002/ana.26313
   Stenton SL, 2020, EBIOMEDICINE, V56, P0, DOI 10.1016/j.ebiom.2020.102784
   Tetsuka S, 2021, METAB BRAIN DIS, V36, P2181, DOI 10.1007/s11011-021-00772-x
   Wang W, 2023, ANN CLIN TRANSL NEUR, V10, P1035, DOI 10.1002/acn3.51787
   Yang MG, 2021, FRONT ENDOCRINOL, V12, P0, DOI 10.3389/fendo.2021.728043
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yen MY, 2006, PROG RETIN EYE RES, V25, P381, DOI 10.1016/j.preteyeres.2006.05.002
   Yu M, 2016, CHINESE MED J-PEKING, V129, P1419, DOI 10.4103/0366-6999.183417
   Yu XL, 2018, CHINESE MED J-PEKING, V131, P2705, DOI 10.4103/0366-6999.245265
   Zhang JJ, 2018, MITOCHONDRION, V42, P84, DOI 10.1016/j.mito.2017.12.003
   Zhang Z, 2018, J NEUROL SCI, V385, P151, DOI 10.1016/j.jns.2017.12.033
   Zhao Y, 2024, MOL GENET GENOM MED, V12, P0, DOI 10.1002/mgg3.2328
NR 47
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9163
EI 1399-0004
J9 CLIN GENET
JI Clin. Genet.
PD AUG 9
PY 2024
VL 0
IS 
BP 
EP 
DI 10.1111/cge.14605
EA AUG 2024
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA C1Y0B
UT WOS:001287371200001
PM 39118480
DA 2024-11-01
ER

PT J
AU Omidsalar, AA
   Mccullough, CG
   Xu, LL
   Boedijono, S
   Gerke, D
   Webb, MG
   Manojlovic, Z
   Sequeira, A
   Lew, MF
   Santorelli, M
   Serrano, GE
   Beach, TG
   Limon, A
   Vawter, MP
   Hjelm, BE
AF Omidsalar, Audrey A.
   Mccullough, Carmel G.
   Xu, Lili
   Boedijono, Stanley
   Gerke, Daniel
   Webb, Michelle G.
   Manojlovic, Zarko
   Sequeira, Adolfo
   Lew, Mark F.
   Santorelli, Marco
   Serrano, Geidy E.
   Beach, Thomas G.
   Limon, Agenor
   Vawter, Marquis P.
   Hjelm, Brooke E.
TI Common mitochondrial deletions in RNA-Seq: evaluation of bulk, single-cell, and spatial transcriptomic datasets
SO COMMUNICATIONS BIOLOGY
LA English
DT Article
ID progressive external ophthalmoplegia; dna deletions; mammalian mitochondria; degenerative diseases; human brain; sequence; mutation; genome; polyadenylation; recombination
AB Common mitochondrial DNA (mtDNA) deletions are large structural variants in the mitochondrial genome that accumulate in metabolically active tissues with age and have been investigated in various diseases. We applied the Splice-Break2 pipeline (designed for high-throughput quantification of mtDNA deletions) to human RNA-Seq datasets and describe the methodological considerations for evaluating common deletions in bulk, single-cell, and spatial transcriptomics datasets. A robust evaluation of 1570 samples from 14 RNA-Seq studies showed: (i) the abundance of some common deletions detected in PCR-amplified mtDNA correlates with levels observed in RNA-Seq data; (ii) RNA-Seq library preparation method has a strong effect on deletion detection; (iii) deletions had a significant, positive correlation with age in brain and muscle; (iv) deletions were enriched in cortical grey matter, specifically in layers 3 and 5; and (v) brain regions with dopaminergic neurons (i.e., substantia nigra, ventral tegmental area, and caudate nucleus) had remarkable enrichment of common mtDNA deletions. A methods application study demonstrates that the Splice-Break2 pipeline can detect large mitochondrial DNA deletions in RNA-Seq data. Analyses includes GTEx and GEO datasets and demonstrate differences across tissues, brain regions, and age.
C1 [Omidsalar, Audrey A.; Mccullough, Carmel G.; Xu, Lili; Boedijono, Stanley; Gerke, Daniel; Webb, Michelle G.; Manojlovic, Zarko; Hjelm, Brooke E.] Keck Sch Med USC, Dept Translat Genom, Los Angeles, CA 90033 USA.
   [Sequeira, Adolfo; Vawter, Marquis P.] Univ Calif Irvine UCI, Sch Med, Dept Psychiat & Human Behav, Irvine, CA USA.
   [Lew, Mark F.] Keck Sch Med USC, Dept Neurol, Los Angeles, CA USA.
   [Santorelli, Marco] Keck Sch Med USC, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA USA.
   [Serrano, Geidy E.; Beach, Thomas G.] Banner Sun Hlth Res Inst BSHRI, Sun City, AZ USA.
   [Limon, Agenor] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Sch Med, Dept Neurol, Galveston, TX USA.
C3 University of California System; University of California Irvine; University of Texas System; University of Texas Medical Branch Galveston
RP Hjelm, BE (corresponding author), Keck Sch Med USC, Dept Translat Genom, Los Angeles, CA 90033 USA.
EM bhjelm@usc.edu
FU USC Department of Translational Genomics; NINDS; NIMH; USC Department of Translational Genomics - William Lyon Penzner Foundation; Della Martin Foundation; Pritzker Neuropsychiatric Disorders Research Consortium; NIA [P30 AG19610, P30AG072980]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Michael J. Fox Foundation for Parkinson's Research; Common Fund of the Office of the Director of the National Institutes of Health; NCI; NHGRI; NHLBI; NIDA
CR Aguila J, 2021, FRONT MOL NEUROSCI, V14, P0, DOI 10.3389/fnmol.2021.699562
   Alvarez M, 2020, SCI REP-UK, V10, P0, DOI 10.1038/s41598-020-67513-5
   Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI 10.1073/pnas.0807297105
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Basu S, 2020, PLOS GENET, V16, P0, DOI 10.1371/journal.pgen.1009242
   Belmonte FR, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep25186
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bosworth CM, 2017, BMC BIOINFORMATICS, V18, P0, DOI 10.1186/s12859-017-1821-7
   Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109
   Cline SD, 2012, BBA-GENE REGUL MECH, V1819, P979, DOI 10.1016/j.bbagrm.2012.06.002
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Damas J, 2014, NUCLEIC ACIDS RES, V42, PD1261, DOI 10.1093/nar/gkt982
   Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112
   DÃ¶lle C, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13548
   Enge M, 2017, CELL, V171, P321, DOI 10.1016/j.cell.2017.09.004
   GoudenÃ¨ge D, 2019, GENET MED, V21, P1407, DOI 10.1038/s41436-018-0350-8
   Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313
   Harris JJ, 2012, J NEUROSCI, V32, P356, DOI 10.1523/JNEUROSCI.3430-11.2012
   Harris KD, 2015, NAT NEUROSCI, V18, P170, DOI 10.1038/nn.3917
   Hjelm BE, 1900, DOI 10.5281/ZENODO.10499097, V0, P0
   Hjelm BE, 2019, NUCLEIC ACIDS RES, V47, P0, DOI 10.1093/nar/gkz164
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Hwang Y, 2013, TRANSL PSYCHIAT, V3, P0, DOI 10.1038/tp.2013.94
   JOHNS DR, 1993, AM J OPHTHALMOL, V115, P108, DOI 10.1016/S0002-9394(14)73533-0
   Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4
   Kim HR, 2015, ANN LAB MED, V35, P1, DOI 10.3343/alm.2015.35.1.1
   Kim S, 2010, NEUROPSYCHOPHARMACOL, V35, P473, DOI 10.1038/npp.2009.151
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024
   Lakshmipathy U, 1999, NUCLEIC ACIDS RES, V27, P1198, DOI 10.1093/nar/27.4.1198
   Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662
   Lavin KM, 2020, FRONT PHYSIOL, V11, P0, DOI 10.3389/fphys.2020.00653
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Li X, 2015, METHODS MOL BIOL, V1269, P137, DOI 10.1007/978-1-4939-2291-8_8
   Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Lujan SA, 2020, GENOME BIOL, V21, P0, DOI 10.1186/s13059-020-02138-5
   Ma S, 2020, CELL, V183, P1103, DOI 10.1016/j.cell.2020.09.056
   Mamdani F, 2014, SCHIZOPHR RES, V159, P370, DOI 10.1016/j.schres.2014.08.026
   Martin FJ, 2023, NUCLEIC ACIDS RES, V51, PD933, DOI 10.1093/nar/gkac958
   Maynard KR, 2021, NAT NEUROSCI, V24, P425, DOI 10.1038/s41593-020-00787-0
   MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561
   MonzÃ³n-Sandoval J, 2020, ANN NEUROL, V87, P853, DOI 10.1002/ana.25719
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Moraes CT, 2003, J MOL DIAGN, V5, P197, DOI 10.1016/S1525-1578(10)60474-6
   MORAES CT, 1989, BIOCHEM BIOPH RES CO, V160, P765, DOI 10.1016/0006-291X(89)92499-6
   Moslemi AR, 1996, ANN NEUROL, V40, P707, DOI 10.1002/ana.410400506
   Nagaike T, 2008, BBA-GENE REGUL MECH, V1779, P266, DOI 10.1016/j.bbagrm.2008.02.001
   NAKAI A, 1994, LANCET, V343, P1397, DOI 10.1016/S0140-6736(94)92527-5
   Nativio R, 2020, NAT GENET, V52, P1024, DOI 10.1038/s41588-020-0696-0
   Nissanka N, 2019, TRENDS GENET, V35, P235, DOI 10.1016/j.tig.2019.01.001
   Omidsalar AA, 1900, DOI 10.5281/ZENODO.10499375, V0, P0
   OZAWA T, 1990, BIOCHEM BIOPH RES CO, V172, P483, DOI 10.1016/0006-291X(90)90698-M
   Paramasivam A, 2016, MITOCHONDRION, V26, P81, DOI 10.1016/j.mito.2015.12.006
   Phillips NR, 2014, ALZHEIMERS DEMENT, V10, P393, DOI 10.1016/j.jalz.2013.04.508
   Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758
   Prakrithi P, 2023, BRIEF BIOINFORM, V24, P0, DOI 10.1093/bib/bbad031
   Preissl S, 2018, NAT NEUROSCI, V21, P1015, DOI 10.1038/s41593-018-0114-4
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Rickner HD, 2019, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/59120
   Rollins Brandi L, 2018, MOL NEUROPSYCHIATRY, V3, P157, DOI 10.1159/000484348
   Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Simchovitz A, 2020, AGING CELL, V19, P0, DOI 10.1111/acel.13115
   Slomovic S, 2005, MOL CELL BIOL, V25, P6427, DOI 10.1128/MCB.25.15.6427-6435.2005
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Thompson LV, 2006, EXP GERONTOL, V41, P1220, DOI 10.1016/j.exger.2006.10.018
   Thyagarajan B, 1996, J BIOL CHEM, V271, P27536, DOI 10.1074/jbc.271.44.27536
   Tumasian RA, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-22168-2
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 1997, SCI AM, V277, P40, DOI 10.1038/scientificamerican0897-40
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   WEI YH, 1992, MUTAT RES, V275, P145, DOI 10.1016/0921-8734(92)90019-L
   Wickham H, 2016, GGPLOT2: ELEGANT GRAPHICS FOR DATA ANALYSIS, V0, P0, DOI DOI 10.1007/978-3-319-24277-4
   Yan F, 2020, GENOME BIOL, V21, P0, DOI 10.1186/s13059-020-1929-3
   Yu YG, 2018, J CEREBR BLOOD F MET, V38, P1339, DOI 10.1177/0271678X17708691
   Zeppillo T, 2022, SCHIZOPHR RES, V249, P25, DOI 10.1016/j.schres.2020.03.037
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
   Zhou L, 2022, BRIEF BIOINFORM, V23, P0, DOI 10.1093/bib/bbac222
NR 89
TC 0
Z9 0
U1 5
U2 10
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 
EI 2399-3642
J9 COMMUN BIOL
JI Commun. Biol.
PD FEB 17
PY 2024
VL 7
IS 1
BP 
EP 
DI 10.1038/s42003-024-05877-4
PG 20
WC Biology; Multidisciplinary Sciences
SC Life Sciences & Biomedicine - Other Topics; Science & Technology - Other Topics
GA IB1Q5
UT WOS:001163774500004
PM 38368460
DA 2024-11-01
ER

PT J
AU Beecher, G
   Gavrilova, RH
   Mandrekar, J
   Naddaf, E
AF Beecher, Grayson
   Gavrilova, Ralitza H.
   Mandrekar, Jay
   Naddaf, Elie
TI Mitochondrial myopathies diagnosed in adulthood: clinico-genetic spectrum and long-term outcomes
SO BRAIN COMMUNICATIONS
LA English
DT Article
DE mitochondrial myopathies; MELAS; POLG; chronic progressive external ophthalmoplegia; inherited myopathies
ID progressive external ophthalmoplegia; dna deletions; peripheral neuropathy; exercise intolerance; muscle involvement; mutation; disease; features; single; common
AB Mitochondrial myopathies are frequently recognized in childhood as part of a broader multisystem disorder and often overlooked in adulthood. Herein, we describe the phenotypic and genotypic spectrum and long-term outcomes of mitochondrial myopathies diagnosed in adulthood, focusing on neuromuscular features, electrodiagnostic and myopathological findings and survival. We performed a retrospective chart review of adult patients diagnosed with mitochondrial myopathy at Mayo Clinic (2005-21). We identified 94 patients. Median time from symptom onset to diagnosis was 11 years (interquartile range 4-21 years). Median age at diagnosis was 48 years (32-63 years). Primary genetic defects were identified in mitochondrial DNA in 48 patients (10 with single large deletion, 38 with point mutations) and nuclear DNA in 29. Five patients had multiple mitochondrial DNA deletions or depletion without nuclear DNA variants. Twelve patients had histopathological features of mitochondrial myopathy without molecular diagnosis. The most common phenotypes included multisystem disorder (n = 30); mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (14); limb myopathy (13); chronic progressive external ophthalmoplegia (12); and chronic progressive external ophthalmoplegia-plus (12). Isolated skeletal muscle manifestations occurred in 27%. Sixty-nine per cent had CNS and 21% had cardiac involvement. Mutations most frequently involved MT-TL1 (27) and POLG (17); however, a wide spectrum of established and novel molecular defects, with overlapping phenotypes, was identified. Electrodiagnostic studies identified myopathy (77%), fibrillation potentials (27%) and axonal peripheral neuropathy (42%, most common with nuclear DNA variants). Among 42 muscle biopsies available, median percentage counts were highest for cytochrome C oxidase negative fibres (5.1%) then ragged blue (1.4%) and ragged red fibres (0.5%). Skeletal muscle weakness was mild and slowly progressive (decline in strength summated score of 0.01/year). Median time to gait assistance was 5.5 years from diagnosis and 17 years from symptom onset. Thirty patients died, with median survival of 33.4 years from symptom onset and 10.9 years from diagnosis. Median age at death was 55 years. Cardiac involvement was associated with increased mortality [hazard ratio 2.36 (1.05, 5.29)]. There was no difference in survival based on genotype or phenotype. Despite the wide phenotypic and genotypic spectrum, mitochondrial myopathies in adults share similar features with slowly progressive limb weakness, contrasting with common multiorgan involvement and high mortality. Beecher et al. describe the clinical, genetic, electrodiagnostic and myopathological features and long-term outcomes in 94 patients diagnosed with mitochondrial myopathy in adulthood. They highlight that despite the wide genotypic and phenotypic spectrum, mitochondrial myopathies in adults share slowly progressive limb weakness, contrasting with common multiorgan involvement and high mortality. Graphical Abstract
C1 [Beecher, Grayson; Gavrilova, Ralitza H.; Mandrekar, Jay; Naddaf, Elie] Mayo Clin, Dept Neurol, 200 First St Southwest, Rochester, MN 55905 USA.
   [Beecher, Grayson] Univ Alberta, Dept Med, Div Neurol, Edmonton, AB, Canada.
   [Gavrilova, Ralitza H.] Mayo Clin, Dept Clin Genom, Rochester, MN 55905 USA.
C3 Mayo Clinic; University of Alberta; Mayo Clinic
RP Naddaf, E (corresponding author), Mayo Clin, Dept Neurol, 200 First St Southwest, Rochester, MN 55905 USA.
EM Naddaf.elie@mayo.edu
CR Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   Arena IG, 2022, J CLIN MED, V11, P0, DOI 10.3390/jcm11030632
   Barca E, 2020, NEUROL-GENET, V6, P0, DOI 10.1212/NXG.0000000000000402
   Barends M, 2016, JIMD REP, V26, P103, DOI 10.1007/8904_2015_449
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Braz LP, 2021, NEUROL-CLIN PRACT, V11, P97, DOI 10.1212/CPJ.0000000000000795
   Choi BO, 2010, EXP MOL MED, V42, P446, DOI 10.3858/emm.2010.42.6.046
   COLLINS S, 1995, ACTA NEUROL SCAND, V91, P287, DOI 10.1111/j.1600-0404.1995.tb07007.x
   Davis RL, 2022, NEUROLOGY, V99, PE730, DOI 10.1212/WNL.0000000000200745
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Finsterer J, 2018, PEDIATR NEUROL, V80, P8, DOI 10.1016/j.pediatrneurol.2017.12.005
   Girlanda P, 1999, CLIN NEUROPHYSIOL, V110, P1284, DOI 10.1016/S1388-2457(98)00041-8
   GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E
   Grier J, 2018, NEUROL-GENET, V4, P0, DOI 10.1212/NXG.0000000000000230
   Hedermann G, 2017, MITOCHONDRION, V32, P27, DOI 10.1016/j.mito.2016.11.007
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Hirano M, 1993, GENEREVIEWS((R)), V0, P0
   Hirano M, 2022, MERRITTS NEUROLOGY, V0, P1011
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horga A, 2014, BRAIN, V137, P3200, DOI 10.1093/brain/awu279
   Howse MLP, 2003, MUSCLE NERVE, V28, P757, DOI 10.1002/mus.10492
   Imai-Okazaki A, 2021, INT J CARDIOL, V341, P48, DOI 10.1016/j.ijcard.2021.06.042
   KAWAI H, 1995, MUSCLE NERVE, V18, P753, DOI 10.1002/mus.880180712
   LAFORET P, 1995, NEUROMUSCULAR DISORD, V5, P399, DOI 10.1016/0960-8966(94)00080-S
   Lu JQ, 2021, MITOCHONDRION, V56, P52, DOI 10.1016/j.mito.2020.11.005
   Lu JQ, 2019, J NEUROPATH EXP NEUR, V78, P508, DOI 10.1093/jnen/nlz029
   Luigetti M, 2016, EUR J NEUROL, V23, P1020, DOI 10.1111/ene.12954
   Mancuso M, 2012, NEUROMUSCULAR DISORD, V22, PS226, DOI 10.1016/j.nmd.2012.10.012
   Mancuso M, 2016, NEUROMUSCULAR DISORD, V26, P272, DOI 10.1016/j.nmd.2016.02.008
   Mancuso M, 2015, J NEUROL, V262, P1301, DOI 10.1007/s00415-015-7710-y
   Mancuso M, 2012, NEUROL SCI, V33, P449, DOI 10.1007/s10072-011-0703-4
   Miller TM, 2008, MUSCLE NERVE, V37, P293, DOI 10.1002/mus.20923
   Montano V, 2022, J NEUROL, V269, P6555, DOI 10.1007/s00415-022-11324-3
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Nardin RA, 2001, MUSCLE NERVE, V24, P170, DOI 10.1002/1097-4598(200102)24:2<170::AID-MUS30>3.0.CO;2-0
   Naue J, 2015, MITOCHONDRION, V20, P82, DOI 10.1016/j.mito.2014.12.002
   Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528
   Ng YS, 2021, LANCET NEUROL, V20, P573, DOI 10.1016/S1474-4422(21)00098-3
   Olimpio C, 2021, NEUROMUSCULAR DISORD, V31, P978, DOI 10.1016/j.nmd.2021.08.005
   Orsucci D, 2017, J NEUROL, V264, P1777, DOI 10.1007/s00415-017-8567-z
   Papadopoulos C, 2020, J INHERIT METAB DIS, V43, P459, DOI 10.1002/jimd.12185
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Paul P, 2020, NEUROLOGY, V95, P933, DOI 10.1212/WNL.0000000000010613
   PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Sleigh K, 2011, MUSCLE NERVE, V43, P795, DOI 10.1002/mus.21962
   TORBERGSEN T, 1991, MUSCLE NERVE, V14, P35
   VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Weber K, 1997, AM J HUM GENET, V60, P373
   YAMAMOTO M, 1991, NEUROLOGY, V41, P1822, DOI 10.1212/WNL.41.11.1822
   Zierz CM, 2015, NEUROPATHOLOGY, V35, P130, DOI 10.1111/neup.12173
NR 56
TC 0
Z9 0
U1 1
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 
EI 2632-1297
J9 BRAIN COMMUN
JI Brain Commun.
PD MAR 1
PY 2024
VL 6
IS 2
BP 
EP 
DI 10.1093/braincomms/fcae041
EA MAR 2024
PG 14
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA JW0T8
UT WOS:001176088900001
PM 38434220
DA 2024-11-01
ER

PT J
AU Keller, SH
   Johnson, GS
   Bullock, G
   Mhlanga-Mutangadura, T
   Schwartz, M
   Pattridge, SG
   Guo, JY
   Kortz, GD
   Katz, ML
AF Keller, Stefan H.
   Johnson, Gary S.
   Bullock, Garrett
   Mhlanga-Mutangadura, Tendai
   Schwartz, Malte
   Pattridge, Savannah G.
   Guo, Juyuan
   Kortz, Gregg D.
   Katz, Martin L.
TI Homozygous <i>CNP</i> Mutation and Neurodegeneration in Weimaraners: Myelin Abnormalities and Accumulation of Lipofuscin-like Inclusions
SO GENES
LA English
DT Article
DE neuronal ceroid lipofuscinosis; neurodegeneration; brain; optic nerve; cardiac muscle; mitochondria; lipofuscin
ID canine degenerative myelopathy; transition pore; gene; localization; disruption
AB A progressive neurological disorder was observed in a male neutered Weimaraner. Clinical signs included fecal incontinence, lethargy, moderate paraparesis, proprioceptive pelvic limb ataxia, falling, cognitive decline, incoordination, decreased interest in food, changes in posture, and episodes of trance-like behavior. Neurologic signs were first observed at approximately 4 years, 10 months of age and progressed slowly. Magnetic resonance imaging showed generalized brain atrophy with areas of white matter pathology. Humane euthanasia was elected at 6 years, 7 months of age due to increasing severity of the neurological signs. Autofluorescent intracellular granules were observed in the cerebral and cerebellar cortexes, optic nerve, and cardiac muscle of the affected dog. These abnormal inclusions in the cerebral cortex and cardiac muscle immunolabeled with antibodies to mitochondrial ATP synthase subunit c protein, like that observed in the neuronal ceroid lipofuscinosis group of lysosomal storage diseases. Immunolabeling also demonstrated pronounced neuroinflammation in brain tissues. The ultrastructural appearances of the disease-related inclusion bodies in the brain and optic nerve were quite variable. The ultrastructure and locations of many of the inclusions in the nervous tissues suggested that they were derived, at least in part, from the myelin surrounding axons. The storage bodies in the cardiac muscle were located in mitochondria-rich regions and consisted of parallel arrays of membrane-like components interspersed with electron-dense flocculent material. The disease was characterized by pronounced abnormalities in the myelin of the brain and optic nerve consisting of distinctive areas of ballooning between the layers of myelin. The whole genome sequence generated from the affected dog contained a homozygous G-to-A missense mutation in CNP, which encodes proteins with CNPase enzyme activity and a structural role in myelin. The mutation predicts a Thr42Met amino acid sequence substitution. Genotyping of archived Weimaraner DNA samples identified an additional G > A variant homozygote with a clinical history and brain lesions similar to those of the proband. Of 304 Weimaraners and over 4000 other dogs of various breeds, the proband and the other Weimaraner that exhibited similar signs were the only two that were homozygous for the CNP missense variant. CNPase immunolabeling was widespread in brain tissues from normal dogs but was undetectable in the same tissues from the proband. Based on the clinical history, fluorescence and electron-microscopy, immunohistochemistry, and molecular genetic findings, the late-onset Weimaraner disorder likely results from the missense mutation that results in CNPase deficiency, leading to myelin abnormalities, accumulation of lysosomal storage bodies, and brain atrophy. Similar disorders have been associated with different CNP variants in Dalmatians and in human subjects.
C1 [Keller, Stefan H.; Johnson, Gary S.; Bullock, Garrett; Mhlanga-Mutangadura, Tendai; Pattridge, Savannah G.; Guo, Juyuan] Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO 65211 USA.
   [Schwartz, Malte] Summit Vet Referral Ctr, Tacoma, WA 98409 USA.
   [Kortz, Gregg D.] VCA Sacramento Vet Referral Ctr, Sacramento, CA 95827 USA.
   [Katz, Martin L.] Univ Missouri, Sch Med, Dept Ophthalmol, Neurodegenerat Dis Res Lab, Columbia, MO 65212 USA.
C3 University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia
RP Katz, ML (corresponding author), Univ Missouri, Sch Med, Dept Ophthalmol, Neurodegenerat Dis Res Lab, Columbia, MO 65212 USA.
EM shkgb6@missouri.edu; gebkd2@mail.missouri.edu; tendai@missouri.edu; sgpgqq@missouri.edu; guoj@missouri.edu; gregg.kortz@vca.com; katzm@health.missouri.edu
FU American Kennel Club Canine Health Foundation
CR Al-Abdi L, 2020, HUM GENET, V139, P615, DOI 10.1007/s00439-020-02144-4
   Anderson GW, 2013, BBA-MOL BASIS DIS, V1832, P1807, DOI 10.1016/j.bbadis.2012.11.014
   Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI 10.1073/pnas.0812297106
   Baburina Y, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19113499
   Bernardi P, 2023, CELL DEATH DIFFER, V30, P1869, DOI 10.1038/s41418-023-01187-0
   BouchÃ© TV, 2023, J VET INTERN MED, V37, P1815, DOI 10.1111/jvim.16829
   Bullock G, 2023, GENES-BASEL, V14, P0, DOI 10.3390/genes14091746
   Bullock G, 2022, GENE, V830, P0, DOI 10.1016/j.gene.2022.146513
   Coates JR, 2010, VET CLIN N AM-SMALL, V40, P929, DOI 10.1016/j.cvsm.2010.05.001
   Edgar JM, 2009, GLIA, V57, P1815, DOI 10.1002/glia.20893
   Elleder M, 2008, ACTA NEUROPATHOL, V116, P119, DOI 10.1007/s00401-008-0349-3
   Goebel H H, 2001, EUR J PAEDIATR NEUROL, V5 Suppl A, P203, DOI 10.1053/ejpn.2000.0463
   Goebel HH, 2000, NEUROL SCI, V21, PS27, DOI 10.1007/s100720070037
   GÃ¶tzl JK, 2014, ACTA NEUROPATHOL, V127, P845, DOI 10.1007/s00401-014-1262-6
   Hagemeyer N, 2012, EMBO MOL MED, V4, P528, DOI 10.1002/emmm.201200230
   Hu Gang, 2019, CURR PROTOC PROTEIN SCI, V95, Pe71, DOI 10.1002/cpps.71
   Jackson EK, 2017, HANDB EXP PHARMACOL, V238, P229, DOI 10.1007/164_2015_40
   Jagannathan V, 2021, GENES-BASEL, V12, P0, DOI 10.3390/genes12060847
   Katz ML, 2017, NEUROBIOL DIS, V108, P277, DOI 10.1016/j.nbd.2017.08.017
   Katz ML, 2005, BIOCHEM BIOPH RES CO, V327, P541, DOI 10.1016/j.bbrc.2004.12.038
   Kountourantzis A, 2023, RES VET SCI, V162, P0, DOI 10.1016/j.rvsc.2023.104959
   Kurata K, 1999, BRAIN DEV-JPN, V21, P63, DOI 10.1016/S0387-7604(98)00062-X
   KURIHARA T, 1990, BIOCHEM BIOPH RES CO, V170, P1074, DOI 10.1016/0006-291X(90)90502-E
   Kursula P, 2001, INT J MOL MED, V8, P475
   Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095
   Lee J, 2006, MOL CELL NEUROSCI, V31, P446, DOI 10.1016/j.mcn.2005.10.017
   Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026
   Mole SE, 2011, THE NEURONAL CEROID LIPOFUSCINOSES (BATTEN DISEASE), V2nd, P0
   Morgan BR, 2014, J NEUROSCI RES, V92, P531, DOI 10.1002/jnr.23332
   Myllykoski M, 2016, BRAIN RES, V1641, P64, DOI 10.1016/j.brainres.2015.09.004
   Olga K, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21093217
   ONeill RC, 1997, J NEUROSCI RES, V50, P248
   Palmer DN, 2013, BBA-MOL BASIS DIS, V1832, P1882, DOI 10.1016/j.bbadis.2013.05.014
   Pemberton TJ, 2014, GLIA, V62, P39, DOI 10.1002/glia.22582
   Raasakka A, 2014, NEUROSCI BULL, V30, P956, DOI 10.1007/s12264-013-1437-5
   Rasband MN, 2005, GLIA, V50, P86, DOI 10.1002/glia.20165
   Robichaux DJ, 2023, J MOL CELL CARDIOL, V174, P47, DOI 10.1016/j.yjmcc.2022.11.003
   Robinson JT, 2017, CANCER RES, V77, PE31, DOI 10.1158/0008-5472.CAN-17-0337
   Safra N, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003646
   Siems SB, 2020, ELIFE, V9, P0, DOI 10.7554/eLife.51406
   Umehara F, 1997, ACTA NEUROPATHOL, V93, P628, DOI 10.1007/s004010050661
   VOGEL US, 1988, J NEUROCHEM, V50, P1667, DOI 10.1111/j.1471-4159.1988.tb02461.x
   Zeng R, 2014, J VET INTERN MED, V28, P515, DOI 10.1111/jvim.12317
   Zhou SY, 2023, CURR PHARM DESIGN, V29, P620, DOI 10.2174/1381612829666230313111314
NR 44
TC 1
Z9 1
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD FEB 15
PY 2024
VL 15
IS 2
BP 
EP 
DI 10.3390/genes15020246
PG 27
WC Genetics & Heredity
SC Genetics & Heredity
GA JS0Y2
UT WOS:001175047900001
PM 38397235
DA 2024-11-01
ER

PT J
AU Sazonova, MA
   Sinyov, VV
   Ryzhkova, AI
   Sazonova, MD
   Doroschuk, NA
   Karagodin, VP
   Popov, MA
   Sukhorukov, VN
   Poggio, P
   Moschetta, D
   Postnov, AY
AF Sazonova, Margarita A.
   Sinyov, Vasily V.
   Ryzhkova, Anastasia I.
   Sazonova, Marina D.
   Doroschuk, Natalya A.
   Karagodin, Vasily P.
   Popov, Mikhail A.
   Sukhorukov, Vasily N.
   Poggio, Paolo
   Moschetta, Donato
   Postnov, Anton Yu.
TI Analysis of Mutational Burden of Mitochondrial Genome in Cells of Different Human Organs and Tissues
SO CURRENT MEDICINAL CHEMISTRY
LA English
DT Review; Early Access
DE Mitochondrial genome; mutation; heteroplasmy level; mutational burden; human organ; human tissue; cells
ID dna control region; mtdna heteroplasmy; sequence heteroplasmy; point mutations; molecular-basis; blood; segregation; atherosclerosis; selection; adult
AB Background Cells of different human organs and tissues contain different numbers of mitochondria. In these organelles, there are different copies of the mitochondrial genome, which is characteristic of a certain organ or tissue.Objective The aim of the investigation was to analyze the results of scientific works dedicated to the analysis of heteroplasmy levels of mitochondrial genome mutations in a number of organs and tissues.Methods Based on literature data, the level of heteroplasmy of mitochondrial genome mutations was analyzed in organs such as the liver, lungs, muscles, small intestine, large intestine, spleen, kidney, brain, heart, and hair. In addition, this parameter was studied in such tissues as leukocytes, buccal epithelium, and epithelial cells from urine.Results Significant differences in the mutational burden of the mitochondrial genome were found in various samples of organs and tissues. The highest heteroplasmy level for mtDNA mutations was in muscles; it was lower in buccal epithelium; and in human blood cells, the heteroplasmy level of mitochondrial mutations turned out to be significantly lower compared to other tissues. During the comparison of samples of patients with different diseases and healthy people, significant differences were found in the heteroplasmy level between some organs and tissues.Conclusion The heteroplasmy level of mitochondrial genome mutations can significantly differ in the organs and tissues of individuals. In addition, in a number of literature sources, it is noted that there is a dependence on the mutational burden of the mitochondrial genome from the type of disease, sex, and age of a person.
C1 [Sazonova, Margarita A.; Ryzhkova, Anastasia I.; Sazonova, Marina D.; Doroschuk, Natalya A.; Karagodin, Vasily P.] Inst Gen Pathol & Pathophysiol, Lab Angiopathol, 8 Baltiiskaya St, Moscow 125315, Russia.
   [Sazonova, Margarita A.; Sinyov, Vasily V.; Postnov, Anton Yu.] Natl Med Res Ctr Cardiol, Inst Expt Cardiol, Lab Med Genet, 15a,3rd Cherepkovskaya Str, Moscow 121552, Russia.
   [Sinyov, Vasily V.; Sukhorukov, Vasily N.; Postnov, Anton Yu.] Petrovsky Natl Res Ctr Surg FSBSI Petrovsky NRCS, Fed State Budgetary Sci Inst, Lab Cellular & Mol Pathol Cardiovasc Syst, Moscow, Russia.
   [Karagodin, Vasily P.] Plekhanov Russian Univ Econ, Stremyanny Lane 36, Moscow 117997, Russia.
   [Popov, Mikhail A.] Moscow Reg Res & Clin Inst MONIKI, Dept Cardiac Surg, 61-2 Shchepkin St, Moscow 129110, Russia.
   [Poggio, Paolo; Moschetta, Donato] IRCCS, Ctr Cardiol Monzino, Unit Study Aort Valvular & Coronary Pathol, Via C Parea 4, I-20138 Milan, Italy.
C3 Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; National Medical Research Center of Cardiology; Plekhanov Russian University of Economics; IRCCS Centro Cardiologico Monzino
RP Sazonova, MA (corresponding author), Inst Gen Pathol & Pathophysiol, Lab Angiopathol, 8 Baltiiskaya St, Moscow 125315, Russia.
EM margaritaasazonova@gmail.com
FU Russian Science Foundation [20-15-00337]
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   An Jisong, 2022, METHODS MOL BIOL, V2493, P153, DOI 10.1007/978-1-0716-2293-3_10
   Andrew T, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0022332
   Arthur CR, 2009, MOL NEURODEGENER, V4, P0, DOI 10.1186/1750-1326-4-37
   Aryaman J, 2019, GENETICS, V212, P1429, DOI 10.1534/genetics.119.302423
   Atilano SR, 2021, PLOS ONE, V16, P0, DOI 10.1371/journal.pone.0246114
   Bi CW, 2023, NUCLEIC ACIDS RES, V51, P3793, DOI 10.1093/nar/gkad209
   Bi R, 2010, CLIN CHIM ACTA, V411, P1671, DOI 10.1016/j.cca.2010.06.026
   Blaha MJ, 2021, J AM COLL CARDIOL, V77, P3195, DOI 10.1016/j.jacc.2021.05.006
   Brockmann SJ, 2023, HUM GENOMICS, V17, P0, DOI 10.1186/s40246-023-00516-1
   Burr SP, 2018, DEV GROWTH DIFFER, V60, P21, DOI 10.1111/dgd.12420
   Calloway CD, 2000, AM J HUM GENET, V66, P1384, DOI 10.1086/302844
   Campbell T, 2022, CELLS-BASEL, V11, P0, DOI 10.3390/cells11182835
   Chakrabarty S, 2021, J NEUROL, V268, P2192, DOI 10.1007/s00415-020-10390-9
   Chen YP, 2022, EUR J NEUROL, V29, P3218, DOI 10.1111/ene.15509
   Chiaratti MR, 2022, PHARMACOL RES, V185, P0, DOI 10.1016/j.phrs.2022.106466
   Chinnery PF, 1999, AM J MED GENET, V85, P498
   Chung UH, 2005, INT J LEGAL MED, V119, P50, DOI 10.1007/s00414-004-0487-7
   Claeys KG, 2016, MUSCLE NERVE, V54, P328, DOI 10.1002/mus.25125
   de Laat P, 2015, NETH J MED, V73, P30
   de Laat P, 2019, MOL GENET GENOM MED, V7, P0, DOI 10.1002/mgg3.523
   de Laat P, 2012, J INHERIT METAB DIS, V35, P1059, DOI 10.1007/s10545-012-9465-2
   Del Bo R, 2003, NEUROBIOL AGING, V24, P829, DOI 10.1016/S0197-4580(02)00233-6
   Duggan AT, 2013, AM J HUM GENET, V92, P279, DOI 10.1016/j.ajhg.2012.12.004
   Fan XY, 2022, NAT BIOMED ENG, V6, P339, DOI 10.1038/s41551-022-00881-7
   Florido R, 2022, J AM COLL CARDIOL, V80, P22, DOI 10.1016/j.jacc.2022.04.042
   Frederiksen AL, 2006, J MED GENET, V43, P0, DOI 10.1136/jmg.2005.039339
   Frederiksen AL, 2009, J CLIN ENDOCR METAB, V94, P2872, DOI 10.1210/jc.2009-0235
   Galera-Monge T, 2019, J CELL PHYSIOL, V234, P19511, DOI 10.1002/jcp.28549
   Giuliani C, 2014, AGING-US, V6, P454, DOI 10.18632/aging.100661
   GonzÃ¡lez MD, 2020, MITOCHONDRION, V50, P88, DOI 10.1016/j.mito.2019.10.006
   Grady JP, 2018, EMBO MOL MED, V10, P0, DOI 10.15252/emmm.201708262
   Gupta R, 2023, NATURE, V620, P0, DOI 10.1038/s41586-023-06426-5
   Guyatt AL, 2019, HUM GENOMICS, V13, P0, DOI 10.1186/s40246-018-0190-2
   Hammond ER, 2016, MOL HUM REPROD, V22, P261, DOI 10.1093/molehr/gaw003
   Harrison TJ, 1997, AM J OPHTHALMOL, V124, P217, DOI 10.1016/S0002-9394(14)70787-1
   Hefti E, 2018, MITOCHONDRIAL DNA A, V29, P587, DOI 10.1080/24701394.2017.1325480
   Holt AG, 2022, J THEOR BIOL, V551-552, P0, DOI 10.1016/j.jtbi.2022.111244
   HÃ¼hne J, 1998, INT J LEGAL MED, V112, P27, DOI 10.1007/s004140050193
   Hummel EM, 2023, PSYCHONEUROENDOCRINO, V148, P0, DOI 10.1016/j.psyneuen.2022.105993
   Imai-Okazaki A, 2022, J INHERIT METAB DIS, V45, P1143, DOI 10.1002/jimd.12547
   Kamiya J, 2003, DIABETOLOGIA, V46, P1559, DOI 10.1007/s00125-003-1215-4
   KÃ¤rppÃ¤ M, 2003, J NEUROL, V250, P216, DOI 10.1007/s00415-003-0981-8
   KÃ¤rppÃ¤ M, 2018, BMC NEUROL, V18, P0, DOI 10.1186/s12883-018-1159-4
   Keeter WC, 2022, SEMIN IMMUNOPATHOL, V44, P363, DOI 10.1007/s00281-022-00914-y
   Klein HU, 2021, MOL NEURODEGENER, V16, P0, DOI 10.1186/s13024-021-00495-8
   Krjutskov K, 2014, CURR GENET, V60, P11, DOI 10.1007/s00294-013-0398-6
   KytÃ¶vuori L, 2017, BMC NEUROL, V17, P0, DOI 10.1186/s12883-017-0883-5
   Langdahl JH, 2018, CLIN GENET, V93, P925, DOI 10.1111/cge.13201
   Latic N, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21186483
   Lee HY, 2006, ANN HUM GENET, V70, P59, DOI 10.1111/j.1529-8817.2005.00217.x
   Lee HY, 2004, ELECTROPHORESIS, V25, P28, DOI 10.1002/elps.200305681
   Lee SR, 2017, ADV EXP MED BIOL, V982, P81, DOI 10.1007/978-3-319-55330-6_5
   Li H, 2017, MOL NEUROBIOL, V54, P4343, DOI 10.1007/s12035-016-9996-x
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Li Y, 2022, LIFE SCI, V306, P0, DOI 10.1016/j.lfs.2022.120834
   Libby P, 2021, NATURE, V592, P524, DOI 10.1038/s41586-021-03392-8
   Lin DS, 2023, CELLS-BASEL, V12, P0, DOI 10.3390/cells12010015
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Litvinova NA, 2015, ROSSIISKII VESTNIK PERINATOLOGII I PEDIATRII, V60, P76
   Maeda H, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-90316-1
   MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41
   MATTHEWS PM, 1995, HUM GENET, V96, P261
   Mitrofanov KY, 2016, EXP MOL PATHOL, V100, P87, DOI 10.1016/j.yexmp.2015.12.003
   Moraes CT, 2019, CURR BIOL, V29, PR746, DOI 10.1016/j.cub.2019.06.029
   Mukhopadhyay A, 2018, NATL MED J INDIA, V31, P228, DOI 10.4103/0970-258X.258225
   Naue J, 2015, MITOCHONDRION, V20, P82, DOI 10.1016/j.mito.2014.12.002
   Naue J, 2011, INT J LEGAL MED, V125, P427, DOI 10.1007/s00414-011-0549-6
   Nayor M, 2021, CIRC RES, V128, P287, DOI 10.1161/CIRCRESAHA.120.315890
   Nie Y, 2022, ACTA NEUROPATHOL, V143, P687, DOI 10.1007/s00401-022-02423-6
   Orekhov AN, 2020, CURR ATHEROSCLER REP, V22, P0, DOI 10.1007/s11883-020-00873-5
   Pai CY, 2006, FORENSIC SCI INT, V156, P124, DOI 10.1016/j.forsciint.2004.12.021
   PanadÃ©s-de Oliveira L, 2020, MITOCHONDRION, V50, P14, DOI 10.1016/j.mito.2019.10.001
   Pereira CV, 2021, CRIT REV BIOCHEM MOL, V56, P510, DOI 10.1080/10409238.2021.1934812
   Pereira CV, 2017, FRONT BIOSCI-LANDMRK, V22, P991, DOI 10.2741/4529
   Pfeiffer H, 2004, INT J LEGAL MED, V118, P71, DOI 10.1007/s00414-003-0409-0
   Pyle A, 2007, J MED GENET, V44, P69, DOI 10.1136/jmg.2006.043109
   Pyle A, 2016, NEUROBIOL AGING, V38, P0, DOI 10.1016/j.neurobiolaging.2015.10.033
   Rai PK, 2018, ESSAYS BIOCHEM, V62, P455, DOI 10.1042/EBC20170113
   Roberts KA, 2011, J FORENSIC SCI, V56, P46, DOI 10.1111/j.1556-4029.2010.01540.x
   Samuels DC, 2013, PLOS GENET, V9, P0, DOI 10.1371/journal.pgen.1003929
   Sarbacher Carolyn Ann, 2019, SUBCELL BIOCHEM, V91, P281, DOI 10.1007/978-981-13-3681-2_11
   Sarig O, 2017, J INVEST DERMATOL, V137, PE79, DOI 10.1016/j.jid.2016.02.818
   Sazonova M, 2009, ATHEROSCLEROSIS, V204, P184, DOI 10.1016/j.atherosclerosis.2008.09.001
   Sazonova M A, 2011, PATOL FIZIOL EKSP TER, V0, P81
   Sazonova MA, 2018, DIS MARKERS, V2018, P0, DOI 10.1155/2018/9749457
   Sazonova MA, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/6934394
   Sazonova MA, 2016, DATA BRIEF, V7, P1570, DOI 10.1016/j.dib.2016.04.055
   Sazonova MA, 2016, CURR PHARM DESIGN, V22, P390, DOI 10.2174/1381612822666151112152335
   Sazonova MA, 2015, EXP MOL PATHOL, V99, P25, DOI 10.1016/j.yexmp.2015.04.003
   Sazonova MA, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/825468
   Schlapakow E, 2019, NEUROMUSCULAR DISORD, V29, P358, DOI 10.1016/j.nmd.2019.02.009
   Sharbrough J, 2023, MOL BIOL EVOL, V40, P0, DOI 10.1093/molbev/msad007
   Sharma MA, 2019, MITOCHONDRION, V46, P298, DOI 10.1016/j.mito.2018.08.002
   Sinyov VV, 2016, RUSS J GENET+, V52, P847, DOI 10.1134/S1022795416080123
   Sinyov V V, 2017, VESSEL PLUS, V0, PP145, DOI 10.20517/2574-1209.2016.04
   SoltÃ©sz B, 2022, MOL CELL PROBE, V66, P0, DOI 10.1016/j.mcp.2022.101875
   Song WH, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/981867
   Spyropoulos A, 2013, JAMA NEUROL, V70, P1552, DOI 10.1001/jamaneurol.2013.4111
   Spyropoulos AC, 2021, HEART INT, V15, P62, DOI 10.17925/HI.2021.15.2.62
   Stefano GB, 2017, ADV EXP MED BIOL, V982, P577, DOI 10.1007/978-3-319-55330-6_30
   Tully G, 2004, FORENSIC SCI INT, V140, P1, DOI 10.1016/S0379-0738(03)00181-6
   van den Ameele J, 2020, SEMIN CELL DEV BIOL, V97, P156, DOI 10.1016/j.semcdb.2019.10.001
   Visuttijai K, 2021, ACTA NEUROL SCAND, V143, P103, DOI 10.1111/ane.13339
   Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Wang AS, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00247
   Wang WL, 2020, CELL BIOL TOXICOL, V36, P391, DOI 10.1007/s10565-020-09549-x
   Wong LJC, 2020, HUM MUTAT, V41, P1783, DOI 10.1002/humu.24082
   Yang X, 2019, ANNU REV NUTR, V39, P201, DOI 10.1146/annurev-nutr-082018-124643
   Yang ZY, 2022, CURR PROTOC, V2, P0, DOI 10.1002/cpz1.412
   Yao YG, 2015, MUTAT RES-FUND MOL M, V779, P68, DOI 10.1016/j.mrfmmm.2015.06.009
   Zhang HX, 2018, ESSAYS BIOCHEM, V62, P225, DOI 10.1042/EBC20170096
   Zhang P, 2016, MITOCHONDRION, V31, P75, DOI 10.1016/j.mito.2016.08.018
   Zhang P, 2016, MITOCHONDRION, V28, P16, DOI 10.1016/j.mito.2016.03.001
   Zhou H, 2020, CLIN CHIM ACTA, V507, P210, DOI 10.1016/j.cca.2020.04.033
NR 116
TC 0
Z9 0
U1 2
U2 2
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES
SN 0929-8673
EI 1875-533X
J9 CURR MED CHEM
JI Curr. Med. Chem.
PD AUG 23
PY 2024
VL 0
IS 
BP 
EP 
DI 10.2174/0109298673296881240816065357
EA AUG 2024
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA E3P7S
UT WOS:001302166400001
PM 39185646
DA 2024-11-01
ER

PT J
AU Kirby, TJ
   Zahr, HC
   Fong, EHH
   Lammerding, J
AF Kirby, Tyler J.
   Zahr, Hind C.
   Fong, Ern Hwei Hannah
   Lammerding, Jan
TI Eliminating elevated p53 signaling fails to rescue skeletal muscle defects or extend survival in lamin A/C-deficient mice
SO CELL DEATH DISCOVERY
LA English
DT Article
ID a-type lamins; nuclear-envelope; dilated cardiomyopathy; muscular-dystrophy; dna-damage; activation; expression; mitochondrial; pathway; genome
AB Lamins A and C, encoded by the LMNA gene, are nuclear intermediate filaments that provide structural support to the nucleus and contribute to chromatin organization and transcriptional regulation. LMNA mutations cause muscular dystrophies, dilated cardiomyopathy, and other diseases. The mechanisms by which many LMNA mutations result in muscle-specific diseases have remained elusive, presenting a major hurdle in the development of effective treatments. Previous studies using striated muscle laminopathy mouse models found that cytoskeletal forces acting on mechanically fragile Lmna-mutant nuclei led to transient nuclear envelope rupture, extensive DNA damage, and activation of DNA damage response (DDR) pathways in skeletal muscle cells in vitro and in vivo. Furthermore, hearts of Lmna mutant mice have elevated activation of the tumor suppressor protein p53, a central regulator of DDR signaling. We hypothesized that elevated p53 activation could present a pathogenic mechanism in striated muscle laminopathies, and that eliminating p53 activation could improve muscle function and survival in laminopathy mouse models. Supporting a pathogenic function of p53 activation in muscle, stabilization of p53 was sufficient to reduce contractility and viability in wild-type muscle cells in vitro. Using three laminopathy models, we found that increased p53 activity in Lmna-mutant muscle cells primarily resulted from mechanically induced damage to the myonuclei, and not from altered transcriptional regulation due to loss of lamin A/C expression. However, global deletion of p53 in a severe muscle laminopathy model did not reduce the disease phenotype or increase survival, indicating that additional drivers of disease must contribute to the disease pathogenesis.
C1 [Kirby, Tyler J.] Amsterdam UMC locat Vrije Univ Amsterdam, Dept Physiol, Amsterdam Cardiovasc Sci, Amsterdam Movement Sci, Amsterdam, Netherlands.
   [Kirby, Tyler J.; Zahr, Hind C.; Fong, Ern Hwei Hannah; Lammerding, Jan] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14850 USA.
   [Zahr, Hind C.; Fong, Ern Hwei Hannah; Lammerding, Jan] Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14850 USA.
C3 Vrije Universiteit Amsterdam; Cornell University; Cornell University
RP Kirby, TJ (corresponding author), Amsterdam UMC locat Vrije Univ Amsterdam, Dept Physiol, Amsterdam Cardiovasc Sci, Amsterdam Movement Sci, Amsterdam, Netherlands.; Kirby, TJ; Lammerding, J (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14850 USA.; Lammerding, J (corresponding author), Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14850 USA.
EM t.kirby@amsterdamumc.nl; jan.lammerding@cornell.edu
FU National Institutes of Health [R01 HL082792]; National Science Foundation [MCB-1715606, URoL-2022048]; Muscular Dystrophy Association [MDA603238]; Volkswagen Foundation [A130142]; Dutch Cardiovascular Alliance
CR AndrÃ©s V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124
   Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017
   Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432
   Batut PJ, 2022, SCIENCE, V375, P566, DOI 10.1126/science.abi7178
   Bencze M, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms24010362
   Bertrand AT, 2011, BIOCHEM SOC T, V39, P1687, DOI 10.1042/BST20110670
   Brayson D, 2017, NUCLEUS-PHILA, V8, P17, DOI 10.1080/19491034.2016.1260798
   Bronshtein I, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms9044
   Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020
   Cao L, 2021, PLOS ONE, V16, P0, DOI 10.1371/journal.pone.0256713
   Carvajal D, 2005, CANCER RES, V65, P1918, DOI 10.1158/0008-5472.CAN-04-3576
   Chai RJ, 2021, NAT COMMUN, V12, P0, DOI 10.1038/s41467-021-24849-4
   Chatzifrangkeskou M, 2015, CURR OPIN CELL BIOL, V32, P1, DOI 10.1016/j.ceb.2014.09.007
   Cheedipudi SM, 2022, JACC-BASIC TRANSL SC, V7, P1232, DOI 10.1016/j.jacbts.2022.06.015
   Cheedipudi SM, 2019, CIRC RES, V124, P1198, DOI 10.1161/CIRCRESAHA.118.314177
   Chen SN, 2019, CIRC RES, V124, P856, DOI 10.1161/CIRCRESAHA.118.314238
   Cho S, 2019, DEV CELL, V49, P920, DOI 10.1016/j.devcel.2019.04.020
   de Leeuw R, 2018, TRENDS CELL BIOL, V28, P34, DOI 10.1016/j.tcb.2017.08.004
   Earle AJ, 2020, NAT MATER, V19, P464, DOI 10.1038/s41563-019-0563-5
   Ebert SM, 2019, J APPL PHYSIOL, V127, P1075, DOI 10.1152/japplphysiol.00363.2019
   Ehrnhoefer DE, 2014, HUM MOL GENET, V23, P717, DOI 10.1093/hmg/ddt458
   En A, 2023, BIORXIV PREPR SERV BIOL., V2023, P0
   Espinola SM, 2021, NAT GENET, V53, P477, DOI 10.1038/s41588-021-00816-z
   Ferdousi LV, 2014, STEM CELL RES, V13, P492, DOI 10.1016/j.scr.2014.08.005
   Fischer M, 2017, ONCOGENE, V36, P3943, DOI 10.1038/onc.2016.502
   Ghavi-Helm Y, 2019, NAT GENET, V51, P1272, DOI 10.1038/s41588-019-0462-3
   Giorgi C, 2015, P NATL ACAD SCI USA, V112, P1779, DOI 10.1073/pnas.1410723112
   Kalko SG, 2014, BMC GENOMICS, V15, P0, DOI 10.1186/1471-2164-15-91
   Haronikova L, 2019, NUCLEIC ACIDS RES, V47, P3257, DOI 10.1093/nar/gkz124
   Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615
   Ing-Simmons E, 2021, NAT GENET, V53, P487, DOI 10.1038/s41588-021-00799-x
   JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6
   Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848
   Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015
   Langer HT, 2022, CELL DEATH DIS, V13, P0, DOI 10.1038/s41419-022-05160-6
   Leong EL, 2022, HUM MOL GENET, V0, P0, DOI DOI 10.1093/hmg/ddac179
   Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723
   Liao CY, 2017, CELL DISCOV, V3, P0, DOI 10.1038/celldisc.2017.39
   Lombardi ML, 2011, J BIOL CHEM, V286, P26743, DOI 10.1074/jbc.M111.233700
   Mahmoudi S, 2009, MOL CELL, V33, P462, DOI 10.1016/j.molcel.2009.01.028
   Misteli T, 2021, NAT GENET, V53, P426, DOI 10.1038/s41588-021-00813-2
   Mitschka S, 2021, ELIFE, V10, P0, DOI 10.7554/eLife.65700
   Morgan JE, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-06057-9
   Mounkes LC, 2005, HUM MOL GENET, V14, P2167, DOI 10.1093/hmg/ddi221
   Muchir A, 2019, CURR OPIN NEUROL, V32, P728, DOI 10.1097/WCO.0000000000000741
   Nader GPD, 2021, CELL, V184, P5230, DOI 10.1016/j.cell.2021.08.035
   Narciso L, 2007, P NATL ACAD SCI USA, V104, P17010, DOI 10.1073/pnas.0701743104
   Nava MM, 2020, CELL, V181, P800, DOI 10.1016/j.cell.2020.03.052
   Nazer E, 2022, BIOCHEM SOC T, V50, P1035, DOI 10.1042/BST20210858
   Onoue K, 2021, FRONT CARDIOVASC MED, V8, P0, DOI 10.3389/fcvm.2021.639148
   Osmanagic-Myers S, 2019, MOL BIOL CELL, V30, P1786, DOI 10.1091/mbc.E18-10-0672
   Park SJ, 2017, CELL METAB, V25, P1135, DOI 10.1016/j.cmet.2017.07.005
   Pimentel MR, 2017, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/55141
   Porrello A, 2000, J CELL BIOL, V151, P1295, DOI 10.1083/jcb.151.6.1295
   SaldaÃ±a-Meyer R, 2011, EPIGENETICS-US, V6, P1068, DOI 10.4161/epi.6.9.16683
   Saleem A, 2015, AM J PHYSIOL-CELL PH, V308, PC319, DOI 10.1152/ajpcell.00253.2014
   Saleem A, 2014, AM J PHYSIOL-CELL PH, V306, PC241, DOI 10.1152/ajpcell.00270.2013
   Schreiber KH, 2013, CELL, V152, P1365, DOI 10.1016/j.cell.2013.02.015
   Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606
   Shah PP, 2021, CELL STEM CELL, V28, P938, DOI 10.1016/j.stem.2020.12.016
   Shurer CR, 2019, CELL, V177, P1757, DOI 10.1016/j.cell.2019.04.017
   Soddu S, 1996, J CELL BIOL, V134, P193, DOI 10.1083/jcb.134.1.193
   Solovei I, 2013, CELL, V152, P584, DOI 10.1016/j.cell.2013.01.009
   Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022
   Stiekema M, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9081884
   Stocks B, 2017, FRONT PHYSIOL, V8, P0, DOI 10.3389/fphys.2017.00941
   Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913
   Swiatkowska A, 2020, RNA BIOL, V17, P1402, DOI 10.1080/15476286.2020.1771944
   Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730
   Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a
   Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019
   Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014
   Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472
   Vilborg A, 2010, J MOL MED, V88, P645, DOI 10.1007/s00109-010-0609-2
   Vogler TO, 2016, METHODS MOL BIOL, V1460, P141, DOI 10.1007/978-1-4939-3810-0_11
   Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037
   Wallace M, 2023, MOL BIOL CELL, V34, P0, DOI 10.1091/mbc.E21-10-0527
   Wang YX, 2006, HUM MOL GENET, V15, P2479, DOI 10.1093/hmg/ddl170
   Wen Y, 2018, J APPL PHYSIOL, V124, P40, DOI 10.1152/japplphysiol.00762.2017
   Williams AB, 2016, CSH PERSPECT MED, V6, P0, DOI 10.1101/cshperspect.a026070
   Wong XR, 2020, ANNU REV GENOM HUM G, V21, P263, DOI 10.1146/annurev-genom-121219-083616
   Xia Y, 2018, J CELL BIOL, V217, P3796, DOI 10.1083/jcb.201711161
   Xiong L, 2020, PLOS BIOL, V18, P0, DOI 10.1371/journal.pbio.3000731
   Zheng XB, 2018, MOL CELL, V71, P802, DOI 10.1016/j.molcel.2018.05.017
NR 84
TC 1
Z9 1
U1 2
U2 2
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 
EI 2058-7716
J9 CELL DEATH DISCOV
JI Cell Death Discov.
PD MAY 22
PY 2024
VL 10
IS 1
BP 
EP 
DI 10.1038/s41420-024-01998-1
PG 14
WC Cell Biology
SC Cell Biology
GA RR0U2
UT WOS:001229278800003
PM 38778055
DA 2024-11-01
ER

PT J
AU Franco, PC
   Patrocinio, M
   Costa-Riquetto, AD
   Junior, ACS
   Gomes, LG
   Teles, MG
AF Franco, Pedro Campos
   Patrocinio, Michelle
   Costa-Riquetto, Aline Dantas
   Santomauro Junior, Augusto Cezar
   Gomes, Larissa Garcia
   Teles, Milena G.
TI Phenotypic and molecular reanalysis of a cohort of patients with monogenic diabetes reveals a case of partial lipodystrophy due to the A8344G mutation in the mitochondrial DNA
SO ARCHIVES OF ENDOCRINOLOGY METABOLISM
LA English
DT Article
AB Familial partial lipodystrophy (FPLD) is a very rare genetic disease characterized by insulin resistance due to a loss of subcutaneous fat from the extremities together with a progressive storage of fat around the face and neck and inside the abdomen. In over 50% of cases, molecular genetic testing reveals pathogenic variants in two nuclear genes, LMNA and PPARG . The case reported here refers to a woman phenotypically diagnosed with FPLD, who presented with diabetes and multiple cervical lipomatosis and in whom no variant had been found in the nuclear genes classically associated with this syndrome that could explain her phenotype. Genetic sequencing using a target panel containing 48 nuclear genes related to monogenic diabetes plus the whole mitochondrial genome revealed the mitochondrial variant m.A8344G in 84.1% heteroplasmy. Following molecular diagnosis, her phenotype was expanded with the recognition of additional clinical characteristics: mild sensorineural hearing loss, proximal myopathy, fatigue, cognitive impairment, sensory ataxia, cardiac abnormalities and, finally, muscle biopsy findings compatible with mitochondrial disease. Therefore, careful and detailed phenotypic and genotypic reanalysis proved crucial in improving molecular diagnosis in FPLD.
C1 [Franco, Pedro Campos; Costa-Riquetto, Aline Dantas; Santomauro Junior, Augusto Cezar; Teles, Milena G.] Univ Sao Paulo, Hosp Clin, Fac Med, Unidade Endocrinol Genet LIM25,Grp Diabetes Monoge, Sao Paulo, SP, Brazil.
   [Patrocinio, Michelle] Hosp Santa Marcelina, Sao Paulo, SP, Brazil.
   [Gomes, Larissa Garcia] Univ Sao Paulo, Hosp Clin, Fac Med, Unidade Desenvolvimento, Sao Paulo, SP, Brazil.
C3 Universidade de Sao Paulo; Universidade de Sao Paulo
RP Teles, MG (corresponding author), Univ Sao Paulo, Hosp Clin, Fac Med, Unidade Endocrinol Genet LIM25,Grp Diabetes Monoge, Sao Paulo, SP, Brazil.
EM milena.teles@gmail.com
FU So Paulo Research Foundation (Fapesp) [2017/14703-4, 2013/19920-2, 2017/15365-5]
CR Altmann J, 2016, J NEUROL, V263, P961, DOI 10.1007/s00415-016-8086-3
   de Santana LS, 2019, MOL GENET GENOM MED, V7, P0, DOI 10.1002/mgg3.962
   Deignan JL, 2019, GENET MED, V21, P1267, DOI 10.1038/s41436-019-0478-1
   Hattersley AT, 2018, PEDIATR DIABETES, V19, P47, DOI 10.1111/pedi.12772
   JÃ©ru I, 2017, EUR J HUM GENET, V25, P0, DOI 10.1038/ejhg.2016.102
   Ng YS, 2021, ENDOCR REV, V43, P583, DOI 10.1210/endrev/bnab036
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   Soejima A, 1996, J BIOL CHEM, V271, P26194, DOI 10.1074/jbc.271.42.26194
   Takano C, 2023, BIOMOLECULES, V13, P0, DOI 10.3390/biom13010126
   Vasandani C, 2020, J CLIN ENDOCR METAB, V105, P2132, DOI 10.1210/clinem/dgaa137
   Zammouri J, 2022, FRONT ENDOCRINOL, V12, P0, DOI 10.3389/fendo.2021.803189
NR 11
TC 0
Z9 0
U1 0
U2 0
PU SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA
PI RIO DE JANEIRO, RJ
PA RUA HUMAITA, 85 CJ 501, RIO DE JANEIRO, RJ, 22261-000, BRAZIL
SN 2359-3997
EI 2359-4292
J9 ARCH ENDOCRIN METAB
JI Arch. Endocrinol. Metab.
PD JUN 15
PY 2024
VL 68
IS 
BP 
EP 
DI 10.20945/2359-4292-2023-0084
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA YE9X4
UT WOS:001266937500001
PM 39420889
DA 2024-11-01
ER

PT J
AU Olimpio, C
   Paramonov, I
   Matalonga, L
   Laurie, S
   Schon, K
   Polavarapu, K
   Kirschner, J
   Schara-Schmidt, U
   LochmÃ¼ller, H
   Chinnery, PF
   Horvath, R
AF Olimpio, Catarina
   Paramonov, Ida
   Matalonga, Leslie
   Laurie, Steven
   Schon, Katherine
   Polavarapu, Kiran
   Kirschner, Janbernd
   Schara-Schmidt, Ulrike
   Lochmueller, Hanns
   Chinnery, Patrick F.
   Horvath, Rita
TI Increased Diagnostic Yield by Reanalysis of Whole Exome Sequencing Data in Mitochondrial Disease
SO JOURNAL OF NEUROMUSCULAR DISEASES
LA English
DT Article
DE Mitochondrial diseases; respiratory chain deficiencies; next generation sequencing; mitochondrial genes
ID medical genetics; american-college; mutations; myopathy; genomics
AB Background: The genetic diagnosis of mitochondrial disorders is complicated by its genetic and phenotypic complexity. Next generation sequencing techniques have much improved the diagnostic yield for these conditions. A cohort of individuals with multiple respiratory chain deficiencies, reported in the literature 10 years ago, had a diagnostic rate of 60% by whole exome sequencing (WES) but 40% remained undiagnosed. Objective: We aimed to identify a genetic diagnosis by reanalysis of the WES data for the undiagnosed arm of this 10-year-old cohort of patients with suspected mitochondrial disorders. Methods: The WES data was transferred and processed by the RD-Connect Genome-Phenome Analysis Platform (GPAP) using their standardized pipeline. Variant prioritisation was carried out on the RD-Connect GPAP. Results: Singleton WES data from 14 individuals was reanalysed. We identified a possible or likely genetic diagnosis in 8 patients (8/14, 57%). The variants identified were in a combination of mitochondrial DNA (n= 1, MT-TN), nuclear encoded mitochondrial genes (n= 2, PDHA1, and SUCLA2) and nuclear genes associated with nonmitochondrial disorders (n= 5, PNPLA2, CDC40, NBAS and SLC7A7). Variants in both the NBAS and CDC40 genes were established as disease causing after the original cohort was published. We increased the diagnostic yield for the original cohort by 15% without generating any further genomic data. Conclusions: In the era of multiomics we highlight that reanalysis of existing WES data is a valid tool for generating additional diagnosis in patients with suspected mitochondrial disease, particularly when more time has passed to allow for new bioinformatic pipelines to emerge, for the development of new tools in variant interpretation aiding in reclassification of variants and the expansion of scientific knowledge on additional genes.
C1 [Olimpio, Catarina; Schon, Katherine; Horvath, Rita] Univ Cambridge, John Van Geest Ctr Brain Repair, Dept Clin Neurosci, Robinson Way, Cambridge CB2 0PY, England.
   [Olimpio, Catarina; Schon, Katherine] Cambridge Univ Hosp NHS Fdn Trust, East Anglian Med Genet Serv, Cambridge, England.
   [Paramonov, Ida; Matalonga, Leslie; Laurie, Steven; Lochmueller, Hanns] Ctr Nacl Anal Genom, Barcelona, Spain.
   [Kirschner, Janbernd; Lochmueller, Hanns] Univ Freiburg, Med Ctr, Fac Med, Dept Neuropediat & Muscle Disorders, Freiburg, Germany.
   [Schara-Schmidt, Ulrike] Univ Hosp Essen, C TNBS, Ctr Neuromuscular Disorders, Dept Pediat Neurol, Essen, Germany.
   [Polavarapu, Kiran; Lochmueller, Hanns] Childrens Hosp Eastern Ontario Res Inst, Ottawa, ON, Canada.
   [Lochmueller, Hanns] Univ Ottawa, Brain & Mind Res Inst, Ottawa, ON, Canada.
   [Polavarapu, Kiran; Lochmueller, Hanns] Ottawa Hosp, Dept Med, Div Neurol, Ottawa, ON, Canada.
   [Chinnery, Patrick F.] Univ Cambridge, Dept Clin Neurosci, MRC Mitochondrial Biol Unit, Cambridge, England.
C3 University of Cambridge; University of Cambridge; University of Freiburg; University of Duisburg Essen; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Cambridge
RP Horvath, R (corresponding author), Univ Cambridge, John Van Geest Ctr Brain Repair, Dept Clin Neurosci, Robinson Way, Cambridge CB2 0PY, England.
EM rh732@medschl.cam.ac.uk
FU Evelyn Trust [G117372]; Wellcome Trust [G118015]; Muscular Dystrophy UK; Medical Research Council (UK) [MR/V009346/1]; Addenbrookes Charitable Trust [G100142]; Evelyn Trust; Stoneygate Trust; Lily Foundation; Action for AT; MRC [MR/S005021/1]; NIHR Cambridge Biomedical Research Centre [BRC-1215-20014]
CR Bartsakoulia M, 2018, HUM MOL GENET, V27, P1186, DOI 10.1093/hmg/ddy033
   Chai GL, 2021, NEURON, V109, P241, DOI 10.1016/j.neuron.2020.10.035
   de Boer E, 2021, EUR J HUM GENET, V29, P1359, DOI 10.1038/s41431-021-00900-2
   Deignan JL, 2019, GENET MED, V21, P1267, DOI 10.1038/s41436-019-0478-1
   Ellard S, 2020, ACGS BEST PRACTICE G, V0, P0, DOI DOI 10.1101/531210
   Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194
   Garret P, 2019, HUM MUTAT, V40, P2430, DOI 10.1002/humu.23885
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Haack TB, 2015, AM J HUM GENET, V97, P163, DOI 10.1016/j.ajhg.2015.05.009
   Issa MY, 2020, BMC MED GENOMICS, V13, P0, DOI 10.1186/s12920-020-0714-1
   Jousserand G, 2016, M S-MED SCI, V32, P10, DOI 10.1051/medsci/201632s203
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Laurie S, 2022, HUM MUTAT, V43, P717, DOI 10.1002/humu.24353
   Matalonga L, 2021, EUR J HUM GENET, V29, P1337, DOI 10.1038/s41431-021-00852-7
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   McCormick EM, 2020, HUM MUTAT, V41, P2028, DOI 10.1002/humu.24107
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Mingirulli N, 2020, J INHERIT METAB DIS, V43, P297, DOI 10.1002/jimd.12156
   OBrien TD, 2022, GENET MED, V24, P192, DOI 10.1016/j.gim.2021.09.007
   Otero LJ, 1998, HUM MUTAT, V12, P114, DOI 10.1002/(SICI)1098-1004(1998)12:2<114::AID-HUMU6>3.0.CO;2-#
   Pennisi EM, 2017, ORPHANET J RARE DIS, V12, P0, DOI 10.1186/s13023-017-0646-9
   Poole OV, 2021, ANN NEUROL, V89, P1240, DOI 10.1002/ana.26063
   Puusepp S, 2018, MOL GENET METAB REP, V15, P80, DOI 10.1016/j.ymgmr.2018.03.004
   Pyle A, 2015, NEUROL-GENET, V1, P0, DOI 10.1212/NXG.0000000000000006
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Sanchis-Juan A, 2023, AM J HUM GENET, V110, P1343, DOI 10.1016/j.ajhg.2023.07.007
   Schon KR, 2021, BMJ-BRIT MED J, V375, P0, DOI 10.1136/bmj-2021-066288
   Sperandeo MP, 2008, HUM MUTAT, V29, P14, DOI 10.1002/humu.20589
   Spinazzola A, 2004, NEUROMUSCULAR DISORD, V14, P815, DOI 10.1016/j.nmd.2004.09.002
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Theunissen TEJ, 2018, FRONT GENET, V9, P0, DOI 10.3389/fgene.2018.00400
   Thompson JLP, 2023, ORPHANET J RARE DIS, V18, P0, DOI 10.1186/s13023-023-02754-x
   TÃ¶pf A, 2021, EUR J HUM GENET, V29, P1348, DOI 10.1038/s41431-021-00851-8
   Wortmann SB, 2017, NEUROPEDIATRICS, V48, P309, DOI 10.1055/s-0037-1603776
   Wright CF, 2023, NEW ENGL J MED, V388, P1559, DOI 10.1056/NEJMoa2209046
   Zurek B, 2021, EUR J HUM GENET, V29, P1325, DOI 10.1038/s41431-021-00859-0
NR 36
TC 0
Z9 0
U1 0
U2 0
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 2214-3599
EI 2214-3602
J9 J NEUROMUSCULAR DIS
JI J. Neuromusc. Dis.
PD JUN 15
PY 2024
VL 11
IS 4
BP 767
EP 775
DI 10.3233/JND-240020
PG 9
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA ZC5C4
UT WOS:001273094500003
PM 38759022
DA 2024-11-01
ER

PT J
AU Casas, RB
   Zuppardo, A
   Risato, G
   Dinarello, A
   Celeghin, R
   Fontana, C
   Grelloni, E
   Gilea, AI
   Viscomi, C
   Rasola, A
   Dalla Valle, L
   Lodi, T
   Baruffini, E
   Facchinello, N
   Argenton, F
   Tiso, N
AF Casas, Raquel Branas
   Zuppardo, Alessandro
   Risato, Giovanni
   Dinarello, Alberto
   Celeghin, Rudy
   Fontana, Camilla
   Grelloni, Eleonora
   Gilea, Alexandru Ionut
   Viscomi, Carlo
   Rasola, Andrea
   Dalla Valle, Luisa
   Lodi, Tiziana
   Baruffini, Enrico
   Facchinello, Nicola
   Argenton, Francesco
   Tiso, Natascia
TI Zebrafish <i>polg2</i> knock-out recapitulates human POLG-disorders; implications for drug treatment
SO CELL DEATH & DISEASE
LA English
DT Article
ID dna-polymerase-gamma; mitochondrial genome maintenance; depletion
AB The human mitochondrial DNA polymerase gamma is a holoenzyme, involved in mitochondrial DNA (mtDNA) replication and maintenance, composed of a catalytic subunit (POLG) and a dimeric accessory subunit (POLG2) conferring processivity. Mutations in POLG or POLG2 cause POLG-related diseases in humans, leading to a subset of Mendelian-inherited mitochondrial disorders characterized by mtDNA depletion (MDD) or accumulation of multiple deletions, presenting multi-organ defects and often leading to premature death at a young age. Considering the paucity of POLG2 models, we have generated a stable zebrafish polg2 mutant line (polg2(ia304)) by CRISPR/Cas9 technology, carrying a 10-nucleotide deletion with frameshift mutation and premature stop codon. Zebrafish polg2 homozygous mutants present slower development and decreased viability compared to wild type siblings, dying before the juvenile stage. Mutants display a set of POLG-related phenotypes comparable to the symptoms of human patients affected by POLG-related diseases, including remarkable MDD, altered mitochondrial network and dynamics, and reduced mitochondrial respiration. Histological analyses detected morphological alterations in high-energy demanding tissues, along with a significant disorganization of skeletal muscle fibres. Consistent with the last finding, locomotor assays highlighted a decreased larval motility. Of note, treatment with the Clofilium tosylate drug, previously shown to be effective in POLG models, could partially rescue MDD in Polg2 mutant animals. Altogether, our results point at zebrafish as an effective model to study the etiopathology of human POLG-related disorders linked to POLG2, and a suitable platform to screen the efficacy of POLG-directed drugs in POLG2-associated forms.
C1 [Casas, Raquel Branas; Risato, Giovanni; Dinarello, Alberto; Fontana, Camilla; Grelloni, Eleonora; Dalla Valle, Luisa; Argenton, Francesco; Tiso, Natascia] Univ Padua, Dept Biol, I-35131 Padua, Italy.
   [Zuppardo, Alessandro; Viscomi, Carlo; Rasola, Andrea] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy.
   [Risato, Giovanni; Celeghin, Rudy] Univ Padua, Dept Cardiothoraco Vasc Sci & Publ Hlth, I-35128 Padua, Italy.
   [Dinarello, Alberto] Univ Copenhagen, Novo Nord Fdn Ctr Stem Cell Med reNEW, DK-2200 Copenhagen, Denmark.
   [Fontana, Camilla] Chiang Mai Univ, Fac Agr, Dept Anim & Aquat Sci, Chiang Mai 50200, Thailand.
   [Gilea, Alexandru Ionut; Lodi, Tiziana; Baruffini, Enrico] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, I-43124 Parma, Italy.
   [Facchinello, Nicola] Neurosci Inst, Italian Res Council CNR, I-35131 Padua, Italy.
C3 University of Padua; University of Padua; University of Padua; University of Copenhagen; Chiang Mai University; University of Parma
RP Argenton, F; Tiso, N (corresponding author), Univ Padua, Dept Biol, I-35131 Padua, Italy.; Facchinello, N (corresponding author), Neurosci Inst, Italian Res Council CNR, I-35131 Padua, Italy.
EM nicola.facchinello@cnr.it; francesco.argenton@unipd.it; natascia.tiso@unipd.it
FU Fondazione Telethon (Telethon Foundation) [GGP20013]; Italian Telethon Foundation [IG-2017-19928]; AIRC [23706]; AFM-Telethon [PNRR M4C2 CN00000041]; Italian Ministry of University and Research; Associazione Luigi Comini Onlus [SID2022]; Department of Biomedical Sciences, UniPD
CR AlestrÃ¶m P, 2020, LAB ANIM-UK, V54, P213, DOI 10.1177/0023677219869037
   Basel D, 2020, CLIN PERINATOL, V47, P123, DOI 10.1016/j.clp.2019.10.008
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Facchinello N, 2021, CELL DEATH DIS, V12, P0, DOI 10.1038/s41419-020-03359-z
   Facchinello N, 2016, METHODS MOL BIOL, V1481, P81, DOI 10.1007/978-1-4939-6393-5_9
   Faria M, 2019, SCI TOTAL ENVIRON, V650, P87, DOI 10.1016/j.scitotenv.2018.08.421
   Fuke S, 2014, ANN CLIN TRANSL NEUR, V1, P909, DOI 10.1002/acn3.133
   Gagnon JA, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0098186
   Guha M, 2013, MITOCHONDRION, V13, P577, DOI 10.1016/j.mito.2013.08.007
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Herst PM, 2017, FRONT ENDOCRINOL, V8, P0, DOI 10.3389/fendo.2017.00296
   Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506
   Kim MJ, 2008, BIOTECHNIQUES, V45, P331, DOI 10.2144/000112909
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Korzh S, 2008, BMC DEV BIOL, V8, P0, DOI 10.1186/1471-213X-8-84
   Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197
   Ma ZP, 2020, ZEBRAFISH, V17, P157, DOI 10.1089/zeb.2019.1824
   MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011
   Nogueira C, 2014, ITAL J PEDIATR, V40, P0, DOI 10.1186/1824-7288-40-34
   Pitayu L, 2016, HUM MOL GENET, V25, P715, DOI 10.1093/hmg/ddv509
   Popoiu TA, 2023, CURR HEART FAIL REP, V20, P76, DOI 10.1007/s11897-023-00592-3
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rahn JJ, 2015, NUCLEIC ACIDS RES, V43, P10338, DOI 10.1093/nar/gkv1139
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x
   Stocco A, 2021, PHARMACOL RES, V165, P0, DOI 10.1016/j.phrs.2021.105421
   Stumpf JD, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011395
   Vettori A, 2017, P NATL ACAD SCI USA, V114, P9948, DOI 10.1073/pnas.1705338114
   Viscomi C, 2017, J INHERIT METAB DIS, V40, P587, DOI 10.1007/s10545-017-0027-5
   Westerfield M, 2000, ZEBRAFISH BOOK GUIDE, V0, P0
   Wojtaszek JL, 2023, NUCLEIC ACIDS RES, V51, P9716, DOI 10.1093/nar/gkad679
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Zhao LL, 2019, ENZYMES, V45, P311, DOI 10.1016/bs.enz.2019.08.004
NR 35
TC 0
Z9 0
U1 0
U2 0
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2041-4889
EI 
J9 CELL DEATH DIS
JI Cell Death Dis.
PD APR 20
PY 2024
VL 15
IS 4
BP 
EP 
DI 10.1038/s41419-024-06622-9
PG 12
WC Cell Biology
SC Cell Biology
GA OF8H3
UT WOS:001205938400001
PM 38643274
DA 2024-11-01
ER

PT J
AU Nakhonsri, V
   Kaewsutthi, S
   Suktitipat, B
   Suthammarak, W
   Chuenkongkaew, WL
   Wasitthankasem, R
   Tongsima, S
   Lertrit, P
AF Nakhonsri, Vorthunju
   Kaewsutthi, Supannee
   Suktitipat, Bhoom
   Suthammarak, Wichit
   Chuenkongkaew, Wanicha L.
   Wasitthankasem, Rujipat
   Tongsima, Sissades
   Lertrit, Patcharee
TI Exome Sequencing Reveals a Rare Autosomal Dominant Variant in MSTO1 Gene as a Novel Leber's Hereditary Optic Neuropathy (LHON) Modifier in a Thai Family with High Penetrance of G11778A Mutation
SO JOURNAL OF HEALTH RESEARCH
LA English
DT Article
DE LHON; G11778A mtDNA; MSTO1; Nuclear modifier
ID mitochondrial-dna mutations; amino-acid substitutions; database; protein; identification; predictions; myopathy; spectrum; dynamics; atrophy
AB Background: Leber's hereditary optic neuropathy (LHON) is a prevalent mitochondrial disease that is predominantly caused by mitochondrial (mtDNA) mutations. However, not all siblings with identical LHON mutations develop visual impairment, suggesting the influence of nuclear genetic variants. This study explores the role of these variants in LHON expression among siblings and relatives with the same maternal LHON mutations. Methods: A family with a homoplasmic G11778A mutation displaying significant LHON penetrance (50 % in female carriers) was examined. Exome sequencing was performed on four members (two affected, two unaffected). Detected variations were predicted using a Variant Effect Predictor (VEP) with a dbNSFP (database for nonsynonymous single nucleotide polymorphisms' functional predictions) plugin. Candidate variants were chosen based on their scores and LHON-related gene variations. Sanger sequencing was used for validation of 15 family members. Results: Exome analysis identified nine potential variations across eight genes. However, only the MSTO1 c.692 693delCC mutation showed a significant linkage to LHON expression in both additive (adj. p -value = 0.04) and dominant models (adj. p -value = 0.0112). This rare variant, located at the cleavage and polyadenylation site of the MSTO1 gene, could disrupt transcriptional termination, and thus alter MSTO1 gene expression. Conclusions: Given the role of the MSTO1 gene in controlling mitochondrial morphology, the MSTO1 c.692 693delCC mutation might instigate mitochondrial dysfunction. Thus, the MSTO1 gene is potentially a novel nuclear modifier for LHON. These findings pave the way for further research into the underlying mechanisms of LHON.
C1 [Nakhonsri, Vorthunju; Kaewsutthi, Supannee; Suktitipat, Bhoom; Suthammarak, Wichit; Lertrit, Patcharee] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Biochem, Bangkok, Thailand.
   [Nakhonsri, Vorthunju; Wasitthankasem, Rujipat; Tongsima, Sissades] Natl Sci & Technol Dev Agcy, Natl Biobank Thailand, Pathum Thani 12120, Khong Luang, Thailand.
   [Chuenkongkaew, Wanicha L.] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Ophthalmol, Bangkok, Thailand.
C3 Mahidol University; National Science & Technology Development Agency - Thailand; Mahidol University
RP Lertrit, P (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Biochem, Bangkok, Thailand.
EM lertrito@yahoo.com
FU Royal Golden Jubilee PhD Program [PHD/0368/2552]; Mahidol University [R015820002]
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Cagalinec M, 2016, PLOS BIOL, V14, P0, DOI 10.1371/journal.pbio.1002511
   Cai Q, 2020, CELLS-BASEL, V9, P0, DOI 10.3390/cells9010150
   Carbon S, 2019, NUCLEIC ACIDS RES, V47, PD330, DOI 10.1093/nar/gky1055
   Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195
   Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109
   Clarke R, 2012, CANCER RES, V72, P1321, DOI 10.1158/0008-5472.CAN-11-3213
   Dagda RK, 2015, REV NEUROSCIENCE, V26, P359, DOI 10.1515/revneuro-2014-0085
   Delettre C, 2002, MOL GENET METAB, V75, P97, DOI 10.1006/mgme.2001.3278
   Donkervoort S, 2019, ACTA NEUROPATHOL, V138, P1013, DOI 10.1007/s00401-019-02059-z
   EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547
   Fu J, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004579
   Gal A, 2017, EMBO MOL MED, V9, P967, DOI 10.15252/emmm.201607058
   Gehring NH, 2001, NAT GENET, V28, P389, DOI 10.1038/ng578
   Giordano C, 2014, BRAIN, V137, P335, DOI 10.1093/brain/awt343
   HARDING AE, 1995, AM J HUM GENET, V57, P77
   Hill JT, 2014, DEV DYNAM, V243, P1632, DOI 10.1002/dvdy.24183
   Janke C, 2020, NAT REV MOL CELL BIO, V21, P307, DOI 10.1038/s41580-020-0214-3
   Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7
   Kimura M, 2007, EXP CELL RES, V313, P1393, DOI 10.1016/j.yexcr.2007.02.004
   Kroeger H, 2019, FEBS J, V286, P399, DOI 10.1111/febs.14522
   Krueger SK, 2005, PHARMACOL THERAPEUT, V106, P357, DOI 10.1016/j.pharmthera.2005.01.001
   Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, PD1062, DOI 10.1093/nar/gkx1153
   Leber T, 1871, ARCH OPHTHALMOL-CHIC, V17, P249
   Lee KY, 2013, J CELL BIOL, V200, P31, DOI 10.1083/jcb.201206084
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   LI AR, 1995, J NEUROSCI, V15, P385
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li K, 2020, EUR J MED GENET, V63, P0, DOI 10.1016/j.ejmg.2019.01.013
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Liu XM, 2013, HUM MUTAT, V34, PE2393, DOI 10.1002/humu.22376
   Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517
   LÃ³pez-Gallardo E, 2018, FOOD CHEM TOXICOL, V120, P89, DOI 10.1016/j.fct.2018.07.014
   MACKEY D, 1992, AM J HUM GENET, V51, P1218
   Mashima Y, 1998, CURR EYE RES, V17, P403, DOI 10.1080/02713689808951221
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   McLaren W, 2016, GENOME BIOL, V17, P0, DOI 10.1186/s13059-016-0974-4
   Nasca A, 2017, HUM MUTAT, V38, P970, DOI 10.1002/humu.23262
   NEWMAN NJ, 1993, ARCH NEUROL-CHICAGO, V50, P540, DOI 10.1001/archneur.1993.00540050082021
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Palmer CS, 2011, CELL SIGNAL, V23, P1534, DOI 10.1016/j.cellsig.2011.05.021
   Phasukkijwatana N, 2006, J HUM GENET, V51, P298, DOI 10.1007/s10038-006-0361-1
   Phasukkijwatana N, 2010, HUM GENET, V128, P39, DOI 10.1007/s00439-010-0821-8
   Plutino M, 2018, BMC MED GENET, V19, P0, DOI 10.1186/s12881-018-0568-y
   R Core Team, 2020, R: A LANGUAGE AND ENVIRONMENT FOR STATISTICAL COMPUTING, V0, P0
   Rubinstein WS, 2013, NUCLEIC ACIDS RES, V41, PD925, DOI 10.1093/nar/gks1173
   Sambrook J, 2006, COLD SPRING HARB PRO, V0, P0, DOI DOI 10.1101/pdb.prot4455
   Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390
   Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890
   Sharma LK, 2020, HUM MOL GENET, V29, P352, DOI 10.1093/hmg/ddz224
   Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225
   Smibert P, 2012, CELL REP, V1, P277, DOI 10.1016/j.celrep.2012.01.001
   Sudoyo H, 2002, J HUM GENET, V47, P594, DOI 10.1007/s100380200091
   Stormo Gary D, 2013, CURR PROTOC BIOINFORMATICS, V43, P0, DOI 10.1002/0471250953.bi1110s43
   Vaser R, 2016, NAT PROTOC, V11, P1, DOI 10.1038/nprot.2015.123
   Wagner AH, 2013, EXP EYE RES, V111, P105, DOI 10.1016/j.exer.2013.03.004
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Ye CT, 2019, RNA BIOL, V16, P785, DOI 10.1080/15476286.2019.1586139
   Yen MY, 2002, JPN J OPHTHALMOL, V46, P45, DOI 10.1016/S0021-5155(01)00460-9
   ZÃ¼chner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 62
TC 0
Z9 0
U1 0
U2 0
PU COLL PUBLIC HEALTH SCIENCES, CHULALONGKORN UNIV
PI BANGKOK
PA Sabbasastravicaya Building, 10-12 Floor for INST BUILDING 3 10 11 FLR, BANGKOK, 10330, THAILAND
SN 0857-4421
EI 2586-940X
J9 J HEALTH RES
JI J. Health Res.
PD JUN 15
PY 2024
VL 38
IS 3
BP 
EP 
DI 
PG 12
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA KJ3K9
UT WOS:001179551200001
DA 2024-11-01
ER

PT J
AU Manzoni, E
   Carli, S
   Gaignard, P
   Schlieben, LD
   Hirano, M
   Ronchi, D
   Gonzales, E
   Shimura, M
   Murayama, K
   Okazaki, Y
   Baric, I
   Ramadza, D
   Karall, D
   Mayr, J
   Martinelli, D
   La Morgia, C
   Primiano, G
   Santer, R
   Servidei, S
   Bris, C
   Cano, A
   Furlan, F
   Gasperini, S
   Laborde, N
   Lamperti, C
   Lenz, D
   Mancuso, M
   Montano, V
   Menni, F
   Musumeci, O
   Nesbitt, V
   Procopio, E
   Rouzier, C
   Staufner, C
   Taanman, JW
   Tal, G
   Ticci, C
   Cordelli, DM
   Carelli, V
   Procaccio, V
   Prokisch, H
   Garone, C
AF Manzoni, Eleonora
   Carli, Sara
   Gaignard, Pauline
   Schlieben, Lea Dewi
   Hirano, Michio
   Ronchi, Dario
   Gonzales, Emmanuel
   Shimura, Masaru
   Murayama, Kei
   Okazaki, Yasushi
   Baric, Ivo
   Ramadza, Danijela Petkovic
   Karall, Daniela
   Mayr, Johannes
   Martinelli, Diego
   La Morgia, Chiara
   Primiano, Guido
   Santer, Rene
   Servidei, Serenella
   Bris, Celine
   Cano, Aline
   Furlan, Francesca
   Gasperini, Serena
   Laborde, Nolwenn
   Lamperti, Costanza
   Lenz, Dominic
   Mancuso, Michelangelo
   Montano, Vincenzo
   Menni, Francesca
   Musumeci, Olimpia
   Nesbitt, Victoria
   Procopio, Elena
   Rouzier, Cecile
   Staufner, Christian
   Taanman, Jan-Willem
   Tal, Galit
   Ticci, Chiara
   Cordelli, Duccio Maria
   Carelli, Valerio
   Procaccio, Vincent
   Prokisch, Holger
   Garone, Caterina
TI Deoxyguanosine kinase deficiency: natural history and liver transplant outcome
SO BRAIN COMMUNICATIONS
LA English
DT Article
DE DGUOK; deoxyguanosine kinase; mitochondrial DNA; nucleosides; liver transplant
ID mitochondrial-dna depletion; respiratory-chain; dguok mutation; gene-mutations; hepatocerebral form; uniparental disomy; membrane protein; de-novo; features; mtdna
AB Autosomal recessive pathogenetic variants in the DGUOK gene cause deficiency of deoxyguanosine kinase activity and mitochondrial deoxynucleotides pool imbalance, consequently, leading to quantitative and/or qualitative impairment of mitochondrial DNA synthesis. Typically, patients present early-onset liver failure with or without neurological involvement and a clinical course rapidly progressing to death. This is an international multicentre study aiming to provide a retrospective natural history of deoxyguanosine kinase deficient patients. A systematic literature review from January 2001 to June 2023 was conducted. Physicians of research centres or clinicians all around the world caring for previously reported patients were contacted to provide followup information or additional clinical, biochemical, histological/histochemical, and molecular genetics data for unreported cases with a confirmed molecular diagnosis of deoxyguanosine kinase deficiency.<br /> A cohort of 202 genetically confirmed patients, 36 unreported, and 166 from a systematic literature review, were analyzed. Patients had a neonatal onset (<= 1 month) in 55.7% of cases, infantile (>1 month and <= 1 year) in 32.3%, pediatric (>1 year and <= 18 years) in 2.5% and adult (>18 years) in 9.5%. Kaplan-Meier analysis showed statistically different survival rates (P < 0.0001) among the four age groups with the highest mortality for neonatal onset. Based on the clinical phenotype, we defined four different clinical subtypes: hepatocerebral (58.8%), isolated hepatopathy (21.9%), hepatomyoencephalopathy (9.6%), and isolated myopathy (9.6%). Muscle involvement was predominant in adult-onset cases whereas liver dysfunction causes morbidity and mortality in early-onset patients with a median survival of less than 1 year. No genotype-phenotype correlation was identified. Liver transplant significantly modified the survival rate in 26 treated patients when compared with untreated. Only six patients had additional mild neurological signs after liver transplant.<br /> In conclusion, deoxyguanosine kinase deficiency is a disease spectrum with a prevalent liver and brain tissue specificity in neonatal and infantile-onset patients and muscle tissue specificity in adult-onset cases. Our study provides clinical, molecular genetics and biochemical data for early diagnosis, clinical trial planning and immediate intervention with liver transplant and/or nucleoside supplementation.
C1 [Manzoni, Eleonora; Carli, Sara; Cordelli, Duccio Maria; Garone, Caterina] Alma Mater Studiorum Univ Bologna, Dept Med & Surg Sci, Via Massarenti 11,Pad 11, I-40138 Bologna, Italy.
   [Carli, Sara; Cordelli, Duccio Maria; Garone, Caterina] IRCCS Ist Sci Neurolog, UO Neuropsichiatria eta Pediat Bologna, I-40124 Bologna, Italy.
   [Gaignard, Pauline] Univ Paris Saclay, Bicetre Hosp, Assistance Publ Hop Paris, Reference Ctr Mitochondrial Dis,Dept Biochem, F-94275 Paris, France.
   [Schlieben, Lea Dewi; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, Sch Med, D-80333 Munich, Germany.
   [Schlieben, Lea Dewi; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Neurogenom, Computat Hlth Ctr, D-80333 Neuherberg, Germany.
   [Hirano, Michio] Columbia Univ, Irving Med Ctr, H Houston Merritt Neuromuscular Res Ctr, Dept Neurol, New York, NY 10033 USA.
   [Ronchi, Dario] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy.
   [Gonzales, Emmanuel] Univ Paris Saclay, Bicetre Hosp, Assistance Publ Hop Paris, Reference Ctr Mitochondrial Dis,Pediat Hepatol & P, F-94270 Paris, France.
   [Shimura, Masaru; Murayama, Kei] Chiba Childrens Hosp, Ctr Med Genet, Dept Metab, Chiba 2600842, Japan.
   [Murayama, Kei; Okazaki, Yasushi] Juntendo Univ, Intractable Dis Res Ctr, Grad Sch Med, Diagnost & Therapeut Intractable Dis, Tokyo 1138421, Japan.
   [Baric, Ivo; Ramadza, Danijela Petkovic] Univ Hosp Ctr Zagreb, Dept Pediat, Zagreb 10000, Croatia.
   [Baric, Ivo; Ramadza, Danijela Petkovic] Univ Zagreb, Sch Med, Zagreb 10000, Croatia.
   [Karall, Daniela] Med Univ Innsbruck, Div Inherited Metab Disorders, Clin Pediat, A-6020 Innsbruck, Austria.
   [Mayr, Johannes] Paracelsus Med Univ PMU, Univ Childrens Hosp, A-5020 Salzburg, Austria.
   [Martinelli, Diego] Bambino Gesu Childrens Hosp IRCCS, Div Metab, I-00165 Rome, Italy.
   [La Morgia, Chiara; Carelli, Valerio] Univ Bologna, Dept Biomed & Neuromotor Sci, I-40123 Bologna, Italy.
   [La Morgia, Chiara; Carelli, Valerio] IRCCS Ist Sci Neurolog Bologna, Programma Neurogenet, I-40124 Bologna, Italy.
   [Primiano, Guido; Servidei, Serenella] Fdn Policlin Univ Agostino Gemelli IRCCS, Dipartimento Neurosci Organi Senso & Torace, Neurol, I-00136 Rome, Italy.
   [Primiano, Guido; Servidei, Serenella] Univ Cattolica Sacro Cuore, Dipartimento Neurosci, I-00168 Rome, Italy.
   [Santer, Rene] Univ Med Ctr Eppendorf, Dept Pediat, D-20246 Hamburg, Germany.
   [Bris, Celine; Procaccio, Vincent] Univ Angers, Angers Hosp, INSERM, CNRS,MITOVASC,SFR ICAT, F-49000 Angers, France.
   [Cano, Aline] CHU Timone Enfants, Ctr reference Malad hereditaires Metab, F-13005 Marseille, France.
   [Furlan, Francesca; Menni, Francesca] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Reg Clin Ctr Expanded Newborn Screening, I-20122 Milan, Italy.
   [Gasperini, Serena] Fdn IRCCS San Gerardo dei Tintori, Dept Pediat, I-20900 Monza, Italy.
   [Laborde, Nolwenn] CHU Toulouse, Hop Enfants, Unite Gastroenterol Hepatol Nutr & Malad Hereditai, F-31300 Toulouse, France.
   [Lamperti, Costanza] Fdn IRCCS Neurol Inst C Besta, Div Med Genet & Neurogenet, I-20133 Milan, Italy.
   [Lenz, Dominic; Staufner, Christian] Univ Hosp Heidelberg, Ctr Paediat & Adolescent Med, Div Neuropaediat & Paediat Metab Med, D-69120 Heidelberg, Germany.
   [Mancuso, Michelangelo; Montano, Vincenzo] Univ Pisa, Neurol Inst, Dept Clin & Expt Med, I-56126 Pisa, Italy.
   [Mancuso, Michelangelo; Montano, Vincenzo] AOUP, I-56126 Pisa, Italy.
   [Musumeci, Olimpia] Univ Messina, Dept Clin & Expt Med, Unit Neurol & Neuromuscular Disorders, I-98125 Messina, Italy.
   [Nesbitt, Victoria] Univ Oxford, Dept Paediat, Med Sci Div, Oxford OX3 9DU, England.
   [Procopio, Elena; Ticci, Chiara] Meyer Childrens Hosp IRCCS, Metab Unit, I-50139 Florence, Italy.
   [Rouzier, Cecile] Univ Cote dAzur, Ctr reference Malad Mitochondriales, Serv Genet Med, CHU Nice,CNRS,INSERM,IRCAN, F-06000 Nice, France.
   [Taanman, Jan-Willem] UCL, UCL Queen Sq Inst Neurol, Dept Clin & Movement Neurosci, London WC1N 3BG, England.
   [Tal, Galit] Ruth Rappaport Childrens Hosp, Metab Clin, Rambam Hlth Care Campus, IL-3109601 Haifa, Israel.
   [Tal, Galit] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, IL-3109601 Haifa, Israel.
C3 University of Bologna; Universite Paris Saclay; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Universite Paris Cite; Hopital Universitaire Saint-Louis - APHP; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; NewYork-Presbyterian Hospital; Columbia University; University of Milan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Hopital Universitaire Saint-Louis - APHP; Universite Paris Saclay; Chiba Children's Hospital; Juntendo University; University of Zagreb; University of Zagreb; Medical University of Innsbruck; Paracelsus Private Medical University; IRCCS Bambino Gesu; University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Hamburg; University Medical Center Hamburg-Eppendorf; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; IRCCS Ca Granda Ospedale Maggiore Policlinico; Fondazione IRCCS San Gerardo dei Tintori; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Ruprecht Karls University Heidelberg; University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Messina; University of Oxford; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Cote d'Azur; CHU Nice; University of London; University College London; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine
RP Garone, C (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Med & Surg Sci, Via Massarenti 11,Pad 11, I-40138 Bologna, Italy.
EM caterina.garone@unibo.it
FU Piano Nazionale di Ripresa e Resilienza [PNRR - M4C2 - 1.4 CN00000041 - CUP: J33C22001140001]; European Union
CR Al-Hussaini A, 2014, J PEDIATR-US, V164, P553, DOI 10.1016/j.jpeds.2013.10.082
   Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Almannai M, 2022, MOL GENET METAB, V137, P40, DOI 10.1016/j.ymgme.2022.07.003
   Almannai M, 2022, MEMBRANES-BASEL, V12, P0, DOI 10.3390/membranes12060625
   Almannai M, 2018, ESSAYS BIOCHEM, V62, P297, DOI 10.1042/EBC20170101
   AlMenabawy N, 2022, MITOCHONDRION, V65, P139, DOI 10.1016/j.mito.2022.06.004
   Arya VB, 2019, CLIN ENDOCRINOL, V91, P900, DOI 10.1111/cen.14084
   Bliksrud YT, 2005, J MOL MED-JMM, V83, P406, DOI 10.1007/s00109-005-0648-2
   Brahimi N, 2009, MOL GENET METAB, V97, P221, DOI 10.1016/j.ymgme.2009.03.007
   Buchaklian AH, 2012, MOL GENET METAB, V107, P92, DOI 10.1016/j.ymgme.2012.04.019
   Bychkov IO, 2021, MITOCHONDRION, V57, P205, DOI 10.1016/j.mito.2021.01.004
   Calvo SE, 2012, SCI TRANSL MED, V4, P0, DOI 10.1126/scitranslmed.3003310
   CÃ¡mara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Caporali L, 2018, BRAIN, V141, P0, DOI 10.1093/brain/awx301
   De Camaret BM, 2007, BIOCHEM J, V402, P377, DOI 10.1042/BJ20060705
   De Greef E, 2012, JIMD REP, V4, P5, DOI 10.1007/8904_2011_29
   DiMauro S, 2013, NEUROLOGY, V81, P281, DOI 10.1212/WNL.0b013e31829bfe89
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Dimmock DP, 2008, LIVER TRANSPLANT, V14, P1480, DOI 10.1002/lt.21556
   Dogulu N, 2021, J PEDIATR ENDOCR MET, V34, P1341, DOI 10.1515/jpem-2021-0108
   DomÃ­nguez-GonzÃ¡lez C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   DomÃ­nguez-GonzÃ¡lez C, 2019, ORPHANET J RARE DIS, V14, P0, DOI 10.1186/s13023-019-1071-z
   Douglas GV, 2011, J HUM GENET, V56, P834, DOI 10.1038/jhg.2011.112
   El-Hattab AW, 1993, GENEREVIEWS, V0, P0
   Eldredge JA, 2024, PEDIATR TRANSPLANT, V28, P0, DOI 10.1111/petr.14625
   Fang WY, 2017, ONCOTARGET, V8, P84309, DOI 10.18632/oncotarget.20905
   Filosto M, 2004, ACTA NEUROPATHOL, V108, P168, DOI 10.1007/s00401-004-0872-9
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Grabhorn E, 2014, LIVER TRANSPLANT, V20, P464, DOI 10.1002/lt.23830
   Hanchard NA, 2011, MOL GENET METAB, V103, P262, DOI 10.1016/j.ymgme.2011.03.006
   Harel T, 2016, AM J HUM GENET, V99, P831, DOI 10.1016/j.ajhg.2016.08.007
   Hassan S, 2020, PEDIATR TRANSPLANT, V24, P0, DOI 10.1111/petr.13714
   Haudry C, 2012, MOL GENET METAB, V107, P700, DOI 10.1016/j.ymgme.2012.10.008
   Jankowska I, 2021, CLIN RES HEPATOL GAS, V45, P0, DOI 10.1016/j.clinre.2020.02.018
   Ji JQ, 2010, MITOCHONDRION, V10, P188, DOI 10.1016/j.mito.2009.11.002
   Kasapkara ÃS, 2013, J PEDIATR GASTR NUTR, V57, PE28, DOI 10.1097/MPG.0b013e31826bd4ed
   KiliÃ§ M, 2011, TURKISH J PEDIATR, V53, P79
   Komal FNU, 2018, NEUROL-GENET, V4, P0, DOI 10.1212/NXG.0000000000000269
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Labarthe F, 2005, J HEPATOL, V43, P333, DOI 10.1016/j.jhep.2005.03.023
   Lam CW, 2019, CLIN CHIM ACTA, V496, P93, DOI 10.1016/j.cca.2019.06.028
   Lee NC, 2009, ARCH DIS CHILD, V94, P55, DOI 10.1136/adc.2008.139584
   Lipinski P, 2020, FRONT PEDIATR, V8, P0, DOI 10.3389/fped.2020.00414
   Mahjoub G, 2019, BMC MED GENET, V20, P0, DOI 10.1186/s12881-019-0893-9
   Majdalani M, 2023, FRONT GENET, V14, P0, DOI 10.3389/fgene.2023.1215083
   Mancuso M, 2005, ARCH NEUROL-CHICAGO, V62, P745, DOI 10.1001/archneur.62.5.745
   Mancuso M, 2003, ARCH NEUROL-CHICAGO, V60, P1445, DOI 10.1001/archneur.60.10.1445
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   McKiernan P, 2016, J PEDIATR GASTR NUTR, V63, P592, DOI 10.1097/MPG.0000000000001345
   Montano V, 2019, CASE REP NEUROL MED, V2019, P0, DOI 10.1155/2019/5918632
   Mudd SH, 2012, MOL GENET METAB, V105, P228, DOI 10.1016/j.ymgme.2011.11.006
   MÃ¼ller-HÃ¶cker J, 2002, HUM PATHOL, V33, P247, DOI 10.1053/hupa.2002.31477
   Munro B, 2019, HUM MOL GENET, V28, P796, DOI 10.1093/hmg/ddy389
   Navarro-Sastre A, 2012, MOL GENET METAB, V107, P409, DOI 10.1016/j.ymgme.2012.08.018
   Nobre S, 2012, BMJ CASE REP, V2012, P0
   Pronicka E, 2011, J APPL GENET, V52, P61, DOI 10.1007/s13353-010-0008-y
   Rabinowitz SS, 2004, J PEDIATR GASTR NUTR, V38, P216, DOI 10.1097/00005176-200402000-00022
   Ronchi D, 2012, BRAIN, V135, P3404, DOI 10.1093/brain/aws258
   Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284
   Sezer T, 2015, J CHILD NEUROL, V30, P124, DOI 10.1177/0883073813517000
   Shieh JTC, 2009, J PEDIATR GASTR NUTR, V49, P130, DOI 10.1097/MPG.0b013e31819de7a6
   Slama A, 2005, MOL GENET METAB, V86, P462, DOI 10.1016/j.ymgme.2005.09.006
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Tadiboyina VT, 2005, AM J MED GENET A, V135A, P289, DOI 10.1002/ajmg.a.30748
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Ãnal Ã, 2017, J PEDIATR ENDOCR MET, V30, P697, DOI 10.1515/jpem-2016-0268
   Vilarinho S, 2016, HEPATOLOGY, V63, P1977, DOI 10.1002/hep.28499
   Waich S, 2019, J PEDIATR GASTR NUTR, V68, PE1, DOI 10.1097/MPG.0000000000002149
   Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005
   Xia JK, 2020, PEDIATR NEONATOL, V61, P558, DOI 10.1016/j.pedneo.2020.04.005
   Yamazaki T, 2014, PEDIATR INT, V56, P180, DOI 10.1111/ped.12249
   ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118
NR 76
TC 1
Z9 1
U1 2
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 
EI 2632-1297
J9 BRAIN COMMUN
JI Brain Commun.
PD MAY 3
PY 2024
VL 6
IS 3
BP 
EP 
DI 10.1093/braincomms/fcae160
EA MAY 2024
PG 14
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA QY7F5
UT WOS:001224487900003
PM 38756539
DA 2024-11-01
ER

PT J
AU Du, JX
   Liu, FC
   Liu, XH
   Zhao, DD
   Wang, DD
   Sun, HS
   Yan, CZ
   Zhao, YY
AF Du, Jixiang
   Liu, Fuchen
   Liu, Xihan
   Zhao, Dandan
   Wang, Dongdong
   Sun, Hongsheng
   Yan, Chuanzhu
   Zhao, Yuying
TI Lysosomal dysfunction and overload of nucleosides in thymidine phosphorylase deficiency of MNGIE
SO JOURNAL OF TRANSLATIONAL MEDICINE
LA English
DT Article
DE TYMP; Thymidine phosphorylase; MNGIE; Lysosomal dysfunction; Nucleotide metabolism
ID cell growth-factor; membrane permeabilization; mitochondria; autophagy; transport; rna; inhibition; expression; depletion; promotes
AB Inherited deficiency of thymidine phosphorylase (TP), encoded by TYMP, leads to a rare disease with multiple mitochondrial DNA (mtDNA) abnormalities, mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). However, the impact of TP deficiency on lysosomes remains unclear, which are important for mitochondrial quality control and nucleic acid metabolism. Muscle biopsy tissue and skin fibroblasts from MNGIE patients, patients with m.3243 A > G mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) and healthy controls (HC) were collected to perform mitochondrial and lysosomal functional analyses. In addition to mtDNA abnormalities, compared to controls distinctively reduced expression of LAMP1 and increased mitochondrial content were detected in the muscle tissue of MNGIE patients. Skin fibroblasts from MNGIE patients showed decreased expression of LAMP2, lowered lysosomal acidity, reduced enzyme activity and impaired protein degradation ability. TYMP knockout or TP inhibition in cells can also induce the similar lysosomal dysfunction. Using lysosome immunoprecipitation (Lyso- IP), increased mitochondrial proteins, decreased vesicular proteins and V-ATPase enzymes, and accumulation of various nucleosides were detected in lysosomes with TP deficiency. Treatment of cells with high concentrations of dThd and dUrd also triggers lysosomal dysfunction and disruption of mitochondrial homeostasis. Therefore, the results provided evidence that TP deficiency leads to nucleoside accumulation in lysosomes and lysosomal dysfunction, revealing the widespread disruption of organelles underlying MNGIE.
C1 [Du, Jixiang; Sun, Hongsheng] Shandong First Med Univ, Dept Rheumatol & Immunol, Shandong Prov Hosp, Jinan 250021, Shandong, Peoples R China.
   [Du, Jixiang; Liu, Fuchen; Zhao, Dandan; Wang, Dongdong; Yan, Chuanzhu; Zhao, Yuying] Shandong Univ, Qilu Hosp, Res Inst Neuromuscular & Neurodegenerat Dis, Cheeloo Coll Med,Dept Neurol, West Wenhua St 107, Jinan 250012, Shandong, Peoples R China.
   [Du, Jixiang; Sun, Hongsheng] Shandong Univ, Shandong Prov Hosp, Cheeloo Coll Med, Dept Rheumatol & Immunol, Jinan 250021, Shandong, Peoples R China.
   [Liu, Xihan] Shandong Univ, Qilu Hosp, Sch Basic Med Sci, Dept Obstet & Gynecol,Key Lab Expt Teratol,Minist, Jinan 250012, Shandong, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Qilu Hosp Qingdao, Cheeloo Coll Med, Mitochondrial Med Lab, Qingdao 266000, Shandong, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Brain Sci Res Inst, Jinan 250012, Shandong, Peoples R China.
C3 Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Shandong University; Shandong University
RP Yan, CZ; Zhao, YY (corresponding author), Shandong Univ, Qilu Hosp, Res Inst Neuromuscular & Neurodegenerat Dis, Cheeloo Coll Med,Dept Neurol, West Wenhua St 107, Jinan 250012, Shandong, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Qilu Hosp Qingdao, Cheeloo Coll Med, Mitochondrial Med Lab, Qingdao 266000, Shandong, Peoples R China.; Yan, CZ (corresponding author), Shandong Univ, Brain Sci Res Inst, Jinan 250012, Shandong, Peoples R China.
EM czyan@sdu.edu.cn; zyy72@126.com
FU National Key Research and Development Program of China [2021YFC2700904]
CR Aizawa S, 2016, AUTOPHAGY, V12, P565, DOI 10.1080/15548627.2016.1145325
   Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200
   Bao FX, 2022, SCI ADV, V8, P0, DOI 10.1126/sciadv.abk2376
   Baris A, 2023, CELL DEATH DIS, V14, P0, DOI 10.1038/s41419-023-05821-0
   Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310
   Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037
   Cai XY, 2018, REDOX BIOL, V18, P65, DOI 10.1016/j.redox.2018.06.010
   CÃ¡mara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Cantarero L, 2020, HUM MOL GENET, V29, P3589, DOI 10.1093/hmg/ddaa243
   Chan XCY, 2015, J MOL CELL CARDIOL, V78, P54, DOI 10.1016/j.yjmcc.2014.10.012
   Chapouly C, 2015, BRAIN, V138, P1548, DOI 10.1093/brain/awv077
   Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010
   Demers-Lamarche J, 2016, J BIOL CHEM, V291, P10263, DOI 10.1074/jbc.M115.695825
   Deus CM, 2020, TRENDS MOL MED, V26, P71, DOI 10.1016/j.molmed.2019.10.009
   Du JX, 2023, J MOL MED, V0, P0, DOI DOI 10.1007/s00109-023-02358-9
   Eapen VV, 2021, ELIFE, V10, P0, DOI 10.7554/eLife.72328
   Fernandez-Mosquera L, 2019, AUTOPHAGY, V15, P1572, DOI 10.1080/15548627.2019.1586256
   Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200
   Frankel LB, 2017, AUTOPHAGY, V13, P3, DOI 10.1080/15548627.2016.1222992
   Gautheron J, 2022, BMC MED, V20, P0, DOI 10.1186/s12916-022-02296-2
   GonzÃ¡lez-Vioque E, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002035
   Guo YT, 2018, CELL, V175, P1430, DOI 10.1016/j.cell.2018.09.057
   Hase K, 2015, NUCLEIC ACIDS RES, V43, P6439, DOI 10.1093/nar/gkv579
   Hirano M, 2021, J INHERIT METAB DIS, V44, P376, DOI 10.1002/jimd.12300
   Honda S, 2014, NAT COMMUN, V5, P0, DOI 10.1038/ncomms5004
   Huang HH, 2015, EMBO J, V34, P154, DOI 10.15252/embj.201489083
   Ivanov A, 2013, J CELL BIOL, V202, P129, DOI 10.1083/jcb.201212110
   Jiao HF, 2021, CELL, V184, P2896, DOI 10.1016/j.cell.2021.04.027
   Juhl AD, 2021, SCI REP-UK, V11, P0, DOI 10.1038/s41598-021-87876-7
   Khalil S, 2017, BLOOD ADV, V1, P1181, DOI 10.1182/bloodadvances.2016003772
   Kleele T, 2021, NATURE, V593, P435, DOI 10.1038/s41586-021-03510-6
   Klionsky DJ, 2021, AUTOPHAGY, V17, P1, DOI 10.1080/15548627.2020.1797280
   Lan YY, 2014, CELL REP, V9, P180, DOI 10.1016/j.celrep.2014.08.074
   Li W, 2014, CIRC RES, V115, P997, DOI 10.1161/CIRCRESAHA.115.304591
   Li Y, 2022, CELL DEATH DIS, V13, P0, DOI 10.1038/s41419-021-04469-y
   Lin H, 2019, ANTIMICROB AGENTS CH, V63, P0, DOI 10.1128/AAC.01443-18
   Liu H, 2016, SCI TRANSL MED, V8, P0, DOI 10.1126/scitranslmed.aad8949
   Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422
   Luhtala N, 2010, TRENDS BIOCHEM SCI, V35, P253, DOI 10.1016/j.tibs.2010.02.002
   Mito T, 2022, CELL METAB, V34, P197, DOI 10.1016/j.cmet.2021.12.017
   MIYAZONO K, 1987, J BIOL CHEM, V262, P4098
   Nakajima A, 2008, J BIOL CHEM, V283, P24128, DOI 10.1074/jbc.M802996200
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256
   OBrien TS, 1996, CANCER RES, V56, P4799
   Olesen MA, 2022, TRANSL NEURODEGENER, V11, P0, DOI 10.1186/s40035-022-00308-y
   Onoue K, 2013, J CELL SCI, V126, P176, DOI 10.1242/jcs.111211
   Pastor-Anglada M, 2022, INT J MOL SCI, V23, P0, DOI 10.3390/ijms23158770
   Peng W, 2020, P NATL ACAD SCI USA, V117, P19266, DOI 10.1073/pnas.2003236117
   PISONI RL, 1989, J BIOL CHEM, V264, P4850
   Rahman MF, 2018, DRUG METAB DISPOS, V46, P600, DOI 10.1124/dmd.117.079400
   Rahman MF, 2017, J BIOL CHEM, V292, P14775, DOI 10.1074/jbc.M117.787952
   Raimundo N, 2016, INT J BIOCHEM CELL B, V79, P345, DOI 10.1016/j.biocel.2016.08.020
   Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483
   Shim MS, 2020, AUTOPHAGY, V16, P1248, DOI 10.1080/15548627.2019.1662584
   Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057
   Stankov MV, 2013, ANTIMICROB AGENTS CH, V57, P543, DOI 10.1128/AAC.01560-12
   Stankov MV, 2012, AIDS, V26, P1995, DOI 10.1097/QAD.0b013e32835804f9
   Toyoda Y, 2014, ARTHRITIS RHEUMATOL, V66, P560, DOI 10.1002/art.38263
   Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002
   Wei CW, 2018, CELL REP, V23, P2330, DOI 10.1016/j.celrep.2018.04.077
   Wong YC, 2018, NATURE, V554, P382, DOI 10.1038/nature25486
   Wyant GA, 2018, SCIENCE, V360, P751, DOI 10.1126/science.aar2663
   Yagi M, 2021, EMBO J, V40, P0, DOI 10.15252/embj.2020105268
   Zhang XL, 2014, PATHOLOGY, V46, P316, DOI 10.1097/PAT.0000000000000094
   Zunke F, 2019, NEUROBIOL DIS, V127, P147, DOI 10.1016/j.nbd.2019.01.018
NR 66
TC 0
Z9 0
U1 12
U2 12
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1479-5876
J9 J TRANSL MED
JI J. Transl. Med.
PD MAY 13
PY 2024
VL 22
IS 1
BP 
EP 
DI 10.1186/s12967-024-05275-8
PG 19
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA QO2M9
UT WOS:001221748900008
PM 38741129
DA 2024-11-01
ER

PT J
AU Zhao, R
   Dong, C
   Liang, Q
   Gao, JL
   Sun, C
   Gu, ZF
   Zhu, YJ
AF Zhao, Rui
   Dong, Chen
   Liang, Qian
   Gao, Jianlin
   Sun, Chi
   Gu, Zhifeng
   Zhu, Yujuan
TI Engineered Mitochondrial Transplantation as An Anti-Aging Therapy
SO AGING AND DISEASE
LA English
DT Review; Early Access
DE Mitochondrial transplantation; Mitochondrial transfer; Anti-aging; Engineered mitochondria
ID skeletal-muscle mitochondrial; tunneling nanotubes; stem-cell; extracellular vesicles; molecular-mechanisms; parkinsons-disease; oxidative stress; oocyte quality; dna deletions; dysfunction
AB Aging is an inevitable and complex biological process involving multi-factorial mechanisms. Mitochondrial dysfunction is a critical factor in the aging process, characterized by a decline in mitochondrial quality and activity, leading to aging and aging-related diseases. Therefore, mitochondria have become an attractive target in anti-aging therapies. Several senolytic drugs targeting mitochondria and antioxidant agents have been used in antiaging research in the past few years. However, these strategies may cause adverse effects with long-term medication. In this extensive review, we propose "mitochondrial transplantation," which transfers healthy mitochondria from donor cells to recipient cells to replace damaged or dysfunctional mitochondria, as a new alternative strategy for treating mitochondrial dysfunction and aging-associated diseases. In this review, we introduce the contemporary landscape of mitochondrial transplantation, then discuss intensely the successful applications of mitochondrial transplantation therapy in aging diseases such as neurodegenerative diseases, cardiovascular aging, and reproductive aging, highlighting its translational potential. Finally, we summarize and prospect the challenges and opportunities mitochondrial transplantation faces in anti-aging therapy.
C1 [Zhao, Rui; Dong, Chen; Liang, Qian; Zhu, Yujuan] Nantong Univ, Affiliated Hosp, Res Ctr Clin Med, Nantong, Peoples R China.
   [Zhao, Rui; Dong, Chen; Liang, Qian; Gao, Jianlin; Sun, Chi; Gu, Zhifeng] Nantong Univ, Res Ctr Gerontol & Longev, Affiliated Hosp, Nantong, Peoples R China.
   [Gu, Zhifeng] Nantong Univ, Affiliated Hosp, Res Ctr Immunol, Dept Rheumatol, Nantong, Peoples R China.
   [Sun, Chi; Gu, Zhifeng; Zhu, Yujuan] Nantong Univ, Dept Geriatr, Affiliated Hosp, Nantong, Peoples R China.
C3 Nantong University; Nantong University; Nantong University; Nantong University
RP Sun, C; Gu, ZF; Zhu, YJ (corresponding author), Nantong Univ, Affiliated Hosp, 20th Xisi Rd, Nantong 226001, Peoples R China.
EM tdfysc@126.com; guzf@ntu.edu.cn; yujuanzhu@ntu.edu
FU National Natural Science Foundation of China [82071838, 82102233, 82101891, 82302048, U23A20470]; Jiangsu Provincial Medical Key Discipline Cultivation Unit [JSDW202205]; Jiangsu Provincial Research Hospital [YJXYY202204]; Shenzhen Fundamental Research Program [JCYJ20210 324102809025]; Industry-University-Research Innovation Fund for Chinese Universities [2023HT041]
CR Abdellatif M, 2023, NAT REV CARDIOL, V20, P754, DOI 10.1038/s41569-023-00881-3
   Abraham A, 2020, STEM CELL TRANSL MED, V9, P28, DOI 10.1002/sctm.19-0205
   Acquistapace A, 2011, STEM CELLS, V29, P812, DOI 10.1002/stem.632
   Acton BM, 2007, BIOL REPROD, V77, P569, DOI 10.1095/biolreprod.107.060806
   Alexeyev MF, 2009, FEBS J, V276, P5768, DOI 10.1111/j.1742-4658.2009.07269.x
   Aslam A, 2021, SCI TOTAL ENVIRON, V772, P0, DOI 10.1016/j.scitotenv.2020.144905
   Austefjord Magnus Wiger, 2014, COMMUN INTEGR BIOL, V7, Pe27934, DOI 10.4161/cib.27934
   BalcÃ¡zar M, 2020, FRONT BIOENG BIOTECH, V8, P0, DOI 10.3389/fbioe.2020.00919
   Barritt JA, 2001, HUM REPROD, V16, P513, DOI 10.1093/humrep/16.3.513
   Benkhalifa M, 2014, INT J BIOCHEM CELL B, V55, P60, DOI 10.1016/j.biocel.2014.08.011
   Beyer EC, 2018, BBA-BIOMEMBRANES, V1860, P5, DOI 10.1016/j.bbamem.2017.05.016
   Bhattacharya D, 2023, AM J PHYSIOL-CELL PH, V325, PC862, DOI 10.1152/ajpcell.00212.2023
   Brenner CA, 2000, FERTIL STERIL, V74, P573, DOI 10.1016/S0015-0282(00)00681-6
   Brestoff JR, 2021, CELL METAB, V33, P270, DOI 10.1016/j.cmet.2020.11.008
   Cabrera F, 2019, BMC BIOTECHNOL, V19, P0, DOI 10.1186/s12896-019-0534-6
   Caicedo A, 2017, STEM CELLS INT, V2017, P0, DOI 10.1155/2017/7610414
   Carlson S, 2008, GENDER MED, V5, PS76, DOI 10.1016/j.genm.2008.03.008
   Cecchino GN, 2018, REPROD BIOMED ONLINE, V36, P686, DOI 10.1016/j.rbmo.2018.02.007
   Chang JC, 2016, TRANSL RES, V170, P40, DOI 10.1016/j.trsl.2015.12.003
   Chang JC, 2013, NEUROSIGNALS, V21, P160, DOI 10.1159/000341981
   Chaudhari SN, 2018, BIOESSAYS, V40, P0, DOI 10.1002/bies.201800005
   Chavda V, 2023, ANTIOXIDANTS-BASEL, V12, P0, DOI 10.3390/antiox12040895
   Chen J, 2021, FRONT CARDIOVASC MED, V8, P0, DOI 10.3389/fcvm.2021.771298
   Chen MM, 2022, FRONT CELL DEV BIOL, V10, P0, DOI 10.3389/fcell.2022.826981
   Chen SS, 2023, FRONT IMMUNOL, V14, P0, DOI 10.3389/fimmu.2023.1166214
   Chen W, 2023, SIGNAL TRANSDUCT TAR, V8, P0, DOI 10.1038/s41392-023-01547-9
   Cheng Jing, 2020, SHENGLI XUEBAO, V72, P475, DOI 10.13294/j.aps.2020.0025
   CLARK MA, 1982, NATURE, V295, P605, DOI 10.1038/295605a0
   Clemente-SuÃ¡rez VJ, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms24108848
   Cohen J, 1997, LANCET, V350, P186, DOI 10.1016/S0140-6736(05)62353-7
   Cowan DB, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-17813-0
   Cowan DB, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0160889
   Crane JD, 2010, J GERONTOL A-BIOL, V65, P119, DOI 10.1093/gerona/glp179
   Dahiya Neha, 2018, INDIAN J MED ETHICS, V3, P169, DOI 10.20529/IJME.2017.097
   De Vuyst E, 2009, CELL CALCIUM, V46, P176, DOI 10.1016/j.ceca.2009.07.002
   Doulamis IP, 2021, METHODS MOL BIOL, V2277, P15, DOI 10.1007/978-1-0716-1270-5_2
   Dupont M, 2018, FRONT IMMUNOL, V9, P0, DOI 10.3389/fimmu.2018.00043
   El Assar M, 2013, FREE RADICAL BIO MED, V65, P380, DOI 10.1016/j.freeradbiomed.2013.07.003
   Ene HM, 2023, MOL PSYCHIATR, V28, P1170, DOI 10.1038/s41380-022-01865-4
   Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088
   Fan MR, 2020, NATURE, V582, P129, DOI 10.1038/s41586-020-2309-6
   Fields M, 2023, INT J MOL SCI, V24, P0, DOI 10.3390/ijms24043739
   Franko A, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0082392
   Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478
   Galluzzi L, 2007, APOPTOSIS, V12, P803, DOI 10.1007/s10495-007-0720-1
   Gao JJ, 2019, SCI ADV, V5, P0, DOI 10.1126/sciadv.aaw7215
   Gollihue JL, 2018, NEURAL REGEN RES, V13, P194, DOI 10.4103/1673-5374.226382
   Gonzalez-Freire M, 2018, AGING CELL, V17, P0, DOI 10.1111/acel.12725
   Gostimskaya I, 2010, J VIS EXP., V0, P0
   Gouspillou G, 2014, FASEB J, V28, P1621, DOI 10.1096/fj.13-242750
   Graham J M, 2001, CURR PROTOC CELL BIOL, VChapter 3, P0, DOI 10.1002/0471143030.cb0303s04
   Guariento A, 2021, J THORAC CARDIOV SUR, V162, P992, DOI 10.1016/j.jtcvs.2020.10.151
   Gumpert AM, 2008, FEBS LETT, V582, P2887, DOI 10.1016/j.febslet.2008.07.024
   Gustafson D, 2017, FRONT CARDIOVASC MED, V4, P0, DOI 10.3389/fcvm.2017.99971
   Haddad D, 2015, FEBS LETT, V589, P3702, DOI 10.1016/j.febslet.2015.10.021
   Hahn A, 2019, ANTIOXIDANTS-BASEL, V8, P0, DOI 10.3390/antiox8090392
   Hammad G, 2018, ANTIOXIDANTS-BASEL, V7, P0, DOI 10.3390/antiox7010019
   Hanyi Z, 2022, JOURNAL OF CHONGQING UNIVERSITY OF TECHNOLOGY :NATURAL SCIENCE, V36, P297
   Harvey AJ, 2007, CURR TOP DEV BIOL, V77, P229, DOI 10.1016/S0070-2153(06)77009-0
   Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928
   Headley CA, 2023, FRONT CARDIOVASC MED, V10, P0, DOI 10.3389/fcvm.2023.1141124
   HOGEBOOM GH, 1948, J BIOL CHEM, V172, P619
   Huang T, 2021, SCI ADV, V7, P0, DOI 10.1126/sciadv.abj0534
   Hubbard WB, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-45568-3
   IbÃ¡Ã±ez B, 2021, J AM COLL CARDIOL, V77, P1089, DOI 10.1016/j.jacc.2021.01.017
   Igarashi H, 2016, HUM REPROD, V31, P2331, DOI 10.1093/humrep/dew203
   Ippolito L, 2019, ONCOGENE, V38, P5339, DOI 10.1038/s41388-019-0805-7
   Jenkins G, 2002, MECH AGEING DEV, V123, P801, DOI 10.1016/S0047-6374(01)00425-0
   JimÃ©nez-Loygorri JI, 2024, NAT COMMUN, V15, P0, DOI 10.1038/s41467-024-45044-1
   Kahn RE, 2023, AM J PHYSIOL-CELL PH, V324, PC1332, DOI 10.1152/ajpcell.00073.2023
   Kelly DA, 1998, J PEDIATR GASTR NUTR, V27, P214, DOI 10.1097/00005176-199808000-00017
   Khan MM, 2023, CURR NEUROPHARMACOL, V21, P1100, DOI 10.2174/1570159X05666220908100545
   Kim MJ, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-21539-y
   Kirkman DL, 2021, AM J PHYSIOL-HEART C, V320, PH2080, DOI 10.1152/ajpheart.00917.2020
   Kong Ling-hong, 2004, ZHONGHUA FU CHAN KE ZA ZHI, V39, P105
   Labarta E, 2019, FERTIL STERIL, V111, P219, DOI 10.1016/j.fertnstert.2018.10.036
   Leduc-Gaudet JP, 2015, ONCOTARGET, V6, P17923, DOI 10.18632/oncotarget.4235
   Lee YH, 2022, AGING-US, V14, P678, DOI 10.18632/aging.203858
   Lehr S, 2005, BIOCHEMISTRY-US, V44, P5117, DOI 10.1021/bi0479656
   Lei T, 2022, CYTOTHERAPY, V24, P1105, DOI 10.1016/j.jcyt.2022.06.007
   Leuner K, 2012, MOL NEUROBIOL, V46, P194, DOI 10.1007/s12035-012-8300-y
   Li QQ, 2017, PROTEIN CELL, V8, P439, DOI 10.1007/s13238-017-0385-7
   Li RF, 2019, J MOL HISTOL, V50, P483, DOI 10.1007/s10735-019-09842-y
   Li Z, 2021, BIOGERONTOLOGY, V22, P165, DOI 10.1007/s10522-021-09910-5
   Liao PC, 2020, METHOD CELL BIOL, V155, P3, DOI 10.1016/bs.mcb.2019.10.002
   Lin RZ, 2024, NATURE, V629, P0, DOI 10.1038/s41586-024-07340-0
   Liu CS, 2014, INT J BIOCHEM CELL B, V53, P141, DOI 10.1016/j.biocel.2014.05.009
   Liu DL, 2021, SIGNAL TRANSDUCT TAR, V6, P0, DOI 10.1038/s41392-020-00440-z
   Liu DQ, 2023, MEDICINE (BALTIMORE), V102, P0
   Liu KM, 2014, MICROVASC RES, V92, P10, DOI 10.1016/j.mvr.2014.01.008
   Liu YS, 2008, MOL CELL PROTEOMICS, V7, P1737, DOI 10.1074/mcp.M800109-MCP200
   Liu YF, 2017, HUM REPROD, V32, P2465, DOI 10.1093/humrep/dex309
   Liu YB, 2024, LAB INVEST, V104, P0, DOI 10.1016/j.labinv.2023.100307
   Liu ZH, 2022, CELL BIOSCI, V12, P0, DOI 10.1186/s13578-022-00805-7
   Ljubojevic N, 2021, TRENDS CELL BIOL, V31, P130, DOI 10.1016/j.tcb.2020.11.008
   LÃ³pez-Otin C, 2023, CELL, V186, P243, DOI 10.1016/j.cell.2022.11.001
   Ma HL, 2020, CLIN SCI, V134, P2161, DOI 10.1042/CS20200530
   Macheiner T, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep35571
   Mailloux RJ, 2024, REDOX BIOL, V72, P0, DOI 10.1016/j.redox.2024.103155
   Main EN, 2023, REGEN BIOMATER, V10, P0, DOI 10.1093/rb/rbad070
   Maneechote C, 2024, LIFE SCI, V344, P0, DOI 10.1016/j.lfs.2024.122575
   Martins RM, 2019, CLIN MOL HEPATOL, V25, P190, DOI 10.3350/cmh.2018.0087
   Marzetti E, 2024, BIOMOLECULES, V14, P0, DOI 10.3390/biom14040415
   Mattam U, 2021, BBA-MOL CELL RES, V1868, P0, DOI 10.1016/j.bbamcr.2020.118852
   McCully JD, 2017, MITOCHONDRION, V34, P127, DOI 10.1016/j.mito.2017.03.004
   McCully JD, 2016, CLIN TRANSL MED, V5, P0, DOI 10.1186/s40169-016-0095-4
   McCully JD, 2009, AM J PHYSIOL-HEART C, V296, PH94, DOI 10.1152/ajpheart.00567.2008
   Mellem D, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0174469
   Meng WR, 2020, DRUG DELIV, V27, P585, DOI 10.1080/10717544.2020.1748758
   Menon GK, 2010, J COSMET DERMATOL-US, V9, P122, DOI 10.1111/j.1473-2165.2010.00496.x
   Mobarak H, 2019, CELL BIOSCI, V9, P0, DOI 10.1186/s13578-019-0360-5
   Morris MC, 2008, BIOL CELL, V100, P201, DOI 10.1042/BC20070116
   Moskowitzova K, 2020, AM J PHYSIOL-LUNG C, V318, PL78, DOI 10.1152/ajplung.00221.2019
   Moskowitzova K, 2019, J HEART LUNG TRANSPL, V38, P92, DOI 10.1016/j.healun.2018.09.025
   Nakamura Y, 2020, EXP NEUROL, V324, P0, DOI 10.1016/j.expneurol.2019.113114
   Nakano T, 2022, COMMUN BIOL, V5, P0, DOI 10.1038/s42003-022-03719-9
   Natarajan V, 2020, PROTEOMICS, V20, P0, DOI 10.1002/pmic.201800404
   Nitzan K, 2019, J ALZHEIMERS DIS, V72, P587, DOI 10.3233/JAD-190853
   Nygren JM, 2008, NAT CELL BIOL, V10, P584, DOI 10.1038/ncb1721
   Oh HSH, 2023, NATURE, V624, P164, DOI 10.1038/s41586-023-06802-1
   Oh HJ, 2016, NEUROPSYCHOPHARMACOL, V41, P3080, DOI 10.1038/npp.2016.126
   Ojano-Dirain CP, 2014, OTOL NEUROTOL, V35, P533, DOI 10.1097/MAO.0000000000000192
   Onishi M, 2021, FEBS LETT, V595, P1239, DOI 10.1002/1873-3468.14060
   Pacak CA, 2015, BIOL OPEN, V4, P622, DOI 10.1242/bio.201511478
   Pacelli C, 2015, CURR BIOL, V25, P2349, DOI 10.1016/j.cub.2015.07.050
   Panasiuk M, 2018, J VIROL, V92, P0, DOI 10.1128/jvi.00090-18
   Park JS, 2018, CURR NEUROL NEUROSCI, V18, P0, DOI 10.1007/s11910-018-0829-3
   Patananan AN, 2020, CELL REP, V33, P0, DOI 10.1016/j.celrep.2020.108562
   Pecoraro M, 2019, CRIT REV EUKAR GENE, V29, P295, DOI 10.1615/CritRevEukaryotGeneExpr.2019028579
   PeÃ±herrera S, 2023, MITOCHONDRION, V70, P41, DOI 10.1016/j.mito.2023.02.012
   Pesaresi M, 2019, FEBS J, V286, P1074, DOI 10.1111/febs.14633
   Picard M, 2022, CELL METAB, V34, P1620, DOI 10.1016/j.cmet.2022.10.008
   Picone P, 2021, J NANOBIOTECHNOL, V19, P0, DOI 10.1186/s12951-020-00748-6
   Piehl M, 2007, MOL BIOL CELL, V18, P337, DOI 10.1091/mbc.E06-06-0487
   Pinkert CA, 1997, TRANSGENIC RES, V6, P379, DOI 10.1023/A:1018431316831
   Pour PA, 2021, AM J PHYSIOL-CELL PH, V321, PC489, DOI 10.1152/ajpcell.00152.2021
   Pour PA, 2020, J AM HEART ASSOC, V9, P0, DOI 10.1161/JAHA.119.014501
   Pourmohammadi-Bejarpasi Z, 2020, BRAIN RES BULL, V165, P70, DOI 10.1016/j.brainresbull.2020.09.018
   Powers JM, 2016, J PHOTOCH PHOTOBIO B, V165, P277, DOI 10.1016/j.jphotobiol.2016.10.030
   Powers JM, 2017, J PHOTOCH PHOTOBIO B, V173, P397, DOI 10.1016/j.jphotobiol.2017.06.020
   Preble JM, 2014, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/51682
   PRIANISHNIKOV VA, 1978, CONTRACEPTION, V18, P213, DOI 10.1016/S0010-7824(78)80015-8
   Qin YM, 2021, FRONT ONCOL, V11, P0, DOI 10.3389/fonc.2021.672781
   Ramirez-Barbieri G, 2019, MITOCHONDRION, V46, P103, DOI 10.1016/j.mito.2018.03.002
   Reddy PH, 2011, CURR ALZHEIMER RES, V8, P393
   Rey F, 2022, NEURAL REGEN RES, V17, P754, DOI 10.4103/1673-5374.322430
   Rossiello F, 2022, NAT CELL BIOL, V24, P135, DOI 10.1038/s41556-022-00842-x
   Rubio-Tomas T, 2024, BIOCHEM PHARMACOL, V0, P0
   Ruiz-Meana M, 2020, CARDIOVASC RES, V116, P1835, DOI 10.1093/cvr/cvaa132
   Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133
   Santanasto AJ, 2015, J GERONTOL A-BIOL, V70, P1379, DOI 10.1093/gerona/glu134
   Sato M, 2013, BBA-MOL CELL RES, V1833, P1979, DOI 10.1016/j.bbamcr.2013.03.010
   Schatten H, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-111
   Sercel AJ, 2021, ELIFE, V0, P10
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Sheng XQ, 2019, MOL REPROD DEV, V86, P516, DOI 10.1002/mrd.23129
   Shin SH, 2023, FRONT PHYSIOL, V14, P0, DOI 10.3389/fphys.2023.1195272
   Shults CW, 2004, MITOCHONDRION, V4, P641, DOI 10.1016/j.mito.2004.07.028
   Simon AM, 1998, TRENDS CELL BIOL, V8, P477, DOI 10.1016/S0962-8924(98)01372-5
   SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x
   Singh KK, 2021, PLAST RECONSTR SURG, V147, P33S, DOI 10.1097/PRS.0000000000007619
   Song ZH, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2014.559
   Sorgen PL, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19051428
   Sreedhar A, 2020, CELL DEATH DIS, V11, P0, DOI 10.1038/s41419-020-2649-z
   Stier A, 2021, AM J PHYSIOL-ENDOC M, V320, PE859, DOI 10.1152/ajpendo.00054.2021
   Stout R, 2019, BIOLOGY (BASEL), V0, P8
   Sun JY, 2022, SCI ADV, V8, P0, DOI 10.1126/sciadv.abp9245
   Sun MC, 2023, J TRANSL MED, V21, P0, DOI 10.1186/s12967-023-04203-6
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Sun XL, 2023, ACS NANO, V0, PP896, DOI 10.1021/acsnano.2c05286
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Tao LC, 2015, CELL PHYSIOL BIOCHEM, V37, P162, DOI 10.1159/000430342
   Tarazona AM, 2006, REPROD DOMEST ANIM, V41, P5, DOI 10.1111/j.1439-0531.2006.00615.x
   Tesarik J, 2021, INT J MOL SCI, V22, P0, DOI 10.3390/ijms22031371
   Tian XC, 2017, J BIOMED SCI, V24, P1, DOI 10.1186/s12929-017-0345-9
   Tian XL, 2023, AGING DIS, V14, P1700, DOI 10.14336/AD.2023.0210
   Tulah AS, 2013, MITOCHONDRION, V13, P444, DOI 10.1016/j.mito.2012.11.007
   Turkel I, 2023, J MOL MED, V101, P645, DOI 10.1007/s00109-023-02326-3
   Ulger O, 2022, BIOCHIMIE, V195, P1, DOI 10.1016/j.biochi.2022.01.002
   van der Pol E, 2016, J THROMB HAEMOST, V14, P48, DOI 10.1111/jth.13190
   van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125
   VILLA RF, 1991, NEUROCHEM RES, V16, P1125, DOI 10.1007/BF00966590
   Wada KI, 2017, BIOL OPEN, V6, P1960, DOI 10.1242/bio.024869
   Wai T, 2015, SCIENCE, V350, P0, DOI 10.1126/science.aad0116
   Wang JY, 2018, STEM CELL RES THER, V9, P0, DOI 10.1186/s13287-018-0832-2
   Wang LL, 2015, CELL MOL LIFE SCI, V72, P1489, DOI 10.1007/s00018-014-1810-1
   Wang LJ, 2022, J ADV RES, V38, P245, DOI 10.1016/j.jare.2021.09.001
   Wang XJ, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0036663
   Wang ZB, 2017, AGING-US, V9, P2480, DOI 10.18632/aging.101332
   Wei WJ, 2019, BRAIN RES, V1724, P0, DOI 10.1016/j.brainres.2019.146406
   Welle S, 2003, J APPL PHYSIOL, V94, P1479, DOI 10.1152/japplphysiol.01061.2002
   Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151
   Woods DC, 2015, SEMIN REPROD MED, V33, P410, DOI 10.1055/s-0035-1567826
   Wu HC, 2020, BIOMED PHARMACOTHER, V130, P0, DOI 10.1016/j.biopha.2020.110520
   Wu SH, 2018, ADV SCI, V5, P0, DOI 10.1002/advs.201700530
   Wu TH, 2016, CELL METAB, V23, P921, DOI 10.1016/j.cmet.2016.04.007
   Yamada Y, 2020, INT J MOL SCI, V21, P0, DOI 10.3390/ijms21176365
   Yan C, 2019, CELLS, V8, P0
   Yang C, 2021, BRIT J HAEMATOL, V193, P1260, DOI 10.1111/bjh.17531
   Yang F, 2022, OXID MED CELL LONGEV, V2022, P0, DOI 10.1155/2022/3613319
   YANG JH, 1994, ARCH DERMATOL RES, V286, P386, DOI 10.1007/BF00371798
   Yang WX, 2023, REGEN THER, V24, P190, DOI 10.1016/j.reth.2023.06.011
   Yang YJ, 2023, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/64217
   Yu TN, 2022, J CLIN MED, V11, P0, DOI 10.3390/jcm11071824
   Zambrano K, 2022, MITOCHONDRION, V64, P125, DOI 10.1016/j.mito.2022.03.003
   Zhang AL, 2023, MOL THER, V31, P1468, DOI 10.1016/j.ymthe.2023.02.016
   Zhang Q, 2023, CELL PROLIFERAT, V56, P0, DOI 10.1111/cpr.13372
   Zhang TG, 2023, ACTA PHARM SIN B, V13, P1028, DOI 10.1016/j.apsb.2022.10.008
   Zhang TC, 2024, FRONT ENDOCRINOL, V14, P0, DOI 10.3389/fendo.2023.1281213
   Zhang Y, 2021, EXPLORATION-PRC, V1, P0, DOI 10.1002/EXP.20210115
   Zhao JQ, 2021, TRANSL RES, V235, P102, DOI 10.1016/j.trsl.2021.03.017
   Zhao ZZ, 2021, BIOENG TRANSL MED, V6, P0, DOI 10.1002/btm2.10209
   Zhou ML, 2022, J CARDIOVASC PHARM, V79, P759, DOI 10.1097/FJC.0000000000001247
   Zhou ZQ, 2018, CELLS-BASEL, V7, P0, DOI 10.3390/cells7120229
   Zhu D, 2022, TRENDS BIOCHEM SCI, V47, P645, DOI 10.1016/j.tibs.2022.03.008
NR 216
TC 0
Z9 0
U1 21
U2 21
PU INT SOC AGING & DISEASE
PI FORT WORTH
PA EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA
SN 2152-5250
EI 
J9 AGING DIS
JI Aging Dis.
PD JUL 19
PY 2024
VL 0
IS 
BP 
EP 
DI 10.14336/AD.2024.0231
EA JUL 2024
PG 28
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA ZF4K9
UT WOS:001273866600001
PM 39122452
DA 2024-11-01
ER

PT J
AU Neueder, A
   Kojer, K
   Gu, ZL
   Wang, YQ
   Hering, T
   Tabrizi, S
   Taanman, JW
   Orth, M
AF Neueder, Andreas
   Kojer, Kerstin
   Gu, Zhenglong
   Wang, Yiqin
   Hering, Tanja
   Tabrizi, Sarah
   Taanman, Jan-Willem
   Orth, Michael
TI Huntington's disease affects mitochondrial network dynamics predisposing to pathogenic mitochondrial DNA mutations
SO BRAIN
LA English
DT Article
DE mitochondrial fission; mitophagy; huntingtin fragments; DNA instability; ultra-deep mitochondrial DNA sequencing; proteomics
ID copy number; mutant huntingtin; cag repeat; heteroplasmy; pathology; protein; mitophagy; replication; leukocytes; depletion
AB Huntington's disease (HD) predominantly affects the brain, causing a mixed movement disorder, cognitive decline and behavioural abnormalities. It also causes a peripheral phenotype involving skeletal muscle. Mitochondrial dysfunction has been reported in tissues of HD models, including skeletal muscle, and lymphoblast and fibroblast cultures from patients with HD. Mutant huntingtin protein (mutHTT) expression can impair mitochondrial quality control and accelerate mitochondrial ageing.Here, we obtained fresh human skeletal muscle, a post-mitotic tissue expressing the mutated HTT allele at physiological levels since birth, and primary cell lines from HTT CAG repeat expansion mutation carriers and matched healthy volunteers to examine whether such a mitochondrial phenotype exists in human HD. Using ultra-deep mitochondrial DNA (mtDNA) sequencing, we showed an accumulation of mtDNA mutations affecting oxidative phosphorylation. Tissue proteomics indicated impairments in mtDNA maintenance with increased mitochondrial biogenesis of less efficient oxidative phosphorylation (lower complex I and IV activity). In full-length mutHTT expressing primary human cell lines, fission-inducing mitochondrial stress resulted in normal mitophagy. In contrast, expression of high levels of N-terminal mutHTT fragments promoted mitochondrial fission and resulted in slower, less dynamic mitophagy. Expression of high levels of mutHTT fragments due to somatic nuclear HTT CAG instability can thus affect mitochondrial network dynamics and mitophagy, leading to pathogenic mtDNA mutations.We show that life-long expression of mutant HTT causes a mitochondrial phenotype indicative of mtDNA instability in fresh post-mitotic human skeletal muscle. Thus, genomic instability may not be limited to nuclear DNA, where it results in somatic expansion of the HTT CAG repeat length in particularly vulnerable cells such as striatal neurons. In addition to efforts targeting the causative mutation, promoting mitochondrial health may be a complementary strategy in treating diseases with DNA instability such as HD. Neueder et al. reveal an accumulation of mitochondrial DNA mutations and impairments in mitochondrial quality control in fresh skeletal muscle samples from patients with Huntington's disease. Accelerated mitochondrial ageing may thus be one of the biological signatures of Huntington's disease, including in peripheral tissues.
C1 [Neueder, Andreas; Kojer, Kerstin; Hering, Tanja; Orth, Michael] Ulm Univ, Dept Neurol, D-89081 Ulm, Germany.
   [Gu, Zhenglong; Wang, Yiqin] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.
   [Tabrizi, Sarah] UCL Queen Sq Inst Neurol, UCL Huntingtons Dis Ctr, London WC1N 3BG, England.
   [Tabrizi, Sarah] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
   [Tabrizi, Sarah] UCL, Dementia Res Inst, London WC1N 3BG, England.
   [Taanman, Jan-Willem] UCL Queen Sq Inst Neurol, Dept Clin & Movement Neurosci, London NW3 2PF, England.
   [Orth, Michael] Siloah AG, Swiss Huntington Ctr, CH-3073 Gumlingen, Switzerland.
   [Orth, Michael] Bern Univ, Univ Hosp Old Age Psychiat & Psychotherapy, Bolligenstr 111, CH-3000 Bern 60, Switzerland.
C3 Ulm University; Cornell University; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London
RP Orth, M (corresponding author), Bern Univ, Univ Hosp Old Age Psychiat & Psychotherapy, Bolligenstr 111, CH-3000 Bern 60, Switzerland.
EM michael.orth@siloah.ch
FU CHDI Foundation Inc. [A-5497]; German Research Foundation (DFG) [NE 2372/ 1-1]
CR Andreux PA, 2019, NAT METAB, V1, P595, DOI 10.1038/s42255-019-0073-4
   Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829
   Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   COORE HG, 1971, BIOCHEM J, V125, P115, DOI 10.1042/bj1250115
   Costa V, 2010, EMBO MOL MED, V2, P490, DOI 10.1002/emmm.201000102
   Demestre M, 2015, STEM CELL RES, V15, P328, DOI 10.1016/j.scr.2015.07.005
   Erie C, 2015, EUR J NEUROSCI, V42, P1941, DOI 10.1111/ejn.12957
   Franco-Iborra S, 2021, AUTOPHAGY, V17, P672, DOI 10.1080/15548627.2020.1728096
   Franich NR, 2019, J NEUROSCI RES, V97, P1590, DOI 10.1002/jnr.24493
   Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419
   Giorgetti E, 2016, CELL REP, V17, P125, DOI 10.1016/j.celrep.2016.08.084
   Greaves LC, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004620
   Guo XX, 2020, NAR GENOM BIOINFORM, V2, P0, DOI 10.1093/nargab/lqaa065
   Guo X, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms12646
   Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911
   Hering T, 2015, EXP NEUROL, V266, P22, DOI 10.1016/j.expneurol.2015.02.004
   Hong EP, 2021, J HUNTINGTONS DIS, V10, P35, DOI 10.3233/JHD-200427
   Hwang S, 2015, EMBO MOL MED, V7, P1307, DOI 10.15252/emmm.201505256
   Jedrak P, 2017, METAB BRAIN DIS, V32, P1237, DOI 10.1007/s11011-017-0026-0
   Jin J, 2013, J NEUROCHEM, V125, P410, DOI 10.1111/jnc.12190
   Khalil B, 2015, CELL DEATH DIS, V6, P0, DOI 10.1038/cddis.2014.581
   KING TE, 1967, J BIOL CHEM, V242, P819
   Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892
   Komsta L, 2006, R NEWS, V6, P10
   Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, PD980, DOI 10.1093/nar/gkt1113
   Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01
   Lee JM, 2019, CELL, V178, P887, DOI 10.1016/j.cell.2019.06.036
   Lee JM, 2015, CELL, V162, P516, DOI 10.1016/j.cell.2015.07.003
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Lieber T, 2019, NATURE, V570, P380, DOI 10.1038/s41586-019-1213-4
   Lott Marie T, 2013, CURR PROTOC BIOINFORMATICS, V44, P0, DOI 10.1002/0471250953.bi0123s44
   Lu AT, 2020, NAT COMMUN, V11, P0, DOI 10.1038/s41467-020-18255-5
   Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0
   Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528
   Matsushima Y, 2010, P NATL ACAD SCI USA, V107, P18410, DOI 10.1073/pnas.1008924107
   MOREADITH RW, 1987, J CLIN INVEST, V79, P463, DOI 10.1172/JCI112834
   Napoli E, 2013, HUM MOL GENET, V22, P989, DOI 10.1093/hmg/dds503
   Neueder A, 2022, GENOME BIOL, V23, P0, DOI 10.1186/s13059-022-02752-5
   Neueder A, 2020, NEURODEGENER DIS MAN, V10, P243, DOI 10.2217/nmt-2019-0033
   Neueder A, 2019, J MOL BIOL, V431, P1780, DOI 10.1016/j.jmb.2018.12.012
   Neueder A, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-018-06281-3
   Neueder A, 2018, ADV EXP MED BIOL, V1049, P85, DOI 10.1007/978-3-319-71779-1_4
   Neueder A, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-01510-z
   Ochaba J, 2014, P NATL ACAD SCI USA, V111, P16889, DOI 10.1073/pnas.1420103111
   Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2
   Penney JB, 1997, ANN NEUROL, V41, P689, DOI 10.1002/ana.410410521
   Petersen MH, 2014, MITOCHONDRION, V17, P14, DOI 10.1016/j.mito.2014.05.001
   Pickles S, 2018, CURR BIOL, V28, PR170, DOI 10.1016/j.cub.2018.01.004
   Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007
   Pinto RM, 2020, HUM MOL GENET, V29, P2551, DOI 10.1093/hmg/ddaa139
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rebolledo-Jaramillo B, 2014, P NATL ACAD SCI USA, V111, P15474, DOI 10.1073/pnas.1409328111
   Rubino F, 2012, NUCLEIC ACIDS RES, V40, PD1150, DOI 10.1093/nar/gkr1086
   Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI 10.1038/nmeth.2019
   Shirendeb UP, 2012, HUM MOL GENET, V21, P406, DOI 10.1093/hmg/ddr475
   Siddiqui A, 2012, FREE RADICAL BIO MED, V53, P1478, DOI 10.1016/j.freeradbiomed.2012.06.008
   Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313
   Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4
   Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887
   Wang K, 2010, NUCLEIC ACIDS RES, V38, P0, DOI 10.1093/nar/gkq603
   Wang YQ, 2021, P NATL ACAD SCI USA, V118, P0, DOI 10.1073/pnas.2014610118
   Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001
   Wharton DC, 1967, METHODS ENZYMOL, V10, P245, DOI 10.1016/0076-6879(67)10048-7
   Yang QY, 2022, NAT CELL BIOL, V24, P181, DOI 10.1038/s41556-021-00840-5
   Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111
   Zhang RY, 2017, BMC GENOMICS, V18, P0, DOI 10.1186/s12864-017-4287-0
NR 73
TC 4
Z9 4
U1 2
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD JUN 3
PY 2024
VL 147
IS 6
BP 2009
EP 2022
DI 10.1093/brain/awae007
EA MAY 2024
PG 14
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA SW1X0
UT WOS:001222909400001
PM 38195181
DA 2024-11-01
ER

PT J
AU Chang, ES
   Song, K
   Song, JY
   Sung, M
   Lee, MS
   Oh, JH
   Kim, JY
   Park, YH
   Jung, K
   Choi, YL
AF Chang, Eun Sol
   Song, Kyoung
   Song, Ji-Young
   Sung, Minjung
   Lee, Mi-Sook
   Oh, Jung Han
   Kim, Ji-Yeon
   Park, Yeon Hee
   Jung, Kyungsoo
   Choi, Yoon-La
TI Real-time assessment of relative mitochondrial ATP synthesis response against inhibiting and stimulating substrates (MitoRAISE)
SO CANCER & METABOLISM
LA English
DT Article
DE Relative mitochondrial ATP synthesis rate; Mitochondrial function; ATP; mtDNA copy number; MitoRAISE
ID skeletal-muscle; mutations; ratios; cells
AB BackgroundMitochondria are known to synthesize adenosine triphosphate (ATP) through oxidative phosphorylation. Understanding and accurately measuring mitochondrial ATP synthesis rate can provide insights into the functional status of mitochondria and how it contributes to overall cellular energy homeostasis. Traditional methods only estimate mitochondrial function by measuring ATP levels at a single point in time or through oxygen consumption rates. This study introduced the relative mitochondrial ATP synthesis response against inhibiting and stimulating substrates (MitoRAISE), designed to detect real-time changes in ATP levels as the cells respond to substrates.MethodsThe sensitivity and specificity of the MitoRAISE assay were verified under various conditions, including the isolation of mitochondria, variations in cell numbers, cells exhibiting mitochondrial damage, and heterogeneous mixtures. Using peripheral blood mononuclear cells (PBMCs), we analyzed MitoRAISE data from 19 patients with breast cancer and 23 healthy women.ResultsThe parameters observed in the MitoRAISE data increased depending on the quantity of isolated mitochondria and cell count, whereas it remained unmeasured in mitochondrial-damaged cell lines. Basal ATP, rotenone response, malonate response, and mitochondrial DNA copy numbers were lower in PBMCs from patients with breast cancer than in those from healthy women.ConclusionsThe MitoRAISE assay has demonstrated its sensitivity and specificity by measuring relative ATP synthesis rates under various conditions. We propose MitoRAISE assay as a potential tool for monitoring changes in the mitochondrial metabolic status associated with various diseases.
C1 [Chang, Eun Sol; Oh, Jung Han; Choi, Yoon-La] Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea.
   [Chang, Eun Sol; Song, Ji-Young; Sung, Minjung; Lee, Mi-Sook; Oh, Jung Han; Jung, Kyungsoo; Choi, Yoon-La] Sungkyunkwan Univ, Samsung Med Ctr, Lab Mol Pathol & Theranost, Sch Med, Irwon Ro 81, Seoul 06351, South Korea.
   [Song, Kyoung] Duksung Womens Univ, Coll Pharm, Seoul, South Korea.
   [Kim, Ji-Yeon; Park, Yeon Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea.
   [Choi, Yoon-La] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Genom, Irwon Ro 81, Seoul 06351, South Korea.
C3 Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Duksung Women's University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center
RP Choi, YL (corresponding author), Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea.; Jung, K; Choi, YL (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Lab Mol Pathol & Theranost, Sch Med, Irwon Ro 81, Seoul 06351, South Korea.; Choi, YL (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Genom, Irwon Ro 81, Seoul 06351, South Korea.
EM ksjung0820@skku.edu; ylachoi@skku.edu
FU National Research Foundation of Korea (NRF) grant funded by the Korean government
CR Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282
   Bandara AB, 2021, BMC MOL CELL BIOL, V22, P0, DOI 10.1186/s12860-021-00370-w
   Boengler K, 2017, J CACHEXIA SARCOPENI, V8, P349, DOI 10.1002/jcsm.12178
   Boyman L, 2020, TRENDS MOL MED, V26, P21, DOI 10.1016/j.molmed.2019.10.007
   Cheng H, 2021, METHODSX, V8, P0, DOI 10.1016/j.mex.2021.101520
   Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007
   Deshpande OA, 2024, BIOCHEMISTRY, V0, P0
   Divakaruni Ajit S, 2014, CURR PROTOC TOXICOL, V60, P0, DOI 10.1002/0471140856.tx2502s60
   Divakaruni AS, 2013, P NATL ACAD SCI USA, V110, P5422, DOI 10.1073/pnas.1303360110
   Farhadi P, 2022, BIOMED PHARMACOTHER, V146, P0, DOI 10.1016/j.biopha.2021.112526
   Gatt AP, 2016, MOVEMENT DISORD, V31, P352, DOI 10.1002/mds.26513
   Gaude E, 2016, NAT COMMUN, V7, P0, DOI 10.1038/ncomms13041
   Hartman ML, 2014, VASC MED, V19, P67, DOI 10.1177/1358863X14521315
   Hensley CT, 2016, CELL, V164, P681, DOI 10.1016/j.cell.2015.12.034
   Hinkle PC, 2005, BBA-BIOENERGETICS, V1706, P1, DOI 10.1016/j.bbabio.2004.09.004
   Kurelac I, 2013, HUM MOL GENET, V22, P226, DOI 10.1093/hmg/dds422
   Langen P, 2008, ANGEW CHEM INT EDIT, V47, P1824, DOI 10.1002/anie.200702929
   Lark DS, 2016, AM J PHYSIOL-CELL PH, V311, PC239, DOI 10.1152/ajpcell.00124.2016
   Marcussen M, 1996, CELL MOTIL CYTOSKEL, V35, P94, DOI 10.1002/(SICI)1097-0169(1996)35:2<94::AID-CM2>3.0.CO;2-I
   Muller B, 2019, SCI REP-UK, V9, P0, DOI 10.1038/s41598-019-53066-9
   Nath S, 2019, BIOPHYS CHEM, V252, P0, DOI 10.1016/j.bpc.2019.106208
   Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006
   Plitzko B, 2018, BIO-PROTOCOL, V8, P0, DOI 10.21769/BioProtoc.2850
   Preble JM, 2014, JOVE-J VIS EXP, V0, P0, DOI DOI 10.3791/51682
   Seyfried TN, 2020, ISCIENCE, V23, P0, DOI 10.1016/j.isci.2020.101761
   Shin JS, 2023, J PATHOL TRANSL MED, V57, P305, DOI 10.4132/jptm.2023.10.09
   Siegel MP, 2012, MECH AGEING DEV, V133, P620, DOI 10.1016/j.mad.2012.08.002
   Stehling O, 2013, CSH PERSPECT BIOL, V5, P0, DOI 10.1101/cshperspect.a011312
   Sun L, 2020, CANCER RES TREAT, V52, P604, DOI 10.4143/crt.2019.444
   Szostaczuk N, 2020, FASEB J, V34, P9003, DOI 10.1096/fj.202000071RR
   Tomas C, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0186802
   Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611
   WARBURG O, 1956, SCIENCE, V124, P269
   Zhao RZ, 2019, INT J MOL MED, V44, P3, DOI 10.3892/ijmm.2019.4188
NR 34
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 2049-3002
J9 CANCER METAB
JI Cancer Metab.
PD AUG 29
PY 2024
VL 12
IS 1
BP 
EP 
DI 10.1186/s40170-024-00353-3
PG 12
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA E4D2H
UT WOS:001302516600001
PM 39210390
DA 2024-11-01
ER

